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Background: Total hip replacements (THRs) and total knee replacements (TKRs) are common elective
procedures. In the REsearch STudies into the ORthopaedic Experience (RESTORE) programme, we explored
the care and experiences of patients with osteoarthritis after being listed for THR and TKR up to the time
when an optimal outcome should be expected.
Objective: To undertake a programme of research studies to work towards improving patient outcomes
after THR and TKR.
Methods: We used methodologies appropriate to research questions: systematic reviews, qualitative
studies, randomised controlled trials (RCTs), feasibility studies, cohort studies and a survey. Research was
supported by patient and public involvement.
Results: Systematic review of longitudinal studies showed that moderate to severe long-term pain affects
about 7–23% of patients after THR and 10–34% after TKR. In our cohort study, 10% of patients with hip
replacement and 30% with knee replacement showed no clinically or statistically significant functional
improvement. In our review of pain assessment few research studies used measures to capture the
incidence, character and impact of long-term pain. Qualitative studies highlighted the importance of
support by health and social professionals for patients at different stages of the joint replacement
pathway. Our review of longitudinal studies suggested that patients with poorer psychological health,
physical function or pain before surgery had poorer long-term outcomes and may benefit from pre-surgical
interventions. However, uptake of a pre-operative pain management intervention was low. Although
evidence relating to patient outcomes was limited, comorbidities are common and may lead to an
increased risk of adverse events, suggesting the possible value of optimising pre-operative management.
The evidence base on clinical effectiveness of pre-surgical interventions, occupational therapy and
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v
physiotherapy-based rehabilitation relied on small RCTs but suggested short-term benefit. Our feasibility
studies showed that definitive trials of occupational therapy before surgery and post-discharge
group-based physiotherapy exercise are feasible and acceptable to patients. Randomised trial results
and systematic review suggest that patients with THR should receive local anaesthetic infiltration for the
management of long-term pain, but in patients receiving TKR it may not provide additional benefit to
femoral nerve block. From a NHS and Personal Social Services perspective, local anaesthetic infiltration was
a cost-effective treatment in primary THR. In qualitative interviews, patients and health-care professionals
recognised the importance of participating in the RCTs. To support future interventions and their
evaluation, we conducted a study comparing outcome measures and analysed the RCTs as cohort studies.
Analyses highlighted the importance of different methods in treating and assessing hip and knee
osteoarthritis. There was an inverse association between radiographic severity of osteoarthritis and
pain and function in patients waiting for TKR but no association in THR. Different pain characteristics
predicted long-term pain in THR and TKR. Outcomes after joint replacement should be assessed with a
patient-reported outcome and a functional test.
Conclusions: The RESTORE programme provides important information to guide the development of
interventions to improve long-term outcomes for patients with osteoarthritis receiving THR and TKR. Issues
relating to their evaluation and the assessment of patient outcomes are highlighted. Potential interventions
at key times in the patient pathway were identified and deserve further study, ultimately in the context of
a complex intervention.
Study registration: Current Controlled Trials ISRCTN52305381.
Funding: This project was funded by the NIHR Programme Grants for Applied Research programme and
will be published in full in Programme Grants for Applied Research; Vol. 4, No. 12. See the NIHR Journals
Library website for further project information.
ABSTRACT
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Plain English summary
Many people with pain and disability caused by osteoarthritis receive hip or knee replacement.In around 10% of patients with hip replacement and 20% with knee replacement, pain and
disability persist.
In the REsearch STudies into the ORthopaedic Experience (RESTORE) programme, we applied appropriate
research methods including literature reviews, interviews with patients and health-care professionals,
studies observing patient recovery over time, and randomised trials to assess new methods. Research
studies were developed in collaboration with patient representatives.
Patients with worse psychological health, disability or pain before surgery are more likely to have a poor
long-term recovery. Patients describe the importance of support by health and social professionals
throughout the joint replacement pathway and may benefit from education, pain management,
counselling, exercise and management of health conditions before surgery.
Previous small randomised trials suggested that patients might have short-term benefit from exercise or
education before surgery, and supply of aids and home modifications and physiotherapy after surgery.
We conducted studies that demonstrated the feasibility of trials evaluating the provision of aids and home
modifications before surgery and group-based exercise after surgery.
In a literature review and randomised trial we assessed whether or not local anaesthetic injections during
surgery improve recovery. In patients with hip replacement, long-term pain was reduced and the treatment
was cost-effective. In patients receiving knee replacement, we could not confirm a reduction in pain,
probably because patients receive extensive pain control during surgery.
In conclusion, the RESTORE programme has provided important information to guide the development
of methods to improve long-term recovery after hip and knee replacement.
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Scientific summary
Background
Total hip replacement (THR) and total knee replacement (TKR) are common elective procedures with over
150,000 performed annually in the NHS. For many patients with advanced osteoarthritis, THR and TKR are
effective in treating pain and restoring physical function. However, some patients report little functional
benefit and long-term pain.
Objectives
Recognising the presence of long-term pain and disability in some patients after joint replacement,
the REsearch STudies into the ORthopaedic Experience (RESTORE) programme explored the care and
experiences of patients at key times in the pathway from being listed for THR and TKR to the time after
surgery when an optimal outcome should be expected. RESTORE consisted of a series of interrelated work
packages with systematic reviews, qualitative studies, randomised controlled trials (RCTs), cohort studies
and economic evaluations.
Specific objectives were to:
1. Synthesise research in THR and TKR on long-term pain prevalence and assessment methods, and review
the impact of comorbidities and pre-surgical factors on long-term patient outcomes.
2. Characterise the patient pathway through THR and TKR and study the experience of trial involvement
for health-care professionals and patients.
3. Compare outcome measures over time in patients with hip or knee replacement and assess how well
they measure impairment, activity limitation and participation.
4. Evaluate in a RCT the clinical effectiveness and cost-effectiveness of perioperative local anaesthetic
infiltration on long-term pain after THR and TKR.
5. Assess relationships between radiographic measures of osteoarthritis severity and patient-reported pain
and function. Explore associations between pre-operative patient factors and patient outcomes after
THR and TKR.
6. Review the effectiveness of pre-surgical education and exercise.
7. Assess feasibility and acceptability of pain self-management for patients undergoing THR.
8. Review existing evidence on effectiveness of occupational therapy and evaluate the feasibility and
acceptability of pre-surgical provision in patients waiting for THR.
9. Update previous reviews of physiotherapy exercise, assess current provision and explore the feasibility of
group-based physiotherapy with individualised exercises for patients with TKR.
Methods
To ensure patient and public involvement throughout the programme, work packages were discussed and
developed in collaboration with patient representatives and a patient forum.
We appraised existing research using systematic review methods and meta-analysis in accordance with
appropriate guidelines.
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In a qualitative study, 34 patients receiving THR and TKR were interviewed before surgery, 2–4 weeks and
6 and 12 months after surgery. Interviews elicited patients’ experiences of preparing for, undergoing and
recovering from surgery. Interviews were audio-recorded, transcribed and analysed using a thematic
approach or interpretive phenomenological analysis.
In the Assessing Disability After Partial and Total joint replacement (ADAPT) study, outcome measures
were studied prospectively in 263 patients receiving joint replacement. Participants were assessed prior
to surgery and at 3 and 12 months. Function was assessed using patient-completed questionnaires,
clinician-administered tools and performance tests.
In the Arthroplasty Pain EXperience (APEX) RCTs, 322 patients receiving THR and 316 patients receiving
TKR were randomised to receive 60ml local anaesthetic infiltration (0.25% bupivacaine and 0.3mg
adrenaline) before wound closure or standard anaesthesia. All patients with TKR received a femoral nerve
block (FNB). The primary outcome was the Western Ontario and McMaster Universities Arthritis Index
(WOMAC) pain score at 12 months. The primary health outcome for economic evaluation was the
quality-adjusted life-year measured using the European Quality of Life-5 Dimensions 3-Level version.
The APEX RCTs were also analysed as cohort studies. Radiographic measures of osteoarthritis severity were
correlated with pre-operative WOMAC pain and function. Associations between measures of pain over
time were explored. Quantitative sensory testing was conducted to assess pre-operative widespread pain
sensitisation. Qualitative interviews were conducted with 24 patients and 15 health-care professionals about
involvement in the APEX trials and views about analgesics. Data were analysed using thematic methods.
Using systematic review and meta-analysis, we identified RCTs evaluating the effectiveness of pre-surgical
education and exercise interventions.
To evaluate the feasibility of conducting a definitive RCT of a pain self-management programme for
patients undergoing THR, the Self-managing Pain In aRthritis and ArthropLasty (SPIRAL) study assessed trial
procedures and data collection, randomisation, recruitment and attrition rates.
The Pilot Randomised controlled trial Of Occupational therapy For – Total Hip Replacement (PROOF-THR)
study evaluated the feasibility of pre-surgical occupational therapy in patients waiting for THR. Primary
objectives were to assess patient identification, recruitment and retention, acceptability of allocation, and
acceptability of health resource use and outcome measures.
Physiotherapy services were surveyed at 24 high-volume orthopaedic centres in England and Wales. In the
Activity orientated REhabilitation following kNee Arthroplasty (ARENA) study, the feasibility of a RCT
evaluating a 6-week activity-orientated rehabilitation programme for patients with TKR was assessed.
Information was collected on uptake rates, reasons for non-attendance, patient satisfaction and outcomes,
acceptability of exercises, outcomes measures and collection of costs.
Results
Prevalence of long-term pain
Studies in representative populations including 25,831 patients suggest that about 7–23% of patients
have moderate or severe pain after THR and about 10–34% after TKR.
Outcome measures to assess long-term pain
Systematic review including 1164 research studies in patients with TKR identified extensive variation in pain
outcome measures. Few studies attempted to capture the incidence, character and impact of long-term
pain. A composite clinician assessment with a single question about pain was widely used but there was
an increase in use of patient-reported outcomes over time.
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Pre-surgical prediction
In prospective studies, patients with better pre-operative physical function and lower pain generally
achieved a better recovery after surgery. Patients with poor physical function before surgery may have
greater absolute improvement.
Patients with depression before THR and TKR had poorer long-term pain and functional outcomes.
For patients with anxiety or poor general psychological health, there was evidence for a relationship with
worse pain and functional outcomes in patients receiving TKR but evidence in THR was equivocal.
Patients with a broad range of body mass index benefited from THR and TKR but those with highest levels
may not achieve good levels of function and pain control.
Comorbid conditions
About 64% and 71% of patients receiving THR and TKR, respectively, have comorbidities. In specific
clinical conditions, we found little research on patient-reported outcomes. In studies looking at long-term
patient outcomes according to diabetic status, research was inconclusive. However, studies show that
patients with diabetes, previous heart disease and anaemia are at greater risk of post-surgical
adverse events.
Patient experience
In qualitative interviews, patients noted that delays to NHS orthopaedic surgery are common. For patients
undergoing joint replacement, changes to the date of surgery have implications for well-being and
patients’ experiences of time differ from the linear conceptualisation required to plan NHS services.
Undergoing surgery can increase feelings of vulnerability and alter a patient’s trust in their own body;
the influence of interactions with others on confidence levels and the fears that patients have concerning
the potential of causing harm to their new prosthesis. Our research also highlights strategies that patients
engage in to limit this. Patients rely extensively on, and value, both informal and formal support networks
over the perioperative period and that transformation from a person living with osteoarthritis to a person
recovering from a surgical intervention can lead to alterations in the assistance participants received from
others. However, when patients are not offered the support of health and social professionals over the
perioperative period, for example to aid recovery, negative consequences can ensue including distress and
feelings of abandonment. The qualitative research also highlights the complexity of patient expectations
for joint replacement surgery and how these expectations can be driven by previous personal experience,
knowledge of others’ experiences, and information resources provided by the hospital around the
perioperative period.
Functional outcomes
In the ADAPT study, a clinically significant improvement occurred in about 90% of patients with THR and
70% of those with TKR. Compared with other outcomes, improvement of walking time was rarely large.
Patients with very severe disease at the time of surgery were more likely to have substantial improvements
in pain and functional ability. But the destination differs for the two joint sites; those with hip disease can
have the similar good destination, irrespective of the starting point, whereas those with knee disease
can never ‘catch up’ (i.e. have as good a final outcome or destination) if they start off with very severe
disease at the time of surgery.
As pain and function measures were highly correlated and people with anxiety or depression may assess
themselves as being worse off than objective measures suggest, measures of function may need
adjustment for pain, psychological status, age and perhaps muscle strength to obtain a satisfactory picture
of functional loss. Results suggested that physical function should be measured with a patient-reported
outcome measure and a performance test. Range of motion is commonly assessed in clinical practice but
correlated poorly with other measures of disease severity.
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Perioperative pain management
Systematic review identified 36 RCTs evaluating local anaesthetic infiltration in patients receiving THR and
TKR. Few reported long-term follow-up. Local anaesthetic infiltration was effective in reducing short-term
pain when compared with no infiltration. Effectiveness was enhanced with the addition of post-closure
analgesia. In TKR, there was no evidence of additional benefit if a FNB had already been sited.
In the APEX RCTs, local anaesthetic infiltration was associated with reduced pain 1-year after THR. Findings
in patients receiving TKR provided no strong evidence that local anaesthetic infiltration reduced long-term
pain additional to that provided by FNB. From the perspective of the NHS and Personal Social Services
(PSS), local anaesthetic infiltration is a cost-effective treatment option in primary THR but evidence
supporting its use in TKR was weaker.
Trial participation and views about medication
In qualitative interviews, patients and health-care professionals reported that they had weighed up the
benefit and cost of involvement. They were interested in involvement in APEX RCTs because they
considered the trials important and relevant. Patients expressed their desire to help others by contributing
to the furthering of clinical knowledge. Many patients thought that they might benefit physically and
psychologically from taking part.
The qualitative study also demonstrated the need for trials to ensure minimal burden. Health-care
professionals wanted the trial to have minimal impact on daily clinical practice and patients wanted data
collection and participation to be as easy as possible.
Further analysis of the qualitative data showed that the experience of joint replacement can temporarily
alter patients’ views of the acceptability, necessity and value of pain relief medication. This alteration is
related to views about pain from intervention compared with pain from chronic condition, and is
influenced by interactions with health-care professionals. However, once initial recovery from surgery has
begun, long-standing beliefs about the appropriate use of pain relief medications may take prominence.
Radiographic osteoarthritis severity and pain
In the APEX cohort study, there was no relationship between the degree of radiographic damage and
pain or function in patients waiting for THR. In patients waiting for TKR, those with the least severe
radiographic damage reported more severe pain and poorer function.
Pain as a predictor of long-term pain
Long-term pain after THR was predominantly associated with pain at rest during the pre-operative and
acute postoperative period. In contrast, long-term pain after TKR was predominantly associated with the
severity of pain on movement during the pre-operative period.
Pre-operative widespread pain sensitisation and chronic pain
Pre-operative widespread pain sensitivity was not associated with change in pain severity from
pre-operative to 12 months post operation in patients with THR and TKR.
Exercise and education interventions before surgery
Systematic review identified 36 interventions targeting optimisation of pre-surgical physical function before
THR and TKR. Interventions showed benefit compared with controls for physical function, pain and anxiety.
In 27 studies targeting in-hospital recovery, post-surgical anxiety was lower in intervention patients and
mobilisation was earlier. In 18 studies, interventions targeting long-term outcomes showed no benefit.
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Group-based pain self-management
Of 385 eligible patients with THR, 88 (23%) consented to participate in the SPIRAL study of group-based
pain self-management. Common reasons for non-participation were views about the course and transport
difficulties. Of the 43 patients randomised to the intervention, 28 attended pre-operative sessions and
11 attended postoperative sessions. Participant satisfaction was high and feedback highlighted that
patients enjoyed the group format. Retention of participants in the RCT was acceptable (83%) with high
questionnaire return rates except resource-use diaries.
Occupational therapy
In patients receiving THR, systematic review identified seven RCTs of occupational therapy, mainly
combined with physiotherapy. There was a suggestion of improved function and reduced pain before
surgery but this was not sustained after surgery. In the PROOF-THR study, 44 patients were randomised to
pre-operative occupational therapy or usual care. Good recruitment rates, acceptability of randomisation of
participants, successful intervention delivery, and reasonable attrition rates suggest a definitive trial would
be feasible.
Physiotherapy exercise
Systematic review and meta-analysis identified a few small studies suggesting that physiotherapy exercise
can have short-term benefits for patients with TKR. In the UK, physiotherapy is usually provided for patients
with THR depending on clinical need. After TKR, group exercises focus on knee-specific strengthening,
stretching and functional exercises. In the ARENA study a 6-week group-based activity-orientated
rehabilitation programme for patients with TKR was evaluated. Of 124 eligible patients, 46 were
randomised (37%). The intervention was generally well received and attendance was good (73%).
Conclusions
The RESTORE programme highlights the importance for patients of support by health and social
professionals at different stages of the joint replacement pathway.
Feasibility studies in patients receiving THR and TKR provided information about the acceptability of
interventions that might help patients achieve better long-term outcomes. Although participation in
pre-operative pain management was low, those who attended provided positive feedback. Research into
occupational therapy provision before surgery is feasible, and group-based post-surgical physiotherapy with
individualised exercise was well received.
Perioperative care should include appropriate multimodal anaesthesia supported by evidence from
adequately powered RCTs. For patients receiving THR, this should include local anaesthetic infiltration but
this may not provide additional benefit to FNB in patients receiving TKR. Local anaesthetic infiltration is a
cost-effective treatment in primary THR from a NHS and PSS perspective.
While specific intervention components should be evaluated in appropriately powered clinical trials, the
best and most acceptable strategies may be complex interventions tailored to THR or TKR. These would
include pre-operative assessment to guide treatment of comorbid conditions, psychological problems and
pain, with support for exercises to prevent functional deterioration and education to prepare patients for
surgery and recovery. Occupational therapy might be provided before hospital admission. Perioperatively,
patients would receive multimodal pain management with evidence-based treatments. After hospital
discharge, group-based and individualised physiotherapy exercise might be provided.
In conclusion, the RESTORE programme has provided important information to guide the development of
new methods to improve long-term recovery after THR and TKR.
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Study registration
This trial is registered as ISRCTN52305381.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Background to the RESTORE
programme
Osteoarthritis of the hip and knee joints
Osteoarthritis is the most common form of joint disease and causes significant pain and disability in about
10% of people aged > 55 years in the UK.1 The joints most frequently affected include joints in the hands,
feet and spine, but osteoarthritis of the hips and knees is particularly likely to cause chronic pain and severe
physical disability. These two conditions result in a huge health burden worldwide,2 particularly among older
people, and are the main reason for the increasing utilisation of hip and knee joint replacements.3
The severity of osteoarthritis of the hips or knees varies considerably. It is often relatively mild, only causing
modest, variable discomfort and some restriction of activities without disrupting the person’s life in a major
way. However, a significant minority of those who have these conditions develop more severe, progressive
symptoms, which may result in their seeking professional help. Only about 50% of those with severe
symptomatic lower limb osteoarthritis seek conventional medical help,4 some prefer to rely on help from
everyday folk remedies, complementary or alternative medicine interventions, and many seek no help at
all, considering their aches and pains and disability as an inevitable part of the ageing process and
something that are not treatable medical problems.5,6 However, the prevalence of these diseases is so high,
that while many do not seek professional help, there are enough that do to result in a huge workload for
general practitioners (GPs), rheumatologists and physical therapists.7 In addition, osteoarthritis is increasing
in prevalence as our population gets older and the number of people with a high body mass index (BMI)
increases,8 and it is the major reason for lower limb joint replacement; thus, is a massive issue for
orthopaedic service provision.
Who gets osteoarthritis of the hip and knee?
Osteoarthritis of the hip and knee are strongly age-related diseases. It is unusual for people to suffer from
these before the age of 45 years and the prevalence then increases sharply with increasing age.8 The three
other main risk factors for osteoarthritis of the hip and knee are family history/genetic predisposition,
previous injury to the joint and high BMI.
Given that age and high BMI are major risk factors for lower limb osteoarthritis, comorbidities related to age
and obesity are very common in people receiving joint replacement for osteoarthritis.9 Cardiovascular
problems, sensory deficits (such as reduced sight or hearing) and diabetes are particularly common problems.10
Treatment options for osteoarthritis of the hip and knee
In the UK, those seeking help for lower limb osteoarthritis generally start with their GP and most of the
management of hip and knee disease occurs in primary care. There is no known treatment able to alter
the progression of osteoarthritis, or anything that can cause an improvement in joint structure – there is no
‘cure’ available. However, there is a wide range of both non-surgical and surgical interventions that can
reduce pain and improve function. Conservative options available through primary care include education
and access to self-help packages, including behavioural change; local or systemic drug therapies; physical
therapies; and orthotics. National Institute for Health and Care Excellence (NICE) and international
guidelines recommend that everyone should be offered simple options to begin with, while recognising
that this will be insufficient to manage the pain and disability in some.11–14
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If pharmacological and conservative treatments provide inadequate relief of symptoms, then total joint
replacement is commonly recommended. The clinical effectiveness and cost-effectiveness of total joint
replacement surgery as a treatment option for patients with advanced osteoarthritis is well established.15,16
One of the challenges for patients and GPs dealing with osteoarthritis is who to refer to the surgeon and
when surgical intervention is appropriate. There are no clear guidelines as to the severity of pain or
disability that warrants moving from conservative management to surgery.17 This difficulty is compounded
by the knowledge that surgery is a dangerous, irreversible step that does not result in adequate relief of
symptoms and restoration of function in everyone who undergoes it.18
Total hip and knee replacement
Total hip and knee replacements are undertaken to relieve pain and improve function in people with
advanced osteoarthritis of the hip or knee joint, whose symptoms are not controlled by conservative
treatment. They are two of the most common elective NHS procedures with 75,366 primary total hip
replacements (THRs) and 76,497 primary total knee replacements (TKRs) performed in England and Wales
between April 2012 and March 2013.3 The main disease resulting in this need for joint replacement is
osteoarthritis, with about 91% of total hip joint replacements and 98% of total knee joint replacements
being carried out for this indication. In England, the number of THRs conducted annually increased by
54% between 2001 and 2011 and the number of TKRs by 108% over the same period.19,20 Projections for
total hip and knee replacement provision for the UK and the USA have largely underestimated current
need.21,22 This continued increase in provision adds to the burden of health-care budgets to cope with
financial pressures while keeping waiting lists to a minimum.23 Therefore, it is important to ensure that any
technological innovations in the management of total joint replacement in relation to decreasing pain and
increasing function are a good use of medical and societal resources.
Patients’ experiences of hip and knee osteoarthritis, and of
joint replacement
Qualitative studies have explored patients’ experiences of living with and managing osteoarthritis,5,24–27
decision-making about joint replacement,28 patient pathways to surgery4,29 and patient satisfaction with
outcomes of joint replacement.28,30 This body of research has highlighted the impact of lower limb
osteoarthritis on individuals and the possibility that patients’ priorities are not always uppermost in current
planning and delivery of treatments, including joint replacement. Research has also highlighted the
importance of patient expectations in relation to the outcomes after joint replacement,31,32 the importance
of what is said to patients about their treatment options5 and the fact that patients may not be satisfied
with the outcome of their joint replacements, even if they tell the surgeon that they are doing well.30 It is
clear that we need to understand much more about what patients think about joint replacement and its
outcomes, and improve the evidence base in this area. We also need to know the patient experience of
joint replacement from pre-operative care to postoperative recovery.
The outcomes of hip and knee joint replacement
Traditionally, the success of a total hip or knee replacement was judged predominantly by the length of time the
implant remained in situ.33 The key issues for surgeons and prosthesis-producing companies were seen to be
the design and fixation of a prosthesis that would last for ≥ 10 years, precluding the need for complex revision
surgery.34 However, owing to advances in surgical technique and prosthetics design, joint replacement now has
good survivorship and post-surgical complication rates are low.35,36 Over 95% of hip and knee replacements
remain unrevised at 9 years after surgery.3 Severe adverse events are uncommon, but complications such as
dislocation,37 infection,38,39 fracture,40 thromboembolism41 and neurovascular damage42 may occur and can
significantly impact on pain, function and quality of life (QoL). There is also a small mortality risk.43,44
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Attention has turned in recent years towards patient-reported outcomes in addition to technical outcomes.45
Studies using patient-reported outcome measures (PROMs) suggest that mean pain and function scores
after initial recovery from surgery are generally good.46–48 However a significant minority of patients have
persistent moderate or severe long-term pain and functional difficulties after joint replacement despite what
appears to be otherwise successful surgery.49–53 This fact has been obscured by the reporting of mean
changes and averages for groups, ignoring the fact that although most people improve after hip or knee
joint replacement, some improve more than others and some get little or no improvement or are worse after
surgery than they were before it.54 Pain and functional problems can impact on a patient’s usual activities
and those suffering from chronic long-term pain may be unable to return to work or leisure activities, and
require a higher level of care from relatives and friends. Long-term pain after joint replacement imposes a
burden on service use and costs to the NHS for those seeking relief, and to patients, carers and society as a
whole. It is a problem that has received little research or service attention in the past.55,56
Patients living with osteoarthritis see function as key to their experience of illness.24,57 Restoring function,
alongside alleviation of pain, is a main aim of joint replacement. As noted, application of instruments such
as the Western Ontario and McMaster Universities Arthritis Index (WOMAC) has suggested that there is an
improvement in function in most (but not all) cases.46,58,59 But the WOMAC, a self-report measure, like
most other self-report measures of function, has no sound theoretical basis.60 There are many alternatives,
including observed measures of function, and more objective techniques such as pedometry or
accelerometry,61 but very few data are available on what the most appropriate means of assessing function
in the context of joint replacement might be.
Management of acute and chronic pain after joint replacement
Acute perioperative pain
The management of acute postoperative pain poses a significant challenge in all surgical specialties.
It has been estimated that approximately 40% of surgical patients experience moderate or severe acute
postoperative pain.62 Poor management of pain can be distressing for patients and can significantly delay
ambulation, lengthen hospital stay, increase the number of unanticipated hospital admissions and
contribute to poor mental health.63–65 Furthermore, severe acute postoperative pain is a risk factor for the
development of chronic post-surgical pain.66
Good perioperative pain management after joint replacement surgery allows early mobilisation and
rehabilitation,67 which minimises risks of complications such as deep-vein thrombosis, pulmonary embolus,
muscle and joint contractures, physical deconditioning, and chest infection.68 Early mobilisation also
facilitates early discharge with associated cost savings.69 However, acute postoperative pain after joint
replacement is often poorly managed70 and many methods of achieving perioperative pain relief, such as
spinal or epidural anaesthetics and the use of opioids, can preclude early mobilisation.71,72 Although there
has been much interest in the management of perioperative pain, research has largely looked at the first
24–48 hours after surgery alone and the likely longer-term effects of good perioperative pain control have
not been explored.
Chronic post-surgical pain
Chronic post-surgical pain is a significant problem after different types of surgery. It has been defined by
the International Association for the Study of Pain (IASP) as ‘pain that has developed after surgery, and
been present for at least three months, which is beyond the time for normal healing’.73 Pain can be
defined as chronic post-surgical pain if four criteria are fulfilled:74
1. pain developing after a surgical procedure
2. pain present for at least 2 months
3. other causes of pain have been excluded
4. the pain is not a continuation of a pre-existing condition.
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However, application of such criteria is difficult for procedures such as joint replacement, for which the
primary aim is relief of pre-existing pain and it can be very difficult to be sure whether or not the chronic
problem is a continuation of a pre-existing one (e.g. through pain sensitisation).75
There is considerable variation in the reported prevalence of chronic post-surgical pain, but it is clear that
somewhere between 10% and 50% of patients experience the problem after different forms of surgery,
including breast surgery, vasectomy, hernia repair and cardiac surgery.76
Perioperative medical care and rehabilitation
In the UK, if a patient is considered for joint replacement for their osteoarthritis and they agree to the
procedure being carried out, they will generally be asked to attend a pre-operative clinic for assessment of
their general medical status and to make sure that the surgical team is clear on what operation will be
performed. The medical screening at this clinic usually involves looking for major health problems that
might preclude anaesthesia or surgery. The patient is also likely to be given some information about joint
replacement, but this does not usually indicate what they should expect, in terms of pain and disability,
after the immediate postoperative period. It is unusual for any action to be taken as a result of this
screening, other than delaying the surgery if a major problem is uncovered.
Postoperatively, attention is paid to the wound, pain control and general health, and patients are usually
encouraged to become active as soon as possible after the operation, with the help of a physiotherapist.
In the UK, it is usual for patients to be discharged from hospital after about 3–5 days. Physiotherapists are
almost always involved in postoperative mobilisation and provide general advice on what patients should
do when they get home. The ability to climb a step or stair is often used as a criterion of a patient having
reached a satisfactory functional status for hospital discharge. In contrast with some other countries, such
as Germany, further rehabilitation is not generally available to UK NHS patients after their hip of knee joint
replacement. Furthermore, there are no agreed standards or guidelines as to what should or should not be
done perioperatively to optimise outcomes (relief of pain and improvement of function), partly because of
the deficiencies in the evidence base. Therefore, it is not surprising that in the UK service provision before
and after joint replacement is perceived to vary in level of provision and content.77,78 Supply of aids and
appliances as well as other occupational therapies are widely offered during the hospital stay.79
The provision of adequate information and formal rehabilitation are potentially important adjuncts to joint
replacement surgery that might both reduce the length of stay in hospitals and improve patient outcomes.
The rehabilitation process aims to support the patient in regaining pre-impairment levels of function and
QoL, and reintegration into their social and personal environment. Ideally, for patients receiving joint
replacement, rehabilitation should commence before surgery and be provided as appropriate throughout
the different stages of recovery.
l Pre-surgical interventions target optimisation of physical health and preparation for hospitalisation
and recovery.
l Occupational therapy and home modifications, provided pre- or postoperatively, help people perform
activities of daily living (ADL) safely at home or at work.
l Postoperative rehabilitation during the hospital stay focuses on regaining range of motion (ROM),
functional independence in ADL and improving mobility.
l Subsequent rehabilitation targets maintenance or improvements in muscle strength, joint range of
movement, balance and co-ordination, mobility, and extended ADL.
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According to the World Health Organization (WHO) International Classification of Functioning, Disability
and Health (ICF) model, rehabilitation should be patient-centred and aim to maximise functional ability,
facilitate activities and increase social participation.80
Evidence on the effectiveness of different aspects of rehabilitation is limited.81 Early systematic reviews
considered interventions relating to pre-operative exercise,82 education83 and physiotherapy exercise.84,85
Recommendations were limited by issues of study size and quality and, since the publication of these trials,
more trials have been reported. There is no published systematic review of occupational therapy
interventions in joint replacement.
The economic implications
In the context of scarce NHS resources, the evaluation of the cost-effectiveness of interventions to improve
the outcomes of patients with osteoarthritis are increasingly pertinent.86 Despite the well-established
cost-effectiveness of providing total joint replacement surgery for advanced osteoarthritis, little is known
about the long-term cost-effectiveness of interventions to improve outcomes after total joint replacement
surgery. Economic evaluations of interventions targeting acute postoperative pain are generally truncated
at point of hospital discharge or a few weeks after surgery. Evaluations in such studies are restricted to
differences in costs of anaesthesia provided.87–91 Other interventions focus on postoperative rehabilitation
programmes but, generally, only the differences in costs in delivering treatment between arms is evaluated
for the duration of the intervention. Longer-term studies to improve outcomes after surgery with a health
economic evaluation have typically focused on delivery of physiotherapy treatments.92,93 However, these
have not included informal care costs and productivity losses which are needed to examine the broader
impact on society. Only the latter, by including patient expenses, estimated costs beyond the health-care
provider perspective. None have included informal care costs and productivity losses which would be
needed to examine the broader impact on society.
Complex package of care
Ultimately, interventions within the joint replacement pathway should combine within a complex package
of care with interaction between components.94 Key areas in the development of a complex intervention
relate to:
l development
¢ identifying the evidence base
¢ identifying and developing theory
¢ modelling process and outcomes
l feasibility/piloting
¢ testing procedures
¢ estimating recruitment/retention
¢ determining sample size
l evaluation
¢ assessing effectiveness
¢ understanding change process
¢ assessing cost-effectiveness
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l implementation
¢ dissemination
¢ surveillance and monitoring
¢ long-term follow-up.
Development of a complex package of care requires input from diverse specialities and research
methodologies. The authors of the Medical Research Council (MRC) guidelines recognise the importance
of developmental studies before large-scale evaluations.94
Overview of the ‘RESTORE’ programme
Recognising the presence of long-term pain and disability in many patients after total hip and knee
replacement, we developed the REsearch STudies into the ORthopaedic Experience (RESTORE) programme
of research. The aim of the RESTORE programme was to conduct research on methods to improve the
experience and outcomes of people undergoing hip or knee replacement for osteoarthritis. As shown in
Figure 1, the programme consisted of a series of interrelated work packages, all supported by appropriate
patient and public involvement (PPI). Here we briefly overview the individual work packages.
FIGURE 1 The RESTORE programme.
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Patient and public involvement
Patient and public involvement has been a major feature of RESTORE. Meaningful patient involvement has
supported all aspects of the programme. This comprised collaboration with Arthritis Care, patient
representation on the RESTORE management group throughout its duration, establishment of a patient
forum, employment of a PPI co-ordinator and having patient partners on each project steering group.
Since 2010, the patient forum, Patient Experience Partnership in Research (PEP-R), has supported RESTORE.
Through facilitated group sessions, the patient forum provided input into refinement of patient recruitment
materials, intervention development, readability of outcome assessment tools and dissemination of
findings. Individual projects also had their own oversight groups, each of which included patients with an
interest in joint replacement surgery to monitor the progress of the project. Patient involvement was
carried out in line with INVOLVE’s guidance. We believe that this work might act as a good example of
how to involve patients meaningfully and effectively in research studies in musculoskeletal disease.
Systematic literature reviews
Synthesis of evidence from previous research using systematic review methods and meta-analysis to:
l assess the prevalence of long-term pain after total hip or knee replacement
l identify methods used to measure chronic pain after TKR
l identify predictors of long-term patient outcomes after total hip or knee replacement
l evaluate the associations between comorbid conditions and patient outcomes after hip and
knee replacement
l evaluate the effectiveness of pre-surgical education and exercise interventions
l support randomised controlled trials (RCTs) with reviews of perioperative pain management,
occupational therapy and physiotherapy exercise.
Understanding the patient experience
To characterise and explore the patient pathway through total hip or knee replacement surgery in current
routine NHS care.
Measuring functional outcomes in a cohort study of patients
having joint replacement: the ADAPT study
In the Assessing Disability After Partial and Total joint replacement (ADAPT) longitudinal cohort study of
patients with primary and revision hip and knee replacement, we compared the properties with
responsiveness of a selection of commonly used outcome tools that assess function, examined how well
they relate to the WHO ICF concepts, and explored the changes in the measures over time.
Randomised controlled trial of perioperative pain control:
the APEX trial with full economic analysis and nested
qualitative research
We examined the clinical effectiveness and cost-effectiveness of multimodal perioperative analgesia in total
hip and knee replacement. The key intervention tested in the Arthroplasty Pain EXperience (APEX) RCT was
an injection of local anaesthetic into the wound during total hip and knee replacement surgery to provide
both short- and long-term pain relief. An economic evaluation was conducted to determine the
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cost-effectiveness of the intervention from a NHS and Personal Social Services (PSS) perspective.
Data were also collected to allow a future economic evaluation from a societal perspective.
The APEX cohort study
Data from the APEX study provided the opportunity to assess the relationships between radiographic
measures of osteoarthritis severity and patient-reported pain and function. We were also able to explore
the associations between pre-operative patient factors and perioperative pain, and long-term patient
outcomes. Pre-operative pressure pain thresholds (PPTs) were measured before surgery and we explored
their value in predicting long-term pain after total hip and TKR.
Pain self-management: the SPIRAL study
In the Self-managing Pain In aRthritis and ArthropLasty (SPIRAL) study we conducted a pilot RCT to assess
the feasibility of delivering a pain self-management course, run by Arthritis Care, to patients
undergoing THR.
Occupational therapy: PROOF-THR
To assess the feasibility of occupational therapy provided before surgery, we conducted the Pilot
Randomised controlled trial Of Occupational therapy For – Total Hip Replacement (PROOF-THR) pilot RCT
in patients undergoing primary THR.
Physiotherapy exercise rehabilitation
We surveyed physiotherapy provision after total hip and knee replacement in large orthopaedic centres in
England and Wales. We also conducted the Activity orientated REhabilitation following kNee Arthroplasty
(ARENA) pilot RCT of an activity-orientated rehabilitation programme for patients undergoing primary TKR.
Economic analyses
We conducted a full economic analysis of the APEX RCT. In addition, for each of the pilot studies within
the complex package of care development work stream, methods to collect resource-use data from a
societal perspective were developed and assessed. These will facilitate full economic analyses in future
definitive studies.
Complex package of care
Based on literature reviews, cohort and qualitative studies and RCTs we aim to provide recommendations
to support the development of a complex package of care for patients receiving total hip and
knee replacement.
BACKGROUND TO THE RESTORE PROGRAMME
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Chapter 2 General systematic review methods:
systematic reviews of long-term pain after hip and
knee replacement, methods used to assess chronic
pain and pre-operative predictors of long-term
patient outcomes
Parts of this chapter have been reproduced from Beswick and colleagues.18 This is an open-access articledistributed under the terms of the Creative Commons Attribution Non-commercial License, which
permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the
use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/
licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. Parts of this chapter have
also been reproduced from Wylde and colleagues95 © 2013 The Authors. Arthritis Care & Research is
published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open
access article under the terms of the Creative Commons Attribution NonCommercial License, which
permits use, distribution, and reproduction in any medium, provided the original work is properly cited and
is not used for commercial purposes.
Abstract
Background
We conducted systematic literature reviews on chronic pain after joint replacement, pre-operative
predictors of patient outcomes and the impact of comorbidities.
Methods
Systematic reviews conducted in accordance with appropriate guidelines.
Results
About 7–23% of patients have moderate or severe pain after THR and about 10–34% after TKR.
There was extensive variation in pain outcome measures used in TKR research. Although there was an
increase in use of patient-reported outcomes over time, few studies attempted to capture the incidence,
character and impact of long-term pain.
Better pre-operative physical function and lower pain was associated with a better recovery in terms of
joint specific pain and function. However, patients with poor physical function before surgery may
have greater absolute improvement. Patients with depression before joint replacement had poorer
long-term pain and functional outcomes. In patients receiving TKR, anxiety and poor general psychological
health were associated with worse pain and functional outcomes. Across a broad range of BMI, patients
benefited from joint replacement but those with highest levels may not achieve good functional and
pain outcomes.
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Although approximately 64% and 71% of patients receiving joint replacement have comorbidities,
research on their relationship with long-term patient outcomes was limited. The impact of diabetes,
previous heart disease and anaemia on the risk of post-surgical adverse events is recognised.
Conclusions
Systematic reviews identified the potential value of intervention before joint replacement and highlight the
importance of appropriate assessment of long-term pain.
Systematic review methods
Comprehensive, systematic literature reviews are an essential prelude to developing interventions and
trials. Systematic reviews aim to appraise evidence from published studies and have two broad objectives:
l a synthesis of knowledge to guide decision-making
l identification of deficits in the evidence base that merit further research.
A literature review can be considered systematic if the methods are sufficiently transparent and unbiased
that it can be reproduced on the basis of:
l sources of literature
l how it was searched
l why a study was included or excluded
l which data were analysed and how
l how study quality was assessed.
Numerous reviews of varying quality have been published on the care of patients receiving total hip or
knee replacement. The first step in our systematic review was to identify previous systematic reviews.
Reviews were updated or started anew depending on our assessment of the systematic nature of the
methods used.
In the context of the RESTORE programme, we conducted systematic literature reviews of both cohort
studies and evaluations of interventions in RCTs.
Reviews of cohort studies relate to assessment of chronic pain after hip or knee replacement, pre-operative
determinants of patient centred outcomes, and comorbid conditions and patient outcomes after hip and
knee replacement.
Reviews of interventions relate to pre-surgical exercise and education interventions, perioperative local
anaesthetic infiltration, physiotherapy exercise after TKR, and occupational therapy in THR.
Methods and guidelines
Systematic reviews were conducted using methods based on those described in the Cochrane handbook
of systematic reviews.96 Guidelines appropriate to the study designs being reviewed were adhered to. In
reviews of RCTs we referred to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines97 and in review of observational studies to Meta-analysis of Observational Studies in
Epidemiology (MOOSE) guidelines.98 Composite PRISMA and MOOSE checklists for the eight systematic
reviews conducted in the RESTORE programme are included in Appendices 1 and 2, respectively.
LONG-TERM PAIN AFTER THR AND TKR
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Each review was conducted following general structured methods as outlined here. Specific methods for
each review are detailed in a separate table following the participants, interventions, comparisons,
outcomes, and study design (PICOS) construct.99
Identification of studies
Studies were identified by searching appropriate online databases with tailored search strategies. MEDLINE
and EMBASE electronic databases were searched via the Ovid SP platform. Additionally, PsycINFO was
searched via Ovid SP, Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCOhost
and The Cochrane Library databases were searched if considered relevant to the topic. For the review of
occupational therapy, Allied and Complementary Medicine Database (AMED) was searched via Ovid SP,
Physiotherapy Evidence Database (PEDro), Education Resources Information Center (ERIC) via ProQuest,
Center for International Rehabilitation Research Information and Exchange (CIRRIE) and OTDbase were
also searched.
Search strategies as applied in MEDLINE and used in appropriate combinations are shown in Appendix 3.
Searches were supplemented with hand-searching of reference lists from trials and review articles.
Key articles were tracked in ISI Web of Science.
Criteria for including studies
Studies were included according to specific criteria described for each review. These covered patient
inclusion, interventions, outcome measures and study type.
In evaluating the clinical effectiveness of interventions, we included studies that were RCTs with
randomisation either at individual or cluster level. Because many relevant studies are not recent and
conducted in diverse health-care settings, we also included studies with a quasi-randomised design (e.g.
alternate allocation) but with no specific evidence of bias owing to allocation method. There were no
language restrictions with the exception for our reviews of cohort studies looking at pre-surgical predictors
and comorbidities.
Study selection
Bibliographic details of the articles identified were exported and managed in EndNote (Thomson Reuters,
CA, USA) databases, where duplicates were removed. Titles and abstracts of articles were screened by one
or two reviewers to exclude studies that were clearly not relevant. As recommended in the Cochrane
handbook, studies were classified as potentially relevant if a reviewer had any doubts about relevance on
the basis of title and abstract.
A final reading of potentially relevant articles and study selection based on defined eligibility criteria were
carried out by two reviewers with further input of a relevant health-care professional, if required. Full
papers for all potentially relevant studies were obtained electronically, from local libraries or through
interlibrary loans. The progress of each review was recorded as a flow diagram.
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Studies reported only as abstracts or for which we were unable to acquire full-text copies using interlibrary
loans or e-mail contact with authors were excluded from the analyses. Reasons for exclusion at this stage
were summarised in individual systematic review flow diagrams (see Figures 2, 4, 7, 8, 21, 37, 42 and 48).
Data extraction
Data were extracted from each paper by two reviewers or by one reviewer with data checked against
source material by a second. For reviews of predictors and comorbidities, about 25% of articles were
checked against source material by a second reviewer. Authors, colleagues and family helped to translate
and interpret studies not published in English.
In reviews of observational cohort studies with no intervention reported, we extracted data relating to how
representative the cohort is of the general population; variables and outcomes collected; methods of
statistical analyses; as well as country, dates of data collection, and summaries of patient characteristics.
Data extracted from intervention studies included when and where the study was conducted; patient
characteristics (mean age, percentage male/female, indication); inclusion criteria; description of
interventions; timing, duration; health-care professionals providing care; and losses to follow-up
and reasons. Results were recorded on piloted data extraction forms and Microsoft Excel® 2007
(Microsoft Corporation, Redmond, WA, USA) spreadsheets. If published reports did not contain the
required data, authors were contacted. We also asked if any outcomes not reported in publications
had been collected. If authors had provided information to other reviewers, then these data were
included in our analyses and acknowledged appropriately. For continuous variables, means and
standard deviations (SDs) were extracted. If outcomes were reported as means and confidence
intervals (CIs), or medians and interquartile ranges (IQRs), appropriate conversions and estimations
were used.96
Data analysis
Outcome data were extracted to Microsoft Excel spreadsheets and analysed in Stata 12 (StataCorp LP,
College Station, TX, USA) or RevMan 5 (The Cochrane Collaboration, The Nordic Cochrane Centre,
Copenhagen, Denmark).
Studies were categorised according to our pre-specified criteria. If a sufficient number of intervention
studies reported common outcomes, data were combined in meta-analyses. Combined outcomes were
summarised as average mean difference (MD) if the outcome used a common measurement scale (e.g.
length of hospital stay) or as average standardised mean difference (SMD) if different methods were used
to assess a particular outcome. Generally we combined outcomes using random-effects meta-analysis96,100
and reported 95% CIs, p-values for the magnitude of effect and tests of heterogeneity. When possible,
results are shown as forest plots.
When two interventions were reported with a shared control group, in meta-analysis the number for
controls was halved.
LONG-TERM PAIN AFTER THR AND TKR
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Quality assessment
For observational cohort studies our quality assessment was based on the diversity of centres (registry,
multiple centres, single centre or surgeon), and losses to follow-up.
For RCTs, the Cochrane risk-of-bias table was used to assess study quality. Bias was assessed
independently by two reviewers or assessed by one and checked by a second, with disagreements resolved
by discussion. Risk of bias was based on random sequence generation, allocation concealment, blinding of
outcome assessment, completeness of outcome data, selective reporting and other potential sources. In
the context of the studies we reviewed, completeness of outcome data collection and blinding of outcome
assessment were considered the key issues relating to risk of bias.
Systematic review of the severity of long-term pain after total
hip or knee replacement
Background
We aimed to identify studies reporting the proportion of people with significant long-term pain after total
hip or knee replacement. Eligible studies reported prospective follow-up of consecutive, unselected
patients who were representative of the primary total hip or knee replacement population. We limited
follow-up to 3 months to 5 years as this reflects the time when pain48 and prosthesis-related outcomes101
can be considered optimal.
Methods
General methods As described in Systematic review methods
Databases and dates MEDLINE and EMBASE from inception to 31 January 2011. Citations of key articles in ISI Web of
Science and reference lists
Search strategy Total hip or knee replacement/osteoarthritis/epidemiological study design/PROM. MEDLINE search
strategy based on terms in Appendix 3
Study design Prospective follow-up of consecutive, unselected patients
Patients Patients with primary total hip or knee replacement
Follow-up 3 months to 5 years
Data extraction Indication, pain outcome, baseline dates, country, study design, follow-up, how group selected,
age, number of patients recruited, number who died and the number lost to follow-up
Outcomes Patient-reported pain in the operated knee. Proportions of people with different severities of pain
at follow-up were summarised as:
l ‘favourable’: no pain or mild pain at follow-up
l ‘unfavourable’: moderate to severe pain or for whom surgery had not relieved pain
l ‘uncertain’: patients who had died, had revision surgery, contralateral surgery or dislocation
and were not followed up with questionnaires, and those lost to follow-up
Quality assessment Representativeness of study population. Losses to follow-up
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Results
Review progress is summarised in Figure 2. Searches identified 1308 studies reporting patient-centred
outcomes in patients with osteoarthritis. Of these, 115 studies were potentially eligible. After detailed
evaluation, 14 articles describing 17 cohorts presented results classifiable as proportions of people with
different extents of pain at follow-up. Six cohorts reported outcomes in hip replacement,49,51,58,102–104 and
11 in knee replacement patients.47,49,50,58,102,105–110 The main reasons for exclusion at this stage were lack of
a pain outcome separate from an overall outcome score or the presentation of results as means only.
Patient and study characteristics are summarised briefly in Table 1 and in more detail with outcome data in
Appendix 4.
Studies ordered within hip and knee replacement groups by decreasing representativeness (multiple
compared with single centre); and by increasing losses to follow-up.
Records identified through
database search to January 2011
and reference lists/citations
hip or knee joint replacement/
osteorthritis/patient-centered outcome
(n = 1308)
Studies included in quantitative synthesis 
(n = 14 studies with 17 cohorts) 
% with pain at follow-up
• Hip, n = 6 cohorts
• Knee, n = 11 cohorts
• Additional publications of
   included studies, n = 7
Studies with patient reported
pain outcome
(n = 115 studies)
Records excluded on basis of title
 and abstract
(n = 734)
Full-text articles excluded 
(n = 459)
• Selected group, n = 54
• Unsuitable study design, n = 158
• > 5-year follow-up, n = 129
• < 3-month follow-up, n = 26
• < 50% OA patients, n = 26
• Hip/knee data combined, n = 3
• No patient pain outcome, n = 53
• Narrative, n = 7
• Abstract only, n = 3
Articles with inadequate data
for quantitative synthesis 
(n = 94)
• Floor/ceiling data only, n = 2
• Pain component not reported
   separately, n = 9
• No proportions with pain 
   reported, n = 83
Records screened
(n = 574)
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FIGURE 2 Systematic review of long-term pain after hip or knee replacement: flow diagram. OA, osteoarthritis.
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TABLE 1 Systematic review of long-term pain after hip or knee replacement: included studies
Author Population
Pain outcome measure; follow-up
time
THR
Nikolajson and colleagues
200651
1231 consecutive patients in a national joint registry Authors’ own scale; 12–18 months
Jones and colleagues
200058
Estimated 242 consecutive patients with hip
replacement in health region
WOMAC pain; 6 months
Quintana and colleagues
2006102
784 consecutive patients scheduled for THR in seven
teaching hospitals
WOMAC pain; 6 months
Nilsdotter and colleagues
2003103
92 consecutive patients with two surgical methods
at single centre
WOMAC pain; mean 43 months
Singh and Lewallen
2010104
9154 consecutive patients from joint registry Authors’ own scale; 24 and
60 months
Wylde and colleagues
201149
1401 consecutive patients at single centre WOMAC pain; median 41 months
TKR
Baker and colleagues
2007105
9417 random sample of patients in joint registry OKS pain; 12 months or latest
available
Jones and colleagues
200058
Estimated 292 patients in health region WOMAC pain; 6 months
Quintana and colleagues
2006102
792 consecutive patients in seven centres WOMAC pain; 6 months
Núñez and colleagues
200747
88 consecutive patients at a single centre WOMAC pain; 36 months
Stephens and colleagues
2002106
68 patients aged ≥ 50 years WOMAC pain; 6 months
Lundblad and colleagues
2008107
69 patients scheduled for knee replacement VAS pain; 18 months
Nilsdotter and colleagues
2009108
102 responders to postal survey on waiting list for
knee replacement
KOOS pain; 60 months
Vuorenmaa and colleagues
2008109
51 patients referred for knee replacement VAS pain; 3 months
Czurda and colleagues
2010110
411 consecutive patients with computer assisted or
conventional surgery
WOMAC pain; mean 26 months
(range 18–42 months)
Wylde and colleagues
201149
1394 consecutive patients at single centre WOMAC pain; median 28 months
(range 14–43 months)
Brander and colleagues
200350
116 consecutive patients operated on by one
surgeon
VAS pain; 12 months
KOOS, Knee Injury and Osteoarthritis Outcome Score; OKS, Oxford Knee Score; VAS, visual analogue scale.
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Total hip replacement
Systematic searches identified six studies including a total of 13,031 patients.49,51,58,102–104 Pain outcome
assessments were based on the WOMAC pain scale or authors’ own methods.
One study was in patients recruited from a national joint registry.51 Two studies were in multiple
centres,58,102 and three were studies in single centres.49,103,104 Cohorts were generally similar with regard
to patient age (range of means or medians 65.0–73.0 years) and sex (range of percentage female
48.3–63%). Losses to follow-up ranged from 5.8% to 47.6%. We considered two markers of study
quality: multiple compared with single centres and lower losses to follow-up.
Overall, an unfavourable pain outcome was seen in at least 4.8% and up to 20.5% of patients after THR
(Figure 3). However these are likely to be underestimates as we do not have information on the outcomes
in between 5.8% and 52.7% of patients.
Proportion of patients with outcome
Applying the conservative assumption that an equal proportion of patients with missing data had an
unfavourable pain outcome, we estimate that at least 7–23% of patients experienced long-term pain after
hip replacement. In three higher-quality, more representative studies conducted in multiple centres, this
would reflect an unfavourable pain outcome in 9%,58 13%51 and 20%102 of patients, and in three studies
with low losses to follow-up in 9%,58 13%51 and 23%103 of patients. Data from two studies considered
more representative and with low losses to follow-up suggested that 9%58 to 13%51 of patients had an
unfavourable pain outcome after THR.
Total knee replacement
Searches identified 11 studies including a total of 12,800 patients.47,49,50,58,102,105–110 Pain outcome measures
were based on the WOMAC and Knee Injury and Osteoarthritis Outcome Score (KOOS) pain scales, the
Oxford Knee Score (OKS) pain dimension or pain measured on a visual analogue scale (VAS). One study
was in patients recruited from a national joint registry.105 Two studies were in patients from multiple
centres,58,102 six studies were in patients treated at a single centre47,106–110 and one study reported all
patients operated on by one surgeon.50 Cohorts were generally similar with regard to patient age (range
of means or medians 66–76 years) and sex (range of percentage female 54–86%), and the indication was
osteoarthritis in ≥ 94% of patients when specified. Losses to follow-up ranged from 0% to 43.5%.
Overall, after TKR, an unfavourable pain outcome was seen in at least 8.0% and up to 26.5% of patients
(see Figure 3). Assuming conservatively that the patients with missing data had similar pain outcomes,
studies suggested that at least 10% to 34% of patients experience long-term pain after knee replacement.
Applying this assumption in the higher-quality studies with potentially more representative populations, at
least 19%,105 20%58 and 31%102 of patients had an unfavourable pain outcome after TKR. In four studies
with low losses to follow-up, 10%,47 13%,105 17%106 and 20%58 of patients reported an unfavourable
pain outcome at follow-up. In one study conducted in multiple centres with low losses to follow-up,
20% of patients reported an unfavourable pain outcome at follow-up.58
Discussion
Well-conducted studies in representative populations of patients with primary total hip and knee
replacement suggest that a significant proportion of people continue to have painful joints after surgery.
Our analyses were limited by the small number of studies and different pain outcome measures. These
precluded meta-analysis, calculation of a summary estimate and exploration of sources of heterogeneity.
The proportion of people with an unfavourable long-term pain outcome in studies ranged from about 7%
to 23% after hip replacement, and 10% to 34% after knee replacement. In the best quality studies an
unfavourable pain outcome was reported in ≥ 9% of patients after total hip and about 20% of patients
after TKR.
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Conclusion
For many people, total hip or knee replacement is effective in treating osteoarthritis pain. However, a
significant proportion of people have painful joints after surgery.
Systematic review of methods used to assess chronic pain after
total knee replacement
Background
Pain is a key outcome after TKR111 and our systematic review showed that 10–34% of patients report
long-term pain. However, there is little guidance about which aspects of pain should be assessed. For
clinical trials investigating efficacy of chronic pain treatments, the Initiative on Methods, Measurement, and
Pain Assessment in Clinical Trials (IMMPACT) recommends that the assessment of pain should include an
assessment of pain intensity, pain medication usage, pain quality and the temporal aspects of pain.112 The
aim of this review was to determine which outcome measures have been used to assess chronic pain after
TKR by reviewing all original research articles published over a 10-year period.
Methods
General methods As described in Systematic review methods
Databases and dates MEDLINE, EMBASE, PsycINFO, The Cochrane Library and CINAHL databases from 1 January 2002
to 22 November 2011
Search strategy Knee replacement/pain. MEDLINE search strategy based on terms in Appendix 3
Study design Study design filters were not applied. Empirical studies
Patients Patients with knee replacement
Data extraction Pain at ≥ 3 months
Outcomes Study objective, study design, setting, country of the first author, number of study participants
recruited, timings of assessments and outcome measures that contained pain items
Quality assessment No assessment conducted
Results
Characteristics of included studies
The review process and reasons for exclusion are summarised in Figure 4. A total of 8486 articles were
identified in the literature searches and screened for potential eligibility by one reviewer. A second reviewer
performed duplicate screening on a random 1000 articles but no relevant articles had been missed by the
first reviewer. After screening, 1164 articles met the eligibility criteria for the review. Studies included in
the review used a variable number of outcome measures that incorporated pain items (range 1–14),
with 506 studies (43%) using two or more measures.
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Multi-item tools
Overall, 54 different multi-item tools containing pain questions were used in the studies of TKR.
Five multi-item tools were used in > 5% of the studies and these included the American Knee Society
Score (AKSS),113 WOMAC,114 Hospital for Special Surgery Knee Score (HSS),115 Short Form questionnaire-36
items (SF-36)116 and OKS.117 Details of the multi-item tools that were used in more than five studies and
the number of items which assessed pain within each of these tools are provided in Table 2.
Geographical trends in the use of multi-item tools
The use of multi-item tools by countries that contributed > 50 articles to the review were compared
(Figure 5). Nation-specific preferences for particular tools were apparent, with the AKSS being the most
commonly used tool in studies from the USA, UK, Germany, South Korea and Australia. The HSS was
most commonly used in studies from China, whereas the WOMAC was the most frequently used in
Canadian studies.
Temporal trends in the use of multi-item tools
The percentage of studies using the five most commonly used multi-item tools over a 10-year period is
displayed in Figure 6. From 2006 to 2011 there was a reduction in the proportion of studies that have used
the AKSS, from 66% in 2006–7 to 52% in 2010–11. Over the same time period, there has been an increase
in the proportion of studies that have used the WOMAC, from 19% in 2006–7 to 32% in 2010–11.
Single-item questions
Single-item questions were used 333 times to assess chronic pain after TKR. The aspects of pain assessed
by the single-item questions, based on the framework provided by IMMPACT, are shown in Table 3. Pain
severity was the most frequently assessed aspect of pain and the VAS was the most commonly used
question format to assess pain severity.
Articles identified through
database search from January 2002
to November 2011
(n = 8486)
Articles included
 (n = 1164 articles)
• Longitudinal cohort, n = 775
• RCT, n = 198
• Cross-sectional, n = 191
Full-text articles excluded
(n = 7322)
• Not primary TKR, n = 2902
• No new data presented, n = 1558
• Pain not assessed beyond 3 months, n = 1188
• Case study or fewer than 10 participants, n = 551
• < 3 months’ follow-up, n = 518
• Conference abstract, n = 340
• No postoperative follow-up, n = 167
• Not in living humans, n = 75
• Retracted articles, n = 2
• Unable to obtain, n = 21
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FIGURE 4 Systematic review of methods used to assess chronic pain after TKR: flow diagram.
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TABLE 2 Systematic review of methods used to assess chronic pain after TKR: multi-item tools
Multi-item tool
Number of studies (%)
that used tool
Number of items
in tool
Number of items that
assess pain
AKSS 675 (58) 10 1
WOMAC 267 (23) 24 5
HSS 184 (16) 7 2
SF-36 165 (14) 36 2
OKS 101 (9) 12 5
SF-12 54 (5) 12 1
KOOS 26 (2) 42 9
EQ-5D 25 (2) 5 1
Feller Patellar Score 20 (2) 4 1
ADL Scale of the Knee Outcome Survey 14 (1) 17 1
Lequesne Index 11 (< 1) 12 5
Tegner and Lysholme score 9 (< 1) 8 1
Total Knee Function Questionnaire 9 (< 1) 55 1
NHP 7 (< 1) 45 8
Self-Administered Patient Satisfaction Scale 6 (< 1) 4 1
Stern and Insall Patellar Score 6 (< 1) 1 1
Bristol Knee Score 6 (< 1) 9 1
15D 6 (< 1) 15 1
EQ-5D, European Quality of Life-5 Dimensions; NHP, Nottingham Health Profile; SF-12, Short Form questionnaire-12 items.
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FIGURE 5 Systematic review of methods used to assess chronic pain after TKR: geographical trends in use of
multi-item tools.
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FIGURE 6 Systematic review of methods used to assess chronic pain after TKR: temporal trends in the use of
multi-item tools.
TABLE 3 Systematic review of methods used to assess chronic pain after TKR: aspects of pain assessed by the
single-item questions
Pain domain Examples of codes
Number (%) of single-item
questions
Pain intensity General pain intensity 227 (68)
Average pain intensity
Worst pain intensity
Presence/absence of pain
Use of pain medication Frequency of use 8 (2)
Adherence
Decreased need
Pain quality Location of pain (e.g. anterior knee pain) 57 (17)
Temporal aspects of pain Pain frequency 33 (10)
Night pain
Constant pain
Intermittent pain
Physical functioning Pain on walking 98 (29)
Pain on climbing stairs
Pain during sports
Pain at rest
Emotional functioning Unbearable pain 5 (1.5)
Bothersome pain
Emotional well-being
Participant ratings of global improvement Satisfaction with pain relief 26 (8)
Reduction in pain from operation
Fulfilment of expectations
Each single-item pain question could be coded into more than one pain domain.
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Discussion
Numerous tools are available to assess general health and functional outcomes after TKR.118 Despite a
growing interest in investigating the burden, character and impact of long-term pain, we found that
assessment has been inconsistent with extensive variation in the outcome measures used after TKR.
The AKSS is widely used in orthopaedic research,119,120 and was the most common method to assess
long-term pain used in 58% of studies. The scale involves a clinician-conducted assessment and a
composite score based on functional ability and measurements such as ROM and joint stability, and
a single question about pain.
Our review showed a reduction over time in the use of the AKSS, accompanied by an increase in the use
of the WOMAC. This may reflect increased awareness of the assessment of outcomes from a patient’s
perspective.121,122 There was also international variation in the use of multi-item tools.
Strengths of this review were the systematic and rigorous methods used to search and screen eligible
articles, the wide inclusion criteria with diverse epidemiological and experimental study designs, and the
inclusion of studies irrespective of language. Owing to the high volume of literature, it was not feasible to
assess whether or not particular methods were used in studies of different quality.
Conclusion
Our systematic review shows that the assessment of long-term pain after TKR could be improved. Despite
the availability of many validated pain-related instruments, few studies have attempted to capture the
incidence, character and impact of chronic pain after TKR. Future research is needed to develop consensus
and standardisation on which pain domains should be assessed after TKR.
Systematic review of pre-operative predictors of patient-centred
outcomes after total hip and knee replacement
Background
Identification of pre-operative determinants and predictors of poor outcomes can guide the development
of interventions and help target the provision of care. For factors that are determinants, the possibility
exists that an intervention may alter the level of the factor and that this may lead to improved outcomes.
Other variables cannot be changed by an intervention but may have value in predicting outcomes with
care tailored for specific patient groups.
Associations between variables measured before joint replacement and post-surgical outcomes have been
studied extensively. Establishment of a cohort study in an orthopaedic setting is relatively straightforward in
the context of routine data collection and follow-up. However, it is important that analyses are conducted
with robust statistical methods taking into account possible confounding factors.
The aim of this review was to identify high-quality systematic reviews and cohort studies that have
assessed the predictive value of pre-surgical factors in relation to long-term post-surgical outcomes.
In keeping with the themes of the RESTORE programme, we considered patient-reported outcomes.
Pre-surgical factors studied in detail were:
l BMI
l mental health status including anxiety and depression
l pain
l physical function.
LONG-TERM PAIN AFTER THR AND TKR
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22
Methods
General methods As described in Systematic review methods
Databases and dates MEDLINE and EMBASE from inception to 15 October 2013
Search strategy Joint replacement/osteoarthritis/specified patient centred outcomes. MEDLINE strategy based on
terms in Appendix 3
Study design Cohort studies with multivariable regression analysis or ANCOVA
Patients Total hip or knee replacement. If both reported, included only if analysed separately and with at
least 100 patients per analysis
Follow-up At least 12 months
Data extraction Date of publication, hip or knee, country, baseline dates, follow-up duration, pre-surgical measures
Outcomes Patient-reported outcomes
ANCOVA, analysis of covariance.
All titles and abstracts of articles published in 2010 were checked for inclusion by two reviewers
experienced in orthopaedic research and systematic reviews. Comparison of inclusion decisions showed
good agreement between reviewers. Subsequently titles and abstracts were checked by one reviewer but
with oversampling in the event of uncertainty.
At an early stage, it became apparent that the literature base for the review was very large. We limited our
inclusion to studies with ≥ 100 patients with at least 12 months’ follow-up and to studies published
in English.
Quality assessment
A level of good quality of studies was implicit with study selection based on seven MINORS criteria:123
l clear stated aim – multivariable analysis
l inclusion of consecutive patients – cohort study
l prospective collection of data – prospective
l end points appropriate to aim of study – pain, function, satisfaction
l unbiased assessment of end point – patient-reported outcomes
l follow-up period appropriate to aim of study – at least 12 months
l prospective calculation of study size – estimated at least 100.
For the eighth criterion we considered:
l per cent follow-up of those at baseline (eligible) – > 80% good quality.
Furthermore we included one classification modified from the Newcastle-Ottawa quality
assessment scale:124
l representativeness of the cohort – registry or multiple centres good quality.
These last two classifications were used to assess quality of the studies relating to generalisability.
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Results
Review progress is summarised as flow diagrams for total hip and TKR in Figures 7 and 8. We identified
one systematic review and 53 cohort studies that explored the relation between pre-surgical factors and
long-term outcomes in multivariable analysis.
Total hip replacement
Searches identified 26 studies reporting multivariable analyses including patients with THR. In this section
we summarise results from 14 studies of pre-operative BMI, mental health, pain and physical function as
predictors of long-term patient-reported outcomes.31,103,104,125–135 Study characteristics are summarised in
Appendix 5 with brief details in Table 4.
Records identified through
database searching
(n = 9325)
Records excluded
(n = 6209)
Records potentially eligible
(n = 3116)
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 analysis with 100 + patients 
with total hip replacement 
and > 1-year follow-up
(n = 26)
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Physical function
(n = 3)
Pain
(n = 2)
Mental health
(n = 7)
Diabetes
(n = 4)
BMI
(n = 8)
Cardiovascular
disease
(n = 1)
Thyroid disease
(n = 1)
Hypertension
(n = 3)
Anaemia
(n = 0)
Full-text articles excluded
(n = 3090)
• Pre-surgery only, n = 68
• Post-surgery only, n = 44
• Perioperative, n = 525
• Retrospective, n = 760
• No patient outcome, n = 457
• Additional publication, n = 6
• Hip/knee combined, n = 7
• No prediction, n = 287
• No multivariable, n = 45
• < 12 months’ follow-up, n = 406
• < 100 patients, n = 459
• Knee only, n = 27
FIGURE 7 Systematic review of pre-operative predictors of patient-centred outcomes after THR: flow diagram.
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 analysis with 100 + patients 
with total knee replacement
and > 1-year follow-up
(n = 33)
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Physical function
(n = 5)
Pain
(n = 5)
Mental health
(n = 12)
Diabetes
(n = 6)
BMI
(n = 13)
Cardiovascular
disease
(n = 4)
Thyroid disease
(n = 1)
Hypertension
(n = 4)
Anaemia
(n = 1)
Full-text articles excluded
(n = 3083)
• Pre-surgery only, n = 68
• Post-surgery only, n = 44
• Perioperative, n = 525
• Retrospective, n = 760
• No patient outcome, n = 457
• Additional publication, n = 6
• Hip/knee combined, n = 7
• No prediction, n = 287
• No multivariable, n = 45
• < 12 months’ follow-up, n = 406
• < 100 patients, n = 459
• Hip only, n = 20
FIGURE 8 Systematic review of pre-operative predictors of patient-centred outcomes after TKR: flow diagram.
TABLE 4 Systematic review of pre-operative predictors of patient-centred outcomes after THR: included studies
Study
Number of patients;
follow-up Predictors Outcome measures
Registry
Rolfson and colleagues 2009125 6158; 12 months Mental health VAS pain, satisfaction,
EQ-5D domains
Multiple centres
Hajat and colleagues 2002126 3600; 12 months Physical function OHS
Jones and colleagues 2012127 Estimated 167; 3 years BMI WOMAC
Judge and colleagues 201131 845; 12 months Physical function WOMAC
Judge and colleagues 2013128 1375; 60 months BMI, mental health,
physical function
OHS
Stevens and colleagues 2012129 653; 12 months BMI WOMAC, SF-36
continued
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
25
Body mass index
There is no clear evidence linking high BMI with the development of hip osteoarthritis,137 but people with
higher BMI are more likely to require THR. For example, in a UK study including over 490,000 women,
those with a BMI of > 30 kg/m2 had nearly 2.5 times the risk of requiring a THR of those with a BMI of
< 22.5 kg/m.138 Patients included in the National Joint Registry for England and Wales in 2012 had an
average BMI of 28.71 kg/m2 (SD 5.29 kg/m2) and about 39% had a BMI of ≥ 30 kg/m2.3 In the RESTORE
APEX RCT, the mean BMI in 322 patients receiving THR was 29.1 kg/m2 (SD 5.5 kg/m2, range 18.6 to
47.8 kg/m2) and 4.3% of patients had a BMI of ≥ 40 kg/m2. The distribution of BMI of patients in the APEX
cohort of patients with THR is shown in Figure 9.
Our searches of MEDLINE and EMBASE considered long-term patient-reported outcomes after THR.
Searches identified eight studies that specifically focused on the relationship between BMI and
patient-reported outcomes at ≥ 12 months after THR. Three studies included patients from multiple
centres,127–129 and five studies were conducted at a single centre.103,104,132,133,135 Study details are
summarised in Table 4. In studies with data that allowed estimation, rates of follow-up ranged from
6% to 38%.
Jones and colleagues followed up approximately 167 patients (72% eligible) from a Canadian health
region 3 years after a THR.127 The authors used WHO criteria to classify patients into groups of BMI
(< 25 kg/m2, 25–29.9 kg/m2, 30–34.9 kg/m2, ≥ 35 kg/m2). In the cohort, 13.9% of patients had a BMI
of ≥ 35 kg/m2. In an analysis with adjustment for age, sex, diabetes and cardiac disease, the authors
reported that similar long-term WOMAC pain and function scores were achieved in patients with
different levels of BMI. Considering data collected at 6 months, the authors noted that recovery of
function and reduction of pain was slower in patients with a high BMI (≥ 35 kg/m2) than groups with
lower BMI.
TABLE 4 Systematic review of pre-operative predictors of patient-centred outcomes after THR:
included studies (continued )
Study
Number of patients;
follow-up Predictors Outcome measures
Single centre
Anakwe and colleagues 2011130 850; 12 months Mental health, physical
function
Satisfaction
Clement and colleagues 2011131 1312; 12 months Mental health, physical
function
OHS
Davis and colleagues 2011132 1095; 60 months BMI SF-36
Gandhi and colleagues 2010133 636; 12 months and up to
72 months (mean 39 months)
BMI, mental health WOMAC, SF-36 physical
function
Garbuz and colleagues 2006134
and Xu and colleagues 2005136
147; 12 months Pain, physical function WOMAC pain
Moran and colleagues 2005135 687; minimum 18 months BMI SF-36
Nilsdotter and colleagues 2003103 198; 12 months and at mean
43 months
BMI, mental health, pain WOMAC function
Singh and Lewallen 2010104 5707; 24 months BMI, mental health Pain (five-response scale)
EQ-5D, European Quality of Life-5 Dimensions; OHS, Oxford Hip Score.
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Judge and colleagues128 followed up 1375 patients (64% eligible) who had received a specific design of
THR prosthesis at seven UK centres 5 years after surgery. The mean BMI of patients in the cohort followed
up was 27.6 kg/m2 (SD 4.8 kg/m2) and it was treated as a continuous variable. In multivariable analyses
including age, sex, primary diagnosis, occupation, comorbidities, health-related quality of life (HRQoL), hip
ROM, surgical variables and Oxford Hip Score (OHS), there was a relationship between increasing BMI and
poorer long-term function and pain as measured by the OHS. The authors considered the differences in
function and pain associated with BMI to be small.
In a study at three orthopaedic centres in the Netherlands, Stevens and colleagues129 followed up
653 patients (77% eligible) 12 months after receiving a THR. The mean BMI was 27.0 kg/m2 (SD 4.1 kg/m2)
and the authors defined three groups (< 25 kg/m2, 25–30 kg/m2, > 30 kg/m2). After adjusting analyses for
age, sex, comorbidities and complications, increased BMI was associated with worse long-term function
but the size of the effect was low, particularly in comparison to that of presence of comorbidities
and complications.
Moran and colleagues135 followed up 687 patients (86% eligible) with THR at a single UK centre.
The mean BMI in this cohort was 27.8 kg/m2 (SD 5 kg/m2) and the authors reported that only 9 out of
687 patients (1.3%) had a BMI of > 40 kg/m2 and that no conclusions could be drawn for these patients.
After adjusting for sex, comorbidities, OHS and SF-36, BMI treated as a continuous variable was not a
significant predictor for any SF-36 domains.
Nilsdotter and colleagues103 reported the follow-up of 198 patients (94% eligible) with THR from a single
centre in Sweden at a mean of 3.6 years. The authors analysed BMI as a continuous variable but did not
report mean or categorical values. Increasing BMI was associated with poorer long-term WOMAC
function in univariate analysis. After adjustment for sex, comorbidities, WOMAC, SF-36 (including mental
health), employment, marital status, contralateral osteoarthritis, need of walking assistance, walking
distance, analgesic use and regional or widespread pain, BMI was not associated with long-term
WOMAC function.
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FIGURE 9 Distribution of BMI in the APEX THR cohort.
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Davis and colleagues132 followed up 1095 patients (68% eligible) from a single UK centre 60 months
after THR. The mean BMI in the cohort was 28 kg/m2 at baseline and 9.2% of patients had a BMI of
≥ 35 kg/m2. Patients were divided into groups according to their BMI (< 25 kg/m2, 25–29.9 kg/m2,
30–34.9 kg/m2, ≥ 35 kg/m2). In multivariable analysis with age, sex, pre-operative hip score, SF-36,
comorbidities and consultant, increasing BMI predicted poorer long-term SF-36 physical function and
bodily pain. However, the authors acknowledged that although absolute levels of long-term pain and
function were poorer than in patients with low BMI, there were dramatic improvements in patient
outcomes in those with high BMI.
Singh and Lewallen104 reported a 2-year follow-up of 5707 patients with THR (62% eligible) at a single US
centre. Four per cent of patients had a BMI of ≥ 40 kg/m2 or greater. The authors divided patients into five
groups according to their BMI (< 25mg/m2, 25–29.9mg/m2, 30–34.9 kg/m2, 35–39.9 kg/m2, ≥ 40 kg/m2).
In an analysis adjusted for age, sex, comorbidities, depression, anxiety, operative diagnosis, distance from
centre and implant design, patients with BMI of ≥ 35 kg/m2 reported significantly greater long-term
moderate or severe pain than the lowest BMI group.
In a study from a single centre in Canada, Gandhi and colleagues133 followed up 636 patients (per cent
eligible not reported) for an average of 3.3 years. The mean BMI in this cohort was 27.6 kg/m2 (SD 4.9 kg/m2)
and was treated as a continuous variable in analyses. After adjusting for age, sex, comorbidities, WOMAC
and SF-36 scores there was a non-significant trend for less improvement in WOMAC score with
increasing BMI.
With the increasing levels of BMI in developed countries, it is important that patients and health-care
providers are aware of any factors that influence the long-term outcome of THR. We identified eight studies
that reported the association between BMI and a long-term patient-reported outcome in multivariable
analysis.103,104,127–129,132,133,135 If reported in the studies we identified, patients had broadly similar average BMIs
to those reported in the National Joint Registry for England and Wales3 and the APEX cohort described in
Chapters 6 and 7.
In three studies, the absolute long-term OHS,128 WOMAC function129 and a simple measure of pain
severity104 were more favourable in lower BMI groups. In another study this was observed for WOMAC
function in univariate but not multivariate analysis.103 In two studies there were no long-term differences in
WOMAC pain or function,127 WOMAC score or SF-36.135 Further to the selection of studies according to
specific quality criteria, studies had either one or no additional marker of quality based on centres studied
and losses to follow-up. Differences in results of studies were not explained by issues relating to these
additional markers of study quality.
In the four studies for which BMI was treated as a continuous variable in multivariable analysis, authors
reported no strong association between BMI and long-term function,103,128,133,135 or pain.128,135 Two studies
reported changes in function which may be a more appropriate method of analysis as patients with higher BMI
generally have poorer function before surgery. There were greater improvements in OHS128 and WOMAC133
in patients with lower BMI. Associations observed were not limited to studies according to additional markers
of quality.
In four studies, authors focused on the relationship between categorical levels of BMI and patient-reported
outcomes. There was some evidence that patients classified as obese (≥ 30 kg/m2) according to WHO
classifications139 had poorer function129,132 or pain outcomes,104 but only one study had an additional
marker of good quality.127 In a fourth study with one additional marker of good quality, no association was
noted between pre-operative BMI and long-term function or pain, although the authors noted a slower
recovery in patients with high BMI.127
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Overall, the absolute levels of physical function and pain achieved after THR in patients with particularly
high BMI may be somewhat lower than that achieved by other patients. However, there is a clear
indication that many patients with high BMI benefit from THR with long-term improvements to physical
function and reduction in long-term pain.
Pre-surgical mental health
The period between being placed on the waiting list and the day of surgery can be a time of distress for
patients and is characterised by pain, poor physical function and uncertainty. Parsons and colleagues140
identified six major themes describing patients’ experiences of waiting for joint replacement: living
and coping with pain; not being able to walk; coping with everyday activities; body image; help, advice
and support; and the effect on family, friends and helpers.
Anxiety and depression are common in people with osteoarthritis.141,142 In the APEX cohort of patients with
osteoarthritis waiting for THR, pre-surgical anxiety and depression was identified using the Hospital Anxiety
and Depression Scale (HADS) questionnaire. Definite or potential anxiety was reported by 33% of patients
and definite or potential depression by 30% of patients.
One previous systematic review explored the relationship between pre-surgical anxiety and long-term
patient outcomes in patients with THR.143 Vissers and colleagues143 searched MEDLINE and EMBASE to
January 2011 and identified nine studies including 8823 patients receiving THR. The authors reported that
there was limited and conflicting evidence on the relationship between psychological factors and
postoperative function and pain.
Our literature searches identified seven studies with ≥ 100 patients with THR followed up for ≥ 12 months
with pre-surgical mental health included in multivariable analyses. One study reported data from a joint
registry,125 one study included patients from multiple centres,128 and five studies collected data from
patients treated at a single centre.103,104,130,131,133 Study details are summarised in Table 4. In studies that
reported the number of patients eligible, between 6% and 38% of patients were not followed up.
In a 12-month follow-up study of 6158 patients (92% eligible) from the Swedish Hip Arthroplasty Register,
Rolfson and colleagues125 assessed the impact of the pre-operative European Quality of Life-5 Dimensions
(EQ-5D) measure of anxiety and depression on long-term pain and satisfaction. In analysis of covariance
adjusting for EQ-5D domains, comorbidities and age and sex, anxiety and depression were strong
predictors of poor long-term pain relief and low patient satisfaction. Furthermore, in patients with
persistent anxiety and depression, only 24% of patients showed improvement in the EQ-5D mobility
dimension compared with 59% in those unaffected by high levels of anxiety or depression.
Judge and colleagues128 followed up 70% of 1375 patients eligible from seven UK centres 5 years after
they had received a specific THR prosthesis. The multivariable model included the SF-36 mental health
score, age, sex, primary diagnosis, occupation, comorbidities, HRQoL and pre-surgical OHS. Poorer mental
health measured by the SF-36 mental health score was associated with a less favourable long-term patient
outcome as measured by the OHS.
Anakwe and colleagues130 followed up 850 patients (94% eligible) 12 months after THR at a single UK
centre. The Short Form questionnaire-12 items (SF-12) mental health component, diabetes, hypertension,
history of depression, age, sex, SF-12 physical components, OHS, and musculoskeletal comorbidities were
included in analyses. Although significant in univariate analyses, neither a history of depression nor the SF-12
mental health component predicted the level of long-term patient satisfaction in multivariable analysis.
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Nilsdotter and colleagues103 followed up 198 patients with THR (94% eligible) at a single centre in Sweden
after a mean of 3.6 years. Multivariable analysis included sex, comorbidities, WOMAC, SF-36 (including
mental health), employment, marital status, contralateral osteoarthritis, need of walking assistance,
walking distance, analgesic use and regional or widespread pain. In preliminary univariate analysis,
pre-operative SF-36 mental health status was not a significant predictor of long-term WOMAC function
and was not entered into multivariable analysis.
In a single-centre UK study, Clement and colleagues131 followed up 1312 patients with THR (per cent
eligible not reported) at 12 months. In a multivariable analysis with age, deprivation, Charlson comorbidities,
OHS, length of stay and SF-12 physical health, SF-12 mental health was a significant predictor of long-term
change in OHS. Depression was the comorbidity with the strongest prediction of poor improvement in OHS.
Gandhi and colleagues133 followed up 636 patients (per cent eligible not reported) from a single centre in
Canada for an average of 3.3 years. In multivariable analysis with age, sex, comorbidities, BMI and fixation
(cemented or uncemented), SF-36 mental health was not associated with long-term changes in WOMAC
score or SF-36 physical function.
In a single-centre US study, Singh and Lewallen104 followed up 5707 patients (62% eligible) 2 years after
THR. Multivariable analyses included anxiety, depression, age, sex, comorbidities, operative diagnosis,
distance from centre and implant design. Patients with depression but not anxiety [International
Classification of Diseases (ICD) classifications] before surgery were more likely to report moderate to severe
long-term pain at 2 years. A trend in a similar direction was not significant at 5 years.
All studies we included in the review reported multivariable analyses with inclusion of comorbidities and
other factors in the statistical model. Authors examined outcomes in patients using generic measures of
mental health (SF-12 mental health and SF-36 mental health), combined measures of anxiety and depression
(EQ-5D anxiety/depression) and specific diagnoses of anxiety and depression (ICD code or clinical history).
In five studies in which generic mental health scores were measured before surgery using SF-36 or SF-12,
results of multivariable analyses were inconsistent.103,128,130,131,133 In two studies, patients with worse
pre-surgical mental health scores had a poorer long-term outcome128 or less improvement measured by
the OHS.131 However, in two studies, SF-36 mental health scores measured before surgery did not predict
long-term WOMAC function103 or change in overall WOMAC score.133 Similarly pre-surgical SF-36 mental
health did not predict long-term change in SF-36 physical function score.133 In one study, the authors
reported that long-term satisfaction was not predicted by pre-surgical SF-12 mental health score.130
Inconsistencies between studies were not explained by differences in additional markers of quality.
Unlike the SF-36, which measures psychological distress and well-being, the mental health component of
the EQ-5D relates specifically to anxiety and depression. In one study considered to be of good quality
based on both additional markers, pre-operative anxiety/depression measured with the EQ-5D was
associated with poorer long-term pain relief, satisfaction and mobility.125 Three studies specifically reported
outcomes in patients with anxiety or depression before surgery. In one study, patients with depression
before surgery had poorer long-term pain outcomes but this was not the case for patients with anxiety.104
In another study, depression before surgery was associated with poor improvement in OHS.131 Both these
studies were single centre and reported high losses to follow-up. In one study from a single centre but
with low losses to follow-up, except in univariate analysis, patients with a history of depression did not
report lower levels of long-term satisfaction after THR.130
Overall, there was some evidence that patients with depression before THR may have poorer long-term
outcomes but evidence for pre-surgical anxiety was weaker. For general mental health measures evidence
was equivocal.
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Pre-surgical pain
Pain is the principal indication for THR144 and the key patient expectations of surgery are good long-term
functional and pain outcomes.145,146 We identified two single-centre studies that had explored the
relationship between pre-operative pain levels and long-term patient-reported outcomes after THR.103,134
Details of studies are shown in Table 4.
In a study of 198 patients (94% eligible) from a single Swedish centre, Nilsdotter and colleagues103
reported a multivariable analysis with follow-up at a mean of 43 months. Increased levels of SF-36 bodily
pain domain measured before surgery were associated with poorer long-term WOMAC function outcomes
in a statistical model including age, sex, comorbidities, BMI and SF-36 physical function and mental
health components.
Garbuz and colleagues134 followed up 147 patients (73% eligible) at a single Canadian centre 12 months
after THR. Greater pre-operative pain measured with the WOMAC pain score was predictive of a poorer
long-term WOMAC pain outcome in univariate analysis and after inclusion of age, sex and comorbidities in
multivariable analysis.
Few studies have reported the relationship between pain levels before THR and long-term patient
outcomes. In two studies with appropriate multivariable analyses, an increased level of pre-operative joint
specific pain was associated with a greater risk of long-term pain and general pre-operative pain was
predictive of poorer long-term functional outcome.
Pre-surgical physical function
As noted previously, the key expectations of patients undergoing total joint replacement are good
long-term functional and pain outcomes.145,146
Searches identified six studies that had followed up patients at 12 months and conducted multivariable
analysis with pre-operative physical function included in the statistical model. Three studies were
conducted in multiple centres,31,126,128 and three in single centres.130,131,134 Characteristics of studies are
summarised in Table 4.
In this classification we included four studies that reported overall WOMAC or OHS. As well as reflecting
physical function these scores also include joint specific pain (OHS) or pain and stiffness (WOMAC).
Hajat and colleagues126 followed up 3600 patients (77% eligible) 12 months after THR at multiple UK
centres. In multivariable analysis with age, sex, waiting time, comorbidities, housing and surgical factors,
a worse pre-operative OHS was predictive of a worse long-term OHS.
In a European multicentre study, Judge and colleagues31 followed up 845 patients (64% eligible) with THR
at 12 months. The authors included the WOMAC score, EQ-5D, age, sex, BMI, education, comorbidities
and radiographic status in a multivariable model. A worse pre-operative WOMAC score was predictive of
a poorer long-term outcome as judged by the Outcome Measures in Rheumatology-Osteoarthritis Research
Society International (OMERACT-OARSI) rated good WOMAC response.
Judge and colleagues128 reported the 5-year follow-up of 1375 patients (70% eligible) who had received
a specific THR prosthesis at seven UK centres.128 In multivariable analyses including age, sex, BMI, primary
diagnosis, occupation, comorbidities and HRQoL, the pre-operative OHS was the strongest determinant of
long-term OHS.
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Anakwe and colleagues130 reported a single UK centre study with 850 patients (94% eligible) followed up
12 months after THR. SF-12 physical and mental health components, diabetes, hypertension, history of
depression, age, sex, OHS and musculoskeletal comorbidities were included in multivariable analysis. The
SF-12 physical component score (PCS) measured before surgery did not predict long-term satisfaction.
The pre-surgical OHS was associated with greater long-term dissatisfaction but only in univariate analysis.
In a study at a single Canadian centre, Garbuz and colleagues134 followed up 147 patients (73% eligible)
12 months after THR. In univariate analysis a 10-out-of-100-point difference in pre-surgical WOMAC
function was associated with a 35% increase in long-term WOMAC function. In multivariable analysis age,
sex, and comorbidity did not change the association.
Clement and colleagues131 reported 12-month follow-up of 1312 patients (per cent eligible not reported)
with THR at a single UK centre. In a multivariable analysis with age, deprivation, comorbidities, length of
stay and SF-12 physical and mental health, the pre-operative OHS was a strong predictor of long-term
improvement in OHS.
The studies we identified suggested that better physical function before THR is associated with a better
long-term functional outcome. This was apparent in one study with a specific functional measure134 and in
four studies with a more general patient-reported outcome.31,126,128,131 This observation was supported
when considering studies with an additional marker of good quality. In one study with a more general
measure of pre-operative physical function, there was no association with long-term satisfaction.130
Total knee replacement
As shown in Figure 8, searches identified 33 studies reporting multivariable analyses including patients
with TKR. In this section we summarise results from 22 studies of pre-operative BMI, mental health, pain
and physical function as predictors of long-term patient-reported outcomes.46,50,127,147–165 One study
included important data in a second publication.166 Details of studies are summarised in Appendix 6 with
brief details in Table 5.
Body mass index
There is a strong association between high BMI (≥ 30 kg/m2) and the development of knee osteoarthritis.137
People with high BMI are also more likely to require a TKR than those with lower BMI.138,167 For example,
in a cohort of 315,495 people in Norway, men and women in the top quartile of BMI (≥ 27.3 kg/m2) had
relative risks compared with the lowest quartile (< 21.6 kg/m2) of undergoing a TKR of 6.16 (95% CI 4.23
to 8.95; p< 0.0001) and 11.06 (95% CI 7.83 to 15.62; p< 0.0001), respectively.167
Analyses of the National Joint Registry for England and Wales3 show that 56% of patients undergoing TKR
in 2012 had a BMI of 30 kg/m2 or greater. In the RESTORE APEX RCT including 311 patients with TKR the
mean BMI was 32.6 kg/m2 (SD 6.5 kg/m2, range 17.0–56.2 kg/m2). The distribution is shown in Figure 10.
Thirteen per cent of patients had a BMI of 40 kg/m2 or greater.
Although clearly of potential importance as a treatment for severe knee pain, irrespective of a patient’s
BMI, concern has been expressed about the outcomes of TKR in patients considered to be obese.137,168,169
Previous reviews have suggested that patients with a high BMI receiving TKR are at increased risk of deep
infection,170–172 complications171–173 and need for revision surgery.170,173 Long-term outcomes measured by
surgeon assessed scores after TKR may be poorer in patients with a BMI of ≥ 40 kg/m2 but not in patients
with BMI of 30–40 kg/m2.173 No previous systematic review has considered the association of pre-operative
BMI and long-term patient-reported outcomes.
Our systematic literature search identified 13 articles that met the inclusion criteria and were included in the
review.46,127,147,149,151–155,159–162 Details of these studies are summarised in Table 5. As a marker of generalisability,
one study reported a registry analysis,147 eight studies included multiple centres,46,127,149,151–155 and four studies
included patients from a single centre.159–162
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TABLE 5 Systematic review of pre-operative predictors of patient-centred outcomes after TKR: included studies
Study
Number of patients;
follow-up Predictors Outcome measures
Registry
Baker and colleagues 2012148 22,691; minimum
6 months
Mental health OKS, EQ-5D
Franklin and colleagues 2008147 8050; 12 months BMI, mental health SF-12 PCS
Multiple centres
Alzahrani and colleagues 2011149 3177; 12 months BMI OKS, WOMAC
Cushnaghan and colleagues
2009151
259; mean 6 years BMI SF-36 PCS
Heck and colleagues 1998157 268; 24 months Mental health, pain,
physical function
SF-36 PCS
Jones and colleagues 2012127 Estimated 209; 3 years BMI WOMAC
Lingard and colleagues 200446 741 at 1 year; 12 and
24 months
BMI, pain, physical
function
WOMAC pain and function,
SF-36 PCS
Lingard and colleagues 2007150
and Lingard and colleagues
200446
682; 12 and 24 months Mental health WOMAC pain and function
Merle-Vincent and colleagues
2011158
264; 24 months Mental health Satisfaction
Naylor and colleagues 2012154 146; 12 months BMI OKS
Papakostidou and colleagues
2012155
204; 12 months BMI, mental health, pain WOMAC
Perruccio and colleagues 2012152 435; mean 12.5 months BMI WOMAC
Singh and Lewallen 2013156 7139; 2 and 5 years Mental health Pain severity questionnaire
Sullivan and colleagues 2011153 120; 12 months BMI, pain WOMAC function and pain
Single centre
Ayers and colleagues 2005163 165; 12 months Mental health, physical
function
WOMAC physical function,
SF-36 PCS
Brander and colleagues 200350 116 (149 TKRs);
12 months
Mental health Pain VAS, McGill Pain
Questionnaire
Clement and colleagues 2013164 966; 12 months Mental health, physical
function
OKS, Satisfaction
Deshmukh and colleagues
2002161
139; 12 months BMI NHP
Gandhi and colleagues 2010160
and Gandhi and colleagues
2010166
551; mean 3 years BMI, mental health WOMAC, SF-36 Role Physical,
SF-36 Physical Function
Núñez, and colleagues 2009159 112; 7 years BMI WOMAC function and pain
Rajgopal and colleagues 2008162 550; 1 year BMI WOMAC
Scott and colleagues 2010165 1141; 12 months Mental health, pain,
physical function
Satisfaction
NHP, Nottingham Health Profile.
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Body mass index as a predictor of joint specific pain and function
Four studies assessed the impact of BMI on joint specific PROMs.154,159,162,166 These provided a composite
measure of pain and functional limitations, specifically the OKS and total WOMAC score.
In the multicentre Australian study reported by Naylor and colleagues,154 146 patients (90% eligible)
were followed up at 12 months after TKR. The mean BMI in this cohort was 32.8 kg/m2 (SD 5.7 kg/m2).
In multivariable analysis including age, sex and knee range of movement, but not comorbidities, patients
with higher BMI reported worse long-term OKS.
Gandhi and colleagues166 followed up a cohort of 677 patients with a total of 889 TKR operations (per
cent eligible not reported) conducted by three surgeons in Canada 12 months after surgery.166 The overall
mean BMI in this cohort was not reported but the inclusion of patients with BMI of > 40 kg/m2 is implied
in the metabolic syndrome groupings shown. After adjustment for age, sex, comorbidities and baseline
WOMAC scores, BMI of > 30 kg/m2 was associated with poorer long-term WOMAC scores.
Patients in the Canadian study reported by Rajgopal and colleagues162 were treated with TKR by four
surgeons at a single centre. At 12 months, 550 patients (per cent eligible not reported) were assessed with
the WOMAC score. In this cohort, 12.5% of patients had a BMI of ≥ 40 kg/m2. BMI was analysed as a
dichotomous variable < 40 or ≥ 40 kg/m2. In multivariable analysis with adjustment for age, sex, mental
health, prior contralateral knee replacement, pre-surgical WOMAC score and comorbidities affecting gait,
patients with a BMI of 40 kg/m2 had a poorer long-term WOMAC score.
In a single-centre Spanish study, Núñez and colleagues159 followed up 112 patients (77% eligible) 7 years
after TKR. A total of 12.5% of patients in this study had a BMI of > 35 kg/m2. BMI was treated as a
categorical variable with groups of < 35 kg/m2 and ≥ 35 kg/m2. In multivariable analyses with age, sex,
comorbidities, sociodemographic and clinical characteristics, intraoperative variables, inpatient variables,
postoperative clinical variables and pre-operative WOMAC scores, long-term WOMAC pain and function
were poorest in patients with BMI of > 35 kg/m2.
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FIGURE 10 Distribution of BMI in the APEX TKR cohort.
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Evidence on the association between BMI and long-term joint specific pain and function is largely based on
analyses where patients with particularly high BMI levels are compared with those with lower levels.
There was evidence that those with high BMI did not achieve the levels of joint specific physical function
and pain control seen in those with a lower BMI. This was supported by the one study with an additional
marker of quality (multiple centres).154 However, this study did not include comorbidities in multivariable
analysis. Across all studies, there was insufficient information to consider the overall range of BMI in
relation to joint specific patient outcomes.
Body mass index as a predictor of WOMAC function scores
Six studies explored the impact of BMI on WOMAC function scores.46,127,152,153,155,159
In a study including 860 patients (70% eligible at 2 years) from several countries, Lingard and colleagues46
reported follow-up at 12 and 24 months after TKR. BMI was treated as a continuous variable and the
overall mean was 29.4 kg/m2 (SD 5.8 kg/m2). In multivariable analysis with age, sex, WOMAC, SF-36
mental health, knee flexion, working status, education, income, comorbidities and country, increasing
pre-operative BMI was associated with poorer WOMAC function at 12-month follow-up, but not
24-month follow-up. The size of the effect was small compared with that observed for pre-operative
WOMAC function score and number of comorbidities.
In a study in multiple Canadian centres, Jones and colleagues127 followed up an estimated 209 patients
(72% eligible) at 3 years after TKR. A total of 19% of patients had a BMI of ≥ 35 kg/m2 before surgery.
In multivariable analysis with age, sex and comorbidities, BMI was treated as a binary variable (< 35 kg/m2
or ≥ 35 kg/m2). Patients with BMI of ≥ 35 kg/m2 had a poorer long-term WOMAC function outcome.
In a study in multiple centres in Greece, Papakostidou and colleagues155 followed up 204 patients (90%
eligible) 12 months after TKR. In this cohort, 52.9% of patients had BMI of ≥ 30 kg/m2. BMI was analysed
as a binary variable. In multivariable analysis with age, sex, education, social support, place of residence
and baseline status of knee, long-term WOMAC function levels were similar in patients with BMI under or
over 30 kg/m2.
Perruccio and colleagues152 followed up 435 patients (88% eligible) at multiple Canadian centres at a
mean of 12.5 months after TKR. In this cohort, 45.3% of patients had a BMI of ≥ 30 kg/m2. The authors
included age, sex, education, comorbidities, other painful joints and WOMAC pain and function in
multivariable analysis with BMI treated as a binary variable. Patients with BMI of < 30 kg/m2 and
≥ 30 kg/m2 reported similar long-term WOMAC function.
Sullivan and colleagues153 followed up 120 patients (per cent eligible not reported) from multiple Canadian
centres 12 months after TKR.153 Patients in this cohort had a mean BMI of 30.8 kg/m2. In multivariable
analysis with age, sex, comorbidities, pain, function, surgery, pain catastrophising, pain-related fear of
movement and depression, BMI was treated as a continuous variable. BMI did not predict long-term
WOMAC function.
Núñez and colleagues159 followed up 112 patients (77% eligible) 7 years after TKR at a single centre in
Spain. In multivariable analysis the authors included age, sex, comorbidities, sociodemographic and clinical
characteristics, intraoperative variables, inpatient variables, postoperative clinical variables and pre-operative
WOMAC scores. BMI was treated as a binary variable and those with BMI of ≥ 35 kg/m2 had worse
long-term WOMAC function.
Overall, there was some suggestion from two studies that patients with more extreme levels of pre-operative
BMI (≥ 35 kg/m2) had poorer long-term physical function. Only one of these studies had an additional
marker of good quality. In two studies for which the analyses applied a division of less than or greater than
30 kg/m2, there was no apparent difference in functional outcome.152,155 Both studies had two additional
markers of study quality. In the two studies for which BMI was analysed as a continuous variable, there was
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either no association153 or a weak association46 between increasing levels of BMI and long-term
WOMAC function.
Body mass index as a predictor of WOMAC pain scores
Six studies looked at whether or not BMI was a predictor of WOMAC pain at ≥ 12 months
after TKR.46,127,152,153,155,159
In a multicentre study from Canada, Jones and colleagues127 followed up an estimated 209 patients
(72% eligible) at 3 years after TKR. A total of 19% of patients had BMI of ≥ 35 kg/m2. In multivariable
analysis with adjustment for age, sex and comorbidities, BMI was treated as a binary variable (< 35 kg/m2
or ≥ 35 kg/m2). There was a borderline significant association between BMI and trajectory of pain recovery
up to 3 years favouring patients with BMI of < 35 kg/m2.
Lingard and colleagues46 reported a multicentre study including 741 patients (86% eligible at 1 year) from
the UK, USA and Australia with TKR followed up at 12 and 24 months.46 The mean BMI was 29.4 kg/m2
(SD 5.8 kg/m2). In multivariable analysis, the authors included age, sex, WOMAC, SF-36 mental health,
knee flexion, working status, education, income, comorbidities and country. With BMI treated as a
continuous variable, there was no association between BMI and long-term WOMAC pain score at
12 months and 24 months.
Papakostidou and colleagues155 followed up 204 patients (90% eligible) from multiple centres in Greece
12 months after TKR. A total of 52.9% of patients had BMI of ≥ 30 kg/m2. In multivariable analysis with
age, sex, education, social support, place of residence and baseline status of knee, BMI was treated as a
binary variable. Long-term WOMAC pain levels were similar in patients with BMI under or over 30 kg/m2.
Perruccio and colleagues152 followed up 435 patients (88% eligible) at multiple Canadian centres at a
mean of 12.5 months after TKR. A total of 45.3% of patients had a BMI of ≥ 30 kg/m2. The authors
included age, sex, education, comorbidities, other painful joints and WOMAC pain and function in
multivariable analysis with BMI treated as a categorical variable. There was no association between BMI
and long-term WOMAC pain.
In a study of patients with TKR at multiple centres in Canada, Sullivan and colleagues153 followed up
120 patients (per cent eligible not reported) at 12 months after surgery. The mean BMI in this cohort was
30.8 kg/m2. The authors reported a multivariable analysis with BMI analysed as continuous variable and
adjustment for pain, function, age, sex, comorbidities, surgery duration, surgeon, pain catastrophising,
pain-related fear of movement and depression. In this analysis BMI was not a predictor of long-term
WOMAC pain.
In a single-centre study from Spain, Núñez and colleagues159 followed up 112 patients (77% eligible)
7 years after TKR. The mean BMI in this cohort was 30.7 kg/m2. In multivariable analysis with age, sex,
comorbidities, sociodemographic and clinical characteristics, intraoperative variables, inpatient variables,
postoperative clinical variables and pre-operative WOMAC scores, patients with BMI of ≥ 35 kg/m2 had
significantly worse WOMAC pain scores than patients with BMI of < 35 kg/m2. However, the analysis in
this study was limited by the small number of patients in the high BMI group (n= 14).
In the six studies with pain measured using the WOMAC score, there was little to suggest that
pre-operative BMI was a determinant of long-term pain with the possible exception of high body mass
index (≥ 35 kg/m2). At these high levels of BMI, patients may be more likely to report long-term pain.
Body mass index as a predictor of general health outcomes
Three studies explored the influence of BMI on general health outcomes after TKR.46,160,161 Outcomes
reported were SF-36 domains or the Nottingham Health Profile (NHP).
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Lingard and colleagues46 reported an international study including 860 patients (70% eligible) receiving
TKR at multiple centres. The mean BMI was 29.4 kg/m2 (SD 5.8 kg/m2). Higher BMI was a predictor of
poorer SF-36 physical function scores at 24 months but not at 12 months after surgery. Other variables
included in this multivariable analysis were age, sex, patient-reported outcomes, mental health, knee
flexion, working status, education, income, comorbidities and country.
Deshmukh and colleagues161 reported a UK study with 139 patients (77% eligible) treated by a single
surgeon with follow-up at 12 months. In this study, the mean BMI was 28 kg/m2 (SD 4.5 kg/m2) and only
two patients initially eligible had a BMI of ≥ 40 kg/m2. In multivariable analysis including age, sex, side of
arthritis, comorbidities, baseline NHP and knee scores, BMI accounted for only a small percentage of the
variation in long-term NHP scores.
In a single-centre study from Canada, Gandhi and colleagues160 followed up 551 patients (per cent eligible
not reported) at a mean of 3 years after surgery. The mean BMI in patients in this study was 30.1 kg/m2
(SD 6.3 kg/m2). After adjustment for age, sex, ethnicity, education, comorbidities and SF-36 mental health
status, BMI was not a predictor of long-term SF-36 role physical or physical function scores.
In summary, there is no clear evidence that BMI is a predictor of long-term general health outcomes after
TKR. However, evidence is lacking at higher levels of BMI.
Body mass index as a predictor of change in patient-reported outcomes
Four studies examined the association between BMI and change in patient-reported outcomes from pre- to
post TKR in multivariable statistical analysis.147,149,151,162 In the two studies reporting eligibility, 53.4%147 and
60.6%151 of patients were not followed up. These high rates were largely explained by the study designs,
a 1-year registry follow-up147 and a follow-up of patients placed on the waiting list for TKR after a mean
of 6 years.151
Franklin and colleagues147 reported a 12-month follow-up of US registry data including 8050 patients
(46% eligible). No information on mean levels of BMI was included. BMI was analysed as a categorical
variable with groups of < 30 kg/m2, 30–40 kg/m2 and > 40 kg/m2. In multivariable analysis with age, sex,
mental health, physical health, diagnosis and quadriceps strength, patients with BMI of > 40 kg/m2 had
less long-term functional gain as measured by the SF-12 PCS.
In the study in 3177 patients (per cent eligible not reported) from multiple centres reported by Alzahrani
and colleagues,149 the mean BMI was 31 kg/m2 and was analysed as a continuous variable.149 In a statistical
model included age, sex and comorbidities, BMI was not a significant predictor of achieving a minimal
clinical improvement on the OKS or WOMAC score at 12 months after surgery.
The study reported by Cushnaghan and colleagues151 included 259 patients (39% eligible) from three UK
health districts followed up for a mean of 6 years after surgery. A total of 41.7% of patients followed up
had BMI of ≥ 30 kg/m2 before surgery. Multivariable analysis included age, sex, SF-36, smoking habits,
comorbidities, Kellgren and Lawrence grade, previous knee injury, other painful joints and Heberden’s
nodes. The authors noted that patients with a BMI of ≥ 30 kg/m2 had a similar improvement in SF-36 PCSs
compared with patients with BMI of < 30 kg/m2.
Rajgopal and colleagues162 followed up 550 patients (per cent eligible not reported) at a single centre
1 year after TKR. A total of 12.5% of patients had a BMI of ≥40 kg/m2. The authors included age, sex,
mental health, prior contralateral surgery, WOMAC score and comorbidities in the multivariable model.
There were no differences in long-term improvement in WOMAC function between patients with BMI of
≥40 kg/m2 compared with those with BMI of ≤ 40 kg/m2.
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In summary, the evidence suggests that greater BMI is not associated with less improvement in PROMs
after TKR, although there is the possibility from one study with no additional markers of good quality that
patients with more extreme levels of BMI have a poorer improvement in general functional health.147
Pre-surgical mental health
In their systematic review with searches of MEDLINE and EMBASE to January 2011, Vissers and colleagues143
identified 19 studies including 6274 patients receiving TKR. There was strong evidence that pre-operative
pain catastrophising was associated with increased pain in the first year after surgery and that poorer
pre-operative mental health was associated with worse long-term physical function and pain. The authors
identified no strong evidence that pre-operative depression influenced functioning in the year after TKR.
In our systematic review, we identified 12 studies with ≥ 100 patients with TKR followed up for ≥ 12 months
with pre-surgical mental health included in multivariable analyses.50,147,148,150,155–158,160,163–165 Two studies
reported data from joint registries,147,148 five studies included patients from multiple centres150,155–158 and
five studies collected data from patients treated at a single centre.50,160,163–165 Study details are summarised in
Table 5.
In an analysis of the National Joint Registry for England and Wales, Baker and colleagues148 reported on
22,691 patients (55% eligible) with TKR followed up for at least 6 months and up to 12 months after
surgery. The authors included age, OKS, EQ-5D, disability, general health, comorbidities, and surgical and
hospital variables in a multivariable model. Pre-operative anxiety and depression measured using the EQ-5D
were associated with poorer long-term improvement in OKS and EQ-5D.
Franklin and colleagues147 followed up 8050 patients (47% eligible) from a US joint registry 12 months
after TKR. In multivariable analysis, the authors included SF-12 PCS, sex, age, BMI, osteoarthritis diagnosis
and poor quadriceps strength in the statistical model. The pre-operative SF-36 mental component score
was an independent predictor of poor long-term physical function measured with the SF-36 PCS.
Heck and colleagues157 followed up 268 patients (92% eligible) 24 months after TKR at multiple US
centres. The authors conducted a multivariable analysis with age, ethnicity, sex, poverty, patient health
status, WOMAC scales, SF-36 physical component, knee ROM, comorbidities, surgical factors and joint
problems in the other knee. Poor pre-operative SF-36 mental health was associated with less improvement
in the SF-36 PCS.
Lingard and Riddle150 followed up 628 patients (70% eligible at 2 years) who had received a specific TKR
prosthesis at 12 international centres.150 In a multivariable model with age, sex and comorbidities, patients
with psychological distress identified using the SF-36 mental health component had worse WOMAC
pain at 12 and 24 months than non-distressed patients. There was no strong evidence to support such
a relationship with long-term WOMAC function although there was a trend in a similar a direction.
The authors reported that there were no strong associations between pre-operative psychological distress
and changes in function and pain over either follow-up period.
In the study of Merle-Vincent and colleagues,158 264 patients (87% eligible) with TKR at multiple centres in
France were followed up after 24 months. In a multivariable analysis with age, sex, BMI, Lequesne index
and joint space narrowing, there was no strong evidence that patients with feelings of depression before
surgery were more dissatisfied with their TKR.
Papakostidou and colleagues155 followed up 204 patients (90% eligible) at two centres in Greece,
12 months after TKR. In a multivariable analysis with age, sex, BMI, education, social support, place of
residence and baseline status of knee, the extent of pre-operative depressive symptoms, measured with
the 10-Item Center for Epidemiologic Studies Short Depression Scale, were predictive of long-term VAS
pain. The authors concluded that depressed mood had a strong positive correlation with long-term pain
and functional limitation.
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Singh and Lewallen156 followed up 7139 patients (65% eligible at 2 years) with TKR at multiple US centres
2 years after surgery.156 Pain outcome was measured using a standardised Mayo Clinic questionnaire. In a
multivariable analysis with age, sex, BMI, operative diagnosis and comorbidities, anxiety identified in the
comorbidity assessment was an independent predictor of moderate to severe pain at 2 years, whereas
depression was marginally not. The authors also followed patients up at 5 years but losses to follow-up
were greater than at 2 years. There was evidence for an association between both pre-operative anxiety
and depression and moderate to severe pain at this longer follow-up.
In a study in 165 patients (per cent eligible not reported) with TKR at a single US centre, Ayers and
colleagues163 reported follow-up at 12 months. In multivariable analysis with age, sex, pre-operative
function and comorbidities, poorer pre-operative SF-36 emotional health was associated with smaller
improvements in SF-36 PCS and WOMAC physical function scores.
Brander and colleagues50 followed up 116 patients (per cent eligible not reported) at a single US centre
at 12 months after TKR. In multivariable analysis with age, sex, other demographics and physiological,
psychometric and pain variables, pre-operative depression and anxiety were associated with greater
long-term VAS pain.
In their study of 966 patients (per cent eligible not reported) with TKR followed up for 12 months at a
single UK centre, Clement and colleagues164 reported a multivariable analysis including age, sex,
comorbidities, socioeconomic deprivation, OKS and the SF-12 components. Poorer pre-operative SF-36
mental health was associated with a poorer long-term improvement in OKS but was not related
to satisfaction.
Gandhi and colleagues160 reported the follow-up of 551 patients (per cent eligible not reported) with TKR
at a single Canadian centre at a mean of 3 years. In multivariable analysis including age, sex, ethnicity,
BMI, education and comorbidity, patients with poorer pre-operative mental health according to the SF-36
had worse long-term WOMAC and SF-36 functional outcomes.
Scott and colleagues165 reported 12-month follow-up at a single UK centre of 1414 patients (87% eligible)
who had received a specific TKR prosthesis.165 In multivariable analysis with age, sex, SF-12 physical
component, OKS and comorbidities, patients with depression or a poor SF-12 mental health status were
more likely to be dissatisfied with their long-term outcome.
Studies investigating the relationship between pre-operative mental health and long-term patient
outcomes used generic measures, specifically the SF-36 and SF-12 mental health components or more
specific measures of anxiety or depression. For generic measures, poor mental health status before TKR
was a predictor of long-term increased pain or poorer function in all seven studies that reported
it.147,150,157,160,163–165 There was a consistent suggestion in three studies that patients with anxiety had worse
long-term pain or other patient outcomes.50,148,156 In five studies, patients with depression or depressive
symptoms had poorer long-term pain or functional outcomes.50,148,155,156,158 Associations between aspects
of pre-operative mental health and long-term patient outcomes were apparent in studies with one or
two additional markers of good-study quality. For satisfaction as an outcome, the associations with
pre-operative mental health measures were inconsistent.
Pre-surgical pain
We identified five studies with ≥ 100 patients with TKR followed up for ≥ 12 months with pre-surgical pain
included in multivariable analyses. Four studies included patients from multiple centres,46,153,155,157 and one
study was based on analyses of patients from a single centre.165 Study details are summarised in Table 5.
Heck and colleagues157 followed up 268 patients (92% eligible) at multiple US centres 24 months after
TKR. The authors conducted a multivariable analysis with the SF-36 mental health component, age,
ethnicity, sex, poverty, patient health status, WOMAC scales, SF-36 physical component, knee ROM,
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comorbidities, surgical factors and joint problems in the other knee. In this analysis pre-operative WOMAC
pain was not a predictor of the long-term SF-36 physical component.
Lingard and colleagues46 followed up 678 patients (79% eligible) from multiple international centres at
12 and 24 months after TKR. In multivariable analysis with age, sex, income, education, BMI, flexion,
country, centre and comorbidities, one of the strongest determinants of long-term WOMAC pain was the
pre-operative WOMAC pain score. The authors considered the difference in WOMAC pain scores to be
clinically important.
In a study of 204 patients (90% eligible) from multiple centres in Greece, Papakostidou and colleagues155
reported follow-up at 12 months after TKR. In multivariable analysis including depression, sex, BMI,
education, social support, age, place of residence and baseline status of knee, pre-operative WOMAC pain
predicted long-term WOMAC pain.
Sullivan and colleagues153 followed up 120 patients (per cent eligible not reported) 12 months after TKR
conducted at multiple Canadian centres. Greater pain catastrophising and pain-related fear of movement
were predictors of poorer long-term WOMAC pain and function outcomes in multivariable analysis
including age, sex, BMI, comorbidities, surgical factors, pain catastrophising, pain-related fear of movement
and depression.
Scott and colleagues165 followed up 1414 patients (87% eligible) at a single UK centre 12 months after
receiving a specific TKR prosthesis. Although significantly associated with long-term dissatisfaction in
univariate analysis, there was no association between pre-operative OKS pain and dissatisfaction in a
multivariable mode including OKS function, SF-12 physical and mental components, age, sex
and comorbidities.
Studies comparing pre- and postoperative pain measures consistently showed that patients receiving TKR
with higher levels of pre-operative pain had worse long-term pain. All studies had one or two additional
markers of good quality. Associations with long-term physical function and satisfaction were inconsistent.
Pre-surgical physical function
We identified five studies with ≥ 100 patients with TKR followed up for ≥ 12 months with pre-surgical
physical function included in multivariable analyses.46,157,163–165 Details of studies are summarised in Table 5.
Two studies were conducted in multiple centres46,157 and three studies in a single centre each.163–165
Heck and colleagues157 followed up 268 patients (92% eligible) 24 months after TKR at multiple US
centres. The authors included WOMAC function in a multivariable model with SF-36 mental health, age,
ethnicity, sex, poverty, patient health status, SF-36, knee ROM, comorbidities, surgical factors and joint
problems in the other knee. Patients with poorer WOMAC function had the greatest long-term
improvement in SF-36 PCS. The authors noted that patients who were more likely to show improvement
to general health had functional impairment at the time of surgery.
Lingard and colleagues46 followed up 678 patients (86% at 1 year) from multiple international centres at
12 and 24 months after TKR. The authors included age, sex, income, education, BMI, flexion, country,
centre and comorbidities in multivariable analysis. Poor pre-operative WOMAC function was an
independent predictor of poor long-term WOMAC function outcome.
In a study including 165 patients (per cent eligible not reported) with TKR from a single US centre, Ayers
and colleagues163 reported follow-up at 12 months. The authors included pre-operative WOMAC physical
function, age, sex and comorbidities in multivariable analysis. The model with increasing age and poorer
physical function predicted a poorer SF-36 and WOMAC physical function outcome.
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Clement and colleagues164 followed up 966 patients (per cent eligible not reported) for 12 months after
TKR at a single UK centre.164 Patients with a better OKS score before surgery had better long-term
OKS but were more likely to be dissatisfied with their operation in multivariable analyses with age, sex,
comorbidities, socioeconomic deprivation, SF-12 physical component and back pain.
Scott and colleagues165 reported a 12-month follow-up of 1414 patients (87% eligible) who had received a
specific TKR prosthesis at a single UK centre. In multivariable analysis with SF-12 mental component, age,
sex, depression and comorbidities, lower pre-operative OKS function was associated with greater satisfaction.
The relationship between pre-operative physical function and long-term patient outcomes after TKR was
complex. In three studies there was a simple association between low pre-operative function before
surgery and a poor long-term functional outcome. However, in another study patients with worse
pre-operative function had a greater improvement in physical function. In two studies those with lower
pre-operative function were more likely to be satisfied with their operation. Results of studies were
consistent in those with one or two additional markers of good quality.
Discussion
Systematic review of cohort studies is a pragmatic exercise requiring specific inclusion criteria. In any
population of people followed up before and after surgery the opportunity exists to carry out multivariable
analyses. Inclusion of published analyses which may focus on the interests of researchers, editors, reviewers
and readers is prone to bias.
For our reviews, we limited inclusion to studies with exclusively hip or knee replacement-based analyses.
We included studies for which separate analyses were reported but not when data were combined as
‘joint replacement’. Studies were excluded if they had < 100 patients and a long-term outcome was
classified as ≥ 12 months. Again this represents a pragmatic approach owing to the large number of
studies reported in the literature.
In the context of study quality, proportion not followed up probably relates more to generalisability as
multivariable analyses include only patients with variables measured before and after surgery (or some estimate).
Our overview of studies reporting long-term patient outcomes according to pre-operative BMI suggests that
many patients with high BMI benefit from total hip and knee replacement with long-term improvements to
physical function and reduction in long-term pain. However, there was some suggestion that the absolute
levels of physical function and pain achieved in patients with especially high BMI may be somewhat lower.
Patients with depression before surgery may have poorer long-term pain and functional outcomes after
total hip and knee replacement. For patients with anxiety or poor general psychological health, there was
evidence for a relationship with worse pain and functional outcomes in patients receiving TKR but
evidence in THR was equivocal.
Patients with better physical function and lower pain before total hip and knee replacement generally
achieved a better recovery in terms of joint specific pain and function. Patients with poor physical function
before surgery may have greater absolute improvement.
Conclusion
Longitudinal studies reporting the associations between pre-surgical factors and long-term patient
outcomes after total hip or knee replacement suggest that interventions before surgery to optimise a
patient’s physical function, pain levels and psychological health merit further study. In the context of
advanced osteoarthritis for which conservative treatments have not controlled symptoms, an exercise and
education intervention may aim to maintain functional levels or prevent further decline and facilitate
recovery. Pain management and psychological counselling may also have a role in preparing patients for
surgery and subsequent rehabilitation.
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Systematic review of comorbid conditions and long-term
patient-centred outcomes after total hip and knee replacement
Background
Multimorbidity is common in older people, with approximately 60% of people aged ≥ 65 years reporting
two or more health conditions.174 In a population aged ≥ 75 years, 60% reported one and 33.4% reported
two or more health problems.175 Among patients with advanced symptoms of osteoarthritis recruited into
the APEX study, comorbid conditions were common; in patients receiving total hip and knee replacement,
64% and 71% of patients, respectively, reported at least one condition additional to osteoarthritis.
Details of prevalence of specific comorbid conditions in the APEX study are summarised in Table 6.
In people receiving THR, commonly reported comorbid conditions were degenerative disc disease (24.7%),
osteoporosis (15.0%), visual impairment (14.0%), upper gastrointestinal problems (14.7%), cardiovascular
disease (12.0%), depression (13.7%), hearing impairment (8.3%), anxiety (11.7%) and diabetes (6.7%).
In people receiving TKR, the commonly reported comorbid conditions were degenerative disc disease
(22.9%), osteoporosis (18.5%), visual impairment (19.5%), upper gastrointestinal problems (18.2%),
cardiovascular disease (20.2%), depression (10.8%), hearing impairment (15.2%), anxiety (9.4%) and
diabetes (14.1%).
TABLE 6 Prevalence of comorbid conditions in the APEX cohorts
Condition
THR TKR
Female Male All Female Male All
Angina 3.9% 4.1% 4.0% 8.5% 11.8% 10.1%
Congestive heart failure 0.6% 1.6% 1.0% 1.3% 1.4% 1.3%
Heart attack 4.5% 4.9% 4.7% 4.6% 12.5% 8.4%
Stroke or transient ischaemic attack 2.8% 4.9% 3.7% 7.2% 9.7% 8.4%
Peripheral vascular disease 1.1% 3.3% 2.0% 2.0% 2.1% 2.0%
Any cardiovascular disease 8.4% 17.2% 12.0% 16.3% 24.3% 20.2%
Degenerative disc disease 28.1% 19.7% 24.7% 23.5% 22.2% 22.9%
Asthma 14.6% 5.7% 11.0% 17.0% 8.3% 12.8%
Chronic obstructive pulmonary disease 2.2% 2.5% 2.3% 7.8% 2.8% 5.4%
Diabetes type 1 and 2 6.2% 7.4% 6.7% 12.4% 16.0% 14.1%
Osteoporosis 15.2% 14.8% 15.0% 18.3% 18.8% 18.5%
Neurological diseases 1.1% 1.6% 1.3% 0.7% 2.8% 1.7%
Upper gastrointestinal disease 14.0% 15.6% 14.7% 23.5% 12.5% 18.2%
Depression 18.0% 7.4% 13.7% 13.7% 7.6% 10.8%
Anxiety or panic disorders 12.9% 9.8% 11.7% 12.4% 6.3% 9.4%
Visual impairment 15.7% 11.5% 14.0% 20.3% 18.8% 19.5%
Hearing impairment 6.7% 10.7% 8.3% 11.1% 19.4% 15.2%
Total number of patients 178 122 300 153 144 297
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Research on pre-surgical comorbidities has often focused on associations with adverse events. In a US
study including > 950,000 patients with joint replacement, the in-hospital rate of serious postoperative
adverse events including infection, non-healing wounds, pulmonary embolism and vascular complications
was 2.6%.36 In 260 patients with knee replacement, Kirschner and colleagues176 reported that 6% of
patients had serious adverse events within 3 months of knee replacement. More general adverse events
occurred in a further 26% of patients.
Adverse events are associated with lower patient satisfaction and poorer long-term HRQoL. In a study of
264 patients followed up 2 years after TKR, patients were more likely to be satisfied if they had no
complications after surgery [odds ratio (OR) 6.6, 95% CI 1.8 to 24.7; p= 0.004].158 In another study of
112 patients followed up 7 years after TKR, the number of post-discharge complications was associated
with poorer WOMAC pain (p< 0.001), stiffness (p= 0.018) and function (p= 0.042).159 Furthermore, in a
study of 1703 patients with TKR, 19% were dissatisfied with their outcome.177 In a multivariable model, the
OR for a patient being dissatisfied was 1.86 in the presence of a complication requiring hospital admission.
The majority of adverse events, after appropriate treatment, mobilisation and rehabilitation, have no serious
effect on long-term recovery. For some patients the adverse events are more serious and the consequences
severe. For example, patients with surgical site infections describe extreme pain, prolonged immobilisation,
isolation and insecurity, and feelings of hopelessness.178 If untreated with revision surgery, infection can result
in severe pain, persistent dislocation and death.179 Similarly, the consequences of pulmonary embolism are
extremely serious, with a 3-month mortality rate of about 17.4%.180 Deep-vein thrombosis is more common
and, although treated effectively in most people with anticoagulant therapy, associated costs are substantial. In
a Canadian study, average medical costs were CA$2503 [approximately £1615 (cost correct as of 2010)] with a
further CA$2677 [approximately £1727 (cost correct as of 2010)] attributable to non-medical costs including
loss of earnings, assistance and transport.181 Khan and colleagues182 estimated that complications after
non-cardiac surgery may lead to increases in hospital stays of 114%, with significant associated hospital costs.
Solomon and colleagues183 explored the predictors of adverse events (death, infection, pulmonary
embolism, pneumonia, and myocardial infarction) within 3 months of knee replacement in a cohort of
9073 patients from 276 US hospitals. The 37% of patients with one or more comorbid health conditions
had a 50% greater risk of an adverse event.
It is important to be aware of the increased risk of adverse events and poorer long-term patient outcomes
in patients with additional comorbid conditions. Scores reflecting the extent of comorbidity are widely used
to assess risk of death and adverse events in patients requiring joint replacement surgery. However, to
guide care of patients receiving joint replacement it is also important to know if patients with specific
comorbidities have different long-term patient-reported outcomes from those who are unaffected.
Appropriate pre-surgical interventions with assessment and management of clinical conditions may help to
reduce the incidence of adverse events and improve long-term patient outcomes after total hip and
knee replacement.
Our aim was to review the evidence on the associations between comorbid conditions and long-term
patient outcomes. When good-quality evidence was available on associations between comorbid
conditions and post-surgical adverse events, we summarise this briefly.
Particular comorbid conditions prevalent in populations of patients receiving total hip or knee replacement
and with potential for treatment were considered, specifically diabetes, cardiovascular disease,
hypertension, thyroid disease and anaemia.
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Methods
General methods As described in Systematic review methods
Databases and dates MEDLINE and EMBASE from inception to 16 October 2013
Search strategy Joint replacement/specified patient centred outcomes. MEDLINE search strategy based on terms in
Appendix 3. In addition, a series of specific searches linking total hip or knee replacement with
specific comorbidities: diabetes, cardiovascular disease, hypertension, anaemia, thyroid disease
Study design Cohort studies
Patients Total hip or knee replacement
Follow-up ≥ 12 months
Data extraction Date of publication, hip or knee, country, baseline dates of study, follow-up duration, pre-surgical
measures
Outcomes Patient-reported outcomes
Quality assessment Quality assessment related to generalisability as described in the systematic review of pre-operative
predictors of patient-centred outcomes after total hip and knee replacement
Results
Total hip replacement
The review flow diagram is shown in Figure 7. Searches identified five studies reporting analyses of specific
comorbid conditions identified before surgery and long-term patient-reported outcomes.127,130,166,184,185
Two of these studies reported separate analyses of different comorbidities in the same cohort.184,185
Study characteristics are summarised in Appendix 7 with brief details in Table 7.
Diabetes
In the APEX study, 6.7% of patients receiving a THR reported that they had type 1 or type 2 diabetes.
Searches identified four studies reporting long-term patient-reported outcomes in patients according to
their pre-surgical diabetic status. Two studies each included patients from multiple centres,127,185 or a single
centre.130,166 The proportion of patients followed up varied from 6.3% to 49.9%, which was largely
explained by lower follow-up rates in studies of longer duration.
TABLE 7 Systematic review of comorbid conditions and long-term patient-centred outcomes after THR:
included studies
Study
Number of patients;
follow-up Comorbidity Outcome measures
Multiple centres
Cushnaghan and colleagues 2007184
Judge and colleagues 2012185
249; mean approximately
96 months
Hypertension SF-36 PCS
Jones and colleagues 2012127 Approximately 167
(231 eligible); 3 years
Cardiovascular disease,
diabetes
WOMAC function
and pain
Judge and colleagues 2012185
Cushnaghan and colleagues 2007184
249; mean approximately
96 months
Diabetes, thyroid disease SF-36
Single centre
Anakwe and colleagues 2011130 850; 12 months Diabetes, hypertension Satisfaction
Gandhi and colleagues 2010166 707; 12 months Diabetes, hypertension WOMAC
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In a study in two Canadian hospitals, Jones and colleagues127 followed up an estimated 167 patients (72%
eligible) after THR. Diabetes mellitus was not a significant independent factor predicting recovery measured
by WOMAC function or pain scores in a multivariable analysis including cardiac disease, age, sex, BMI,
education, principal diagnosis, living arrangements, type of living accommodation, previous joint surgery,
ambulatory status and number of comorbid conditions.
Judge and colleagues127 followed up 249 patients (50% eligible) from two UK health districts at a mean of
96 months.185 In multivariable analysis with diabetes, hypertension, thyroid disease, age, sex, BMI, smoking
habit, previous knee injury, Heberden’s nodes, number of painful joints and radiographic grade, the OR for
no improvement in SF-36 physical function was 5.45 (95% CI 0.99 to 29.89) in patients with diabetes
compared with non-diabetics. This was close to statistical significance. In another analysis of this cohort,
the MD in change in SF-36 physical function was 25.8 points (95% CI 6.8 to 44.9 points) favouring
patients with no diabetes.184 However, both analyses were based on only eight patients with diabetes.
In a study at a single UK centre, Anakwe and colleagues130 followed up 850 patients (84% eligible) with
THR for 12 months. Diabetes was not associated with long-term patient satisfaction in multivariable
analyses including other comorbidities, age, sex, OHS, SF-12 physical and mental components and
musculoskeletal comorbidities (p= 0.227).
Gandhi and colleagues166 followed up 707 patients (83% eligible) after a THR at a single Canadian centre.
In a multivariable analysis with BMI, hypertension, hypercholesterolaemia, age, sex, WOMAC score, and
cumulative illness rating scale, self-reported diabetic status did not predict the extent of WOMAC function
improvement 12 months after THR (p= 0.46). However, in analyses considering the combination of
medical conditions relating to metabolic syndrome (hypertension, obesity, hypercholesterolaemia and
diabetes), presence of all four conditions was associated with a poorer long-term WOMAC
score (p= 0.04).
The four studies we identified did not provide any conclusive evidence on the impact of diabetic status on
long-term patient-reported outcomes.127,130,166,185 This may be explained by good glycaemic management in
patients with diabetes receiving THR in the cohorts we identified.
Patients with diabetes may be more likely to have complications after their THR. During the hospital stay,
patients with diabetes may be at greater risk of stroke, pneumonia and requirement for a blood
transfusion but not prosthetic joint infection.186 In a literature search relating to infection including all
studies reporting outcomes in patients according to diabetic status we identified 10 longitudinal studies
with 376,138 patients in which 2487 deep infections were recorded.186–195 As shown in Figure 11, the
relative risk of developing a deep infection was 2.14 (95% CI 1.44 to 3.18) in patients with diabetes
compared with non diabetics. We used a random-effects model owing to the high extent of heterogeneity
(I2= 74%). This was largely explained by one large study with follow-up only to hospital discharge.186
In an analysis of the US National hospital discharge survey including 43,215 patients receiving any
orthopaedic surgery, diabetes was associated with an increased risk of inpatient mortality in univariate
analysis but this was not statistically significant in multivariable analysis (OR 1.23; p= 0.18).196
In a study of 16,317 patients with total hip or knee replacement, there was an increased risk of
myocardial infarction and venous thromboembolism after joint replacement in patients with diabetes or
hypertension.197 Considering the cluster of hypertension, diabetes, obesity and dyslipidaemia that
constitute metabolic syndrome, the risk of myocardial infarction was increased by 128% and the risk of
venous thromboembolism more than tripled.
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In a US cohort of 1,030,013 patients receiving total hip or knee replacement, patients with diabetes were
compared by the level of glycaemic control.198 In those patients with uncontrolled diabetes, the risk of
surgical and systemic complications was significantly higher and mortality greater than in those with
controlled diabetes. Danish hip registry data from 3278 patients also suggests increased risk of revision
due to deep infection in patients with diabetes, particularly in those with short diabetes duration or
diabetic complications probably reflecting poor blood glucose control.194
Cardiovascular disease
In the APEX study, 12.0% of patients receiving THR reported a cardiovascular-related condition.
Our searches identified one study in multiple centres with multivariable analysis assessing patient-reported
outcomes according to presence of cardiovascular disease.127
In the study of Jones and colleagues127 at two Canadian centres, an estimated 167 patients (72% eligible)
with THR were followed up at 3 years. In an analysis adjusted for age, sex, BMI, education, principal
diagnosis, living arrangements, type of living accommodation, previous joint surgery, ambulatory status
and number of comorbid conditions, patients with cardiac disease had worse long-term WOMAC pain
(p= 0.014) and function (p= 0.012), and a slower recovery.
The mortality rate within 90 days after THR is about 1%199 and cardiovascular disease is generally the
leading cause of death.43 Research in patients receiving a THR with comorbid cardiovascular disease has
mainly focused on adverse events after surgery.
Ackland and colleagues200 developed a risk index based on patient history of ischaemic heart disease, heart
failure and cardiac risk factors. This method was able to stratify patients with elective orthopaedic surgery
by risk of in-hospital adverse events. However, with an area under the receiver operating characteristic
curve of 0.62 (95% CI 0.57 to 0.67), the predictive ability was modest.
Bozic and colleagues201 developed a risk calculator for 90-day mortality and prosthetic joint infection
in patients with THR. The risk model included age, sex, ethnicity and socioeconomic status and
29 pre-operative comorbidities including cardiopulmonary conditions. The authors concluded that levels of
risk could be used to counsel patients with heart disease before surgery. Sanders and colleagues202
explored the effect of time since a vascular event (stroke, myocardial infarction and unstable angina) on
outcomes of total hip and knee replacement in 414,985 patients. The authors concluded that patients
with a vascular event in the year before surgery were at greatest risk of death within 30 days of surgery.
In an analysis considering long-term outcomes, Singh and Lewallen203 noted a greater risk of periprosthetic
fractures in patients with heart disease identified before THR.
Hypertension
In a US study including 53,252 Medicare patients with THR, 66% of patients had hypertension
before surgery.201
Our searches identified three studies that included hypertension before surgery in multivariable analysis for
the prediction of long-term patient-reported outcomes.130,166,185
Cushnaghan and colleagues151 reported a multivariable analysis in 249 patients (50% eligible) from two
UK health districts followed up for 96 months after THR. Hypertension was not a significant predictor of
change in SF-36 physical function score, MD in change 0.5 points (95% CI –6.5 to 7.6 points).
In a single-centre UK study with 850 patients (94% eligible) followed up for 12 months, Anakwe and
colleagues130 compared levels of satisfaction with THR in patients with and without hypertension.
A total of 8.7% of hypertensive patients were dissatisfied with their THR compared with 6.4% of those
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without hypertension. This did not reach the specified level of statistical significance (p< 0.10) for inclusion
in multivariable analysis.
In their study of metabolic syndrome, Gandhi and colleagues166 followed up 707 patients (83% eligible)
12 months after THR at a single Canadian centre. In multivariable analysis with BMI, self-reported diabetic
status, hypercholesterolaemia, age, sex, WOMAC and comorbidity score, hypertension was a significant
predictor of lower overall WOMAC improvement at 1 year (p= 0.006).
Overall, there was limited evidence that patients with hypertension identified before surgery have poorer
long-term patient outcomes. As described previously, its importance may be as part of the cluster of
cardiovascular risk factors that constitute metabolic syndrome.
Considering adverse outcomes after THR, Bozic and colleagues201 reported that patients with hypertension
had an increased risk of mortality and joint infection. In a multivariable analysis, hypertension was an
independent variable included in a risk equation to identify patients at risk of joint infection and mortality.
Anaemia
We did not identify any studies reporting the association between pre-surgical anaemia and long-term
patient-reported outcomes after THR. Searches identified one systematic review by Spahn204 looking at
studies of perioperative anaemia and clinical outcomes. The author concluded that pre-operative anaemia
in patients with hip and knee surgery was associated with increased need for blood transfusion, infection
and death, poorer physical functioning and recovery, and longer hospital stay.
More recent analyses of registries and large cohort studies support this review. Jämsen and colleagues205
reported a multivariable analysis comparing mortality rates in 1998 patients with hip and knee
replacement. After extensive adjustment for patient and clinical characteristics including other
comorbidities, the hazard ratio for death was 1.47 (95% CI 1.08 to 1.99) in patients with pre-operative
anaemia compared with those without. In another multivariable analysis including 15,722 patients
reported by Greenky and colleagues,206 pre-operative anaemia was associated with a greater risk of
prosthetic joint infection but not mortality. In a multivariable analysis including 40,919 patients with THR
followed up for 90 days, Bozic and colleagues207 reported that patients with pre-operative anaemia had a
greater risk of prosthetic joint infection (hazard ratio 1.36, 95% CI 1.15 to 1.62). Pre-operative anaemia
was not associated with mortality within 90 days in multivariable analysis in this cohort.
O’Malley and colleagues208 identified factors associated with major complications after THR leading to delays
in hospital discharge. In multivariable analysis including BMI, pre-operative bleeding disorder, comorbidities
and surgical factors, pre-operative anaemia was associated with increased risk of major complications before
discharge. Major complications resulted in a mean increase in hospital stay of 62 days.
In a prospective analysis of data from patients with THR at a single centre, Myers and colleagues209 noted a
higher infection rate and need for transfusion in patients with pre-clinical anaemia on admission. Inpatient
stay was, on average, 18 days in patients with anaemia compared with 11 days in patients with no
pre-clinical anaemia.
Research on anaemia and THR has focused on early adverse events and death. Patients with anaemia may
be at greater risk of infection and other major complications, are more likely to require blood transfusion
and may have a substantially increased length of hospital stay.
Thyroid disease
In the Whickham survey of men with a median age of 58 years and women with a median age of
59 years, the prevalence of hypothyroidism was 1.3% and 9.3%, respectively.210 This compares with the
prevalence of treatment for hypothyroidism in people with severe osteoarthritis of 7.0% and 14.0% in
men and women, respectively, in the APEX cohort.
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Our searches identified one study with long-term patient outcomes after THR according to whether or not
patients had thyroid disease.185 Details of the study are summarised in Table 7.
In the study of Judge and colleagues,185 249 patients (50% eligible) with THR in two UK health districts
were followed up for a mean of approximately 96 months. In univariate analysis, there was no suggestion
of a difference in long-term SF-36 physical function in patients with thyroid disease compared with people
without thyroid disease (OR for no improvement or worse SF-36 physical function 0.96, 95% CI 0.36 to
2.53). The OR for a meaningful improvement in SF-36 physical function score (at least 30 points) was 0.33
(95% CI 0.07 to 1.49), a non-significant trend favouring patients with no thyroid disease.
Total knee replacement
The review flow diagram is shown in Figure 8. Searches identified six studies that reported analyses of
specific comorbid conditions identified before surgery and long-term patient-reported outcomes.127,151,163–166
Study characteristics are summarised in Appendix 8 with brief details in Table 8.
Diabetes
Diabetes is a common comorbid condition in patients receiving TKR. In an Australian cohort of 1214
patients with knee replacement, the prevalence of diabetes was 17.0%.211 Of 3,672,247 patients
discharged from US hospitals after unilateral TKR, about 13% were diabetic.212 In the APEX study, 14.1%
of patients with TKR recruited into a UK RCT had type 1 or type 2 diabetes.
Six studies reported long-term patient outcomes according to pre-operative diabetic status. Of these,
two were from multiple centres127,151 and four included patients from a single centre.163–166
Cushnaghan and colleagues151 followed up 259 patients (39% eligible) from three UK health districts at a
mean of 72 months after TKR. In multivariable analysis, a trend for greater improvement in SF-36 physical
function in diabetic patients was not statistically significant (mean relative change 3.8, 95% CI –8.5 to
16.2). The analysis included only 16 patients with diabetes.
TABLE 8 Systematic review of comorbid conditions and long-term patient-centred outcomes after TKR:
included studies
Study Number of patients; follow-up Comorbidity Outcome measures
Multiple centres
Cushnaghan and colleagues
2009151
259; mean 6 years Diabetes, hypertension,
thyroid disease
SF-36 physical function
Jones and colleagues
2012127
Estimated 209; 3 years Cardiovascular disease,
diabetes
WOMAC
Single centre
Ayers and colleagues
2005163
165; 12 months Cardiovascular disease,
diabetes
WOMAC function, SF-36
physical component
Clement and colleagues
2013164
966 (number eligible not specified)
12-month follow-up, losses to
follow-up not described
Diabetes, cardiovascular
disease, hypertension,
anaemia
OKS, satisfaction
Gandhi and colleagues
2010166
889 (approximately 1067 eligible);
12 months, 16.7% not followed up
Diabetes, hypertension WOMAC
Scott and colleagues
2010165
1141 (1290 eligible); 12 months,
13.1% not followed up
Diabetes, cardiovascular
disease, hypertension
Satisfaction
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Jones and colleagues127 followed up an estimated 209 patients (72% eligible) after TKR at two Canadian
centres. At 3 years, there was little to suggest that WOMAC pain and function differed according to
diabetic status; however, the authors observed that pain and function scores worsened slightly after
6 months among diabetic patients but not in non-diabetics.
Ayers and colleagues163 followed up 165 patients (per cent eligible not reported) from a single US centre
at 12 months after TKR. In multivariable analysis there was no association between diabetic status and
long-term physical function measured by WOMAC and SF-36 scales.
In a study from a single UK centre with 1141 patients (87% eligible) followed up at 12 months, Scott and
colleagues165 found no association between diabetic status and long-term satisfaction after TKR.
In a study from a single Canadian centre, Gandhi and colleagues166 followed up 889 patients (83%
eligible) after TKR. Self-reported diabetic status showed a trend for poorer WOMAC score at 12 months
but this was not statistically significant (p= 0.07). In analyses considering the combination of medical
conditions relating to metabolic syndrome (hypertension, obesity, hypercholesterolaemia and diabetes), in
the presence of all four conditions there was a trend for poorer long-term WOMAC score but this was not
statistically significant (p= 0.08).
Clement and colleagues164 followed up 966 patients (per cent eligible not reported) at a single UK centre
12 months after TKR. In multivariable analysis, diabetes was not associated with a poorer long-term patient
outcome (p= 0.47).
There is no strong evidence to suggest that long-term patient outcomes after TKR differ according to
diabetic status; however, much research has focused on the risk of adverse events. In our literature search
on the incidence of infection by diabetic status, we obtained data from 14 studies including 633,813
patients in which 3988 deep infections were recorded.186,191,192,207,211,213–221 In a random-effects
meta-analysis shown in Figure 12, the relative risk for infection in patients with diabetes compared with
non-diabetics was 2.03 (95% CI 1.54 to 2.67).
In studies with more general orthopaedic inclusion criteria, patients with diabetes had an increased risk of
myocardial infarction and venous thromboembolism. This was particularly evident in patients with the
metabolic syndrome cluster of risk factors.197 There was also a suggestion of an increased risk of inpatient
mortality for patients with diabetes, but this was not statistically significant.196
Cardiovascular disease
In the APEX study, 20.2% of patients receiving TKR reported a cardiovascular-related condition.
Our literature searches identified four studies reporting multivariable analysis of patient-reported outcomes
according to presence of cardiovascular disease. One study was conducted in multiple centres127 while
three studies included patients from a single centre.163–165
Jones and colleagues127 followed up an estimated 209 patients (72% eligible) at 3 years after TKR at two
centres. Cardiac disease before surgery was not a predictor of long-term WOMAC pain or function.
In the study of Ayers and colleagues,163 165 patients (per cent eligible not reported) with TKR at a single
centre were followed up at 1 year. Only univariate analyses were reported for individual comorbid
conditions. There was a lower improvement in the SF-36 physical component in patients with
cardiovascular comorbidity than those without but the relationship was not strong. For WOMAC physical
function, there was a suggestion that patients with cardiovascular comorbidity had a lesser improvement in
physical function than those without.
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Scott and colleagues165 followed up 1141 patients (87% eligible) with TKR at a single centre 12 months
after surgery. In univariate analysis, there was little difference in long-term satisfaction in those with heart
disease compared with those with no heart disease.
In the study of Clement and colleagues,164 966 patients (per cent eligible not reported) with TKR at a single
centre were followed up for 12 months. Patients with a history of heart disease had a poorer improvement
in OKS compared with those with no history of heart disease.
Overall, there was a suggestion that people with heart disease had somewhat poorer long-term
improvement in pain and function, but this was only evident in two studies with no additional markers of
good quality. Further research has studied the association between comorbid cardiac disease and
adverse events.
Variables in the risk calculator for in-hospital adverse events described by Ackland and colleagues200
included specific cardiac diseases and risk factors but the discriminatory ability of the model was modest.
Gill and colleagues222 looked at factors predicting mortality within 90 days of TKR in a cohort of
3048 patients, of whom 14 died. Patients with any major cardiovascular disease before surgery had a
greater risk of death within 90 days of surgery. In the study of Sanders and colleagues,202 a greater risk of
death within 30 days of surgery was observed in patients with a vascular event in the year preceding total
hip and knee replacement.
Hypertension
Searches identified four studies reporting long-term patient outcomes according to whether or not patients
had hypertension before surgery. Studies were in multiple151 or single centres.164–166
In a study in three UK health districts, Cushnaghan and colleagues151 followed up 259 patients (39% eligible)
from three centres at a mean of 72 months after TKR. In multivariable analysis, hypertension was not a
significant predictor of change in SF-36 physical function score.
Gandhi and colleagues166 followed up 889 patients (83% eligible) after a TKR at a single Canadian centre.
Similar WOMAC function improvement was observed at 1 year, irrespective of presence of hypertension.
The authors noted a trend for poorer long-term WOMAC score in patients with the four conditions
relating to metabolic syndrome but this was not statistically significant.
Scott and colleagues165 followed up 1141 patients (87% eligible) from a single UK centre 12 months after
TKR. In univariate analysis, more patients with hypertension were dissatisfied with their outcome than
those with no hypertension.
In a study at a single UK centre, Clement and colleagues164 followed up 966 patients (per cent eligible not
reported) 12 months after TKR. There was no difference in change in OKS in patients with hypertension
compared with those with no hypertension.
Considering adverse events, Bozic and colleagues223 followed up 83,011 patients with TKR 90 days after
surgery. In multivariable analysis, hypertension identified pre-operatively was not associated with infection
or mortality.
There was no clear evidence that patients with hypertension had worse long-term pain and function
outcomes after TKR. As observed with diabetes, management of blood pressure may affect studies of the
association between pre-operative hypertension and post-surgical outcomes. Most people with a diagnosis
of hypertension will be treated before surgery; indeed management of undiagnosed hypertension may be
required in the preparation for elective surgery.
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Anaemia
We identified one study with patients from a single centre that reported long-term patient outcomes after
TKR according to pre-operative anaemia status.164
Clement and colleagues164 followed up 966 patients (per cent eligible not reported) 12 months after TKR
at a single UK centre. There was a small difference in improvement in OKS between patients favouring
those with no anaemia but the relationship was not strong.
The systematic review of Spahn204 considered clinical outcomes of patients with hip and knee surgery.
Pre-operative anaemia was associated with post-surgical mortality and infection, increased need for blood
transfusion, poorer physical functioning and recovery, and longer hospital stay.
More recently, Bozic and colleagues223 followed up 83,011 patients with TKR for 90 days after surgery.
In multivariable analysis, pre-operative anaemia was associated with an increased risk of infection but
not mortality.
Jämsen and colleagues205 reported an increased risk of death in 1998 patients receiving knee or hip
replacement with pre-operative anaemia compared with those without. In a multivariable analysis including
patients with total hip or knee replacement, Greenky and colleagues206 reported a greater risk of infection
but not mortality.
In summary, there was no strong evidence relating pre-operative anaemia to long-term patient outcomes.
However, by reducing adverse events and limiting hospital stay, strategies to manage anaemia before
surgery may have substantial benefits for both patients and health-care providers.
Thyroid disease
Searches identified one study conducted in multiple centres reporting patient-reported outcomes in
patients with or without thyroid disease who received a TKR. Cushnaghan and colleagues151 followed up
259 patients (39% eligible) in three English health districts at a mean of 72 months after TKR. In multivariable
analysis, thyroid disease was not a significant predictor of change in the SF-36 physical component.
Discussion
Approximately 60–70% of patients receiving total hip and knee replacement report one or more comorbid
condition and are at risk of an adverse event after surgery. Although this is valuable information in itself
with the possibility of extra monitoring and care, preparatory strategies with treatment of individual
conditions may prevent adverse events and improve long-term patient outcomes. Our systematic review of
large prospective cohort studies investigating the relationship between pre-operative comorbidities and
long-term patient outcomes highlighted some possible areas for intervention.
We did not confirm a relationship between diabetic status and long-term patient outcomes after total hip
or knee replacement; however, patients with diabetes are at greater risk of early adverse events and are
over twice as likely to have a deep infection after their total hip or knee replacement with potentially
devastating consequences for patients and substantial health-care implications. Supported by the
observation that patients with uncontrolled diabetes have poorer outcomes than those with better
glycaemic control, optimisation of diabetes control before surgery may be of long-term benefit to patients
receiving total hip or knee replacement and merits appropriate evaluation.
Although not consistently so, there was some suggestion that patients with cardiovascular disease
had poorer patient outcomes after total hip and knee replacement. As with diabetes the impact of
cardiovascular disease on patients may be an increased rate of adverse events, possibly limited to those
patients with more recent occurrence of acute coronary syndromes.
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Evidence on the importance of hypertension on long-term outcomes in patients with hip or knee
replacement was equivocal. As a widely treated condition in older people, it is unlikely that the patients
receiving joint replacement would have uncontrolled hypertension. No studies were found looking at
outcomes by level of blood pressure control.
There was evidence from one study that diabetes and hypertension, in combination with other conditions
(high BMI and hypercholesterolaemia) that make up metabolic syndrome may be associated with poorer
long-term patient outcomes.166 However, this was only statistically significant in patients with THR.
We identified no studies reporting long-term patient outcomes in patients according to presence of
pre-operative anaemia. Patients with anaemia had increased need for perioperative blood transfusion and
increased risk of early adverse events, which probably explains a substantially longer average hospital stay.
Further evidence is now required from intervention studies on whether or not improved management of
conditions before surgery can improve long-term patient outcomes, possibly mediated through a reduction
in adverse events. Encouragement for this approach in diabetes comes from two large studies.194,198
In the US Nationwide Inpatient Sample of nearly 1 million patients with joint replacement, the risk of
postoperative complications was increased in patients with uncontrolled diabetes.198 This was supported by
data from the Danish Hip Arthroplasty Registry suggesting that those with complications due to diabetes
had a greater risk of revision, owing to deep infection.194 However, an analysis of data from a US
integrated health-care system did not report a poorer outcome in patients with HbA1c (glycated
haemoglobin) ≥ 7%, a marker of poor diabetes control.213
In this review, we focused on five specific comorbidities. Further studies are required to explore the
associations between other conditions and long-term patient outcomes. For example, in the APEX cohort
of patients receiving TKR, 19.5% of patients reported visual impairment and 15.2% reported hearing
impairment. If there is evidence linking these to poor outcomes, this would indicate the potential value of
appropriate screening and treatment.
In the UK, the Royal College of Anaesthetists and Association of Anaesthetists of Great Britain and Ireland
provides patient guidance on preparation for surgery.224 Recommendations include giving up or quitting
smoking, reducing weight, dental check-up and GP check-up for long-standing medical problems.
Numerous blood tests are routinely performed before surgery but their value in predicting adverse events225
and management of health conditions226,227 is uncertain. The best evidence on clinical effectiveness and
cost-effectiveness of interventions and prognostic models comes from their evaluation in randomised trials
and, ultimately, in systematic review and meta-analysis.
Conclusion
In specific clinical conditions, we found little research on patient-reported outcomes. In studies looking at
long-term patient outcomes according to diabetic status, research was inconclusive. However, studies
show that patients with diabetes, previous heart disease and anaemia are at greater risk of post-surgical
adverse events and study of appropriate interventions through systematic review and RCTs is indicated.
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Chapter 3 Patient and public involvement in the
RESTORE programme
There has been ongoing PPI throughout the programme as follows.
Collaboration with Arthritis Care, a national charity supporting
people with arthritis
The previous regional director (Pippa English-Penfold) and, subsequently, the Director of Service
Development (Phil Baker) have taken part in programme meetings to determine the direction of work
packages and the programme as a whole. We also held a mid-programme event at which Arthritis Care
was represented and contributed. Within the SPIRAL study there has been active collaboration with
Arthritis Care through the design and delivery of the ‘Challenging Pain’ and ‘Keep Challenging Pain’
interventions, pre- and post joint replacement. We have also attended Arthritis Care’s AGM in 2011 and
presented an introduction to randomised trials and discussed SPIRAL with members of Arthritis Care.
Engagement with the Patient Experience Partnership
in Research
In 2010 a patient group, the PEP-R group, was established to provide a forum through which patients could
provide who contribute to the design and delivery of research in the University of Bristol’s Musculoskeletal
Research Unit (MRU). This group currently comprises eight people who have musculoskeletal conditions,
many of whom also have had joint replacements. Group members totalled 18 (nine women and nine men,
aged 25–85 years), with a maximum of 11 members at any one time. The group meets for 2 hours every
6–8 weeks. In keeping with guidance from INVOLVE – the national advisory group that supports greater
public involvement in NHS, public health and social care research228 – group members were reimbursed for
their time and travel expenses.
Support and training for the patient partners was provided by a dedicated PPI co-ordinator who is a
trained researcher with several years’ experience supporting patient partners in research. Support included
structured training sessions and one-to-one meetings with patient partners. Training and learning is
incorporated into PEP-R meetings. Researchers have described and discussed study design (e.g. randomised
trials) in the context of studies. In response to group members’ feedback, sessions have also included
discussion of epidemiology, statistics and qualitative methods. PEP-R members have also visited the MRU.
The co-ordinator liaised between research staff and patient partners. Researchers from the MRU work
closely with the new ‘People and Research West of England’ partnership promoting and supporting service
user involvement in research, and patient partners had access to events and the service user network.
PEP-R group members are regularly provided with information about how their input has influenced the
implementation of studies so that they can see their impact on the research, including verbal feedback on
previously discussed projects at the start of every meeting and written feedback in the form of leaflets
every few months.
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Patient Experience Partnership in Research inputs into many studies within the unit and one of them was
RESTORE. Researchers from RESTORE have attended eight meetings of the PEP-R group. The format of
these sessions includes group discussion, presentations, card-sorting tasks and written answer sheets. It
was important for researchers to have a written record of the session, so discussions are recorded on a flip
chart or written sheets completed by group members. Material is sent out to group members in advance
so that they have the chance to read it beforehand. They had the choice of providing their input verbally
during a session, or by telephone or e-mail afterwards.
All of the work packages have been discussed and developed in collaboration with patient representatives
and PEP-R. Patient representatives have provided input into patient recruitment and information literature,
research processes, identifying outcomes of importance to patients, questionnaire design and
dissemination and helped ensure that outputs of packages informed one another.
The work of the PEP-R group, including work on the RESTORE project and other projects was recognised in
a University of Bristol’s engagement award 2014.
APEX
Patient representatives inputted into the refinement of patient information materials to ensure that they
were clear. One issue with early recruitment materials in APEX was the inclusion of information about
spinal anaesthesia. Through discussions with patients it became clear that this was confusing and
potentially worrying. Therefore, this information was removed from the recruitment packs. PEP-R has
learned about randomised trials through discussion of the APEX trial and of trials in general with
researchers facilitating PEP-R sessions. Issues of blinding and sharing results with participants have been
discussed with patient representatives and these discussions helped to inform the decision to tell
participants in APEX about their allocation to intervention or control groups. Patient representatives
advised on the appropriate terminology and the level and amount of information provided to participants
when contacted to arrange their 12-month research follow-up visits. They confirmed that the proposed
explanation of the visit made the need to undress for an examination explicit and favoured the less clinical
term ‘surgical site’ as opposed to ‘wound’ or ‘scar’ with regard to the examination of the replaced joint.
As a result, the research nurses were able to incorporate these changes into their subsequent interaction
with the participants.
ADAPT
Patient representatives provided suggestions about how to frame the requirements of study participation
to participants and in relation to questionnaires. In ADAPT, questionnaires were long and data were
collected at three time points. This meant that data collection would involve patients visiting the hospital
on three occasions each and also completing long questionnaires. Patient input helped in the presentation
of the questionnaires to make them easier to read and complete; however, as these were validated
instruments, changes could not be made to the questions or response options. Since study completion,
patient representatives provided suggestions for feedback in leaflet form to study participants as well as
suggestions of other ways of disseminating findings to the public. Their suggestions included providing a
brief summary of the project as participants might have forgotten, using visual representations, signposting
to other ways the information will be used and where participants could read about the study in greater
detail, for example, giving links to journal articles.
SPIRAL
Patient representatives discussed the study in detail and provided their input into the intervention and
study recruitment material, which led to refinements to all these aspects of the study. These discussions
resulted in a change in the name of the study to SPIRAL and improving the formatting of the patient
information sheet. They also discussed issues around non-participation in the study and made suggestions
about how it could be made easier for patients to take part, including providing help with transport and
holding the groups in local venues rather than hospitals. These suggestions will be used to guide the
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design of future research protocols. Since study completion, patient representatives provided suggestions
for feedback in leaflet form to study participants.
ARENA
Patient representatives were asked to feedback on the development of this study. They provided input into
the development of the exercise class in terms of patients’ requirements during the class and opinions of
the exercises proposed. For example, they highlighted the importance of providing assistance with travel
arrangements for those with transport difficulties, the inclusion of refreshment breaks and music during
the class, and the additional of an exercise aimed to improve patients’ ability to get in and out of bed.
They also emphasised the importance of study participants having details of person whom they could
contact between classes. In response to this, a contact name and telephone number was available to all
participants throughout the study. In addition, they provided the research team with reassurance that the
introduction of an exercise class after knee replacement was a positive approach and they supported the
concept of providing function-based exercises within a group setting. Following completion of the ARENA
study, the patient representatives have supported further proposals to pursue a larger trial comparing the
exercise class with usual care. They felt that providing further individualised treatment within the exercise
class would be beneficial to patients. This has been included the design of a grant proposal to explore the
exercise class in a future study.
PROOF-THR
Patient representatives discussed the protocol and study materials, leading to refinements in these. As a
direct result of these discussions, the design of the main study compared with the pilot was changed by
adding in a follow-up visit to check progress by the same occupational therapist (OT) who had visited them
before surgery if the patient requested one. In addition, as a compromise for the patient input regarding
follow-up, the OTs were given a pre-paid mobile phone each and the patients were given the number to
call for verbal advice. This was actually used quite a lot and proved very popular with the patients. It was
also suggested that the visiting OT give advice on benefits, but this is not standard OT practice as it is a
complex area that requires specialist advice. Instead, helpful phone numbers were given to participants
if requested.
Systematic reviews
The importance and value of systematic reviews has been discussed with the patient representatives. This
has been particularly helpful in developing new projects with extensive discussions on how to follow-up
results of reviews relating to comorbidities and rehabilitation.
Patient experience study
Patient representatives discussed this study in detail, leading to the addition of questions in the interview
topic guide such as questions around when and why problems first developed with the joint. Other
suggestions taken on board include adding an e-mail address to the back of the patient information
booklet to enable potential participants to contact the research team via e-mail and the positive
implications of including the Hip Disability and Osteoarthritis Outcome Score (HOOS) or KOOS
questionnaires in the 12-month follow-up interview in addition to the pre-operation interview. Since study
completion, the patient representatives have provided suggestions for feedback in leaflet form to
study participants.
In addition, in January 2013 we held a dissemination event with members of PEP-R. Arranged as a ‘science
café’, the event provided opportunity for discussion about all work carried out on the RESTORE programme.
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Patient and public representation on steering groups
The overarching study group includes representation from a patient with experience of bilateral hip
replacement. She has attended programme and work package meetings providing input into the
development of questionnaires, suggestions for improvements to the studies and ensuring that the
programme is relevant to patients (see Patient involvement in Patient Experience Partnership in Research:
a personal view). In addition, the steering groups in the individual work packages APEX and the Patient
Experience Study included patient and public representatives. Their role differed from those on the patient
forum. Oversight groups monitored progress and conduct of the work package. These patient and public
representatives discussed the study design, delivery and identifying avenues for dissemination and to
ensure that study findings will be presented to a range of stakeholders. They were supported by the PPI
co-ordinator.
Evaluation of patient and public involvement
We assessed patient involvement in the programme by collecting regular, systematic feedback from patient
partners and researchers. This helped us refine our involvement processes as the programme progresses,
as well as to provide advice on PPI activity to others within NHS and University sectors.
Eight patients, who were members of PEP-R at the time of the evaluation (November 2011), and
14 researchers completed a questionnaire examining the impact of the activity on themselves and the
research. Group members described their interest and learning about the topics and research in general.
They particularly valued feedback about how PEP-R’s input had shaped studies. Researchers identified
the benefits of obtaining patients’ views on the importance, relevance and feasibility of their projects.
They welcomed the opportunity to speak to an interested and knowledgeable group and stressed the
importance of early involvement. A selection of comments are shown in Table 9.
TABLE 9 Example comments on PEP-R by group members and researchers
Group member Comments
Group member E We have been asked and listened to about our opinions, which has led to improved layout of
information leaflets and questionnaires. Also the content and language used in leaflets
and questionnaires
Group member A Where funding has been granted, I am sure that PEP-R has contributed – our combined
experience as patients has made a big contribution to the process. We know the research
team listen carefully to our input
Group member C Feedback from researchers also indicates that modifications to documentation, etc. have also
been made
Researcher V As a researcher you can have many ideas for research projects, but without consultation with
patients, it can be difficult to know whether these issues are actually of importance to
patients. I wanted to engage with PEP-R as it provided an opportunity to ensure that the
research was of interest and relevance to patients
Researcher U The ethics committee asked me about patient involvement . . . I picked up a feeling that my
contact with the group more than satisfied this requirement. I also found many of the
suggestions that were made by the group helped me to improve my study design
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Dissemination of research findings
Working with Arthritis Care and patient representatives, we have developed a dissemination strategy that
addresses the needs of policy-makers, health professionals and service users. We envisage that this
will be achieved by dissemination in reports, end of project feedback leaflets for research participants,
peer-reviewed articles, conference presentations, lay summaries of findings in magazines and websites.
Engagement with PEP-R will continue, particularly focusing on identification of dissemination strategies
and working in partnership with researchers to develop plain English summaries of research.
Patient involvement in Patient Experience Partnership in
Research: a personal view
Victoria Wells has been a patient-partner in RESTORE throughout its duration. She previously underwent
joint replacement. This section outlines her experience of patient involvement in the programme and her
views about the research.
I came from the operating table to sitting around the research table. I remember the first research
meeting where everyone was introducing themselves and talking about RESTORE. Being part of that
from a lay perspective gave the research extra grounding in experiences. It’s been good having nurses,
patients, physios and surgeons working alongside researchers as they all bring different views, painting
the whole picture. It’s very easy to have research that misses the patient and it’s good to have the
patient there.
In RESTORE I’ve had individual conversations with the study leads, and researchers were able to
approach me so that I could answer their questions. There were no barriers there and the researchers
seemed not to be worried about asking me questions. They were able to ask me questions and were
sensitive to the patient journey that I had had. As result of personal experience I’m able to put in real
life experience into the research or make suggestions to approach other patient partners. I could also
break down academic text into more readable forms, for example for patient leaflets. I was able to
bring in some influence from ‘outside the box’ and it was also like being able to turn a box inside out.
With APEX my input was in how the study would be described to patients at the sensitive stage before
surgery when people needed to know about their pain relief. My thoughts were listened at that early
stage. I really remember coming to my second research meeting as we talked about information in
the APEX trial and about the information that would eventually be disclosed to patients in the trial.
Blinding was important, and so was the information about the treatment that patients got.
With ADAPT the questionnaires needed a lot of input before they went to patients, and that was
important. With ARENA there were quite a few informal conversations for my input, although SPIRAL
and ARENA the studies were patient-centred anyway. In the patient experience study I had quite a few
conversations looking at the patient experience in the long-term, beyond the ward, and making the
most of your joint replacement. I’ve had interesting conversations around the systematic review work,
and there were informal discussions and I do feel like that work has taken my views onboard. With
the health economics my engagement has also been informal and the cost-effectiveness side of the
work is hugely important. With the informality it’s less like being interviewed and it’s more of a
discussion and the team members are more relaxed and feel able to ask me questions, which is what
you’d get in qualitative research because it would be a conversation and no pressure for a particular
outcome because you can just explore the study and think about things in different ways. With the
health economics and systematic reviews it’s been explained in ways that I can understand and made
me think in a different way, and this is kind of hidden and useful.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
59
Having contact with researchers hasn’t always been about having a specific outcome in mind, it’s
about exploring a study that enables involvement, so that the thought processes are clear. Patient and
public involvement doesn’t always need to be prescriptive, but this can only happen if you’ve built up
a relationship over time and the involvement I have had I have built this up with the RESTORE team.
As a result of early involvement in RESTORE and my understanding of patient and public involvement
I was able to advise on the creation of PEP-R (the Unit’s patient forum), which gave richer information
from a collective of patients rather than an individual. I feel like it’s creating a minibus of people and
we are passengers because no two experiences are the same. I’ve been involved in PEP-R but have
also been able to hand over that baton to others, I was on the planning and steering group and was
able to hand that over and that felt good.
Victoria Wells, University of Bristol, 2014, personal communication, reproduced with permission
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Chapter 4 Understanding patient’s experiences of
total hip and knee replacement: a qualitative study
Parts of this chapter have been reproduced with permission from Johnson EC, Horwood J, Gooberman-Hill R.Patients’ journeys through total joint replacement: patterns of medication use.Musculoskeletal Care
2014;12:92–102229 © 2013 John Wiley & Sons, Ltd; and reproduced with permission from Johnson
and colleagues.230
Abstract
Background
We aimed to characterise and explore the patient pathway through total hip or knee replacement surgery
in current routine NHS care.
Methods
In a qualitative study, 34 patients receiving joint replacement were interviewed before surgery, 2–4 weeks,
6 and 12 months after surgery. Interviews elicited patients’ experiences of preparing for, undergoing and
recovering from surgery. Analyses used a thematic approach or interpretive phenomenological analysis.
Results
Patients noted that delays to joint replacement in the NHS are common, which has implications for
well-being. Patients’ experiences of time differ from the linear conceptualisation of time required to plan
NHS services.
Undergoing surgery can increase feelings of vulnerability and alter a patient’s trust in their own body, the
influence of interactions with others on confidence levels, and fears concerning the potential for causing
harm to their new prosthesis. Patients rely extensively on, and value, both informal and formal support
networks over the perioperative period. Transformation from a person living with osteoarthritis to a person
recovering from a surgical intervention can lead to alterations in the assistance people receive from others.
When patients are not offered the support of health and social professionals, patients may feel distress
and abandonment. Patient expectations for joint replacement surgery are complex and can be driven by
previous personal experience, experiences of others and information provided by the hospital.
Conclusions
Our findings suggest important ways in which the provision and delivery of care and education for people
undergoing joint replacement in routine NHS care can be refined and improved.
Background
Qualitative work has provided insight into the experience and impact of living with osteoarthritis including
treatment options and surgery.5,24–27 In relation to surgery, studies have explored pathways to surgery;4,29
decision-making about joint replacement;231 and patient satisfaction and outcome.28,30 However, little
research has explored how patients experience their journeys through joint replacement from pre-operative
care to postoperative recovery. Our qualitative research addresses this gap in evidence by focusing on
experiences of pre-operative circumstances and preparation, views about the hospital stay and the
operation, as well as exploring longer-term recovery, rehabilitation and outcome in the year after surgery.
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The research aimed to provide robust patient-centred evidence that could inform future design and
delivery of health care for people undergoing joint replacement. We used an inductive approach to the
work and the areas of literature that we draw on are those that became most relevant as data collection
and analysis progressed. These were related to the wait for surgery, the experience of delay, confidence
and expectations as well as the experience of time in the lead up to surgery.
Understanding the patient experience: total hip replacement
Waiting for hip replacement surgery
Within the NHS, waiting times for medical interventions are a recognised element of current health care,232
as patients passing through the system are provided with appointment dates for consultations and
treatments by a system increasingly predicated on a discourse of patient choice.233–235 A continual drive to
reduce waiting times for intervention, to monitor and measure the passage of time, highlights the salience
and relevance of a consideration of the temporal landscape within current health-care processes. The issue
of waiting times is important given that a growing body of research highlights the detrimental impact that
waiting for elective surgery can have. For example, patients awaiting hip surgery have previously reported
experiencing significant increases in pain and physical disability,236 high levels of psychological distress237
and an overall deterioration in HRQoL.238 Our exploration of patients’ experience of time aimed to provide
in-depth understanding of the impact and implications of waiting for surgery in current NHS care.
The role of confidence during the journey through hip replacement
Confidence, which is concerned with a person’s judgement about their own, or others’, abilities
and vulnerability,239 which can be defined as capable of being physically or emotionally wounded
(www.merriam-webster.com/dictionary/vulnerable)240 are both concepts evident in the literature concerning
the experience of older age. For example falls, which are common in this population,241,242 can result in
reduced confidence and an enduring fear of falling. This can lead to people choosing to disengage from
usual activities.243 As osteoarthritis is associated with ageing, affecting 10% of people > 5 years of age
in the UK,1 confidence and vulnerability may have particular relevance to the experiences of patients
undergoing joint replacement. A subtheme ‘building confidence’ arose in a recent study,32 involving
interviews with patients after they had undergone THR. This encompassed patients’ experiences of feeling
fearful of falling and damaging their new hip and also related to confidence and use of walking aids
after surgery. This builds on earlier work by Grant and colleagues244 which reported that with increasing
confidence, patients who had undergone THR 4–6 months previously talked of slowly relinquishing
their reliance on mobility aids. A metasynthesis of older adults’ lived experiences of discharge from hospital
after undergoing orthopaedic intervention reports that patients’ confidence can be influenced by their
perception of the expertise of staff and consistency of information received around the perioperative
period.245 This small body of work provides some initial understanding regarding the influence and
relationship of elements of the orthopaedic surgical experience on patients’ confidence level and
vulnerability. Our exploration of patients’ experiences aimed to build on and extend these insights by
providing an in-depth understanding of the ways in which their confidence was affected by, and affected,
their journey through hip replacement surgery.
The experience of support during the journey through knee replacement
Living with osteoarthritis and undergoing surgery brings about pain and functional limitations. We know
from existing literature that at times of disability, informal care has a large part to play246 and recent work
highlights the importance of informal support for people living with osteoarthritis. This shows that
assistance from family and friends with everyday activities (such as help around the home) is valued140 and
has positive implications for mental and physical health.247,248 People with osteoarthritis also engage with
more formal support, including contact with health professionals and social services.249 However, patients
may have little contact with health-care professionals after discharge from surgery, at which time family
are particularly important in provision of support, including personal care.32,250 The value of this support is
well documented32,244 but can cause mixed reactions including gratitude and frustration towards family and
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concern about placing burden on others.245,250,251 Importantly, previous research has not considered how
patients’ relationships with others may change as they move from living with pain and limitations
associated with osteoarthritis, through to postoperative recovery and to functional independence.
Therefore, we conducted research to explore how undergoing and recovering from knee replacement
surgery affects patients’ experiences and use of support networks.
An exploration of patients’ hopes and expectations for hip and knee
replacement surgery
A large body of quantitative work has investigated patients’ expectations for recovery from elective orthopaedic
surgery.32,145,165,252–254 This evidence has highlighted the importance of considering the role and function of
expectations around the perioperative period. For example, we have learned that patients’ pre-operative
expectations for joint replacement are both important in their decision to have surgery252 and can help to
predict outcomes.253 We also know that realisation of patients’ pre-operative expectations after hip and knee
replacement surgery are significant in influencing their reported outcomes and satisfaction.145,165,254 This body of
work has not provided detailed understanding of expectations for recovery from joint replacement from the
patient perspective. A recent qualitative study,32 attempted to address this gap through an examination of the
experiences of patients undergoing THR. The authors report that participants held high expectations of what
having surgery ‘would do for them’ and suggest the value of patients having the opportunity to discuss their
expectations of joint replacement in order to limit ‘false optimism’. This work illustrates the importance of using
qualitative methods in order to gain novel insights into expectations of joint replacement surgery. However,
McHugh and Luker32 report only on the expectations of hip replacement patients and interviews were
undertaken 6–8 months after surgery, a time-point when participants’ recovery may have still been incomplete.
Therefore, we were interested in gaining an in-depth understanding of patients’ expectations for recovery from
both hip and knee replacement surgery, with a focus on the fulfilment of these expectations 12 months after
surgery. We hoped to gain insight both into the processes by which patients’ expectations were formed and
the reasons why their expectations were, or were not, met.
Methods for qualitative studies
Sampling and recruitment
Patients who were listed to undergo either total hip or knee replacement surgery in the Avon Orthopaedic
Centre (AOC) were eligible to take part in the qualitative study. Between February 2011 and August 2012,
study invitation packs were posted to 179 patients (111 hips and 68 knees). Of those who returned a reply
slip to the research team expressing their agreement to be contacted about the study (n= 52), we purposively
identified a sample of men and women who were a range of ages. These comprised 29 patients undergoing
hip replacement and 10 undergoing knee replacement. The programme’s qualitative researcher contacted
individuals in this sample to discuss the study in more detail and for any concerns to be addressed.
Of the 29 hip patients contacted, 24 agreed to meet with the researcher to take part in an initial interview.
The remaining five were no longer eligible to take part (e.g. they had been recruited into an alternative
study that precluded their inclusion, their operation date had been brought forward). All knee patients
who were contacted agreed to meet with the researcher. These sample sizes ensured that data from the
hip sample was at saturation point, such that no new themes were emerging from analysis by the end of
data collection at the first data collection point.255 The sample size for the knee cohort was determined as
appropriate for the conduct of fine-grained interpretive phenomenological analysis.256
Data collection
In-depth semistructured interviews were conducted with all participants after they had been placed on the
surgical list for joint replacement surgery. We also aimed to interview participants 2–4 weeks, 6 and
12 months post surgery. All participants provided their written, informed consent to take part immediately
prior to the initial interview. As the study was longitudinal, the researcher also sought participants’ verbal
agreement to ongoing participation before each follow-up interview.
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Initial interviews, which lasted between 65 and 135 minutes, took place at participants’ preferred location:
either in their own homes (n= 29) or on University premises (n= 5). Follow-up interviews, which lasted
from 20 to 90 minutes, largely took place over the telephone, other than when a participant requested a
face-to-face interview in their own home (n= 6) or on University premises (n= 1). In addition, participants
whose surgery was delayed by > 3 months from their original admission date (n= 3) were asked if they
were willing to take part in an additional interview focusing specifically on their experience of delay.
Two participants (one hip patient and one knee patient) agreed to this additional contact.
Interviews were carried out with 21 of the 24 hip patients and 8 of the 10 knee patients at the three
follow-up points. Five participants did not take part in postoperative interviews: three because they chose
not to have surgery, one because their medical circumstances precluded a follow-up interview, and one
because the date of the surgery moved beyond the time constraints of this study.
The data collection time points and numbers of participants for hip and knee patients are shown in
Tables 10 and 11.
TABLE 10 Understanding the patient experience: data collection time points for hip patients
Time point number
Approximate time of
interview in relation to
surgery Number of participants and interviews
Time point 1 When on the waiting list for
surgery
24 participants
Time point 2 2–4 weeks after surgery 21 participants (one had no operation and was not followed up,
one had a delayed surgery date and was not contactable,
one was interviewed about their delayed operation)
Time point 3 6 months after surgery 21 participants
Time point 4 12 months after surgery 21 participants
Additional time point When a patient had a delayed
surgery date
One participant
Total number of
interviews
88 interviews, with 24 participants
TABLE 11 Understanding the patient experience: data collection time points for knee patients
Time point number
Approximate time of
interview in relation to
surgery Number of participants and interviews
Time point 1 When on the waiting list for
surgery
10 participants
Time point 2 2–4 weeks after surgery Eight participants (one did not have an operation and was not
followed up, one had delayed operation)
Time point 3 6 months after surgery Eight participants
Time point 4 12 months after surgery Eight participants
Additional time point When a patient had a delayed
surgery date
One participant
Total number of
interviews
35 interviews, with 10 participants
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Interview procedure
Interview questions were framed by topic guides specific to each time point. They were informed by
existing literature and developed through discussion with patient representatives. Core questions aimed to
elicit participants’ experiences of preparing for, undergoing and recovering from surgery and additional
probes were used to facilitate elaboration and to achieve depth. Pre-surgery interviews addressed pain and
functional limitations, expectations, existing knowledge about surgery and its outcomes, and preferences
for pre-operative management. Post-surgery interviews addressed pain, function, views on the care that
patients have received as well as their future plans and hopes for/of rehabilitation and recovery. At the
6- and 12-month interviews, participants were asked to talk about their experiences of long-term recovery
and adaptation. These interviews also revisited topics that arose from earlier interviews, including ongoing
and missing support needs. Interviews exploring delay to surgery addressed participants’ views about delay
and their experiences of support. Interviews were conducted by qualitative methodologists with social and
behavioural science backgrounds and it was made clear to participants that the researchers were not
clinical staff.
Interviews were audio-recorded, transcribed and anonymised, with the exception of two interviews which
were recorded in note form owing to audio-recording equipment failure. Ethical approval was provided by
NHS South West 1 REC (10/H0203/44).
Data analysis
Initially, we analysed data from all time points of patients undergoing hip replacement separately from the
data from patients undergoing knee replacement. We used different analytic approaches with each data
set. Once the analysis of the two data sets was completed, we brought the hip and knee data together
and conducted analysis on the pre-operative and 12-month data together.
Hips: inductive thematic analysis
We used inductive thematic analysis for the data set of interviews with patients undergoing hip
replacement. This was chosen as a means of exploring change over time as well as comparing and
contrasting experiences in a relatively large data set which comprised 88 interviews by the time of
completion. Analysis was iterative with data collection, with use of software to enable data organisation.
Anonymised transcripts of audio-recordings and notes from interviews with patients undergoing hip
replacement were imported into the qualitative data management software package ATLAS.ti® 6 (ATLAS.ti
software; ATLAS.ti, Berlin, Germany). Initial analysis of transcripts began shortly after data collection started
and was ongoing and iterative. Analysis informed further data collection such that early findings were
used to refine the topic guides and identify questions to ask in future interviews. Transcripts from each
participant were combined and treated as one single data set and were analysed using inductive thematic
analysis.257 A member of the research team first identified thematic codes which were grounded in the
data. Next, through identifying connections between the codes, the research team clustered them into
superordinate themes. To enhance analysis and enable team discussion and interpretation, double coding
was conducted on a sample of four interview transcripts at each time point (total double coding on
16 interview transcripts). The double coding was conducted independently by members of the team who
also had social and behavioural science backgrounds. The double-coding process was used as a means to
stimulate close reading of the transcripts by the qualitative research team, who met regularly to discuss the
codes and who worked to achieve a consensus about coding. Consensus, as agreement, was arrived at
through discussion. To improve understanding of the whole data set, those aspects of data that appeared
to contradict general experiences were identified and explored. The data from all patients, including those
who did not have THR, were included in the analysis because their experiences of preparing for and waiting
for surgery provide valuable insights.
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Knees: interpretative phenomenological analysis
We used interpretative phenomenological analysis (IPA) to analyse data from knee replacement patients.
This was chosen as a way to explore participants’ personal lived experiences and how they make sense of
them in detail and depth with an emphasis on the detail of cases in a group of participants likely to be
undergoing similar experiences.256,258 IPA is an idiographic approach, focusing on the particular rather than
the universal and starts with the detailed examination of case studies, which then tentatively progresses to
more general statements about groups of individuals.259 Taking this approach we were able to describe
patients’ lived experiences and their process of preparing for, undergoing and recovering from surgery
(i.e. how their experiences unfolded). The process of analysis was guided by a series of principles gleaned
from the reflections of Smith and colleagues within research methods publications, e.g. Smith and
Eatough258 and Smith and Osborn.260
Hips and knees: inductive thematic analysis
After identifying salient themes relating to expectations in the hip replacement data and having conducted
IPA with the knee replacement patient data, we were interested in also exploring these issues for knee
patients. Therefore, we imported knee transcripts into ATLAS.ti and undertook thematic analysis on this
data set, employing the procedures previously described to investigate these issues further. This enabled us
to explore patients’ hopes and expectations of surgery across the longitudinal qualitative data set as
a whole.
Results
As described in Methods for qualitative studies, 24 hip replacement patients and 10 knee replacement
patients took part in the longitudinal qualitative study. Of the hip patients, 13 were men and 11 were
women, with ages ranging from 52 to 82 years (Table 12). Of the knee replacement patients, six were
men and four were women, with ages ranging from 61 to 78 years (Table 13).
Waiting for hip replacement surgery
Within the hip data set we explored each participant’s journey from his or her initial referral to secondary
care through to his or her final surgery date. As shown in Table 14, accounts revealed that participants
took one of five main routes from referral to surgery.
The experience of waiting for surgery after entering secondary care and impact of delay and cancellation
emerged from our analysis as salient issues for participants. We present a summary of experiences from
two angles: (1) the psychosocial impact of waiting and (2) the conceptualisation and experience of ‘time’
during this period.
The psychosocial impact of waiting to undergo hip replacement
Two overarching themes relating to the psychosocial impact of waiting for THR were identified: emotional
reactions and impact, and wider impact on social support networks (Box 1). The impact of waiting was
influenced by the time that patients had spent waiting for surgery and their journeys through health care
before surgery. These aspects of waiting for hip replacement are described in turn.
Psychological impact
Whether or not they experienced delay, participants all described emotional reactions to the experience
of waiting.
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TABLE 12 Understanding the patient experience: participant demographics for hip patients
Pseudonym Age (years) Sex
Mr Bedford 73 Male
Mrs Burton 70 Female
Mr Day 74 Male
Mr Everett 66 Male
Mr Foreman 61 Male
Mr Golding 62 Male
Mr Granta 82 Male
Mrs Hardcastle 71 Female
Mr Higgs 71 Male
Mr Horton 73 Male
Mrs Kade 73 Female
Mrs King 53 Female
Mrs Lovell 69 Female
Mr McKenzie 66 Male
Mrs Noble 74 Female
Mrs O’Brian 65 Female
Mrs Quinn 69 Female
Mr Raynerb 79 Male
Mr Smith 75 Male
Mr Thomas 58 Male
Mr Upton 52 Male
Mrs Vickers 80 Female
Mrs Warburtonc 77 Female
Mrs Young 72 Female
a Did not have surgery – felt ‘too old’ to undergo major surgery.
b Medical circumstances precluded follow-up interviews.
c Did not have surgery – reasons unknown.
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TABLE 14 Understanding the patient experience: pathways to surgery
Pathway Route from referral to surgery
Pathway A No delay experienced (n= 12) in their secondary care pathway
Pathway B Journey affected/delayed by hospital factors (n= 4). For example, earlier operations in the day over-running;
unforeseen circumstances; administrator error and equipment failure
Pathway C Journey affected/delayed by underlying health conditions (n= 5). These encompass both pre-existing
conditions and those that were only diagnosed during pre-operative health screening. Appropriate pre- and
perioperative management of a participant’s health result in both short- and long-term postponement of
their operation
Pathway D Journey affected/delayed by others health (n= 1). A patient chooses to postpone their surgery because of
caring responsibilities/duties
Pathway E Mixed pathways (n= 2). Participants experience more than one influence on their pathway. For example,
initial postponement of their operation because of health issues and further cancellation owing to hospital
factors
TABLE 13 Understanding the patient experience: participant demographics for knee patients
Pseudonym Age (years) Sex
Mr Armstrong 70 Male
Mr Cook 64 Male
Mr Ostafewa 78 Male
Mrs French 76 Female
Mr Ings 64 Male
Mr Jackson 68 Male
Mrs Parkerb 67 Female
Mr Clark 65 Male
Mrs Evans 74 Female
Mrs Biggs 61 Female
a Did not have surgery – reasons unknown.
b Date of surgery moved beyond time of study.
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BOX 1 Quotations to illustrate the psychosocial impact of waiting to undergo hip replacement
Psychological impact
Interviewer: Yes, and can you recall how you felt on that morning, when you got that phone call saying,
where are you?
Mr Foreman: To some extent I was taken a little bit in disbelief and quite devastated, to be perfectly
honest. I’ve had operations before, but psychologically you build yourself up and think right, this is the
day, it’s going to happen today, fine. But getting that phone call at . . . And yes, psychologically it knocked
me for six. Probably for a couple of days I was obviously not very happy at all.
It’s frustrating for me because I can’t do anything.
Mr Rayner
Wider impact on social support networks
Because he definitely got it arranged for, he could come down when I was going in on the, this week,
on the 25th. But it’s rearranging his work shifts, its rearranging things, whether he could get the time off
to come down the next time.
Mrs Vickers
Mr Foreman: Yes, it was [a difficult time], not only for me, for the rest of my family as well, because they’d
obviously geared everything up for everything to happen on that particular day.
Interviewer: What sort of alterations did they then have to make to their plans?
Mr Foreman: Transportation wise, my wife does some part time work, and she had to reorganise things
so that we could make the trip on the Monday as well. It was probably more the fact that a phone call at
that time, saying where are you, was a bit of a blow, to be perfectly honest.
Consequences of preceding pathway on current experience
I feel I wasted nearly a year of my life. Uh, not happy about it but uh, a certain amount of responsibility
was mine, I went in and said I got sciatica. Um, I, most patients diagnose themselves in the first place but
nobody questioned it. Nobody said ‘ah, hang on a minute it might be something else’. You know. Course
it was not bad to start with, be fair it was not bad, but you know, it did not start full force, it’s gradually
got more and more painful as time’s gone on.
Mr Horton
It’s been long enough now so. . . . Well we said we are ruling out most of this year. This year’s a
non-entity.
Mr Smith
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Participants on pathways B, C and E who experienced postponement of their surgery date experienced a
range of emotional reactions. Frustration and disappointment were frequently reported; however, some
participants expressed understanding and acceptance of postponement. They tried to rationalise the news
and described their gratitude when delay was a matter of weeks rather than months. The wait for surgery
can also have more detrimental emotional consequences, for instance leading to a feeling of helplessness
and utter desperation. Participants talked of feeling as if they were ‘left to linger’ in the secondary care
system and forced to ‘live in limbo’.
Participants on pathway A without any delay or changes to their surgery date also described some
disappointment at the length of time that they had had to wait for their operation. They recalled their
dissatisfaction that their operations were not scheduled as soon as they had hoped and the disruption to
their lives caused by this. The impact of delay on physical well-being and functioning also had some
psychological effects. Mr Rayner’s experience provides a useful example. He experienced recurrent
postponement of his operation owing to investigative but inconclusive tests for additional health problems.
While waiting for THR he then experienced a rapid deterioration in his general health and functional
well-being, and expressed ‘frustration’ at the situation.
Wider impact
Accounts illustrated how cancellation of operations could have wider impact, particularly affecting support
networks. Participants explained how their friends and family also had to cope with and manage the
participants’ own deteriorating health as well as share in their disappointment about a delay to the surgery
date. Participants described how family and friends put their lives on hold and had to cope with the
detrimental impact of ‘living in limbo’. Cancellation and delay also had a more practical impact as friends
and family had to renegotiate their own plans to remain supportive during the perioperative period.
Consequences of preceding pathway on current experience
Participants’ views of their wait for surgery and the detrimental impact of the waiting period were
influenced by their experience of time already spent living with pain and discomfort. Many participants
described complex and sometimes slow journeys through health care from initial onset of their problems
through to eventual referral to secondary care.
Two key factors were central in accounts of patients’ journeys through care. First, participants reported
that they had initially delayed seeking advice and support from primary care practitioners. Reasons cited for
this included a fear of the undesirable inevitable (i.e. surgery); other priorities (e.g. caring for a sick spouse);
and choosing to ‘put up’ with pain and discomfort. Second, many participants reported the sense that
referral from primary to secondary care had been delayed. Explanations provided for this delay included
receiving an incorrect diagnosis; that their GP saw them as ‘too young’ to undergo THR; and that their GP
strongly advocated alternative strategies (e.g. weight loss, use of pain relief). Participants’ accounts
highlighted the interaction between frustration with management in primary care and subsequent
impatience with the time spent waiting in secondary care.
Conceptualisation of time
Two overarching themes relating to conceptualisation of time were identified: unavoidable changes to use
and passage of time in the lead-up to surgery, and time in the context of health care.
Unavoidable changes to use and passage of time in the lead-up to surgery
The progression of time from onset of osteoarthritis towards THR was marked by the experience of pain
and patients made unavoidable changes to their use of time (Box 2).
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Participants’ accounts highlighted how they had been living with pain for long periods of time and many
had experienced deterioration and acceleration of their problems in the lead-up to surgery. As well as
describing the long periods for which they had lived with pain, participants also described the experience
of pain in terms of time. They described fleeting spasms (a ‘horrible twang’) that lasted seconds as well as
constant, unrelenting pain or ‘throbbing ache’. Living a life in continuous pain with no respite appeared to
provide the sense that time was drawn out during the lead-up to, and wait for, surgery.
Participants described making unavoidable and considerable changes to the way in which they spent their
time because of pain and functional difficulties. When waiting for their operation, participants described
withdrawal from their everyday activities and no longer actively engaging with life. For example,
participants talked of inability to walk or stand for long because doing so resulted in ‘unbearable pain’.
Many talked of giving up pastimes that had previously provided much pleasure, such as golf and
gardening. Most of those who had been working had stopped doing so. Participants found themselves
progressively unable to fill and enjoy their time as they once had done and, instead, described how they
often found themselves ‘sitting down and doing nothing’ in their homes rather than actively engaging
with life and ‘doing’. They talked about feelings of ‘lost time’ and a sense that time had slowed. The sense
was in part due to the long process before diagnosis and then referral to secondary care. For some, such
as Mr Horton, this was seen as a failure to diagnose the problem and working ‘along the wrong lines’.
BOX 2 Unavoidable changes to use and passage of time in the lead up to surgery
The left hip, um the pain has been there for years, but not severe. I’ve felt it for years. Then when the
right hip was done, yeah, it was definitely there then, that was in the end of 2004. Since then it’s
progressed slowly, and then in the last year it’s got a lot worse.
Mrs Quinn
It’s made me feel very isolated because of not being able to get out and go and see people and do things
. . . it does restrict your life really to the sofa. The more, the longer it goes on before the operation the
more I’m sitting on the sofa.
Mrs Burton
It was um, anywhere from you know January 2010 to October 2011 or something like that you know. Uh,
uh, we were working on the wrong lines . . . I feel I wasted nearly a year of my life.
Mr Horton
Well I can’t do anything for anybody really at the moment. Just stuck. I managed to get to my daughter’s
wedding in April and my friends funeral in May. But apart from that I just don’t go anywhere. I just can’t
do it. . . . I like going on coach trips and things but I haven’t been able to do anything you know.
Mrs Kade
Well I’m constantly aware, constantly aware of it. Well um, when you say totally, I suppose it’s, it governs
your life, let’s put it like that.
Mr Bedford
The other night it was bad and I had to get up and move about, just to try and relieve it. I take
paracetamol and sort of get back into bed and read . . . in the night-time everything is worse because it’s
so quiet and dark and there’s nobody awake . . . it’s a long night. I get up and turn the television on . . .
but I’ve been forcing myself not to do that, because then I’ll go and make a cup of coffee and then it sort
of rolls in . . . I was waking up at three o’clock and not having any sleep until I went to bed the next night.
Mrs Young
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In addition, the accounts of some participants indicated that day and night became conflated in the
lead-up to surgery. While they would have previously been awake in the daytime, some reported resting
and sleeping during the day to seek relief from the exhaustion of living in pain and due to side effects of
pain medication. Participants also described pain onset or increasing intensity at night, which regularly woke
them up or kept them awake. Unable to sleep well at night and sleeping during the day, participants
experienced time slowing down as they waited for surgery and expressed distress, isolation and upset.
Time in the context of health care
Participants reported that their journeys through health care to arrive at surgery were lengthy, partly
because they did not necessarily seek help for joint problems, but also because of slow processes of
referral from primary to secondary care (Box 3). Such delays earlier in their journey through health care
could influence the experience and impact of the wait for surgery once within the secondary care system.
BOX 3 Time in the context of health care
I think the doctors [GPs] could have assessed the problem quicker no doubt . . . initially the first doctor I
saw didn’t think I needed a hip operation. Four months after another doctor decided that maybe I should
get checked out in [Hospital name] . . . That was a long wait. It would have been nice to have gone in
maybe March or so and get an assessment and said this needs doing then. I’d have had it done by now
. . . It’s been long enough now so . . . we’re ruling out most of this year. This year’s a non-entity.
Mr Smith
Anyway, psychologically preparing, yes it’s really thinking about um the actual day of going in, I guess.
And there’s a lot of things to do in preparation for going in, reorganising things that you normally do
every day, and that sort of thing . . . warning people that you cannot do this and you cannot do that, and
yeah there’s a lot of that, takes up quite a lot of time.
Mrs Quinn
They give me exercises to do at home and I’ve been doing them religiously. Well they told us to do it twice
a day. So I’ve been doing it twice a day . . . I would have been working today but I thought I’d take the
day off. Give me a chance to get the shopping done, get myself packed, get myself in the right frame of
mind to go.
Mr Golding
I wish it had happened a bit quicker but I suppose everybody wishes that. There seems to have been an
awful long time from when he [anaesthetist] said to me it should be about six to eight weeks. It’s been a
lot longer than that.
Mrs Noble
Mr Golding: Well this actually you see, what happened was I was originally planned to go in this Saturday,
then they said we want to call you forward to the Saturday before.
Interviewer Did they explain the reasons for that?
Mr Golding: No. No I think they had somebody who had dropped out. For some reason but I do not
know. Um so yes I said ok but I had this funny feeling it would not happen. Um, I said to my wife I do not
think it will happen . . . And I was right but um, yeah so they have had what they call a desktop
conference i.e. I suppose across computers with the Consultant anaesthetist and they must decide on a
plan and they’ll follow that plan through on Saturday.
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Once in the secondary care system and before admission to hospital for surgery, participants’ time was
also increasingly filled with activities relating to surgery. These included trips to hospital for pre-operative
education, assessments and consultations, and tasks relating to psychological and physical preparation.
These activities focused participants’ attention on, and heightened their awareness of, the upcoming date
in their calendar and also meant that they had to arrange their other commitments and activities.
Participants also described how time in the lead-up to surgery did not always pass at a regular, steady
pace. They felt that the date of their planned admission to hospital could appear closer or further away.
Some participants felt that the date was approaching too quickly and this evoked anxiety and nervousness.
Others were eager and impatient to have surgery and expectations about how long their wait would be
were influenced by discussions with health-care professionals in secondary care. However, some were also
unsure about how long they would have to wait and thought that the timing of their operation was not
static, but would be changed. Participants described uncertainty and, in relation to their experience of
time, how they had to put their lives on hold when waiting for surgery.
Participants also experienced changes to their admission date and this could be due to hospital factors,
ill health or the option of a date change by choosing to change surgeon. However, the impact of these
factors was sometimes complicated; for instance, one participant accepted the offer to change her surgeon
because it would mean that she did not have as long to wait for her operation. The new date for her
operation was then postponed because her glycaemic control for type 2 diabetes was not deemed
adequate for surgery. A referral ‘back’ to primary care aimed to ensure support to achieve better glycaemic
control, which was then followed by a wait to re-enter the secondary care system and to learn her
surgery date.
The role of confidence during the journey through hip replacement
Within the longitudinal hip data set, we also explored how participants experienced confidence and
vulnerability during their journeys through joint replacement surgery. Six themes were identified:
participants’ changing trust in their bodies; feelings of vulnerability in relation to a surgical procedure; use
and function of aids to be better safe than sorry; damage limitation and obeying the rules; awareness and
fear of dislocation; and the influence of interactions with others on confidence.
Participants’ changing trust in their bodies
Participants’ accounts highlighted how their faith and trust in their body changed over the perioperative
period (Box 4). During pre-operative interviews, participants described lack of confidence in their hip joints,
describing their hips as ‘worn’, ‘damaged’ and no longer ‘strong’. Many had experienced the sense of their
leg giving way beneath them, which meant that they felt that their bodies were letting them down and, as
a result, participants spoke of feeling fearful of falling, ‘unsteady’ and ‘unsafe’; all of which impacted their
daily lives. Before surgery, participants also spoke of feeling ‘frightened’ when using stairs without a rail
and avoided certain movements to avoid putting too much pressure on their affected joint. Some
participants also spoke of a sense of vulnerability in public areas, believing that they were unable to react
quickly or effectively to situations (such as a physical attack).
After surgery, many participants described how they had quickly attained new or increased confidence in
their body and prosthesis. They talked of feeling more physically capable and of how their leg no longer
threatened to give way. Freedom from this, together with ability to engage in physical tasks that were
previously difficult, enhanced trust and confidence in their bodies’ capabilities. Some participants spoke of
their absolute confidence in their new hip joint and a belief that it would outlast them. However, at
12 months after their surgery, some participants said that they remained troubled by lack of confidence
and faith in their body and the prosthesis. These participants described becoming more nervous of slipping
over and falling since having surgery. They also spoke of a sense that the leg for which the hip joint was
replaced felt weaker after surgery and uncertainty about the ability of their bodies. This had detrimental
impact on their QoL.
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BOX 4 Participants’ changing trust in their bodies
Pre-operative experience: lacking confidence
I can still walk about which I’m glad that I can walk but as for sort of relying on it to uh, for movement, no
I haven’t got a lot of confidence in it.
Mr Day (time point 1)
It gives me um, the stabbing pain and feels like it’s going to collapse.
Mr Smith (time point 1)
You know, you can’t go down and step into the garden and just dead head a few plants you know. Um.
Try to use the walking sticks. Um I’m scared of using them because I don’t feel safe. I know I’ve got to
practice with them but I’m scared of falling. I know with my luck if I fell it would be the other hip that
went you know and then where would I be. So I sort of try and do what I can but think to myself no
that’s really not safe. Don’t do that.
Mrs Kade (time point 1)
. . . and I think also just you know, you don’t feel so confident about doing things. You go out now and
with all the crap you got going on out there, you know, you never know out there. I never worried about
that, um, 2 years ago there was a big fight outside the house and I went out and broke it up and stopped
half a dozen lads trying to kill a couple of others you know. Uh, went to court, did all my bit, you know, I
wouldn’t do that now. I would feel vulnerable if I did that now, I would get hurt. Uh, because I don’t feel
physically capable enough . . . I’m not able to move, I can’t run. Um, I certainly can’t change direction.
Mr Thomas (time point 1)
Postoperative experience: increased or changed confidence
I think things have worked out excellently. I believe – I feel um more confident in what I can do physically. Er,
you know, doing jobs around and about. I feel er, in activity terms, I feel fitter, and I feel more capable of doing
things er than I did before. So to me, you know, personally I think it’s exceeded what I probably expected.
Mr Thomas (time point 3)
Yeah I’m very confident. When you’re on two sticks, then you go down to – down to one stick, then you
can have the confidence to – to walk without a stick initially. But then once you get that initial confidence
over and say, ‘Oh I can do it with – do it without’, and then it just grows and grows and grows and it just
happens, you just think of – of another hip, without the pain.
Mr McKenzie (time point 4)
Well I haven’t . . . I haven’t got the confidence in my leg I’ve had done. It’s because like seeing an X-ray to
what they’ve done, I just fear that I don’t wanna damage it. D’you know what I mean . . . But I just haven’t
got that confidence after this 12 months, I always fear that I don’t wanna fall down . . . I think it does take
a bit of the quality of life away because you . . . for the moment you’re not . . . you’d like to do a lot more,
and yet I haven’t got the confidence really with it. D’you know what I mean? Thinking about it, then will I
be doing myself harm.
Mr Higgs (time point 4)
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Feelings of vulnerability in relation to a surgical procedure
Participants also articulated feelings of vulnerability in relation to the operation itself (Box 5). These feelings
included concern about the body’s ability to withstand surgery and apprehension about the potential for
surgery to go wrong (e.g. in relation to potential detrimental side effects of anaesthetic). Participants
described concern about leaving hospital to return home, seeing hospital as a safe environment. Feelings
Um I’m um trying obviously to get myself sort of mentally and physically, you know, back to um how I
was. Um but I’m um sort of struggling with the mental side of things at the moment . . . I do not know
perhaps what my capabilities are now. Um so every now and again I sort of like push myself to um doing
something, and I think, yes, I can do that, um and would have to go on to the next stage. Um I suppose
where you have been physically impaired um in some respects, that you’re not quite sure what you can
achieve now. Um so I’m having to do it in sort of small stages. And to say to myself, right, yes, you can do
that, carry on to the – to the next thing.
Mr Foreman (time point 3)
BOX 4 Participants’ changing trust in their bodies (continued)
BOX 5 Feelings of vulnerability in relation to a surgical procedure
Pre-operative concerns
I shouldn’t say this, but it worried me, I got myself in a – because they say that, you know, you’ve got to
be in pretty good nick for operations, and it did worry me a bit, you know, whether my body’ll stick up
to it.
Mr Higgs (time point 1)
Mr Smith (time point 1): Getting a bit scared now day by day. Yeah a little more scared.
Interviewer: What is it specifically that you feel a bit scared of or apprehensive about?
Mr Smith (time point 1): Having the operation . . . Just thinking what if it’s going to go wrong.
Um, but as to the operation yeah I am nervous. I hate hospitals anyway and I seem to be in and out in the
last few years with various things being done so, you know, but previously there’s always been somebody
in the house to look after me when I get home and there isn’t going to be anybody now. So I am a bit
worried about that.
Mrs Burton (time point 1)
Postoperative concerns
I did, I felt quite sort of vulnerable and I didn’t want to be out of this sort of safe environment at that
point . . . . I didn’t want anyone to think I was malingering and didn’t want to get on because that wasn’t
true but there’s, it’s quite daunting when you leave that safe place.
Mrs Lovell (time point 2)
I always wonder if the joint will come out again. Because they do fail occasionally. There’s also been a bit
of a scandal about um, wrong materials being used.
Mr Horton (time point 4)
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of vulnerability were heighted for those participants who were concerned about returning home if they felt
that there would be no one there to look after or support them. Some participants were also concerned
about the potential for the failure of the prosthesis and the presence in their bodies of the materials from
which the prosthesis was made.
Use and function of aids: better safe than sorry
Participants spoke about their use of, and the benefits of, walking aids over the perioperative period (Box 6).
Before surgery, many used walking aids on a regular basis. They were used to maintain and boost
confidence, offer reassurance, prevent falls and offer support in situations that evoked vulnerability. Use of
aids peaked in the early weeks after surgery. At the 2- to 4-week postoperative interview, many participants
continued to use walking aids, saying that this reduced the risk of harm to their new joint; this was in spite
of feeling that they should be able to manage now without this ‘safety net’.
At the time of the 6-month interview, most participants were no longer using walking aids; however, this
was not universal. Some spoke of occasional use, for instance, when extra security was needed but others
continued to use a walking stick regularly when outside, saying that aids were ‘just like a comfort blanket’
that provided reassurance.
BOX 6 Use and function of aids: better safe than sorry
Use and function of aids before surgery
. . . but sometimes when I’ve been out walking; it feels as though the joint is going to give way . . . And of
course you get excruciating pain when that happens and I suppose the stick has just helped as a little bit
of a confidence booster, the fact that you’ve got something else that you’re not going to fall over with.
Mr Foreman (time point 1)
Use and function of aids after surgery
I can almost walk without a stick now but er, just to be on the safe side, I stay on it.
Mr Bedford (time point 2)
I have not used one [a stick] for months and months. Except when I’m on a rough walk, then I do because
if you’re trudging through mud, the last walk I went on it was very, very muddy. Yes, I use one of those
special walking sticks.
Mrs Quinn (time point 4)
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Damage limitation and obeying the rules
After surgery, participants avoided and restricted movements and activities that could cause potential
damage to their new joint (Box 7). They spoke of not wanting to ‘push their luck’ or to ‘push the joint to
the limit, you know, before it’s settled’. They were nervous and described a need to remain respectful of
their prosthesis and of the need to follow the postoperative restrictions and ‘rule book’. They talked of
their ‘fear’ of ‘overdoing it’ and were careful and aware of their movements (e.g. standing for too long,
twisting). Accounts suggested that these concerns and behaviours were driven both by a fear of harming
their new joint and of not wanting to ‘undo any good that’s been done’. Some participants explained
that after the initial postoperative weeks had passed they became more adventurous in the activities
and movements that they engaged in. However, others remained apprehensive of particular activities
(e.g. lifting, higher impact sports, dancing and gardening) and were careful when performing certain
movements (e.g. bending to put tights on). This was related to a concern of not wanting to damage their
new joint by placing strain on it.
BOX 7 Damage limitation and obeying the rules
Postoperative concerns
I was dead scared to disobey any of the rules, I followed them religiously.
Mr Horton (time point 3)
I’m taking it really strictly and I follow the rules, I do not bend at the moment and I don’t lift anything, well
nothing that might be heavy. Um so following all their rules, um move carefully, so at the moment I can’t
say that anything is causing me any pain . . . I’m not allowed to bend or lift anything for 6 weeks. So I will
go for 6 weeks before I try doing anything like bending or sort of going back to normal. Like sleeping, I
don’t normally sleep on my back, but um I’ve been told that I have to stay on my back for 6 weeks, so I’ve
been doing that . . . But I will follow exactly what they say until the 6 weeks are up.
Mr Golding (time point 2)
I don’t really want to get down on my hands and knees yet. I feel a little bit tremulous. But um that’s just
me . . . I suppose once you’ve got something inside you that’s artificial and could go possibly wrong, it sort
of er stops you. I don’t want to get down on hands and knees.
Mrs Hardcastle (time point 3)
I am always aware of it [new hip] because, as I say, I am, I um limit what I do because I don’t want, I
won’t push myself. You know, I won’t [deep breath] run, jump and bend and I worry that I might do
something to my hip. So I am aware all the time really.
Mrs King (time point 4)
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Awareness and fear of dislocation
Before surgery, participants were mindful of the need to ‘look after’ their new joint to avoid dislocation.
Concerns about dislocation peaked in the weeks after surgery (Box 8). At this time participants
experienced occasions when they felt that their hip was about to dislocate and spoke of their
apprehension. Awareness of the potential for dislocation was informed by the verbal information and
written literature provided by the hospital. This was heightened by knowledge of other people’s
experiences and previous personal experience. For some participants, concerns about potential dislocation
became an enduring fear, continuing to influence their behaviour and activities in the long term.
The influence of interactions with others on confidence
Although interactions with others and knowledge about dislocation could reduce confidence, participants
also described how their confidence could be increased through encounters (Box 9). For instance, some
described how conversations with surgeons before surgery boosted their confidence in care and treatment
that they would receive. Some spoke of the importance of education and information in order to feel
informed about the operation and recovery. Health professionals also continued to bolster participants’
confidence in the weeks and months after surgery. In addition, observing the experiences of others who
had had positive experiences of joint replacement enhanced confidence.
BOX 8 Awareness and fear of dislocation
Concerns before surgery
This is the only thing I’m having trouble with getting used to, is that I know, once I’ve had it done,
I mustn’t do that . . . Once they’ve done it, um I don’t want to – I’ll make damn sure I don’t dislocate it.
Mr Upton (time point 1)
Concerns after surgery
I think it was a couple of days after I came home, I was standing up and I was getting ready for bed, and I
felt the head of the femur move. And I thought, ‘Oh my God, it’s going to dislocate.’ But it didn’t, it
couldn’t have been in properly . . . I was a bit frightened.
Mrs O’Brian (time point 2)
I think what done me was I was talking to a gentleman who – who said um this friend he worked with
had a new hip, and um he went back to work after three months, and like a silly fool, he lifted something
heavy, and his joint come out. And it kind of done something to me, ‘cos I don’t want mine to do that.
Mr Higgs (time point 3)
Interviewer: And what sort of things have you been doing, or what have you done to get to that?
Mr Upton (time point 3): Well I think, if anything, it’s probably a question of what I haven’t been doing,
I think, rather than what I have been doing. Um I haven’t been doing the sort of um – the wrong
movements, um sort of crossing my legs and sort of twisting myself and doing whatever. Um by sticking
to the rules, really the sort of not dislocating it bit, um that I came out with in my head, by sticking to that
and not doing what I shouldn’t do, I think it’s helped it cure itself . . . I suppose, in a way, I was frightened
to stop them, because I still felt that, you know, we were given this 12 weeks sort of time slot um about
the fear of dislocation. But I think perhaps I was um so worried that I could still dislocate it, I made damn
sure I wasn’t going to. Um and so even this time when I went in again, I was sort of pre-programmed,
I didn’t have to be told what I had to do this time because I was still doing it with the other one.
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Understanding the patient experience: total knee replacement
The experience of support during the journey through knee replacement
We were also interested in exploring how undergoing and recovering from knee replacement surgery
alters patients’ experiences and use of their support networks. Using IPA259 we examined patients’
experience of knee replacement at all time points and identified three superordinate themes relating to
the experience of support: (1) relationships with health professionals over the knee replacement journey;
(2) implications for informal relationships and support networks; and (3) providing support to others.
Relationships with health professionals over the knee replacement journey
‘I’ve got faith in him’: trust and confidence in the surgical team
Participants who were undergoing knee replacement expressed considerable ‘trust’ and ‘faith’ in surgical
teams. This seemed to relate to their experience of living with osteoarthritis, in which participants dealt
with increasing pain and impaired mobility. By the time that they had reached secondary care, many felt
BOX 9 The influence of interactions with others on confidence
So actually going into the place, um again [name of Surgeon] said, ‘I’m going to come round to see you
before I – you get wheeled off’, or whatever. And so, you know, I’ve got every confidence he’s going to
come round and check I’m ready for it, and if I tell him, ‘I’ve got last minute thoughts and I don’t want
you chopping my leg off’, um fine . . . well we had a joke when he first saw me, he said um, ‘I’ll try and
make sure they’re both the same length when you come out’. Um to me, the human side of things is –
is great.
Mr Upton (time point 1)
Mr Higgs (time point 4): Um [clears throat] well prior to the operation there was a booklet. And there was
a meeting, and er it was um – it was informative and comprehensive, and um I think that sort of
everything that was mentioned fell into place. So as far as the information, there was plenty
of information.
Interviewer: OK and did that information influence your recovery, do you think?
Mr Higgs (time point 4): Yes it gave me a little bit more confidence. It’s er – it’s not knowing is which er
chips away at the confidence, doesn’t it?
Um at first it felt a bit sort of um different. And er I sort of – I was afraid to sort of move my leg and, you
know, you’re anticipating er – the anticipation of having the surgery, and you think, ‘Well what can I do?
What am I able to do?’ But the physiotherapist, she sort of put me at ease and she um just told me what I
can do gently to start with, and she helped me like move me leg, showed me which way I’ve got to move
me legs and things, and what I’ve got to do.
Mr Day (time point 2)
I know several people. I actually work at a golf centre and, of course, a lot of the senior people have had
hips and knees done. And yeah, they tell me how good the operations are. I know several people, actually
. . . Well, they did say that one person didn’t feel any pain at all after he’d had . . . his knee, it was. They
gave me a lot of confidence. Everybody I spoke to, they seemed to have had a good result . . . It does
boost your confidence.
Mr Everett (time point 1)
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that they had no choice but to rely on medical opinion and expertise, and that surgery was inevitable. This
was rooted in previous positive encounters in consultations as well as experiences (their own and others) of
successful outcomes after other types of surgery.
Contact with secondary care team
After having their operation, participants’ contact with secondary care health professionals shifted from the
surgical team to a team of nurses, physiotherapists and auxiliaries. Relationships with health professionals
also changed; participants wanted to receive support and guidance rather than the total control that they
had wanted from surgical teams. After returning home, all participants had some contact, although often
infrequent, with secondary care professionals – predominantly consultants and sometimes physiotherapists.
They were ‘keen’ to receive follow-up appointments and ‘eager’ to obtain clinical opinion about aspects of
the recovery process, for instance when they should stop using walking aids or return to leisure activities.
These interactions bolstered confidence and offered reassurance.
‘You were sort of cut adrift’: unmet support needs during the recovery process
Participants also spoke of unmet support needs during the recovery process. For example, many felt that
input from physiotherapists was received too late in the recovery process and that earlier involvement
would have helped to reduce feelings of abandonment, enhanced motivation to exercise and facilitated
earlier recovery. Postoperative aftercare in the community was also described as lacking. After discharge
from hospital one participant, a widow, was not offered the support of a district nurse. Instead she
described struggling with her own care, such as changing her surgical stockings, and had to implement
her own support by paying for help. This participant felt that more formal support would have provided
reassurance and reduced her feelings of isolation.
Differing perceptions of expertise: primary versus secondary care health professionals
Although confidence in secondary care health professionals was consistently high, participants trust in and
willingness to seek support from primary health-care professionals was more mixed. Perceptions of support
on offer and that received from primary care during the postoperative period was influenced by experience
of care received before surgery. For example, some participants expressed dissatisfaction with primary care
before surgery, describing their sense that care and advice had been inconsistent. When patients felt that
primary care had not been helpful before their surgery, they were less likely to seek support actively from
primary care on return home from hospital (Box 10).
Implications for informal relationships and support networks
Changes in level and type of assistance
There were changes in level and type of assistance provided and received at different points in the journey
through knee replacement. Before surgery, participants described the importance of help provided by
family and friends for everyday activities (such as fetching groceries and household chores). Immediately
after surgery, the need for this kind of support sharply increased, with support needed for many more
daily tasks, such as carrying a drink. Undergoing surgery also led to changes in participants’ roles in their
relationships and family units. For example, one participant described how, when recovering from surgery,
he was looked after by his children who were ‘running errands and things’ and felt that his wife treated
him ‘like a baby’. These changes sometimes evoked negative emotions, including despondency and
helplessness. However, as recovery from surgery progressed, the need for support and associated sense of
helplessness reduced.
‘She’s always there you know when I want her’: the assumption that family will help
For participants who were married, help often came from spouses. Married participants (n= 7) who all
lived with their spouses initially turned to their spouses for assistance during the journey through knee
replacement. After surgery, in addition to spouses taking on increased responsibility for tasks relating to
everyday living and functioning, they also assumed additional caring responsibilities, including help with
personal care (e.g. helping to bathe). Some also played a role in medical aspects of the recovery process.
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For example, Mr Armstrong’s wife administered postoperative anticlotting injections and Mr Clark’s wife, a
retired nurse, removed his stiches. Although many participants appeared comfortable in accepting that
their spouse was occupying this novel role, others felt ‘awkward’ and embarrassed at asking spouses to
undertake duties that they felt should be provided by paid professionals.
Use of extended informal support networks
Participants looked outside their immediate household to other family members (e.g. children,
grandchildren, siblings) and friends to meet their postoperative support needs when they could not be
fulfilled by a spouse. For example, several participants were the only driver in a household and this meant
that friends and family were asked to drive on their behalf while postoperative restrictions were still in
place (patients are currently told not to drive for 6–8 weeks after knee replacement). Participants who did
not live with spouses asked friends and family for help, particularly in the early postoperative period.
BOX 10 Quotations to illustrate relationships with health professionals over the knee replacement journey
‘I’ve got faith in him’: trust and confidence in the surgical team
He [has] done my brother’s leg, both legs, about 6 years before me, and he’s had – you know, brilliant. I
asked for him. And he’s been there for a long time as well, he’s not a new chap.
Mr Jackson (time point 3)
Contact with secondary care team
They were caring . . . they’d be available any time um . . . the only trouble was then I wasn’t allowed to
walk at all for that intervening more or less a week like, 4 days, 5 days . . . if I wanted to go to the loo I
had to call for a nurse to come with a wheelchair to take me there.
Mr Armstrong (time point 2)
‘You were sort of cut adrift’: unmet support needs during the recovery process
I rang them week before last . . . he [physiotherapist] said ‘Of course we are very busy at the moment, but
I will be in touch with you again, but there is a two to three week wait’ . . . But I was quite annoyed . . . I
felt like saying to him well don’t bother. I mean they say I can drive within six to seven weeks . . . I
wouldn’t even of had any physio by then . . . I know everybody is very busy and you’re only one of a
number really aren’t you, but this physio thing really that did annoy me, because they stress about you
having physio and making sure you bend your knee and all this and then nobody comes . . . it don’t make
sense to me.
Mrs French (time point 2)
Differing perceptions of expertise: primary versus secondary care
health professionals
I’m afraid my doctors are very poor at the moment . . . we’ve had the same doctor for about 40 years and
he retired and at this practice we got now we get a different doctor every week, they seem to be coming
and going. If you go to see anybody, they don’t know nothing about you . . . I had an experience with
them, one doctor give me these tablets for pain killers, something I’d never tried before and then when I
went back a couple of . . . I don’t know 3 or 4 weeks later I said ‘Oh your colleague gave me these’ and
she said ‘He shouldn’t of never give you them’ and chucked them in the waste bin. I thought blimey they
can’t even trust each other . . . So that’s put me off a bit.
Mr Jackson (time point 2)
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‘I’m lucky’: willingness to accept help
Participants expressed mixed emotions about the help they received from their friends and family around
the time of surgery. Several viewed such support as ‘helpful’ and ‘invaluable’ and felt fortunate to be
‘spoilt’ by friends and family who ‘rallied’ around them. Although surgery was often seen as a way of
maintaining independence the time around surgery was a period when help and support from others was
a necessity. Many participants craved their return to self-sufficiency and most participants did eventually
regain the independence that they had sought (Box 11).
BOX 11 Quotations to illustrate implications for informal relationships and support networks
Changes in level and type of assistance
Well my wife has been working like a trooper you know [since discharged from hospital]. I mean, trouble
is she won’t let me do stuff. . . . going to the shop. Um, you know getting a magazine, treating me like a
baby. Um, I mean just doing extra. . . . I mean I cannot drive a car so, you know, I used to do virtually all
the driving. Now my wife is doing all the driving.
Mr Cook (time point 2)
‘She’s always there you know when I want her’: the assumption that family
will help
Interviewer: And where did you have that done, having the staples out?
Mr Clark (time point 3): Er now um [laughs] um my wife, [name], is a nurse. And um well she retired
about a year ago. And um we thought rather than, you know, um – she knew the people in um – in the
hospital, and they gave her a thing for taking them out, um she’s ever so good and ever so careful, rather
than go into hospital. Um she took them out at home for me.
Use of extended informal support networks
Interviewer: What sort of things have they [friends and extended family members] been doing?
Mr Jackson (time point 2): Lifts everywhere, my wife can’t drive . . . so to and from hospital for any
appointments or to do the shopping, anything.
‘I’m lucky’: willingness to accept help
Interviewer: what sort of support have you had?
Mr Ings (time point 4): Well I’ve been lucky like that; the wife and the kids are pretty good, you know, I’ve
had the support of them around me. I suppose if it was somebody living on their own it might be a
bit different.
Interviewer: Yeah, what in particular are you thinking of?
Mr Ings (time point 4): Oh loneliness and getting to do things.
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Providing support to others
Although not a shared experience, a striking feature in the accounts of some participants was the impact
that knee replacement had on the support they provided to others and how caring responsibilities
influenced their journey through joint replacement (Box 12). For example, Mrs Biggs, a widow and sole
provider of support for her mother and brother-in-law, was particularly articulate about the reliance of
others on her and the impact of surgery on this. Owing to her caring responsibilities, and despite
limitations and pain imposed on her by osteoarthritis, she strived to maintain her role and not let others
down. Undergoing surgery meant that Mrs Biggs temporarily passed her normal caring responsibilities onto
her sister. Keenness and determination to decrease ‘burden on others’ as soon as possible and to return to
her original role supporting others served to drive and motivate Mrs Biggs in her recovery from the
operation. Successful knee replacement also meant that some participants felt able to assume a new role
offering support to others, which they felt would have been impossible before their surgery.
Combined hip and knee data sets
An exploration of patients’ hopes and expectations for hip and knee
replacement surgery
We were interested in learning more about participants’ expectations for recovery from hip and knee
replacement surgery and how their expectations were met. We present here the findings of our analysis
from the pre-operative and 12-month data sets.
Hopes and expectations relating to long-term pain after joint replacement
All participants hoped that hip or knee replacement would reduce their pain (Box 13). For most, this was a
key motivating factor for their decision to have the operation. Some participants described awareness that
long-term pain was a potential issue after surgery. However, some thought this might be mild while many
hoped to achieve complete freedom from pain in their operated joint in the year after surgery. Expectations
relating to pain were based on previous personal experience of undergoing joint replacement surgery,
knowledge of others’ experiences – both successful and unsuccessful – and information resources provided
by the hospital. Most participants also described a hope that they would be able to stop use of pain relief
and anti-inflammatory medication in the year after surgery. However, some also thought that they would
BOX 12 Quotations to illustrate providing support to others
Interviewer: are you where you thought you’d be six months ago in terms of recovery?
Mrs Biggs (time point 4): Um, yes I think I, because things moved so well after. Yeah, yeah. But I was
determined any way that I wouldn’t be a burden to anyone.
Interviewer: No and does that make a difference do you think?
Mrs Biggs (time point 4): Yes, oh yeah . . . Well for me mentally it does because of course uh, you know I
feel I got a lot of responsibility here to keep the home running and I don’t want uh, to feel any one else
has to come in and um, you know take over from me . . . it certainly encouraged me to get going, yes, yes.
Yesterday, we got a little local, uh, pamphlet or whatever you’d like to call it down [town name] it was
looking for volunteers actually to help families that might be in, were going through different kinds of
troubles . . . so I’m going to ring them. And I wouldn’t have done that, well I would, you know – I’d, I’d, I
couldn’t really move efficiently, you know. . . . I wouldn’t have done it 12 months ago. I wouldn’t have
been physically able to just go out and be confident enough to walk.
Mrs Evans (time point 4)
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BOX 13 Hopes and expectations relating to long-term pain after joint replacement
Having the hip replacement, the motivation is to get rid of the pain.
Mrs Quinn (time point 1)
Interviewer: What about the pain, what are you hoping for?
Mr Bedford (time point 1): Zero actually. I nearly, because I said that’s what happened with this. If it’s the
same before when I had that one done it’s unbelievable.
Mr Thomas (time point 1): I was telling him [a friend] about having mine done. He said ‘the one thing
you’ll do when you wake up, he said you won’t have that friend with you’, and that’s why I call it a friend.
Yeah, he said ‘you won’t have that annoying, nagging little thing that’s you know, grinding away quietly
there’, he said. ‘It just won’t be there’ and he said that’s what he liked about it the most. He said ‘that
sort of’ he said it was gone. He said it was completely not there. And [another friend] actually said the
same as well. He said his pain just disappeared . . . He just said ‘my pain had gone away’. He said it was
absolutely gorgeous.
Interviewer: Is that what you’re expecting or?
Mr Thomas (time point 1): That’s what I would hope yes. You know, I won’t have that grumbling
irritation, yeah.
Interviewer: So how else do you think your life will be different 6 months after your operation?
Mr Thomas (time point 1): Well if I haven’t got pain I won’t be such a grumpy old git . . . because I’m sure
I’m grumpy because I’m, I’m not, yeah I’m in pain. I’m not noticing it because you, yeah I’m saying I do
affectively show it. But yeah I’m hope I’m not such a grumpy old sod. [Wife] will be able to tell you that
probably better than me.
I read it in one of the leaflets that they [the hospital] gave me . . . you may still be in some pain. That’s one
of the down, downsides of having a hip replacement, you may have one leg longer than the other,
infection, still pain. It’s one of those risks. But hopefully that won’t be me.
Mrs King (time point 1)
Interviewer: After you’ve had the operation, would you expect to reduce or change the pain relief
you have?
Mrs Parker (time point 1): I expect to be reducing but I don’t expect to do without, because I have quite a
bad neck . . . obviously the Co-codamol helps that as well, so I don’t expect to give up pain killers but I
hope it will go down a bit.
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have to continue using medication to manage pain in other parts of their body. Participants also described
their hopes for the positive benefits of reduced pain in the longer term after surgery, for instance improved
mood and enhanced sleep quality.
Expectations relating to postoperative function
Before surgery participants described living with restrictions on movement and mobility, reliance on
walking aids and inability to ‘do a lot physically nowadays’ (Box 14). They anticipated that joint
replacement would confer better function and bring about a future in which they would be able to ‘get
around easier’, walk further and with a ‘normal stride’, navigate stairs and steps with more confidence and
ease, and achieve independence from walking aids. They also spoke of hoping to once again be able to
kneel down, bend down and reach their toes and have the capability to return to riding a bike again.
As a result of these changed functional abilities, participants anticipated that they would, in the year
following surgery, be able to become more active and enhance their general level of health and fitness.
However, several participants also acknowledged that there would continue to be some restrictions on
their physical capabilities. For example, they spoke of how they would have to continue to avoid lifting
heavy objects even in the long term and would also be unable to return to playing high-impact sports.
They also believed that although walks to the local shops would become a future reality, hill trekking and
climbing mountains would not. In addition, expectations relating to postoperative function were tempered
by a sense that they may not achieve the level of function that they had before the onset of the problems
with their hip or knee joint. This was informed by the sense that they continued to age and that some
lived with problems in other parts of their body.
Like their expectations for pain, hopes for postoperative function were informed and shaped by their own
and others’ experiences of undergoing similar medical interventions, in addition to information received
around the time of surgery.
Expectations for changed engagement in social, work and life activities
Participants described expectations for participation in social and work activities after hip or knee
replacement (Box 15). These expectations were related to anticipation of reduced pain and increased
function and were particularly driven by observations of how well others had recovered from similar
operations. For example, participants hoped to return to work and looked forward to attending social
clubs again, meeting friends for lunch and other valued activities including golf, bowls, bell ringing and
ballroom dancing. They also hoped to be able to take holidays once more, have day trips out and travel to
see friends and family, both within the UK and abroad. Participants had to stop or limit these kinds of
activities before surgery because of difficulties relating to their osteoarthritis.
Participants’ accounts also showed how they hoped that joint replacement would provide them with the
chance to engage with life once again: ‘to be able to get out again’, to ‘go out and enjoy themselves’,
‘get on with their life’ and to ‘get back their quality of life’. For some, this also meant taking up new
hobbies and interests such as joining a walking club and starting voluntary work. Many participants talked
of their hope to be able to participate in these activities by certain points in time, for instance Christmas or
their birthday. However, a few participants did not put time markers on when, and if, their goals would be
achieved, talking of ‘just having to wait and see’ and ‘just depending on how I get on’.
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BOX 14 Expectations relating to postoperative function
Interviewer: And if we did speak in a year’s time, how do you think that life will have changed?
Mr Everett (time point 1): Well, I just hope that I can walk normally. And it would be nice to think I’d be
pain free. This is the hip. And what more can you ask for? Hopefully to be able to do more or less what
you did before, other than lifting.
Interviewer: Are you hoping to be doing some things in six months time, twelve months time that you are
not now?
Mr Ings (time point 1): Well yeah I hoping to get out on the garden, kneeling down doing planting seeds,
or weeding. At the moment I got to do it all standing up . . . Sit in the bath and have a bath. Kneeling in
the bath, that’s a problem at the moment. I cannot kneel in the bath . . . I hope to be able to get up and
down the stairs. At the moment I’m going up the stairs a stair at a time, not like the normal [banging on
the table]. I go up one, rest up, one.
Well I’m hoping I can just walk out the door, I will be grateful just for that. I do not have big inspirations
of climbing Mount Everest.
Mrs Young (time point 1)
I know I won’t be out Olympic sprinting but I accept that, I will hope that I will be um, far more capable
than I am and that’s what I’m looking forward to.
Mr Thomas (time point 1)
Well everybody that I’ve spoken to has been very satisfied and uh, they’ve gone on well. As I say they’re
walking again and walking with the group. So they can do what four or five miles I suppose, which is
pretty good for anybody really. Um, and yes they’ve been very pleased . . . you think well if they can do it,
I can do it as well.
Mrs Noble (time point 1)
Also a friend of mine, a lady up the road there, she’s had both of hers done and she’s walking now
without sticks or anything.
Mr Bedford (time point 1)
Interviewer: Would you anticipate that you would be using any walking aids in the future?
Mr Upton (time point 1): I would always, unfortunately, have to use walking aids. It would be nice to think
that I didn’t have to use them in the house. I always have to outside because I could have a fit at any time,
and outside if you have a fit there tends to be things like concrete pavements and – and buses and things
like that, that you might fall in front of.
Um, the surgeon when I saw him he said that its um its, what he was saying there was we’ll probably get
your knee working like it did 10 years or 15 years ago. Don’t expect to go any better than that. And um
he did tend to, so well that’s not too bad if I can get back to that.
Mr Armstrong (time point 1)
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BOX 15 Expectations for changed engagement in social, work and life activities
Well when it started I thought that uh, it would be an advantage for me playing golf. Because as I say my
mate who I play golf with for a long time, uh, he had both his knees done and he was getting bad. He
had to pack up golf and he had his both done and he came back and he was playing all right. When I say
playing all right he had no trouble with his knees. I thought this is fantastic you know.
Mr Ostafew (time point 1)
Interviewer: What are your motivations for having the operation?
Mr Higgs TP1: Well to enjoy life I suppose like and, you know, not to sit back and think, ‘Well I’m finished
for now.’ Because er the only time I’ll be finished for is when I’m underground, gone. Yeah that’s how I’m
built inside. You know, I like get out and do something. And I might even do like little jobs again, because
people – [I’m] in big demand.
I’ll go over and see my daughter and my, I’ve got three grandchildren over there [name of country] and
then my life over there which I enjoy. I enjoy that over there . . . we’ll see how it works out. But that’s
going too far ahead for me. I can only go so far at one time. I’m only gonna do one step at a time and see
how I’ll, go into hospital first get that over and done with. Get up out of hospital, get up and going.
Mr McKenzie (time point 1)
I can’t get down to pick the ball up. My son’s got to come with me and pick the balls up for me so I can
throw them down like you know [when playing the bowls]. I know it might sound a silly little thing but its,
it’s an embarrassing sort of thing . . . it’s you know another little thing that I hope, in about 6 months
time, when the season starts next year, I shall be able to go up and pick the balls up no problem.
Mr Day (time point 1)
Mrs Quinn (time point 1): I think um er you get – you do feel quite tired with the pain. And I think – I’m
hoping that you get more energy so, you know, enthusiasm for things. I can’t say it’s completely gone or
anything like that, but I think that you will – you will have more enthusiasm to do things. I haven’t actually
stopped doing things much, but I realise that um some – some social things have gone down. I mean I still
do all the activities um basically but um maybe with less enthusiasm. And so that will come back, and so
quality of life.
Interviewer: What’s quality of life for you?
Mrs Quinn (time point 1): Well yes it’s, it’s feeling um enthusiasm for doing the things that you do. And
being able to do things like babysitting grandchildren, like going visiting exhibitions like, you know, all the
sort of things that would be nice to do, that maybe have been cut back.
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Fulfilment of expectations relating to pain
Twelve months after surgery, 15 participants described complete relief from pain in their operated joint
(Box 16). This group talked of being ‘absolutely over the moon’ with this outcome and of how they now
‘felt a hundred times better’. The operation had surpassed their expectations and they revealed how it was
a ‘wonderful’ relief to be free of long-term pain. They described how it was ‘lovely’ to ‘move around
without pain’; for example, how they were now able to bend down and walk without experiencing a
‘terrible pain’. As a result, as hoped, those in this group who were not living with pain in other parts of
their body had halted their use of pain relief. However, 12 participants said that although they were free
from the pre-operative intensity of pain arising from the grating of ‘bone on bone’, they continued to
experience discomfort, soreness, tenderness, a dull ache or twinges in the area of their operated joint.
They attributed this pain to a variety of causes. For example, some said that the discomfort was caused by
their muscles tightening, while others thought that their recovery from surgery was not yet complete.
Participants with ongoing problems were also able to identify triggers that intensified these sensations,
BOX 16 Fulfilment of expectations relating to pain
No pain at all . . . no painkillers . . . I was on eight paracetamol a day I think it was, on the maximum and
you couldn’t sleep at night because you could be comfortable in bed, so everything just hard work and
just more complicated where I’ve got nothing like that now.
Mrs Noble (time point 4)
I don’t even think about it [the knee replacement] . . . I mean the only huge difference is, I’m not in any
pain at all.
Mrs Evans (time point 4)
I’m very happy with it. I didn’t realise how good it would be to be free of pain, you know, as I am now
like, you know. But um, yeah, I’ve been very happy with it.
Mr Day (time point 4)
I don’t normally think of it until it actually hurts . . . it’s when I’m in bed normally. Um not right away but
in the middle of the night sort of thing you know . . . I put it down to me muscles, tightening up and you
know, you can’t have things happen to your body and nothing you know, no come back on it.
Mrs Young (time point 4)
Mrs King (time point 4): It’s uncomfortable then when I move. I sort of have – I’m like a little old lady
again getting up, you know, I have to sort of push down on my arms to [deep breath] you know, like
struggle to get – get up. But, you know, but I’d still rather be like that than have the pain I had before,
definitely . . . before I had it done, yeah, that was – that was like a constant grinding, you know, when I
walked it felt like it was – it was horrible. But this is like – I’m sure it’s muscles now.
Interviewer: Is this what you were expecting at this point to be sort of feeling?
Mrs King (time point 4): I wasn’t expecting anything, to be honest . . . But I’m – I’m – I’m pleased if I’m not
in that horrible pain. I can put up with the discomfort. Be nice not to wake up in the night like that but
then, you know, suppose it’ll go in time . . . it’s more dull to what it was . . . like I say, it’s not pain, it’s not
er, ‘Oh my God, you know, I’ve gotta go and take some tablets’. . . . And it’s not enough to warrant
taking tablets.
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such as exercise, ‘stretching themselves too much’, moving from sitting to standing, or standing in the
same position for too long. Although living with ongoing discomfort, most members still said that they
were ‘grateful’ for the treatment that they had. In keeping with attitudes to pain relief medication before
surgery, participants in this group did not see pain to be ‘bad enough’ to warrant taking pain relief
medication; however, two knee replacement participants described continued experience of a more ‘severe
pain’ and they expressed frustration and unhappiness with this outcome. Again, as they did during the
pre-operative interview, participants reflected on how previous experiences of joint replacement – their
own and others’, in addition to information received around the time of surgery, played an important role
in their expectations relating to pain after surgery.
Fulfilment of expectations relating to postoperative function
Participants spoke of how a reduction in the pain experience meant that at 12 months post operation they
were able to move their body around with less difficulty and to walk further than they could before having
joint replacement surgery (Box 17). They were also able to ride a bicycle, more confidently navigate steps
and stairs and had experienced the anticipated independence from walking aids. However, this was not a
universal outcome, with walking aids still used by some participants when they walked for any distance as
they continued to offer reassurance, as they had done before surgery. Participants also talked of ways in
which they continued to experience a lack of freedom and restrictions on the way in which they were
able to move their body. For example, some highlighted how they were unable to run or experienced
difficulties when bending down to the floor to, for example, pick up objects. Accounts also showed how
participants continued to experience difficulties in walking up hills, how their walking pace had slowed
and that they were unable to cope with longer walks, as they had hoped. Many of those who had
undergone knee replacement surgery spoke of how they were now unable to kneel down. Nonetheless,
these restrictions on movement, for most, did not seem to interfere with satisfaction with recovery and
were perceived as ‘no major hindrance’. A perception among participants that general ageing also played
a significant role in limiting the overall potential for movement and mobility can perhaps help to explain
this view.
Fulfilment of expectations relating to engagement in social, work and life activities:
‘I’ve got my life back’
Participants talked of the ways in which their lives had positively changed since undergoing joint
replacement surgery (Box 18). They described how they were now ‘more active’ and how life had become
‘more enjoyable’ as a result of having the operation. They spoke of having ‘a new lease of life’, of ‘making
up for lost time’ and of how they were able to actively engage with more activities in each day now. As
hoped, they had returned to many of the activities that they undertook prior to the onset of the difficulties
with their hip or knee joint – a return to employment, social clubs, gardening, playing skittles, improved
intimate relationships with partners and had already enjoyed holidays and trips to see family and friends.
Planning for, and engaging in, these activities provided them with a psychological ‘lift’ and they talked
of feeling ‘more positive’ and ‘optimistic’ about the future. However, for some participants, their
pre-operative expectations to engage in particular social activities (e.g. taking holidays and games of golf)
once they had recovered from their joint replacement surgery, were tempered, or had to be put on hold,
because of other health conditions. In addition, a few participants who did not talk of additional health
conditions also revealed that they continued to hold themselves back from undertaking the hobbies and
activities that they had previously enjoyed and had hoped to return to (e.g. ballroom dancing). This was
attributed to a lack of confidence in their new joint and concerns relating to falling.
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BOX 17 Fulfilment of expectations relating to postoperative function
Interviewer: Are there any things you’re doing now that you could not do before the operation?
Mr Higgs (time point 4): Um yeah I can – I can walk further . . . I’ve been up a ladder this week, and um
there was no problem at all. Um so getting up and down stairs now, I can – I can do that naturally
without sort of doing up one step at a time, if you know what I mean.
I used to take big strides when I walk but you can’t do that. Um but that’s no bother . . . Well I do have
trouble at walking up a slope since I’ve had my leg done . . . but it will improve.
Mrs Young (time point 4)
Interviewer: And how are you finding the walking now?
Mrs Kade (time point 4): Slowly, I walk quite slowly to be honest but I don’t know why I do, but I do but
then my daughter said to me the other day ‘but mum, you don’t have to walk quickly, you’ve got all day
to do it in, you don’t have to rush to the shops, just walk at a nice even pace’ . . . Looking at it logically
she’s right, and then, but the thing is, when you get older you still think you’re 21 and you think your
body should do what you did then and everything was at double speed wasn’t it, and then logic kicks in
and you think no, no, that’s 50 years ago, just pace it a little bit . . . so I’m learning slowly.
Mr Horton (time point 4): So but um, walking any distance I’m better but I can’t. I mean we’ve left the
walking group. We can’t. We tried it one day and we couldn’t keep up by miles. So I said to [walking
group leader] ‘you’d better go on’ I said ‘we’ll catch the bus home’.
I am walking without sticks . . . I take the stick with me but very rarely do I need it and in actual fact I have
found that walking with a stick makes my hip hurt so it is just an emergency thing really.
Mr Cook (time point 4)
Interviewer: Are there other things that you’re doing now that you couldn’t do before the operation?
Mr Clark (time point 4): Um hmm not – I feel happier carrying things, weights and sort of moving, yeah,
just normal sort of things which I was reluctant to do before. Um I do feel safer up steps and ladders,
because I didn’t realise how much you brace yourself through your legs, um I feel more confident with
that . . . getting in and out of some cars and things, I find it easier, because I can bend my knee,
you know.
Interviewer: Yeah and are there any things that you can’t do now?
Mr Clark (time point 4): I don’t kneel on it um at all. I haven’t knelt on it.
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BOX 18 Fulfilment of expectations relating to engagement in social, work and life activities: ‘I’ve got my life back’
I actually played nine holes um about a fortnight, three weeks ago, on a Sunday. We had a nice, sunny
Sunday. Um, yeah, I got on with it all right. Um it’s my back which is the biggest sort of problem there but
um, no, I coped with sort of nine holes, you know, on quite a long course, um without any problems at
all really.
Mr Clark (time point 4)
I’ve been on holiday twice and I’m going on holiday twice again next year and I didn’t do anything like
that for the last two year because I had too much pain to do it, and you know if we get a chance we go
out for the day and so I really, I really have got a new lease of life completely.
Mrs Noble (time point 4)
Mrs Vickers (time point 4): I do my hand bells and, you know, we go out, um do little concerts. And er I
play bridge during the wintertime and odd times during the summertime, um that’s Monday and Tuesday.
Wednesday, if I don’t play golf, I go up the golf club for lunch and then go out to the women’s fellowship
at church. So, you know, I’m out a lot.
Interviewer: Yeah and that’s quite a change from this time last year, isn’t it?
Mrs Vickers (time point 4): Yes um well I’m enjoying going out more, yes.
My life’s back, back to uh, normal. You know, huh, how can we put it. I suppose being an Englishman I’m
always a bit sensitive about it. My sex life with my wife is now back to a much better position than it used
to be. You know because sex became almost uh, impossible with my hip. But that is now, you know, back
to a normal, sensible proportions. That has been a huge move forward.
Mr Thomas (time point 4)
Interviewer: How is it going with the skittle playing, are you still doing that?
Mr Day (time point 4): Skittles, yeah, I played last night. [Laughs] Yeah, oh yeah, it’s improved it a bit . . .
you know, once I couldn’t bend down and pick the balls up – um easy now.
Interviewer: And in terms of your recovery, how satisfied are you with it?
Mrs Vickers (time point 4): Oh satisfied 100%. I mean it’s, I was so crippled really beforehand. I couldn’t
do things. I’ve got my life back again which, you know, is important to me . . . I do all the um – my
activities at um – I go out quite a lot.
Unfortunately because of my neck we won’t be going on holiday abroad this year, I gave my holiday to my
son that I’d booked because I can’t, don’t think I could cope with travelling by plane and that. We were
going to the [name of county] but I don’t think I can cope with the travel at the moment.
Mr Golding (time point 4)
I mean if I want to I could go back dancing again but I’m a bit, I’m a little bit nervous about that so . . .
and you see you’ve got the slippery floor at the dance and also I will, I wear flat shoes around the house,
whereas if I went dances I would have a small heel on my shoe and that makes you a bit more unstable.
And you can’t really go round the dance floor with a walking stick, so I’ll probably give that a miss but I
think I’m doing as much, if not more this year than I thought I ever would be able to.
Mrs Noble (time point 4)
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Discussion
Through employing a qualitative, longitudinal design, we have achieved a detailed understanding of a
range of issues concerning the experience and impact of hip and knee replacement. Specifically, we have
gained a comprehensive understanding of patients’ routes from referral to hip replacement surgery and
have learned about the impact of waiting for surgery. This includes focus on patients’ psychosocial
well-being and their conceptualisation of time. We have gained an understanding of how confidence
influences, and is influenced by, experiences of undergoing and recovering from hip replacement surgery.
We have also generated novel perspectives on the trajectories of support used by patients over the journey
through knee replacement. We have also achieved an in-depth understanding of the nature of patients
expectations for hip and knee replacement surgery, how these expectations are formed and the ways in
which they are accomplished (or not) 12 months after surgery. All of these insights have been made
possible by the study designs, which is one of the first to explore patients’ experiences of joint replacement
in such detail from the pre- to 12-month postoperative period. Furthermore, a key strength of our work is
the inductive nature of the approach, which ensured that the issues that we have addressed in this chapter
are of particular salience and relevance to participants.
We have identified that delays to surgery are a common occurrence for patients in the NHS awaiting
orthopaedic intervention. These changes to the date of surgery made by the system and patients’ changing
perceptions while waiting for health care both have implications for patients’ well-being and this finding
helps to explain views about health care. Our findings suggest that patients’ experiences of time in the lead
up to surgery are complex and multidimensional and clearly differ from the linear conceptualisation of time
that is required to plan NHS services. We have gained detailed and useful insights into how undergoing
surgery can increase feelings of vulnerability and alter a patient’s trust in their own body, and the influence
of interactions with others on confidence levels and the fears that patients have concerning the potential of
causing harm to their new prosthesis. The research also highlights some of the strategies that patients
engage in to limit this. We have learned that patients rely extensively on, and value, both informal and
formal support networks over the perioperative period and that transformation from a person living with
osteoarthritis to a person recovering from a surgical intervention can lead to alterations in the assistance
participants received from others, including the source, type and level of assistance. However, when patients
are not offered the support of health and social professionals over the perioperative period, for example to
aid recovery, negative consequences can ensue (e.g. distress and feelings of abandonment). We have
highlighted the complexity of patients’ expectations for joint replacement surgery and how these
expectations can be driven by previous personal experience of undergoing joint replacement surgery,
knowledge of others’ experiences – both successful and unsuccessful – and information resources provided
by the hospital around the perioperative period. These insights will be useful in helping health-care
professionals in educating, supporting and managing patients expectations to ensure that patients form
realistic and achievable expectations for outcomes relating to pain, function and engagement with work,
social and life activities.
Use of in-depth interviews facilitated a detailed exploration of participants’ experience of undergoing and
recovering from joint replacement surgery. Follow-up interviews allowed for clarification of any issues
raised in earlier interviews. They also facilitated the development of a closer researcher–participant rapport,
which encouraged the disclosure of personal accounts, helping to generate novel insights and richer data.
The use of topic guides allowed consistent exploration of salient issues across participants but also the
opportunity for additional probing and reflection in order to facilitate examination of prominent and
unanticipated issues. To ensure analytic rigour, analysis was conducted by a team of experienced
qualitative methodologists with backgrounds in social and behavioural sciences. The analysis process
included double coding, discussion and agreement to arrive at the final list of themes. Furthermore, we
engaged in several other validation strategies: discussion of findings with patient representatives, reflexivity
and seeking out and paying attention to negative cases. We do not claim that the experiences of the
participants were representative of everyone awaiting hip and knee replacement surgery; however, the
rigour of analysis helps to improve the credibility of findings. In addition, although the research was carried
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out with patients undergoing surgery at a single orthopaedic centre, men and women were included and
the sample sizes were designed to accord with robust approaches. In the thematic approach used in the
hips data set, we were confident that data saturation had been achieved. In the knees data set, use of IPA
provided us with the opportunity to achieve depth in analysis and the data set size is within the norms of
IPA methodology. The inclusion of patients from only one orthopaedic centre has the potential to affect
transferability of findings, but the orthopaedic centre serves a diverse population in the region and it is
likely that the results will resonate with the experiences of patients from other areas of the UK.
We took care in the design of the study to consider data collection approaches. Qualitative researchers
have traditionally chosen to meet face to face with participants when carrying out in-depth interviews.
However, research in the area now indicates that the mode of interview may have little impact on the
number, character and depth of data generated during an interview.261 However, we designed the study
such that initial interviews took place in person to build rapport and consider it likely that this enabled the
generation of even richer data during subsequent interviews that were conducted by telephone. The study
had excellent retention; interviews were carried out with 21 out of the 24 hip patients and 8 out of the
10 knee patients at the three follow-up points.
Conclusion
Our findings suggest important ways in which the provision and delivery of care and education to people
undergoing joint replacement in routine NHS care could be refined and improved. For example, patients
can experience a range of emotional reactions if they experience delay and cancellation of their surgery
date. Even without a delay, the wait for surgery alone can have detrimental physical and emotional
consequences and cause wider psychosocial disruption. It is important that health professionals recognise
these consequences, affirm patients’ experiences, identify those at increased risk and work towards
minimising delay and cancellation of operation dates when possible. In addition, findings demonstrate the
value of recognising the fluid and dynamic nature of time and broader temporal issues embedded in the
perceptions, interpretations and experiences of patients in the lead up to joint replacement. Findings also
highlight how patients appear to value the offer of postoperative physiotherapy shortly after surgery as
well as longer-term follow-up in secondary care. The latter may be of particular value for those patients
who experience complications after surgery or who are particularly troubled by a lack of confidence and
faith in their prosthesis.
The findings of our analysis suggest the importance of future directions for work that concerns patients’
experiences of undergoing joint replacement surgery. For example, for some participants, concerns about
potential dislocation became an enduring fear, something that influenced their behaviour and activities
1 year after surgery. This suggests the need to investigate the influence and impact of these concerns in
the longer term and learn more about how best to support this group of patients. In addition, findings
suggest the value of future work to address the specific impact of age, sex and cohabitation status on
patients’ use of support networks around the perioperative period.
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Chapter 5 Measuring functional outcomes in
patients having hip and knee replacement:
a cohort study
Parts of this chapter have been reproduced from Wylde and colleagues.262 © 2012 Wylde et al.; licenseeBioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited. Some parts have also been
reproduced with permission from Wylde V, Lenguerrand E, Brunton L, Dieppe P, Gooberman-Hill R, Mann C,
et al. Does measuring the range of motion of the hip and knee add to the assessment of disability in people
undergoing joint replacement? Orthop Traumatol Surg Res, vol. 100, pp. 183–6.263 Copyright © 2014
Elsevier Masson SAS. All rights reserved. Parts of this chapter have also reproduced from Lenguerrand and
colleagues264 © 2016 Lenguerrand et al. This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.
Abstract
Background
In the ADAPT study we aimed to compare outcome measures over time in patients with hip or knee
replacement and assess how well they measure impairment, activity limitation and participation.
Methods
Outcome measures were studied prospectively in 263 patients receiving joint replacement. Function
was assessed prior to surgery and at 3 and 12 months using patient-completed questionnaires,
clinician-administered tools and performance tests.
Results
A clinically significant improvement occurred in about 90% of patients with hip replacement and 70% of
those with knee replacement. Patients with severe disease at the time of surgery were more likely to have
substantial improvements in pain and functional ability.
Pain and function measures were highly correlated. People with anxiety or depression may assess themselves
as being worse off than objective measures suggest. Measures of function may need adjustment for pain,
psychological status, age and perhaps muscle strength to obtain a satisfactory picture of functional loss.
Results suggested that physical function should be measured with both a PROM and a performance test.
ROM is commonly assessed in clinical practice but did not correlate well with other measures of
disease severity.
Conclusions
The ADAPT study highlighted the importance of different methods of assessing pain and function in
patients receiving hip and knee replacement. Different pain characteristics predicted long-term pain in hip
and knee replacement. Outcomes after joint replacement should be assessed with a patient-reported
outcome and a functional test.
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Background
In medical research it is conventional to use ‘outcome measures’ to assess change over time and the
response to any intervention, such as a joint replacement.265 Outcome measures are an artificial construct,
as everyone’s life and health changes continuously and well-being is influenced by many factors other than
a specific illness or its treatment.266 Nevertheless, we need outcome measures at appropriate time points
when comparing the value of different approaches to health care. Research suggests that most of the
benefit that can accrue from a successful joint replacement has occurred by 12 months after the
operation.48 In addition, we need to measure the long-term costs of providing treatments, which allows us
to assess whether or not incremental health benefits are worth the incremental costs required to
provide them.
It is essential that patient-reported outcomes after joint replacement are continuously reviewed and
monitored to improve practice and optimise the results of surgery. However, the use of many different
outcome measures can lead to difficulty in applying evidence to clinical practice and renders comparisons
across studies and meta-analyses problematic.267 One recent systematic review found extensive variation in
the outcome measures used in RCTs of joint replacement.119
Measurement by clinician or patient report
The outcome after a hip or knee replacement can be assessed in different ways and can be classified
according to who makes the judgement – a clinician, the patient alone, a ‘significant other’, or a mixture
of two or more groups. In early studies, adverse events such as infection and prosthesis survival were the
main issues of concern.45 As prosthesis design and the control of adverse events improved, these issues
become less important and attention turned towards clinician administered tools, such as the Harris Hip
Score (HHS)268 and AKSS113 and more recently towards PROMs.121 Clinician-administered tools have been
widely criticised because of the recognised discordance between views of patients and clinicians.269,270
Research studies in joint replacement frequently use PROMs assessing different domains. Patients rate their
pain, function, HR-QoL, social participation, mental health and satisfaction with the outcome of health-
care interventions. In England, following the report of Lord Darzi,121 PROMs are routinely collected after
elective surgery.271
General or specific measures
Outcome measures may be general reflecting overall pain, function and well-being or specific relating to
an arthritic hip or knee. ‘Joint specific’ measures are used to assess the effectiveness of an intervention
targeting a joint (such as joint replacement); however, it is important to find out if a patient’s general QoL
has been affected.
It is generally agreed that we should assess pain and function when treating arthritis, as these are the two
problems that bother people most. But it is not known what aspect of the pain (e.g. activity related pain,
night pain or resting pain) and types of function (e.g. stair climbing, shopping, getting on a bus or playing
golf) cause researchers endless problems. In addition, these often depend on issues such as culture
and context.
There are many different outcome measures for use in assessment of health status and the response to
interventions for people with arthritis and such instruments need to be validated before use. We need
to be sure that they measure the outcome appropriately and that they are reproducible, responsive to
change, consistent and acceptable to patients. Many researchers choose an instrument because it is widely
used by others and this will help them to compare their results with those in the published literature.
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Utilities
In health care, we attribute a measure of ‘utility’ to the time patients spend with a particular QoL profile.
Utility is an economic term to describe the benefit that individuals derive from consuming goods or
services. Because goods and services are scarce, individuals are faced with choices and their preferences
are revealed by choosing to consume some goods and services over others. Individuals would rationally
prefer goods and services that provide them with a higher utility level. In terms of health and health care,
we consider that each patient has a given health profile that gives them a certain amount of health benefit
or ‘utility’. Better health profiles are those for which patients have a higher QoL and, therefore, higher
utility scores as well. We measure each individual’s health profile by asking patients to fill in generic
HRQoL questionnaires. Such questionnaires can be filled in a myriad of ways, each corresponding to a
different health profile. These are then sent for valuation to a random sample of individuals from the same
population with a particular health profile. The weighted average of values for each health profile is the
‘utility score’ that a particular society has attributed to the specific health profiles.
Outcomes used in RESTORE
In Table 15, we summarise the key outcome measures used in the RESTORE programme.
The main issues of concern to patients undergoing total hip or knee joint replacement include pain and
functional problems that are related to the joint disease, as well as general QoL and satisfaction with the
surgery. In this chapter we consider joint specific pain and function. Pain is a purely subjective domain,
so that we are dependent on patient self-report to assess it. In contrast, function can be assessed in many
different ways, which include patient report, observation of specific or general activities, measurement of
certain activities and third party observations and perceptions.
The WHO introduced the ICF,80 which provides a theoretical framework on which to base the assessment
of function. This framework splits function into three separate domains: impairment, activities limitations
and participation restrictions. The value of this in the context of total hip or knee replacement can be
illustrated by taking the example of climbing a step, a common problem for people considering a total hip
or knee replacement. The impairments might include reduced joint movement, pain on movement and
muscle weakness; the resulting activities limitations might be difficulty climbing stairs or difficulty getting
onto a bus. Consequent participation restrictions might be inability to get to the shops or to go to stay
with grandchildren because of the need to use stairs. Research has shown that the relationship between
the impairment, activities limitations and participation restrictions domains of the ICF are not simple,
with other factors such as self-efficacy and comorbidities acting as independent determinants of the
relationships between these variables.300
It has been recommended that a combination of outcome measures should be used to assess function
after total hip or knee replacement.301,302 However, there are many reasons not to use a wide number of
measures with every patient, whether in clinical practice or research. These include patient fatigue and
burden, time constraints of clinic and research appointments, and time taken to process and analyse
multiple information sources. Therefore, there is a need for guidance about which outcome measures are
the most useful in assessing function before and after total hip or knee replacement.
The aims of the ADAPT study were to compare the properties and responsiveness of a selection of
commonly used measures that are either self-assessment tools or functional tests, to examine how well
they relate to the ICF concepts of impairment, activities limitations and participation restrictions, and to
explore the changes in the measures and domains of outcome over time.
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TABLE 15 Outcome measures used in the RESTORE programme
Name of measure
Mode of
completion
General or
joint
specific Health domain measured Study used in
WOMAC114 Self-complete Joint specific Joint pain, function and
stiffness
SPIRAL, APEX,
ADAPT, PROOF-THR
HOOS272 Self-complete Joint specific Joint-related QoL, pain and
function
Experience
KOOS273 Self-complete Joint specific Joint-related QoL, pain and
function
Experience, ARENA
OHS274 Self-complete Joint specific Joint pain and function PROOF-THR
OKS117 Self-complete Joint specific Joint pain and function
Pain Self-Efficacy
Questionnaire275
Self-complete General Self-efficacy for pain SPIRAL, APEX
Brief COPE276 Self-complete General Coping strategies SPIRAL, APEX
Beliefs and Medicines
Questionnaire277
Self-complete General Beliefs about medicines SPIRAL
EQ-5D278 Self-complete General HR-QoL and utilities SPIRAL, APEX,
ARENA, PROOF-THR
Functional Comorbidity
Index279
Self-complete General Medical comorbidities SPIRAL, APEX,
ADAPT, ARENA
ICOAP280 Self-complete Joint specific Joint pain APEX
HADS281 Self-complete General Depression and anxiety APEX, ADAPT,
PROOF-THR
Illness Perceptions
Questionnaire-Revised282
Self-complete General Illness perceptions APEX
painDETECT283 Self-complete General Neuropathic pain APEX
Self-Administrated
Patient Satisfaction Scale
for Primary Hip and
Knee Arthroplasty284
Self-complete Joint specific Satisfaction with the outcome
of joint replacement
ADAPT
Ab-IAP285 Self-complete General Impairments, activity limitations
and participation restrictions
ADAPT, ARENA,
PROOF-THR
SF-12286 Self-complete General HRQoL ADAPT
MYMOP2287 Patient-generated
questionnaire
completed by patient
with assistance from
researcher
Joint specific
and general
Individualised symptoms and
restricted ADL, well-being and
medication usage
ADAPT, ARENA
HHS268 Assessment by
clinician
Joint specific Joint pain, function, deformity
and ROM
ADAPT
AKSS113 Assessment by
clinician
Joint specific Joint pain, function, stability,
ROM
ADAPT
Timed 20-metre walk288 Completed by
patient, assessed by
clinician
General Function (locomotion) ADAPT
Timed get-up-and-go
test289
Completed by
patient, assessed by
clinician
General Function (transfers and
locomotion)
ADAPT
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Methods
The ADAPT study is a single-centre cohort study at the AOC. Based in the south-west of England, this is
one of the largest elective orthopaedic units in the UK, with approximately 800 hip operations and 800
knee operations performed in 2011.303 The ADAPT study was approved by Southwest 4 Research Ethics
Committee (09/H0102/72) and all participants provided their informed, written consent to take part.
The study was registered on the NIHR Clinical Research Network Portfolio (UKCRN ID 8311).
Inclusion/exclusion
Recruitment into the study began in February 2010 and finished in November 2011. Patients listed for one
of the following operations were eligible: primary TKR, revision TKR, unicompartmental knee replacement,
patellofemoral replacement, primary THR, revision THR or hip resurfacing. We included patients with
different surgical procedures so that functional measures could be assessed across a range of people with
diverse issues and degrees of functional loss.
Patients were excluded from the study if they lacked the capacity to provide informed consent. This was
assessed by the research nurse in accordance with guidance from the integrated research application
system, which is responsible for providing ethical approval in the UK and the Mental Capacity Act of
2005.304 This decision was made by a research nurse if the patient met one of the following criteria:
(1) they could not understand the information relevant to the decision to participate; (2) they were unable
TABLE 15 Outcome measures used in the RESTORE programme (continued )
Name of measure
Mode of
completion
General or
joint
specific Health domain measured Study used in
Sit-to-stand-to-sit290 Completed by
patient, assessed by
clinician
General Function (transfers) ADAPT
Step test291 Completed by
patient, assessed by
clinician
General Function (ascending and
descending stairs)
ADAPT
Balance test292 Completed by
patient, assessed by
clinician
General Function (balance) ADAPT
Inertial sensor293 Completed by
patient, assessed by
clinician
General Function ADAPT, PROOF-THR
LEFS294 Self-complete Specific Function ARENA
UCLA Activity Score295 Self-complete General Activity level ARENA
Activities-specific
Balance Confidence
Scale296
Self-complete General Balance ARENA
Self-efficacy for
Rehabilitation297
Self-complete General Self-efficacy for rehabilitation ARENA
NEADL Questionnaire298 Self-complete General Function PROOF-THR
ICECAP-O299 Self-complete General Well-being and utilities PROOF-THR
Ab-IAP, Aberdeen impairment, activity limitation and participation restriction measure; ICECAP-O, ICEpop CAPability
measure for Older people; ICOAP, Measure of Intermittent and Constant Osteoarthritis Pain; LEFS, Lower Extremity
Functional Scale; MYMOP2, Measure Yourself Medical Outcome Profile 2; Nottingham Extended ADL; UCLA, University of
California at Los Angeles.
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to retain the information about the study; (3) they were unable to use or weigh that information as part of
the decision-making process; and (4) they were unable to communicate their decision about participation
(whether by talking, using sign language or any other means). Another exclusion criterion was severe
functional limitations such that the patient was unable to walk because this would prevent the patient
from being able to attempt any of the functional tests. This was assessed in the discussion between the
research nurse and the potential participant and was always a mutual decision by the researcher and the
patient. Being unable to complete questionnaires in the English language was also an exclusion criterion
because not all the validated questionnaires have been translated into other languages.
Participant recruitment
Potential participants were identified from the joint replacement waiting list by the code for the intended
operation and sent a postal invitation. Patients who returned a reply form were telephoned by a research
nurse to discuss participation. This included a full explanation of study involvement and a preliminary
eligibility assessment by asking about the intended operation and assessing understanding of the
information provided. Those that did not reply or who were missed from the initial postal invitation list
owing to late scheduling of hospital appointments were approached by a research nurse when they
attended the pre-operative assessment clinic. These patients were identified by daily checking of the clinic
lists. If they were interested, eligibility was assessed and a full explanation of study involvement was
provided. The first appointment was arranged then or patients were telephoned a few days later if they
needed time to consider. Demographic data (age, sex and postcode) was recorded from all patients.
Assessment times
Participants attended a research appointment, lasting approximately 1 hour, at the AOC. Appointments
were scheduled before surgery and then at 3 months and 1 year after surgery. Assessments were conducted
at 3 months post operation to coincide with the standard clinical review, by which time most patients should
have experienced a large improvement in pain and function.48 Assessments were also conducted at 1 year
post operation as outcomes can continue to improve up until this time point.48 The inclusion of two
postoperative assessments also allowed exploration of outcome trajectories and comparison of rates of
improvement between different outcome domains (e.g. pain, function, participation).
At the initial pre-operative appointment, eligibility was confirmed, informed written consent was obtained
and a questionnaire was given to participants to return by post before their operation. For the postoperative
assessments, a questionnaire was sent out prior to the research appointment. At each time point,
participants underwent a clinical assessment. These assessments were conducted by trained research nurses
who followed standard operating procedures to ensure consistency and standardisation in data collection
and who were assessed for competency in the examination procedures by a senior research nurse and
orthopaedic surgeon. Risk assessments of the functional tests were undertaken and safe operating
procedures specified. The data collected during the assessments were recorded by the research nurses on
standardised proformas.
Selection of outcome measures
Table 16 provides a summary of the functional assessment measures used in the ADAPT study. The table
also provides an overview of the ICF domains included within each functional assessment measure, with
classification of self-completed PROMs and clinician-administered measures based on the results of an
expert consensus study by Pollard and colleagues60 We also conducted a gait analysis using a single inertial
sensor to derive motion parameters during ADL.305
There are a number of other measures that could have been included in this study such as the OHS and
OKS,117,274 HSS,113 KOOS306 and NHP.307 However, to avoid participation burden and fatigue only a selection
of measures was chosen.
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TABLE 16 Measures used in the ADAPT study to assess function pre-operatively and at 3 and 12 months
post operation
Measure
ICF domains
assessed
Mode of completion ScoringI A P
PROMsa
WOMAC function
subscale
– ++ +/– Patient 0–68
Ab-IAP ++ ++ ++ Patient I scale= 9–45, A scale= 17–85,
P scale= 9–45
SF-12 PCS +/– ++ +/– Patient 0–100
MYMOP2b +/– +/– +/– Patient with assistance
from research nurse
0–6
Clinician-administered measuresc
AKSS + ++ – Research nurse and patient 0–100
HHS + ++ +/– Research nurse and patient 0–100
Performance tests and motion analysisc
Timed 20-metre walk – ++ – Research nurse and patient Time, difficulty, motion parameters
Timed get-up-and-go test – ++ – Research nurse and patient Time, difficulty, motion parameters
Sit-to-stand-to-sit test – ++ – Research nurse and patient Completion, difficulty, motion parameters
Step tests – ++ – Research nurse and patient Completion, difficulty, motion parameters
Single stance balance
tests
– ++ – Research nurse and patient Completion, difficulty, motion parameters
Gait analysis parametersd
Walking speed ++ – – Research nurse and patient Metre/second
Walking cadence ++ – – Research nurse and patient Step/minute
ROM pelvic obliquity ++ – – Research nurse and patient Degree
Time to complete a step ++ – – Research nurse and patient Second
Length of step ++ – – Research nurse and patient Metre
Step Irregularities ++ – – Research nurse and patient Variability in successive steps of the same
leg
Asymmetries ++ – – Research nurse and patient Ratio of asymmetry between steps time
(seconds) of both legs
A, activity limitations; Ab-IAP, Aberdeen impairment, activity limitation and participation restriction measure; I, impairments;
MYMOP2, Measure Yourself Medical Outcome Profile 2; P, participation restrictions.
The extent to which I, A and P is assessed within each tool is indicated using the following symbol system: – no items
assessing domain, –/+ a small number of items assessing domain, + some items assessing domain, ++ the majority of items
assessing domain.
a Scores were self-completed by the patient in a postal questionnaire, excepting MYMOP2 which was completed during a
research appointment.
b The MYMOP2 asks patients to generate two symptoms (impairments or activity limitations) and one activity (which could
be activity limitation or participation restrictions) that are restricted by their symptoms.
c Scores and tests were assessed by a research nurse during a research appointment. Participants were also invited to rate
their performance on the functional tests.
d Information captured during the 20-metre walk test with body-fixed inertial sensors containing accelerometers and
gyroscopes wireless connected to a computer.
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Patient-reported outcome measures
The following validated measures were used to provide disease-specific and generic self-reported measures
of outcome.
The WOMAC function scale.114 This disease-specific subscale, validated in osteoarthritis patients, consists of
17 questions assessing the extent of function limitations when performing a range of daily activities.
Responses are provided on a 5-point Likert-type scale.
Aberdeen impairment, activity limitation and participation restriction measure (Ab-IAP).285 This 35-item
disease-specific measure, validated in osteoarthritis patients, uses the ICF framework to assess disability
and produces scores for impairment, activities limitations and participation restrictions. Responses are
provided on a 5-point Likert-type scale.
Short Form questionnaire-12 items.116 This 12-item general health measure produces a PCS and mental
component score scale. Responses are provided as binary options (yes/no) or on a Likert-type scale.
Measure Yourself Medical Outcome Profile 2 (MYMOP2).287 This patient-generated instrument allows
participants to generate and rate the severity of two symptoms that are concerning them and one activity
important to them that is restricted by the symptoms. Participants also rate their general well-being,
duration of symptom 1 and medication usage for symptom 1. At follow-up, participants are asked to rate
the severity of the symptoms and degree of restriction of the activity that they identified at the first data
collection point. Ratings are provided on scales of 0–6. The MYMOP2 was completed during research
appointments by participants with the assistance of research nurses.
Participants also completed a number of other questionnaires to assess factors that have been found to
influence outcomes after total hip or knee replacement (Table 17). At each assessment time, participants
completed the HADS281 and the WOMAC pain and stiffness subscales.114 Participants were also asked to
rate how disabled they perceived themselves because of their joint problems and why, and to list three
things that they were hoping for from their total hip or knee replacement. Pre-operatively, medical
comorbidities were recorded using the Functional Comorbidity Index279 and information was collected
about socioeconomic status (marital status, living arrangements, educational attainment, employment
TABLE 17 Measures used to assess factors influencing function in the ADAPT study
Measure Dimensions
Mode of
completion Scoring
Assessment times
Pre-operation 3 month 1 year
WOMAC pain subscale Joint pain Patient 0–20 ✓ ✓ ✓
WOMAC stiffness subscale Joint stiffness Patient 0–8 ✓ ✓ ✓
HADS Depression,
anxiety
Patient 0–21 ✓ ✓ ✓
SF-12 mental component score Mental health Patient 0–100 ✓ ✓ ✓
Perceived level of disability Function Patient 0–10 ✓ ✓ ✓
Three things hoping for from surgery Expectations Patient Categorical ✓ ✓ ✓
Functional Comorbidities Index Comorbidities Patient 0–18 ✓
Arthritis and surgery in other joints Comorbidities Patient By joint/count ✓
Socioeconomic status Socioeconomic Patient Categorical ✓
Self-Administered Patient Satisfaction
Scale
Satisfaction Patient 0–100 ✓
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status), joints affected by arthritis and previous surgery on other joints. In the 1-year postoperative
questionnaire, satisfaction with the outcome of surgery was assessed using the Self-Administered Patient
Satisfaction Scale for Primary Hip and Knee Arthroplasty.284
Clinician-administered measures
The HHS was completed with patients receiving hip replacement.268 This assessment measure provides a
total score of between 0 and 100 (worst to best) collected over four domains. Function, which includes
limp, use of assistive devices, walking distance, managing stairs, using public transport, sitting comfortably
and putting on shoes and socks, is weighted the most heavily and is assigned 47 points. Pain is assigned
44 points. The physical examination involves assessing deformity (4 points) and ROM (5 points).
The AKSS was completed with patients receiving knee replacement.113 This assessment consists of a knee
score and a function score, both with a total score ranging from 0 to 100 (worst to best). The knee
score incorporates examiner’s rating of patients’ pain (50 points) and a clinical assessment of stability
(25 points) and ROM (25 points), with deductions for flexion contracture, extension lag and misalignment.
The function score consists of questions about walking distance (50 points) and stair climbing ability
(50 points), with deductions for the use of walking aids.
Performance tests
Before performing each of these tasks, participants were asked if they thought that they would be able to
perform the task and estimate how difficult they thought the test would be to perform on a 0–10 scale
(no difficulty at all to impossible). After they had completed the test, they were asked to rate how difficult
the task actually was to perform on the same 0–10 scale. The research nurse conducting the assessment
also provided a rating of how difficult it appeared to be for the participant to perform the task. If
participants were unwilling to attempt the test or the research nurse was unhappy to proceed because of
safety concerns, the test was not performed. All tests were performed without the use of supportive aids
except the timed 20-metre walk and are described in the order in which they were performed.
Timed 20-metre walk288
Participants were timed as they walked a 20-metre straight distance on level ground at their normal,
comfortable speed. If the participant normally used a walking aid they were asked to try without it but, if
they felt unable to do so, they completed the test using the walking aid. The recorded outcome was the
time taken to complete the test.
Timed get-up-and-go test289
Participants sat on a height-adjustable chair such that a 90° angle was formed when the femur was
horizontal and the tibia vertical with their feet shoulder width apart and their arms crossed against their
chest. Participants were timed as they stood up from the chair without using their hands, walked at a
normal pace past a marker 3 metres away, turn around, walked back and sat down again. The recorded
outcome was whether or not participants were able to complete the activity and how long it took.
Sit-to-stand-to-sit290
Participants sat on a height-adjustable chair as described for the previous test. Participants then stood up,
waited 2 seconds and sat down again without using their hands. The recorded outcome was whether or
not participants were able to complete the activity.
Step test291
Participants stepped up onto a 20-cm-high block leading with the contralateral leg, waited
2 seconds and then stepped down from the block with the index leg leading, without using their arms.
The test was then repeated with the index leg leading. If participants successfully completed this test, the
test was repeated with a 30-cm-high block. The recorded outcome was whether or not participants were
able to complete the activity.
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Single stance balance test292
Participants stood with their feet together facing the research nurse and placed their palms gently on top
of the research nurse’s palms. Participants then lifted their index leg and attempted to balance on their
contralateral leg for 15 seconds. If the participant lost balance within 3 seconds, then the test was
reattempted. If the participant lost balance before 15 seconds, the length of time was recorded. This test
was then repeated while balancing on the index leg. If these tests were completed successfully, the
participant repeated the tests with no stability support from the research nurse. The recorded outcome
was whether or not participants were able to maintain the stance for 15 seconds.
Inertial sensor-based motion and gait analyses
Movement analysis by body-fixed inertial sensors containing accelerometers and gyroscopes enables the
objective assessment of the translational and angular movements of body segments outside a gait
laboratory.293,308 We used a single 3 dimensional (3D) inertial sensor [41 × 63 × 24mm; 39 g; Microstrain
Inertia Link (Williston, VT)] containing accelerometers (± 5 g) and gyroscopes (± 300°/second) along the
three orthogonal axes in frontal, sagittal and transverse plane and positioned centrally between both
posterior superior iliac spines to measure trunk movements near the centre of gravity. Based on the 3D
linear accelerations, angular rates and angular positions put out by the sensor and sent wirelessly to a
computer at a 100 Hz sampling frequency via a Bluetooth® (Bluetooth SIG, Inc., Kirkland, WA) link, analysis
algorithms calculated motion parameters such as step frequency, step asymmetry or trunk sway.
The inertial sensor was used to derive motion parameters from a battery of movement tasks which were
clinically feasible to perform during a routine outpatient visit and which challenged the patient’s functional
capacity in different ways: (1) locomotion (walking), (2) transfers (sit-to-stand-to-sit test, get-up-and-go
test), (3) rising and descending (step test) and (4) balance tests (single-leg stance). The walk test309 and
the step-test were repeated twice and the sit-to-stand-to-sit test was repeated three times to derive
representative mean values or study possible effects of fatigue or warming up.
Data collection
Information on BMI, diagnosis, side of surgery, type of surgery and surgical approach was extracted from
participants’ medical records.
Data recording
All data were entered into a password-protected database by research nurses or study administrators.
The study was overseen by an independent Steering Committee which met every 6 months to discuss the
progress of the study. Data monitoring, which involved double data entry and quality checks, was
conducted every 3 months. All data were cleaned before data analysis was performed. Any inconsistencies
were collegially discussed by an internal board of researchers involved in the data collection.
Sample size
This study involved exploratory analysis to compare different measures to assess function after total hip or
knee replacement. Therefore, no formal sample size calculation was performed, although we aimed to
recruit a sufficient number of patients to allow meaningful data analysis. We approached all patients listed
for surgery with participating surgeons between February 2010 and November 2011. Previous longitudinal
studies comparing measures of function in an orthopaedic population have included between 30 and
200 patients.310–318
Analysis
The statistical methods used to analyse the data are described in each section of the results, which have
been divided into three sections:
l baseline demographic data
l cross-sectional correlations of baseline data
l analysis of change from longitudinal data including preliminary results from the gait analysis.
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Results
Demography of the cohort
A total of 130 patients receiving hip replacement and 133 patients receiving knee replacement were
recruited to the ADAPT study.
The patients listed for a hip surgery were planned to receive a primary THR (n= 78), revision THR (n= 44)
or a hip resurfacing (n= 8). The 133 patients listed for a knee surgery were planned to receive a primary
TKR (n= 51), revision TKR (n= 45), unicompartmental knee replacement (n= 32) or patellofemoral
replacement (n= 5). The five patients awaiting patellofemoral joint replacement were excluded from the
cross-sectional analysis owing to the isolated nature of their knee disease.
Not all data were available on all 258 patients and at each measurement point, so the subsequent analyses
reported below are often on slightly smaller groups.
Patient demographics for the 249 participants with available pre-operative data (125 listed for hip
replacement and 124 listed for knee replacement) are summarised in Table 18.
Cross-sectional analysis of the different measures of function
Introduction
As noted above, one of the main aims of this study, within the overall programme was to improve our
understanding of the best ways of measuring function before and after hip or knee joint replacement. In
this section of the results, we describe the correlations between the different measures of function that we
have data on at the baseline visit. We also describe the disparities/similarities in the associations between
these measures and patient characteristics. Investigating these issues provides insight into how the
outcomes as measured by these various tools can be interpreted and sheds insight into the comparability
of the tests. The data should also aid those investigating disability caused by severe hip and knee
pathology to make an informed choice of measurement tool.
Statistical analysis
The relationships between the different functional measures were assessed with correlation statistics.
Spearman’s rank-order coefficients were used to assess correlations between continuous variables and
point-biserial coefficients to assess correlations between continuous and dichotomous variables. These
measures range from –1 to 1. The strength of correlation was interpreted as |0.00–0.25|= none–little,
|0.26|–|0.49|= low, |0.50|–|0.69|=moderate, |0.70|–|0.89|= high, |0.90|–|1.00|= very high. Correlations
between two binary measures were assessed with Cramér’s V-statistic, which ranges from 0 to 1. A value
> 0.3 was considered very strong.
The association between participants’ characteristics and functional measures was investigated with linear
regression for HHS, AKSS, WOMAC function, Aberdeen activity limitation subscale (Ab-A), Aberdeen
participation restriction subscale (Ab-P) [transformed as root squared (score)], walking speed and get-up-and-go
tests (transformed as 1/time). The step and balance tests produced dichotomous outcomes (able/unable to do
test) and were investigated with a modified Poisson regression with robust variance estimation.
Individual patient characteristics were first considered in a univariate model. Factors that were found to be
significant (p≤ 0.05) were then investigated in a multivariate analysis to determine if their effects were
confounded by other factors.
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The analyses were conducted separately for hip and knee patients. Although few participants had missing
information for one or more of the considered variables, missing data were addressed using a multiple
imputation by chained equations approach. Ten imputations were generated and estimates were
combined using Rubin’s rules. Statistical analyses were performed in Stata 12.1.
Results
The mean/median and range of scores for each of the functional measures are shown in Table 19. These
data show that most participants had significant functional limitations, although the wide range of each of
the measures suggests considerable variability.
TABLE 18 Characteristics of participants in the ADAPT study
Characteristic Hip (n= 125) Knee (n= 124)
Surgery type (%) Primary replacement 65.6 40.3
Revision surgery 34.4 33.9
Unicompartmental surgery – 25.8
Sex (%) Female 50.4 51.6
Age (years) Median (25th, 75th)a 64.4 (57.1, 72.5) 68.3 (60.5, 73.9)
Painb Mean (95% CI) 53.9 (50.0 to 57.8) 44.1 (40.7 to 47.4)
Psychological distressc (%) 32.0 33.1
BMI, kg/m2 (%) Median (25th, 75th)a 27.0 (24.3, 30.4) 30.4 (27.4, 34.5)
Overweight 41.0 39.8
Obese 26.8 52.7
Comorbidities (%) 0 comorbidities 46.0 36.0
1 comorbidity 35.9 27.3
≥ 2 comorbidities 18.1 36.8
Arthritis (%) 0 joint 21.3 14.9
1 joint 25.0 21.1
2 joints 19.7 14.1
3 joints 15.0 16.4
≥ 4 joints 19.0 33.5
Living alone (%) 24.2 29.3
Education (%) Normal leaving-school age or before 54.2 61.1
College 23.0 25.1
University 22.8 13.8
Working status (%) Paid or volunteer activity 46.4 30.7
Retired 48.0 62.9
Unemployed 5.6 6.4
Q, quartile.
a Q1= 25th percentile and Q3= 75th percentile.
b (WOMAC) pain subscale; the higher the score the better the outcome (range 0–100).
c HADS.
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Relationships between functional measures
Correlations between the different functional measures were all statistically significant, but some were
much stronger than others (Table 20). The HHS correlated relatively well with PROMS and with walk time
in patients with hip disease, but not so well with the other performance tests. The AKSS correlated poorly
with all other types of functional measures in patients with knee disease. The highest correlations, in both
hip and knee patients, were between the WOMAC and Ab-A scores – the two PROMs for disability;
between the walking speed and the get-up-and-go test – the two timed tests; and between the balance
test and 30-cm step test.
Associations between patient characteristics and functional measures
Associations between patient characteristics and the different functional measures are shown in Tables 21
(hip) and 22 (knee). Pain was an important determinant of all measures of function in both patient groups.
In contrast, age, sex and comorbidities discriminated between hip and knee patients as well as between
the different methods of assessing disability. Sex affected most measures of disability in hip patients, but
not in knee patients. Age affected the performance tests more than the PROMs or clinician-administered
tests, whereas anxiety and depression had much more effect on the PROMs and clinician-administered
measures than on the performance tests. BMI does not seem to be important and other comorbidities
have more effect on tests of function in people with knee disease than those with hip disease.
TABLE 19 Pre-operative function in ADAPT participants
Outcome measure
Hip (n= 125) Knee (n= 124)
Mean SD Minimum Maximum Mean SD Minimum Maximum
Patient-reported measures (mean score)
WOMACa function 55.3 22.0 0.0 100.0 50.9 18.5 0.0 97.0
Ab-Ab 23.9 11.6 0.0 56.0 25.1 10.7 2.0 50.0
Ab-Pc,d 8.0 9.0 0.0 31.0 10.0 10.0 2.0 28.0
Clinician-administered measures (mean score)
HHSe 54.0 17.5 23.2 97.0
AKSS-functionf 53.7 15.4 0.0 90
AKSS pain, stability and ROM
g
43.1 15.2 10.0 82.4
Performance tests
Walking speede (m/second) 0.9 0.4 0.2 1.7 0.9 0.5 0.3 2.0
Get-up-and-go test duratione
(seconds)
17.0 11.0 9.0 118.0 17.2 10.6 8.0 56.0
Stepped 20-cm achievement
(mean %)
81.4 77.4
Stepped 30-cm achievement
(mean %)
60.4 55.6
Balance test achievement
(mean %)
46.6 33.9
a Range 0–100, worst to best.
b Range 0–68, best to worst.
c Range 0–36, best to worst.
d For these outcomes, the median and IQR (75th percentile – 25th percentile) are reported instead of the mean and SD.
e Range 0–100, worst to best.
f Range 0–100, worst to best.
g Range 0–100, worst to best.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
107
TA
B
LE
20
C
o
rr
el
at
io
n
s
b
et
w
ee
n
fu
n
ct
io
n
al
m
ea
su
re
s
in
A
D
A
PT
p
ar
ti
ci
p
an
ts
O
u
tc
o
m
e
m
ea
su
re
W
O
M
A
C
A
b
-A
A
b
-P
A
K
SS
fu
n
ct
io
n
A
K
SS
p
ai
n
,s
ta
b
ili
ty
an
d
R
O
M
H
H
S
W
al
ki
n
g
sp
ee
d
a
G
et
-u
p
-a
n
d
-g
o
te
st
b
20
-c
m
st
ep
te
st
c
30
-c
m
st
ep
te
st
c
H
ip
A
b-
A
–
0.
87
A
b-
P
–
0.
71
0.
73
H
H
S
0.
71
–
0.
73
–
0.
67
W
al
ki
ng
sp
ee
d
0.
56
–
0.
65
–
0.
52
0.
67
G
et
-u
p-
an
d-
go
te
st
–
0.
56
0.
63
0.
42
–
0.
59
–
0.
85
20
-c
m
st
ep
te
st
0.
33
–
0.
38
–
0.
28
0.
50
0.
48
–
0.
44
30
-c
m
st
ep
te
st
0.
37
–
0.
49
–
0.
28
0.
48
0.
60
–
0.
50
0.
58
Ba
la
nc
e
te
st
d
0.
27
–
0.
32
–
0.
17
e
0.
38
0.
58
–
0.
39
0.
44
0.
66
K
ne
e
A
b-
A
–
0.
88
A
b-
P
–
0.
63
0.
69
A
K
SS
fu
nc
tio
n
0.
46
–
0.
47
–
0.
51
A
K
SS
pa
in
,
st
ab
ili
ty
an
d
RO
M
0.
40
–
0.
33
–
0.
37
W
al
ki
ng
sp
ee
d
0.
51
–
0.
54
–
0.
51
0.
67
0.
29
G
et
-u
p-
an
d-
go
te
st
–
0.
46
0.
50
0.
43
–
0.
60
–
0.
21
–
0.
73
20
-c
m
st
ep
te
st
0.
25
–
0.
28
–
0.
27
0.
50
0.
27
0.
46
–
0.
60
30
-c
m
st
ep
te
st
0.
34
–
0.
37
–
0.
37
0.
57
0.
31
0.
57
–
0.
60
0.
43
Ba
la
nc
e
te
st
0.
22
–
0.
29
–
0.
26
0.
33
0.
21
0.
27
–
0.
29
0.
31
0.
61
a
W
al
ki
ng
sp
ee
d
in
m
et
re
s
pe
r
se
co
nd
.
b
D
ur
at
io
n
in
se
co
nd
s
to
co
m
pl
et
e
th
e
te
st
.
c
A
ch
ie
ve
m
en
t
of
th
e
20
-/
30
-c
m
st
ep
te
st
.
d
A
ch
ie
ve
m
en
t
of
th
e
ba
la
nc
e
te
st
.
e
A
ll
th
e
co
rr
el
at
io
ns
ar
e
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
(p
<
0.
05
)
ex
ce
pt
th
e
po
in
t-
bi
se
ria
lc
or
re
la
tio
n
co
ef
fic
ie
nt
be
tw
ee
n
th
e
A
b-
P
sc
or
e
an
d
th
e
ba
la
nc
e
te
st
fo
r
hi
p
pa
tie
nt
s.
N
o
te
Th
e
co
rr
el
at
io
ns
in
vo
lv
in
g
th
e
20
-m
et
re
w
al
k
an
d
th
e
ge
t-
up
-a
nd
-g
o
te
st
s
w
er
e
de
riv
ed
on
ly
on
th
e
pa
tie
nt
s
w
ho
co
m
pl
et
ed
th
es
e
ta
sk
(n
=
12
4
an
d
n
=
11
1
am
on
g
hi
p
pa
tie
nt
s,
re
sp
ec
tiv
el
y,
an
d
n
=
12
2
an
d
n
=
11
0
am
on
g
kn
ee
pa
tie
nt
s,
re
sp
ec
tiv
el
y)
.
Th
e
ot
he
r
co
rr
el
at
io
ns
w
er
e
pe
rf
or
m
ed
on
al
lt
he
12
5
hi
p/
12
4
kn
ee
pa
tie
nt
s.
A
ll
th
e
fu
nc
tio
na
lm
ea
su
re
s
ar
e
co
nt
in
uo
us
va
ria
bl
e
ex
ce
pt
th
e
20
-c
m
st
ep
,
30
-c
m
st
ep
an
d
ba
la
nc
e
te
st
s,
w
hi
ch
ar
e
bi
na
ry
m
ea
su
re
s.
C
or
re
la
tio
ns
be
tw
ee
n
tw
o
co
nt
in
uo
us
m
ea
su
re
s
w
er
e
as
se
ss
ed
w
ith
th
e
Sp
ea
rm
an
’s
rh
o
st
at
is
tic
s,
ra
ng
in
g
fr
om
–
1
to
1.
C
or
re
la
tio
ns
be
tw
ee
n
co
nt
in
uo
us
an
d
bi
na
ry
m
ea
su
re
s
w
er
e
as
se
ss
ed
w
ith
th
e
po
in
t-
bi
se
ria
lc
or
re
la
tio
n
co
ef
fic
ie
nt
s,
ra
ng
in
g
fr
om
–
1
to
1.
C
or
re
la
tio
ns
be
tw
ee
n
tw
o
bi
na
ry
m
ea
su
re
s
w
er
e
as
se
ss
ed
w
ith
th
e
C
ra
m
ér
’s
V
-s
ta
tis
tic
s,
ra
ng
in
g
fr
om
0
to
1.
MEASURING FUNCTIONAL OUTCOMES IN PATIENTS HAVING HIP AND KNEE REPLACEMENT: A COHORT STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
TA
B
LE
21
Pa
ti
en
ts
w
ai
ti
n
g
fo
r
h
ip
re
p
la
ce
m
en
t:
as
so
ci
at
io
n
s
b
et
w
ee
n
p
at
ie
n
t
ch
ar
ac
te
ri
st
ic
s
an
d
fu
n
ct
io
n
al
m
ea
su
re
s
H
ip
W
O
M
A
C
fu
n
ct
io
n
a
A
b
-A
a
A
b
-P
a ,
b
H
H
Sa
W
al
k
(s
p
ee
d
)a
G
et
-u
p
-a
n
d
-g
o
te
st
a ,
c
20
-c
m
st
ep
te
st
d
30
-c
m
st
ep
te
st
d
B
al
an
ce
d
A
ge
(y
ea
rs
)
<
0.
00
01
<
0.
00
1
<
0.
05
e
<
0.
00
01
Se
x
<
0.
05
<
0.
05
<
0.
00
01
<
0.
00
1
<
0.
01
<
0.
05
Pa
in
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
05
<
0.
01
<
0.
05
H
A
D
S
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
01
<
0.
05
BM
I
Fu
nc
tio
na
lC
om
or
bi
di
ty
In
de
x
<
0.
05
<
0.
01
<
0.
05
<
0.
01
A
rt
hr
iti
s
Li
vi
ng
al
on
e
<
0.
05
<
0.
05
Ed
uc
at
io
n
<
0.
05
W
or
ki
ng
st
at
us
<
0.
01
<
0.
01
<
0.
05
<
0.
05
<
0.
01
a
A
ss
oc
ia
tio
ns
in
ve
st
ig
at
ed
w
ith
lin
ea
r
re
gr
es
si
on
s.
b
A
b-
P
sc
or
e
m
od
el
le
d
as
ro
ot
sq
ua
re
d
(s
co
re
).
c
G
et
-u
p-
an
d-
go
te
st
tim
e
(m
od
el
le
d
as
1/
tim
e)
.
d
20
-c
m
st
ep
an
d
30
-c
m
st
ep
an
d
ba
la
nc
e
te
st
s
ac
hi
ev
em
en
t;
as
so
ci
at
io
ns
in
ve
st
ig
at
ed
w
ith
m
od
ifi
ed
Po
is
so
n
re
gr
es
si
on
s
w
ith
ro
bu
st
va
ria
nc
e
es
tim
at
io
n.
e
Th
e
re
la
tio
ns
hi
p
be
tw
ee
n
ag
e
an
d
ac
hi
ev
in
g
th
e
30
-c
m
st
ep
te
st
is
m
od
el
le
d
as
ag
e,
ag
e2
an
d
ag
e3
.
A
ss
oc
ia
tio
ns
w
hi
ch
re
m
ai
ne
d
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
(p
≤
0.
05
)
in
m
ul
tiv
ar
ia
te
an
al
ys
is
ar
e
hi
gh
lig
ht
ed
in
bo
ld
.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
109
TA
B
LE
22
Pa
ti
en
ts
w
ai
ti
n
g
fo
r
kn
ee
re
p
la
ce
m
en
t:
as
so
ci
at
io
n
s
b
et
w
ee
n
p
at
ie
n
t
ch
ar
ac
te
ri
st
ic
s
an
d
fu
n
ct
io
n
al
m
ea
su
re
s
K
n
ee
W
O
M
A
C
fu
n
ct
io
n
a
A
b
-A
a
A
b
-P
a ,
b
A
K
SS
-f
a
A
K
SS
a
W
al
ki
n
g
sp
ee
d
a
G
et
-u
p
-a
n
d
-g
o
te
st
a ,
c
20
-c
m
st
ep
te
st
d
30
-c
m
st
ep
te
st
d
B
al
an
ce
d
A
ge
(y
ea
rs
)
<
0.
05
e
<
0.
00
1e
<
0.
05
e
<
0.
05
e
Se
x
<
0.
01
Pa
in
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
01
<
0.
05
H
A
D
S
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
01
<
0.
05
BM
I
Fu
nc
tio
na
lC
om
or
bi
di
ty
In
de
x
<
0.
01
<
0.
00
1
<
0.
05
<
0.
01
<
0.
05
<
0.
05
<
0.
05
<
0.
01
A
rt
hr
iti
s
Li
vi
ng
al
on
e
<
0.
05
<
0.
05
Ed
uc
at
io
n
<
0.
05
<
0.
05
W
or
ki
ng
st
at
us
<
0.
00
1
<
0.
05
a
A
ss
oc
ia
tio
ns
in
ve
st
ig
at
ed
w
ith
lin
ea
r
re
gr
es
si
on
s.
b
A
b-
P
sc
or
e
m
od
el
le
d
as
ro
ot
sq
ua
re
d
(s
co
re
).
c
G
et
-u
p-
an
d-
go
te
st
tim
e
(m
od
el
le
d
as
1/
tim
e)
.
d
20
-
an
d
30
-c
m
st
ep
an
d
ba
la
nc
e
te
st
s
ac
hi
ev
em
en
t;
as
so
ci
at
io
ns
in
ve
st
ig
at
ed
w
ith
m
od
ifi
ed
Po
is
so
n
re
gr
es
si
on
s
w
ith
ro
bu
st
va
ria
nc
e
es
tim
at
io
n.
e
Th
e
re
la
tio
ns
hi
p
be
tw
ee
n
ag
e
an
d
th
es
e
ou
tc
om
es
is
m
od
el
le
d
as
ag
e
an
d
ag
e2
.
A
ss
oc
ia
tio
ns
w
hi
ch
re
m
ai
ne
d
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
(p
≤
0.
05
)
in
m
ul
tiv
ar
ia
te
an
al
ys
is
ar
e
hi
gh
lig
ht
ed
in
bo
ld
.
MEASURING FUNCTIONAL OUTCOMES IN PATIENTS HAVING HIP AND KNEE REPLACEMENT: A COHORT STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
110
Discussion
This study compared different ways of assessing function in patients awaiting hip or knee replacement.
Correlations were stronger within the same type of measures (PROMS, clinician-administered or
performance test) than between approaches. Correlations that were usually < 0.9 imply that each of these
measures describes a slightly different construct of function and that several of them would be needed to
provide an accurate and exhaustive assessment of function. Nevertheless, the WOMAC function, Ab-A,
HHS, walking test and the get-up-and-go tests had satisfactory convergence validity (correlation ≥ 0.3).
This suggests that each of these measures can individually provide a reasonably comprehensive description
of function if it is possible to conduct only one test. However, the AKSS and the balance test correlated
poorly with most of the measures and should not be used alone. These findings are consistent with
previous research which found moderate to strong (> 0.4) correlations with the WOMAC function and stair
climbing, walking or the get-up-and-go test.319–323 Moderate to strong correlations have also been reported
pre-operatively between the WOMAC function and the HHS or its components,319,321,324 and small to
moderate correlations have been found between the WOMAC function and the AKSS.319,325,326 Our finding
of a strong relationship between the Ab-A and WOMAC function score is not surprising as the Ab-A is
based on several items of the WOMAC.285 In this study, the Ab-A measure had slightly better correlations
than the WOMAC function with all the other measures. This suggests that it may be the preferred tool for
assessment of function in this population.
Previous inconclusive studies exploring the association between the HHS or AKSS and performance tests
were based on moderate sample sizes, and mainly focused on associations between joint ROM and
performance tests.285,327–329 Our study highlighted that associations between patient characteristics and
function differed according to the measurement approach used. For example, obesity was associated with
poor AKSS but not with functional outcomes as measured any other way.
Responses to PROMs are influenced by factors including age, sex, mental health or socioeconomic
characteristics.322,330–333 Clinical assessments can also be influenced by patients’ characteristics; for instance,
fat mass and bony structure affect the reliability and validity of extremity measurements,334 while age and
vulnerability may influence communication with health professionals or interviewers.335 Performance testing
may not always assess ADL of relevance to an individual and may not take into account environmental or
behavioural adaptations.336 Tests are also likely to be confounded by factors such as sarcopenia, which in
turn can be influenced by other patient characteristics such as activity or self-efficacy.337
Although pain is a major determinant of function irrespective of measurement method, we found that
psychological health influenced self-assessment more than performance-based methods. In addition, age
affected performance measures, but not self-assessment. This has several implications. First, a causal
investigation of function will be accurate, exhaustive and corroborative only if conducted simultaneously
with several measures of function. Second, the investigation of any risk factor of function should be
adjusted for the patient’s psychological status (if a self-assessment measure is used) or for patient age
(if a performance test is used), and in both cases for pain. Third, any comparison of measures of function
obtained with different measurement methods is flawed unless the effects of pain, age and psychological
status are considered. Fourth, there is an age-related decline in function when measured objectively,
but this is not evident on PROMs. Fifth, the effect of psychological factors on self-reported function, but
not on objective measures, indicates that psychological status influences the perception of function more
than the ability to do something; patients may be able to do more than they say they can do and may
need encouragement to overcome anxiety. Finally, it seems that any assessment of function should be
accompanied by pain assessment to obtain unconfounded assessment. The association of pain with
function, even after taking into account the age and psychological status of the patients, confirms
the lack of discriminant validity of currently used functional measures. This is to be expected with the
clinician-completed HHS and AKSS, which include a pain component. It has also been observed previously
between self-reported measures of pain function.318 However, the association with the performance tests is
more problematic as even the most ‘objective’ measures of function are confounded by pain.
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These findings were obtained on patients from a single-centre orthopaedic unit; however, this is a large
sample with a representative age range undergoing a diversity of procedures. The study also focused on a
discrete number of assessment measures and did not include measures such as the OHS, OKS, KOOS or
HOOS. Measures were selected to include a broad range of tools that could be administered at the same
time alongside demographic information. Through this, we were able to compare effectively the measures
and the influence of patient characteristics.
Conclusion
Our study shows that associations between patient characteristics and function differed according to the
measurement approach used. Measures of pain and psychological health could be routinely used alongside
self-report of activity limitations to enable appropriate adjustments. Performance-based tests are strongly
influenced by age, possibly owing to age-related sarcopenia. If this is correct, for research purposes the
inclusion of a simple muscle strength test, such as grip strength, alongside performance-based methods
might aid interpretation of the findings.
Cross-sectional analysis of joint range of motion and its relevance to
functional measures
Introduction
Range of motion is often routinely assessed in orthopaedic surgery. Measures of ROM are included in both
the AKSS113 and HHS.268 However, the relationship between ROM and function is contested, with some
authors regarding ROM as a good determinant of function329 but others reporting poor correlations.317,338
In view of ongoing use of ROM and continuing uncertainty about its relationship with function, this
analysis of the ADAPT data was undertaken to investigate the relationship between ROM and our other
measures of function. In this analysis we have also specifically looked at the different domains of function
as described in the WHO ICF, that is, we have analysed the relationships between ROM and impairment,
activities limitations and participation restriction separately.
Statistical analysis
Analyses were conducted separately for patients listed for hip and knee replacement. Spearman’s
rank-order correlation coefficients were used to assess correlations between continuous variables.
Point-biserial correlation coefficients were used to assess correlations between continuous and dichotomous
variables. These correlation measures range from –1 to 1. The strength of correlation was interpreted
as |0.00|–|0.25|= none–little, |0.26|–|0.49|= low, |0.50|–|0.69|=moderate, |0.70|–|0.89|= high,
|0.90|–|1.00|= very high. Linear regression was conducted to adjust for the effect of demographic factors
(age, sex, socioeconomic status, joints affected by arthritis, comorbidities and psychological status)
on the relationship between WOMAC pain and self-report activity limitations. To adjust for the effect of
demographic factors on the relationship between WOMAC pain and participation restrictions, the
participation restrictions scale of the Aberdeen impairment, activity limitation and participation restriction
measure (Ab-P) was transformed with a root square function to comply with the assumptions of the
linear model.
To compare functional measures between patients with low and high active flexion, patients were
dichotomised into those with low flexion (< 110° for knee patients and < 95° for hip patients) and those
with high flexion (≥ 110° for knee patients and ≥ 95° for hip patients). This cut-off was chosen because
90° of hip and knee flexion is required when rising from sitting to standing in order for the centre of
gravity in the sagittal plane to transfer from behind the midline (in sitting) to in front of the midline
(in standing). Continuous variables were compared between these two groups using unpaired t-tests or
Mann–Whitney U-tests for non-normally distributed variables. Categorical variables were compared using
chi-squared tests. Statistical analysis was performed using Stata 12.
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Results
Relationship between measures of impairment and activity limitations Correlations between the
measures of impairment (ROM and WOMAC pain) and measures of activity limitations [WOMAC function,
activity limitations scale of the Aberdeen impairment, activity limitation and participation restriction
measure (Ab-A), performance tests] are displayed in Table 23.
Hip and knee ROM correlated weakly with self-report (Spearman’s rank-order correlation coefficients
ranging from |0.11| to |0.43|) and observed activity limitations (|0.09| to |0.38|). In comparison, correlations
between pain and self-report activity limitations were moderate to high (|0.63| to |0.80|) and remained so
after adjustment for demographic factors (data not shown). However, correlations between pain and
observed activity limitations were low (|0.13| to |0.44|). Correlations between individual WOMAC function
items and ROM measurements were investigated to determine if ROM correlated with specific functions.
All correlations were found to be low (|0.01| to |0.40|). The highest correlation in patients listed for hip
replacement was between flexion and getting on/off toilet (–0.37) and in patients listed for knee
replacement it was between flexion and getting in/out of a car (–0.40) and putting on socks/
stockings (–0.40).
Relationship between measures of impairment and participation restrictions
Correlations between measures of impairment and participation restrictions (Ab-P) are displayed in Table 23.
Hip and knee ROM correlated poorly with participation restrictions (|0.06| to |0.32|). In comparison,
correlations between pain and participation restrictions were high in patients listed for hip replacement
(–0.71) and moderate in patients listed for knee replacement (–0.53), and these correlations remained strong
after adjustment for demographic factors.
TABLE 23 Correlations of ROM and pain with measures of activity limitations and participation restrictions
Outcome measure
Self-report activity
limitations Function performance tests
Self-report
participation
restrictions
WOMAC
function Ab-A
20-metre
walk
Sit-to-stand-to-sit
test
20-cm step
test Ab-P
Patients listed for hip replacement
Flexion 0.29** –0.35*** –0.29** 0.30*** 0.34*** –0.17
Abduction+ adduction 0.29*** –0.32*** –0.36*** 0.16 0.13 –0.23*
Arc of rotation 0.20* –0.27** –0.36*** 0.11 0.25** –0.17
Pain 0.80*** –0.71*** –0.44*** 0.13 0.23** –0.71***
Patients listed for knee replacement
Active flexion 0.43*** –0.35*** –0.38*** 0.31*** 0.31*** –0.32***
Active extension –0.18 0.11 0.09 –0.19* –0.35*** 0.06
Pain 0.78*** –0.63*** –0.32*** 0.18* 0.17 –0.53***
*p< 0.05, **p< 0.01, ***p< 0.001.
Correlations= Spearman’s rank-order correlation coefficients for continuous variables and point-biserial correlation
coefficients for continuous and dichotomous variables. Correlation interpretation: |0.00|–|0.25|= none–little correlation,
|0.26|–|0.49|= low correlation, |0.50|–|0.69|=moderate correlation, |0.70|–|0.89|= high correlation, |0.90|–|1.00|= very
high correlation.
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Comparison of functional measures between patients with low and high active flexion
Patients listed for knee replacement with low flexion had significantly worse results on all measures of
impairment, activity limitations and participation restrictions than patients with high flexion (Table 24).
Patients listed for hip replacement with low flexion had significantly worse activity limitations than patients
with high flexion.
Discussion
The WHO ICF model offers a theoretical framework for describing and assessing disability. The data from
this study show that in patients listed for joint replacement, there is a poor relationship between ROM and
any of the disability measures used in this study, which contrasts with the strong relationship found
between pain, activity limitations and participation restrictions. Previous studies have arrived at discordant
conclusions about the relationship between function and ROM. Some reports suggest that ROM is an
important determinant of function321,329 while others disagree.317,338 Furthermore, it is suggested that ROM
is important for some specific functions, or that a threshold of around 95–100° of flexion is required for
adequate function.338 Our data suggest that there may be such a threshold, but that ROM does not
correlate with specific activities on the WOMAC function and modest restrictions of ROM are of little
relevance to functional outcomes.
These findings are important for two reasons. First, commonly used methods of assessing patients’
disability, such as the AKSS and HHS, include ROM. Second, many orthopaedic surgeons often consider
the achieved ROM of a replaced joint to be an important measure of surgical outcomes and discuss this
with their patients. We suggest that as a measure of impairment, ROM is of little relevance to function and
the only concern should be whether or not knee flexion is restricted to < 110° and, to a lesser extent,
whether or not hip flexion is limited to < 95°.
TABLE 24 Comparison of functional measures between patients with low and high active flexion
Outcome measure
Patients listed for knee replacement Patients listed for hip replacement
Low flexion
(< 110°)
(n= 54)
High flexion
(≥ 110°)
(n= 67) p-value
Low flexion
(< 95°)
(n= 77)
High flexion
(≥ 95°)
(n= 48) p-value
Impairment measures
WOMAC pain score
(mean, 95% CI)
37 (32 to 42) 50 (46 to 54) < 0.0001 54 (49 to 58) 54 (47 to 62) 0.8873
Activity limitation measures
WOMAC function score
(mean, 95% CI)
43 (38 to 47) 58 (53 to 62) < 0.0001 54 (49 to 59) 59 (52 to 66) 0.2548
Ab-A score (mean, 95% CI) 28 (26 to 31) 22 (19 to 24) 0.0007 25 (23 to 28) 20 (17 to 24) 0.0381
20-metre walk test time
in seconds, median
(25th, 75th centiles)a
28 (22, 36) 20 (17, 27) 0.0002 23 (18, 30) 10 (17, 25) 0.3493
Sit-to-stand-to-sit test
(% completed)
78 94 0.0009 84 97 0.048
20-cm step test
(% completed)
67 85 0.017 78 91 0.073
Participation restriction measures
Ab-P, median
(25th, 75th centiles)
13 (8, 17) 8 (5, 13) 0.0013 8 (5, 16) 8 (4, 12) 0.2867
a Q1–Q3= 25th percentile to 75th percentile.
p-values presented are for unpaired t-tests or Mann–Whitney U-tests.
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Weaknesses of the study were the lack of randomisation of the order of the performance tests and
inclusion of patients from only one specialist orthopaedic unit. However, by including patients listed for a
range of joint replacement procedures, a diverse and varied sample was achieved. Strengths include the
study’s relatively large size, the extent of and care taken with the measures of ROM and disability, and the
good interobserver and intraobserver reliability for ROM.
Conclusion
These findings suggest that measuring ROM adds little value to assessment of impairment in patients
undergoing joint replacement, unless hip or knee flexion is restricted to < 90° and, therefore, should not
be used to assess disability in a pre-operative context.
Longitudinal analysis of changes in the different measures of function
over time
Introduction
One of the main aims of the ADAPT study was to assess the responsiveness of various different measures of
function and, in particular, to contrast the value of the three main different approaches (self-assessment,
clinician-administered tools and functional tests) in assessing change after joint replacement. An important part
of such an analysis is to assess which measures might have an important ceiling effect, that is which measures
often reach their limits after joint replacement surgery, such that they cannot detect further improvement.
In this section we describe the changes seen in function between the pre-operative and 12-month
postoperative assessment.
Statistical analysis
Analyses were conducted separately for patients listed for hip and knee replacement.
Change in function ability (as measured by the WOMAC function subscale, the SF-12 physical function
subscale, the Ab-IAP, the MYMOP2 score, the get-up-and-go test, the timed 20-metre walk, the HHS and
the AKSS) was defined as the 12-month postoperative score minus the pre-operative score. Patients were
categorised into three groups: those with deteriorated function, those with unchanged function and those
with improved function.
To determine if the individual changes were due to chance or not, we used the following approach. After
transformation of the pre- and postoperative scores (using inverse, root square or logarithm function), the
changes in physical function were normally distributed. Therefore, we used linear mixed models with random
intercept and slope to regress the transformed outcomes on the time of assessment.339 We then determined if
the individual changes between pre- and post-surgery assessments were different from 0 using the 95% CI
around each participant’s trajectories. This was derived from the post-estimation of the above models using
fixed effects and subject-specific random effects. A 95% CI including 0 is not statistically significant, that is,
the observed change is no different than a flat trajectory. This approach was preferred over the traditional
relative change index measure as it does not depend on a deterministic external measure of test–retest
reliability, which was not available for the studied scores. It also allows a better control of the regression to the
mean effect by assuming that all scores are drawn from the same population distribution (shrinkage effect).
We also derived the minimum clinical important improvement (MCII) of each score, that is the improvement
in functional score between two time points likely to be important from the patient’s perspective. We used
an anchoring question about participant satisfaction with recreational activities at 12 months post surgery284
to dichotomise the ADAPT participants into two groups (very or somewhat satisfied vs. somewhat or very
dissatisfied). We then calculated the cut-off point (MCII) on the distribution of score change, using a receiver
operating characteristic curve analysis, to determine the threshold maximising the sensitivity and specificity.
Patients experiencing an improvement greater or equal to this threshold were defined as having a clinically
meaningful change in function.
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We also determined the observed ceiling effect for each score at 12 months post operation. The ceiling
effect was defined as the percentage of patients with a score equal to the highest possible score. For
example, a patient with a WOMAC function subscale score of 100 [score ranges from 0 to 100 (worst to
best)] has reached the ‘ceiling’ of the score and is considered to have the maximum possible functional
ability. For ease of interpretation, the lowest values of scores ranging in the opposite direction to the
WOMAC function scoring system such as the Ab-IAP measures [Ab-I 0–36, Ab-A 0–68, Ab-P 0–36; best to
worst] or the MYMOP2 score [0–6 (best to worst)] were considered as the ‘maximum score’.
Results
This analysis was undertaken on patients who participated in both the baseline and 12-month assessments
and provided information on at least one of the functional measures. Of the total cohort (n= 263, 130 hip
replacement and 133 knee replacement patients), there were 104 hip replacement and 101 knee
replacement patients who had this full data set and were included in these analyses.
Change in scores
The scores for the various functional measures, at baseline and 12 months post operation, are shown in
Tables 25 and 26. Tables 27 and 28 also record the changes in each of the scores between baseline and
12 months.
TABLE 25 Functional assessment measures before and after surgery
Outcome measure Site
Pre-operative assessment
12-month postoperative
assessment
n Mean SD Median n Mean SD Median
WOMAC function Hip 103 56.3 22.3 56.7 103 88.9 15.3 95.6
Knee 101 51.9 18.4 50 101 75.2 23.1 83.8
SF-12 physical function subscale Hip 100 33.1 8.9 32.3 97 47.5 11.0 51.5
Knee 92 30.5 7.2 30.3 88 39.4 11.3 38.5
Ab-I Hip 94 17.9 6.6 18 98 4.5 5.1 3
Knee 94 19.6 5.4 20.0 99 10.2 7.4 8.0
Ab-A Hip 99 23 11.7 22 102 7 8.5 4
Knee 97 24.4 10.5 25.0 97 13.1 12.8 8.0
Ab-P Hip 100 9.6 7.1 8 102 2.8 4.7 1
Knee 96 11.0 6.0 10.0 95 5.5 5.8 3.0
MYMOP2 Hip 104 4.1 0.9 4.0 101 1.1 1.2 0.8
Knee 99 4.3 0.8 4.3 101 2.0 1.5 1.8
Get-up-and-go test time (duration in
seconds to complete the test)
Hip 96 20.8 14.8 17 97 13.7 6.0 12.0
Knee 90 19.4 8.8 17.0 96 16.3 9.1 13.0
20-metre walk time (duration in
seconds to walk a 20-metre distance)
Hip 102 25.5 14.8 22 103 18.8 5.8 17
Knee 99 24.7 9.4 22.0 100 21.2 7.4 18.5
HHS Hip 103 53.5 16.8 54.8 102 86.9 15.9 93.1
AKSS pain, stability and ROM Knee 98 44.1 14.9 45 99 73.1 20.6 81
AKSS function Knee 100 55.9 13.1 52.5 101 66.2 19.5 65.0
n, number of participants who completed the functional measure of interest.
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Table 25 demonstrates that, as expected, scores on the function measures improve from baseline to
12 months. People in this cohort had better function after surgery than before they had the
surgical intervention.
Table 26 shows similar results, suggesting that people’s function improves after surgery. However, a
particular feature of these data is the number of participants who were able to complete certain tasks.
Nearly everyone could complete most of the tests, both before and after surgery. However, two of the
tests appear to be more discriminatory – the 30-cm step test and the balance test. As shown in Table 26,
only 61.5% of people with hip disease could do the 30-cm step test prior to surgery, and this improved to
82.4% postoperatively; the equivalent figures for those with knee disease were 40.0% and 70.3%,
respectively. The balance test was also difficult for patients with knee disease; only 38.6% of patients
could perform the test pre-operatively and 46.0% postoperatively. Those with hip disease could do a little
better – 48.1% were able to do it pre-operatively, and 60.6% postoperatively.
TABLE 26 Functional assessment measures before and after surgery: proportion of participants who achieved
performance tests
Outcome Site
Pre-operative assessment 12-month postoperative assessment
n % n %
Sit-to-stand-to-sit test Hip 95 91.4 99 96.1a
Knee 90 89.1 95 94.1
Missing Hip 0 1
Knee 0 0
20-cm step test Hip 104 81.7 98 94.2
Knee 82 81.2 92 91.1
30-cm step test Hip 64 61.5 84 82.4a
Knee 40 40.0a 71 70.3
Missing Hip 0 2
Knee 1 0
Balance Hip 50 48.1 63 60.6
Knee 39 38.6 46 46.0a
Missing Hip 0 0
Knee 0 1
Get-up-and-go test Hip 96 92.3 98 94.2
Knee 93 92.1 96 95.1
20-metre walk Hip 104 100.0 103 99.0
Knee 100 99.0 100 99.0
n, number of participants who achieved the specific test.
a Percentage of participants who achieved a specific performance test derived from the subsample of subjects with
available information (e.g. at 12 months postoperatively, 99 participants out of the 103 with available information were
able to perform the sit-to-stand-to sit test, i.e. 96.1% of the available sample).
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Change for better or worse and clinically important improvements
The above scores tell only a part of the story. They do not provide information about what proportion of
people got better or worse, or whether or not the improvements were clinically, as well as statistically,
important. In order to answer these questions, we investigated the following:
1. the number of patients with scores that indicated improvement, deterioration or no change in function
between baseline and 12 months
2. the numbers of patients in the improved or deteriorated function categories whose changes were
statistically significant
3. the proportion of patients for whom these changes reached clinical significance, using the anchoring
satisfaction question.
The results of these analyses are shown in Tables 27 and 28. The data also allow us to further compare
the degree of improvement following knee or hip replacement.
As shown in Tables 27 and 28, there were a small number of people whose function did not change or
deteriorate after surgery. Overall, each of the functional assessment methods is telling a similar story of a
few people getting worse (but rarely significantly so) and most getting better, often significantly better.
The walking time was more likely to show deterioration than other tests and arguably the ‘get-up-and-go
test’ showed more differentiation between changes for the better or worse than other tests. Overall
patients having hip surgery were more likely to improve functionally than those having knee replacement,
with most of the measures used, although it is interesting to note that walking speed changes were very
similar in both groups.
We also looked for ceiling effects on each of the functional measures at baseline and 12 months, as
shown in Tables 29 and 30.
The striking finding here is that many of the self-assessment questionnaires that are routinely used to
assess function in people with lower limb osteoarthritis show an important ceiling effect in response to
joint replacement. The problem is particularly evident in the assessment of function after hip replacement;
the WOMAC function subscale, SF-12 physical function measure and all three domains of the Aberdeen
scale all reach a maximum score in between 20% and 50% of patients postoperatively. Rather fewer
patients reached the maximum score after knee surgery, but the problem is a very real one for this
intervention as well (between 8% and 22% of patients reaching the maximum on one or other of the
scores). Timed tests such as the walk time or ‘get-up-and-go’ test, cannot, by definition, suffer from this
problem and it is interesting to note that very few people achieved ‘top marks’ on either the HHS or AKSS.
Discussion
It is well known that, on average, people undergoing a hip or knee joint replacement get some functional
benefit.340 Our data support this, showing that, on average, there was a large improvement in the
functional scores between baseline and 12 months after surgery. Our data also confirm findings from
previous research that those undergoing hip surgery can, on average, expect more improvement in
function that those having a knee replacement.341,342
However, average scores obscure the fact that there can be big differences in the change and that some people
may experience a decline in function. Our data suggest that very few people get worse, although quite a lot of
those who improve are not achieving a level of improvement that can be called clinically, rather than statistically,
significant. For example, if we examine the data in Table 27 carefully, they tell us that the WOMAC function
score improved in 93% of people having hip replacement and 86% of those having knee replacement, and
that this change was statistically significant in 90% and 82%, respectively. However, the change for the better
was clinically significant in only some 70% of those having hip replacement and 61% of the knee replacement
patients. Clearly, there is a need to be cautious in relation to the information given to people when they have a
joint replacement regarding expected functional outcomes (as opposed to pain improvement).
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TABLE 27 Changes and MCII in self-reported functional measures between pre- and 12-month
postoperative assessments
Outcome
Hip Knee
Sample Statistical changea %MCIIb Sample Statistical changea %MCIIb
n % n % n % n % n % n %
WOMAC function
Deterioration 5 4.9 2 40.0 12 11.9 3 25.0
No change 2 2.0 2 2.0
Improvement 95 93.1 90 94.7 66 69.5 87 86.1 82 94.3 62 71.3
Total 102 100.0 92 90.2 66 64.7 101 100.0 85 84.2 62 61.4
Unknown 2 0
SF-12 physical function
Deterioration 8 8.4 6 75.0 15 18.8 9 60.0
No change 0 0.0 0 0.0
Improvement 87 91.6 78 89.7 70 80.5 65 81.3
Total 95 100.0 84 88.4 70 73.7 80 100.0 65 81.3 31 38.8
Unknown 9 21
Ab-I
Deterioration 2 2.2 1 50.0 11 11.8 7 63.6
No change 1 1.1 2 2.2
Improvement 87 96.7 86 98.9 61 70.1 80 86.0 75 93.8 62 77.5
Total 90 100.0 87 96.7 61 67.8 93 100.0 82 88.2 62 66.7
Unknown 14 8
Ab-A
Deterioration 6 6.2 4 66.7 15 16.0 7 46.7
No change 1 1.0 2 2.1
Improvement 90 92.8 87 96.7 80 88.9 77 81.9 68 88.3 66 85.7
Total 97 100.0 91 93.8 80 82.5 94 100.0 75 79.8 66 70.2
Unknown 7 7
Ab-P
Deterioration 5 5.1 2 40.0 8 8.8 4 50.0
No change 6 6.1 7 7.7
Improvement 87 88.8 83 95.4 77 88.5 76 83.5 73 96.1 48 63.2
Total 98 100.0 85 86.7 77 78.6 91 100.0 77 84.6 48 52.8
Unknown 6 10
MYMOP2
Deterioration 3 3.0 1 33.3 8 8.1 5 62.5
No change 0 0.0 1 1.0
Improvement 98 97.0 95 96.9 77 78.6 90 90.9 84 93.3 61 67.8
Total 101 100.0 96 95.1 77 76.2 99 100.0 89 89.9 61 61.6
Unknown 3 2
continued
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TABLE 27 Changes and MCII in self-reported functional measures between pre- and 12-month
postoperative assessments (continued )
Outcome
Hip Knee
Sample Statistical changea %MCIIb Sample Statistical changea %MCIIb
n % n % n % n % n % n %
Get-up-and-go test time
Deterioration 10 11.0 8 80.0 18 20.2 12 66.7
No change 3 3.3 9 10.1 9 100.0
Improvement 78 85.7 74 94.9 74 94.9 62 69.7 56 90.3 62 100.0
Total 91 100.0 82 90.1 74 81.3 89 100.0 68 76.4 71 79.8
Unknown 13 12
ROC, receiver operating characteristics curve.
a Proportion of participants who had experienced a statistically significant change. The change and its 95% CI were
derived for each participant using a linear mixed model (with random intercept and slope). A participant change was
considered statistically significant if the 95% CI of the change did not include 0 (i.e. rejection of the hypothesis of a
flat trajectory).
b %MCII is the percentage of patients experiencing a functional improvement equal or larger than a specific threshold.
This threshold is estimated from the subgroup of patients satisfied with their recreational activities at 12 months post
surgery using a ROC approach.
Deterioration: decrease in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
No change: absence of change in functional ability, as measured by the score of interested, between the pre- and
12-month postoperative assessments.
Improvement: improvement in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
TABLE 28 Changes and MCII in clinician-administered tools and functional tests between pre- and 12-month
postoperative assessments
Outcome
Hip Knee
Sample Statistical changea MCII ROC Sample Statistical changea MCII ROC
n % n % n %b n % n % n %b
20-metre walk time
Deterioration 15 14.9 12 80.0 19 19.4 15 79.0
No change 10 9.9 12 12.2
Improvement 76 75.3 67 88.2 67 88.2 67 68.4 57 85.1 47 70.2
Total 101 79 78.2 67 66.3 98 72 73.5 47 48.0
Unknown 3 3
HHS
Deterioration 5 5.0 2 40.0
No change 0 0.0
Improvement 96 95.1 91 94.8 86 89.6
Total 101 93 92.1 86 85.2
Unknown 3
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TABLE 28 Changes and MCII in clinician-administered tools and functional tests between pre- and 12-month
postoperative assessments (continued )
Outcome
Hip Knee
Sample Statistical changea MCII ROC Sample Statistical changea MCII ROC
n % n % n %b n % n % n %b
AKSS – knee score
Deterioration 10 10.4 6 60.0
No change 0 0.0
Improvement 86 89.6 75 87.2 47 54.7
Total 96 81 84.4 47 49.0
Unknown 5
AKSS – knee function
Deterioration 15 15.0 15 100.0
No change 16 16.0
Improvement 69 69.0 69 100.0 56 81.16
Total 100 84 84.0 56 56
Unknown 1
ROC, receiver operating characteristics curve.
a Proportion of participants who had experienced a statistically significant change. The change and its 95% CI were
derived for each participant using a linear mixed model (with random intercept and slope). A participant change was
considered statistically significant if the 95% CI of the change did not include 0 (i.e. rejection of the hypothesis of a
flat trajectory).
b %MCII is the percentage of patients experiencing a functional improvement equal or larger than a specific threshold.
This threshold is estimated from the sub-group of patients satisfied with their recreational activities at 12-month
post-surgery using a ROC approach.
Deterioration: decrease in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
No change: absence of change in functional ability, as measured by the score of interested, between the pre- and
12-month postoperative assessments.
Improvement: improvement in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
TABLE 29 Ceiling effects in patient-reported function measures at 12 months post operation
Outcome
Hip Knee
Sample Maximum scorea Sample Maximum scorea
N= 104 n % N= 101 n %
WOMAC function
Deterioration 5 12
No change 2 2 100.0 2 0 0.0
Improvement 95 23 24.2 87 10 11.5
Total 102 25 24.5 101 10 9.9
Unknown 2 0
continued
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TABLE 29 Ceiling effects in patient-reported function measures at 12 months post operation (continued )
Outcome
Hip Knee
Sample Maximum scorea Sample Maximum scorea
N= 104 n % N= 101 n %
SF-12 physical function
Deterioration 8 15
No change 0 0 0.0 0 0 0.0
Improvement 87 0 0.0 65 0 0.0
Total 95 0 0.0 80 0 0.0
Unknown 9 21
Ab-I
Deterioration 2 11
No change 1 0 0.0 2 0 0.0
Improvement 87 20 23.0 80 6 7.5
Total 90 20 22.2 93 6 6.5
Unknown 14 8
Ab-A
Deterioration 6 15
No change 1 1 100.0 2 0 0.0
Improvement 90 23 25.6 77 10 13.0
Total 97 24 24.7 94 10 10.6
Unknown 7 7
Ab-P
Deterioration 5 8
No change 6 3 50.0 7 0 0.0
Improvement 87 43 49.4 76 17 22.4
Total 98 52 46.9 91 17 16.8
Unknown 6 10
MYMOP2
Deterioration 3 8
No change 0 0 0.0 1 0 0.0
Improvement 98 22 22.5 90 9 10.0
Total 101 22 21.8 99 9 8.9
Unknown 3 2
a % of patients with maximum possible functional ability as defined by the score; e.g., a patient with a WOMAC function
score of 100 (0 worst to 100 best function); or with a Ab-A score of 0 (0 best to 68 worse function) would be
considered by the WOMAC or Ab-IAP scoring system as having reaching the maximum possible functional ability.
Deterioration: decrease in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
No change: absence of change in functional ability, as measured by the score of interested, between the pre- and
12-month postoperative assessments.
Improvement: improvement in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
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TABLE 30 Ceiling effects in clinician-assessed function measures at 12 months post operation
Outcome
Hip Knee
Sample Maximum scorea Sample Maximum scorea
N= 104 n % N= 101 n %
Get-up-and-go test time
Deterioration 10 NA NA 18 NA NA
No change 3 NA NA 9 NA NA
Improvement 78 NA NA 62 NA NA
Total 91 NA NA 89 NA NA
Unknown 13 12
20-metre walk time
Deterioration 15 NA NA 19 NA NA
No change 10 NA NA 12 NA NA
Improvement 76 NA NA 67 NA NA
Total 101 NA NA 98 NA NA
Unknown 3 3
HHS
Deterioration 5
No change 0 0 0.0
Improvement 96 4 4.2
Total 101 4 4.0
Unknown 3
AKSS – knee score
Deterioration 10
No change 0 0 0.0
Improvement 86 2.0
Total 96 2 2.1
Unknown 5
AKSS – knee function
Deterioration 15
No change 16 0 0.0
Improvement 69 11.0
Total 100 11 11.0
Unknown 1
NA, not applicable.
a % of patients with maximum possible functional ability as defined by the score; e.g., a patient with a WOMAC function
score of 100 (0 worst to 100 best function); or with a Ab-A score of 0 (0 best to 68 worse function) would be
considered by the WOMAC or Ab-IAP scoring system as having reaching the maximum possible functional ability.
Deterioration: decrease in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
No change: absence of change in functional ability, as measured by the score of interested, between the pre- and
12-month postoperative assessments.
Improvement: improvement in functional ability, as measured by the score of interested, between the pre- and 12-month
postoperative assessments.
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The data do suggest that there are important differences in what is being assessed by self-report,
clinician-administered tools and functional assessments, as was apparent in our cross-sectional data. An
important finding in relation to that is the fact that the self-assessment tests often used by rheumatologists
to detect change in response to non-surgical interventions (e.g. WOMAC and SF-12) show a big ceiling
effect when used in the surgical setting.
Assessment of the trajectories of change
Introduction
The analysis presented in the previous section (see Longitudinal analysis of changes in the different
measures of function over time) showed that the majority of participants experienced an improvement in
function after joint replacement. To supplement and extend on this work, we undertook further analyses
to investigate participants’ trajectories of recovery after joint replacement surgery, using data collected
pre-operatively and at 3 months and 12 months after surgery.
First, we explored the trajectory of recovery, in terms of pain and function, in the first year postoperatively,
with a particular focus on patients undergoing revision joint surgery. By including patients listed for
different sort of surgical procedures, the ADAPT cohort study allowed us to investigate the specificities of
pain and function changes following revision surgery. We then investigate how recovery of pain and
function were interrelated. In these analyses, we used both a self-reported (WOMAC function) and
objective measure of function (time to complete a 20-metre walk test) to identify any disparities in recovery
pattern induced by assessment measure. Pain is a subjective experience and, therefore, we used the
self-report WOMAC pain score for assessing pain severity. Finally, we present findings from a gait analysis
study conducted on total primary hip replacement to shed light on the above self-reported versus objective
findings comparison.
Statistical analysis
Analyses were conducted separately for patients undergoing hip and knee replacement surgery using
Stata 13.1 (StataCorp LP, College Station, TX, USA).
Pain and function were analysed jointly using a multivariate linear mixed (MLM) regression with random
intercepts and slopes. This approach allows the modelling of the longitudinal trajectory (patients’
trajectory) of each outcome measure and the assessment of the correlations within and between these
outcome measures (correlation structure) in a single regression framework while providing unbiased
estimations in a context of missing data (under the missing at random assumption). Postoperative change
over time was modelled as two linear splines: one spline for the ‘immediate change’ occurring between
the pre-operative assessment and the first postoperative assessment (3 months) and another spline for
the ‘long-term change’ occurring between the two postoperative assessments (3 and 12 months). These
changes were normally distributed for each outcome allowing the use of MLM regression. However,
the postoperative function and pain scores were not normally distributed preventing the use of this
modelling framework to compare participants’ scores at specific postoperative time points. Mann–Whitney
U-tests were used for this purpose. The strength of correlation between parameters was interpreted
as |0.00|–|0.25|= none–little, |0.26|–|0.49|= low, |0.50|–|0.69|=moderate, |0.70|–|0.89|= high,
|0.90|–|1.00|= very high. p-values of ≤ 0.05 were considered statistically significant.
The MLM models were conducted on WOMAC pain and WOMAC function and replicated on WOMAC
pain and time to complete the 20-metre walk test to investigate disparities in findings according to the
method of functional assessment (self-reported vs. objective). The inverse of the 20-metre walk test
completion time (Time–1) was derived to facilitate the comparison of the effects between outcomes
(lower scores: worse function/pain score/time of test completion; higher scores: best function/pain
score/time of test completion).
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To assess if the pattern of changes differed by surgery type, patients were split into two groups: primary
surgeries (including primary total hip and knee surgeries, knee unicompartmental and patellofemoral
surgeries and revision surgeries). WOMAC pain, WOMAC function and Time–1 were modelled separately
with univariable linear mixed (ULM) regressions. It was not possible to model all these outcomes in a single
multivariate framework as the numbers of patients in the subgroups were not sufficient to fit a MLM
(hip: revision, n= 43; primary, n= 80; knee: revision, n= 42; primary, n= 84). The ULM models were
adjusted for the two time splines defined above, surgery type, their interaction and random effects on
each of these parameters. Differences in the immediate- and long-term changes by surgery type (primary
vs. revision) were tested using appropriate contrasts. A similar approach was used to investigate the
influence of pre-operative pain/function score on the postoperative recovery pattern: patients were split
into groups of high or low level of pre-operative pain using the pre-operative WOMAC pain median as a
cut-off point (hip: median= 55; knee: median= 40); they were also split into groups of high or low level
of pre-operative functional ability using the pre-operative WOMAC function and time to complete the
20-metre walk test medians as cut-off points (hip: median WOMAC function= 56, time to complete
the 20-metre walk test= 22–1 seconds; knee: 50 and 22–1 seconds, respectively).
Results
A total of 123 hip replacement participants were considered. Of these patients, 80 (65%) had a primary
THR and 43 (35%) had a revision hip replacement. They had a mean age of 65 years (SD 11 years) and
BMI of 28 kg/m2 (SD 5 kg/m2). Half of them were female (n= 62) and retired or unemployed (n= 67) and
24% (n= 30) were living alone. Approximately 75% (n= 91) had osteoarthritis in at least one other joint.
Of the 123 hip replacement participants with a pre-operative assessment, 121 (98%) completed a
WOMAC pain and function measure and 118 (96%) performed the timed 20-metre walk test. Of the 112
(91%) patients who participated in a 3-month assessment, all completed the WOMAC pain and function
scores and 107 (87%) completed the 20-metre walk test. At 12 months, 110 (89%) hip patients were still
in the study, 109 (89%) completed the WOMAC function score, and 108 (88%) completed the WOMAC
pain score and the 20-metre walk test.
A total of 126 knee replacement participants were considered. Of these patients, 48 (38%) had a primary
TKR, 42 (33%) a unicompartmental knee replacement, 5 (4%) a patellofemoral knee replacement and 42
(33%) a revision knee replacement. They had a mean age of 67 years (SD 10 years) and a BMI of 31 kg/m2
(SD 6 kg/m2). Approximately 55% (n= 69) were female, 66% (n= 83) were retired or unemployed and
29% (n= 37) were living alone. Approximately 83% (n= 104) had osteoarthritis in at least one other joint.
Of the 126 knee replacement participants with a pre-operative assessment, 123 (98%) completed the
three outcome measures. Of the 115 (91%) patients who participated in a 3-month assessment, 113
(90%) completed the WOMAC function score and 114 (91%) the WOMAC pain score and the 20-metre
walk test. At 12 months, 112 (89%) patients were still in the study, 111 (88%) completed the WOMAC
scores and 102 (81%) the 20-metre walk test.
Pain and function measures at the different assessment points are presented in Table 31.
Hip replacement: change in function and pain
As expected, both function (Figure 13a) and pain scores (Figure 13b) improved after surgery. These
improvements occurred mainly within the first 3 months following surgery [Table 32: +0.24 of WOMAC
function point/day (p< 0.001); +0.28 WOMAC pain point/day (p< 0.001)]. There was no evidence of
further changes after 3 months (see Table 32: WOMAC function and WOMAC pain, p-values= not
significant). A similar pattern of recovery was observed with the objective measure of function (Figure 13c
and Table 32) with a statistically significant mean immediate change (+0.002 seconds–1/month; p< 0.001)
but no significant long-term mean change (p= 0.057). This latter effect is close to the 0.05 significance
level, suggesting a marginal effect, but a larger sample would be required to provide a more
definitive answer.
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FIGURE 13 Change in pain and function from pre-operative to 12 months after hip replacement. (a) WOMAC
function; (b) WOMAC pain; and (c) 20-metre walk test.
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TABLE 32 Changes (Δ) and correlations between and within pain and function after hip replacementa
Hip Self-reported functionb and painc Objective functiond and painc
Fixed effects Coefficient 95% CI p-value Coefficient 95% CI p-value
Pre-operative score: functione 59.93 56.30 to 63.57 < 0.001 0.05 0.04 to 0.05 < 0.001
Immediate Δ:f functiong,h 0.24 0.20 to 0.28 < 0.001 0.002 0.001 to 0.002 < 0.001
Long-term Δ:i functiong,h 0.01 –0.01 to 0.01 NS 0.00 –0.00 to 0.00 0.057
Preoperative score: paine 59.74 56.20 to 63.28 < 0.001 59.74 56.20 to 63.28 < 0.001
Immediate Δ: paing 0.28 0.24 to 0.31 < 0.001 0.28 0.24 to 0.31 < 0.001
Long-term Δ: paing 0.00 –0.01 to 0.01 NS 0.00 –0.01 to 0.01 NS
Random effects SDj 95% CI SDj 95% CI
Pre-operative score: function 20.48 17.72 to 22.92 0.01 0.01 to 0.01
Immediate Δ: function 0.20 0.17 to 0.22 0.003 0.003 to 0.004
Long-term Δ: function 0.05 0.04 to 0.05 0.001 0.001 to 0.001
Preoperative score: pain 19.93 17.24 to 22.30 19.93 17.24 to 22.30
Immediate Δ: pain 0.20 0.17 to 0.22 0.20 0.17 to 0.22
Long-term Δ: pain 0.05 0.04 to 0.06 0.05 0.04 to 0.06
Correlations Correlationk 95% CI Correlationk 95% CI
Preoperative function:
preoperative pain
0.78 0.71 to 0.85 0.39 0.24 to 0.54
Preoperative function:
immediate Δ function
–0.61 –0.72 to –0.49 –0.47 –0.62 to –0.33
Preoperative function:
long-term Δ function
–0.12 –0.31 to 0.06 –0.12 –0.31 to 0.07
Immediate Δ function:
long-term Δ function
–0.36 –0.52 to –0.19 –0.33 –0.50 to –0.16
Preoperative pain: immediate
Δ pain
–0.56 –0.69 to –0.44 –0.56 –0.69 to –0.44
Preoperative pain: long-term
Δ pain
0.13 –0.05 to 0.32 0.13 –0.05 to 0.32
Immediate Δ pain: long-term
Δ pain
–0.56 –0.69 to –0.43 –0.56 –0.69 to –0.43
Preoperative function:
immediate Δ pain
–0.45 –0.60 to –0.31 –0.17 –0.35 to 0.01
Preoperative function:
long-term Δ pain
0.06 –0.13 to 0.25 –0.04 –0.23 to 0.15
Preoperative pain: immediate
Δ function
–0.36 –0.52 to –0.20 –0.45 –0.60 to –0.30
Preoperative pain: long-term
Δ function
–0.10 –0.29 to 0.09 0.22 0.03 to 0.40
Immediate Δ function:
immediate Δ pain
0.76 0.68 to 0.84 0.49 0.34 to 0.63
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The mean trajectories are derived from the fixed effects of linear mixed models regressing WOMAC pain,
WOMAC function and Time–1 to perform the 20-metre walk test on the time of assessment parameterised
as two linear splines (to assess immediate changes and long-term changes, see Table 32, footnotes f and i).
This overall pattern of change in self-reported function was observed in both primary and revision surgery
patient groups (Figure 14a). However, the immediate change was twice as large (p< 0.001) for the
primary (+0.28/day, 95% CI 0.24 to 0.33; p< 0.001) than for the revision (+0.15/day, 95% CI 0.10 to
0.20; p< 0.001) surgery group. No significant long-term improvement in function was observed after
3 months for either group. As a result of the different pace in immediate recovery, and despite similar
levels of pre-operative WOMAC function scores, the median level of functional ability observed at
12 months post operation was higher in the primary surgery group (p= 0.01).
Similar results were observed for WOMAC pain (Figure 14b). Those patients listed for a primary surgery
had more pain pre-operatively than those in the revision surgery group (p= 0.03), but their immediate
improvement was twice as large (+0.33/day, 95% CI 0.29 to 0.38, vs. +0.17/day, 95% CI 0.11 to 0.22);
long-term mean changes in pain were not significant for both groups. At 12 months, the primary surgery
group had caught up with the revision group and had similar pain score levels (p= not significant).
In contrast, to the two other outcomes, the immediate improvements in walking time were similar for both
surgical groups but their changes in objective function after 3 months were different (p= 0.05), being
nearly flat for the revision group (p= not significant) whereas patients in the primary surgery group
continued to experience an improvement in their function (p< 0.01). Both groups had the same
pre-operative walking speed, but at 12 months the primary surgery group did better (p< 0.01).
TABLE 32 Changes (Δ) and correlations between and within pain and function after hip replacementa (continued )
Hip Self-reported functionb and painc Objective functiond and painc
Immediate Δ function:
long-term Δ pain
–0.38 –0.54 to –0.21 –0.14 –0.33 to 0.05
Immediate Δ pain: long-term
Δ function
–0.25 –0.43 to –0.07 –0.15 –0.34 to 0.04
Long-term Δ function:
long-term Δ pain
0.64 0.53 to 0.75 0.05 –0.14 to 0.25
NS, not significant.
a The fixed, random effects and correlations are estimated in one MLM model regressing (WOMAC pain and WOMAC
function) and another regressing (WOMAC pain and Time–1 to perform 20-metre walk test) on the time of assessment
parameterised as two linear splines (to assess immediate changes and long-term changes, see footnotes f and i).
b WOMAC function subscale.
c WOMAC pain subscale.
d Inverse of the time to perform a 20-metre walk-test.
e Intercepts: estimated mean function or pain score on the day of surgery.
f Immediate change: change in function or pain between the pre-operative and first postoperative assessment
(≈3 months).
g The fixed-effect coefficient represents the daily change in WOMAC pain or WOMAC function for the period of change
of interest (immediate- or long-term change). For example, around one-quarter of a WOMAC function point (0.24) per
day during the first 3 months.
h The fixed-effect coefficient represents the monthly change in the inverse of time to complete the 20-metre walk test for
the period of change of interest.
i Long-term change: change in function or pain between the first and second postoperative assessments (≈3 and
≈12 months).
j SD of the random effects associated with each of the parameters. Indicate the variability of the parameters
across participants.
k Correlation coefficient between set of two parameters derived from the MLM models.
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Hip replacement: correlation structure between and within pain and function
Two sets of correlations are presented in Table 32, one relating to the joint MLM modelling of pain and
self-reported function (‘self-reported model’) and another relating to the modelling of pain and objective
measure of function (‘objective model’).
Participants were more likely to concomitantly report high/low level of pre-operative pain and functional
disability (correlation: + 0.78), similar direction of immediate (+ 0.76) and long-term (+ 0.64) pain and
function improvements. When an objective measure of function was considered, these correlations were
weaker or non-existent (0.39, 0.49 and 0.05). With regard to the ‘functional improvement journey’,
high pre-operative functional disability was correlated with large functional improvement within the first
3 months following surgery and those with more favourable pre-operative functional scores had smaller
immediate functional gain (–0.61 in the ‘self-reported’ and –0.47 in the ‘objective’ models). This evidence
is illustrated in Figure 15a and b. Participants in the low pre-operative function group had an immediate
functional improvement nearly 2.5 times larger than those who were in the high function group
(difference in slope between high/low groups: p< 0.0001 for both self-reported and objective function).
As reported in Table 31, the two groups of patients had statistically significantly different levels of
pre-operative function but had similar levels of functional ability 12 months after surgery (WOMAC
function). A significant difference was still observed after surgery when an objective measure of function
was considered but the gap had reduced (see Figure 15b).
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FIGURE 14 Change in pain and function from pre-operative to 12 months after primary and revision hip
replacement. (a) WOMAC function; (b) WOMAC pain; and (c) 20-metre walk test. The mean trajectories are derived
from the fixed effects of linear mixed models regressing WOMAC pain, WOMAC function and Time–1 to perform
the 20-metre walk test on the time of assessment parameterised as two linear splines (to assess immediate changes
and long-term changes, see Table 32, footnotes f and i), the surgery type and their interactions.
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No relationship was observed between the pre-operative functional scores and long-term changes
(see Table 32, correlations < 0.25). Large/small immediate functional improvements were correlated with
small/large long-term functional improvement (–0.36 in the ‘self-reported’ and –0.33 in the ‘objective’ models).
With regard to the ‘functional improvement journey’, high pre-operative functional disability was
correlated with large functional improvement within the first 3 months following surgery while those with
more favourable pre-operative functional scores had smaller immediate functional gain (–0.61 in the
‘self-reported’ and –0.47 in the ‘objective’ models). This evidence is illustrated in Figure 15a and c.
Participants in the low pre-operative function group had an immediate functional improvement nearly
2.5 times larger than those who were in the high function group (difference in slope between high/low
groups: p< 0.0001 for both self-reported and objective function). As reported in Table 31, the two groups
of patients had statistically different levels of pre-operative function but had similar levels of functional
ability 12 months after surgery (WOMAC function). A significant difference was still observed after surgery
when an objective measure of function was considered but the gap had reduced (see Figure 15b).
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FIGURE 15 Change in pain and function from pre-operative to 12 months after hip replacement by pre-operative
pain/function. (a) WOMAC function; (b) 20-metre walk test; and (c) WOMAC pain. The mean trajectories are
derived from the fixed effects of linear mixed models regressing WOMAC pain, WOMAC function and Time–1 to
perform the 20-metre walk test on the time of assessment parameterised as two linear splines (to assess immediate
changes and long-term changes, see Table 32, footnotes f and i), the pre-operative status and their interactions.
Pre-operative level of pain/function status are defined using median scores as cut-off threshold (median WOMAC
pain= 55, WOMAC function= 56, time to complete the 20-metre walk test= 22–1 seconds).
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No relationship was observed between the pre-operative functional scores and long-term changes
(see Table 32, correlations < 0.25). Large/small immediate functional improvements were correlated
with small/large long-term functional improvement (–0.36 in the ‘self-reported’ and –0.33 in the
‘objective’ models).
With regard to the pain improvement trajectory, a similar picture was found, with evidence of relationships
between the pre-operative scores and immediate changes (–0.56) and between the immediate- and
long-term changes (–0.56). Participants with a high level of pre-operative pain had an immediate change
that was twice as large as those in the low-pain group (Figure 15c, difference in slope between high/low
groups: p< 0.001) and the pre-operative difference in pain severity was no longer present at 12 months
postoperatively (see Table 31).
Pain and function were inter-related and appeared to influence each others ‘recovery journey’ as shown
by the correlations between them. The patient-reported pre-operative level of functional ability was
related to immediate change in pain (–0.45), with higher functional improvement for patients with worse
pre-operative pain and lower pain improvement for those with better baseline functional ability. This
relationship was not observed when function was objectively measured (objective model). Similarly, the
level of pre-operative pain was related to the immediate changes in self-reported function (–0.36) as well
as with immediate changes in objective function (–0.45). Pre-operative self-reported function did not seem
to be correlated with long-term changes in pain and pre-operative pain did not seem to be correlated
with long-term changes in self-reported function. Immediate self-reported functional improvement was
correlated with long-term pain improvements (–0.38), with smaller long-term changes for those who had
large immediate changes or larger long-term changes. Similarly, immediate improvement in pain was
correlated with long-term improvement in perceived functional ability (–0.25). These relationships were not
observed in the ‘objective model’.
Knee replacement: change in function and pain
Patients experienced an improvement in function (Figure 16a) and pain (Figure 16b) after their knee surgery.
The improvements occurred mainly within the first 3 months following surgery (Table 33: + 0.18 of
WOMAC function point/day, p< 0.001; + 0.21 WOMAC pain point/day, p< 0.001). There was no evidence
of further changes after 3 months for WOMAC function (see Table 33: p= not significant) but there was
some suggestion of further long-term improvement for pain (p= 0.051). Contrary to the self-reported
measure of function, the time to complete the 20-metre walk test (Figure 16c and see Table 33) improved
significantly until the 12-month assessment [immediate change + 0.001 seconds–1/month (p< 0.001);
long-term change + 0.0002 seconds–1/month (p< 0.01)], with steeper improvement in the first 3 months
(difference between the two slopes, p= 0.04).
The differences in improvement patterns by surgical type group are presented in Figure 17. Patients in
both the revision and primary groups experienced significant improvements within the first 3 months
following their surgery in their subjective (Figure 17a; p< 0.0001 for both groups) and objective
(Figure 17b, revision surgery, p= 0.02; other surgery, p= 0.01) measures of function. These immediate
improvements in function were higher in the primary surgery group, the difference was not statistically
significant (p> 0.05). Pain improved for both groups during the first 3 postoperative months (Figure 17c)
but at a slower pace for the revision surgery group (+ 0.14/day, 95% CI 0.08 to 0.20; p< 0.0001) than for
the primary surgery group (+ 0.25/day, 95% CI 0.21 to 0.29; p< 0.0001). No evidence of function or pain
change was observed between 3 and 12 months, except in patients in the primary surgery group who
experienced an improvement in their 20-metre walk test time completion (+ 0.0009 seconds–1/month;
p= 0.01). Pre-operative levels of pain and function (subjective and objective) were similar in both surgery
groups (p> 0.05), but at 12 months those who had a revision surgery had worse median scores (WOMAC
function, p< 0.02; WOMAC pain, p< 0.01; 20-metre walk test time, p= 0.03).
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FIGURE 16 Change in pain and function from pre-operative to 12 months after knee replacement. (a) WOMAC
function; (b) WOMAC pain; and (c) 20-metre walk test. The mean trajectories are derived from the fixed effects of
linear mixed models regressing WOMAC pain, WOMAC function and Time–1 to perform the 20-metre walk test on
the time of assessment parameterised as two linear splines (to assess immediate changes and long-term changes,
see Table 32, footnotes f and i).
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TABLE 33 Changes (Δ) and correlations between and within pain and function after knee replacementa
Knee Self-reported functionb and painc Objective functiond and painc
Fixed effects Coefficient 95% CI p-value Coefficient 95% CI p-value
Pre-operative score:
functione
54.07 50.86 to 57.28 < 0.001 0.05 0.04 to 0.05 < 0.001
Immediate Δ:f functiong,h 0.18 0.15 to 0.20 < 0.001 0.001 0.000 to 0.002 < 0.001
Long-term Δ:i functiong,h 0.01 –0.00 to 0.02 NS 0.0002 0.0001 to 0.0004 < 0.01
Preoperative score: paine 47.64 44.38 to 50.90 < 0.001 47.64 44.38 to 50.90 < 0.001
Immediate Δ: paing 0.21 0.18 to 0.25 < 0.001 0.21 0.18 to 0.25 < 0.001
Long-term Δ: paing 0.01 –0.00 to 0.02 0.051 0.01 –0.00 to 0.02 0.051
Random effects SDj 95% CI SD j 95% CI
Pre-operative score:
function
18.25 15.80 to 20.40 0.01 0.01 to 0.02
Immediate Δ: function 0.15 0.13 to 0.17 0.003 0.003 to 0.004
Long-term Δ: function 0.05 0.05 to 0.06 0.001 0.001 to 0.001
Preoperative score: pain 18.48 16.00 to 20.67 18.48 16.00 to 20.67
Immediate Δ: pain 0.20 0.18 to 0.23 0.20 0.18 to 0.23
Long-term Δ: pain 0.06 0.05 to 0.07 0.06 0.05 to 0.07
Correlations Correlationk 95% CI Correlationk 95% CI
Preoperative function:
preoperative pain
0.81 0.75 to 0.87 0.29 0.13 to 0.45
Preoperative function:
immediate Δ function
–0.26 –0.43 to –0.09 –0.31 –0.48 to –0.15
Preoperative function:
long-term Δ function
–0.06 –0.25 to 0.13 –0.08 –0.27 to 0.12
Immediate Δ function:
long-term Δ function
–0.19 –0.37 to –0.01 –0.49 –0.64 to –0.35
Preoperative pain:
immediate Δ pain
–0.30 –0.46 to –0.13 –0.30 –0.46 to –0.13
Preoperative pain:
long-term Δ pain
–0.01 –0.20 to 0.18 –0.01 –0.20 to 0.18
Immediate Δ pain:
long-term Δ pain
–0.38 –0.54 to –0.22 –0.38 –0.54 to –0.22
Preoperative function:
immediate Δ pain
–0.16 –0.33 to 0.02 0.06 –0.12 to 0.24
Preoperative function:
long-term Δ pain
0.03 –0.16 to 0.21 0.12 –0.07 to 0.30
Preoperative pain:
immediate Δ function
–0.22 –0.40 to –0.05 –0.11 –0.29 to 0.07
Preoperative pain:
long-term Δ function
–0.09 –0.28 to 0.10 0.02 –0.18 to 0.21
Immediate Δ function:
immediate Δ pain
0.80 0.74 to 0.87 0.33 0.17 to 0.50
Immediate Δ function:
long-term Δ pain
–0.24 –0.42 to –0.07 –0.07 –0.26 to 0.12
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TABLE 33 Changes (Δ) and correlations between and within pain and function after knee replacementa (continued )
Knee Self-reported functionb and painc Objective functiond and painc
Immediate Δ pain:
long-term Δ function
–0.05 –0.24 to 0.14 –0.01 –0.20 to 0.18
Long-term Δ function:
long-term Δ pain
0.64 0.52 to 0.75 –0.04 –0.23 to 0.15
NS, not significant.
a The fixed, random effects and correlations were estimated in one MLM model regressing (WOMAC pain and WOMAC
function) and another regressing (WOMAC pain and Time–1 to perform the 20-metre walk test) on the time of assessment
parameterised as two linear splines (to assess immediate changes and long-term changes, see footnotes f and i).
b WOMAC function subscale.
c WOMAC pain subscale.
d Inverse of the time to perform a 20-metre walk test.
e Intercepts: estimated mean function or pain score on the day of surgery.
f Immediate change: change in function or pain between the pre-operative and first postoperative assessment (≈3 months)
g The fixed-effect coefficient represents the gain in WOMAC pain or WOMAC function per day for the period of interest
(immediate- or long-term change). For example, around 0.18 WOMAC function point per day during the first 3 months.
h The fixed-effect coefficient represents the monthly improvement in time to perform the walk time.
i Long-term change: change in function or pain between the first and second postoperative assessments (≈3 and
≈12 months).
j SD of the random effects associated with each of the parameters. Indicate the variability of the parameters across participants.
k Correlation coefficient between set of two parameters derived from the MLM models.
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FIGURE 17 Change in pain and function from pre-operative to 12 months after primary and revision knee
replacement. (a) WOMAC function; (b) 20-metre walk test; and (c) WOMAC pain. a, Other surgery includes primary,
unicompartmental and patellofemoral procedures. The mean trajectories are derived from the fixed effects of
linear mixed models regressing WOMAC pain, WOMAC function and Time–1 to perform the 20-metre walk test on
the time of assessment parameterised as two linear splines (to assess immediate changes and long-term changes,
see Table 33, footnotes f and i), the surgery type and their interactions.
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Knee replacement: correlation structure between and within pain and function
The correlation structures of the ‘self-reported’ and ‘objective’ models are presented in Table 33.
Participants were more likely to concomitantly report high/low level of pre-operative pain and functional
disability (+ 0.81), similar direction of immediate (+ 0.80) and long-term (+ 0.64) pain and functional
improvements. When an objective measure of function was considered, the corresponding correlations
were much weaker or negligible (+ 0.29, + 0.33 and –0.04).
With regard to the ‘functional improvement journey’, low/high pre-operative function scores were
correlated with high/low immediate improvement in function (self-reported model –0.26, objective model
–0.31). In Figure 18a and b, we can notice steeper immediate improvements for those in the low
pre-operative function group than in those in the high pre-operative function group (difference in slope
between high/low groups: WOMAC function, p< 0.001; Time–1, p= 0.012).
The long-term changes in function did not seem to be related with the pre-operative scores (see Table 33).
A weak relationship between the self-reported immediate- and long-term function change was observed
(–0.19) whereas high/small immediate improvement in the 20-metre walk test completion time was
correlated with small/high long-term improvement (–0.49).
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FIGURE 18 Change in pain and function from pre-operative to 12 months after knee replacement by pre-operative
pain/function. (a) WOMAC function; (b) 20-metre walk test; and (c) WOMAC pain. The mean trajectories are
derived from the fixed effects of linear mixed models regressing WOMAC pain, WOMAC function and Time–1 to
perform the 20-metre walk test on the time of assessment parameterised as two linear splines (to assess immediate
changes and long-term changes, see Table 33, footnotes f and i), the pre-operative status and their interactions.
Pre-operative level of pain/function status are defined using median scores as cut-off threshold (median WOMAC
pain= 40, WOMAC function= 50, time to complete the 20-metre walk test= 22–1 seconds).
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With regard to the ‘pain improvement journey’, large immediate pain improvements were correlated with
high pre-operative pain level and small immediate improvement with low pre-operative level of pain
(–0.30). This is illustrated in Figure 18c, which shows that immediate improvement was steeper for patients
in the low pre-operative pain group than for those in the high pre-operative pain group (difference in
slope between high/low groups, p< 0.01).
The long-term pain change was not related to the pre-operative pain scores (see Table 33). Those with
larger/smaller immediate pain improvements also had smaller/larger long-term pain improvement (–0.38).
With regard to the pain–function inter-relation, that is, the influence on each other’s ‘journey’, no
evidence of relationship between the pre-operative function level and the postoperative changes in pain
was observed. Pre-operative pain level was weakly correlated (–0.22) with immediate self-reported function
change. This relation was not found with the objective measure of function. Long-term change in function
appeared independent of the pre-operative pain severity. The self-reported immediate functional change
was weakly correlated (–0.24) with long-term pain change, although this relationship was not observed in
the objective model. The immediate pain change was not related to long-term change in function.
Assessment of function using accelerometry in patients receiving
hip replacement
Patients were also invited to wear an inertial ambulatory motion sensor incorporating accelerometers and
gyroscopes during the completion of the 20-metre walk test (see Inertial sensor-based motion and gait
analyses). Participants were asked to walk along a straight flat corridor at their own preferred speed.
Participants wore their own clothes and shoes but high-heeled shoes were not permitted. After crossing
the finish line, one last step was allowed to establish a complete stop avoiding a significant slowdown
within the 20metres. The exact distance covered (20metres+ the last step) was measured and used for
the following analyses. The test was conducted on the 36 patients listed for a primary THR without any
history of previous lower limb joint surgery and with available longitudinal WOMAC function and
ambulatory gait analysis data.
The collected measures are presented in Table 34 and longitudinal changes are reported in Figure 19.
The 36 participants had the same pattern of WOMAC function recovery (see Figure 19) as the pattern
observed in the overall sample (see Figure 13) – a large significant improvement within the first 3 months
following the surgery (p< 0.0001) but no further improvement between 3 months and 12 months
postoperatively (p> 0.05).
Pre-operatively, all the gait parameters had some weak to moderate correlations with WOMAC function
(see Table 34). Apart from the ‘range of motion pelvic obliquity’ gait parameter, all the others maintained
some weak correlations 12 months after the surgery. These findings suggest that the patient-reported
measure partially reflect functional aspects captured by the gait analysis objective parameters.
Steps cadence and time to complete a step had the same course of longitudinal changes as the WOMAC
function scores (see Figure 19).
Conversely, speed, ROM pelvic obliquity and step length continued to improve after the 3-month
postoperative assessment (p< 0.0001).
The postoperative average changes in step irregularity and asymmetry were not statistically significant,
suggesting that these aspects of function are not altered by THR surgery. However, there is a large
heterogeneity in the patterns of individual changes (see Figure 19).
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FIGURE 19 Change in patient-reported function and gait parameters from pre-operative to 12 months after hip
replacement. (a) WOMAC function; (b) speed; (c) cadence; (d) ROM; (e) step time; (f) step length; (g) irregularities;
and (h) asymmetries. The mean trajectories are derived from the fixed effects of linear mixed models regressing
teach outcome on the time of assessment parameterised as two linear splines (to assess immediate changes and
long-term changes, see Table 33, footnotes f and i). (continued )
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and (h) asymmetries. The mean trajectories are derived from the fixed effects of linear mixed models regressing
teach outcome on the time of assessment parameterised as two linear splines (to assess immediate changes and
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Discussion
These findings indicate that the pain and function trajectories in the first year following hip or knee surgery
are similar, with most of the improvement occurring within the first 3 postoperative months. No clear
indication of further improvement was observed after the 3 months postoperative assessment for those
undergoing hip surgery. However, for those who had knee surgery, function measured objectively
(20-metre walk test) continued to improve until 12 months post operation.
The absence of improvement after 3 months post operation could be viewed as an artefact resulting from
the ceiling effect inherent to score bounded PROMs such as WOMAC limiting the ability to detect
improvement for patients recovering very quickly.343,344
However, the long-term mean changes associated with the objective function measures were marginal and
much smaller than the one that occurred before 3 months and observed only among patients undergoing
knee surgery. The gait analysis also revealed steeper slopes before 3 months and not all gait parameters
had a statistically significant improvement beyond 3 months. Only residual changes might have to be
expected after 3 months in proportion to those occurring before. The modest sample size of ADAPT
limited our ability to adjust for factors known to be associated with the postoperative outcome such as
age, sex, mental health and other comorbidities, and adjusted findings might have provided a slightly
different picture. Our results are consistent with the existing literature.48,341,342,345–350 Improvements in
WOMAC physical function beyond 3 months were observed by Bachmeier and colleagues48 in patients
who had undergone hip replacement. However, changes in WOMAC pain were marginal. For patients
with knee replacement, changes beyond 3 months in both WOMAC function and pain were marginal.
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FIGURE 19 Change in patient-reported function and gait parameters from pre-operative to 12 months after hip
replacement. (a) WOMAC function; (b) speed; (c) cadence; (d) ROM; (e) step time; (f) step length; (g) irregularities;
and (h) asymmetries. The mean trajectories are derived from the fixed effects of linear mixed models regressing
teach outcome on the time of assessment parameterised as two linear splines (to assess immediate changes and
long-term changes, see Table 33, footnotes f and i).
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Heiberg and colleagues,347 in Norway, found a small but significant improvement after 3 months post
operation among hip surgery patients for pain and subjective and objective measures of function [HOOS
and 6-metre walk test (6MWT)]. Kennedy and colleagues348,349 found some further improvement between
3 and 6 months post knee or hip surgery but none thereafter using objective or PROMs measure of function
[Lower Extremity Functional Scale (LEFS) and 6MWT] in a Canadian population. Halket and colleagues,341
in Canada, and Naylor and colleagues,350 in Australia, found hardly any improvement after 3 months in
PROM measures of pain including WOMAC pain.
Interesting relationships have been found between the pre-operative score levels and postoperative
changes. The pre-operative situation is negatively related to the immediate postoperative changes. The
worse the situation before the surgery, the more likely the participants are to improve within the first few
postoperative months; therefore, the better the pre-operative situation, the lower the immediate
postoperative improvement. These findings can be induced by the ceiling effect inherent in the scoring
system of PROMs in which those doing well have less room for improvement, magnifying the effect of
those starting with lower scores. However, these negative correlations were also observed with the
objective measure of function suggesting that more can be expected from the surgery when the patients
have very poor pre-operative pain and function. Twelve months after their hip surgery, patients with poor
pre-operative scores had caught up with those who had better pre-operative score. However, after their
knee surgery, and despite a faster immediate improvement, participants with low function or high pain
before their surgery still had significantly poorer function or pain level, even if the gap had reduced. This
suggests that, even if there is a lot to expect from the joint surgery, any delay in the knee surgery might be
associated with functional and/or pain degradation, which cannot be corrected by the operation. It is
unlikely that these findings are driven by the revision/non-revision status of the knee participants. The
prevalence of patients listed for a knee revision did not differ between high- and low-score groups; their
pain or function pre-operative median scores did not differ from those listed for a first-time joint surgery.
For both groups, any intervention modifying the pre-operative pain level is likely to affect its course of
immediate postoperative improvement, and the same is true for function. However, the relationship
between pain and function differed between those having hip or knee surgery. For the hip patients,
pain and function were interrelated whereas, for knee disease, no correlation between patients’
pre-operative score levels and postoperative changes was found. This could suggest that separate
interventions specific to pain and function need to be designed for knee pre- and postoperative
rehabilitation whereas more generic hip intervention could affect both domains simultaneously.
Our findings suggest that patients undergoing primary or revision surgery will experience an improvement
in pain and function but the pattern of recovery will differ between these two types of surgery. Despite
similar or better function and pain scores for patients undergoing a revision surgery than for those
undergoing a primary joint surgery, a revision surgery does not seem to bring as much pain and functional
improvement 12 months later. This finding is congruent with the existing literature351,352 and needs to be
kept in mind when patients and clinicians discuss post-surgical expectations.
Finally, the pattern of functional recovery seems to be influenced by the method used to assess function,
with significant long-term improvement observed in objective measure of function, but not with the
self-reported measure. This could reflect the well-documented ceiling effect of the WOMAC function
score. However, some of the gait analysis parameters, less subject to a ceiling effect, have a similar course
of postoperative improvement as the self-reported measure of function. As the WOMAC function score
is capturing information on several daily activities, this might also suggest that the potential loss of
information induced by the use of a score-bounded instrument might not be as important as we think.
It might also reflect the actual improvement pattern of some specific dimensions of function. Moreover,
pain appears more correlated with the self-reported than with the objective measure of function. This
might confirm previous work by Stratford and Kennedy353 which suggested an internal limitation of the
WOMAC index scores: ‘activity overlap on the pain and function subscales plays a causal role in limiting
the WOMAC physical function subscale’s ability to detect change’.
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In all cases, these findings imply that it is valuable to use both self-reported and objective measures of
function whenever possible. Doing so will capture a comprehensive longitudinal functional ability picture of
patients undergoing joint replacement.
Discussion and conclusions
The ADAPT study aimed to investigate the different measures used to assess function in people
undergoing hip or knee replacement and their responsiveness to the change resulting from joint
replacement. The cohort included 263 people undergoing a mixture of hip and knee replacement, and
primary and revision surgeries. This provided a mix of patients with a wide variety of different levels of
disability, but the disadvantage of lacking homogeneity.
Our theoretical basis for the assessment of disability was the ICF, which differentiates between
impairments, activities limitations and participation restrictions. We deliberately chose a number of
different types of approach to functional assessment:
l standard self-report measures widely used in rheumatology practice (the WOMAC and SF-12)
l the Aberdeen measure, a recently developed self-assessment tool which differentiates between
impairments, activities limitations and participation restrictions
l clinician-administered tools widely used by orthopaedic practitioners (HHS and AKSS)
l performance-based tests widely used by geriatricians (‘get-up-and-go test’, step tests, balance tests and
walking time)
l accelerometry tests, which are a recent development and have the promise of providing us with a more
objective way or assessing function.
Measures were made immediately prior to surgery, at the standard 3-month follow-up visit and at 1 year.
Our key findings are:
1. There is no ‘right’ way to assess function in patients undergoing joint replacement.
We had hoped at the outset of this study that we might be able to conclude that some measures should
be used, and others discarded, but the data do not support this. Arguably the ‘knee score’ component of
the AKSS is of questionable value because it correlates poorly with other measures. Each of the different
methods of assessing function appears to be measuring something a little different and is influenced by
different covariates, so nothing is ‘right’ and nothing is ‘wrong’. The strongest correlations were between
the different self-assessment measures and also between the different performance tests. However, the
correlations between self-assessment measures and performance tests were much lower. This suggests
that it might be wise to use one of each type of measure to obtain a satisfactory picture of the degree of
functional loss in any individual patient. This is also confirmed by our comparisons of the longitudinal
changes between patient-reported and performance test functional measures.
2. Self-assessment measures and functional tests are influenced by different factors.
We have shown that:
l Pain affects every type of functional assessment measure.
l Mental health status has a large influence on self-assessment measures but little effect on
functional testing.
l Age (and sex in the case of the hip replacement) affects laboratory tests of function but not
self-assessment measures.
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We interpret this as confirming previous research that suggests pain and function are inextricably linked in
musculoskeletal disability, that people with anxiety or depression may assess themselves as being worse off
than they objectively are and that the influence of age on functional tests may be mediated by sarcopenia
(a hypothesis that requires further investigation).
The implication is that measures of function may need adjustment for pain, psychological status, age and
perhaps muscle strength if we are to obtain a satisfactory picture of functional loss.
3. Range of joint motion is not a satisfactory surrogate measure for function.
It is relatively easy to assess the ROM of the hip or knee and this measure is commonly carried out in
clinical practice. Health-care professionals and patients often assume that it provides a useful surrogate
measure of osteoarthritis severity and/or functional problems. It constitutes an important part of both the
HHS and the AKSS.
Our data indicate that ROM does not correlate well with other measures of disease severity and we would
suggest that it should not be given any weight in patient assessment.
The ROM, within the ICF classification, is a measure of impairment. Pain is generally considered to be an
impairment measure as well300 but in contrast to ROM correlates well with measures of activities limitations
and participation restrictions. We would argue that it may be inappropriate to classify pain as an
impairment measure in this context.
4. Function is improved 1 year after surgery in most, but not all, people.
Data on the outcomes of joint replacement are usually presented simply as the average difference in pain
or function before and after surgery.
However, ‘averages’ do not tell us how many people might have got significantly (for them) better and,
conversely, how many did not change or got worse. Our data are presented in such a way as to make
these aspects of outcome totally explicit. They show that improvement that is both clinically and statistically
significant will occur in some 90% of patients having a hip replacement and 70% of those having a knee
replacement (an important difference between the two joint sites) and that, in contrast, some 5% of
those having a hip replacement and 10% of those having a knee replacement will stay much the same
or experience a deterioration in function 1 year after surgery. However, the degree of deterioration is rarely
of clinical significance.
These data are important to patients and surgeons counselling them about the likely outcome of a
joint replacement.
5. ‘Ceiling effects’ are a major problem for many measures of function.
A possible limitation of a measure of function, and one that we were keen to explore, is that it reaches a
ceiling, so that patients cannot improve further on that score, even if their clinical status does improve.
Our data indicate that this is a significant problem for self-assessment measures such as WOMAC in the
context of joint replacement and, to a lesser extent, for the clinician-administered HHS and AKSS. The
longitudinal and gait analyses revealed that some ‘objective’ functional parameters were still improving
after the surgery when the WOMAC function scores were reaching a plateau. However, other ‘objective’
gait parameters did have a similar pattern of improvement, suggesting that perhaps this ceiling effect is
not necessarily as extensive as we might think and the WOMAC function score is still providing an
acceptable reflection of functional change.
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6. Walking speeds tell a different story.
We have put a reasonable amount of emphasis on the walking speed of patients in this study for three
main reasons: first, it is a reasonably objective measure; second, it does not have a ceiling effect;
and, third, it is a widely used surrogate measure of participation.354–356 It also has some correlation with
life expectancy.357–362
Our data indicate that walking does not show such as good a response to joint replacement as most of
the other measures used. Patients are more likely to be worse 1 year after surgery on their walking time
than on other measures and the amount of improvement is rarely large. We believe that walking time is
more dependent on other variables, many of which are age related, than the other measures.
7. Patients with hip and knee disease respond differently to joint replacement.
It is widely thought that people have a better outcome after a hip replacement than after a knee
replacement, and our data support this idea. The likelihood of improvement and the amount of
improvement is much greater for people having hip replacement than knee replacement, and there are
subtle but important differences in the nature of the response and its determinants.
Patients and joint replacement surgeons need to consider hip and knee osteoarthritis as different diseases.
Pain and function seem also to be differently inter-related over time between these two diseases. A more
tailored course of intervention may be required for knee osteoarthritis to tackle pain and function, whereas
an intervention tackling one of these domains is also likely to affect the other one for hip osteoarthritis.
8. The chances of a good response to joint replacement depend on the severity of the disease at the time
of surgery.
Our data show this very clearly. This is not a new finding, but the ADAPT cohort does shed some new light
on this important aspect of joint replacement.
Our findings suggest that we should think about the journey (the amount of change after surgery) and the
destination (the ‘final’ point reached 1 year after surgery). Patients with very severe disease at the time of
surgery are more likely to have a good journey (i.e. pain and functional ability will probably improve
substantially), whether patients have hip or knee disease. But the destination differs for the two joint sites.
Those with hip disease can have a similar good destination, irrespective of the starting point, whereas
those with knee disease can never ‘catch up’ (i.e. have as good a final outcome or destination) if they start
off with very severe disease at the time of surgery. This is an important finding with the possibility that we
may be delaying surgery too long for many people with knee disease.
Finally, our findings show that patients listed for a revision surgery had slightly better pre-operative pain
and similar functional ability than those listed for primary surgery. However, their postoperative gains do
not seem to be as large as the improvement experienced by patients with primary joint surgery. Clinicians
and patients should be aware of this to discuss and set the expectations from a revision surgery.
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Chapter 6 Perioperative pain management with
local anaesthetic infiltration in total hip and knee
replacement: systematic review, randomised
controlled trial, cost-effectiveness study, evaluation
of nurse recruitment methods and qualitative study of
views and experiences of trial participation and use
of analgesics
Parts of this chapter have been reproduced with permission from Horwood and colleagues.363 CrownCopyright © 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Some parts have also been reproduced from
Marques and colleagues364 © 2015 Marques et al. This is an Open Access article distributed under the
terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated; and from
Wylde and colleagues365 © 2011 Wylde et al; licensee BioMed Central Ltd. This is an Open Access article
distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. In addition, some parts of this chapter have been reproduced from
Marques and colleagues366 © 2014 Marques et al.; licensee BioMed Central Ltd. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated; from Wylde and colleagues367 © 2015 International Association for the
Study of Pain. This is an open-access article distributed under the terms of the Creative Commons
Attribution-NonCommercial-NoDerivatives 3.0 Licence; and from Mann C, Delgado D, Horwood J,
Evaluation of internal peer-review to train nurses recruiting to a randomized controlled trial – Internal
Peer-review for Recruitment Training in Trials (InterPReTiT), J Adv Nurs 2014, vol. 70, pp. 777– 90,
with permission from John Wiley & Sons Ltd. © 2013 John Wiley & Sons Ltd.368
Abstract
Background
We evaluated the clinical effectiveness and cost-effectiveness of perioperative local anaesthetic infiltration
on long-term pain after joint replacement. We also studied the experience of trial involvement for
health-care professionals and patients.
Methods
In the APEX RCTs, 322 patients receiving total hip and 316 patients receiving TKR were randomised to
local anaesthetic infiltration or standard anaesthesia. All patients with TKR received a femoral nerve block
(FNB). We also appraised existing research in a systematic review and conducted qualitative interviews with
24 patients and 15 health-care professionals about involvement in the APEX trials.
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Results
In the APEX RCTs, local anaesthetic infiltration was associated with reduced pain 1 year after THR.
In patients receiving TKR, there was no strong evidence that local anaesthetic infiltration reduced pain
additional to that provided by FNB. From the NHS and PSS perspective, local anaesthetic infiltration is a
cost-effective treatment option in THR.
Systematic review identified 36 RCTs. Local anaesthetic infiltration was effective in reducing short-term
pain, particularly with addition of post-closure analgesia. In TKR, there was no evidence of benefit
additional to a FNB.
Patients and health-care professionals recognised the importance of participating in RCTs.
Conclusions
Patients with THR should receive local anaesthetic infiltration, which is a cost-effective treatment option for
the management of long-term pain. For patients receiving TKR, it may not provide additional benefit
to FNB.
Background
Many patients undergoing total hip or knee replacement experience significant pain while in hospital.70 In
addition to the obvious benefits of reducing patient suffering and distress, good perioperative pain control
has the added advantage of allowing early mobilisation and rehabilitation.67 This minimises risks of
complications such as deep-vein thrombosis, pulmonary embolus, muscle and joint contractures, physical
deconditioning and chest infection. Early mobilisation allows early discharge, with short-term inpatient
cost-savings for the NHS. Unfortunately, many of the traditional methods of achieving perioperative pain
relief, such as spinal or epidural anaesthetics and the use of opioids, can preclude early mobilisation.71,72
In diverse surgeries there is also evidence that increased levels of perioperative pain are associated with
long-term pain, for example after breast surgery,369 inguinal hernia repair370 and thoracic surgery.371 Large
amounts of noxious input induced by surgery may contribute to the transition from acute to chronic pain
through hyperexcitability and sensitisation of neurones within the central nervous system, leading to
long-lasting amplification of pain signalling within the spinal cord.66
Perioperative pain is managed with multimodal pain control strategies, with analgesics relieving pain with
additive or synergistic effects.372 Incorporation of high-volume local anaesthetic infiltration into the
multimodal regimen has been used during different surgical procedures. In a systematic review of local
anaesthetic infusion into wounds at the end of surgical procedures, Liu and colleagues373 identified studies
dating from as early as 1983. The authors concluded that local anaesthetic infusion can improve analgesia,
reduce opioid use and side effects, increase patient satisfaction and lead to reduced hospital stay.
However, only one study included patients with TKR or THR.374 Subsequently, more evaluations of local
anaesthetic infiltration in joint replacement have been reported.365
Aims
Our aims were to:
l synthesise evidence from RCTs using systematic review and meta-analysis on the effectiveness of
perioperative local anaesthetic infiltration for pain control in total hip and knee replacement
l assess, in RCTs, the clinical effectiveness of local anaesthetic infiltration administered before wound
closure as part of the multimodal regimen on the short- and long-term severity of joint pain after total
hip or knee replacement
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NIHR Journals Library www.journalslibrary.nihr.ac.uk
148
l conduct an economic evaluation to determine the cost-effectiveness of local anaesthetic infiltration
from a NHS and PSS perspective
l identify and address training needs of nurses involved in patient recruitment to RCTs using embedded
qualitative methods
l explore, using qualitative methods, the experience of trial participation and surgery among patients and
of trial involvement by health-care professionals.
Systematic review and meta-analysis of the effectiveness of
perioperative local anaesthetic infiltration in total hip and
knee replacement
Using systematic review methods and meta-analysis, our objective was to synthesise evidence from RCTs
evaluating the effectiveness of perioperative local anaesthetic infiltration in reducing short- and long-term
pain after hip and knee replacement. Secondary outcomes relate to opioid requirement, mobilisation and
hospital stay.
Methods
General methods As described in Chapter 2, Systematic review methods
Databases and dates MEDLINE, EMBASE and The Cochrane Library from inception to 11 December 2012. Citations of
key articles in ISI Web of Science and reference lists
Search strategy Hip or knee replacement/RCTs/anaesthesia and analgesia. MEDLINE search strategy based on terms
in Appendix 3
Study design RCTs
Patients Adults receiving primary total hip or knee replacement
Intervention Local anaesthetic infiltration before wound closure. In addition, studies with intervention patients
receiving additional delivery of analgesics through catheters and injections after wound closure.
We excluded studies with interventions applied exclusively after wound closure
Controls Patients receiving no local anaesthetic infiltration or placebo, or alternative analgesia regimens
Follow-up Any time post operation
Data extraction Country, baseline dates, participants (indication, age, sex), inclusion criteria, anaesthesia procedures
common to randomised groups, intervention (including content of infiltrate, timing and volume),
additional intervention group treatments, and control group treatment including placebo and
alternative analgesia regimens
Outcomes Pain at rest or during activity during hospital admission (24 and 48 hours after surgery); opioid
consumption; mobilisation; length of hospital stay; and long-term pain and function. Complications
were recorded and classified as serious (altered state of consciousness, atrial fibrillation, cardiac and
hemodynamic changes requiring treatment, cardiac toxicity, central nervous system toxicity,
dysarthria, dyspnoea, major surgical complications, pneumonia, pulmonary embolism, respiratory
depression, seizures, swollen knee) or relating to deep infection. Vomiting and nausea
Quality assessment Cochrane risk of bias: blind outcome assessment and losses to follow-up
Statistical analyses
We conducted meta-analyses for pain at rest and during activity at 24 and 48 hours, length of hospital
stay and complications. Follow-up times were approximated to the closest timing. When not specified, we
assumed measurements were taken at rest. Analyses were carried out in Stata 12 and RevMan 5. Results
are reported with 95% CIs and funnel plots were inspected to assess for small study effects.375 Given the
number of potential effect modifiers, we used random-effects models for all meta-analyses.
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In meta-analysis, means and SD values of continuous variables, such as pain intensity, are required for
intervention and control groups. Pain outcomes are sometimes reported as medians and IQRs owing to the
recognised floor and ceiling effects of pain measures after successful pain management. This is less of an
issue during early recovery. Kerr and Kohan376 presented distributions of pain intensity scores at rest and
while walking on the first and second day after total hip or knee replacement. The proportion of people
reporting no pain and, thus, reflecting a floor effect, ranged from 2% to 35% on days 1 and 2, and pain
intensities showed near normal distributions.
When no measures of variance were reported, we contacted authors to obtain SDs. If necessary we
estimated means and SDs from medians and IQRs96 from ranges using the method of Walter and Yao,377
or imputed values from the average per arm across studies.
As pain scores are reported on different scales we used the SMD as our measure of treatment effect in
meta-analyses.378 To help in the interpretation of these pooled estimates, we multiplied SMD values by the
mean SD on the widely reported 100-point VAS scale for the outcome. As the use of this method is
entirely dependent on the chosen ‘typical’ value,379 we used a mean SD calculated from control groups of
all studies reporting the outcome.96
For length of hospital stay, we compared means and medians in studies reporting both and examined
individual-level data provided by some authors.380,381 Distributions were right-skewed and followed a
log-normal distribution. Some studies reported means and SDs directly. For studies that reported medians
and IQRs, or ranges, we estimated means and SDs on the log scale and then back-transformed them to
the natural (unlogged) scale.382
Complications were compared between randomised groups using meta-analysis with summary statistics
calculated as the Peto’s OR, the method of choice when event rates are low.96,383
Analgesia regimen comparisons
Not all studies compared a local anaesthetic infiltration intervention with no intervention or placebo.
Thus meta-analyses are reported separately for different regimen comparisons. These are summarised in
Figure 20. Studies in patients with THR include comparisons A and B only. We report the combined
comparison of groups (A+ B) and further report A and B results separately. For studies in patients with
TKR, we also report results from a combined meta-analysis across the first two subgroups (A+ B),
comparing local anaesthetic infiltration with or without further post-closure intervention against control.
We further report all comparisons from A to E separately. Although we considered epidural analgesia as
‘usual care’ and, thus, included studies fort which this was used in comparisons A–E, we provide a
summary of results.
Heterogeneity and subgroup analyses
Heterogeneity within meta-analyses was studied using tau-squared and I2-statistics.384 Sensitivity and
subgroup analyses explored risk of bias in the study, use of additional analgesia delivered through a
catheter or injection and inclusion of non-steroidal inflammatory agents or steroids in the infiltrate.
We used meta-regression to quantify the differences in treatment effects between groups A and B.
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Intervention Comparator (control)
Additional post-closure 
analgesia delivered through
a catheter or as an injection
Local anaesthetic infiltration
Local anaesthetic infiltrationB
No wound infiltration/placebo
Additional post-closure 
analgesia delivered through
a catheter or as an injection
Local anaesthetic infiltrationD
FNB
FNB
Local anaesthetic infiltrationE
FNB
A No wound infiltration/placebo
Local anaesthetic infiltrationF Epidural/other
Local anaesthetic infiltrationC FNB
FIGURE 20 Systematic review of the effectiveness of perioperative local anaesthetic infiltration in total hip and
knee replacement: possible anaesthesia regimens.
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Results
The review process is summarised in Figure 21. Searches identified 839 articles, of which 33 described 36
RCTs evaluating local anaesthetic infiltration in total hip or knee replacement. Characteristics of included
studies are shown in Table 35 and a risk-of-bias assessment in Appendix 9. Thirteen studies were in
patients undergoing THR385–396 or included a large majority of THR patients.374 Twenty-three studies were
in patients undergoing TKR.380,381,386,397–414
Small study effects
Inspection of funnel plots for each meta-analysis gave no strong indication of publication bias or small
study effects, but numbers of studies in individual analysis groups were small, such that assessment of
asymmetry was difficult.
Total hip replacement
In 13 studies with 909 patients identified by searches, the mean number of patients with THR randomised
was 70 (range 37–120). We assessed that 10 studies were at low risk of bias while three studies had
unclear risk of bias owing to uncertainty about blinding of outcome assessments.
Results of the meta-analysis are summarised in Table 36.
Records identified through database 
searching and reference lists
(n = 839)
Full-text articles for eligibility
(n = 201)
Studies included
(n = 33)
Randomised comparisons
(n = 36)
Full-text articles excluded
(n = 168)
• Not empirical study, n = 71
• Not RCT, n = 37
• Protocol only, n = 1
• Steroid infiltration, n = 5
• Post-wound closure, n = 23
• Magnesium sulphate only, n = 1
• Bilateral studies, n = 13
• Conference abstract only, n = 12
• Unable to obtain, n = 1
• Additional report, n = 3
• Retraction, n = 1
Records excluded
(n = 638)
• Not primary hip or knee arthoplasty, n = 362
• Not local anaesthetic wound infiltration
   intervention, n = 276
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FIGURE 21 Systematic review of the effectiveness of perioperative local anaesthetic infiltration in total hip and
knee replacement: flow diagram.
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Pain
Data for meta-analysis were available for up to 12 studies depending on follow-up.374,385–388,390–396 Overall,
as shown in Table 36 and Figures 22 and 23, there was a reduction in pain at 24 and 48 hours at both
rest and activity. For example, at rest at 24 hours, the average SMD favouring local anaesthetic infiltration
was –0.61 (95% CI –1.05 to –0.16; p= 0.008) and during activity at 48 hours was –0.85 (95% CI –1.45 to
–0.25; p= 0.006). This reflected reduced pain at 24 hours at rest by an estimated 12 points (95% CI 3 to
21 points p= 0.008) and during activity by 24 points (95% CI 7 to 42 points; p= 0.006) on a 100-point
scale. Average effect sizes at 48 hours were smaller for pain at rest (SMD –0.29, 95% CI –0.52 to –0.05;
p= 0.018) and during activity, (SMD –0.43, 95% CI –0.78 to –0.09; p= 0.014), corresponding to 5 and
10 points on a 100-point scale, respectively.
In seven studies, the comparison was between patients receiving local anaesthetic infiltration with
no additional analgesia delivered through a catheter or injection (A group), and controls receiving no
intervention or saline infiltration.386,390–395 At rest at 24 hours, the local anaesthetic infiltration group reported
reduced pain (average SMD –0.63, 95% CI –1.21 to –0.06; p= 0.031), equivalent to an estimated 12 points
lower pain. There was no strong evidence that the intervention had an effect during activity or at 48 hours.
TABLE 36 Systematic review of the effectiveness of perioperative local anaesthetic infiltration in THR: meta-analyses
THR studies n Method
Pooled effect size
(random effects) 95% CI p-value I2 (%) τ2
(A +B) any local anaesthetic infiltration +usual anaesthesia vs. usual anaesthesia
Pain at rest at 24 hours 12 SMD –0.605 –1.051 to –0.160 0.0078 89 0.541
Pain during activity at 24 hours 9 SMD –0.848 –1.450 to –0.246 0.0058 92 0.765
Pain at rest at 48 hours 11 SMD –0.285 –0.520 to –0.050 0.018 58 0.09
Pain during activity at 48 hours 8 SMD –0.432 –0.776 to –0.089 0.014 71 0.171
Length of hospital stay 9 WMD –0.829 –1.540 to –0.118 0.022 84 0.866
(A) local anaesthetic infiltration +usual analgesia vs. usual anaesthesia
Pain at rest 24 hours post
operation
7 SMD –0.633 –1.208 to –0.059 0.031 90 0.529
Pain during activity 24 hours
post operation
4 SMD –0.241 –0.637 to 0.155 0.23 68 0.11
Pain at rest 48 hours post
operation
6 SMD –0.134 –0.348 to 0.080 0.22 19 0.014
Pain during activity 48 hours
post operation
3 SMD –0.225 –0.559 to 0.109 0.19 35 0.03
Length of hospital stay 5 WMD –0.257 –0.622 to 0.108 0.17 14 0.029
(B) local anaesthetic infiltration +post-closure analgesia +usual anaesthesia vs. usual anaesthesia
Pain at rest 24 hours post
operation
5 SMD –0.572 –1.383 to 0.240 0.17 90 0.767
Pain during activity 24 hours
post operation
5 SMD –1.378 –2.499 to –0.257 0.016 94 1.525
Pain at rest 48 hours post
operation
5 SMD –0.489 –0.963 to –0.015 0.043 73 0.209
Pain during activity 48 hours
post operation
5 SMD –0.599 –1.158 to –0.040 0.036 80 0.319
Length of hospital stay 4 WMD –1.117 –2.474 to 0.239 0.11 88 1.621
WMD, weighted mean difference.
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Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Parvataneni hip 2007386
Lee 2009391
Lu 2010393
Liu 2011392
Lunn 2011394
Dobie 2012390
Murphy 2012395
Subtotal (I2 = 90.2%; p = 0.000)
VAS 0–10
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS mm
VAS 0–10
VAS 0–100
VAS 0–100
WOMAC pain 0–100
VAS 0–100
NRS 0–10
35
30
20
40
59
50
39
18
38
19
36
29
36
30
20
40
60
45
39
19
37
18
36
28
Yes
Yes
No
Yes
No
No
No
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Bianconi 2003374
Andersen KV 2007385
Andersen LJ 2007388
Aguirre 2012387
Rikalainen-Salmi 2012396
Subtotal (I2 = 90.3%; p = 0.000)
Overall (I2 = 89.3%; p = 0.000)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
–0.54 (–1.02 to –0.07)
–0.87 (–1.40 to –0.34)
–3.07 (–4.02 to –2.13)
–0.73 (–1.19 to –0.28)
0.46 (0.10 to 0.82)
–0.36 (–0.76 to 0.05)
0.06 (–0.38 to 0.51)
–0.63 (–1.21 to –0.06)
–0.96 (–1.65 to –0.28)
0.65 (0.19 to 1.12)
–1.63 (–2.39 to –0.88)
–1.04 (–1.54 to –0.55)
0.00 (–0.52 to 0.52)
–0.57 (–1.38 to 0.24)
–0.61 (–1.05 to –0.16)
SMD (95% CI)
–2 –1 0
Local anaesthetic
infiltration reduces pain
Local anaesthetic 
infiltration increases pain
1
(a)
Study
(b)
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Parvataneni hip 2007386
Busch 2010389
Liu 2011392
Lunn 2011394
Subtotal (I2 = 67.8%; p = 0.025)
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
WOMAC pain 0–100
VAS 0–100
NRS 0–10
35
32
40
49
18
38
19
36
29
36
32
40
53
19
37
18
36
28
Yes
No
Yes
No
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Bianconi 2003374
Andersen KV 2007385
Andersen LJ 2007388
Aguirre 2012387
Rikalainen-Salmi 2012396
Subtotal (I2 = 93.9%; p = 0.000)
Overall (I2 = 91.6%; p = 0.000)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
–0.86 (–1.35 to –0.37)
0.16 (–0.33 to 0.65)
–0.19 (–0.63 to 0.25)
–0.09 (–0.48 to 0.29)
–0.24 (–0.64 to 0.15)
–1.89 (–2.68 to –1.10)
0.24 (–0.21 to 0.70)
–1.63 (–2.39 to –0.88)
–2.83 (–3.49 to –2.17)
–0.88 (–1.42 to –0.33)
–1.38 (–2.50 to –0.26)
–0.85 (–1.45 to –0.25)
SMD (95% CI)
–2 –1 0
Local anaesthetic infiltration
 reduces pain
Local anaesthetic 
infiltration increases pain
1
FIGURE 22 Total hip replacement: 24-hour VAS pain score at rest and during activity by local anaesthetic
infiltration grouping. SMD in pain at 24 hours post surgery. Nc, number in the control group; Ni, number in the
intervention group. (a) Pain at rest; and (b) pain during activity.
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Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Parvataneni hip 2007386
Lee 2009391
Lu 2010393
Liu 2011392
Dobie 2012390
Murphy 2012395
Subtotal (I2 = 19.1%; p = 0.289)
VAS 0–10
VAS 0–10
VAS 0–100
VAS 0–100
VAS mm
VAS 0–10
VAS 0–100
VAS 0–100
WOMAC pain 0–100
NRS 0–10
VAS 0–100
35
30
20
40
50
39
18
38
19
29
36
36
30
20
40
45
39
19
37
18
28
36
Yes
Yes
No
Yes
No
No
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Bianconi 2003374
Andersen KV 2007385
Andersen LJ 2007388
Rikalainen-Salmi 2012396
Aguirre 2013387
Subtotal (I2 = 72.8%; p = 0.005)
Overall (I2 = 58.1%; p = 0.008)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
–0.35 (–0.82 to 0.12)
–0.40 (–0.91 to 0.11)
–0.54 (–1.17 to 0.10)
0.00 (–0.44 to 0.44)
0.16 (–0.24 to 0.56)
0.01 (–0.43 to 0.46)
–0.13 (–0.35 to 0.03)
–0.65 (–1.31 to 0.01)
–0.54 (–1.00 to –0.08)
–1.51 (–2.25 to –0.77)
0.00 (–0.52 to 0.52)
0.00 (–0.46 to 0.46)
–0.49 (–0.96 to –0.01)
–0.29 (–0.52 to –0.05)
SMD (95% CI)
–2 –1–3 0
Local anaesthetic infiltration
reduces pain
Local anaesthetic 
infiltration increases pain
1
(a)
Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Parvataneni hip 2007386
Busch 2010389
Liu 2011392
Subtotal (I2 = 34.7%; p = 0.216)
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
WOMAC pain 0–100
VAS 0–100
NRS 0–10
35
32
40
18
38
19
36
29
36
32
40
19
37
18
36
28
Yes
No
Yes
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Bianconi 2003374
Andersen KV 2007385
Andersen LJ 2007388
Aguirre 2012387
Rikalainen-Salmi 2012396
Subtotal (I2 = 80.0%; p = 0.001)
Overall (I2 = 71.3%; p = 0.001)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
–0.56 (–1.04 to –0.09)
–0.13 (–0.63 to 0.36)
0.00 (–0.44 to 0.44)
–0.22 (–0.56 to 0.11)
–1.31 (–2.03 to –0.60)
–0.44 (–0.90 to 0.02)
–1.51 (–2.25 to –0.77)
0.00 (–0.46 to 0.46)
0.00 (–0.52 to 0.52)
–0.60 (–1.16 to –0.04)
–0.43 (–0.78 to –0.09)
SMD (95% CI)
–2 –1–3 0
Local anaesthetic infiltration
 reduces pain
Local anaesthetic 
infiltration increases pain
1
(b)
FIGURE 23 Total hip replacement: 48-hour VAS pain score at rest and during activity by local anaesthetic
infiltration grouping. SMD in pain at 48 hours post surgery. Nc, number in the control group; Ni, number in the
intervention group. (a) Pain at rest; and (b) pain during activity.
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In five studies, the intervention group received local anaesthetic infiltration and further analgesia through a
catheter or injection after wound closure (B group).374,385,387,388,396 Pain was reduced on average at 24 hours
during activity (SMD –1.38, 95% CI –2.5 to –0.26; p= 0.016), equivalent to a 40-point decrease, and at
48 hours at rest (SMD –0.49, 95% CI –0.96 to –0.02; p= 0.043) and during activity (SMD –0.6, 95% CI
–1.16 to –0.04; p= 0.036) equivalent to 8- and 14-point decreases, respectively.
In one study, control patients received an epidural analgesia infusion.385 Pain was lower for the duration of
the epidural infusion but, at 48 hours, pain was higher in the control group than in the local anaesthetic
infiltration group. In a study in which control patients received additional intrathecal morphine, there was
no difference in pain outcomes at any time point.396
Heterogeneity as expressed by the between-study variance (τ2) and the I2-statistic (see Table 36) was high
and separate analysis for A and B groups did not appear to reduce this heterogeneity.
Considering nine studies with low risk of bias, the benefit for any local anaesthetic infiltration was still
apparent.374,386–388,390,392,394–396 Studies with low risk of bias had a marginally smaller reduction in pain after
24 hours at rest, averaging (SMD –0.49, 95% CI –0.89 to –0.09; p= 0.017), but during activity average
pain reduction was greater (SMD –0.99, 95% CI –1.64 to –0.35; p= 0.003), corresponding to 28 points
on a 100-point scale.
Opioid consumption
In 11 studies reporting an appropriate outcome, opioid consumption was reduced in local anaesthetic
infiltration groups compared with controls.374,385,387–390,392–396 The difference ranged from 12% to 92%.
There was no suggestion of different effects in groups with or without additional post-closure
analgesia through a catheter or injection. In the studies in which control patients received epidural385 or
intrathecal analgesia,396 patients receiving local anaesthetic infiltration consumed 20% and 12% less
morphine, respectively.
Mobilisation
Several different measures of mobilisation were reported. In three studies, patients receiving local
anaesthetic infiltration with no additional postoperative component achieved a straight leg raise earlier
than control patients.386,391,392
More patients were able to walk during the first postoperative day in two studies in which further
postoperative analgesia was provided through a catheter.385,396 In one study with no additional analgesia,
with the exception of those with adverse events, all patients were mobilised on the first postoperative
day.390 However, the mean walking speed over 6 metres was improved in intervention patients at a 2-day
functional assessment.
In one study, 35% of patients receiving local anaesthetic infiltration were able to walk after 8 hours,
compared with 87% of control patients receiving an epidural infusion.385 In the study for which control
patients received intrathecal morphine, 33% of these patients could walk further than 5 metres on the first
postoperative day, compared with 71% of patients receiving local anaesthetic infiltration.396
Length of hospital stay
As shown in Table 36 and Figure 24, patients receiving local anaesthetic infiltration spent an average of
0.83 fewer days (95% CI 0.12 to 1.54 fewer days; p= 0.022) in hospital than control patients. Benefit
was mainly limited to local anaesthetic infiltration interventions with additional analgesia through a
catheter (B group). Heterogeneity across studies was high (I2= 84%), mainly in studies with additional
postoperative analgesia.
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When the comparison group received an epidural infusion, patients with local anaesthetic infiltration had
on average a 2-day shorter hospital stay. In the study in which the comparison group received intrathecal
morphine, there was no clear difference in discharge times.
Complications
The Peto’s OR for a major complication in patients with local anaesthetic infiltration compared with
controls was 0.30 (95% CI 0.05 to 1.77; p= 0.18). This was based on only one major complication in
448 patients randomised to local anaesthetic infiltration and four major complications in 448 controls.
Across all studies with 909 patients, five deep infections were reported, four in local anaesthetic infiltration
patients and one in controls (Peto’s OR 3.47, 95% CI 0.58 to 20.81; p= 0.17). Four infections occurred in
the 218 patients who received post-closure delivery of infiltrate through a catheter.
The incidence of vomiting (or vomiting and nausea if not reported separately) was reduced in patients
receiving local anaesthetic infiltration in the five studies with data, (Peto’s OR 0.46, 95% CI 0.27 to 0.80;
p= 0.006). There was only slight heterogeneity between studies.
Long-term outcomes
Five studies reported long-term outcomes. In the study of Andersen and colleagues,388 the median
WOMAC pain scores at 6 weeks in intervention and control groups were 2 (range 0–50) and 7 (range
0–13), but this difference favouring intervention was not statistically significant (p= 0.07). At the 8-week
follow-up, Rikalainen-Salmi and colleagues396 reported no significant differences in mobilisation or intensity
or duration of pain. Parvataneni and colleagues386 reported that VAS pain scores 3 months after surgery
were ‘comparable between groups’. Similarly Aguirre and colleagues387 reported no difference in analgesic
consumption or pain during normal daily activities between groups at 3 months. In the study of Busch
and colleagues,389 mean overall WOMAC scores at 2 years were more favourable in the intervention group
(69.3, SD 23.5) than in the control group (76.6, SD 25.9) but this was not statistically significant (p= 0.24).
Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Parvataneni hip 2007386
Lee 2009391
Busch 2010389
Lunn 2011394
Dobie 2012390
Subtotal (I2 = 14.0%; p = 0.325)
35
30
32
60
50
18
38
19
29
36
30
32
60
45
19
37
18
28
Yes
No
No
No
No
No
No
Yes
No
–1.00 (–2.27 to 0.27)
–1.80 (–4.91 to 1.31)
–0.55 (–1.45 to 0.35)
0.00 (–0.35 to 0.35)
–0.40 (–1.16 to 0.36)
–0.26 (–0.62 to 0.11)
–2.45 (–3.15 to –1.75)
1.98 (–2.97 to –0.99)
0.58 (–1.18 to 2.35)
–0.21 (–0.91 to 0.50)
–1.12 (–2.47 to 0.24)
–0.83 (–1.54 to –0.12)
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Bianconi 2003374
Andersen KV 2007385
Andersen LJ 2007388
Rikalainen-Salmi 2012396
Subtotal (I2 = 88.4%; p = 0.000)
Overall (I2 = 84.0%; p = 0.000)
Note: weights are from random-effects analysis
Ni Nc SD imputed SMD (95% CI)
–2 –1 0
Local anaesthetic infiltration
 reduces LoS
Local anaesthetic infiltration 
increases LoS 
1 2
FIGURE 24 Total hip replacement: length of hospital stay by local anaesthetic infiltration grouping. Weighted
mean difference in days. LoS, length of hospital stay. Nc, number in the control group; Ni, number in the
intervention group.
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Total knee replacement
Searches identified 23 studies with 1439 patients with TKR randomised. The mean number of patients
randomised was 63 (range 32–101). We assessed that 17 studies were at low risk of bias386,399–409,411–413
and that five studies had unclear risk of bias based on uncertainty about blinding of outcome
assessments.380,397,398,410,414 One study was assessed to be at high risk of bias owing to a large uneven loss
to follow-up between randomised groups.381
Results of the meta-analysis are summarised in Table 37.
Pain
In patients receiving patients receiving local anaesthetic infiltration (A and B groups), pain at rest at
24 hours and during activity at 48 hours was reduced by SMD –0.40 (95% CI –0.58 to –0.22; p< 0.001)
and –0.27 (95% CI –0.50 to –0.05; p= 0.018), respectively. This reflected reductions in pain at rest at
24 hours by an average of 10 points (95% CI 6 to 15 points; p< 0.001) and during activity at 48 hours by
8 points (95% CI 1.5 to 15 points; p= 0.018) on a 100-point scale.
TABLE 37 Systematic review of the effectiveness of perioperative local anaesthetic infiltration in TKR:
meta-analyses
TKR studies
Number of
studies Method
Pooled effect size
(random effects) 95% CI p-value I2 (%) τ2
(A +B) any local anaesthetic infiltration +usual anaesthesia vs. usual anaesthesia
Pain at rest at 24 hours 12 SMD –0.398 –0.576 to –0.219 < 0.001 32 0.032
Pain during activity at
24 hours
12 SMD –0.453 –0.671 to –0.235 < 0.001 54 0.078
Pain at rest at 48 hours 12 SMD –0.325 –0.546 to –0.103 0.0041 56 0.084
Pain during activity at
48 hours
11 SMD –0.273 –0.500 to –0.046 0.018 56 0.081
Length of hospital stay 8 WMD –0.866 –1.622 to –0.109 0.025 77 0.805
(A) local anaesthetic infiltration with no additional post-wound closure analgesia +usual anaesthesia vs. usual
anaesthesia
Pain at rest 24 hours post
operation
6 SMD –0.248 –0.452 to –0.044 0.017 14 0.009
Pain during activity 24 hours
post operation
6 SMD –0.283 –0.470 to –0.096 0.0031 0 0
Pain at rest 48 hours post
operation
6 SMD –0.155 –0.458 to 0.148 0.32 61 0.086
Pain during activity 48 hours
post operation
6 SMD –0.077 –0.263 to 0.110 0.42 0 0
Length of hospital stay 1 WMD 0.092 –0.890 to 1.073 0.85 100 < 0.001
(B) local anaesthetic infiltration +post-wound closure analgesia +usual anaesthesia vs. usual anaesthesia
Pain at rest 24 hours post
operation
6 SMD –0.587 –0.829 to –0.346 < 0.001 9 0.008
Pain during activity 24 hours
post operation
6 SMD –0.693 –1.152 to –0.234 0.0031 74 0.24
Pain at rest 48 hours post
operation
6 SMD –0.52 –0.778 to –0.262 < 0.001 21 0.022
Pain during activity 48 hours
post operation
5 SMD –0.594 –0.997 to –0.191 0.0039 61 0.128
Length of hospital stay 7 WMD –1.023 –1.822 to –0.224 0.012 76 0.761
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Heterogeneity as expressed by the between-study variance (τ2) and the I2-statistic was moderate to low.
Among studies with low risk of bias, heterogeneity reported was higher, possibly owing to variability
across comparators and surgical characteristics.
Data were available for up to six trials comparing local anaesthetic infiltration with no additional
post-closure analgesia (A group), with controls receiving no intervention or saline infiltration.401,404–406,414
As shown in Table 37 and Figure 25, pain at 24 hours was reduced both at rest and during activity [SMDs
–0.25 (95% CI –0.45 to –0.04; p= 0.017) and –0.28 (95% CI –0.47 to –0.10; p= 0.003), respectively].
In six trials where additional analgesia was delivered through a catheter or as an injection after wound
closure (B group),398,402,403,412,413 reduction in pain at 24 hours was somewhat greater than controls at
both rest and activity [SMDs –0.59 (95% CI –0.83 to –0.35; p< 0.001) and –0.69 (95% CI –1.15 to
–0.23; p= 0.003)].
TABLE 37 Systematic review of the effectiveness of perioperative local anaesthetic infiltration in TKR:
meta-analyses (continued )
TKR studies
Number of
studies Method
Pooled effect size
(random effects) 95% CI p-value I2 (%) τ2
(C) local anaesthetic infiltration + FNB +usual anaesthesia vs. FNB +usual anaesthesia
Pain at rest 24 hours post
operation
3 SMD 0.253 –0.514 to 1.021 0.52 81 0.37
Pain during activity 24 hours
post operation
3 SMD 0 –0.317 to 0.317 1 0 0
Pain at rest 48 hours post
operation
2 SMD 0.254 –0.429 to 0.937 0.47 67 0.166
Pain during activity 48 hours
post operation
2 SMD –0.073 –0.446 to 0.299 0.7 0 0
Length of hospital stay 2 WMD 0.07 –0.838 to 0.978 0.88 0 0
(D) local anaesthetic infiltration +usual anaesthesia vs. FNB +usual anaesthesia
Pain at rest 24 hours post
operation
3 SMD –0.241 –0.604 to 0.122 0.19 44 0.046
Pain during activity 24 hours
post operation
0
Pain at rest 48 hours post
operation
1 SMD –0.18 –0.571 to 0.211 0.37 100 0
Pain during activity 48 hours
post operation
1 SMD 0.094 –0.296 to 0.485 0.64 100 0
Length of hospital stay 1 WMD 1.52 0.054 to 2.986 0.042 100 0
(E) local anaesthetic infiltration +post-wound closure analgesia +usual anaesthesia vs. FNB +usual anaesthesia
Pain at rest 24 hours post
operation
3 SMD –0.076 –0.632 to 0.480 0.79 69 0.166
Pain during activity 24 hours
post operation
3 SMD 0.159 –0.869 to 1.187 0.76 90 0.741
Pain at rest 48 hours post
operation
2 SMD 0.056 –0.300 to 0.412 0.76 0 0
Pain during activity 48 hours
post operation
2 SMD –0.202 –1.034 to 0.631 0.63 75 0.275
Length of hospital stay 2 WMD –0.069 –0.634 to 0.497 0.81 0 0
WMD, weighted mean difference.
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Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Han (additional morphine) 2007406
Han (no additional morphine) 2007406
Zhang 2007414
Fu 2009404
Fu 2010405
Chen 2012401
Subtotal (I2 = 14.3%; p = 0.323)
VAS 0–10
VAS 0–10
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
30
30
30
40
50
40
22
21
24
33
33
25
30
30
30
40
50
40
20
19
23
33
33
23
No
No
No
Yes
Yes
Yes
No
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Vendittoli 2006413
Andersen KV 2010398
Essving 2010402
Spreng no i.v. 2010412
Spreng with i.v. 2010412
Essving 2011403
Subtotal (I2 = 9.1%; p = 0.358)
Overall (I2 = 58.9%; p = 0.000)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
0.20 (–0.30 to 0.71)
–0.15 (–0.65 to 0.36)
–0.56 (–1.07 to –0.04)
–0.23 (–0.67 to 0.21)
–0.23 (–0.62 to 0.17)
–0.50 (–0.94 to –0.05)
–0.25 (–0.45 to –0.04)
–0.40 (–1.01 to 0.21)
–1.07 (–1.74 to –0.41)
–0.94 (–1.54 to –0.33)
–0.59 (–1.09 to –0.10)
–0.26 (–0.74 to 0.22)
–0.51 (–1.08 to 0.07)
–0.59 (–0.83 to –0.35)
NRS 0–10
NRS 0–10
VAS (NRS) 0–10
38
20
20
35
20
20
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. FNB + usual anaesthetics
Toftdahl 2007380
Carli 2010400
Affas 2011397
Subtotal (I2 = 80.9%; p = 0.005)
0.00 (–0.46 to 0.46)
1.12 (0.45 to 1.79)
–0.31 (–0.93 to 0.32)
0.25 (–0.51 to 1.02)
NRS 0–10
VAS 0–10
VAS 0–10
35
49
26
32
52
26
No
No
No
Local anaesthetic infiltration + FNB + usual anaesthetics vs. FNB + usual anaesthetics
Krenzel 2009408
Koh 2012407
Mahadevan 2012410
Subtotal (I2 = 44.2%; p = 0.167)
–0.37 (–0.86 to 0.11)
–0.44 (–0.83 to –0.04)
0.19 (–0.36 to 0.73)
–0.24 (–0.60 to 0.12)
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FIGURE 25 Total knee replacement: 24-hour VAS pain score at rest and during activity by local anaesthetic infiltration
grouping. SMD in pain at 24 hours post surgery. i.v., intravenous; Nc, number in the control group; Ni, number in the
intervention group; NRS, numerical response scale. (a) Pain at rest; and (b) pain during activity. (continued )
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As shown in Figure 26, improvement in pain relief was sustained at 48 hours, but only if additional
analgesia was provided postoperatively (B group), (SMD –0.52, 95% CI –0.78 to –0.26; p< 0.001) at rest
and during activity (SMD –0.59, 95% CI –1.0 to –0.19; p= 0.004).
Heterogeneity as expressed by the between-study variance (τ2) and the I2-statistic was moderate to low.
Nine studies in TKR included a FNB analgesia regimen.380,386,397,400,402,407–410 In three studies for which both
randomised groups received a FNB (E),407–409 there was no evidence for added benefit of local anaesthetic
infiltration in any outcome. In the six studies of a direct comparison of local anaesthetic infiltration with or
without post-closure analgesia with a FNB in addition to usual analgesia (C and D),380,386,397,400,410,411 there
was also no evidence of improved pain at any time point.
In eight comparisons between local anaesthetic infiltration with controls,381,398,399,402,403,412,413 additional
ketorolac was included in the wound infiltrate. In seven comparisons with data, patients receiving
additional analgesia in the infiltrate had lower pain than controls.398,399,402,403,412,413 For example, pain was
reduced on average at rest at 24 hours by SMD –0.68 (95% CI –0.94 to –0.42; p< 0.001) and during
activity at 48 hours by SMD –0.59 (95% CI –1.01 to –0.17; p= 0.006), equivalent to a reduction of 17 and
30 points, respectively, on a 100-point scale compared with controls.
Study
Local anaesthetic infiltration + usual anaesthetics vs. usual anaesthetics
Busch 2006399
Han (additional morphine) 2007406
Han (no additional morphine) 2007406
Fu 2009404
Fu 2010405
Chen 2012401
Subtotal (I2 = 0.0%; p = 0.972)
VAS 0–100
VAS 0–10
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–10
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
VAS 0–100
32
30
30
40
50
40
22
21
24
33
33
25
32
30
30
40
50
40
20
19
23
33
33
23
Yes
No
No
Yes
Yes
Yes
Yes
No
No
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. usual anaesthetics
Vendittoli 2006413
Andersen KV 2010398
Essving 2010402
Spreng no i.v. 2010412
Spreng with i.v. 2010412
Essving 2011403
Subtotal (I2 = 73.7%; p = 0.002)
Overall (I2 = 70.4%; p = 0.000)
Note: weights are from random-effects analysis
Pain scale Ni Nc SD imputed
–0.28 (–0.77 to 0.21)
–0.27 (–0.78 to 0.24)
–0.43 (–0.94 to 0.08)
–0.18 (–0.61 to 0.26)
–0.21 (–0.60 to 0.18)
–0.39 (–0.83 to 0.06)
–0.28 (–0.47 to –0.10)
–1.65 (–2.37 to –0.94)
–0.81 (–1.46 to –0.17)
–0.69 (–1.28 to –0.10)
–0.14 (–0.62 to 0.34)
–0.07 (–0.55 to 0.41)
–1.03 (–1.63 to –0.42)
–0.69 (–1.15 to –0.23)
NRS 0–10
NRS 0–10
VAS (NRS) 0–10
38
20
20
35
20
20
No
No
No
Local anaesthetic infiltration + post + usual anaesthetics vs. FNB + usual anaesthetics
Toftdahl 2007380
Carli 2010400
Affas 2011397
Subtotal (I2 = 0.0%; p = 1.000)
0.00 (–0.46 to 0.46)
0.00 (–0.62 to 0.62)
0.00 (–0.62 to 0.62)
0.00 (–0.32 to 0.32)
VAS 0–10
0–10
Patient pain score 0–10
31
44
16
29
43
16
Yes
No
No
Local anaesthetic infiltration + usual anaesthetics vs. FNB + usual anaesthetics
Parvataneni knee 2007386
Meftah 2012410
Ng 2012411
Subtotal (I2 = 90.5%; p = 0.000)
–0.88 (–1.41 to –0.34)
0.52 (0.09 to 0.95)
0.87 (0.14 to 1.60)
0.16 (–0.87 to 1.19)
–0.30 (–0.52 to –0.07)
SMD (95% CI)
–2 –1 0
Local anaesthetic infiltration
 reduces pain
Local anaesthetic infiltration 
increases pain
1
(b)
FIGURE 25 Total knee replacement: 24-hour VAS pain score at rest and during activity by local anaesthetic infiltration
grouping. SMD in pain at 24 hours post surgery. i.v., intravenous; Nc, number in the control group; Ni, number in the
intervention group; NRS, numerical response scale. (a) Pain at rest; and (b) pain during activity.
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Study
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FIGURE 26 Total knee replacement: 48-hour VAS pain score at rest and during activity by local anaesthetic infiltration
grouping. SMD in pain at 48 hours post surgery. i.v., intravenous; Nc, number in the control group; Ni, number in the
intervention group; NRS, numerical response scale. (a) Pain at rest; and (b) pain during activity. (continued )
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In four studies, control patients received either an epidural infusion,381,398,412 or intrathecal morphine.403
Results of all studies supported a reduction in pain for patients receiving local anaesthetic infiltration
compared with epidural or intrathecal morphine.
Opioid consumption
In all four studies reporting opioid consumption, this was reduced by 35–40% in the local anaesthetic
infiltration group with no analgesia.399,401,404,405 In three studies with additional post-closure analgesia opioid
consumption was 32–52% lower than in the control groups.402,403,413
In six studies for which the control group or both groups received FNB, there was little difference in opioid
consumption between randomised groups.380,386,397,400,407,408
In four studies for which patients receiving local anaesthetic infiltration with further post-closure analgesia
were compared with patients receiving epidural anaesthesia, there was no consistent difference
between groups.381,398,412
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FIGURE 26 Total knee replacement: 48-hour VAS pain score at rest and during activity by local anaesthetic infiltration
grouping. SMD in pain at 48 hours post surgery. i.v., intravenous; Nc, number in the control group; Ni, number in the
intervention group; NRS, numerical response scale. (a) Pain at rest; and (b) pain during activity.
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Mobilisation
A range of mobilisation outcomes were reported in 19 studies.380,381,386,398,400–410,412,413 Differences in
outcome measures precluded meta-analysis.
In three studies, the time to achieve a straight leg raise was reduced by 44–50%,401,404,405 and in one study
three times as many intervention patients could achieve a straight leg raise on the first postoperative day
as controls.386 In two studies in which FNB was given to all patients, the benefit for local anaesthetic
infiltration was statistically significant; more patients receiving local anaesthetic infiltration were able to
achieve a straight leg raise during the first postoperative day.407,408
In four out of five studies, patients receiving local anaesthetic infiltration achieved better knee
flexion.405,406,409,413 Four studies reported ambulation as part of discharge-readiness criteria.398,402,403,410 These
criteria were met earlier in intervention patients in three studies,398,402,403 but were similar in one study in
which control patients received a FNB.410
Times to achieve diverse walking goals were reported in six studies.380,381,400,408,412 In three studies,
improvements were evident in intervention patients that received epidural analgesia381 or FNB compared
with control groups.380,400 Marginal improvements in walking outcomes for intervention patients compared
with controls were reported in three studies.408,412
One study each showed that intervention patients could get out of bed earlier than controls receiving
epidural analgesia,381 and that the ability to hold quadriceps tension was improved compared with those
receiving FNB.380
Length of hospital stay
Data on length of hospital stay were available for eight studies in which patients were randomised to local
anaesthetic infiltration or control. Results are summarised in Table 37 and Figure 27. There was some
evidence that length of hospital stay was reduced in patients receiving local anaesthetic infiltration and
additional post-closure delivery (B) by 1.0 day on average (95% CI 0.2 to 1.8 days; p= 0.012) compared
with controls. In the one study (A) with no post-closure analgesia component, there was no difference in
length of hospital stay.
In three studies for which the comparison group received FNB,380,400,410 there was no suggestion of a
difference in length of hospital stay. In one study in which all randomised patients received a FNB the
length of hospital stay was about 1.5 days shorter in the control patients who also received an additional
sciatic nerve block.409
Complications
Based on 11 reported events in 1439 patients, the odds of a major complication after TKR in patients
receiving local anaesthetic infiltration compared with controls was 1.17 (95% CI 0.35 to 3.86; p= 0.80).
Three deep infections were reported: two in the intervention group380,398 and one in the control group412
(Peto’s OR 1.85, 95% CI 0.19 to 17.83; p= 0.59). All infections occurred in patients receiving a catheter
although in control patients nothing was injected through it.
Excluding one study in which intervention patients received additional morphine,406 the incidence of
vomiting was lower in patients receiving local anaesthetic infiltration groups than in controls in eight
studies (548 patients) with data (Peto’s OR 0.56, 95% CI 0.39 to 0.80).401–406,412 Rates were similar whether
or not additional analgesia was delivered through a catheter or injection. There was minor heterogeneity
between studies.
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Long-term outcomes
Five studies reported long-term patient outcomes measured at 6 weeks399,400 or 3 months.386,402,403 Busch
and colleagues399 found a non-significant difference in mean VAS pain scores at 6 weeks favouring the
intervention group. Parvataneni and colleagues386 reported comparable pain scores between groups at
the 3-month follow-up. In the studies of Essving and colleagues,402,403 there were no differences between
median OKS at 3 months.
In a study comparing different approaches to perioperative pain control, Carli and colleagues400 reported
an improved WOMAC score after 6 weeks in the control group who received FNB compared with the local
anaesthetic infiltration group.
Discussion
Our results indicate that in patients with total hip and knee replacement, those receiving local anaesthetic
infiltration experience less pain after 24 hours at rest and after 48 hours during activity than controls.
For patients with THR, the reduction in pain was, on average, about 35% at rest at 24 hours and 28% at
48 hours during activity when compared with no infiltration analgesia or placebo. For patients with TKR,
the estimated average reduction of pain was 26% at rest at 24 hours and 16% at 48 hours during activity
for local anaesthetic infiltration when compared with no infiltration analgesia or placebo. In patients
receiving TKR, inclusion of the non-steroidal anti-inflammatory agent ketorolac in the infiltrate seemed to
enhance postoperative pain relief.
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FIGURE 27 Total knee replacement: length of hospital stay by local anaesthetic infiltration grouping. Weighted
mean differences in days. i.v., intravenous; LoS, length of stay; Nc, number in the control group; Ni, number in the
intervention group.
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Local anaesthetic infiltration was associated with 0.83 and 0.87 fewer days in hospital for patients with
THR and knee replacement, respectively, reduced opioid consumption, earlier mobilisation and fewer
complications. The improvement in pain control and shorter hospital stay was greatest for patients
receiving additional post-wound closure analgesia. However, this should be weighed against a suggestion
of a higher risk of deep infection when delivered through an active catheter. Six infections occurred in
505 patients who received an active catheter (1.19%), compared with eight infections in all 2348 patients
randomised (0.34%). Regarding other serious post-surgical complications, there was little evidence of
differences between randomised groups.
In studies in patients with TKR comparing local anaesthetic infiltration against FNB, or using a FNB in both
groups, there was no benefit for local anaesthetic infiltration. FNB is a well-established method of
providing analgesia after TKR and is associated with reduced opioid requirement and, therefore, a
reduction in the undesirable side effects of opiates, such as nausea and vomiting. However, after a FNB,
there is decreased quadriceps function for a time and an increased risk of falls.415,416
Our finding that mobilisation was consistently achieved earlier in patients receiving local anaesthetic
infiltration may be a consequence of the reduced requirement for opioids, which may have contributed to
the shorter average hospital stay. Opioid medication represents a key strategy in the management of
post-surgical pain but its use can delay mobilisation and rehabilitation.417 The majority of studies were
concerned only with improving short-term outcomes, with only one study reporting outcomes beyond
3 months.389 However, acute postoperative pain is an important risk factor for long-term pain418,419 and
deserves appropriate consideration in future studies of perioperative pain control.
Our study evaluated the clinical effectiveness of local anaesthetic infiltration interventions and has a
number of limitations. We noted a range of analgesia regimens, with different studies making different
comparisons, particularly for TKR. Although meta-analyses performed were enhanced by extensive contact
with authors, imputation was required for some measures of variability. The skewed nature of the hospital
length of stay outcome required transformation of outcomes under assumptions of a log-normal
distribution.382 For opioid consumption and mobilisation outcomes, there was insufficient consistency in
measures reported to conduct anything but a systematic narrative overview.
Conclusion
Our systematic review shows that local anaesthetic infiltration is effective in reducing short-term pain after
TKR and THR when compared with no infiltration. It is enhanced with the addition of post-closure
analgesia, although this needs to be considered in light of the infection risks associated with catheters.420
In TKR, there may be no additional benefit if a FNB has already been sited.
The effect of local anaesthetic wound infiltration on chronic
pain after total hip and knee replacement: APEX randomised
controlled trials
Background
The need to evaluate the effectiveness of perioperative local anaesthetic infiltration in reducing long-term
pain after joint replacement in appropriately powered RCTs is recognised.421 The other components of the
multimodal anaesthesia regimen were based on recommendations from the European Society of Regional
Anaesthesia and Pain Therapy, PROcedure SPECific postoperative pain managemenT (PROSPECT), (procedure
specific postoperative pain management) guidelines and, in patients receiving TKR, included FNB.422
Aim
The aim of these two single-centre double-blind RCTs was to determine if using local anaesthetic infiltration,
in addition to the standard anaesthetic regimen at the AOC, is clinically effective and cost-effective at
reducing joint pain at 1 year after THR and TKR.
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Patients and methods
The trials are registered as an International Standardised RCT (96095682). The protocol for the APEX
trials was published in BMC Musculoskeletal Disorders.365 The trials were approved by Southampton and
South West Hampshire Research Ethics Committee B (09/H0504/94) and registered as a Clinical Trial
of an Investigational Medicinal Product with the Medicine and Healthcare Regulatory Authority
(18524/0215/001-0001) and EudraCT (2009-013817-93). The trials were overseen by a Data Monitoring
Committee and Trial Steering Committee, which regularly reviewed safety data and monitored trial
conduct. A Consolidated Standards of Reporting Trials (CONSORT) checklist is included in Appendix 10.
Patient recruitment
Patients were posted information about the study after they were listed for a joint replacement at the
AOC. Eligible patients were then approached for recruitment by a research nurse when they attended a
pre-operative assessment clinic. All participants provided informed written consent. Inclusion criteria
included being listed for a primary THR or primary TKR for osteoarthritis and being willing and able to
provide fully informed consent. Exclusion criteria included (1) any medical comorbidity that precludes spinal
anaesthesia, regional blocks or the use of strong analgesics postoperatively, (2) severe dementia or
psychiatric illness such that the patient was unable to complete the questionnaires or provide informed
consent, (3) listed for simultaneous bilateral joint replacement, (4) having been in the APEX trial for a
previous joint replacement and (5) being unable to understand English because not all the questionnaires
have been translated and validated into other languages. In order to explore the problem of ascertainment
bias (the patients enrolled in the trial not being representative of those undergoing arthroplasty),
anonymised demographic data were recorded for all eligible patients.
Randomisation
Prior to surgery, patients were randomised to the standard care or the intervention group using an online
computer-generated code (provided by the Bristol Randomised Trials Collaboration). Randomisation was
stratified by operation site (THR/TKR) and minimised by baseline pain severity and surgical approach.
The results of randomisation were concealed from the surgeons and anaesthetists until the beginning of
the operation list so that knowledge of randomisation could not affect any clinical decisions they may have
made. Trial participants and research nurses were blinded to the treatment allocation throughout the trial.
Intervention: total hip replacement
Standard care group
The standard anaesthetic care for THR patients was a spinal anaesthetic with 3ml of 0.5% plain bupivacaine
placed at the L3–4 or L4–5 interspace. Intraoperatively, the patient was either awake, sedated or under a
light general anaesthetic. If there was intraoperative discomfort, then rescue analgesia in the form of
intravenous (i.v.) fentanyl was titrated to effect. All participants were given 1 g of i.v. paracetamol
30 minutes before the end of the operation. In the recovery area immediately post operation, patients
received (if no contraindications were present) 400mg of ibuprofen administered orally. A patient-controlled
analgesia (PCA) device was started containing 1mg/ml morphine, a 1-mg bolus dose and a 5-minute
lockout. If, on awakening, the patient was in pain with a rating of > 50mm on a 100-mm pain VAS, a
morphine bolus up to 0.2mg/kg was administered as rescue analgesia. Each day during their hospital stay
patients received a visit from a pain specialist nurse. Postoperative analgesia consisted of oral or i.v.
paracetamol every 6 hours and, if no contraindications were present, 400mg of oral ibuprofen every
8 hours. When the PCA was no longer needed, 30–60mg of oral codeine phosphate every 6 hours,
50–100mg of tramadol every 6 hours and 10–20mg of morphine sulphate (Oramorph®, Boehringer
Ingelheim) were prescribed as rescue analgesia.
Intervention group
The intervention group received the same anaesthetic and analgesic regime as the standard care group,
plus an intraoperative local anaesthetic wound infiltration. The local anaesthetic mixture consisted of 60ml
of 0.25% bupivacaine with 1 in 200,000 adrenaline. If the patient weighed < 60 kg or was particularly
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frail, the volume of injectate was reduced to 50ml, or lower if necessary. The surgeon injected the
anaesthetic mixture into the joint capsule and short external rotators, fascia, fat and subcutaneous tissue.
Intervention: total knee replacement
Standard care group
In line with evidence-based guidance from PROSPECT, standard care consisted of a FNB and a spinal or
general anaesthetic, depending on patient factors.422 postoperative analgesia was provided as necessary
and recorded.
Intervention group
The intervention group received the same anaesthetic regime, plus an intraoperative local anaesthetic
infiltration, which consisted of 60ml of 0.25% bupivacaine with 1 in 200,000 adrenaline. The local
anaesthetic mixture was injected directly into the posterior capsule (25ml), medial and lateral capsule
(10ml), fascia and muscle (10ml) and subcutaneous tissues (15ml), prior to wound closure.
Assessment times
Assessments are conducted pre-operatively, daily during the hospital stay and then at 3, 6 and 12 months
postoperatively. Outcomes were assessed using self-report questionnaires, joint examinations, radiograph
analysis, pressure algometry and extraction of data from hospital records.
Primary outcome measure
The primary outcome measure was the self-completed WOMAC pain scale114 at 12 months
postoperatively. The five-item WOMAC pain scale is a widely used and validated measure of pain severity
when performing daily activities. The questionnaire was completed with reference to the operated hip or
knee. Scores were transformed onto a 0–100 scale, with lower scores indicating more severe pain.
Secondary outcome measures
Secondary outcomes were collected during the postoperative inpatient stay and at 3, 6 and 12 months
postoperatively. Pain severity on admission to, and discharge from, the post-surgical recovery ward was
rated on a 4-point Likert-type scale (none to severe pain). Pain severity for the remainder of the day of
surgery was rated every 4 hours on a 0–10 scale (best to worst). On postoperative days 1–3, patients rated
the severity of night pain, pain on movement and pain at rest on a 100-mm VAS. Satisfaction with pain
relief and the occurrence of nausea and vomiting were also recorded daily during the inpatient stay.
Length of hospital stay and postoperative analgesia use were extracted from medical records. At 3, 6 and
12 months postoperatively, patients completed the WOMAC function and Stiffness subscales114 and the
Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).280 The painDETECT questionnaire,283
a measure of neuropathic pain, was completed at 12 months postoperatively.
Pressure pain thresholds of the volar forearm were measured pre-operatively, at discharge from hospital
and 12 months postoperatively using an algometer. Data on medical and surgical complications
were recorded from hospital records during the inpatient stay, by a telephone call to patients at
3 months and by a comprehensive joint assessment by a research nurse at 12 months postoperatively.
Cost-effectiveness was assessed through data on health services resource use collected from hospital
records and patient self-report questionnaires. Preference-based HRQoL was measured by administering
the European Quality of Life-5 Dimensions 3-Level version (EQ-5D-3L)278 at baseline and at all follow-up
points. This provides a single index score for each patient’s health state profile.
Details of medical and surgical adverse events were recorded throughout the trial through review of
medical records, self-report by patients and assessment by a research nurse.
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Potential prognostic factors
Measures of possible effect modifiers included sociodemographic factors, Functional Comorbidity Index,279
Kellgren and Lawrence osteoarthritis grading scheme,423 HADS,281 Pain Self-Efficacy questionnaire,275 Illness
Perceptions Questionnaire-Revised282 and Brief COPE.276 Any imbalance between trial arms in factors that
might influence the perception of pain and pattern of recovery was considered in sensitivity analyses.
Sample size calculation
A sample size of 300 patients in each trial provided 90% power to detect a difference of 0.5 SDs on the
WOMAC pain scale with a two-sided 1% significance level, allowing for a 20% dropout rate. Previous
research suggests SDs of around 17 on the WOMAC pain scale before surgery.424 Hence, a difference
between the treatment groups of 0.5 SDs equates to a difference of approximately 8–9 units on the
WOMAC pain scale, which represents a minimally perceptible clinical improvement.425
Statistical analysis
The hip and knee trials were analysed separately, undertaken in Stata 13.1, and reported in accordance
with CONSORT guidelines.
Primary analyses
Following a predefined analysis plan agreed with the Trial Steering Committee,365 we used linear
regressions to estimate between-group differences in mean WOMAC pain scores at 12 months
postoperatively, adjusted for pre-operative WOMAC pain scores and surgical approach. All patients in their
original assigned groups with available primary outcome data (THR, n= 281; TKR, n= 273) were included
in the primary analyses [intention-to-treat complete cases (ITT-CC)].
Sensitivity analyses
Analyses were repeated on all the randomised 322 patients with THR and 316 patients with TKR using
multiple imputation technique by chained equations (20 imputations for the THR trial, 25 imputations for
the TKR trial) stratified by randomisation arm to handle missing outcomes [intention-to-treat imputed
(ITT-imputed)].426 The analyses were also conducted on a per-protocol basis, excluding participants who did
not receive their allocated intervention or did not have a primary outcome (participants who opted out,
died or were lost to follow-up). Per-protocol analyses included 266 patients with THR and 259 patients
with TKR [per protocol complete cases (PP)].
In addition, any potential imbalance in patients baseline characteristics were controlled for in the ITT-CC,
ITT-imputed and PP analyses.
Post hoc analyses
To explore the impact of potential ceiling effect in the WOMAC pain score on the primary analyses, that is
the robustness of the linear regression coefficient standard errors, CIs and p-values (via violations of the
assumptions of homoscedasticity and normality), we conducted two further sensitivity analyses. First,
we investigated transformations of WOMAC pain scores to model the primary outcomes as continuous
variables in the linear regressions. Second, the scores were then modelled as a categorical variable using
published threshold definitions [severe/extreme (0–50), moderate (51–75), mild (76–99), no (100) pain],49
and partial proportional odds regressions.427 These categories relate to the original ordinal WOMAC pain
scale (e.g. a patient who reports no pain for every item will score 100, and a patient who reports mild pain
on all the items will score 75, etc.).
Secondary analyses
Drug intake, length of hospitalisation and patients’ complications after surgery were compared by
treatment arm with the use of chi-squared or Fisher exact tests for categorical variables, t-tests or
Wilcoxon Mann–Whitney U-tests for continuous variables. All analyses were performed on complete cases
(patients with available outcome information) and the proportion of missing data is reported for each of
these variables for information only.
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Investigations of pain scores on days 1–3 after the operation were conducted using linear mixed models
to account for repeated measurements within participants339 and using adequate transformation of the
outcomes when required. The effect of the intervention on WOMAC pain scores at 3 months and
6 months post operation was also modelled using a mixed linear regression.
Period-specific intervention effects were modelled with interaction terms between the intervention and the
assessment day/period parameters. The choice of modelling the raw or transformed continuous scores was
based on the normality of the distribution of residuals assessed in a linear regression. When no suitable
transformation was identified, the outcome was categorised and modelled with a non-linear regression.
For the THR trial, ICOAP and WOMAC Stiffness scores at 12 months post operation were dichotomised
and modelled with a Poisson modified regression with robust variance estimation, a preferable approach to
logistic regression when the outcome of interest has a high prevalence.428 Investigations of the intervention
effects on these outcomes at 3 and 6 months were conducted with an extension of this model accounting
for the clustering of outcomes by patients.429 For the TKR trial, ICOAP and WOMAC stiffness and function
scores at 12 months post operation were modelled with linear regression and adequate transformation
of the outcomes, when required. Investigations of the intervention effects on these outcomes at 3 and
6 months after surgery were conducted with a linear mixed model.
The WOMAC function scores at 12 months and then at 3 months and 6 months post operation were
investigated with linear and linear mixed models in both THR and TKR trials. The painDETECT score at
12 months post operation was dichotomised and modelled with a Poisson modified regression with robust
variance estimation in both trials.
The modelling strategy of the secondary outcomes was similar to the one described in the statistical
analysis section of the main manuscript using an ‘intention-to-treat complete cases’ approach (THR,
n= 281; TKR, n= 273), an ‘intention-to-treat imputed’ approach (n= 322 THR patients and n= 316 TKR
patients) and a per-protocol approach (n= 266 THR patients and n= 259 TKR patients). Baseline analyses
were adjusted for pre-operative WOMAC pain and surgical approach. Imbalanced baseline patients’
characteristics were then controlled for.
Results
Total hip replacement
Participants
Between November 2009 and February 2012, 630 eligible patients were approached about the trial.
Of these patients, 322 (51%) were recruited and randomised: 163 to the intervention arm and 159 to the
standard care arm (Figure 28). Primary outcome data were collected from 288 patients (87%). Baseline
demographic and clinical characteristics were generally well balanced between the trial arms (Table 38).
Differences between trial arms in sex, living arrangement and number of comorbidities were adjusted for
in the analysis.
Primary outcome
As shown in Table 39, the majority of patients in both trial arms had excellent pain relief at 12 months
after surgery, with a median WOMAC pain score in the intervention arm of 100 out of 100 (i.e. no pain)
and in the standard care arm of 95 out of 100.
As shown in Table 40, the primary analysis found some evidence that patients in the intervention group
had less pain at 12 months post operation than patients in the standard care group (coefficient 4.74,
95% CI 0.95 to 8.54; p= 0.015). This difference remained after further adjustments for baseline
imbalances between groups, although it was less apparent in the adjusted intention to treat (ITT) with
imputed data and per-protocol analyses.
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Assessed for eligibility
(n = 803)
Eligible
(n = 630)
Ineligible
(n = 173)
Excluded
• Not contactable in clinic, n = 42
• Refused to participate, n = 266
Randomised
(n = 322)
Standard care
(n = 159)
Local anaesthetic
(n = 163)
Surgery
Had surgery elsewhere, n = 3
Had surgery postponed for
> 6 months, n = 4
Had surgery elsewhere, n = 2
Had surgery postponed for
> 6 months, n = 3
Inpatient period
(n = 153)
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Received allocated intervention, n = 146
Did not receive allocated intervention, n = 7
Opted out, n = 1
Withdrawn for clinical reasons, n = 2
Surgery
Received allocated intervention, n = 143
Did not receive allocated intervention, n = 8
Opted out, n = 2
Withdrawn for clinical reasons, n = 1
Completed the 3-month follow-up, n = 133
Lost to follow-up, n = 16
Opted out, n = 4
Completed the 3-month follow-up, n = 138
Lost to follow-up, n = 12
Patient died, n = 1
Completed the 6-month follow-up, n = 134
Lost to follow-up, n = 12
Opted out, n = 3
Completed the 6-month follow-up, n = 141
Lost to follow-up, n = 8
Opted out, n = 1
Completed the 12-month follow-up, n = 141
Lost to follow-up, n = 5
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Patients included in the intention-to-treat analysis, n = 322
Patients included in the per-protocol analysis, n = 266
Completed the 12-month follow-up, n = 140
Lost to follow-up, n = 3
Opted out, n = 1
Patient died, n = 5
FIGURE 28 Total hip replacement: APEX patient recruitment, randomisation and follow-up. Quest, in patient
questionnaire; LtF, lost to follow-up.
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TABLE 38 Total hip replacement: baseline characteristics of APEX participants by trial arm
Characteristic Intervention (n= 163) Standard care group (n= 159)
Female sex, n (%) 86 (53) 103 (65)
Age (years), mean (SD) 66.0 (11.4) 66.4 (10.2)
BMI (kg/m2), mean (SD) 28.9 (5.6) 29.4 (5.4)
Living arrangement, n (%)
Live with someone 110 (68) 123 (77)
Live alone 43 (26) 32 (20)
Missing 10 (6) 4 (3)
Working status, n (%)
Paid employment/voluntary work 47 (29) 52 (33)
Retired 104 (64) 104 (65)
Missing 12 (7) 3 (2)
Education, n (%)
Compulsory age or before 98 (60) 108 (68)
College 34 (21) 30 (19)
University 20 (12) 17 (11)
Missing 11 (7) 4 (2)
Comorbidities, n (%)
0 to 1 57 (35) 53 (33)
2 48 (30) 36 (23)
3 25 (15) 36 (23)
≥ 4 21 (13) 28 (18)
Missing 12 (7) 6 (4)
Anxiety, n (%)
Definite 26 (16) 31 (19)
Potential 26 (16) 23 (15)
None 100 (61) 100 (63)
Missing 11 (7) 5 (3)
Depression
Definite, n (%) 20 (12) 25 (16)
Potential, n (%) 25 (15) 28 (18)
None, n (%) 106 (65) 101 (63)
Missing, n (%) 12 (7) 5 (3)
Self-efficacy, mean (SD) 35.6 (13.7) 34.2 (13.3)
WOMAC pain, mean (SD) 43.4 (19.0) 41.5 (17.9)
WOMAC function, mean (SD) 43.7 (20.2) 41.2 (17.2)
WOMAC stiffness, mean (SD) 47.4 (24.9) 42.6 (20.7)
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As described in the statistical methods, the assumptions of homoscedasticity and normality underlying the
use of linear regression, our a priori primary analysis, were violated. Therefore, we performed a further
secondary analysis of the primary outcome to test the robustness of the above findings by categorising the
WOMAC pain score and using a partial proportional odds model. This method of analysis found similar
results (Table 41), with evidence that patients in the intervention group were less likely to have severe pain
at 12 months post operation than those in the standard care group (OR 10.19, 95% CI 2.10 to 49.55;
p= 0.004). This finding remained after further adjustments for baseline imbalances between groups and
was also observed in the ITT with imputed data and the per-protocol approaches.
TABLE 38 Total hip replacement: baseline characteristics of APEX participants by trial arm (continued )
Characteristic Intervention (n= 163) Standard care group (n= 159)
Surgical approach, n (%)
Posterior 151 (93) 147 (92)
Lateral 12 (7) 12 (8)
Kellgren and Lawrence grade, n (%)
< 3 4 (3) 8 (4)
≥ 3 136 (83) 128 (81)
Non-interpretable 12 (7) 12 (8)
Missing 11 (7) 11 (7)
TABLE 39 Total hip replacement: WOMAC pain scores at 12 months after surgery
Outcome Intervention (n= 163) Standard care (n= 159)
WOMAC pain at 12 months
Continuous score, by categorised pain level
Median (IQR) 100 (10) 95 (20)
None= 100 72 (44%) 59 (37%)
Mild= 75–100 51 (31%) 53 (33%)
Moderate= 50–75 16 (10%) 16 (10%)
Severe= 0–50 2 (1%) 12 (8%)
Missing data 22 (14%) 19 (12%)
TABLE 40 Total hip replacement: primary analysis of WOMAC pain scores at 12 months after surgery
Model
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Baseline 4.74 (0.95 to 8.54) 0.015 5.35 (1.33 to 9.34) 0.009 3.81 (–0.02 to 7.63) 0.051
Adjusted 4.31 (0.63 to 7.98) 0.022 4.36 (0.48 to 8.25) 0.028 3.45 (–0.26 to 7.16) 0.068
Baseline model: linear regression – adjusted for baseline pain score and surgical approach. Adjusted model: baseline
model+ adjustments for sex, living arrangement and number of comorbidities.
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Secondary outcomes
Details of the analysis of secondary outcomes are shown in Table 42 and Appendices 11–28. There was no
difference in any of the secondary outcomes except that patients in the intervention group reported less
pain on postoperative night 2 (coefficient –0.81, 95% CI –1.40 to –0.23; p= 0.006) and less neuropathic
pain at 12 months post operation (ITT adjusted model: relative risk 0.17, 95% CI 0.03 to 0.82; p= 0.028).
Post-surgical superficial and deep wound infection rates were similar in the intervention group and
standard care group (1.8% vs. 1.9%; p= 1.000).
TABLE 41 Total hip replacement: secondary analysis of WOMAC pain scores at 12 months after surgery
Groups compared
Baseline model Adjusted model
OR (95% CI) p-value OR (95% CI) p-value
(Moderate, mild or none) vs. reference = (severe)
ITT-CC (n= 281) 10.19 (2.10 to 49.55) 0.004 10.78 (2.15 to 54.17) 0.004
ITT-imputed (n= 322) 6.81 (1.81 to 25.68) 0.005 6.26 (1.61 to 24.36) 0.008
PP (n= 266) 8.93 (1.83 to 43.62) 0.007 9.50 (1.88 to 47.76) 0.006
(Mild or none) vs. reference = (severe or moderate)
ITT-CC (n= 281) 1.72 (0.90 to 3.30) 0.100 1.70 (0.86 to 3.33) 0.125
ITT-imputed (n= 322) 1.76 (0.95 to 3.26) 0.073 1.59 (0.84 to 3.02) 0.157
PP (n= 266) 1.56 (0.81 to 3.02) 0.186 1.54 (0.77 to 3.05) 0.220
(None) vs. reference = (severe, moderate or mild)
ITT-CC (n= 281) 1.40 (0.89 to 2.25) 0.168 1.35 (0.82 to 2.22) 0.243
ITT-imputed (n= 322) 1.42 (0.90 to 2.26) 0.136 1.30 (0.80 to 2.10) 0.290
PP (n= 266) 1.31 (0.80 to 2.14) 0.277 1.27 (0.76 to 2.12) 0.363
Baseline model: partial proportional odds model adjusted for baseline pain score and surgical approach. Adjusted model:
baseline model+ adjustments for sex, living arrangement and number of comorbidities.
TABLE 42 Total hip replacement: ITT and per-protocol analyses of the effect of the intervention on pain during the
inpatient stay
Model
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Pain over night (square root)
Day 1
Baseline model 0.29 (–0.29 to 0.87) 0.325 0.25 (–0.36 to 0.85) 0.419 0.36 (–0.22 to 0.95) 0.223
Adjusted model 0.39 (–0.19 to 0.97) 0.184 0.34 (–0.27 to 0.94) 0.276 0.45 (–0.12 to 1.03) 0.124
Day 2
Baseline model –0.81 (–1.40 to 0.23) 0.006 –0.87 (–1.43 to 0.30) 0.003 –0.75 (–1.34 to 0.16) 0.012
Adjusted model –0.71 (–1.30 to –0.13) 0.016 –0.78 (–1.35 to –0.20) 0.008 –0.66 (–1.25 to –0.08) 0.025
Day 3
Baseline model –0.29 (–0.89 to 0.31) 0.347 –0.40 (–0.98 to 0.18) 0.173 –0.09 (–0.70 to 0.51) 0.765
Adjusted model –0.18 (–0.78 to 0.41) 0.545 –0.31 (–0.89 to 0.27) 0.301 0.01 (–0.59 to 0.60) 0.986
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Total knee replacement
Participants
Between November 2009 and February 2012, 585 eligible patients were approached to take part in the
trial. Of these patients, 316 (54%) were recruited and randomised: 157 to the intervention arm and 159 to
the standard care arm (Figure 29). Primary outcome data were collected from 273 patients (86%). Baseline
demographic and clinical characteristics were generally well balanced between the trial arms (Table 43).
Differences between trial arms in working status, number of comorbidities, anxiety and depression were
adjusted for in the analysis.
Primary outcome
The majority of patients in both trial arms had good pain relief at 12 months after surgery, with a median
WOMAC pain score in the intervention group of 90 (IQR 30) and in the standard care group of 85 (IQR 35)
(Table 44).
TABLE 42 Total hip replacement: ITT and per-protocol analyses of the effect of the intervention on pain during the
inpatient stay (continued )
Model
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Pain at rest (square root)
Day 1
Baseline model 0.12 (–0.36 to 0.60) 0.621 0.12 (–0.35 to 0.59) 0.619 0.15 (–0.33 to 0.63) 0.546
Adjusted model 0.19 (–0.28 to 0.66) 0.432 0.17 (–0.30 to 0.65) 0.468 0.21 (–0.27 to 0.68) 0.394
Day 2
Baseline model –0.22 (–0.69 to 0.26) 0.373 –0.27 (–0.75 to 0.21) 0.270 –0.05 (–0.53 to 0.43) 0.848
Adjusted model –0.15 (–0.62 to 0.33) 0.546 –0.21 (–0.70 to 0.27) 0.381 0.01 (–0.46 to 0.49) 0.962
Day 3
Baseline model –0.34 (–0.83 to 0.15) 0.171 –0.45 (–0.92 to 0.02) 0.062 –0.21 (–0.71 to 0.28) 0.391
Adjusted model –0.27 (–0.75 to 0.22) 0.282 –0.39 (–0.86 to 0.08) 0.108 –0.15 (–0.64 to 0.33) 0.545
Pain on movement
Day 1
Baseline model 1.52 (–3.90 to 6.95) 0.582 1.25 (–4.20 to 6.69) 0.653 1.26 (–4.21 to 6.74) 0.651
Adjusted model 2.01 (–3.46 to 7.48) 0.471 1.52 (–4.02 to 7.05) 0.591 1.88 (–3.62 to 7.38) 0.503
Day 2
Baseline model 1.57 (–3.88 to 7.02) 0.573 1.66 (–3.79 to 7.12) 0.549 2.07 (–3.44 to 7.57) 0.462
Adjusted model 2.07 (–3.43 to 7.56) 0.461 1.93 (–3.61 to 7.48) 0.494 2.69 (–2.83 to 8.21) 0.339
Day 3
Baseline model 0.01 (–5.56 to 5.58) 0.997 –0.47 (–5.88 to 4.95) 0.866 0.27 (–5.35 to 5.89) 0.925
Adjusted model 0.54 (–5.07 to 6.16) 0.849 –0.16 (–5.64 to 5.31) 0.954 0.94 (–4.70 to 6.57) 0.745
Baseline model: linear mixed model adjusted for baseline pain score and surgical approach. Adjusted model: baseline
model+ adjustments for sex, living arrangement, number of comorbidities and self-efficacy.
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Assessed for eligibility
(n = 826)
Eligible
(n = 585)
Ineligible
(n = 24)
Excluded
• Not contactable in clinic, n = 19
• Declined to participate, n = 250
Randomised
(n = 316)
Standard care
(n = 159)
Local anaesthetic
(n = 157)
Surgery
Had surgery elsewhere, n = 2
Had surgery postponed for
> 6 months, n = 7
Had surgery elsewhere, n = 1
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> 6 months, n = 7
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Completed the 3-month follow-up, n = 126
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Opted out, n = 5
Patient died, n = 2
Completed the 3-month follow-up, n = 134
Lost to follow-up, n = 11
Opted died, n = 2
Completed the 6-month follow-up, n = 122
Lost to follow-up, n = 13
Opted out, n = 1
Completed the 6-month follow-up, n = 134
Lost to follow-up, n = 10
Withdrawn for clinical reasons, n = 1
Completed the 12-month follow-up, n = 133
Lost to follow-up, n = 1
Opted out, n = 1
Patients with primary outcome at 12 months included in the main analysis, n = 273
Patients included in the ITT analysis, n = 316
Patients included in the per-protocol analysis, n = 259
Completed the 12-month follow-up, n = 140
Lost to follow-up, n = 1
Opted died, n = 1
Patient died, n = 1
Withdrawn for clinical reasons, n = 1
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FIGURE 29 Total knee replacement: APEX patient recruitment, randomisation and follow-up. LtF, lost to follow-up;
Quest, in patient questionnaire. a, Withdrawn: one patient died, two opted out during the inpatient period;
b, withdrawn: one patient was withdrawn for clinical reasons, one opted out during the inpatient period.
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TABLE 43 Total knee replacement: baseline characteristics of APEX participants by trial arm
Characteristic Intervention group (n= 157) Standard care group (n= 159)
Female sex, n (%) 81 (52) 86 (54)
Age (years), mean (SD) 69.5 (9.4) 68.7 (7.9)
BMI (kg/m2), mean (SD) 32.4 (6.5) 32.8 (6.5)
Living arrangement, n (%)
Live with someone 112 (71) 103 (65)
Live alone 41 (26) 44 (28)
Missing 4 (3) 12 (7)
Working status, n (%)
Paid employment/voluntary work 41 (26) 27 (17)
Retired 111 (71) 117 (74)
Missing 5 (3) 15 (9)
Education, n (%)
Compulsory age or before 115 (73) 109 (69)
College 26 (17) 25 (16)
University 9 (6) 10 (6)
Missing 7 (4) 15 (9)
Comorbidities, n (%)
0 to 1 46 (29) 39 (24)
2 30 (19) 41 (26)
3 36 (23) 25 (16)
≥ 4 38 (24) 43 (27)
Missing 7 (5) 11 (7)
Anxiety, n (%)
Definite 33 (21) 18 (11)
Potential 24 (15) 32 (20)
None 93 (59) 99 (62)
Missing 7 (5) 10 (6)
Depression
Definite, n (%) 30 (19) 16 (10)
Potential, n (%) 29 (19) 30 (19)
None, n (%) 91 (58) 104 (65)
Missing, n (%) 7 (4) 9 (6)
Self-efficacy, mean (SD) 36.0 (13.4) 37.3 (12.0)
WOMAC pain, mean (SD) 42.5 (17.3) 42.4 (16.1)
WOMAC function, mean (SD) 46.1 (17.7) 46.0 (17.9)
WOMAC stiffness, mean (SD) 41.9 (21.0) 41.1 (19.4)
continued
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The primary analysis revealed that there was no evidence that pain severity at 12 months after surgery was
different between the intervention and standard care group (ITT-CC coefficient 3.83, 95% CI –0.83 to
8.49; p= 0.107; Table 45). This finding was consistently observed in the different approaches.
Similar to the THR trial, the assumptions of the linear regression were violated. The partial odds model also
revealed no difference in pain severity between the two groups with the exception that the per-protocol
and ITT-CC analysis showed some evidence that the intervention reduced the number of patients with
severe to moderate pain (Table 46).
TABLE 43 Total knee replacement: baseline characteristics of APEX participants by trial arm (continued )
Characteristic Intervention group (n= 157) Standard care group (n= 159)
Surgical approach, n (%)
Medial parapatellar 122 (78) 125 (79)
Subvastus 35 (22) 34 (21)
Kellgren and Lawrence grade, n (%)
< 3 133 (84) 133 (84)
≥ 3 1 (1) 3 (2)
Non-interpretable 1 (1) 5 (3)
Missing 22 (14) 18 (11)
TABLE 44 Total knee replacement: WOMAC pain scores at 12 months after surgery
Outcome
Continuous score, by categorised pain level
Intervention (n= 157) Standard care (n= 159)
WOMAC pain at 12 months
Median (IQR) 90 (30) 85 (35)
None= 100 45 (29%) 36 (23%)
Mild= 75–100 44 (28%) 44 (28%)
Moderate= 50–75 29 (18%) 42 (26%)
Severe= 0–50 15 (10%) 18 (11%)
Missing data 24 (15%) 19 (12%)
TABLE 45 Total knee replacement: primary analysis of WOMAC pain scores at 12 months after surgery
Model
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Baseline 3.83 (–0.83 to 8.49) 0.107 3.33 (–1.21 to 7.88) 0.146 4.21 (–0.66 to 9.09) 0.090
Adjusted 4.14 (–0.51 to 8.80) 0.081 4.16 (–0.37 to 8.69) 0.082 4.60 (–0.28 to 9.50) 0.064
Baseline model: linear regression – adjusted for baseline pain score and surgical approach. Adjusted model: baseline
model+ adjustments for working status, number of comorbidities, depression and anxiety.
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Secondary outcomes
Details of the analysis of secondary outcomes can be found in Table 47 and Appendices 11–28. There was
some evidence that patients in the intervention group had fewer drugs administered on the recovery ward
(98 vs. 118; p= 0.010) and reported less vomiting (26% vs. 39%; p= 0.025) and nausea (58% vs. 85%;
p= 0.005) on postoperative day 1. There was no difference in any of the other secondary outcomes.
Post-surgical superficial and deep wound infection rates were similar in the intervention group and
standard care group (3.2% vs. 1.9%; p= 0.500).
Comparison of the results of the hip and knee trial
Table 48 presents the effect of the intervention when all the participants of the THR and TKR trials are
combined. The results are adjusted for pre-operative WOMAC pain scores, surgical approach and surgical
site (hip or knee). Patients in the intervention group had a higher mean WOMAC score at 12 months after
surgery than those in the standard care group (ITT-CC, between-group difference in mean WOMAC at
12 months: 4.10, 95% CI 1.08 to 7.12; p= 0.008; Table 48). This finding was consistently observed in the
different approaches.
The intervention effect observed in the hip patients was then contrasted with the intervention effect
observed in the knee using an interaction term between the intervention effect (intervention or standard
care) and site of surgery (hip or knee) in the above model. Despite the statistical significant effect observed
in the hip group (ITT-CC, MD: 4.74; p= 0.015; see Table 40) and the non-significant effect observed in the
knee group (ITT-CC, MD: 3.83; p= 0.107; see Table 45), these two effects were not statistically different
(ITT-CC: p= 0.904; ITT-imputed: p= 0.657; and P: p= 0.682).
TABLE 46 Total knee replacement: secondary analysis of WOMAC pain scores at 12 months after surgery
Groups compared
Baseline model Adjusted model
OR (95% CI) p-value OR (95% CI) p-value
(Moderate, mild or none) vs. reference = (severe)
ITT-CC (n= 273) 1.28 (0.60 to 2.72) 0.515 1.27 (0.58 to 2.78) 0.543
ITT-imputed (n= 316) 1.28 (0.63 to 2.61) 0.497 1.34 (0.64 to 2.81) 0.444
PP (n= 259) 1.28 (0.60 to 2.72) 0.515 1.29 (0.59 to 2.81) 0.527
(Mild or none) vs. reference = (severe or moderate)
ITT-CC (n= 273) 1.61 (0.96 to 2.71) 0.071 1.77 (1.02 to 3.07) 0.042
ITT-imputed (n= 316) 1.48 (0.89 to 2.48) 0.131 1.65 (0.95 to 2.86) 0.077
PP (n= 259) 1.75 (1.03 to 2.97) 0.039 1.94 (1.11 to 3.42) 0.021
(None) vs. reference = (severe, moderate or mild)
ITT-CC (n= 273) 1.41 (0.82 to 2.43) 0.216 1.55 (0.87 to 2.75) 0.135
ITT-imputed (n= 316) 1.39 (0.82 to 2.35) 0.227 1.54 (0.88 to 2.69) 0.133
PP (n= 259) 1.48 (0.85 to 2.59) 0.168 1.64 (0.91 to 2.67) 0.099
Baseline model: partial proportional odds model adjusted for baseline pain score and surgical approach. THR adjusted
model: baseline model+ adjustments for sex, living arrangement and number of comorbidities. TKR adjusted model:
baseline model+ adjustments for working status, number of comorbidities, depression and anxiety.
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TABLE 47 Total knee replacement: ITT and per-protocol analyses of the effect of the intervention on pain during
the inpatient stay
Model
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Pain over night
Day 1
Baseline model 3.81 (–3.07 to 10.69) 0.278 4.12 (–2.87 to 11.12) 0.248 5.46 (–1.50 to 12.41) 0.124
Adjusted model 3.75 (–3.08 to 10.58) 0.282 3.70 (–3.21 to 10.62) 0.294 5.43 (–1.47 to 12.33) 0.123
Day 2
Baseline model 2.30 (–4.49 to 9.10) 0.506 2.39 (–4.47 to 9.25) 0.494 2.35 (–4.52 to 9.21) 0.503
Adjusted model 2.20 (–4.54 to 8.95) 0.522 1.97 (–4.85 to 8.80) 0.571 2.26 (–4.56 to 9.08) 0.516
Day 3
Baseline model –3.55 (–10.58 to 3.49) 0.323 –2.13 (–9.14 to 4.89) 0.552 –3.77 (–10.87 to 3.33) 0.298
Adjusted model –3.94 (–10.92 to 3.04) 0.269 –2.54 (–9.50 to 4.41) 0.473 –4.13 (–11.18 to 2.91) 0.250
Pain at rest
Day 1
Baseline model –2.53 (–7.62 to 2.56) 0.330 –2.39 (–7.74 to 2.95) 0.379 –1.89 (–7.12 to 3.34) 0.478
Adjusted model –2.49 (–7.46 to 2.49) 0.327 –2.37 (–7.67 to 2.93) 0.380 –1.70 (–6.82 to 3.41) 0.514
Day 2
Baseline model 2.48 (–2.58 to 7.54) 0.337 2.56 (–2.70 to 7.83) 0.339 2.22 (–2.98 to 7.42) 0.402
Adjusted model 2.52 (–2.42 to 7.46) 0.318 2.59 (–2.58 to 7.76) 0.325 2.41 (–2.67 to 7.50) 0.352
Day 3
Baseline model 0.63 (–4.56 to 5.83) 0.811 0.73 (–4.47 to 5.94) 0.782 0.06 (–5.27 to 5.38) 0.983
Adjusted model 0.54 (–4.53 to 5.62) 0.833 0.76 (–4.33 to 5.85) 0.769 0.12 (–5.08 to 5.33) 0.963
Pain on movement
Day 1
Baseline model –1.08 (–6.64 to 4.47) 0.702 –1.06 (–6.88 to 4.77) 0.721 –0.69 (–6.41 to 5.03) 0.814
Adjusted model –1.12 (–6.66 to 4.41) 0.690 –0.98 (–6.90 to 4.93) 0.744 –0.73 (–6.42 to 4.96) 0.802
Day 2
Baseline model 0.68 (–4.84 to 6.20) 0.809 0.79 (–4.85 to 6.42) 0.784 0.66 (–5.03 to 6.35) 0.820
Adjusted model 0.64 (–4.87 to 6.15) 0.818 0.86 (–4.86 to 6.58) 0.768 0.62 (–5.04 to 6.28) 0.830
Day 3
Baseline model 1.00 (–4.65 to 6.65) 0.729 1.07 (–4.86 to 6.99) 0.724 0.58 (–5.23 to 6.39) 0.845
Adjusted model 0.90 (–4.75 to 6.53) 0.753 1.14 (–4.82 to 7.11) 0.706 0.49 (–5.29 to 6.27) 0.868
Baseline model: linear mixed model adjusted for baseline pain score and surgical approach. Adjusted model: baseline
model+ adjustments for working status, number of comorbidities, depression and anxiety.
TABLE 48 Combined analysis of WOMAC pain scores at 12 months for THR and TKR participants: linear regression
Intervention
effect
ITT-CC ITT-imputed PP
Coefficient (95% CI) p-value Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Effect 4.10 (1.08 to 7.12) 0.008 4.28 (1.19 to 7.36) 0.007 3.89 (0.77 to 7.00) 0.014
PERIOPERATIVE PAIN MANAGEMENT WITH LOCAL ANAESTHETIC INFILTRATION IN THR AND TKR
NIHR Journals Library www.journalslibrary.nihr.ac.uk
190
Discussion
These are the first reported RCTs powered to investigate the clinical effectiveness of local anaesthetic infiltration
at reducing chronic pain at 12 months after THR and TKR. Administering local anaesthetic infiltration is easy
and quick, with no increased morbidity or hospital stay. Our trials found evidence that local anaesthetic wound
infiltration can reduce pain severity at 12 months after THR, but not TKR. The reasons for the observed
difference in the effectiveness of the intervention in TKR and THR patients are unclear and require further
research, but one contributing factor could be the use of FNB in both arms of the TKR trial.
Strengths of these trials include the long-term postoperative follow-up, the use of robust and validated
outcome measures to assess pain, good rates of data collection for the primary outcome measure and
use of an independent allocation system and blinding to minimise bias. Our sample population is
representative of the population undergoing THR and TKR as a whole with a similar disease profile,
sex mix and age range as reported by the National Joint Registry for England and Wales,3 and other
national registries;430 thus, we believe our results to be generalisable. However, our trials do have
weaknesses and it is important to note that the number of patients with severe chronic post-surgical pain
in the THR trial was small, generating wide 95% CIs for the ORs in the secondary analysis of the primary
outcome. These risks should be interpreted with caution. It is also important to keep in mind that the trials
were not powered for the analyses of the primary outcome as categorical variables or to detect differences
in treatment effect for the secondary outcomes. This may explain the lack of strong evidence for an
intervention effect on acute postoperative pain in the two trials.
For many patients, THR and TKR are effective treatments for painful osteoarthritis, and additional
interventions to improve pain relief are not required. However, a sizeable proportion of people report
chronic post-surgical pain.18 The findings of this trial suggest that local anaesthetic infiltration is beneficial
for decreasing long-term pain in THR patients but not in TKR patients. In addition, we found some
evidence that the intervention may reduce neuropathic pain at 12 months after THR, indicating that
infiltration may benefit those patients experiencing severe and/or neuropathic pain in the long term, both
of which can be difficult to treat once established.431 Given that approximately 80,000 THR operations are
performed annually in England, Wales and Northern Ireland,3 and 7–23% of patients are likely to develop
severe chronic post-surgical pain,18 our findings suggest that routine use of local anaesthetic infiltration has
the potential to improve pain outcomes for between 4600 and 15,300 patients every year in the NHS.
Conclusion
The double-blind APEX RCTs provide evidence that administering local anaesthetic infiltration before
wound closure reduces chronic post-surgical pain at 1 year after THR. This suggests that the routine use
of infiltration would be beneficial in improving long-term pain relief for THR patients. Findings from our
TKR trial suggest that local anaesthetic infiltration would have little long-term benefit for TKR patients.
However, it must be noted that the majority of patients had good or excellent long-term pain relief after
both hip and knee replacement, regardless of whether they were randomised to local anaesthetic
infiltration or not.
The cost-effectiveness of local anaesthetic wound infiltration
on chronic pain after lower limb joint replacement:
APEX randomised controlled trials
Introduction
The APEX economic evaluation assessed the cost-effectiveness of local anaesthetic wound infiltration in
patients receiving (1) TKR and (2) THR, compared with usual care, at 1 year post surgery, from a NHS and PSS
perspective. We also collected data allowing for a future economic evaluation from a societal perspective.
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Methods
Resource use identification and collection
Collection of resource-use data was identical for both the hip and the knee trials. Resources used during
the initial inpatient stay for joint replacement and subsequent inpatient stays and outpatient visits at
Southmead Hospital during the 12 months of follow-up were extracted from medical records onto study
designed proformas. Initial inpatient resource use included operating theatre time, perioperative local
anaesthetic infiltration in the intervention group, time spent in recovery and number of days admitted to a
ward after surgery. After initial hospital discharge, inpatient and outpatient resource-use data collected
included the duration and reason for visit, ward details of inpatient admissions including day-case
admissions, accident and emergency visits, and outpatient visits and specialty clinics attended during the
12-month follow-up period.
Use of PSS and other NHS resources was collected using patient-completed questionnaires, sent by post at
3, 6 and 12 months’ follow-up. Patient-reported data included secondary care visits at other hospitals;
community-based health-care visits including GP, practice nurse, district nurse, community physiotherapist
and OT contacts; medication use; and use of PSS, such as food at home and home care worker services,
contacts with social workers, equipment provided to patients and changes made to patients’ homes during
the follow-up period. We further collected private expenses, such as travel expenses, prescription costs,
over-the-counter medications, privately paid equipment, changes made to the patient’s home, the burden
of informal care and productivity losses through the collection of time-off work and leisure activities,
and help from friends and relatives to allow for further future economic work.
We gave patients resource-use logs at hospital discharge at 3 and 6 months in order to facilitate their
completion of these questionnaires.432 Both the logs and the questionnaires were tailored to the type of
joint replacement. Examples of the 3-month resource-use questionnaire and log are available online on the
Data Instruments for Resource Use Measurement (DIRUM) database.433,434
Valuation of resource use
Resources used during the initial hospital stay were valued using a microcosting approach, using unit costs
obtained from the North Bristol Trust finance department. Estimates for time spent in theatre and recovery
and admissions to hospital wards included staff time, overheads, consumables and medications. Unit costs
for the local anaesthetic infiltration injection were provided by the Management and Procurement
Department at Southmead Hospital.
Hospital resources used during the follow-up period were macrocosted and valued using Department of
Health Reference costs435 for specialty outpatient clinic and tariffs for inpatient admissions. When tariffs
could not be derived because of insufficient information, inpatient admissions were microcosted using
the number of nights spent in the ward and a day ward cost estimate from the North Bristol Trust
finance department.
Community-based resources and PSS were valued using Curtis’s Unit Costs of Health and Social Care.436
Equipment and changes to patients’ homes, such as dressing aids, furniture raisers, walking aids and
chair lifts, were financed by social services, but provided to patients – on loan – through OTs and
physiotherapists at Southmead Hospital. We assumed a 2-year life period for all equipment and valued it
as the fraction of equipment cost proportional to the duration of patient use. Unit costs were obtained
from equipment suppliers to Southmead Hospital or online sources from other suppliers when
procurement costs were not available.
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Economic outcome measured
The primary health outcome for the APEX economic evaluation was the quality-adjusted life-year (QALY).
A QALY is a measure of disease burden that weights survival by QoL. This generic measure allows for
direct clinical effectiveness and cost-effectiveness comparisons between interventions across all patient
groups and health conditions. NICE guidelines provide recommendations for the UK’s societal willingness
to pay for one QALY gained (section 6.3, Decision-Making86) which allows for inferences about the
absolute cost-effectiveness of interventions to be made. QALYs for the APEX trial were derived using the
EQ-5D-3L questionnaire.437 APEX patients completed the EQ-5D-3L at baseline, and at the 3-, 6- and
12-month follow-ups. The EQ-5D-3L questionnaire is a simple and quick tool developed by health
economists to measure generic HRQoL with the purpose of estimating QALYs. It comprises five
dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension
has three levels: no problems, some problems or severe problems. Each of the possible 243 health states
has been assigned a quality weight (utility) through a valuation survey of a sample of the UK population.
The preference-based quality weights are measured on a scale anchored at zero for death and 1 for the
best imaginable health. Negative values for ‘health states worse than death’ are also possible.438 The scale
has cardinal properties, for example spending 1 year in a health state with a quality weight of 0.5 is
equivalent to spending 6 months in perfect health (quality weight equal to 1). QALYs within APEX were
derived for each trial arm, attributing the quality weights from the UK population to the patients’ answers
to the EQ-5D-3L questionnaire,439 at baseline (pre-operative), and at the 3-, 6- and 12-month follow-ups.
QALYs were then estimated using the area under the curve approach, which assumed a linear change
between time points.440
Data analysis
The economic evaluations in relation to total hip and TKR were conducted as two separate analyses;
however, the same methodology was used for both analyses. The primary analysis for both of these
evaluations was an ITT analysis and took a NHS and PSS perspective, in line with NICE guidelines.86
Costs and QALYs were not discounted because of the 1-year duration of follow-up. All costs are reported
in 2012–13 prices.
Costs were estimated by multiplying units of resource use by its unit cost (Table 49).
The total cost for each individual patient for each of the 17 resource-use categories was calculated as the
sum of the cost of the resource-use items. All available data were used to calculate means and SDs for
resource use and costs for each category by trial arm. This enables comparisons between trial arms of
absolute resource use and costs to aid decision-making. The cost categories were then grouped into initial
inpatient stay costs, secondary care costs during the follow-up period, community-based health-care costs
including medication, and PSS costs. The total cost for each individual patient for these four groups as well
as total NHS costs and total NHS and PSS costs were calculated as above.
Mean and SDs for QALYS were calculated for each arm of the two trials.
Incremental costs for the four main cost groupings, and QALY differences between arms, were then
estimated using ordinary least squares (OLS) regression, with robust standard errors adjusting for the APEX
trial treatment group allocation and minimisation variables: baseline WOMAC pain score and surgical
approach (see Equation 1). QALYs were further adjusted for baseline utility imbalances (see Equation 2).443
Equation 1 for costs:
Costijk = β0j + β1j × Treatment group + β2j × Baseline pain score + β3j × Surgical approach + eij. (1)
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TABLE 49 Unit costs for total hip and knee replacement resource use
Resource use Unit cost Assumption Source
Initial inpatient admission
Theatre (per minute) £14.22 Includes implant cost, staff time,
overheads, consumables, facilities
Mr Michael Iwasiuk, North Bristol
NHS Trust Finance Department,
2014, personal communication
Injection of local anaesthesia
infiltration
£2.00 Box of bupivacaine with adrenaline
0.25%/1 in 200,000 is £20.00. One box
contains 10 ampoules
Mrs Helen Wright, North Bristol
NHS Trust Finance Department,
2014, personal communication
Recovery (per minute) £3.84 Includes staff time with overheads,
consumables, facilities and medications
administered during stay. Base cost
per minute
Mr Michael Iwasiuk, North Bristol
NHS Trust Finance Department,
2014, personal communication
Day in general orthopaedics
ward: Frome, Severn,
Kennett and Critical Care
Unit
£311 Includes staff time with overheads,
consumables, facilities and medications
administered during stay. Base cost
per day
Mr Michael Iwasiuk, North Bristol
NHS Trust Finance Department,
2014, personal communication
Day in other orthopaedics
ward: Chew
£250 Includes staff time with overheads,
consumables, facilities and medications
administered during stay. Base cost
per day
Mr Michael Iwasiuk, North Bristol
NHS Trust Finance Department,
2014, personal communication
Day in high-dependency unit £1356 Includes staff time with overheads,
consumables, facilities and medications
administered during stay. Base cost
per day
Mr Michael Iwasiuk, North Bristol
NHS Trust Finance Department,
2014, personal communication
Inpatient admissions following discharge from initial surgery
Revision surgery: TKR £9439 HB22 A Major Knee Procedures for
Non-Trauma, with Major CC
NHS Reference Costs 2012–13:
Non elective Long Stay435
Revision surgery: THR £8890 HB12 A Major Hip Procedures for
Non-Trauma, with Major CC
NHS Reference Costs 2012–13:
Non elective Long Stay435
Manipulation under
anaesthetic: TKR
£2044 HB24C Minor Knee Procedures for
Non-Trauma, Category 2, without CC
NHS Reference Costs 2012–13:
Non elective Long Stay435
Infections £4124 Infections of Bones or Joints, with CC
Score 5–8
NHS Reference Costs 2012–13:
Non elective Long Stay435
Day case procedures: TKR £655 Day case: HB29Z Minimal Knee
Procedures for Non-Trauma
NHS Reference Costs 2012–13:
Non elective Day Case435
Day case procedures: THR £788 Day case: HB19Z Minimal Hip
Procedures for Non-Trauma
NHS Reference Costs 2012–13:
Non elective Day Case435
Nights in hospital for other
admissions
£311 Unit cost based on SMH cost per night
in general orthopaedics ward
North Bristol NHS Trust Finance
department
A&E and outpatient visits
A&E £117 Average of all accident and emergency
visits
NHS Reference Costs 2012–13:
Outpatient appointments: 180
Accident and Emergency435
Trauma and orthopaedics:
consultant led
£102 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 110
Trauma and Orthopaedics435
Trauma and orthopaedics:
non-consultant led
£90 Non-admitted face-to-face attendance,
follow-up, non-consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 110
Trauma and Orthopaedics435
Physiotherapy:
non-consultant led
£39 Non-admitted face-to-face attendance,
follow-up, non-consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 650
Physiotherapy435
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TABLE 49 Unit costs for total hip and knee replacement resource use (continued )
Resource use Unit cost Assumption Source
General medicine:
consultant led
£145 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 300
General Medicine435
Neurology: consultant led £157 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 400
Neurology435
Respiratory: consultant led £137 Non-admitted face-to-face attendance,
first appointment, consultant Led
NHS Reference Costs 2012–13:
Outpatient appointments: 340
Respiratory Medicine435
Pain management:
consultant led
£136 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 191
Pain management435
Vascular: consultant led £133 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 107
Vascular surgery435
Dermatology: consultant led £95 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 330
Dermatology435
Haematology: consultant led £209 Non-admitted face-to-face attendance,
follow-up, consultant led
NHS Reference Costs 2012–13:
Outpatient appointments: 303
Clinical Haematology435
Community-based health services
GP surgery visit £45 Base cost per patient contact with GP
with qualifications, including direct care
staff costs, lasting 11.7 minutes
PSSRU 2013: 10.8b General
practitioner441
GP home visit £114 Base cost per out of surgery visit with
GP with qualifications, including direct
care staff costs, lasting 23.4 minutes
PSSRU 2013: 10.8b General
practitioner441
Phoned GP for advice £27 Base cost per telephone consultation
with GP with qualifications, including
direct care staff costs, lasting
7.1 minutes
PSSRU 2013: 10.8b General
practitioner441
GP practice nurse visit £13.43 Based on 15.5 minutes per surgery
consultation using the base cost (£52) of
1 hour of face-to-face contact with GP
nurse with qualifications
PSSRU 2013: 10.6 Nurse
(GP practice)441
Phoned GP practice nurse
for advice
£4 Based on 6 minutes of GP nurse time
using the base cost (£40) of 1 hour of
GP nurse time with qualifications
PSSRU 2013: 10.6 Nurse
(GP practice)441
Repeat prescription
(without seeing doctor)
£11.40 Based on 3 minutes of GP time, using
the base cost of 1 minute GP patient
contact time (£3.80), with qualifications,
including direct care staff costs
PSSRU 2013: 10.8b General
practitioner441
District nurse £18.08 Based on the assumption that the
duration of a DN visit is the same as GP
nurse visit (15.5 minutes) and using the
base cost of 1 hour of community nurse
visit (£70) with qualifications including
travel
PSSRU 2013: 10.1 Community
nurse441
OT at home/GP surgery/clinic £17 Based on 30 minutes contact using the
base cost (£34) of 1 hour of OT contact
with qualifications
PSSRU 2013: 9.2 NHS community
OT441
continued
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
195
TABLE 49 Unit costs for total hip and knee replacement resource use (continued )
Resource use Unit cost Assumption Source
Community physiotherapist
at home/GP surgery/clinic
£17 Based on 30 minutes contact using
the base cost (£34) of 1 hour of
physiotherapist contact with qualifications
PSSRU 2013: 9.1 Community
physiotherapist
Prescriptions costs per
consultation
£44.64 Prescription costs per consultation
(net ingredient cost)
PSSRU 2013:10.8b General
practitioner
Social services
Home care worker (home
help) provided by social
services
£24 Based on 1 hour of face-to-face
weekday contact for independent sector
home care provided for social services
PSSRU 2013: 11.6
Food at home service
(meals on wheels)
£3.14 Based on one meal a day using the
meals on wheels average weekly cost
(2012/13) of £44, assuming two meals
per day, 7 days a week
PSSRU 2013: 8.1.1 Community
care package for older people:
very low cost
Social worker visits £113 Based on a 30-minute visit using the
base cost (£226) of 1 hour of
face-to-face contact of social worker
with qualifications
PSSRU 2013: 11.2 Social worker
(adult services)
Social worker telephone calls £39.50 Based on a 30-minute telephone call
using a base cost (£79) 1 hour of client
related work of a social worker with
qualifications
PSSRU 2013: 11.2 Social worker
(adult services)
Home changes and
equipment provided by
social services
All unit costs for home changes and
equipment are based on 3-month loan
period, assuming a 24 months life span
Toilet seat or toilet raiser £1.80 Cost of equipment £14 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Dressing aids: socks,
shoes, etc.
£1.25 Cost of equipment £10 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Furniture raisers £2.48 Cost of equipment £20 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Perching stool £6.00 Cost of equipment £48 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Walker or trolley £7.50 Cost of equipment £60 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
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TABLE 49 Unit costs for total hip and knee replacement resource use (continued )
Resource use Unit cost Assumption Source
Crutches £3.75 Cost of equipment £30 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Commode £5.69 Cost of equipment £46 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Rails and hand grips £2.85 Cost of equipment £23 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Bath boards £3.00 Cost of equipment £24 NRS price – equipment provider
for Southmead Hospital
(Mrs Catherine Hale, Head of
Occupational Therapy at North
Bristol NHS Trust, 2014, personal
communication)
Hospital bed at home £59.88 Cost of equipment £479 Google (Google Inc., Mountain
View, CA, USA) search for
procurement prices (cheaper
range)
Bath lift £44.75 Cost of equipment £358 Google search for procurement
prices (cheaper range)
Chair and stair lift £125.00 Cost of equipment £1000 Google search for procurement
prices (cheaper range)
A&E, accident and emergency; NRS, numerical response scale.
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Equation 2 for QALYs:
QALYij = γ1j + γ1j × Treatment group + γ2j × Baseline utility + γ3j × Baseline pain score + γ4j
× Surgical approach + µij, (2)
where i= individual patient, j= surgery: TKR or THR, k= cost category, and error terms eijk and µijk are
heteroskedasticity consistent (or robust) standard errors.442 Baseline WOMAC pain score and surgical
approach are the two variables used in the minimisation process for randomisation in both APEX trials.
Missing cost and QALY data were imputed using White’s chained equations for multiple imputation426 and
Royston’s ‘ice’ command in Stata 13,444 to generate 20 complete data sets. This method uses regression
techniques to estimate missing values, based on the values of available data. The 17 cost categories and
four EQ-5D utility scores (baseline and three follow-up time points) were imputed jointly, by treatment
group allocation, adjusting for trial minimisation variables and patient baseline characteristics [age, sex,
BMI and dichotomous variables for education level (high vs. medium or low) and marital status (single vs.
married or other)]. The imputation model was run for the hip and knee trial data separately and used
predictive mean matching by trial arm. This avoided unrealistic utility scores or cost values. QALYs and
grouped cost categories were then recalculated using the imputed values and incremental costs and
QALYs with imputed data were then re-estimated using the models in Equations 1 and 2. A decision was
made prior to the analysis that if the missing data were > 30%, then the primary analysis results would be
based on the imputed data.
The incremental costs and QALYs for both trials were then examined for dominance, that is, when one of
the arms cost less but had improved outcome compared with the other arm. If no arm was dominant then
incremental cost-effectiveness ratios were estimated.
Incremental net monetary benefit (INMB) statistics for a range of societal willingness-to-pay thresholds
were estimated. The net monetary benefit statistic is estimated by multiplying the QALY gained by
the societal willingness to pay for QALY gained (λ) and then deducting the cost difference between the
intervention and the control arm (see Equation 3).
Equation 3 for the INMB:
INMBof LAI in relation to control= (QALYLAI −QALYcontrol) × λ− (COSTLAI −COSTcontrol), (3)
where LAI is the local anaesthetic infiltration arm and λ is the societal willingness to pay for a
QALY threshold.
The INMB statistic quantifies whether or not society is willing to pay for incremental cost of providing the
intervention. Positive INMB statistics indicate a cost-effective intervention, whereby society is willing to pay
more for the health gain than the intervention costs, for a given willingness to pay threshold. We used the
thresholds (λ) of £10,000 per QALY and NICE recommended £20,000 and £30,000 per QALY86 to estimate
INMB statistics. In order to account for the uncertainty around the economic results, bootstrapped confidence
intervals (BCIs) with 1000 replications were estimated for the adjusted costs, QALYs and the three INMB
statistics. We further plotted bootstrapped cost and QALY estimates in cost-effectiveness planes.
Cost-effectiveness acceptability curves (CEACs) illustrate the probability of the intervention being cost-effective,
given a range of societal willingness-to-pay thresholds. All analyses were conducted using Stata 13.
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Results
Tables 50 and 51 show the mean resource use and costs in total hip and total knee by trial arm.
Available case categorical resource use and costs
For both total hip and knee replacement, the available case results do not suggest that administering local
wound infiltration analgesia perioperatively increases operation time in theatre; however, local anaesthetic
infiltration may reduce time in recovery by about 10 minutes. For THR, during the initial inpatient stay, the
mean number of days spent in the ward was the same (5.2 days) for both trial arms. However, for TKR,
the intervention arm had 5.9 mean number of ward days compared with 5.2 in the control arm.
TABLE 50 Mean resource use and cost by APEX trial arm for THRs (available cases)
Resource
Intervention (N= 163) Control (N= 159)
n
Mean
resource
use SD
Mean
cost (£) SD (£) n
Mean
resource
use SD
Mean
cost (£) SD (£)
Initial inpatient stay
Theatre time (minutes) 148 99 29 1407 411 147 101 31.6 1441 449
Recovery time (minutes) 143 103 65 397 251 144 113 77.4 435 297
Days in wards 153 5.2 3.3 1597 1516 154 5.2 2.8 1553 886
Secondary care after initial discharge
Inpatient admissions after
initial dischargea
115 – – 341 1847 122 – – 101 554
Orthopaedics appointments 142 1.96 1.2 199 121 146 1.97 1.4 201 138
Physiotherapy appointments 142 0.19 0.8 7 32 146 0.23 0.8 9 30
A&E visits 142 0.06 0.4 7 46 146 0.04 0.3 5 30
Other appointments 142 0.04 0.3 5 37 146 0.04 0.3 7 59
Community-based resources
GP contacts 107 1.90 3.3 61 113 108 2.66 4.5 83 145
Nurse contacts 110 1.60 4.1 25 70 114 1.24 2.7 18 41
OT contacts 113 0.04 0.4 1 7 116 0.08 0.5 1 8
Community physiotherapist
contacts
109 0.25 1.1 4 19 113 0.58 1.8 10 30
Prescriptions at GP consultation 108 0.72 1.3 32 60 111 1.13 2.0 50 87
Total NHS cost 94 3768 1534 90 3818 1086
PSS
Home care worker (hours) 139 1.11 8.1 27 195 144 5.36 56.3 129 1351
Meals (food at home services) 137 2.76 24.0 9 75 138 0.00 0.0 0 0
Contacts with social worker 138 0.05 0.5 4 36 144 0.13 1.1 7 59
Home changesa 161 – – 1 3 158 – – 2 5
Total NHS+ PSS cost 90 3828 1618 88 3999 2088
A&E, accident and emergency.
a The category combines different types of resource use; therefore, an overall mean could not be calculated.
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In both THR and TKR, the intervention group seemed to have less community-based resource use,
particularly in relation to GP contacts, than the control group.
For TKR, there were lower costs owing to hospital readmission for patients in the intervention group,
whereas the reverse was true for patients receiving THR.
Personal Social Services costs contributed minorly to the overall costs of delivering treatment for both types
of joint replacement.
All cost drivers for these trials display high variability, with large SDs around the categorical mean cost estimates.
TABLE 51 Mean resource use and cost per trial arm in TKR (available cases)
Resource
Intervention (N= 157) Control (N= 159)
n
Mean
resource
use SD
Mean
cost (£) SD (£) n
Mean
resource
use SD
Mean
cost (£) SD (£)
Initial inpatient stay
Theatre time (minutes) 142 102 32 1449 453 145 103 32.9 1461 469
Recovery time (minutes) 140 94 44 359 169 136 104 69.1 398 265
Days in wards 147 5.9 3.9 1789 1224 149 5.2 2.9 1586 1034
Secondary care after initial discharge
Inpatient admissions after
initial dischargea
103 – – 104 533 110 – – 296 907
Orthopaedics appointments 128 2.06 1.5 209 149 137 1.99 1.4 202 143
Physiotherapy appointments 128 0.44 2.1 17 82 137 0.40 1.3 16 50
A&E visits 128 0.16 0.7 18 84 137 0.18 1.2 20 145
Other appointments 128 0.00 137 0.03 0.2 4 34
Community-based resources
GP contacts 85 2.65 4.3 84 151 102 3.83 5.7 122 212
Nurse contacts 90 0.98 1.4 14 22 104 1.09 2.7 16 43
OT contacts 95 0.28 1.1 5 19 105 0.25 1.3 4 22
Community physiotherapist
contacts
90 1.03 2.7 18 45 107 1.29 3.5 22 60
Prescriptions at GP consultation
(GP practice)
87 1.30 2.7 58 121 105 1.74 3.7 78 165
Total NHS cost 72 3862 1310 82 4239 1803
PSS
Home care worker (hours) 135 1.17 12.9 28 310 136 1.24 14.4 30 346
Meals (food at home services) 132 0.14 1.6 0 5 129 0.11 1.2 0 4
Contacts with social worker 133 0.11 1.1 4 45 134 0.14 1.6 7 84
Home changesa 157 – – 3 13 158 – – 1 4
Total NHS+ PSS cost 72 3868 1309 79 4276 2076
A&E, accident and emergency.
a The category combines different types of resource use; therefore, an overall mean could not be calculated.
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Complete case costs
In the THR trial, 90 out of the 163 (55%) patients in the intervention arm and 88 out of the 159 (55%)
patients in the control arm had complete NHS and PSS cost data. In the TKR trial, the corresponding
figures were 72 out of 157 (46%) for the intervention arm and 79 out of 159 (50%) for the control arm
patients. For the complete case analysis total unadjusted mean NHS and mean NHS+ PSS cost were lower
in the intervention group than in the control group for the two types of joint replacement.
Tables 52 and 53 report the economic evaluation results and differences between arms in outcomes with
BCIs and totals by cost categories.
In both the THR and the TKR analyses, differences in the imputed and adjusted NHS and NHS+ PSS costs
between the arms indicated that patients in the intervention group had lower mean costs than those in
the control arm at 1 year.
TABLE 52 Total hip replacement: differences in costs and outcomes between APEX randomised groups
Outcome or cost
Difference (intervention – control)
n Mean 95% CI p-value
QALYs
QALY gain: available cases (unadjusted) 216 0.071 0.018 to 0.124
QALY gain: available cases (adjusted)a 216 0.064 0.018 to 0.110 0.007
QALY gain: imputed data (adjusted)b 322 0.056 0.015 to 0.097 0.008
Cost (£)
Initial inpatient stay
Total of inpatient stay: available cases (unadjusted) 274 –127 –367 to 114
Total of inpatient stay: available cases (adjusted)c 273 –123 –364 to 118 0.32
Total of inpatient stay: imputed data (adjusted)b 322 –24 –345 to 297 0.88
Secondary care after initial discharge
Inpatient admissions after initial discharge: available cases (unadjusted) 237 240 –115 to 595
Inpatient admissions after initial discharge: available cases (adjusted)c 236 251 –114 to 617 0.18
Inpatient admissions after initial discharge: imputed data (adjusted)b 322 63 –308 to 434 0.74
Total outpatient visits: available cases (unadjusted) 288 –4 –39 to 30
Total outpatient visits: available cases (adjusted)c 287 –2 –36 to 32 0.92
Total outpatient visits with: imputed data (adjusted)b 322 2 –36 to 39 0.94
Total secondary care cost after initial discharge: available cases (unadjusted) 232 239 –138 to 617
Total secondary care cost after initial discharge: available cases (adjusted)c 231 251 –136 to 639 0.2
Total secondary care cost after initial discharge: imputed data (adjusted)b 322 64 –314 to 443 0.74
Community-based resources
Total community-based costs: available cases (unadjusted) 209 –25 –82 to 31
Total community-based costs: available cases (adjusted)c 209 –23 –79 to 33 0.41
Total community-based costs: imputed data (adjusted)b 322 –47 –116 to 22 0.18
Total NHS cost: available cases (unadjusted) 184 –50 –436 to 335
Total NHS cost: available cases (adjusted)c 184 –43 –427 to 341 0.83
Total NHS cost: imputed data (adjusted)b 322 –7 –535 to 521 0.98
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TABLE 52 Total hip replacement: differences in costs and outcomes between APEX randomised groups (continued )
Outcome or cost
Difference (intervention – control)
n Mean 95% CI p-value
PSS
Total PSS: available cases (unadjusted) 264 –100 –343 to 142
Total PSS: available cases (adjusted)c 263 –83 –289 to 123 0.43
Total PSS: imputed data (adjusted)b 322 –167 –421 to 88 0.2
Total NHS+ PSS cost: available cases (unadjusted) 178 –170 –724 to 383
Total NHS+ PSS cost: available cases (adjusted)c 178 –151 –680 to 377 0.57
Total NHS+ PSS cost: imputed data (adjusted)b 322 –173 –762 to 415 0.56
RESULTS
Mean QALY gain (adjusted, bootstrapped)b 322 0.056 0.020 to 0.092 0.002
Mean NHS+ PSS cost difference (£) (adjusted, bootstrapped)b 322 –173 –658 to 312 0.480
INMB statistic: λ= £10,000 (adjusted, bootstrapped)b 322 £729 £62 to £1397 0.032
INMB statistic: λ= £20,000 (adjusted, bootstrapped)b 322 £1285 £329 to £2242 0.009
INMB statistic: λ= £30,000 (adjusted, bootstrapped)b 322 £1841 £559 to £3122 0.005
λ, societal willingness-to-pay threshold.
a Adjusted for baseline utility and minimisation variables.
b Adjusted for minimisation variables (and baseline utility for QALYs), Number of multiple imputation sets= 20, BCIs with
1000 replications.
c Adjusted for minimisation variables.
TABLE 53 Total knee replacement: differences in costs and outcomes between APEX randomised groups
Outcome or cost
Difference (intervention – control)
n Mean 95% CI p-value
Outcome
QALY gain: available cases (unadjusted) 201 0.015 –0.045 to 0.075
QALY gain: available cases (adjusted)a 201 0.010 –0.039 to 0.060 0.68
QALY gain: imputed data (adjusted)b 316 0.012 –0.035 to 0.058 0.62
Cost (£)
Initial inpatient stay
Total of inpatient stay: available cases (unadjusted) 268 76 –215 to 367
Total of inpatient stay: available cases (adjusted)c 268 89 –194 to 371 0.54
Total of inpatient stay: imputed data (adjusted)b 316 179 –119 to 476 0.24
Secondary care after initial discharge
Inpatient admissions after initial discharge: available cases (unadjusted) 213 –191 –391 to 8
Inpatient admissions after initial discharge: available cases (adjusted)c 213 –170 –365 to 24 0.086
Inpatient admissions after initial discharge: imputed data (adjusted)b 316 –278 –517 to –38 0.024
Total outpatient visits: available cases (unadjusted) 265 2 –46 to 50
Total outpatient visits: available cases (adjusted)c 265 2 –47 to 52 0.92
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For THR, differences between the arms in terms of NHS costs were very minor (–£7). In the intervention
group, the mean cost per patient was £24 lower for the initial inpatient stay (95% BCI –£345 to £297;
p= 0.88), £47 lower for community-based health-care costs (95% BCI –£116 to £22; p= 0.18) and £63
more for readmission costs (95% BCI –£308 to £434; p= 0.74) when compared with the control group.
Mean PSS costs were lower in the intervention group by £167 per patient (95% BCI –£421 to £88;
p= 0.2). This meant that the combined PSS+NHS mean cost per patient was £173 lower in the
intervention group (95% BCI –£762 to £415; p= 0.56).
TABLE 53 Total knee replacement: differences in costs and outcomes between APEX randomised groups (continued)
Outcome or cost
Difference (intervention – control)
n Mean 95% CI p-value
Total outpatient visits with: imputed data (adjusted)b 316 15 –38 to 68 0.57
Total secondary care cost after initial discharge: available cases (unadjusted) 203 –194 –423 to 36
Total secondary care cost after initial discharge: available cases (adjusted)c 203 –165 –391 to 61 0.15
Total secondary care cost after initial discharge: imputed data (adjusted)b 316 –263 –516 to –9 0.043
Community-based resources
Total community-based costs: available cases (unadjusted) 177 –69 –176 to 37
Total community-based costs: available cases (adjusted)c 177 –65 –181 to 50 0.27
Total community-based costs: imputed data (adjusted)b 316 –51 –153 to 51 0.32
Total NHS cost: available cases (unadjusted) 154 –377 –875 to 121
Total NHS cost: available cases (adjusted)c 154 –281 –761 to 200 0.25
Total NHS cost: imputed data (adjusted)b 316 –135 –559 to 289 0.53
PSS
Total PSS: available cases (unadjusted) 259 –4 –95 to 86
Total PSS: available cases (adjusted)c 259 –4 –95 to 87 0.93
Total PSS: imputed data (adjusted)b 316 4 –138 to 145 0.96
Total NHS+ PSS cost: available cases (unadjusted) 151 –408 –962 to 146
Total NHS+ PSS cost: available cases (adjusted)c 151 –329 –851 to 193 0.21
Total NHS+ PSS cost – imputed data (adjusted)b 316 –131 –595 to 332 0.58
Results
Mean QALY gain (adjusted, bootstrapped)b 316 0.013 –0.027 to 0.052 0.530
Mean NHS+ PSS cost difference (£) (adjusted, bootstrapped)b 316 –131 –501 to £239 0.490
INMB statistic: λ= £10,000 (adjusted, bootstrapped)b 316 £258 –£362 to £879 0.410
INMB statistic: λ= £20,000 (adjusted, bootstrapped)b 316 £386 –£585 to £1356 0.440
INMB statistic: λ= £30,000 (adjusted, bootstrapped)b 316 £513 –£832 to £1857 0.450
λ, societal willingness-to-pay threshold.
a Adjusted for baseline utility and minimisation variables (baseline WOMAC pain score and surgical approach).
b Adjusted for minimisation variables (and baseline utility for QALYs), M= 20 multiple imputation sets, BCIs with
1000 replications.
c Adjusted for minimisation variables (baseline WOMAC pain score and surgical approach).
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In contrast, for the intervention group receiving TKR, mean cost per patient for the initial inpatient stay
was greater by £179 (95% BCI –£119 to £476; p= 0.24) and the mean cost per patient of readmissions
was lower by £278 (95% BCI –£517 to –£38; p= 0.024). This meant an overall lower combined PSS+NHS
mean cost of £131 per patient in the intervention group (95% BCI –£595 to £332; p= 0.58) compared
with the control group.
For patients receiving THR, the adjusted and imputed 0.056 incremental QALY gain per patient (95% BCI
0.02 to 0.09; p= 0.002) for the intervention group was markedly higher than for those in the control
group. This corresponded to patients in the intervention arm spending on average an estimated 20 more
days in ‘perfect health’ than patients in the control arm. For the TKR patients, the estimated health benefit
for the intervention arm was also positive but the findings were more uncertain, with a mean of 0.012
QALYs gained per patient and wider CIs crossing the null (95% BCI –0.027 to 0.052 QALYs; p= 0.53).
The cost and QALY results indicate that local anaesthetic infiltration is the dominant treatment option,
that is, it is cost-saving and more effective than current clinical practice for both THR and TKR surgery.
The INMB statistics in relation to the THR study were positive, even at the more stringent willingness-to-pay
threshold of £10,000 per QALY, resulting in a mean INMB of £729 (95% BCI £62 to £1397; p= 0.032).
In the TKR analysis, our findings also indicate positive INMB statistics at all willingness-to-pay thresholds, but
smaller absolute value statistics and more uncertainty around these estimates, with all BCIs crossing the null.
Figures 30 and 31 plot the 1000 replications of the adjusted bootstrapped incremental cost-effectiveness
estimates for THR and TKR in the cost-effectiveness plane and the corresponding CEACs.
Our findings are depicted in the cost-effectiveness planes for THR and TKR, with most estimates falling
within the south-east quadrant of dominant strategies, more notably so for THR than for TKR. The CEAC
shows the uncertainty around the economic results, with a probability of local anaesthetic infiltration being
cost-effective in TKR only slightly > 60% at the £10,000 and £20,000 threshold, whereas the probability of
it being cost-effective is > 99% in THR at £20,000 per QALY and > 96% at £10,000 per QALY.
Discussion
Our findings suggest that administering local anaesthetic infiltration before wound closure is a cost-effective
treatment option, compared with current clinical analgesia regimens in joint replacement surgery. These
findings are supported in THR surgery with large positive INMB statistics for the willingness-to-pay thresholds
of £10,000, £20,000 and £30,000 and a probability of being cost-effective of > 96% at the lowest
threshold. There is no statistical evidence for the positive INMB statistics for TKR surgery, the probability of
being cost-effective is only slightly > 60% at £10,000 and £20,000, although results point to local
anaesthetic infiltration being the dominant treatment option in both surgeries. Considering results from a
NHS perspective only, the cost differences in favour of the intervention arm are greater for TKR than for THR.
Our study has limitations. The economic evaluation was carried out alongside the two APEX RCTs, which were
powered to detect a difference in the primary clinical outcome between arms but not in the cost-effectiveness
outcomes. Secondary economic analyses to include private expenses and productivity losses incurred during
the follow-up period of these trials are planned but have not yet been conducted. Methodological
uncertainties need to be explored in sensitivity analyses. For example, in the THR trial, PSS cost differences
favouring the intervention arm were driven mainly by one control patient requiring many hours of home
care provision. Excluding this patient would potentially lead to a decrease in net monetary benefits. Our
bootstrapping methods will have under-represented the uncertainty of our results with smaller CIs; sensitivity
analysis on multiple imputation and bootstrapping techniques would address this. Collection of resource-use
data, particularly community-based resources and use of PSS, relied on patient-reported data from postal
questionnaires completed at three follow-up points. This led to a substantial number of missing data and
imputation was therefore needed. The imputed value estimates varied substantially from available case
estimates. Such methodological uncertainties need also to be explored in sensitivity analyses.
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FIGURE 30 APEX cost-effectiveness plane and CEAC for THR. (a) Cost-effectiveness plane; and (b) CEAC. LAI, local
anaesthetic infiltration.
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FIGURE 31 APEX cost-effectiveness plane and CEAC for TKR. (a) Cost-effectiveness plane; and (b) CEAC. LAI, local
anaesthetic infiltration.
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Conclusion
The addition of local anaesthetic infiltration to the usual analgesia regimen from the perspective of the
NHS and PSS is a cost-effective treatment option in primary THR. Given that the intervention was
dominant, any uncertainty addressed through future analyses is unlikely to alter the intervention being
cost-effective at current NICE thresholds. Our findings also indicate positive health benefits and cost
savings in TKR, but with considerably more uncertainty around the cost-effectiveness result. Therefore,
there is less evidence in favour of adopting local anaesthetic infiltration before wound closure in routine
clinical practice for patients receiving TKR surgery.
Evaluation of patient recruitment
Sound recruitment processes are critical to the success of RCTs and ethical conduct mandates informed
decision-making by participants. How trial information is explained is vital but communication and training
can be inadequate.
In the early stages of the APEX RCTs, recruitment interviews between research nurses and potential
participants were recorded and transcribed and used as the basis of a peer-review intervention to improve
trial processes and recruitment. This study describes how this process we have named Internal Peer review
for Recruitment Training in Trials (InterPReTiT)368 was developed and used to address the training needs of
nurses recruiting to the APEX RCTs.
The aim of this study was to discuss the potential benefits, effectiveness and acceptability of this process as
a universal method of training recruiters to trials. The discussion is informed by examination of the review
forms the nurses completed over 3 months from 2009 to 2010 when they listened to audio-recordings of
their recruitment interviews and by qualitative evaluation of the audio-recordings of the nurses’ discussions
of these reviews.
Methods
Ethics approval was gained to record recruitment interviews to allow the peer-review process. The
recruiting team consisted of four nurses working in clinical research roles. Before starting recruitment,
the recruiting team familiarised themselves with the APEX trial protocols and research literature regarding
best practice for trial recruitment.
Role-play was used to rehearse presenting study information using an interactive style. When recruitment
began, the nurses gained consent from potential participants to audio-record using a digital recorder.
It was explained to potential participants that the recruitment interview was being recorded for training
purposes. Two potential participants declined to be recorded. In total, 53 recruitment interviews were
recorded, including four interviews with individuals who declined trial participation.
Team members listened to their own, as well as their colleagues’, recruitment interviews and reviewed
them using a standardised checklist to identify whether or not the trial aims, the trial arms, equipoise, trial
involvement, voluntary participation, blinding and randomisation had been adequately explained. Free-text
space was included to record patients’ questions, requests for extra information/clarification and any
notable reactions. A roster ensured a different reviewer for each member of the team each week and
meetings of the team were scheduled to discuss the reviews. The recruiting team met five times over a
12-week period during pilot phase of the trial.
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The recruiting team completed 50 feedback forms, covering 35 recruitment interviews. Recruitment
interviews were selected to be reviewed by more than one nurse because they were of particular interest.
These included recruitment interviews for which potential participants ultimately declined trial participation
and recruitment interviews when communicating the information had been challenging. When the first
reviewer thought that a recruitment interview provided an example of good practice, it was recommended
to the whole team to review.
Analysis
The findings presented derive from audio-recordings of three out of five peer-review meetings and from
the review forms.
Review forms were scrutinised for instances of where the recruiting nurse had failed to convey items of
trial information. When one recruitment interview was reviewed by more than one nurse, the review forms
were compared to assess concordance across reviewers, both of the checklist items and of the free-text
comments. Three out of the five review meetings were audio-recorded with the consent of the recruiting
nurses and used in the evaluation. The first meeting was not recorded as we did not immediately
recognise the value of doing so. The fifth meeting was not recorded as it had already been agreed at the
previous meeting that the training process was complete. No outstanding concerns or uncertainties
remained and the nurses now felt confident in their recruitment practice. Only two nurses attended the
fifth meeting and nothing new arose from the discussion.
The three audio recordings of the review meetings were transcribed verbatim and analysed using
Framework methodology.445 This accommodates both predetermined themes and themes that arise
inductively from the data. Each transcript was read and reread and then coded in duplicate so that salient
content was integrated into the coding framework. The review forms were scrutinised for instances where
the recruiting nurse had failed to convey one or more items of trial information and the free-text
comments were integrated into the coding framework. The coding framework was developed from a
review of the literature regarding recruitment difficulties for RCTs and from the need to check the content
and delivery of trial information during the recruitment interviews. Certain codes including equipoise,
understanding of randomisation and specific information about the trial process were included as
predetermined themes in the coding framework. New codes arising from the data were added to these
and amalgamated into a final overarching framework. New codes derived from the data, included the role
of relatives and managing those who wished to decline.
The data were initially coded by one researcher who is a recruiting nurse who has qualitative research
experience and also training in counselling skills. A second researcher who is an experienced qualitative
researcher with a social and behavioural science background independently double coded the transcripts
and no additional codes were identified.
Results
A flow diagram summarising the peer-review process in the APEX trials is shown in Figure 32.
In the interviews that were reviewed by more than one nurse (n= 7), the inter-rater concordance was
between 78% and 100% (mean 97%). There was universal agreement over which interviews
demonstrated good practice and those which did not.
Interview durations ranged from 6 to 30 minutes, with a mean of 12.4 minutes. Review meetings lasted
from 40 to 60 minutes.
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Five main themes were identified from the qualitative analysis: provision of information, flexible
communication of information, verifying participant understanding, ensuring voluntary participation and
recruiters’ perceptions of the peer-review process. The results presented outline each theme and direct
changes made to the design and conduct of the APEX trials as a consequence of the findings. Supporting
data are presented in Table 54.
Provision of information
To ensure that participants’ consent is fully informed, it is essential that trial information is conveyed accurately
and consistently and in a manner that is clearly understood by potential participants. The analysis identified
both faults in the communication of trial information and participants misunderstanding information.
From comparing recruitment interviews, the nurses identified that the information they were conveying
regarding anaesthesia was not consistent between recruiters. It became apparent that the study protocol
was unclear regarding how the standard anaesthetic technique for patients undergoing THR differed from
that for patients undergoing TKR. Consequently, the diagram used to explain the different anaesthetic
techniques to potential participants was incorrect regarding standard anaesthetic care (see Table 54,
section A, quotation 1).
53 recruitment interviews 
recorded with permission from 
prospective trial participants
35 recruitment interviews 
reviewed by at least one of the 
four nurses using the review form 
roster to ensure all nurses 
reviewed each team member
Peer-review meetings attended by 
all four nurses. Discussed all 
interviews reviewed by more than 
one nurse and 22 others. 
In addition communication 
and information issues and 
strategies and role of peer review
Eight reviewed by more than one
nurse because they were of
particular interest
50 review forms completed
Analysed regarding information
conveyed and comments made.
Consistency between reviews
compared when two or more of
same interview
Audio-recordings of review 
meetings transcribed and 
independently double coded by
two researchers
Three out of five peer-review 
meetings recorded
FIGURE 32 The peer-review process and evaluation.
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TABLE 54 Quotations from research nurse meetings
Section A: provision of information
1 RN1 second meeting She was given the message that whether or not she had a spinal was nothing to do with
the study whereas what we’ve now found out is that if they’re a hip and they cannot
have a spinal they can’t be in the study so if anyone who is for a hip is saying clearly I
don’t want a spinal then they shouldn’t be recruited
2 RN3 second meeting From reading the information sheet, she hadn’t grasped the trial because she didn’t
think she was going to get an anaesthetic, she thought she was just going to get a local
by the sounds of what she asked
3 RN4 third meeting I think people are reading [the anaesthetic leaflet] and really taking a lot of notice of that
and then maybe not giving perhaps quite so much attention to the information sheet
4 RN1 third meeting The major benefit is that [the peer-review process] has made us all clarify exactly what
the anaesthetic options are
Section B: flexible communication of information
5 RN2 second meeting Patients are very different and you do have to tailor it and you try and make it
conversational so it’s not so stilted and so artificial
6 RN4 third meeting Most people have dental experience and it’s a good one to use, isn’t it, because people
have that understanding
7 RN3 second meeting If you have a planned kind of set routine to your patter, you know that you’re
potentially going to cover every point but then if you make it fresh for each patient you
might miss something
8 RN1 second meeting I was . . . trying to keep in my head what I was trying to say and keep it clear and get to
the end of it so you kind of override what the patient wants to say
9 RN2 second meeting When it’s more participant led . . . you perhaps don’t give everything but you’ve still had
a good consenting process, . . . they’re reassured and they actually understand it . . . and
that’s come back that . . . they’ve got it
Section C: verifying participant understanding
10 RN4 second meeting I found myself just repeating things just because I wasn’t really getting any feedback
from her at all. And I found it really difficult because . . . there wasn’t really any verbal or
any other sort of communication from them
11 RN1 second meeting It’s checking comprehension isn’t it, which is different to asking if they’ve got any
questions, because they might not have questions but they might have completely the
wrong idea of the trial
12 RN3 second meeting The patient told you their understanding of the study and you gap-filled . . . you could
actually tell . . . from listening to it that she understood the study and she was
consenting because she knew what was going to happen
13 RN2 second meeting I think it’s doing that delicately without patronising. It’s sort of open questions but I
know I find it difficult . . . how to get it from them, without patronising them or . . .
putting them on the spot
Section D: ensuring voluntary participation
14 RN2 third meeting I’ve said to a guy ‘you’re not quite sure or perhaps this isn’t for you’ and they’ve leapt
on that with you know, enthusiasm, ‘yes, that’s quite right’ you know, and that having
given them that door they’re out and down the corridor
15 RN1 fourth meeting I thought . . . how we can break this up a bit more so that we get a bit more from her
and make it possible for her to say no
16 RN4 second meeting It is difficult because she had a daughter with her . . . You don’t know if she’s agreeing
because, yes OK she is happy or is she agreeing because her daughter thinks it is a
good idea?
17 RN3 fourth meeting And it also shows . . . with the husband interjecting so much, how much it’s not just the
patient you need to win over but the relative with them
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In addition, it became apparent that the description of the different anaesthetic techniques in the
participant information sheet was frequently misunderstood and that many patients feared they might only
receive a local anaesthetic during surgery (see Table 54, section A, quotation 2). This was partly because a
separate information booklet about spinal anaesthesia produced by the Royal College of Anaesthetists in
the UK was included with the study information. This deterred some participants from considering
participation (see Table 54, section A, quotation 3).
Impact on trial design
A substantial amendment was submitted to the ethics committee to amend the participant information
sheet, clarifying that the intervention anaesthetic was additional to the current standard anaesthetic.
The explanatory diagram used in recruitment was amended to reflect the correct anaesthetic information.
The protocol was also amended to remove the booklet about spinal anaesthesia from the study
information pack sent to potential participants. Information routinely provided to patients receiving
standard care did not include this booklet. The nurses were satisfied that they had now achieved clarity
regarding the anaesthetic options (see Table 54, section A, quotation 4).
Flexible communication of information
The nurses recognised that ensuring information needs were properly met required a flexible, interactive,
conversational style tailored to each patient, while still conveying standardised information (see Table 54,
section B, quotation 5). Different ways of conveying key concepts were explored and the whole group
subsequently adopted ones that were felt to be the most effective at communicating the concept because
they drew on experiences familiar to the participant, for example explaining the intervention anaesthetic by
likening it to the local anaesthetic used for dental work (see Table 54, section B, quotation 6).
TABLE 54 Quotations from research nurse meetings (continued )
Section E: recruiters’ perceptions of the peer-review process
18 RN4 second meeting I just don’t feel very comfortable with tape-recording. I think it is a good way to learn . . .
I think it does highlight your own strengths and weaknesses which is a good thing
19 RN3 second meeting I was a bit like cringe . . . Oh my god, we’re going to record, we’re going to record and
I’m slightly better with it now, but I can see the value of it and the learning experience
from it
20 RN4 second meeting I think once we knew that it was going to remain within this group that made me feel a
bit more comfortable
21 RN2 third meeting You want people to feel comfortable so that you can constructively say things about
other people, you can reflect on yourself
22 RN1, RN2, RN4 third
meeting
But it helps to increase trust, doesn’t it? In that we are all kind of working the same way
Reassurance as well, isn’t it
I think it’s brought us together more as a team
23 RN2 third meeting You are more aware of reflecting on was that good, was that bad, why wasn’t it? . . .
I think with any new study you develop your pattern and you often get stuck in that
pattern. I think with this, I have definitely changed mine . . . and put things differently
which I wouldn’t have done otherwise
24 RN4 third meeting Wouldn’t you feel if you move onto another study that you’d want to do this
RN, research nurse.
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In the early stages of recruitment, the recruiting nurses identified difficulty conveying all the necessary
information while also making the recruitment interviews interactive and tailored to individual communication
needs (see Table 54, section B, quotations 7 and 8). However, the nurses agreed that presenting all the
information at once, using a script, made it harder for patients to comprehend and express questions or
concerns and was less likely to elicit evidence of understanding (see Table 54, section B, quotation 9).
Impact on trial design
To allow for an interactive, tailored approach to engage participants and address their concerns and
information needs, while still ensuring that all the information was conveyed, the use of a checklist instead
of script was adopted.
Verifying patient understanding
In order to gain evidence that consent was informed, the nurses needed to stimulate sufficient interaction
to address all potential concerns and questions and to confirm understanding. However, some patients
were less responsive or did not ask questions (see Table 54, section C, quotations 10 and 11). Recruitment
interviews were critiqued regarding helpful and unhelpful techniques to overcome this, such as using open
questions, encouraging patients to interrupt, asking what understanding patients had of the study and
asking them to summarise what the recruiting nurse had told them. The strategic use of open questions
facilitated a participant-centred interaction in which potential gaps in understanding could be explored.
However, the task of checking understanding needed to be accomplished respectfully and sensitively
(see Table 54, section C, quotations 12 and 13).
Impact on trial design
Different ways of checking participants’ understanding were discussed and subsequently all the recruiters
began by asking the potential participant what they had understood about the study from what they had
read in the information leaflet. This conferred the advantages of confirming whether or not the patient
had read the information leaflet, clarifying how much information they understood and recalled, and
inviting the patient to take an active part in the discussion of the trial information from the outset.
Ensuring voluntary participation
Sometimes it was difficult to gauge potential participants’ understanding of the trial and whether or not
they were genuinely willing to participate. The nurses realised that some patients may have difficulty in
freely discussing their potential participation owing to anxiety about their intended operation, being out of
their own environment and feeling somewhat intimidated by professional roles, or might simply find it
difficult to say no. Sensitivity to both verbal and non-verbal cues prompted nurses to create opportunities
for potential participants to decline (see Table 54, section D, quotations 14 and 15).
The role of participants’ relatives was also discussed as their presence could complicate assessment of
truly informed consent. Relatives were often helpful in facilitating the patient to understand key trial
information, but sometimes took it on themselves to decide about study involvement on behalf of the
patient and had their own questions and concerns that needed addressing (see Table 54, section D,
quotations 16 and 17). The nurses identified the need to deal respectfully with relatives’ questions and
opinions while at the same time maintaining the focus on the potential participant’s wishes.
Recruitment interviews that ended without consent were felt to be particularly useful in the peer-review
process because they provided an opportunity to review whether or not the recruiting nurse might have
achieved a different result if the interaction had been managed differently or communication conveyed in
a different way. They also provided an opportunity to evaluate the appropriate level of encouragement
to participate and to check that if potential participants were reluctant to participate this was respected
and handled appropriately. Reviewing these interactions provided an excellent opportunity to discuss the
potential tension between maximising recruitment and ensuring that consent was truly voluntary and fully
informed. The nurses were reassured that patients were being recruited appropriately and not subject to
undue persuasion.
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Recruiters’ perceptions of the peer-review process
The recruiting nurses also reflected on their experience of the peer-review process. Initially they were
apprehensive about recording and hearing their own recruitment interviews, but recognised the potential
benefits (see Table 54, section E, quotations 18 and 19). There was anxiety about feeling judged or being
considered less effective than colleagues, but seeing it as a mutual learning experience contained within the
nurse team helped to overcome reservations and was important to enable open discussion (see Table 54,
section E, quotations 20 and 21).
Important perceived benefits of the peer-review process were reassurance about individual and team
practice and increased team cohesion (see Table 54, section E, quotation 22). Other benefits included
reflection on personal practice, which prompted changes in individual conduct of recruitment interviews
(see Table 54, section E, quotation 23). Overall, the process was felt to be a valuable learning tool because
it facilitated reflection and learning from others’ practice in a supportive and reassuring environment. All
felt that overall practice and safeguards in recruitment were enhanced and that they would want to repeat
this process in subsequent trials (see Table 54, section E, quotation 24).
Discussion
As recruitment to RCTs is pivotal to their success,446 it is crucial to equip recruiters adequately for their
important role. In addition to a sound knowledge of protocol and ethical principles, those involved in
recruitment require good interpersonal communication skills to respond flexibly to the specific information
and comprehension needs of individual participants and to identify their concerns. Previous qualitative
analysis of recordings of recruitment interviews447 has highlighted the need to improve communication
techniques, in particular adequately explaining equipoise and the process of randomisation, in order to
ensure fully informed consent. Acquisition of these skills has been identified as a key area to address
to optimise recruitment,447,448 but there is as yet no reproducible process that has been demonstrated to be
both effective and acceptable in a range of trials.
We have drawn on prior work conducted in the Prostate Testing for Cancer and Treatment (ProtecT) study,
which sought to improve trial processes and recruitment to a multisite RCT using a variety of approaches,
including using a peer-review process in which senior staff from one site reviewed the practice of another
site.449 Further work focused on using qualitative analysis of recruitment interviews, followed by feedback
to recruiting staff in other trials to see if it could be used to improve recruitment.450 However, difficulties
relating to both logistics and acceptability limited effectiveness. de Salis and colleagues450 found that,
because the analysis and feedback process had not been included in the initial study protocol of the trials,
they were faced with governance issues which made it very difficult to implement peer review quickly
enough to make a difference in trials currently under way.450 They also found it difficult to get all members
of the study team on board and to commit to the process, concluding that it was important to build it into
the study protocol at the trial design stage. In addition, reluctance among recruiting nurses to take part in
recording recruitment interviews that would be listened to and scrutinised by researchers outside the study
team seriously hampered the process.
We aimed to overcome these difficulties. First, the initial APEX trial protocol specified that recordings of
the recruitment interviews would be analysed during the pilot phase in order to ensure consistency of trial
recruitment and assist with training needs of the study recruitment staff and this was included in all
research governance applications. Embedding the peer-review process in the trial design from the outset
ensured that all members of staff recruited to deliver the trial were made aware that recording recruitment
interviews would be standard practice. Building this process into the protocol also means that the time
and costs needed to conduct the peer-review process can be factored in when writing grant applications.
Study performance gains, such as increased recruitment and acceptance of randomisation may potentially
outweigh the cost of staff time to complete the process, but this needs to be formally evaluated in future
work. In our study, the total time taken to listen to the recordings and complete review forms was
10.33 hours, based on an average of 12.42 minutes per recording and a total of 50 recruitment interviews
reviewed. The total nurse time spent in review meetings was approximately 16 hours. Not all the
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interviews that were recorded were reviewed but having a good sample size allowed the purposive
selection of interviews that were of particular value for the training process, because they provided
examples of good practice, had been particularly challenging, or demonstrated the need for additional
clarification about aspects of the trial. Furthermore, the length of time needed to complete the training
process was not predetermined and the meetings concluded when consensus was reached among the
nurses that no new learning was likely to be achieved and each felt competent in their recruitment
practice. The period of time required for training is likely to differ according to the complexity of the trial
and the intervention, and the experience of the recruiting nurses, but sufficient time needs to be given
for at least two cycles of reviewing, evaluating and sharing practice, implementing new techniques or
adjusting practice, and re-evaluating. Sufficient interviews need to be recorded to capture a good variety
of interviews and circumstances and of participant interactions and responses.
Second, whereas de Salis and colleagues450 had been hampered by recruiting nurses’ reluctance to record
recruitment interviews, we circumvented the nurses’ apprehension that others might scrutinise and
appraise them by confining the peer review to the recruiting nurses. In addition, making the peer review
exclusive to the recruiting nurse team enhanced team cohesion by helping to build trust and foster
working relationships, benefiting both communication and efficiency.
Qualitative methods were used to evaluate the intervention from the points of view of both effectiveness
and acceptability to the recruiting nurses. Effectiveness, in terms of benefits for the recruitment process,
was evident in several areas. First, adherence to the protocol was improved. As a result of peer review,
the recruiters increased their knowledge of the trial design, identified areas of the protocol that were
ambiguous and clarified the eligibility criteria. Second, a barrier to recruitment was identified in the
information that patients received prior to meeting the recruiting nurse and was subsequently addressed.
Third, use of a checklist during review of recruitment recordings improved the consistency and
completeness of information given verbally to potential participants. It would have been difficult to identify
these issues using other quality control methods449 and, without this structured process during the initial
pilot phase, problems may have continued for some time. Fourth, compliance with good clinical practice
was enhanced by developing strategies to check participant understanding of trial information and key
concepts, ensuring equipoise and gaining better evidence of informed voluntary consent, all of which can
impact on trial recruitment and retention.451 A formal trial of our methods could provide additional
important evidence regarding effectiveness, as in this case we had no comparator and were unable to
determine whether or not the intervention made a difference to recruitment rates. In future evaluations it
would also be valuable to gain consent to analyse the recruitment interviews to unpack the processes at
work and to directly compare patients’ and recruiting nurses’ perspectives of the same interview.
The acceptability of recruitment training by means of peer review was evident in the qualitative data.
Our evaluation provided similar findings to other studies involving other health professionals and different
contexts. Those involved in peer review as a training method often experience initial apprehension but
later conclude that it is both supportive and valuable for improving practice.452 Once initial apprehension
was overcome, the recruiting nurses considered peer review to have been a very productive and acceptable
training method. Each nurse within the team benefited from individual feedback and the opportunity to
learn from other members of the team, which contributed to professional development in a way that
was clearly recognised. Consideration needs to be given to how peer review is facilitated so that group
members feel safe enough to share examples of practice that they feel are suboptimal.453 The requisite
skills and knowledge also need to be available to the group, either from the facilitator or from within
the group as a whole.452 In our case, one member had previous training in group facilitation and
communication skills and others had extensive experience of trial recruitment.
Implications for nurses recruiting patients into clinical trials
Nurses recruiting to trials require additional training because they must obtain consent for an intervention
that is administered for reasons other than anticipated benefit to the individual patient. Recruitment
training should address both generic and study-specific skills as ‘each RCT has a unique – and uniquely
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complex – recruitment pathway and its own set of issues that need to be resolved’.450 Although training
those responsible for recruitment to a RCT is a crucial part of the set-up phase of a trial, it is often not
done in a structured way. Our intervention provided a constructive forum to compare and critique ways of
conveying the study information and become skilled at clearly articulating the trial design, which is vital to
maximising recruitment.454 From this process, we developed a set of recruitment competencies, specific
to the APEX trial, that were then used in conjunction with the peer-review training method to train new
members of the nurse recruiting team in a structured way. This was an important step towards formalising
and evaluating recruitment training and in creating a process that could be applied to other trials. As a
result of this work, the NHS sponsoring organisation adopted the principle of assessing the competencies
of nurses recruiting to RCTs, creating a two-part competency framework based on the competencies
developed in this study. The first part consists of generic competencies related to International Council for
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice
principles. The second part consists of competencies specific to the individual trial, which must be specified
and assessed by the principal investigator (PI) in order to delegate responsibility for recruitment to suitably
experienced and qualified recruiters.
Conclusions
Sharing experience of recruitment and formal comparison of recruitment interviews in a creative and
supportive environment can lead to the identification of best practice, improved communication skills and early
awareness of issues and problems which might otherwise have an impact on recruitment for much longer.
Views and experiences of trial participation and use
of analgesics
In addition to our longitudinal qualitative research focusing on experience of patients undergoing hip and
knee replacement, we also conducted qualitative research with patients and health-care professionals who
were involved in the APEX trials. This qualitative study aimed to describe and explore the experience of
health-care professionals who were involved in the trials and patients’ experience of participation. The
qualitative research with patients also aimed to explore patients’ experiences of joint replacement, with a
focus on surgery and medication. Using qualitative methods in the context of controlled trials has long
been advocated455 and such methods are valuable to improve understanding of the experiences of patients
receiving, and staff delivering, a trial and intervention.456,457
Background
Involvement in clinical trials
Previous research has highlighted weakness in the present orthopaedic literature, as studies are being
given poor ratings in independent meta-analyses and the American Academy of Orthopaedic Surgeons
evidence-based clinical guidelines.458,459 This has led to a growing emphasis on the importance of
orthopaedic evidence through higher-quality RCTs.460
The success of a RCT is dependent on adequate recruitment and retention of patients within a timely
manner. It has been suggested that 50% of RCTs fail to recruit their planned number of participants,451
which can undermine the power the study, lead to sampling bias and limit generalisability of results. Little
is known about why patients may be motivated to take part in trials, or their experiences of taking part.
Understanding these can be integral to successful recruitment and retention.461 Trial success is equally
dependent on the engagement of a large multidisciplinary clinical team and involves effective
communication and attention to the study protocol. Less is known about clinical staff members’
experiences of trial involvement. Exploring the views of health-care professionals involved in a delivering
RCTs and patients’ participating in the same trials enables the identification of factors that may enhance
understanding of how to best deliver RCTs in orthopaedics.
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Attitudes to analgesics
Patients living with osteoarthritis use medication including paracetamol, non-steroidal anti-inflammatory
drugs and opioid medication to manage their condition.26,27,462,463 Research has provided insights into how
people living with osteoarthritis feel about and use pain relief, highlighting the complexity of adherence to
these medications.26,27 In addition, although persistent pain is the key indication for total hip or knee
replacement, the need for pain management continues after surgery.464,465 Over half of patients
undergoing total hip or knee replacement report moderate to severe pain on the first day after surgery.70
Chronic post-surgical pain is also common, with 10–34% of TKR patients and 7–23% of THR patients
reporting long-term pain after their operation.18 The pain associated with both osteoarthritis and total hip
or knee replacement confirms the need for patients to receive appropriate intervention at all stages of the
illness trajectory. Therefore, it is important to learn how undergoing total hip or knee replacement affects
existing attitudes and behaviours with regard to pain medications.
Methods
Sampling and recruitment
During recruitment to the APEX trials, patients were asked if they were willing to be contacted about
taking part in a qualitative interview. From those who agreed to contact we identified a sample of men
and women who were a range of ages and comprised a balance of THR and TKR patients. The
programme’s qualitative researcher telephoned individuals in this sample and asked if they were still
interested in taking part in a qualitative interview. Of the 26 people contacted, 25 agreed to see the
researcher to discuss study participation and interview; however, one of these subsequently withdrew from
APEX and was no longer eligible to take part. Interviews were also conducted with a range of health-care
professionals involved in the APEX trial. Health-care professionals were purposely sampled to include those
involved in pre-assessment, surgery and recovery phase of the trial and contacted by telephone or e-mail.
Fifteen health-care professionals took part in interviews. The samples are described at the start of Results,
below. Data collection proceeded in parallel with analysis and continued until data saturation was reached
such that no new insights were being achieved by the end of data collection.255
Data collection
All participants provided their written, informed consent immediately prior to interview. Interview topic
guides were used, informed by the literature. Patients were asked to describe their decision-making
regarding trial participation, understanding and experience of the trial. In addition, patients were asked
about their views on, and experience of, pain and pain relief as a way of contextualising their experiences
of trial participation. Health-care professionals were asked to talk about their views and experiences of
trial involvement.
Interviews with patients were conducted 2–4 weeks after surgery in participants’ own homes between
April 2010 and January 2011 and lasted between 45 and 120 minutes. Health-care professional interviews
were undertaken in hospital premises between March 2011 and June 2012 and lasted between 19 and
40 minutes. The research team comprised qualitative methodologists with backgrounds in social and
behavioural sciences.
Data analysis
Interviews were audio-recorded, transcribed and anonymised. Interview transcripts were checked for
accuracy and then imported into ATLAS.ti qualitative data analysis software, which aids the management
and indexing of qualitative data. Analysis began shortly after data collection started and was ongoing and
iterative. Thematic analysis,257 utilising a data-driven inductive approach,466 was used to scrutinise the data
in order to identify and analyse patterns and themes of particular salience for participants and across the
data set using constant comparison techniques.467 Transcripts from patients and health-care professionals
were analysed separately and, using an inductive approach, we assigned codes to all of the data. We
developed a coding framework, which was refined as analysis progressed. The research team grouped the
codes and coded material into superordinate themes by identifying connections between the codes and
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data.259 To ensure robust analysis a subset of transcripts was independently double coded by other
members of the research team and compared, any discrepancies were discussed within the research team
and resolved in order to ensure robust analysis. We did not analyse the patient data according to the
group allocation of participants within the randomised trial. This is because this nested qualitative study
aimed to explore beliefs and behaviour relating to pain around the time of surgery and trial involvement.
The trials aimed to study impact of additional analgesia on outcome at 12 months after surgery.
Results
The 24 patients who participated were 11 men and 13 women, aged 26–92 years. Fourteen were in
the trial to undergo hip replacement and 10 were in the trial for knee replacement (Table 55). The 15
health-care professionals consisted of four men and 11 women, aged 28–56 years. They comprised three
pre-operative clinical nurses, four ward nurses, four orthopaedic surgeons, two anaesthetists and two ward
managers. We have not provided a table of participating health-care professionals so anonymity is not
compromised. Patients were assigned pseudo initials and health-care professionals were assigned a
number with their job role listed when we provide illustrative quotations.
TABLE 55 Views and experiences of trial participation and use of analgesics: patient characteristics
Pseudonym Age (years) Sex Operated joint
Mrs A 73 Female Hip
Mrs B 65 Female Hip
Mrs C 72 Female Knee
Mr D 72 Male Knee
Mrs E 79 Female Hip
Mr F 67 Male Hip
Mrs G 59 Female Hip
Mrs H 73 Female Hip
Mr I 53 Male Knee
Mrs J 64 Female Knee
Mrs K 63 Female Knee
Mrs L 46 Female Knee
Mr M 50 Male Hip
Mr N 45 Male Hip
Mrs O 52 Female Hip
Mrs P 76 Female Knee
Mr Q 75 Male Hip
Mr R 26 Male Hip
Mr S 76 Male Knee
Mr T 74 Male Hip
Mrs U 71 Female Knee
Mr V 66 Male Knee
Mr W 92 Male Hip
Mrs X 77 Female Hip
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Findings from the interviews with health-care professionals
Health-care professionals views on trial involvement
Clinical staff said that they were happy to be involved in a trial that they understood as important, relevant
to patient experiences and central to the clinical staff members’ professional practice (Table 56).
Staff weighed up the perceived benefits and costs of being involved in the trial. Some clinical staff
reported initial concerns relating to expectations of the research staff, the possibility of an increased
workload and the logistics of recruiting patients in a busy clinic. These initial concerns were alleviated once
they learned more about the study, with many commenting that they appreciated that the trial had been
designed to have minimal impact on, and normalised into, their daily clinical practice (Table 57).
Clinical staff noted that the research nurses played a central support role in clarifying procedural details
and their flexibility in smoothing out any initial issues and reducing any burden of the trial on clinical staff
was appreciated and welcomed (Table 58).
TABLE 56 Health-care professionals’ views on trial involvement
Health-care professional Quotation
S8, senior nurse I think it’s really valuable because the more you can help people with pain, you know,
it’s really - I think that’s one thing that the patients are frightened of, isn’t it, when they
have surgery with anybody? I would be. . . . So, you know, the advances in pain relief
and making sure they’re relatively pain-free, has got to be good
S9, trainee nurse practitioner That’s really good. Because I mean that comes – you know, that rolls into what we’re
doing as well, to what you’re doing, and everything is just contributing towards trying
to keep the patient pain-free for longer, and to get them more mobile, and to get them
out back into their own home, which is good
S10, surgeon I thought that it was a good idea to give a little local anaesthetic, you know, so the
patient um, they’re more comfortable when they wake up um and er the body gets
time to acclimatise, so to speak, to the pain, rather than they wake up in serious pain.
. . . I’ve never thought about doing an objective assessment, you know, um, you know,
as qualitative as this
TABLE 57 Health-care professionals’ views about benefits and costs of trial involvement
Health-care professional Quotation
S2, ward nurse It was a little bit worrying and we’d think, ‘Oh gosh, you know, we’re all being
watched.’ [Laughs.] You know, because you do think, oh research, are people going to
be coming in, and are they going to be asking lots of questions? And I suppose
sometimes there is a fear there of thinking, ‘Oh my gosh, you know, what is going to
be expected?’
S7, pre-operation clinic
manager
Well it’s just like part of what happens now
S14, consultant anaesthetist No I have no problem, I mean it’s a great opportunity to contribute to research . . .
So there’s not much that we have to do there. OK, we had to just do a standardised
anaesthetic and fill in the form, so I think you didn’t ask for too much
S12, consultant anaesthetist I thought it was going to be OK because essentially it was using the same anaesthetic
that we were already using for the knee, um for our primary knee replacements. So I
didn’t think it would have much impact on what I did, in terms of the anaesthetic, so I
was quite happy to go along with it
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Health professionals’ views of patient benefit from trial participation
During the interview, some ward staff also commented on the benefits that they thought patients
achieved by participating in a trial. These included patients gaining a better understanding of their
situation through completing study questionnaires, an increased sense of security as patients felt that they
received additional monitoring and satisfaction from involvement in health research (Table 59).
Findings from the interviews with patients
Trial participation
Benefiting others Patients reported several different reasons for trial participation. Altruistic reasons
focusing on benefit to society were common; patients viewed their participation in trials as contributing to
advancement of scientific knowledge. In addition, patients expressed gratitude to unknown members of
previous generations who had participated in research that had contributed to improvements in medical
care that they were currently receiving. This motivated them to participate in research to help future
generations (Table 60).
Perceived benefits and costs of trial participation Patients weighed up potential risks and benefits of
trial participation and were motivated to take part in the trial if they saw few negative consequences in
relation to being randomised to either of the trial arms. Patients said that APEX was seen as a low-risk trial
to participate in owing to being randomised to standard care or standard care plus additional treatment.
Patients did not feel like they would be ‘losing out on anything’ (Mrs L). The requirements of the trials in
terms of data collection were not seen as a burden to the majority of patients. They considered the data
collection methods and length of follow-up to be clear, acceptable and undemanding (Table 61).
TABLE 59 Health-care professionals’ perceptions of patients’ trial participation
Health-care professional Quotation
S2, ward nurse Oh they like it, because they’re involved. They feel like they’re involved and they’re
participating in a trial, ‘I’m doing a study, I’m helping them do a study, looking at how
we’re going to help patients in pain.’ So yeah, most – well all of them seem to be
pleased about being on the trial
S3, senior ward nurse I think it’s [trial participation] probably given the patients a lot more support and security
maybe understanding in their own pain relief and to know they are being followed
through as well
S6, ward manager I think most of them [patients] seem very laid back about it. They have expressed
absolutely no worries about it whatsoever and they seem very well informed.
My feeling is that they probably think it’s quite exciting
TABLE 58 Role of research nurses
Health-care professional Quotation
S5, ward manager Seeing someone every day is good. You know they are going to come up, if there’s any
issues. Um. . . . So I think that’s worked well that they’re very visible
S6, ward manager We haven’t really asked for as much help as they [research nurses] have offered. They
have been here and given us a lot of information and they have again been offering
staff any support they can possibly think of and um you know whether it was to do
with filling out the forms or where we put the forms after we have completed them.
You know what sort of support we need to give the patients. So yes they’ve been
excellent really
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Potential personal benefits Patents were additionally motivated to participate in the trial by the hope
that they may also have personal benefit from trial participation. Trial involvement brought with it the
chance that patients might obtain the latest medical care, possibly receiving medical treatment that is not
routinely available. Patients described the potential benefit of receiving more anaesthetic if they had been
randomised into the intervention arm of the trial, while also demonstrating a good understanding of the
process and the need for randomisation and blinding (Table 62).
TABLE 61 Patients’ trial participation decision-making
Health-care professional Quotation
Mrs L I thought well it’s not as though it’s going to be a new drug what you’re testing on her,
it’s only going to be anaesthetic but it’s only going to be a trial if it works or it didn’t
work. I mean it’s not as though I’m going to lose anything if it doesn’t work. I thought if
it does work then I’ve gained a lot so it’s not as though it’s going to be a new drug
you’re trying out if it’s only anaesthetic. So I thought well yeah, if it’s going to help me
with the pain afterwards then yeah
Mrs K It’s all self explanatory isn’t it really, no I don’t think so no, I understood and knew what
it all entailed like. I mean it doesn’t really entail much apart from a few forms
Mrs E Yeah, I thought, ‘Well, somebody got to do it’, I mean, all these things take time, and
someone’s got to do it, and I thought, ‘Well, I don’t mind, I won’t be doing anything
when I come home’. [Laughs.] Yeah, it’d be an interest anyway
Mr M What harm can it do? I am sitting at home so I might as well, better than doing
a crossword
TABLE 62 Patients’ perceived potential physical benefits of trial participation
Health-care professional Quotation
Mrs P When she said they would inject into the scar before they send it up I thought ‘oh lovely
a bit more pain, less pain’ [yes], but I don’t know whether I had it done so I suppose it is
in my mind. I might have had it I don’t know
Mrs X I just thought what a good thing um, you know, to have that extra help at that time, er
to relieve pain, you know. So I thought it – yeah, I said to my daughter, ‘No, I will do
that, because I think it’s really good’
TABLE 60 Altruistic and reciprocal reasons for patient trial participation
Health-care professional Quotation
Mrs B Well I just thought that anything that might help people in the future. You know if
people don’t do things like that [then] improvements might take place but probably a
lot more slowly. I think that it’s a good thing to do for the benefit of people who are
having operations in the future really that’s why
Mrs G I think, well unless you have guinea pigs how do you know how things are going to
work? Yeah you don’t know if you were one of the people that got the stuff or if you
were one of the people that didn’t but unless you have people to talk to and to find out
about things how do you know? You’re never going to learn
Mrs Q My attitude to that is things they know now somebody has done that in the past so if
they learn more it’s going to be valuable to people in the future. I’m all for that. . . .
Years ago they used to cut peoples legs off with saws, they’ve moved on quite a bit
from that haven’t they
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Patients also reported a range of psychological benefits of trial participation. Patients described that a
potential personal benefit from trial participation could be from increased surveillance by the researcher
team. Even though trial participation may not directly improve their situation, the extra monitoring reassured
patients. Patients also thought that completion of the questionnaires may have helped them to consider and
better understand their pain and outcomes and helped quantity the patients’ pain experience (Table 63).
Pain relief medication Patients who took part in the qualitative study nested within the APEX trials also
reflected on their use of pain relief medication pre-surgery, during their hospital stay and while recovering
from their operation at home. The analysis of the data relating to pain relief medication identified two
superordinate themes relating to use of pain relief over these periods: shifting acceptability, and necessity
and value. We also found that behaviour and beliefs relating to pain relief medication were influenced by
external factors that are described after the two themes.
Summaries of patients’ experiences at different time points in their journeys through joint replacement are
illustrated in Figure 33 and are summarised in Box 19. We present a description of the themes that
describe how and why patients made their decisions about pain relief.
Shifting acceptability (Table 64) Patients’ decisions about use of pain relief medication were influenced
by their beliefs about the acceptability of medication use. This changed over time, with short-term use
seen as acceptable but longer-term use seen as not acceptable. Patients’ willingness to use pain relief
medication changed from their time before surgery, during their time in hospital and subsequently on their
return home. Immediately after surgery, patients thought that recovery in the acute postoperative phase
was time-limited and they started to reduce their use of pain medication. This was directly related to their
wish to return to a situation of some normality in which they limited their use of pain relief. As time
passed, long-term use was no longer acceptable. Decisions about medication use were also influenced by
other factors including the acceptability of using pain medication compared with living with pain and
associated limitations, concerns about side effects and beliefs about ‘light’ non-prescription medications
compared with ‘heavy’ prescription medications.
TABLE 63 Patients’ perceived psychological benefits of trial participation
Health-care professional Quotation
Mr M I think for a certain degree that I had some scepticism to a degree in my own mind that
if there is a what if it went wrong, somebody else is looking from another corner at me,
it may help to decipher why, when, where, what how it went wrong
Mrs P Oh my pain going down? Yes because you don’t think do you. You think everyday ‘oh it
is the same, oh I wish it would hurry up oh it is still there’. But it wasn’t you could tell
and as like when I get up in the morning and I would go to the toilet, have my wash
and come back in and then I would sit and fill it and I would think ‘oh it is a lot
better today’
At home
Short-lived acceptance
Reduced medication
Concern
In hospital
Willingness
Recovery
Trust
Pre-surgery
Restraint
Resistance
Concern
FIGURE 33 Summary of patients’ pain relief experiences over the total hip or knee replacement journey.
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BOX 19 Summary of patterns of pain relief use over the total hip or knee replacement journey
Patterns of pain relief use during the pre-operative period
l Patients were living with chronic pain.
l Patients had access to non-prescription medication and prescriptions for stronger pain relief.
l However, use of pain relief medication was avoided and restricted.
I would take very, very rarely and only when the pain was unbearable . . . I could go a month or six weeks
without because I don’t like taking tablets.
Mr N
Patterns of pain relief use during the hospital stay
l Patients were faced with the threat of acute postoperative pain.
l Many changed their use of pain relief during this period.
l They were motivated and more willing to take full and regular doses of pain medication.
But I felt that I needed that, by golly that was needed without a doubt and I used to have one eye on the
clock . . . especially as things started to wear off.
Mr M
Patterns of pain relief use while recovering at home
l After discharge, patients initially took their medications as they had done in hospital.
l However, within a few days of coming home, they returned to their pre-surgical pattern of medication use.
l Patients cut back on their use of pain medication whether or not they were still in pain.
I was on regular medication [when I came home after total hip or knee replacement], I was obediently
taking it, accepting my bag of drugs that I came out with thinking, maybe I won’t need all of that, but I
did, and I went back to the GP, I did get some of the prescription replenished. But since then I’ve dropped
the lower level medication down considerably.
Mrs O
TABLE 64 Shifting acceptability
Health-care professional Quotation
Mrs O So over a sort of time scale, means to an end, I’m very compliant. But it’s the
long-term aspect that I’m so defiant about. . . . I’m fine around accepting it when it’s
short-term, short-term issue, and it’s, it’s deemed with a current problem. I can handle it
then, yeah it’s becoming a long-term reliance that frightens me
Mrs P I don’t like this feeling. . . . I would rather put up with the pain than be feeling nauseous
because it is a horrible feeling. . . . So I have cut down to one now. I have got to stop
because they are not doing me any good. They are stopping the pain but they are not
making me eat
Mrs O I was very, very reluctant to get on that, on that track as far as the heavier duty
medication was concerned. So I was managing with over-the-counter stuff really. . . .
I suppose you always needed to know that you had a margin to, to operate with.
I don't know, yeah letting yourself down
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Necessity and value (Table 65) Patients described beliefs about the necessity and value of medication
to help them manage their changing pain experience. Use of medication was in part a moral decision,
based on notions about when it was right to take analgesia. Although many talked of experiencing
chronic pain before their operation, most did not think the pain was ‘bad enough’ to justify use of pain
relief medication. Patients first waited to see if they could manage without use of pain relief and only took
it as a last resort to enable them to ‘live’ and function with pain. However, patients also reported that the
intensity of pain and discomfort that they experienced immediately after surgery outweighed their
concerns about certain medications, resulting in increased pain relief medication use. This view that
medication was needed to facilitate coping with pain caused by surgery also influenced their decisions
about medication in their early recovery period after discharge. Taking regular pain relief after their
operation was also recognised by patients as an imperative component of their recovery process, an
outlook that served to over-ride any long-held negative attitudes towards analgesia. Patients’ thoughts
about the value of pain medication were also balanced against the intensity of their pain in the weeks
after their operation. At 2–4 weeks post surgery, some patients had stopped taking pain medication. They
explained that this was because they were no longer experiencing what they considered to be significant
pain and, therefore, saw no real value or continued benefit in doing so.
External influence on behaviour and beliefs (Table 66) Narratives illustrated the central role that
health-care professionals can have in influencing patients’ views on and use of pain relief during their
journey through total hip or knee replacement. Before patients had their operation, consultations
with health-care professionals were useful in encouraging them to increase the effectiveness of their
self-management by moving from ‘light’ pain relief to the ‘heavier’ prescription-only drugs. The influence of
health-care professionals in patients’ use of pain relief increased when they went into hospital to have their
operation. It was then that most no longer held firm to their long-standing beliefs about the acceptability,
necessity and value of pain relief when ‘experts’ were directly on hand to provide pain management.
TABLE 65 Necessity and value
Health-care professional Quotation
Mrs C I felt well see if I could go around without taking them. . . . You know if you can
manage without the tablets
Mrs G And you can’t tell when the shooting pain’s going to come anyway so what was
the point?
Mr M Interviewer: And how did you feel when you woke up?
Mr M: Rough, bloody rough, yes really rough, not right, and I was on a drip that I could
control [PCA: morphine] but it was timed but I had to press the button to get any more,
and it went to 2 minutes and 39 seconds because I counted 37, 39, yes, because
I wanted that extra . . . I was a bit worried, especially with morphine, of becoming
addicted to morphine because I have heard stories about people who are but I am fine
Mrs X When I was in hospital, yes. And I had to struggle to get out of bed and, and take
myself to the toilet. So in order to fortify myself, I had to, I knew I would have to take
those painkillers, you see
Mrs E I felt, ‘Oh, I don’t know what the pain’s about, so I’ll take . . . come off of them and
see’, but I haven’t had any pain since. Touch wood. And then the next day, I thought,
‘I’m coming off this sickness one as well, because why am I taking it if I’m not being sick
now’. So I came off that as well. So all I’m taking is my blood pressure tablets and two
aspirin, that’s all I’m taking now
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Instead, they put their faith in health-care professionals to provide them with only those medications that
were essential to help with their recovery. Accounts also revealed the heightened influence of health-care
professionals over the ways in which patients used pain relief after their surgery. For example, the influence
they had over decisions to carry on regularly using pain medications during their initial period of recovery
at home.
Discussion
Trial involvement
Both patients and health-care professionals reported that their initial interest in APEX was a result of the
trial being perceived as an important area of research that was highly relevant to the patients’ experience
of surgery. The data demonstrate the importance of addressing a question of substantial interest,
relevance and value to health-care professionals and patients to get ‘buy-in’ from all. In addition, revealing
the need to produce clear trial information for both patients’ and health-care professionals to explain the
rational and importance of the RCT.
Patients and health-care professionals both stated weighing of perceived benefits and costs associated
with involvement in APEX. The data demonstrate the need for minimal personal burden when undertaking
a trial.468 For health-care professionals, this was achieved by employing research nurses to ensure that the
trial had minimal impact on daily clinical practice and also to be available to clarify procedural details to
ensure the protocol was adhered to. Patients thought that participation in the trial had minimum costs to
them and they felt that the possibility of randomisation to either trial arm, and the requirements of data
collection, were acceptable. A limitation of the study is that we only captured the views of patients who
agreed to take part in the trials and we were unable to speak with patients who declined to take part.
Patients motivations for trial involvement are multifaceted and complex,469 and include a range of personal
and social elements.470 Patients often stated altruistic reasons and expressed the desire to help others by
contributing to the furthering of clinical knowledge.471 However, only a minority of patients stated purely
altruistic reasons, with many reporting a range of perceived physical and psychological benefits.461 It is
therefore vital during recruitment that time is spent on identifying and dispelling expectations that might
not be met by the RCT.
TABLE 66 External influences
Health-care professional Quotation
Mrs H Pre-surgery
I was only taking paracetamol, four times a day, two four times a day. And then my
doctor said ‘well you ought to be taking ibuprofen that will get the inflammation
down’ so I was taking ibuprofen
Mr N In hospital
Always coming round with your tablets . . . and on their little rounds and anything
from a couple of tablets at a time to about eight. You could have had a right cocktail
sometimes. . . . I took whatever they gave me because . . . I, they know what they’re
doing. I wouldn’t have dreamt of not taking any of them because it’s tried and tested
so I had all the belief in it
Mr N At home
Interviewer: So all the painkillers you’ve been taking since your operation, was that
something that was discussed with you?
Mr N: Yes. They explained what benefits . . . and obviously I’ve had to lower my guard
on my tablet intake . . . and I go with the experience and knowledge of people
telling me
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Pain relief medication
Attitudes to pain relief medication are dynamic. Undergoing total hip or knee replacement has the
potential to temporarily alter an individual’s view of the acceptability, necessity and value of pain relief
medication. This alteration is related to views about the cause of pain (pain from intervention vs. pain from
chronic condition) and interactions with health-care professionals. However, once initial recovery from
surgery has begun, long-standing beliefs about the appropriate use of analgesia in the management of
pain may again take prominence.
Health-care professionals appeared to exert considerable influence on patients’ beliefs about the essential
nature of pain medication during the hospital stay. Although there is notable contact with health-care
professionals during this period, in the pre-surgical period this contact is less frequent. After surgery,
patients are discharged from hospital with pain medications, but contact with health-care professionals
may be minimal, which means that contact before surgery might be particularly important. It was clear
from this study that interactions between health-care professionals can provide crucial opportunities to
discuss pain management. During these interactions, health-care professionals may wish to consider
challenging or reinforcing patients’ beliefs about pain relief medication with a view to ensuring that
patients’ pain is as well managed as possible.
Local anaesthetic anaesthesia: overall discussion
and conclusions
Perioperative care should include appropriate multimodal anaesthesia supported by evidence from
adequately powered RCTs. Systematic review identified 36 RCTs evaluating local anaesthetic infiltration
in patients receiving THR and TKR. Few reported long-term post-surgical follow-up. Local anaesthetic
infiltration was effective in reducing short-term pain when compared with no infiltration. Clinical
effectiveness was enhanced with the addition of post-closure analgesia through drains that had been sited
intraoperatively. However, there was some evidence to suggest that this was associated with an increased
risk of infection. In patients receiving TKR, there was no evidence of additional benefit if a FNB had already
been sited. FNBs affect knee extension and could delay postoperative mobilisation. Therefore, we need to
compare local anaesthetic infiltration with FNB to see which is most effective and which allows earlier
mobilisation and discharge.
In the APEX RCTs, local anaesthetic infiltration was associated with reduced long-term pain 1 year after
THR. Findings in patients receiving TKR provided no strong evidence that local anaesthetic infiltration
reduced long-term pain in addition to that provided by FNB. From the perspective of the NHS and PSS,
local anaesthetic infiltration is a cost-effective treatment option in primary THR but evidence supporting its
use in TKR was less strong.
Patients’ views on pain medication are dynamic and change in the perioperative period when they have
more clinician contact and perceive a necessity to take analgesic to treat surgical pain. After surgery,
clinician contact diminishes and patients tend to revert to traditional and long-standing beliefs about pain
medication. The attitudes of patients to pain and pain medication throughout the patient journey need to
be explored more fully, particularly with regard to whether or not patients’ needs are being addressed
prior to surgery, and for those who have long-term pain.
In addition to the clinical results from the trial, we have learned valuable lessons about the running of trials
from our qualitative work with patients, clinicians and researchers. Patients are willing to participate in a
trial if they feel the question being addressed is important, if the participation burden is low and if there is
a perceived or possible benefit for them. Clinicians are willing to participate if the appointment of research
staff does not result in the trial impinging on clinical time.
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Chapter 7 Exploring and understanding pain
in the context of hip and knee replacement:
a cohort study
Parts of this chapter have been reproduced from Wylde and colleagues472 © 2015 Wlyde V, Sayers A,Lenguerrand E, Gooberman-Hill, Pyke M, Beswick AD, et al. Preoperative widespread pain sensitization
and chronic pain after hip and knee replacement: a cohort analysis. Pain 2015;156:47–54 and from Sayers
and colleagues473 © 2016 The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on
behalf of the American College of Rheumatology. This is an open access article under the terms of the
TODO: click through URL Creative Commons Attribution-Non Commercial-No Derivs License, which
permits use and distribution in any medium, provided the original work is properly cited, the use is
non-commercial and no modifications or adaptations are made.
Abstract
Background
The wealth of data collected in the APEX RCTs provided the opportunity for further analyses as a
cohort study.
Methods
The APEX cohort study included 322 patients receiving a THR and 316 patients receiving a TKR.
Radiographic measures of osteoarthritis severity were correlated with pre-operative WOMAC pain and
function. Associations between measures of pain over time were explored. The association between pain
and widespread pain sensitivity, measured using quantitative sensory testing (QST), was investigated.
Results
There was no relationship between the degree of radiographic damage and pain or function in patients
waiting for THR. In patients waiting for TKR, those with the least severe radiographic damage reported
more severe pain and poorer function.
Long-term pain after THR was predominantly associated with pain at rest during the pre-operative and
acute postoperative period. In contrast, long-term pain after TKR was predominantly associated with the
severity of pain on movement during the pre-operative period.
Pre-operative widespread pain sensitivity was not associated with change in pain severity from
pre-operatively to 12 months postoperatively in patients with total hip or knee replacement.
Conclusions
There was an inverse association between radiographic severity of osteoarthritis and pain and function in
patients waiting for TKR but no association in THR. Different pain characteristics predicted long-term pain
in total hip and knee replacement. Pre-operative widespread pain sensitivity did not predict the amount of
pain relief that patients experienced after joint replacement.
Background
As described in Chapter 6, between 2009 and 2012 322 patients undergoing THR and 316 undergoing
TKR were recruited into the APEX trials.
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The main purpose of the APEX trials was to assess the relationships between perioperative pain and
patient outcomes at 12 months. However, the study also provides us with a large cohort of patients having
hip and knee joint replacement surgery and the opportunity to investigate the associations between
baseline characteristics, as well as the associations between baseline characteristics and outcomes at 1 year
after surgery. The primary focus of these cohort analyses was on pain because we have comprehensive
assessments of pre-operative pain, acute postoperative pain and chronic post-surgical pain.
Relationship between structural joint changes and pain
and function
Background
Osteoarthritis can be defined on clinical terms, by radiographic evidences of changes, or on the basis of
the pathology in the joint. Epidemiological studies of osteoarthritis have generally used radiographic
assessment of joint damage to define the disease and the most widely used tool is the Kellgren and
Lawrence X-ray grading system.423
The relationship between radiographic evidence and pain is generally poor,474,475 although relatively few
data have been published on this relationship in patients with osteoarthritis that is severe enough to result
in them having joint replacement, as opposed to population- or service-based cohorts with milder forms of
the disease. Furthermore, very few studies have looked at the separate relationships between pain and
function and radiographic severity. Some recent data suggest that those patients coming to surgery who
have milder radiographic changes respond less well to joint replacement than those with the most severe
evidence of joint damage on a radiograph.476,477
In the APEX study we have assessed all pre-operative radiographs available, using standard methods, and
we are relating radiographic data to pre-operative pain and function data.
Methods
A single observer assessed all radiographs. The observer was a specialist registrar in trauma and
orthopaedic surgery who had undergone two training sessions on the specific study research methods with
one of the coPIs of the project who has extensive experience with radiographic changes in osteoarthritis.
Standard proformas used to report the findings are shown in Appendices 29 and 30. After first checking
that the radiograph was readable and reporting the presence on any existing implant, the Kellgren and
Lawrence score423 was assessed using standard definitions of the five grades (0–4). We then assessed
individual radiographic features (osteophyte, joint space narrowing, subchondral sclerosis and cysts) using
the Altman and Gold atlas of individual radiographic features in osteoarthritis.478 Finally, the pattern of
osteoarthritis within the joint was reported. From these data, we then calculated a modified Kellgren and
Lawrence grading, as previously reported by Dieppe and colleagues.479 This divides the two most severe
grades (3 and 4) into two subcategories each, based on the amount of joint space narrowing reported and
the presence or absence of major subchondral bone remodelling. The purpose of this is to provide a finer
differentiation of the severity of radiographic damage in severe osteoarthritis, which, on the traditional
Kellgren and Lawrence score, will almost always be grade 3 or 4.
Inter-reader reliability was assessed by the main reader and his mentor assessing 30 random films selected
from both the hip and knee cohorts independently, at the end of the study, and the κ-statistic
was calculated.
One-way analyses of variance (ANOVAs) were used to analyse the differences between grades of modified
Kellgren and Lawrence score WOMAC pain or function means. Tukey post hoc tests were conducted to
identify which means differed from each other.
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Results
A total of 322 hip patients and 316 knee patients were randomised in the APEX trials. The WOMAC pain
scores were collected for each of these patients. The WOMAC function scores were available for only
304 hip and 296 knee participants. Data could not be obtained for 49 hip and 45 knee patients either
because the pre-operative radiograph could not be found or because the quality of the film was too poor.
The tests of inter-reader reliability between the two observers for the modified Kellgren and Lawrence
scores showed a moderately good level of agreement (κ= 0.55 for the hip and 0.48 for the knee).
The WOMAC pain and function scores are presented in Table 67. As can be seen, the modified Kellgren
and Lawrence scoring resulted in four levels of osteoarthritis severity, with reasonable numbers in each
category to relate to data on pain and other baseline variables. A small number of patients had little or no
evidence of radiographic damage at the time of surgery (14 hip patients and five knee patients). This is
both surprising and unexplained, but has been noted in other cohorts.477,479
No between-group differences in mean scores of self-reported pain and function were observed for the hip
participants. These findings suggest the absence of relationship between the degree of radiographic
damage and the severity of either pain or function in patients about to undergo a hip replacement for
their advanced osteoarthritis.
However, at the knee joint we do see some interesting in different relationships. Participants in the
modified Kellgren and Lawrence 3a group (those with the least severe radiographic evidence of
osteoarthritis) had the worst pain and function scores. Their mean pain scores differed significantly
(p< 0.05) from participants in the 4a, 4b and not-gradable groups, while their mean function score
differed from each of the other groups. Participants in the other three groups (3b, 4a and 4b), who have
the more severe damage on radiography, had comparable pain and function score levels – suggesting a
possible threshold effect – but self-reported pain and function were significantly worse in those with the
least severe radiographic evidence of osteoarthritis.
TABLE 67 Pre-operative WOMAC pain and function by grade of modified Kellgren and Lawrence for patients
undergoing primary hip or knee surgery
Outcome WOMACa
Hip Knee
n mean SD F-test; p-valueb n mean SD F-test; p-valueb
Pain mK&L < 3 14 37.1 8.9 F(5,316)= 1.78;
p= 0.116
5 38.0 23.1 F(5,310)= 2.42;
p= 0.036
mK&L-3a 35 42.1 21.4 14 30.0 12.9
mK&L-3b 71 46.5 18.3 109 40.8 17.0
mK&L-4a 64 43.8 16.5 96 44.3 17.0
mK&L-4b 89 42.0 19.6 47 44.8 14.9
Not gradable 49 37.4 18.1 45 44.3 16.2
Function mK&L < 3 12 32.6 16.7 F(5,298)= 2.06;
p= 0.070
4 52.6 12.1 F(5,290)= 2.52;
p= 0.030
mK&L-3a 34 45.2 16.8 10 27.9 11.8
mK&L-3b 68 46.8 17.6 104 45.4 16.7
mK&L-4a 59 43.3 19.2 92 47.2 18.6
mK&L-4b 86 40.5 18.8 45 48.5 19.1
Not gradable 45 39.1 20.5 41 46.2 16.7
mK&L, modified Kellgren and Lawrence.
a WOMAC scores range from 0 to 100 (worse to best).
b One-way ANOVA.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
229
Discussion
Overall, the radiographic evidence of osteoarthritis changes that we observed are consistent with other
cohort studies of people with severe hip or knee osteoarthritis.477,479 The finding of no relationship between
pain and radiographic severity at the hip is also consistent with previous data.479 The striking and new
finding from this study is the quite large differences between the severity of both self-reported pain and
function in those with modest radiographic evidence of osteoarthritis changes at the knee compared with
those with severe radiographic changes.
This key finding is at odds with the data from a similar cohort studied in a very similar way in Australia.477
In that cohort, no relationship was found between pre-operative radiographic severity and baseline pain
and function. However, the Australian health-care system is quite different from the NHS and there are
long waiting lists for joint replacement;480 therefore, patients tend to come to surgery at a very late stage
so one explanation for these differences could be the relative paucity of patients in the 3a modified
Kellgren and Lawrence grade in the Australian cohort.
In our view, this finding makes sense in relation to decision-making regarding joint replacement. If a
patient has significant pain and/or functional problems, and radiographic evidence of severe osteoarthritis
changes, then surgery is likely to be recommended. However, if the radiographic changes are less severe,
then the doctors will be more cautious, questioning whether or not the joint damage is the main cause of
the pain. But if the patient is complaining of terrible pain and or functional problems, then the decision to
operate is more likely to go ahead, even if the radiographic changes are mild.481 However, it is interesting
to note that we found no such relationship at the hip joint, emphasising the important difference between
end-stage hip and knee osteoarthritis.
Pain
Background
Pain is the primary reason for patients electing to undergo joint replacement surgery and the expectations
are that the surgery will provide pain relief. However, our work has shown that 7–23% of THR patients
and 10–34% TKR patients experience chronic pain after surgery.18 The difference in the prevalence of pain
after THR and TKR is important and adds to the growing body of evidence that hip and knee osteoarthritis
are different diseases. Within the APEX cohort, there are longitudinal pain data on both THR and TKR
patients, which allows us to compare and contrast pain pathways with the aim of informing the clinical
treatment of these diseases.
Within the surgical literature, there is a growing recognition of the importance of distinguishing between
pain at rest and pain on movement due to differing mechanistic pathways and clinical implications, such as
differential effectiveness of pharmacological therapies and impact on functional recovery.482 The aim of this
analysis was to compare and contrast the associations between pre-operative pain, acute post-surgical
pain and chronic post-surgical pain after THR and TKR, focusing on the differences between pain at
rest pain and pain on movement.
Methods
Exposures/mediators
The primary exposures of interest were:
1. pre-operative pain, measured using the WOMAC pain scale
2. acute postoperative pain measured on postoperative day 1, 2 and 3 using a VAS; the severity of pain
on rest and pain on movement were rated
3. chronic post-surgical pain, measured using the WOMAC pain scale at 12 months after surgery.
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Confounding variables
This analysis involved analysing data from the APEX trials as cohort data and, therefore, additional
adjustment was required to control for confounding factors (as per any cohort study) and trial
randomisation. Analyses were adjusted for sex and socioeconomic status, which consisted of employment
status, cohabitation and educational attainment.
Statistical methods
Descriptive statistics
Population characteristics and outcome measures are reported as means, SDs and interquartile cut-off
points for continuous measures, and as frequencies for categorical variables.
Traditional approach
Using linear (OLS) regression, the association between pre-operative pain, acute postoperative pain on
movement and at rest, and chronic pain were investigated. Results are reported in natural units (per unit
increase in the exposure) and the association with the outcome, 95% CIs, standard errors and p-values are
also reported.
Pre- and postoperative WOMAC pain scores were transformed to a 0–100 scale and VAS scores were
converted into a 10-point ordered response scale. Acute pain on movement and acute pain at rest scores
were averaged across the nine measurement occasions.
Structural equation modelling approach
A structural equation modelling (SEM) framework was adopted for three reasons: (1) it provides a
framework to conduct mediation analyses, that is, investigate the direct effect of pre-operative pain on
chronic pain and indirectly via acute pain on movement or acute pain at rest, (2) it allows multi-item pain
assessments to be investigated without simple aggregation of scores and (3) it can be estimated in the
presence of missing data under the missing at random assumption using maximum likelihood with
missing values.483
Importantly, results from SEM are interpreted with respect to the latent constructs of pre-operative pain,
acute pain on movement, acute pain at rest and chronic pain. The results are interpreted on the same
scale as the scores were originally measured, that is the WOMAC pain scale (a 5-point scale), and the
acute pain on movement or acute pain at rest are 10-point scales. Although using a SEM approach does
not affect the interpretation of the association between pre-operative and chronic pain compared with
the more traditional approach (as the scales are changed equally), the association between pre- and
postoperative pains scores and VAS scores will be approximately 1/20th of the size, as the WOMAC is
scored from 0 to 100 in the traditional approach.
Further analyses were conducted by grouping items in the pre-operative/postoperative WOMAC
assessment more strongly associated with acute pain on movement and acute pain at rest. This subdivision
enables the two main constructs of the WOMAC pain scale to be investigated simultaneously.
All analyses were investigated in THR and TKR patients separately. All analyses were conducted in Stata
13.1. Traditional analyses were conducted using the regress command and SEM models were estimated
using the sem command using maximum likelihood with missing values.483
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Results
Descriptive data
Baseline characteristics of participants are provided in Table 68. Patients undergoing THR had a mean age
of 66.2 years (SD 10.9 years), which was slightly younger than the mean of 69.1 years (SD 18.6 years) for
TKR patients. A total of 321 THR and 316 TKR patients completed a pre-operative WOMAC pain scale and
were included in the analyses. Pre-operative WOMAC pain scales contained very little missing information
and pain levels were very similar between THR and TKR patients (Table 69).
During the acute post-surgical phase, VAS scales were well completed (90% and 87% for THR and TKR
patients, respectively); however, lower completion rates were observed on postoperative day 3 (see Table 69).
At 12 months postoperatively, 15% of patients with THR and 33% of patients with TKR reported severe/
extreme pain, defined as WOMAC pain score of ≤ 50.
Traditional approach
Using simple linear regression, the association between pre-operative WOMAC (0/100) pain and chronic
WOMAC (0/100) pain, adjusted for confounding factors, was investigated in THR and TKR patients
(see Table 69). Pre-operative pain was significantly positively associated in both instances; however, the
association in TKR patients was four times as large as in THR patients.
Acute pain on movement and acute pain at rest were also significantly positively associated with chronic
pain in both THR and TKR patients. Owing to the traditional inverse coding of the WOMAC pain score
(0 extreme pain, 100 no pain), this was an inverse association. The association between acute pain at rest
and chronic pain was stronger than the association between acute pain on movement and chronic pain
(Table 70).
Adjusting the association between pre-operative and chronic pain for acute pain on movement and/or
acute pain at rest resulted in minor attenuation of the association in THR patients, and a slightly stronger
attenuation in TKR patients.
Structural equation modelling approach
Using the SEM approach resulted in a stronger association between pre-operative and 12-month WOMAC
pain in both THR and TKR patients. The majority of the increase in the strength of association can be
attributed to the more efficient use of data via the latent constructs as opposed to excluding those
individuals with missing data (results not shown). Similarly, the associations between acute pain on
movement, acute pain at rest and chronic pain have changed. In THR patients, the association between
acute pain on movement and chronic pain has been attenuated (0.074 × 20= |1.48| vs. |–1.86|), and the
association between acute pain at rest and chronic pain has been enhanced (0.176 × 20= |3.52| vs. |–2.2|).
The pattern of change in TKR patients is different with the strength of association between acute pain at
rest or acute pain on movement being greater than the traditional approach (see Table 70).
Furthermore, when the association between pre-operative pain and chronic pain is adjusted for acute pain,
either on movement or at rest, there is stronger attenuation in the SEM approach, suggesting a stronger
mediating effect of acute pain (see Table 70).
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TABLE 68 Demographic characteristics of APEX hip and knee patients
Location Variable n Missing
Hip Randomisation
Standard care 159
Intervention 163 0
Sex
Male 134
Female 188 0
Employment
Unemployed 195
Employed 103 24
Retired
Not retired 133
Retired 189 0
Cohabitation
Alone 74
Not alone 232 16
Education
≤ 16 years 208
> 16 years 99 15
Knee Randomisation
Standard care 159
Intervention 157 0
Sex
Male 150
Female 166 0
Employment
Unemployed 220
Employed 66 30
Retired
Not retired 98
Retired 218 0
Cohabitation
Alone 84
Not alone 213 19
Education
≤ 16 years 224
> 16 years 69 23
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TABLE 70 Regression (OLS and SEM) analysis of pre-operative and acute pain assessments and postoperative pain
in hip and knee patients
Region Outcome Model Exposure Adjusted Beta SE 95% CI p-value
OLS regression
Hip Postoperative
WOMAC
1 Pre-operative
WOMAC
Confounders 0.105 0.05 0.006 to 0.204 0.0385
2 Acute move Confounders –1.866 0.57 –2.986 to –0.746 0.0012
3 Acute rest Confounders –2.200 0.62 –3.414 to –0.986 0.0004
4 Pre-operative
WOMAC
Confounders+ acute
move
0.095 0.05 –0.003 to 0.192 0.0575
5 Pre-operative
WOMAC
Confounders+ acute
rest
0.092 0.05 –0.005 to 0.190 0.0631
6 Pre-operative
WOMAC
Confounders+ acute
move+ acute rest
0.092 0.05 –0.005 to 0.190 0.0636
Knee Postoperative
WOMAC
1 Pre-operative
WOMAC
Confounders 0.434 0.07 0.295 to 0.574 0.0000
2 Acute move Confounders –1.996 0.65 –3.283 to –0.708 0.0025
3 Acute rest Confounders –2.234 0.62 –3.452 to –1.016 0.0004
4 Pre-operative
WOMAC
Confounders+ acute
move
0.402 0.07 0.258 to 0.546 0.0000
5 Pre-operative
WOMAC
Confounders+ acute
rest
0.389 0.07 0.245 to 0.534 0.0000
6 Pre-operative
WOMAC
Confounders+ acute
move+ acute rest
0.389 0.07 0.244 to 0.533 0.0000
SEM (MLMV)
Hip 1LV postoperative
WOMAC
1 Pre-operative
WOMAC
Confounders 0.169 0.07 0.038 to 0.300 0.0112
2 Acute move Confounders 0.074 0.03 0.008 to 0.140 0.0289
3 Acute rest Confounders 0.176 0.05 0.087 to 0.266 0.0001
4 Pre-operative
WOMAC
Confounders+ acute
move
0.158 0.07 0.028 to 0.289 0.0174
5 Pre-operative
WOMAC
Confounders+ acute
rest
0.141 0.07 0.013 to 0.268 0.0311
6 Pre-operative
WOMAC
Confounders+ acute
move+ acute rest
0.147 0.07 0.019 to 0.275 0.0247
continued
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Mediation analysis
Single latent variable WOMAC
Using the WOMAC score as a single latent variable, the association between pre-operative pain, acute
pain on movement/rest and chronic pain was investigated. Figure 34a and b illustrates the path models
between latent variables for the THR and TKR patients, respectively. Arrows indicate the direction of
effects. Coefficients are in the natural units of the measurement scales and p-values are based on
z-distribution. Models are estimated using maximum likelihood allowing for missing values.
The WOMAC single latent variable models differ to those presented in Table 70, by allowing for
pre-operative pain to influence acute pain on movement and acute pain at rest. In THR patients, the direct
effect of pre-operative pain on chronic pain is nearly identical and only a minor increase in the standard
error is observed. This model also highlights that the attenuation observed in model 6 compared with
model 1 (see Table 70) is primarily as a result of the acute pain at rest pathway and not acute pain
on movement.
The pattern of results in TKR patients is somewhat less clear. There is a strong association between
pre-operative pain and both acute pain on movement and acute pain at rest. However, there is only a
relatively weak effect of acute pain on movement and acute pain at rest on chronic pain.
TABLE 70 Regression (OLS and SEM) analysis of pre-operative and acute pain assessments and postoperative pain
in hip and knee patients (continued )
Region Outcome Model Exposure Adjusted Beta SE 95% CI p-value
Knee 1LV postoperative
WOMAC
1 Pre-operative
WOMAC
Confounders 0.669 0.11 0.452 to 0.886 0.0000
2 Acute move Confounders 0.138 0.04 0.052 to 0.224 0.0016
3 Acute rest Confounders 0.218 0.06 0.104 to 0.331 0.0002
4 Pre-operative
WOMAC
Confounders+ acute
move
0.622 0.11 0.403 to 0.841 0.0000
5 Pre-operative
WOMAC
Confounders+ acute
rest
0.583 0.12 0.353 to 0.812 0.0000
6 Pre-operative
WOMAC
Confounders+ acute
move+ acute rest
0.567 0.13 0.305 to 0.830 0.0000
1LV, one latent variable; MLMV, maximum likelihood with missing values; SE, standard error.
Notes
Confounding variables include trial randomisation, education, cohabitation, employment and sex. WOMAC pain scale in
OLS regression-based analyses range from 0 to 100 (extreme pain/no pain). SEM analyses are based on a 1LV analyses of
WOMAC pain items which range from 1 to 5 (extreme pain/no pain); SEM models are estimated using MLMV which
assumes missing data are missing at random given other covariates.
In OLS analyses, acute pain on movement and acute pain at rest are based on a.m., noon and p.m. averages across the
3 days, and acute pain assessments range from 0 to 10.
In SEM analyses, acute pain on movement and pain on rest are modelled using a latent variable approach for which the
three daily assessments (a.m., noon and p.m.) on days 1, 2 and 3 are used to model the acute pain on movement/rest
latent variables. p-values in OLS regression models are based on student t-distribution and SEM p-values are based on
z-distributions.
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Two latent variable WOMAC
Using the WOMAC score as a two latent variable (rest/movement) pain model pre- and postoperatively,
the direct and indirect effects of pre-operative pain (rest/movement) were investigated with acute pain on
movement/acute pain at rest and chronic pain (rest/movement). Figures 35 and 36 illustrate the path
models between latent variables for the THR and TKR patients, respectively. Single-headed arrows indicate
direction of effects, coefficients are in the natural units of the measurement scales, and p-values are based
on z-distribution. Double-headed arrows indicate correlation coefficients. Models are estimated using
maximum likelihood allowing for missing values.
In THR patients, the SEM approach clearly shows that the majority of the association previously seen in the
single latent variable model between pre-operative and chronic pain is mediated directly via pre-operative
pain at rest, with little or no effect of indirect pathways or directly via pre-operative pain on movement.
However, an independent association of acute pain at rest is positively associated with chronic pain both
on movement and at rest.
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FIGURE 34 Structural equation model of the association between latent variables pre-operative WOMAC (W–1),
acute postoperative pain on movement (M), acute pain at rest (R) and postoperative WOMAC (W12). (a) Hip
patients (n= 322); and (b) knee patients (n=316).
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FIGURE 35 Structural equation model of the association between latent variables pre-operation WOMAC
movement (Wm,–1), pre-operation WOMAC rest (Wr,–1), acute post-operation pain on movement (M), acute pain at
rest (R), post-operation WOMAC movement (Wm,12) and post-operation WOMAC rest (Wr,12) in hip patients (n= 322).
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In TKR patients, the results are quite different and the two latent variable model highlights that the
strongest association is between pre-operative pain on movement and chronic pain on movement. Similar
to the THR patients, pre-operative pain at rest is also associated with chronic pain at rest, and acute pain
at rest is also associated with chronic pain at rest, but not chronic pain on movement.
In Figure 35, the strong association between pre-operative pain and acute pain on movement/rest is
clarified, demonstrating that pre-operative pain on movement is the strongest predictor of chronic pain at
rest or on movement.
There was no evidence of significant indirect effects in either THR or TKR patients despite significant
intermediate paths.
Discussion
Using a traditional OLS regression approach and a SEM approach, we have demonstrated that the
associations between pain over time are different in THR and TKR patients, which has clinical implications
for the treatment of painful hip and knee osteoarthritis. Furthermore, we have explored the unique
constructs of pain on movement and pain at rest to gain further insights and further understand pain
within the context of orthopaedic surgery.
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FIGURE 36 Structural equation model of the association between latent variables pre-operation WOMAC movement
(Wm,–1), pre-operation WOMAC rest (Wr,–1), acute post-operation pain on movement (M), acute pain at rest (R),
post-operation WOMAC movement (Wm,12) and post-operation WOMAC rest (Wr,12) in knee patients (n= 316).
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Our study has highlighted the complex and unique relationships between pre-operative, acute
postoperative and chronic post-surgical pain in patients undergoing THR and TKR. The different
contributions of pain at rest and pain on movement were stark; chronic pain after THR was driven
predominantly by pain on rest and chronic pain after TKR was driven predominantly by pain on movement.
These findings allude to different patterns of pain mechanisms within hip and knee osteoarthritis and
highlight the importance of future work to identify the sources and potential treatment options for these
different pain mechanisms.
Pain sensitivity
Background
Understanding pain within the context of joint replacement surgery is one of the core themes of the
RESTORE programme. In the previous analyses, we explored the associations between pre-operative, acute
postoperative and chronic post-surgical pain after THR and TKR. In the analyses presented in this section,
we are interested in further understanding why people develop chronic pain after joint replacement by
exploring whether or not pre-operative pain sensitivity was a risk factor for developing this condition.
Previous research has been undertaken to identify risk factors for the development of chronic pain after
joint replacement. However, this work has highlighted that very little of the variation in pain severity after
joint replacement can be explained by pre-operative risk factors such age, sex, depression, joint pain and
BMI.52 This highlights the need to explore other pre-operative factors that could be used to identify
patients at a high risk of chronic post-surgical pain. There is some preliminary research which suggests that
pre-operative central pain sensitisation is associated with chronic pain after joint replacement.107,484 Central
pain sensitisation involves amplification in neuronal activity that occurs at a generalised level, leading to
increased sensitivity to nociceptive input and reduced pain thresholds at sites distant to the painful area.
It is now well established in the research literature that some patients with painful osteoarthritis have
evidence of central pain sensitisation.485 It is possible that patients with central pain sensitisation may be at
a higher risk of experiencing chronic post-surgical pain after joint replacement because removal of the
peripheral pain source may not reverse augmented central pain processing changes. Further research is
needed to explore whether or not pre-operative central pain sensitisation, assessed using QST, contributes
to the development of chronic pain after joint replacement.
The aim of these analyses was to determine if pre-operative PPTs measured at a pain-free body site are
predictive of chronic post-surgical pain at 12 months after primary THR and TKR, independent of
pre-operative pain.
Methods
Exposure
Quantitative sensory testing is a non-invasive method that measures participants’ responses to external
stimuli of controlled intensity. Pre-operative PPTs were assessed at the volar forearm using a digital
algometer (Somedic, Hörby, Sweden) with a 1-cm probe. The probe was held perpendicular to the skin
and force applied at a constant rate of 10 kPa per second. The patient was instructed by the research
nurse to say ‘stop’ when the sensation of pressure became the very first sensation of pain. Pressure
algometry was repeated three times and between each reading the position of the algometer on the skin
was altered very slightly to avoid sensitisation of the test area. The primary exposure is a standardised
average of the three PPT measurements.
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Outcome
The primary outcome for this analysis was the WOMAC pain score at 12 months after surgery. Total
WOMAC pain scores were calculated as an average of all five items. As our previous analyses
demonstrated the importance of distinguishing between movement pain and rest pain, we conducted
further analysis with these subcomponents of the WOMAC pain score. Movement pain was calculated as
an average of items 1, 2 and 4 and rest pain was calculated as an average of items 3 and 5.
Confounding variables
This analysis was adjusted for trial randomisation, age at recruitment, sex, cohabitation (living alone),
employment status, educational attainment (after 16 years of age), height and weight.
Statistical methods
Descriptive statistics
Population characteristics and outcome measures are reported as means, SDs, interquartile cut-off points
for continuous measures and as frequencies for categorical variables. In addition, the SD of the individual
three PPTs was also calculated and summarised to indicate the variability of the QST measurements.
Cross-sectional/prospective analysis
Simple linear regression was used to investigate the association between average pre-operative pain
(cross-sectional analysis) and postoperative pain (prospective analysis) and standardised PPTs. Three
adjusted models were fitted: (1) minimally adjusted for sex and randomisation, (2) more fully adjusted, that
is, model 1 and age, height, weight, cohabitation, employment and education, and (3) baseline adjusted,
that is, model 2 and pre-operative pain score. The analyses were repeated using the average of all five
WOMAC pain items, WOMAC items associated with movement pain and WOMAC items associated with
rest pain. Results are interpreted per SD increase in PPT and its association with 1-unit change in pain
response on the WOMAC pain scale either pre-operatively or postoperatively while holding all other
factors constant.
Longitudinal analysis
Using a multilevel model, a longitudinal analysis of pain was assessed pre-operatively and at 12 months
postoperatively. A multilevel approach allows simultaneous investigation of the effect of PPT on pre-operative
pain and change in pain following surgery. This is subtly different from model 3 described in the prospective
analysis, as the effect of PPT on pre-operative pain is not modelled. The effect of PPT on pre-operative pain
is investigated by the inclusion of an interaction between the pre-operative measurement occasion and
standardised PPT. Results are interpreted as per SD increase in PPT and its association with pre-operative
pain. In addition, the effect of PPT on the change in pain response is also modelled by the inclusion of an
interaction between standardised PPT and time. Results are interpreted as per SD increase in PPT and its
association with change in reported pain from pre- to postoperative pain assessments while taking into
account any effect of PPT on pre-operative pain.
To investigate the linearity of the PPT pain response on pre-operative pain and change in pain, two
additional models were fitted. Using quintiles of pre-operative PPT, a longitudinal model was refitted with
separate intercepts and a common slope. In addition, a fully stratified model of pain was fitted using
five different intercepts and five different slopes. Models were compared using likelihood ratio tests.
All models are fitted using iterative generalised least squares in MLwiN (MLwiN, Centre for Multilevel
Modelling, Bristol, UK) using the runmlwin command486 in Stata.
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Results
Descriptive data
A total of 254 patients undergoing THR and 239 patients undergoing TKR had complete covariate
information and were included in these analyses. Baseline characteristics of participants are provided in
Table 71. Patients undergoing THR had a mean age of 66.5 years (SD 10 years), which was slightly
younger than the mean of 69.1 years for the TKR patients.
Pre-operative WOMAC pain scores were similar between patients undergoing THR and TKR, for both total
pain scores and movement pain scores (Table 72). However, patients undergoing TKR had more severe
pre-operative rest pain than those undergoing THR. WOMAC pain scores at 12 months after surgery were
generally worse in patients undergoing TKR than in those undergoing THR, whether considering overall
pain severity, movement pain or rest pain. The mean pre-operative PPT (kilopascals, kPa) for THR patients
was 212 kPa (SD 98 kPa), which was similar to the mean PPT of 206 kPa (SD 103 kPa) for TKR patients.
TABLE 71 Demographic characteristics of APEX hip and knee patients with QST measures
Patient characteristic Hips Knees
Randomised group
Standard care 130 124
Intervention 124 115
Sex
Male 105 114
Female 149 125
Employment
Unemployed 163 183
Employed 91 56
Retired
Not retired 96 58
Retired 158 181
Cohabitation
Alone 53 70
Not alone 201 169
Education
≤ 16 years 169 179
> 16 years 85 60
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Pain sensitivity and pre-operative pain severity
Total hip replacement
In both the minimally and fully adjusted linear regression models, pre-operative PPT was strongly
associated with pre-operative pain severity (p= 0.002 and p= 0.001, respectively; Table 73). The same
pattern of association was found using a linear mixed model (p= 0.001; Table 74). When the pre-operative
WOMAC pain score was broken down in the subconstructs of movement pain and rest pain, PPT was
significantly associated with movement pain but rest pain was not (see Tables 73 and 74).
Total knee replacement
The patterns of associations were much weaker in TKR patients than in THR patients (see Table 73).
In minimally adjusted models, there was no evidence of an association of PPT with total, movement or
rest pain before surgery (p> 0.1). However, following more complete adjustment, the strength of the
association increased to borderline significant for total pain severity (p= 0.047). Similarly, a weak
association between PPT and pre-operative total pain severity (p= 0.045), but not with movement pain or
rest pain, was found in the linear mixed model (see Table 74).
Pain sensitivity and 12-month postoperative pain severity
Total hip replacement
In the minimally and fully adjusted linear regression models, there was strong evidence of an association
between pre-operative PPT and pain severity at 12 months following surgery (p= 0.01 and p= 0.015,
respectively; see Table 73). These models showed that lower PPTs (higher pain sensitivity) were associated
with more severe pain at 12 months following surgery. When the analyses were repeated with movement
pain and rest pain, PPT was associated with movement pain but not rest pain at 12 months after surgery
(see Table 73).
TABLE 72 Descriptive statistics for average pre-operative and postoperative total WOMAC pain scores, movement
pain scores (WOMAC pain items 1, 2 and 5) and rest pain scores (WOMAC pain items 3 and 4), and mean PPTs and
the average SD across the three replicates
Joint
replacement Time Measure Mean SD 25th percentile Median 75th percentile
Hip Pre operation PPT mean 212.17 97.68 137.7 193.3 266.0
PPT SD 38.42 31.86 16.7 29.2 53.4
WOMAC 3.28 0.74 2.8 3.2 3.8
WOMAC move 3.41 0.77 3.0 3.3 4.0
WOMAC rest 3.08 0.90 2.5 3.0 3.5
Post operation WOMAC 1.43 0.67 1.0 1.2 1.6
WOMAC move 1.45 0.71 1.0 1.0 1.7
WOMAC rest 1.40 0.70 1.0 1.0 1.5
Knee Pre operation PPT mean 205.65 102.62 132.0 185.7 253.0
PPT SD 33.90 27.47 16.2 27.4 41.5
WOMAC 3.27 0.65 2.8 3.2 3.6
WOMAC move 3.57 0.63 3.0 3.7 4.0
WOMAC rest 2.83 0.92 2.5 3.0 3.5
Post operation WOMAC 1.74 0.83 1.0 1.4 2.2
WOMAC move 1.85 0.90 1.0 1.7 2.3
WOMAC rest 1.59 0.83 1.0 1.0 2.0
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TABLE 73 Associations between average PPT and total WOMAC pain scores, movement pain scores and rest pain
scores, adjusted for confounding variables including sex, living alone, working status, education, height, weight
and age at recruitment in hip and knee patients
Model Outcome Model adjustments Beta SE 95% CI p-value
Hip
Cross-Sectional Pre-operative WOMAC 1. Minimal –0.144 0.05 –0.235 to –0.054 0.002
Pre-operative WOMAC
Move
–0.183 0.05 –0.278 to –0.088 0.000
Pre-operative WOMAC
Rest
–0.086 0.06 –0.198 to 0.026 0.131
Prospective WOMAC 12 –0.110 0.04 –0.193 to –0.027 0.010
WOMAC 12 move –0.131 0.04 –0.219 to –0.043 0.004
WOMAC 12 rest –0.078 0.04 –0.165 to 0.009 0.079
Cross-Sectional Pre-operative WOMAC 2. Adjusted –0.148 0.05 –0.238 to –0.058 0.001
Pre-operative WOMAC
move
–0.187 0.05 –0.281 to –0.092 0.000
Pre-operative WOMAC
rest
–0.091 0.06 –0.203 to 0.021 0.111
Prospective WOMAC 12 –0.104 0.04 –0.187 to –0.020 0.015
WOMAC 12 move –0.127 0.05 –0.216 to –0.038 0.005
WOMAC 12 rest –0.068 0.04 –0.155 to 0.019 0.126
WOMAC 12 3. Adjusted+ pre-operative
pain
–0.091 0.04 –0.176 to –0.006 0.036
WOMAC 12 move –0.114 0.05 –0.205 to –0.022 0.015
WOMAC 12 rest –0.059 0.04 –0.147 to 0.028 0.181
Knee
Cross-Sectional Pre-operative WOMAC 1. Minimal –0.068 0.04 –0.156 to 0.019 0.126
Pre-operative WOMAC
Move
–0.067 0.04 –0.152 to 0.019 0.125
Pre-operative WOMAC
Rest
–0.071 0.06 –0.193 to 0.052 0.258
Prospective WOMAC 12 –0.063 0.06 –0.174 to 0.047 0.259
WOMAC 12 move –0.064 0.06 –0.184 to 0.056 0.292
WOMAC 12 rest –0.062 0.06 –0.173 to 0.049 0.271
Cross-Sectional Pre-operative WOMAC 2. Adjusted –0.088 0.04 –0.175 to –0.001 0.047
Pre-operative WOMAC
move
–0.080 0.04 –0.165 to 0.005 0.066
Pre-operative WOMAC
rest
–0.100 0.06 –0.222 to 0.022 0.106
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TABLE 73 Associations between average PPT and total WOMAC pain scores, movement pain scores and rest pain
scores, adjusted for confounding variables including sex, living alone, working status, education, height, weight
and age at recruitment in hip and knee patients (continued )
Model Outcome Model adjustments Beta SE 95% CI p-value
Prospective WOMAC 12 –0.093 0.06 –0.204 to 0.017 0.097
WOMAC 12 move –0.097 0.06 –0.217 to 0.023 0.114
WOMAC 12 rest –0.088 0.06 –0.199 to 0.023 0.118
WOMAC 12 3. Adjusted+ pre-operative
pain
–0.053 0.05 –0.157 to 0.051 0.313
WOMAC 12 move –0.062 0.06 –0.177 to 0.054 0.293
WOMAC 12 rest –0.059 0.05 –0.165 to 0.047 0.273
SE, standard error; WOMAC 12, WOMAC at 12 months.
Notes
The overall average WOMAC score is calculated using items 1 to 5, whereas average WOMAC movement pain is calculated
using items 1, 2 and 4 and WOMAC rest pain is calculated using items 3 and 5.
PPT measurements are averaged across three replicates and standardised using a z-transformation. p-values and CIs are
based on t-distributions.
Three different models adjustments are used: model 1= sex, randomisation; model 2=model 1+ age, height, weight,
education, cohabitation, employment; and model 3=model 2+ pre-operative pain score.
TABLE 74 Linear mixed model of WOMAC pain scores adjusted for confounding variables including sex,
living alone, working status, education, height, weight, and age at recruitment in hip (N= 254) and knee
(N= 239) patients
Outcome Beta SE 95% CI p-value Likelihood
Hip
Pre-operative WOMAC pain –0.157 0.05 –0.250 to –0.065 0.001 –507.2
Change WOMAC pain 0.047 0.06 –0.071 to 0.164 0.44
Pre-operative WOMAC movement pain –0.196 0.05 –0.293 to –0.099 0.000 –536.9
Change WOMAC movement pain 0.057 0.06 –0.069 to 0.183 0.37
Pre-operative WOMAC rest pain –0.101 0.06 –0.215 to 0.013 0.083 –572.9
Change WOMAC rest pain 0.031 0.07 –0.103 to 0.164 0.65
Knee
Pre-operative WOMAC pain –0.087 0.04 –0.173 to –0.002 0.045 –491.8
Change WOMAC pain –0.013 0.05 –0.119 to 0.093 0.81
Pre-operative WOMAC movement pain –0.076 0.04 –0.160 to 0.008 0.075 –514.3
Change WOMAC movement pain –0.036 0.06 –0.153 to 0.080 0.54
Pre-operative WOMAC rest pain –0.108 0.06 –0.226 to 0.010 0.074 –577.2
Change WOMAC rest pain 0.022 0.06 –0.104 to 0.148 0.74
Notes
Parameter estimates show the association between standardised pre-operative PPT and pre-operative pain score and the
interaction between change in WOMAC pain score and its interaction with standardised pre-operative PPT. p-values and
CIs are based on z-distributions. All models were adjusted for sex, age, height, weight, randomisation, cohabitation,
employment and education.
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Total knee replacement
There was no evidence of an association between pre-operative PPT and pain severity at 12 months after
surgery in any of the linear regression models (see Table 73). Similarly, further analysis found that PPT was
not associated with rest pain or movement pain at 12 months post operation (see Table 73).
Pain sensitivity and change in pain severity
Total hip replacement
After adjusting for pre-operative pain severity, the associations in the linear regression models between PPT
and 12-month pain severity were mildly attenuated; however, the association persisted (p= 0.036).
Analysis was then undertaken to explore the association between pre-operative PPT and change in
WOMAC pain scores from before surgery to 12 months after surgery (see Table 74). There was no
evidence of an association between PPT and change in pain scores (p= 0.44). Similarly, no association was
found between PPT and change in movement pain (p= 0.37) or rest pain (p= 0.65). Further analyses using
PPT quintiles to explore the relationship between pre-operative PPT and change in pain scores showed
similar results (data not shown).
Total knee replacement
There was no evidence of any association between PPT and change in pain score from pre-operative to
12 months after TKR surgery (p= 0.81; see Table 74). This finding was the same when pain severity was
analysed as change in movement pain (p= 0.54) and rest pain (p= 0.74). Further analyses using PPT
quintiles to explore the relationship between pre-operative PPT and change in pain scores showed similar
results (data not shown).
Discussion
Using data from the APEX cohort study, we found a relationship between measures of before surgery
central pain sensitisation and pre-operative pain severity in a large sample of patients with advanced hip
and knee osteoarthritis. Our longitudinal study design also allowed us to demonstrate that there is a
strong association between pre-operative PPTs and pain severity at 12 months after THR, but not after
TKR. Uniquely, we have shown there is no evidence of effect modification of PPT on the efficacy of surgery
in patients undergoing THR or TKR. This suggests that pre-operative pain sensitivity, assessed through
measurement of forearm PPTs, does not influence the amount of pain relief that patients gain from
joint replacement.
EXPLORING AND UNDERSTANDING PAIN IN THE CONTEXT OF HIP AND KNEE REPLACEMENT: A COHORT STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
246
Chapter 8 Systematic review and meta-analysis of
exercise and education interventions before total hip
and knee replacement
Abstract
Background
We aimed to evaluate the clinical effectiveness of exercise and education in patients waiting for total hip
or knee replacement.
Methods
We searched MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane and Web of Science databases from
inception to March 2014. Searches covered hip and knee replacement, randomised trials and pre-surgery.
Interventions targeted optimisation of pre-surgical health, preparation for in-hospital recovery and
long-term health. Outcomes extracted in duplicate were combined in meta-analyses with additional data
provided by authors. Study quality was assessed.
Results
Interventions targeting optimisation of pre-surgical health (n= 36) showed benefit compared with controls
in physical function (SMD 0.28, 95% CI 0.16 to 0.40); pain (SMD 0.21, 95% CI 0.10 to 0.33); and anxiety
(SMD 0.38, 95% CI 0.11 to 0.65). Benefit was mainly limited to THR and effect sizes were largely
unaffected by study quality or exercise/education content.
In studies targeting in-hospital recovery (n= 27), post-surgical anxiety was lower in intervention patients
(SMD 0.38, 95% CI 0.13 to 0.63) who also mobilised earlier.
Interventions targeting long-term outcomes (n= 18) showed no benefit.
Conclusions
Exercise and education before total hip and knee replacement can improve patients’ pre-surgical health
and early recovery. Further research is required for knee replacement, intervention content and in relation
to long-term outcomes.
Background
Previous systematic reviews of interventions before surgery have focused on the effectiveness of
education83 and physiotherapy.82 In this section we update these with a series of more recent reviews of
RCTs using systematic review methods. Acknowledging the overarching aims of exercise and education
before hip and knee replacement, we classified studies according to their primary objectives. Thus,
interventions are targeting making improvements to one or more of pre-surgical physical and psychological
health, preparedness for recovery in hospital, and long-term post-surgical outcomes.
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Methods
General methods As described in Chapter 2, Systematic review methods
Databases and dates MEDLINE, EMBASE, CINAHL, PsycINFO and The Cochrane Library from inception to 17 October
2013. Citations of key articles in ISI Web of Science and reference lists. Previous systematic reviews
and meta-analyses were checked
Search strategy Hip or knee replacement/RCT/pre-surgery. MEDLINE search strategy based on terms in Appendix 3
Study design RCTs with individual or cluster randomisation. Quasi-randomised designs (e.g. alternate allocation)
Patients Adults waiting for total hip or knee replacement
Intervention Non-pharmacological pre-surgical intervention with the aim of improving outcomes before or after
joint replacement. Interventions between being placed on the waiting list and surgery:
l optimising pre-surgical health
l preparation for recovery in hospital
l improving long-term outcomes
l not electrical stimulation, acupuncture, or smoking cessation
Controls Usual care or minimal intervention
Follow-up ≥ 3 months
Data extraction Country, baseline dates, participants (indication, age, sex), inclusion and exclusion criteria,
intervention and control group content, setting, timing, duration and intensity, follow-up time,
losses to follow-up and reasons
Outcomes Patient-reported physical function, pain and anxiety measured before surgery
Patient-reported anxiety and pain, mobilisation measured in hospital or < 1 month after surgery,
and length of hospital stay
Patient-reported physical function and pain from 3 months after surgery (longest follow-up
reported unless large loss to follow-up)
Quality assessment Good, reasonable (e.g. non-blind follow-up with self-complete questionnaires), or possible bias
(unequal or major loss to follow-up, or important baseline differences)
Studies were classified into groups A, B and C independently by two reviewers with final decisions on
classifications decided by consensus with input from other programme contributors.
Results
Review progress is summarised as a flow diagram in Figure 37. Searches identified 5073 articles. After
screening and detailed evaluation, 48 articles describing 52 interventions met the inclusion criteria and
study characteristics are summarised in Table 75. Studies reported interventions in patients before hip
(n= 22),487–508 knee (n= 21),500,503,509–525 or either hip or knee replacement (n= 9).526–534 Interventions
focused on optimising pre-surgical health (n= 36), preparation for recovery in hospital (n= 27) and
improving long-term outcomes (n= 18). Potential sources of bias are summarised in Appendix 8. Results of
meta-analyses are summarised in Table 76.
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Optimising pre-surgical health
Of the 36 interventions (32 articles) targeting optimisation of pre-surgical health, 14 interventions were in
patients waiting for THR,487–489,493–497,500–504,507 17 in patients waiting for TKR,500,503,509–515,517,519–521,523–525 and
five in total hip and knee patients together.526–529,534
Eighteen interventions were specifically exercise based,488,494,497,502,503,509,511–515,519,520,523–525 nine were
education based,52,489,495,500,501,526,527,529 while nine were multifactorial with exercise and education
components and, in some cases, an occupational therapy base.487,493,496,504,507,510,517,521,528
Effect on pre-surgical physical function
Physical function before surgery was measured after 21 interventions using WOMAC (physical function or
total), SF-36 physical function, HHS, HOOS, HSS, Arthritis Impact Measure Score 2 (AIMS2), AKSS or locally
devised scores.
Search of multiple databases for
RCTs with pre-surgical intervention. 
In addition reference lists and citation 
search (duplicates removed)
(n = 5073)
Included studies
(n = 48 articles, 52 interventions)
Interventions targeting
• Optimising pre-surgical health, n = 36
• Preparation for recovery in hospital, n = 27
• Improving long-term outcomes, n = 18
Full-text articles assessed for eligibility
(n = 93)
Records excluded on basis of title
 and abstract
(n = 4980)
Full-text articles excluded 
(n = 45)
Reasons
• Not total hip or knee 
   replacement, n = 4
• No pre-surgical intervention, n = 8
• Review/commentary, n = 8
• Not RCT, n = 4
• Smoking, n = 6
• Not obtainable, n = 2
• Additional, n = 5
• Pre- and post-surgical 
   component, n = 4
• No follow-up/protocol, n = 2
• Comparison of methods, n = 1
• Abtract only, n = 1
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FIGURE 37 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: flow diagram.
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Aoki and colleagues 2009;509
Japan; 2004–5; A
Knee; severe knee
osteoarthritis; n= 36
(17 : 19); 73.4 years (100%)
Exercise (stretching); home;
from registration for
surgery until admission;
control: no intervention
After admission to hospital;
VAS pain; no losses to
follow-up
Beaupre and colleagues
2004;510 Canada; date not
specified; A, B and C
Knee; non-inflammatory
arthritis; n= 131 (65 : 66) –
16 patients (10 intervention,
6 control) did not have joint
replacement: still eligible for
review A. It is possible that
the intervention was ‘highly
effective’ in improving
function and pain; 67 years
(55%)
Multifactorial: exercise
(gait re-education,
functional, ROM,
strengthening) and
education; community
physical therapy clinic
group; three times per
week for 4 weeks, 6 weeks
before surgery; control:
no intervention
Pre-operation, 3, 6 and
12 months after surgery;
WOMAC, SF-36, LOS; 16
(10 : 6) patients cancelled
surgery, six (4 : 2) patients
lost to 12-month follow-up
Berge and colleagues
2004;487 UK; date not
specified; A and C
Hip; osteoarthritis; n= 40
(19 : 21) – 4 intervention
patients dropped out before
programme; 71.3 years
(67.5%)
Multifactorial: exercise
(strengthening and
stretching) and education
with relaxation pain
management programme;
outpatient group; once
or twice a week for
6 weeks, ≥ 6 months
pre-surgery; control: no
intervention
Follow-up 3 months after
programme and minimum
1 year; NRS pain, AIMS;
3 (0 : 3) patients lost to first
follow-up (surgery early).
Overall 7 (1 : 6) lost to
1-year follow-up
Bitterli and colleagues
2009;488 Switzerland 2004–7;
A and C
Hip; unilateral osteoarthritis
or avascular necrosis; n= 80
(41 : 39); 66.8 years (38.8%)
Exercise (strengthening and
balance); home; two times
per day, 10 repetitions for
2–6 weeks; control: no
intervention
Follow-up at 10 days,
4 months and 12 months
after surgery; SF-36,
WOMAC; (5 : 2) lost to
pre-surgical follow-up;
18 (9 : 9) lost to 12-month
follow-up
Bondy and colleagues
1999;526 USA; date not
specified; A and B
Hip and knee; not specified;
n= (65 : 69) – 200 patients
randomised but baseline and
pre-surgery questionnaires
completed by 134 patients;
65.2 years (59.5%)
Education; home;
< 3 weeks before surgery;
control: pre-operative
anaesthetist visit
No follow-up after surgery;
STAI anxiety; of 200
randomised, 148 returned
questionnaires of which
134 (67%) were completed
sufficiently
Börjesson and colleagues
1996;511 Sweden; date not
specified; A
Knee; unilateral medial
osteoarthrosis I-III; n= 68
(34 : 34); 64 (50%)
Exercise (strengthening,
ROM); hospital outpatient
group; three times per
week lasting 40 minutes
for 5 weeks; control: no
intervention
After 3 months (as close to
end of intervention as
possible), no follow-up
after surgery; pain on
walking using Borg scale;
0 losses to follow-up
Brown and colleagues
2012;512 USA; date not
specified; A and C
Knee; osteoarthritis; n= 32
(17 : 15); age and sex not
described
Exercise; home and physical
therapy clinic; partially
supervised resistance and
flexibility exercises and step
training, training booklet;
twice a week at home and
once a week at physical
therapy clinic for
50 minutes from 8 weeks
before surgery; usual
pre-operative care
3 months; SF-36 (physical
functioning and bodily
pain); 14 (6 : 8) lost to
follow-up
EXERCISE AND EDUCATION INTERVENTIONS BEFORE THR AND TKR
NIHR Journals Library www.journalslibrary.nihr.ac.uk
250
TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Butler and colleagues
1996;489 Canada; 1993–4;
A and B
Hip; not specified; n= 80
(32 : 48); 62.6 years (51.3%)
Education; home;
4–6 weeks before surgery;
control: mailed
preadmission package only
To discharge; anxiety STAI,
LOS; one patient died and
no follow-up data from
eight patients
aClode-Baker and colleagues
1997;490 UK; date not
specified; B
Hip (76% primary); not
specified; n= 78 (41 : 37) –
91 randomised, 13
operations cancelled or
postponed; mean age not
specified (66.7%)
Education; home;
approximately 4 weeks
before surgery; control
patients seen routinely by
nursing staff on admission
Day before surgery, days
1–7 after surgery and
8 days after discharge;
NHP, Hamilton Anxiety and
Depression, days to
mobilisation, LOS, pain
(descriptive ordinal scale);
four (1 : 3) lost to
postoperative anxiety
follow-up
Cooil and Bithell 1997;491
UK; date not specified; B
Hip; not specified; n= 42
(21 : 21); 69 years (71.4%)
Education; hospital during
admission, individual; day
before surgery; control:
information sheet but no
further contact
Days 1 and 2 after
operation; no outcomes
relevant to review; no
losses to follow-up reported
Crotty and colleagues
2009;527 Australia; 2005–6; A
Hip or knee; osteoarthritis;
n= 152 (77 : 75); 67.5 years
(60.5%)
Education; home,
outpatient and community;
individual and group;
5 weeks’ duration; control:
no intervention
6 months after intervention
(11 patients in each group
followed up mean 106 days
after surgery); WOMAC; no
losses to follow-up reported
aCrowe and Henderson
2003;528 Canada; date not
specified; A and B
Hip or knee; osteoarthritis,
rheumatoid arthritis; n= 133
(65 : 68); 70 years (80%)
Multifactorial: exercise
(strengthening and
endurance), education and
occupational therapy;
hospital outpatient,
individual and group;
one session soon after
randomisation with
additional physiotherapy
and attendance at day care
hospital; control: single
standard pre-operative
clinic visit
To hospital discharge; LOS,
anxiety STAI, days to
mobilisation; one patient
did not receive surgery
aCuñádo Barrio and
colleagues 1999;529 Spain;
1996–7; A and B
Hip or knee; not specified;
n= 84 (42 : 42); 65 years
(66.7%)
Education; hospital,
individual; 2 days before
the operation lasting
20 minutes; control:
standard pre-operative
programme
Pre-operative and 4 to
5 days post operation
(as appropriate); anxiety
STAI, mobilisation, LOS;
eight (1 : 7) lost to follow-up
Daltroy and colleagues
1998;530 USA; 1985–7; B
Hip or knee; rheumatoid or
osteoarthritis; n= 222, 2 × 2
factorial (58 : 58 : 52 : 54);
64 years (66%)
Education; hospital,
individual; day before
surgery; control: usual
pre-operative preparation
Day 4 post operation;
anxiety STAI, pain (Likert
scale), LOS, no data were
suitable for meta-analysis;
data not available for
six patients
continued
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
D’Lima and colleagues 1996
(cardiovascular);513 USA; date
not specified; A and C
Knee; rheumatoid or
osteoarthritis; n= 20
(10 : 10); 70.6 years (35%)
Exercise (stretching,
strengthening,
cardiovascular
conditioning); hospital,
individualised; 45-minute
sessions, three times a
week for 18 weeks
commencing 6 weeks
before surgery; control:
one meeting with physical
therapist
Follow-up at 6 weeks and
1 week preoperation,
and 3, 12, 24 and 48 weeks
postoperatively; HSS; no
losses to follow-up reported
D’Lima and colleagues 1996
(physical therapy);513 USA;
date not specified; A and C
Knee; rheumatoid or
osteoarthritis; n= 20
(10 : 10); 69.0 years (60%)
Exercise (strengthening,
ROM); hospital,
one-on-one programme;
45-minute sessions, three
times a week for 18 weeks
commencing 6 weeks
before surgery; controls:
one meeting with physical
therapist
Follow-up at 6 weeks and
1 week preoperation, and
3, 12, 24 and 48 weeks
postoperatively; HSS; no
losses to follow-up reported
aDoering and colleagues
2000;492 Austria; date not
specified; B
Hip; osteoarthritis; n= 100
(46 : 54); 59.6 years (38%)
Education; hospital,
individual; day before
surgery; control: no
intervention
1, 2 and 3 days post
operation; STAI anxiety,
VAS pain, LOS
Evgeniadis and colleagues
2008;514 Greece; 2006;
A and C
Knee; idiopathic
osteoarthritis; n= 48
(24 : 24); 68.3 years (76.3%)
Exercise (strengthening);
home; 1 month before
surgery for 3 weeks, three
alternative days a week;
controls: standard pre- and
postoperative care
Day before surgery and 2,
6, 10 and 14 weeks after
surgery; SF-36, ILAS; five
(3 : 2) lost to follow-up
Ferrara and colleagues
2008;493 Italy; 2006–7;
A and C
Hip; end-stage
osteoarthritis; n= 23
(11 : 12); 63.4 years (60.9%)
Multifactorial: exercise
(strengthening, stretching,
cardiovascular) and
occupational therapy;
hospital, individual and
group; 1 month prior to
surgery, 60 minutes per
day for 5 days per week;
controls: no intervention
Day before surgery and
15 days, 4 weeks and
3 months after surgery;
SF-36, WOMAC; two (0 : 2)
patients lost to 3-month
follow-up
Gilbey and colleagues
2003;494 Australia, 1997–9;
A (C not included as
post-surgical intervention)
Hip; osteoarthritis, post-
traumatic and inflammatory
arthritis, osteonecrosis,
Paget’s disease; n= 68
(37 : 31) – a further eight
patients withdrew before
surgery; 65.2 years (61.8%)
Exercise (strengthening,
ROM, gait re-education,
hydrotherapy); clinic and
home, group and
individual; 8 weeks before
surgery, two clinic- and
two home-based sessions
per week, clinic sessions
lasted 1 hour; control
group received in-hospital
physical therapy
Week before surgery and
3, 12, and 24 weeks after
surgery; WOMAC; two
(2 : 0) chose to delay
surgery
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Giraudet-Le Quintrec and
colleagues 2003;495 France;
1997–9; A and B
Hip; osteoarthritis; n= 100
(48 : 52); 63.5 years (56%)
Education; teaching
hospital, small group (three
to six patients); 2–6 weeks
before surgery, one class
lasting half day; controls
received verbal information
and leaflet
Follow-up 1–7 days post
surgery; VAS pain, STAI
anxiety, days to standing,
LOS; one (0 : 1) patient did
not complete STAI after
surgery
Gocen and colleagues
2004;496 Turkey; date not
specified; A, B and C
Hip; primary or secondary
osteoarthritis; n= 59
(29 : 30); 51.3 years (35.6%)
Multifactorial: exercise
(strengthening, stretching)
and education; home and
hospital; 8 weeks before
surgery, three times
per day; control: no
intervention
Immediately pre-operative,
at discharge, 3 months and
2 years; HHS, VAS pain,
days to walking; one (1 : 0)
not operated
Gstoettner and colleagues
2011;515 Austria; date not
specified; A and C
Knee; severe unilateral
osteoarthritis; n= 38
(18 : 20); 69.8 years (79%)
Exercise (strengthening,
proprioception, balance,
functional); home and
hospital; 6 weeks before
surgery, taught once per
week for 45 minutes, then
at home; control treatment
received no intervention
Intervention patients
followed up 6 weeks
before surgery for
WOMAC, 6 weeks after
surgery; WOMAC; three
(3 : 0) lost to follow-up
Heikkinen and colleagues
2008;516 Finland; 2005–6; B
Knee (study also included
patients with shoulder
arthroscopy); n= 59 (27 : 32)
specifically knee; age and
sex of knee patients not
described
Education; home; website
used on an average of
14 days before surgery
(SD 19.1, range
1–121 days); control group
received face-to-face
education with nurse
2 weeks postoperatively;
no outcomes relevant to
review; three (1 : 2) lost to
follow-up but some of
these may be shoulder
arthroscopy patients
Hoogeboom and colleagues
2010;497 The Netherlands;
2007–8; A
Hip; end-stage
osteoarthritis; n= 21
(10 : 11); 76 years (66.6%)
Exercise (strengthening,
cardiovascular, function);
outpatient and home,
individual and group;
3–6 weeks before surgery,
twice a week for
60 minutes; control group
received usual pre- and
postoperative care
Pre-operative and to
discharge; HOOS; one
(0 : 1) lost to follow-up
Huang and colleagues
2012;517 Taiwan; 2008–10;
A and B
Knee; advanced
osteoarthritis; n= 243
(126;117); 70.2 years
(71.6%)
Exercise (strengthening)
and education; clinic and
home, group and
individual; 2–4 weeks
before surgery, 40-minute
meeting in clinic followed
by home-based
programme; control:
no intervention
To discharge and
complications; LOS, VAS
pain; no losses to follow-up
reported
continued
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Johansson and colleagues
2007;498 Finland; 2003–4; B
Hip; elective; n= 123
(62 : 61); 62.4 years (51.2%)
Education; hospital
pre-operative clinic,
individual; 2 weeks before
surgery, for up to 1 hour;
control group received
written education materials
only
To discharge; LOS; 17
(7 : 10) lost to follow-up
Lewis and colleagues 2002;531
USA; date not specified; B
Hip or knee; not specified;
n= 58 (29 : 29); 68.5 years
(58.6%)
Education (interactive);
pre-admission test centre,
individual; controls were
shown a non-interactive
video
Days 1, 2 and 3 post
operation; LOS; two (1 : 1)
lost to follow-up
Lilja and colleagues 1998;499
Sweden; date not specified; B
Hip; consecutive patients
waiting for THR; n= 50
(22 : 28) – further five
patients excluded after
randomisation; median
65 years (34%)
Education; hospital; day
before surgery, 30 minutes;
control: no intervention
Days 1, 2 and 3 post
operation; VAS pain;
no losses to follow-up
further than one refused
to participate after
randomisation and four
(3 : 1) withdrawn for
medical reasons
Liu and Lu 2004;532 China;
2002; B
Hip and knee surgery (also
arthroscopy); not specified
but included tibia and fibula
wounds and leg joint fusion;
n= 74 years (39 : 35);
53.8 years (47.3%)
Education; location of
intervention not specified,
individual; time scale
before surgery when
education given not
specified; traditional
education
Time after post surgery not
specified; LOS; no losses to
follow-up reported
Mancuso and colleagues
2008 Hip;500 USA; 2001–3; A
Hip; 94.5% osteoarthritis;
n= 177 (90 : 87); 70.5 years
(55.9%)
Education; hospital, group;
one class with additional
15-minute module; control
patients received standard
pre-operative class
Mean 4 days after class,
no further follow-up; no
relevant outcome
Mancuso and colleagues 2008
Knee;500 USA; 2001–3; A
Knee; 94.0% osteoarthritis;
n= 143 (70 : 73); 71.5 years
(57.3%)
Education; hospital, group;
one class with additional
15-minute module; control
patients received standard
pre-operative class
Mean 4 days after class,
no further follow-up; no
relevant outcome
McDonald and colleagues
2001;533 USA; 1998–9; B
Hip and knee; osteoarthritis,
primary and revision; n= 40
randomised, data on 31
reported (13 : 18); 74 years
(74.2%)
Education; urban medical
centre or home, group or
individual; one session at
pre-operative joint
replacement class; control
patients received a slide
show on pain management
and use of pain intensity
scale
Postoperative days 1
and 2; McGill Pain
Questionnaire-short form
(measures sensory and
effective pain and pain
intensity); nine (7 : 2) lost
to follow-up as some
patients unable to
complete questionnaires
McDonald and Molony 2004
(communication);518 USA;
2000–1; B
Knee; osteoarthritis; n= 26
(17 : 9); 71.8 years (63.4%)
Education; medical centres,
group; one pre-operative
class; comparison group
received usual
pre-operative class
Postoperative days 1 and 2,
and 1 and 7 days
post-hospital discharge by
telephone; SF-MPQ
affective pain, LOS; no
losses to follow-up reported
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
McDonald and Molony 2004
(pain management);518 USA;
2000–1; B
Knee; osteoarthritis; n= 24
(15 : 9); 71.8 years (63.4%);
Education; medical centres,
group; 10-minute film at
pre-operative class;
comparison group received
usual pre-operative class
Postoperative days 1 and 2,
and 1 and 7 days
post-hospital discharge by
telephone, no longer-term
follow-up; SF-MPQ affective
pain, LOS; no losses to
follow-up reported
McGregor and colleagues
2004;501 UK; 1998–9; A, B
and C
Hip; osteoarthritis; n= 39
(19 : 20); 71.9 years (42.9%)
Education; hospital and
home, group; hip class
2–4 weeks before surgery;
controls received standard
care
3 months postoperatively;
WOMAC, LOS; four (4 : 0)
patients lost to follow-up
McKay and colleagues
2012;519 Canada; 2010;
A and C
Knee; osteoarthritis, primary;
n= 22 (10 : 12); 61.9 years
(59%)
Exercise (strengthening);
research facility; 3 times a
week for 6 weeks; control:
non-specific upper-body
strength training
Follow-up immediately
before surgery and at 6
and 12 weeks after
surgery; WOMAC; five
(3 : 2) lost to 12-week
follow-up
Mitchell and colleagues
2005;520 UK; 1999–2000;
A (not C as intervention
patients received additional
postoperative care)
Knee; osteoarthritis; n= 114
(57 : 57) – 160 randomised
but 45 (23 : 22) withdrew;
70.3 years (57.9%)
Exercise (gait re-education,
ROM) and occupational
therapy; home; 8 weeks
before surgery, minimum
of three pre-operative visits
with up to 6 postoperative
visits; control group
received outpatient
physiotherapy
Follow-up 12 weeks; no
outcome reported before
additional post-surgery
physiotherapy; one (0 : 1)
died postoperatively
Nuñez and colleagues
2006;521 Spain; 2001; A
Knee; osteoarthritis; n= 100
(51 : 49); 71.1 years (71%)
Multifactorial: exercise
(strengthening, ROM, gait
re-education, general)
and education; hospital
and home, groups of
12 patients, maximum;
3-month programme with
30-minute individual visits
lasting in first week and at
3 months, and two group
sessions of approximately
90 minutes in weeks 3 and
4; control group were seen
individually twice by a
physician
9-month follow-up (after
intervention); WOMAC,
SF-36, self-reported
HRQoL, number of GP visits
and costs; 20 (8 : 12) lost to
follow-up
Oosting and colleagues
2012;502 The Netherlands;
date not specified; A and C
Hip; osteoarthritis,
age > 65 years, frail; n= 30
(15 : 15); 78 years (80%)
Exercise (functional);
outpatient and home;
twice per week for
3–6 weeks and home four
times per week; one
physical therapist-led group
session 3 weeks before
surgery
2–4 days before admission
and up to 6 weeks after
surgery; HOOS; 0 (0 : 2) lost
to follow-up at pre-surgery
assessment
continued
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Pellino and colleagues
1998;534 USA; 1995–6; A
(surgery delayed in control
group)
Hip and knee; elective
orthopaedic surgery; n= 74
(39 : 35), 83 eligible;
53.8 years (50%) included
in analysis
Education; learning centre,
group and individual; one
class; controls received
traditional teaching at the
hospital clinic
Up to 1 month follow-up
after surgery; ability to
complete perioperative
care; seven patients did not
complete questionnaires
and two had surgery
cancelled
Rooks and colleagues 2006
Hip;503 USA; 2001–3;
A and C
Hip; osteoarthritis; n= 63
(32 : 31); 62 years (57.1%)
Exercise (strengthening,
flexibility, cardiovascular,
pool exercises); community
fitness facility; three times
per week for 6 weeks,
30–60 minutes; control:
two education mailings
and three telephone calls
Follow-up post intervention
and at 8 and 26 weeks
post surgery; WOMAC; 14
(7 : 7) lost to follow-up
Rooks and colleagues 2006
Knee;503 USA; 2001–3;
A and C
Knee; osteoarthritis; n= 45
(22 : 23); 67.0 years (53.3%)
Exercise (strengthening,
flexibility, cardiovascular,
pool exercises); community
fitness facility; three times
per week for 6 weeks,
30–60 minutes each,
increasing intensity from 4
to 6 weeks; control: two
education mailings and
three telephone calls
Follow-up post intervention
and at 8 and 26 weeks
post surgery; WOMAC; 16
(8 : 8) lost to follow-up
Sandell and colleagues
2008;504 UK; 2003; A and B
Hip; waiting time of
6 months or more; n= 89
(43 : 46); 68.2 years (65.1%)
Multifactorial: exercise
(strengthening and gait),
occupational therapy and
pain management;
outpatient clinic;
3–16 months before
surgery; control: no
intervention
Follow-up pre-surgery;
AIMS2; 26 (10 : 16) lost to
follow-up
Santavirta and colleagues
1994;505 Finland; 1989; B
Hip; n= 60 (27 : 33) –
73 patients randomised;
58 years (63%)
Education; during hospital
admission; 10- to
60-minute session after
admission; all patients
received an 18-page
illustrated patient guide
During admission and
2–3 months postoperatively;
no relevant outcome;
13 (7 : 6) had operation
postponed or dropped out
for other reasons
Sjoling and colleagues
2003;522 Sweden; date not
specified; B
Knee; osteoarthritis; n= 60
(30 : 30); 71 years (60%)
Education; hospital; day
before surgery or 4 days
pre-operatively; controls
received standard
information
7–8 days postoperatively;
state and trait anxiety,
Daily Pain Index based on
multiple VAS pain scores,
LOS; no losses to follow-up
(some data missing at time
points)
Swank and colleagues
2011;523 USA; 2003–8; A
Knee; osteoarthritis and
intractable pain; n= 71
(35 : 36); 62.8 years (65%)
Exercise (strengthening,
stretching, walking, step
training); hospital clinic
and home, individual;
commenced 4–8 weeks
before surgery; control:
no intervention
Week before surgery; VAS
pain after functional tests;
no losses to follow-up
reported
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TABLE 75 Systematic review and meta-analysis of exercise and education interventions before total hip and knee
replacement: included studies (continued )
Publication; location;
date of study; focus
of intervention
(A=optimising health,
B=hospital preparation,
C= long term)
Hip or knee; indication;
number randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of
intervention; study
setting; timing, duration
and intensity; control
group care
Follow-up interval;
outcomes; losses
to follow-up
(intervention : control)
Vukomanovic and colleagues
2008;506 Serbia; 2005–6;
B and C
Hip; osteoarthritis; n= 45
(23 : 22); 58.2 years (66.7%)
Multifactorial: exercise
(functional) and education;
home; one education
appointment with
physiatrist, two
practical classes with
physiotherapist; controls
received no education or
physical therapy
Pre-operative period,
immediate postoperative
period and 15-month
follow-up; VAS pain, OHS,
time to walking, LOS, VAS
sense of uncertainty; four
(2 : 2) lost to 15-month
follow-up, nine (5 : 4) total
lost to follow-up
Weidenhielm and colleagues
1993;524 Sweden; date not
specified; A and C
Knee (unicompartmental);
osteoarthritis; n= 40
(20 : 20); 63.5 years (51.3%)
Exercise (strengthening);
outpatient and home,
group and individual;
three times per week for
5 weeks; commenced
3 months before surgery;
controls received no
pre-operative therapy
Immediately before and
3 months after surgery;
Pain (4 grade scale); one
(1 : 0) had a heart attack
and did not complete study
Wijgman and colleagues
1994;507 The Netherlands;
1991–2; A and B
Hip; primary coxarthrosis;
n= 64 years (31 : 33);
65 years (75% female)
Multifactorial: exercise
(strengthening, gait) and
education; group; single
30-minute session, 2 days
to 1 month before surgery;
controls received standard
care
Day 1 after surgery to
14 months; VAS pain, LOS,
time to standing; 1 (1 : 0)
lost to follow-up with
surgical complication
Williamson and colleagues
2007;525 UK; 2004–6;
A and C
Knee; osteoarthritis; n= 121
(60 : 61); 69.8 (52.9%)
Exercise (strengthening,
balance); outpatient group;
1 hour once a week for
6 weeks; controls received
an exercise and advice
leaflet
7 and 12 weeks after start
of intervention and
3 months postoperatively;
OKS, WOMAC, VAS pain,
HADS; 9 (7 : 2) at 7 weeks,
42 (23 : 19) at 3 months
post surgery
Wong and Wong 1985;508
Canada; 1982–3; B
Hip; elective; n= 98
(51 : 47); 66.7 years (68%)
Education; hospital; day
of admission; controls
received traditional
pre-operative instruction
Six times daily for 4 days
after surgery, no relevant
outcomes; no losses to
follow-up reported, three
withdrawals with
complications
AIMS, Arthritis Impact Measure Score; AIMS2, Arthritis Impact Measure Score 2; ILAS, Iowa Level of Assistance Scale;
LOS, length of stay; NRS, numerical response scale; SF-MPQ, Short-form McGill Pain Questionnaire; STAI, State–Trait
Anxiety Inventory.
a Additional information in McDonald and colleagues.83
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Data for meta-analysis were available for 19 interventions with 1026 participants.488,493,494,496,497,501–503,510,
513–515,519,521,525,527,534 In the random-effects meta-analysis shown in Table 76 and Figure 38, the average SMD
was 0.28 (95% CI 0.16 to 0.40) favouring intervention. Inspection of the funnel plot did not suggest
publication bias. Benefit for interventions was limited to eight studies with 343 patients waiting for THR
(average SMD 0.40, 95% CI 0.18 to 0.61) and two studies with 226 hip and knee patients reported
together. There was no heterogeneity across all studies or in those in patients waiting for hip replacement.
In eight studies with 457 patients waiting for knee replacement, there was a non-significant trend for
benefit (average SMD 0.19, 95% CI –0.04 to 0.42). In three education-based interventions with 261
patients, physical function was better in intervention patients (average SMD 0.33, 95% CI 0.09 to 0.58).
Similarly, in 12 exercise-based interventions with 494 patients, interventions showed benefit (average SMD
0.26, 95% CI 0.08 to 0.44).
No heterogeneity was apparent. In four multifactorial interventions with 271 patients there was a trend for
benefit (SMD 0.32, 95% CI –0.03 to 0.66). Considering studies separately in patients waiting for hip and
knee replacement there was no suggestion that particular types of interventions were more effective.
In a sensitivity analysis with 10 interventions of good or reasonable quality with 610 patients, benefit was
still apparent (SMD 0.21, 95% CI 0.04 to 0.38). Numbers in groups were small but benefit was mainly in
patients waiting for hip replacement.
To evaluate physiotherapy content we analysed studies by intervention intensity (frequency and duration)
and specific components. Higher intensity interventions showed benefit in seven studies with 308 patients
waiting for hip replacement (SMD 0.39, 95% CI 0.16 to 0.62), and a trend for benefit in nine studies
with 457 knee arthroplasty patients (SMD 0.19, 95% CI –0.04 to 0.42). However, numbers of studies with
medium or low intensity exercise content were small.
In patients waiting for THR, five interventions focusing on strengthening showed benefit (SMD 0.36,
95% CI 0.09 to 0.62), as did three studies with cardiovascular exercise (SMD 0.48, 95% CI 0.03 to 0.93).
Numbers of studies including other components targeting stretching, gait re-education, ROM, balance,
endurance, flexibility, proprioception, pool-based exercises and functional exercises were too low to draw
conclusions on content. There was no evidence to suggest that any interventions had an adverse effect on
physical function.
In patients waiting for knee replacement, nine physiotherapy exercise interventions had a strengthening
component. As shown in Table 76, there was a non-significant trend for benefit in improved physical
function for interventions with a strengthening component compared with controls (SMD 0.19, 95% CI
–0.04 to 0.42). As with studies in hip replacement, there were too few studies to draw conclusions on
other exercise content.
Pain
Pain measured before surgery was reported for 25 interventions, with data suitable for meta-analysis in
21 interventions with 1375 patients. Interventions were associated with reduced pain (SMD 0.21, 95% CI
0.10 to 0.33), but this was limited to patients waiting for hip replacement (SMD 0.47, 95% CI 0.28
to 0.67). There was only slight heterogeneity and the funnel plot did not suggest publication bias
(data not shown).
In 16 studies judged to be of good or reasonable methodological quality comprising 1141 patients,487,488,
493–495,497,503,509–511,514,515,517,521,524,527 there was benefit for interventions (SMD 0.24, 95% CI 0.09 to 0.38),
but this was statistically significant only in hip patients.
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In 13 studies with 597 patients,488,494,497,502,503,509,511,514,515,519,524,525 exercise-based interventions showed
benefit, SMD 0.23 (95% CI 0.07 to 0.39). In three education-based interventions495,501,527 and five
multifactorial interventions,487,493,510,517,521 there were trends for benefit, with SMDs of 0.20 (95% CI
–0.03 to 0.44) and 0.27 (95% CI –0.04 to 0.58). Numbers in some groups were small but all types of
programme content showed benefit for patients waiting for THR.
Anxiety
Anxiety was reported pre-operatively for eight interventions, using the State–Trait Anxiety Inventory (STAI)
in six studies,489,495,526,528,529 and HADS525 and Arthritis Impact Measure Score (AIMS) anxiety487 in one each.
In eight studies487,489,495,525,526,528,529 with 660 patients, interventions were associated with lower anxiety with
SMD 0.38 (95% CI 0.11 to 0.65). However, in quality assessment, five studies were classified as having risk
of bias.489,495,525,526,529
Preparation for recovery in hospital
In 27 studies (26 articles), a specific focus of the intervention was preparing patients for their hospital stay,
including what to expect before, during and after surgery.489–492,495,496,498,499,501,504–508,510,516–518,522,526,528–533 We
identified 14 interventions in patients waiting for hip replacement,489–492,495,496,498,499,501,504–508 six interventions
in patients waiting for knee replacement510,516–518,522 and seven intervention in patients waiting for either hip or
knee replacement.526,528–533 Nineteen interventions489,490,492,495,498,499,501,505,508,516,518,522,526,529–533 were primarily
education based and eight were multifactorial with education and exercise content.491,496,504,506,507,510,517,528
Post-surgical anxiety
Eight interventions reported anxiety outcomes within a month of surgery.489,490,492,495,506,522,529,530 Five studies
with 381 patients presented data suitable for the meta-analysis in Table 76 and Figure 39.489,492,495,506,529 Four
studies recorded anxiety using the STAI questionnaire during the hospital stay or the change from baseline
and included either hip or hip and knee patients analysed together.489,492,495,529 In a random-effects model,
the MD was 2.97 (95% CI 0.64 to 5.30) in favour of reduced anxiety in the intervention group. One study
reported sense of uncertainty on discharge using a VAS scale.506 Inclusion of this in the meta-analysis and
excluding one study with change scores gave an average SMD of 4.15 (95% CI 1.46 to 6.84).
There was no evidence of heterogeneity and exclusion of one study with differing losses to follow-up
between randomised groups did not affect the outcome.529
Post-surgical pain
Fifteen interventions reported a pain outcome up to 1 month after surgery. For meta-analysis, we included
the latest data at a fixed time point up to 1 month after surgery. If not available, we used data collected at
discharge but such data may be affected by time in hospital. When possible, we used pain at movement in
preference to pain at rest. Using these criteria, 12 interventions with 842 patients were included in the
meta-analysis. Up to 1 month after surgery, pain was non-significantly lower in intervention groups than in
controls (SMD 0.18, 95% CI –0.01 to 0.38). Similar trends were noted in hip and knee patients separately.
There was no evidence of publication bias from inspection of the funnel plot but some heterogeneity was
evident in trials including knee replacement patients (data not shown).
Results and heterogeneity were similar after exclusion of studies with possible bias owing to differences in
patient characteristics, group follow-up rates or inclusion of data collected at discharge.
Length of hospital stay
Length of hospital stay was reported after 19 interventions with 997 patients. There was no statistically
significant benefit for interventions (MD –0.16 days, 95% CI –0.78 to 0.45 days) reflecting a trend for
lower length of hospital stay in intervention groups. The corresponding funnel plot did not suggest
presence of publication bias. Heterogeneity (I2= 67%) was not explained by one study with different
follow-up rates in randomised groups. Although benefit for reduced length of stay was noted in knee
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replacement patients, this was based on two studies510,517 and was not supported by studies including both
hip and knee patients.528,529,531
Mobilisation after surgery
In six studies with 471 patients, time to mobilisation was reported.495,496,506,507,528,529 Studies included only
hip or hip and knee patients. Measures of mobilisation were time to walking in five studies495,496,506,528,529
and time to standing in one study.507 In meta-analysis, time to mobilisation was shorter in the intervention
groups (MD –0.17 days, 95% CI –0.30 to –0.04 days) and this was little changed if only time to walking
was considered. Overall, there was no heterogeneity among studies.
Improving long-term outcomes
Nine pre-surgical interventions explicitly targeted improvement in long-term outcome after hip
replacement487,488,493,496,501–503,506 and nine after knee replacement.503,510,513–515,519,524,525 The focus of the
intervention was exercise in 12 interventions, education in one intervention and multifactorial in
five interventions.
Long-term physical function
All but three studies reported a functional outcome at 3 months or longer after surgery.502,515,524 As shown
in the meta-analysis in Table 76 and Figure 40, including 15 studies with 577 patients, there was no
overall long-term benefit in intervention compared with control groups (SMD 0.08, 95% CI –0.09 to 0.26).
Only moderate heterogeneity was apparent and there was no suggestion of publication bias.
Long-term pain
As shown in Table 76, there was no benefit for reduced long-term pain after interventions in 10 studies
with 414 patients (SMD 0.03, 95% CI –0.16 to 0.23). In addition, there was no heterogeneity among
the studies.
Discussion
Before joint replacement, many interventions have been evaluated that aim to improve pre-surgical
physical health, preparation for surgery and recovery, and achievement of good long-term outcomes.
Studies were generally small and a minority reported long-term follow-up.
Evidence from studies considered to be of reasonable or good quality suggests that, in patients waiting for
hip replacement, physical function can be enhanced and pain reduced before surgery. For patients with
knee replacement, trends were apparent but were not statistically significant. There was some suggestion
that interventions led to reduced anxiety before surgery but this was more convincing in patients followed
up shortly after surgery in better-quality studies. Patients receiving interventions mobilised quicker after
surgery but length of hospital stay did not differ significantly. For patients followed up after surgery, there
was little to suggest that interventions had long-term benefit.
Interpretation of the effect size when using SMDs as the outcome can be difficult. Cohen interpreted
effect sizes as ‘small’ (0.10), ‘medium’ (0.25) and ‘large’ (0.40).535 Thus, interventions in patients waiting
for hip replacement can be considered to show a medium to large effect on pre-surgical physical function
and pain, depending on the study quality. The effect of interventions in hip and knee patients on
reducing post-surgical anxiety was medium to large. Mobilisation was brought forward by about 4 hours
in intervention groups, a potentially large effect in the context of recent studies with mean times to
mobilisation of 48–72 hours.
The small number of interventions and the size of trials limited the analysis of long-term outcomes and
there was little to suggest benefit. Differences in outcomes at long-term follow-up, particularly in small,
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underpowered studies, are likely to be overwhelmed by changes in physical function and pain that occur
after hip or knee arthroplasty in the majority of patients.18,48
Exercise provides the main focus of interventions aiming to improve pre-surgical physical function.
However, the importance of specific exercise content was unclear. This may reflect the aims of pre-surgical
physiotherapy exercise focusing on the maintenance of functional ability and prevention of decline, rather
than post-surgical rehabilitation, which is substantially based on adjustment to physical changes associated
with the prosthesis.
Conclusion
In randomised evaluations of pre-surgical exercise and education identified in our systematic review, there
was a suggestion that physical function can be enhanced and pain reduced before surgery in patients
waiting for hip replacement. Studies on patients with knee replacement did not provide strong evidence of
benefit. Interventions were associated with reduced anxiety during the hospital admission and quicker
mobilisation. The value of specific exercise content was unclear, which may reflect the aims of pre-surgical
exercise to maintain functional ability and prevent decline whereas post-surgical rehabilitation is
substantially based on adjustment to physical changes associated with the prosthesis.
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Chapter 9 Clinical effectiveness and
cost-effectiveness of a group-based pain
self-management intervention for patients undergoing
total hip replacement: feasibility study for a
randomised controlled trial – SPIRAL
Parts of this chapter have been reproduced from Wylde and collegaues.536 © 2014 Wylde et al.;licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited.
Abstract
Background
We conducted the SPIRAL study to evaluate the feasibility of a definitive RCT to assess the clinical effectiveness
and cost-effectiveness of a group-based pain self-management course for patients undergoing THR.
Methods
Participants were randomised to attend a pain self-management course plus standard care or standard
care only. The course consisted of two half-day sessions before surgery and one full-day session after
surgery. Participants provided outcome and resource-use data prior to surgery and 1 month, 3 months and
6 months after surgery. Telephone interviews were conducted with non-participants to explore barriers
to participation.
Results
Out of the 385 eligible patients with THR, 88 (23%) consented to participate. Common reasons for
non-participation were views about the course and transport difficulties. Of 43 patients randomised to
the intervention, 28 attended the pre-operative sessions and 11 attended the postoperative session.
Participant satisfaction was high and feedback highlighted that patients enjoyed the group format.
Retention of participants in the RCT was acceptable (83%) with high questionnaire return rates, with the
exception of resource-use diaries.
Conclusions
Although participation in the group-based pain self-management course was low, those who attended
provided positive feedback. The SPIRAL study highlights the importance of conducting feasibility work and
evaluating the acceptability of an intervention prior to undertaking a full-scale RCT to assess the clinical
effectiveness and cost-effectiveness of an intervention.
Background
Evidence is needed on the clinical effectiveness and cost-effectiveness of pain self-management
programmes for patients undergoing THR. Previous studies of self-management programmes for patients
with arthritis have faced challenges owing to low recruitment rates, poor uptake of the intervention and
high attrition rates.537–541 Therefore, prior to undertaking a RCT with an economic evaluation component of
a pain self-management programme for patients undergoing THR, it is important to evaluate the feasibility
of such a trial and the acceptability of the intervention to patients.
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Feasibility and pilot work to explore trial processes can include testing trial procedures and data collection
methods, randomisation processes, recruitment rates and attrition rates.542 For example, attrition rates for
self-management programmes have been found to be as high as 40–50%,540,541 and in one research
study 29% of recruited patients attended none of the sessions on a 6-week self-management course.537
Preliminary work prior to undertaking the definitive trial can often highlight unanticipated issues with trial
design and conduct,543,544 which can then be addressed to maximise the success of intervention evaluation
in a full-scale RCT. The importance of feasibility work to evaluate trial processes has been highlighted in a
systematic review of cluster RCTs in primary care, which concluded that a number of reported issues with
recruitment, adherence to trial protocol and data collection methods could have been pre-emptively
identified and addressed through feasibility work.545
In addition to testing trial processes, another objective of preliminary work prior to a full-scale RCT can
be to test the acceptability of an intervention, particularly if the intervention is complex in nature.546
Preliminary work to develop, refine and pilot complex interventions is recommended by the MRC.94 Early
evaluation of the acceptability of a complex intervention can highlight aspects of the intervention which
can then be modified prior to a definitive trial. For example, feasibility work highlighted that booster
sessions for a group-based cognitive–behavioural therapy intervention were poorly attended.547 A feasibility
study of a group-based acceptance and commitment therapy for chronic pain found that some patients
found the sessions too long.548 A pilot study of a complex intervention for diet and activity behaviour
change in obese pregnant women found that increased flexibility of the timing of sessions was necessary
to improve attendance and some activities, such as goal-setting, were better conducted individually rather
than in a group setting to minimise perceptions of being judged.549
Therefore, the aims of this study were twofold: (1) to evaluate the feasibility of conducting a RCT to assess
the clinical effectiveness and cost-effectiveness of a group-based pain self-management course for patients
undergoing THR, and (2) to assess the acceptability of the intervention. Specific objectives were to assess
the feasibility of trial design and procedures, ascertain recruitment and retention rates, identify barriers to
participation, develop resource-use data collection methods, assess questionnaire completion rates, and
evaluate uptake and patient satisfaction with the course.
Patients and methods
The study was approved by the South West Central Bristol Research Ethics Committee (reference 11/SW/0056)
and all participants provided their informed, written consent to participate. The trial was registered on the
NIHR Clinical Research Network Portfolio (UKCRN ID 11270) and ISRCTN register (ISRCTN52305381).
Participant recruitment
Between June 2011 and June 2012, potential participants were identified from the joint replacement
waiting list at one elective orthopaedic centre and sent a postal study invitation. Patients interested in
participating in the study were asked to return a signed consent form and reply slip to the research team.
Study recruitment materials were designed with input from patient representatives through the unit’s
dedicated patient forum (PEP-R).550 A researcher then contacted interested patients to ensure that they met
the eligibility criteria and answer any questions they may have about the study. The inclusion criterion was
being listed for a primary THR because of osteoarthritis. Exclusion criteria comprised lack of capacity or
unwillingness to provide informed consent and inability to complete English-language questionnaires. In
order to explore whether or not the patients enrolled in the study were representative of those undergoing
joint replacement, basic demographic data on age and sex were recorded for all eligible patients who were
approached about the study.
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Telephone interviews with non-participants
To explore potential barriers to participating in the study, short, structured telephone interviews were
conducted with patients who declined to participate in the study but returned a reply form giving
permission for a researcher to telephone them to discuss why they decided not to participate. Reasons for
non-participation were recorded on a standardised proforma by the researcher and entered into a
Microsoft Excel spreadsheet.
Randomisation
Participants were randomised after recruitment using a computer-generated randomisation system
(Minim).551 Blinding of the research team or patients was not possible because the intervention involved
attending a course. Participants were informed of the results of randomisation via a letter and those
randomised to the intervention group were contacted by telephone to discuss course arrangements.
Assessment times
All participants completed postal questionnaires at baseline (after recruitment), prior to surgery and then at
1, 3 and 6 months after surgery. If no reply was received after 2 weeks then a single reminder was sent.
Questionnaires
At each assessment time, participants completed the following validated PROMs.
WOMAC114
This consists of 24 items and produces individual scores for hip pain, function and stiffness. Scores were
transformed onto a 0–100 scale (worst to best).
Pain Self-Efficacy questionnaire275
This consists of 10 items regarding a person’s confidence in their ability to perform general activities,
despite their pain. Scores range from 0 to 60, with a higher score reflecting stronger perceived self-efficacy.
Brief COPE276
This consists of 28 items about coping strategies and provides 14 distinct two-item subscales of coping
reactions. Each subscale is scored from 1 to 4, with higher scores representing a greater reliance on a
particular coping strategy.
Beliefs about Medicines Questionnaire – Specific277
This consists of 10 items assessing a person’s beliefs about their medication (limited to pain medication in
this study). The questionnaire produces two subscales about the necessity of prescribed medication and
concerns about potential adverse effects of prescribed medications, both of which are scored from 5 to 25,
with a higher score indicating stronger beliefs.
European Quality of Life-5 Dimensions-5 Levels278
This consists of five questions with five levels each (from no problems to severe problems) which provides a
standardised measure of general HRQoL across five dimensions.
Patients also completed questions about pain in other joints, fatigue and pain distress (both measured on a
VAS), length of time spent on various exercises each week and current pain medication usage. In the
baseline questionnaire, medical comorbidities were recorded using the Functional Co-morbidity Index279
and information was collected about socioeconomic status.
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Resource use
The 3- and 6-month postoperative questionnaire included a full resource-use questionnaire to identify and
measure NHS resources used including community-based doctor and nurse visits, physiotherapy and
occupational therapy visits, secondary care inpatient and outpatient visits and medication, use of social
services, patient expenses, informal care and productivity losses incurred in the period. Participants were
given a pre-operative resource-use diary to record any resources used from randomisation until they had
their surgery. They were asked to return the completed pre-operative diary to the research team when
they returned their 1-month postoperative questionnaire. At 1 and 3 months post operation, patients were
given a resource-use log to prospectively record their use of resources in the following period in order to
aid them in the completion of the resource-use questions in the 3-month and 6-month questionnaires.432
The aim of these questionnaires was not to formally evaluate the differences in costs and consequences of
delivering a pain self-management course to patients undergoing THR, but to refine resource-use data
collection methods. Therefore, analyses of these questionnaires focused on rates of missing data, which is
a common issue with patient-completed postal resource-use questionnaires.432
Intervention
The Challenging Pain and Keep Challenging Pain courses were delivered by Arthritis Care, a registered UK
charity that has been delivering self-management courses since 1994. The courses were delivered by two
lay trainers, who had experience of living with chronic pain. All the courses were held at the AOC,
Southmead Hospital. Reimbursement of travel costs (mileage and parking fees) or a pre-paid taxi was
offered to all participants who attended the courses.
Challenging Pain course
The pre-operative Challenging Pain course consisted of two sessions running over consecutive weeks, with
each session lasting 2.5 hours. The 2-week course was developed from a longer 6-week course and has
been evaluated by Arthritis Care.552 The emphasis of the course was on pain management and introduced
participants to a variety of cognitive pain management techniques, with the aim of providing coping skills
to enable patients to manage their pain and its impact more effectively. Delivery involved a combination of
presentations, group work, pair work, practical demonstrations and interactive sessions. The first session
included introductions to conscious breathing, full-body relaxation, exercise, goal-setting and managing
stress. The second session reviewed these topics and introduced pacing, medications and other therapies,
guided imagery, managing negative thoughts and effective communication.
Postoperative Keep Challenging Pain course
All participants randomised to the intervention group were invited to attend an additional top-up Keep
Challenging Pain course at between 6 weeks and 3 months post operation. This course was designed by
Arthritis Care in conjugation with a physiotherapist specifically to be delivered to postoperative THR
patients. This 5-hour session reviewed the pain management strategies that were introduced in the
pre-operative course, provided advice on recovery after THR, reviewed goal-setting and problem solving,
and included a practical exercise session lead by a registered physiotherapist.
Course evaluation
A short structured feedback questionnaire about the course was completed by participants at the end of
the both the Challenging Pain and Keep Challenging Pain courses.
Surgery and postoperative physiotherapy
All participants received a primary THR using a posterior or anterolateral approach, at the discretion of the
surgeon. Standard postoperative inpatient physiotherapy at the AOC consists of strengthening of the hip
abductor muscle, flexor and extensor exercises, transfers to and from bed, and walking and stair climbing,
with hydrotherapy and gym exercises if required. Outpatient physiotherapy is not routinely provided
after discharge.
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Sample size
No formal sample size calculation can be performed for a feasibility study. The average sample size for
feasibility studies assessing trial design and the acceptability of interventions is approximately 60 patients.553
A minimum of 80 patients (40 per arm) was deemed an appropriate sample size for this trial to allow an
estimate of recruitment and retention rates and explore the acceptability of the intervention.
Analysis
In line with recommendations about good practice in the analysis and reporting of feasibility and pilot
trials, analysis is descriptive and no comparisons of the outcomes between the two arms of the trial was
conducted.542 Descriptive statistics on recruitment rates, baseline patient characteristics, retention of
participants and questionnaire return rates are presented as means and 95% CIs, medians and IQRs or
percentages. Resource-use data collected from patient self-completed questionnaires were considered
complete when the patient recorded enough data to allow costing using a national tariff. Completion
rates were reported per question and aggregated per two economic perspectives – the NHS and PSS
perspective – and a broader societal perspective. Data on reasons for non-participation in the trial were
coded into themes by one researcher and these themes were then discussed and agreed with a
second researcher.445
Results
Recruitment rate and participants
Postal invitations were sent to 385 eligible patients and 88 patients consented to participate, giving a
recruitment rate of 23%. A CONSORT flow diagram is shown in Figure 41.
Baseline demographic and clinical characteristics of the participants are displayed in Table 77. Mean
WOMAC scores indicated that patients had high levels of hip pain and functional limitations prior to
surgery. Mean pain self-efficacy scores indicate the patient population were suitable for a pain
management intervention.275 Participants underwent THR surgery at a median of 12 weeks (IQR 8–15 weeks)
after recruitment into the study. Non-participants had a similar median age (67 years, 95% CI 66 to 69 years)
to participants but were more likely to be male (46% male).
Reasons for non-participation
Brief telephone interviews were conducted with 57 (19%) non-participants. These patients had a
mean age of 71 years (95% CI 68 to 74 years) and 37 were female. Patients gave 91 reasons for
non-participation, most frequently relating to perceptions and views about the pain self-management
course (Table 78). These reasons included previously attending pain self-management courses and finding
them unhelpful, a perceived lack of need because pain was adequately managed, a dislike of group
formats and concerns over difficulty in attending the course because of pain, age and/or other health
conditions. The second most frequently given reason for non-participation concerned issues around
travelling to the hospital to attend the course.
Retention
Fifteen patients were withdrawn from the study (17% of recruited participants): seven from the
intervention group and eight from the standard care group (see Figure 41). Of the withdrawn patients,
nine were withdrawn because they did not undergo surgery during the study period, five self-withdrew
and one was withdrawn because they were recruited into another trial whose protocol precluded
participation in two trials.
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Assessed for eligibility
(n = 409)
Excluded
(n = 321)
• Did not meet inclusion criteria, n = 24
• Declined to participate, n = 297
Pre-operative Challenging Pain workshops
Attended workshops 
(n = 28)
Did not attend workshops 
(n = 15)
• Unable to arrange course pre-surgery, n = 8
• Withdrawal from study, n = 4
• Patient unable to attend, n = 3
Non-participant patients
consented to telephone interview
(n = 57)
Recruited and randomised
(n = 88)
Allocation to intervention
(n = 43) Allocated to usual care
(n = 45)
Postoperative Keep Challenging Pain workshop
Attended workshops 
(n = 11)
Did not attend postoperative workshops 
(n = 32)
• Unable to arrange workshop, n = 6
• Withdrawn, n = 7
• Patient unable to attend, n = 16
• Satisfied with pain relief, no pain, n = 3
Surgery
(n = 36)
Surgery
(n = 36)
Completed follow-up 
(n = 36)
Withdrawals 
(n = 7)
• Self-withdrawal prior to surgery, n = 3
• Recruited into another trial, n = 1
• Did not have surgery, n = 3
Completed follow-up 
(n = 37)
Withdrawals 
(n = 8)
• Did not have surgery, n = 6
• Self-withdrawal after surgery, n = 2
FIGURE 41 SPIRAL CONSORT flow diagram.
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TABLE 77 SPIRAL baseline demographic and clinical characteristics of participants
Patient characteristics Overall (n= 88)
Allocated to intervention
(n= 43)
Allocated to standard
care (n= 45)
Mean age (95% CI) 66 (64 to 68) 65 (61 to 69) 67 (64 to 70)
Female :male, % 65 : 35 65 : 35 64 : 36
Living alone, % 19 18 20
With college or university education, % 35 32 39
Retired, % 60 61 59
Mean WOMAC pain score (95% CI) 38 (33 to 42) 37 (31 to 43) 38 (32 to 44)
Mean WOMAC function score (95% CI) 37 (33 to 41) 39 (33 to 45) 35 (30 to 41)
Pain self-efficacy score (95% CI) 32 (29 to 35) 35 (30 to 39) 30 (26 to 34)
Notes
WOMAC pain and function scores range from 0 to 100 (worst to best).
Pain Self-Efficacy questionnaire scores range from 0 to 60 (low self-efficacy to high self-efficacy).
TABLE 78 SPIRAL reasons for non-participation
Barriers to participation (number of patients) Examples of reasons given
Thoughts about attending the course (25) Difficult to sit and concentrate during workshops because of pain/age/
other health conditions
Dislike of group session format
Found previous pain management course unhelpful
Can already manage pain
Workshops would not be helpful as pain not too bad
Difficult to attend because of other health conditions
Would rather spend time doing other things
Difficulty getting to hospital (22) Unable to drive/use public transport owing to hip problems
Distance to hospital perceived as too far
Would have to rely on family/friends for transport
Limited mobility or uses wheelchair
Other commitments (13) Carer for family member
Employment
Children
Questionnaires (8) Dislike of completing questionnaires
Difficult to complete because of other health conditions
Lack of time because of other commitments
Other hospital appointments (6) Lack of time for additional visits to hospital
Inconvenient to make additional visits to hospital
Feels already has enough knowledge (6) Previous hip replacement
Knows people who have had hip replacement
Has attended physiotherapy/exercise session
Health-care related (6) Operation may not be going ahead
Dissatisfied with co-ordination of care
Other (5) Emigrating
Recently widowed
Has taken part in research before
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Intervention: attendance and acceptability
Pre-operative Challenging Pain course
Four pre-operative Challenging Pain courses were held, with between four and nine participants on each
course. Out of the 43 participants randomised to the intervention group, 28 patients attended the
pre-operative course (17 attended both workshops, 11 attended one workshop) at a median of 5 weeks
(IQR 2–8 weeks) prior to surgery. Reasons for non-attendance are presented in Figure 41. Results from
the course evaluation questionnaire are presented in Table 79. Free-text comments on the evaluation
questionnaires frequently gave positive feedback on the group format of the workshop, which provided
the opportunity to meet other people undergoing THR.
Postoperative Keep Challenging Pain course
Three postoperative Keep Challenging Pain course were held, with between two and five participants
on each course. Out of the 43 participants randomised to the intervention group, 11 patients attended
the postoperative course at a median of 9 weeks post operation (IQR 5–14 weeks). Reasons for
non-attendance are presented in Figure 41. The results of the course evaluation questionnaire are
presented in Table 79. Free-text comments on the evaluation questionnaires most frequently gave positive
feedback on the physiotherapy session and the group format of the workshop.
Outcomes assessment and economic evaluation
The questionnaire return rates at each assessment time were high, ranging from 72% to 93% (Table 80).
The rate of questionnaire return was similar between trial arms, with < 10% difference in return rates at
each time point, except for the 3-month postoperative questionnaire, which was returned by more patients
in the standard care arm than in the intervention arm (91% vs. 72%, respectively). Return rates for the
pre-operative resource-use diaries were low, with only 35% of patients returning their diary.
TABLE 79 Results from the Challenging Pain and Keep Challenging Pain evaluation questionnaires
Evaluation question
Challenging Pain course
(n= 27)
Keep Challenging Pain course
(n= 11)
Has the course been useful? (% yes) 100 100
Recommend for other THR patients? (% yes) 100 100
Mean usefulness (95% CI) 7.3 (6.5 to 8.1) 8.9 (8.4 to 9.5)
Mean satisfaction with content (95% CI) 8.0 (7.2 to 8.7) 9.0 (8.4 to 9.6)
Men satisfaction with delivery (95% CI) 8.4 (7.7 to 9.0) 9.0 (8.2 to 9.8)
Note
Usefulness and satisfaction questions rated on 0–10 scale (worst to best).
TABLE 80 Percentage completion rate of patients returning completed questionnaires at each time point
Time point
Median (25th, 75th percentile)
time of completion
Intervention group,
n/N (%)
Usual care group,
n/N (%)
Overall,
n/N (%)
Baseline 10 weeks (5, 13) prior to surgery 38/43 (88) 42/45 (93) 80/88 (91)
Preoperative 1 week (0.5, 1.3) prior to surgery 25/33 (76) 29/34 (85) 54/67 (81)
Pre-operative resource-use
diary
Pre-operative to 1-month after
surgery
11/36 (31) 15/38 (39) 26/74 (35)
1 month post operation 4 weeks (3, 5) after surgery 32/36 (89) 35/38 (92) 67/74 (91)
3 months post operation 13 weeks (13, 14) after surgery 26/36 (72) 34/37 (92) 60/73 (82)
6 months post operation 26 weeks (26, 27) after surgery 32/36 (89) 32/37 (86) 64/73 (88)
GROUP-BASED PAIN SELF-MANAGEMENT INTERVENTION FOR PATIENTS UNDERGOING THR
NIHR Journals Library www.journalslibrary.nihr.ac.uk
276
Table 81 presents the completion rates of resource-use data in the 3- and 6-month postoperative
questionnaires. For those who returned the resource-use questionnaire, completion rates for NHS
resource-use questions were high for secondary-care resource use (> 90% completion on both arms) and
medication use (> 80%), but less for community-based resources (65% and 66% for intervention and
control arms, respectively). PSS data also had high completion rates (> 86% for all categories), particularly
in the intervention group. When accounting for non-returners of follow-up questionnaires (10 in the
intervention group and seven in the control group), completion rates were lower, with community-based
resources being the lowest completed category. Overall, data for an economic evaluation from a NHS and
PSS perspective were available for 33% of patients in the intervention group and 43% of patients in the
standard care group. When considering other categories of resource use beyond health and social care,
cost of travel was the least completed category. As a result, for an economic evaluation from a societal
TABLE 81 Completion rates for resource-use categories over the follow-up period
Resource-use
category
Intervention Standard care
Number
complete
% of returners
(n= 26)
% all
(n= 36)
Number
complete
% of returners
(n= 29)
% all
(n= 37)
NHS resource use
Community-based visits 17 65% 47% 19 66% 51%
Hospital inpatient visits 24 92% 67% 28 97% 76%
Outpatient and A&E
visits
25 96% 69% 28 97% 76%
Prescribed medications 22 85% 61% 24 83% 65%
PSS
Home care worker 26 100% 72% 27 93% 73%
Food at home services 26 100% 72% 26 90% 70%
Social worker visits 26 100% 72% 25 86% 68%
Home changes 24 92% 67% 25 86% 68%
NHS+ PSS perspective 12 46% 33% 16 55% 43%
Other resources: productivity losses, informal care, private expenses and other
Time off work 23 89% 64% 24 83% 65%
Time off usual and
leisure activities
26 100% 72% 21 72% 57%
Informal care time 26 100% 72% 23 79% 62%
Charities and support
group visits
26 100% 72% 25 86% 68%
Privately paid therapies
used
23 89% 64% 25 86% 68%
Travel costs 13 50% 36% 14 48% 38%
Over-the-counter
medications
25 96% 69% 27 93% 73%
Societal perspective 6 23% 17% 7 24% 19%
A&E, accident and emergency.
Note
Number of participants completing the questions in a resource-use category at both 3- and 6- month follow-ups. Data are
presented for the 73 patients in the trial at final follow-up.
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perspective, complete data were available only for 17% of patients in the intervention group and 19% of
patients in the standard care group. The percentage of missing data was similar between trial arms, with
the exception of four categories (social worker visits, time off usual activities, informal care time, and
charities and support group visits), which had > 10% difference in completion rates between the trial
arms. For these categories, patients in the intervention arm had higher completion rates than those in the
standard care arm.
Discussion
This study looked at the feasibility of a RCT to evaluate the clinical effectiveness and cost-effectiveness of a
group-based pain self-management intervention for patients undergoing THR and the acceptability of this
intervention. Although feasibility studies are conducted to address trial design and methodology, a
systematic review found that articles often include only a minimal discussion of the methodological
findings and implications.554 This feasibility study highlighted several methodological considerations that
warrant further discussion.
Barriers to participation
Barriers to participation were explored using brief interviews with non-participants. These interviews
identified that the most frequent reasons for non-participation were views and perceptions of the pain
management course. These findings are in line with previous research, that identified that perceptions of the
course and satisfaction with current self-management were reasons for non-participation in a trial of an
arthritis self-management programme.538 Difficulty in getting to the hospital was the second most frequent
reason for non-participation, despite the offer of reimbursement of travel costs or a pre-paid taxi. Travel
issues and the burden of additional appointments are commonly reported barriers to trial participation.538,555
Future trials of group-based interventions may benefit from consideration of the location of the intervention.
For example, interventions held in the community may have greater uptake than those delivered in a
hospital, although trials of community-based group interventions also found that difficulties with travel is a
common reason for non-participation.538 Conducting these short interviews with non-participants identified
a number of barriers to participation that could be addressed in further refinement work, highlighting the
importance and value of conducting research with non-participants in feasibility studies.
Recruitment, retention and outcomes assessment
The recruitment rate for this trial was 23%, which is lower than the 42–79% recruitment rates reported in
previous trials of pain self-management interventions for patients undergoing joint replacement.487,527
However, other feasibility and pilot studies using a postal recruitment method have reported similarly low
response rates.547,556,557 Despite the low recruitment rate, retention of participants and questionnaire
completion were high and similar between the trial arms, suggesting that randomisation and outcomes
assessment were acceptable.
Recruitment into trials is known to be challenging and considerable research has been conducted into
improving trial recruitment. Methods such as telephone reminders to non-responders, ‘opt-out’ recruitment
strategies and financial incentives have been found to improve recruitment rates.558 However, potential
issues around coercion and undue influence can pose challenges to the implementation of these strategies.
Financial incentives for research participation is a debated issue and ambiguities remain around what level
of incentive constitutes undue influence, with little standardised guidance for Ethics Committees.559 For
example, we planned to offer participants free 1-year membership to Arthritis Care but the Ethics
Committee perceived this as potentially coercive and asked for this offer to be removed from the study
protocol. This demonstrates the challenges researchers can face in implementing measures to maximise
recruitment into trials while remaining in-keeping with preferences of the NHS Research Ethics Committee.
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Economic evaluation
The economic evaluation work highlighted the difficulty of collecting resource-use data from
randomisation until surgery for this patient group. However, average waiting time for surgery in this
patient group was 3 months and we would not expect the intervention to lead to behaviour change that
would produce differences in cost drivers in the shorter term. In comparison with the pre-operative diaries,
the postoperative resource-use questionnaires achieved good completion rates, allowing for a health and
social care payer evaluation perspective to be taken. The completion rates could be further improved after
imputation of community-based resource data. Although completion rates for a societal perspective were
low, categories on productivity losses and informal carer time were well completed and can be of added
value to a sensitivity analysis in a definite economic evaluation.
Acceptability of the intervention
In addition to assessing trial processes, this study evaluated the acceptability of the intervention. Feedback
on the course was positive, suggesting that the course was acceptable and well received by those who
attended. In particular, positive feedback was received on the group-based format, with patients
commenting that they appreciated the opportunity to meet other people undergoing THR surgery.
Studies evaluating group-based interventions in other clinical settings have also reported positive feedback
on this format of intervention delivery.549,557,560 Therefore, although the group format was a reason for
non-participation for some patients, those who attended the course enjoyed the format and engagement
with other patients. This highlights an issue affecting many trials: a potentially biased sample because of
the self-selection of participants with a preference for the intervention. Differences in the characteristics
of participants and non-participants are well known, with an underrepresentation of older people, women
and ethnic minorities in clinical research.561 Addressing willingness to participate owing to the nature of
the intervention in feasibility work has the potential to lead to refinements in the intervention for a
definitive trial and this knowledge has implications for the roll-out and uptake of interventions if
subsequently implemented in clinical practice.
The Challenging Pain and Keep Challenging Pain courses were highly rated by participants, but attendance
at the postoperative course was lower than at the pre-operative course. Reasons given for non-attendance
were predominantly that people were unavailable on the dates set for the course. The logistics of
scheduling group-based interventions is challenging, as many patients have limited availablity owing to
other commitments.538,549 Increasing flexibility in the scheduling of group-based interventions can be
challenging, particularly within the financial constraints of a trial, but having the flexibility to run multiple
courses is an important factor to consider when costing a trial.
Conclusion
Undertaking feasibility work for a RCT and evaluating the acceptability of an intervention can be a
labour-intensive exercise. However, this study highlights the importance of conducting such work prior to
undertaking a full-scale RCT to assess the clinical effectiveness and cost-effectiveness of an intervention.
Several key messages can be taken from our experience. First, conducting brief telephone interviews with
non-participants is an efficient and valuable method of collecting data on barriers to participation and we
recommend including this as a core component of feasibility studies. These data can also provide insight
into whether or not unwillingness to participate is due to the nature of the intervention, thereby providing
early indications of potential issues in a definitive trial and with uptake of the intervention if implemented
into clinical practice. Second, attempts to implement methods to improve patient recruitment need
to be carefully designed in light of ethical considerations, such as the potential for inducements to
be seen as coercion. Third, the logistical difficulties in scheduling groups and ensuring high attendance
should not be underestimated and the potential to increase flexibility by running multiple courses should
be considered when designing a budget for a trial. Finally, the ability of piloting resource-use
questionnaires is a major advantage to improve the quality of the resource-use data available in the
definitive economic evaluation.
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Chapter 10 Occupational therapy in total hip
replacement: systematic review and feasibility
randomised controlled trial
Parts of this chapter have been reproduced with permission from Jepson P, Sands G, Beswick AD,Davis ET, Blom AW, Sackley CM. A feasibility randomised controlled trial of pre-operative occupational
therapy to optimise recovery for patients undergoing primary total hip replacement for osteoarthritis
(PROOF-THR). Clin Rehabil 2015;30:156–66.562
Abstract
Background
Occupational therapy is routinely provided for patients with THR as part of the rehabilitation service but
little is known about its clinical effectiveness.
Methods
We conducted a systematic review of the clinical effectiveness of occupational therapy interventions in
patients receiving THR.
The PROOF-THR study evaluated the feasibility of a RCT of pre-surgical occupational therapy in patients
waiting for THR. Primary objectives were to assess patient identification, recruitment and retention,
acceptability of allocation and health resource use, and outcome measures.
Results
In patients receiving THR, the systematic review identified seven RCTs of occupational therapy, mainly combined
with physiotherapy. There was a suggestion of improved function and reduced pain before surgery but this
was not sustained after surgery. In the PROOF-THR study, 44 patients were randomised to pre-operative
occupational therapy or usual care. Good recruitment rates, acceptability of randomisation of participants,
successful intervention delivery, and reasonable attrition rates suggest a definitive trial would be feasible.
Conclusions
The successful recruitment and randomisation of participants and delivery of the intervention, plus the
reasonable attrition rate, suggest that this trial design would be feasible to take forward into a definitive
trial of occupational therapy provision before THR.
Background
Occupational therapy is routinely provided for patients with THR as part of the rehabilitation service but little is
known about its effectiveness. The provision of compensatory equipment is a key aspect of occupational
therapy practice but evidence is needed on its clinical effectiveness and to optimise its delivery. Economic
pressures have had a dramatic impact on length of hospital stay following THR, such that reduction in length
of stay has been a common outcome measure used to justify many pre-operative interventions. Hospitalisation
for ≥ 10 days post surgery was common practice prior to 2000;563 however, now most patients are discharged
after 4–5 days.564 An important corollary of this reduced length of stay is the time available in hospital for
recuperation, inpatient rehabilitation, education and discharge procedures.565 Although some variation in
practice does exist, it is usual practice in the UK for OTs to provide compensatory equipment, together with
education on its use, in this short post-surgery/pre-discharge period. Pre-surgery home-based provision has
been identified as desirable by patients and potentially assistive in functional rehabilitation.566
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
281
To investigate evidence on the clinical effectiveness of a broad range of occupational therapy interventions
in patients receiving THR, we conducted a systematic review of RCTs. We also conducted a feasibility
study for a definitive randomised evaluation of the clinical effectiveness of a pre-surgery home-based
occupational therapy intervention compared with hospital-based usual care.
Systematic review and meta-analysis of the effectiveness of
occupational therapy interventions in total hip replacement
Background
Our aim was to identify RCTs evaluating occupational therapy interventions in isolation or as part of
multifaceted interventions in patients receiving a THR. The key outcomes in occupational therapy relate to
patient physical function, activity, social participation, HRQoL and pain, and prevention of dislocation.
Methods
General methods As described in Chapter 2, Systematic review methods
Databases and dates MEDLINE, EMBASE, CINAHL, PsycINFO, AMED, PEDro, ERIC, CIRRIE, OTDbase and The Cochrane
Library from inception to 24 June 2013. Citations of key articles in ISI Web of Science and reference
lists
Search strategy Hip replacement/RCT/occupational therapy. MEDLINE search strategy based on terms in Appendix 3
Study design RCTs with randomisation either at individual or cluster level. Quasi-randomised designs
(e.g. alternate allocation)
Patients Adults waiting for THR
Intervention Occupational therapy
Controls No occupational therapy intervention additional to usual care
Follow-up Any post surgery
Data extraction Country, baseline dates, participants (indication, age, sex), content of intervention and comparison
group, length of follow-up, losses to follow-up
Potential outcomes Patient-reported physical function
Patient-reported pain
Limitations in self-care ADL
Restrictions in extended or instrumental ADL
Societal reintegration or discretionary activities
Hip dislocation
Adverse events including deep infection or joint revision surgery
Quality assessment Cochrane risk-of-bias table
Results
Review progress is summarised as a flow diagram in Figure 42. Searches identified 4865 articles.
Twenty-nine articles were reviewed in full. After screening and detailed evaluation, seven interventions met
the inclusion criteria.489,493,496,501,504,567,568 Study characteristics are summarised in Table 82. As our review
focused on THR and the specific occupational therapy content provided to this patient group, we excluded
two studies with both total hip and TKR patients with no separate outcome reporting.528,569 Two studies
were conducted in the UK and one each in Iceland, Turkey, the USA, Canada and Italy.
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Search of multiple databases
(n = 4865)
Included studies
(n = 7)
Full-text articles assessed for eligibility
(n = 29)
Records excluded on basis of title
 and abstract
(n = 4836)
Full-text articles excluded 
(n = 21)
Reasons
• No/limited occupational therapy, n = 7
• Minority total hip replacement, n = 4
• Hip and knee, n = 7
• Not RCT, n = 3
• No control group, n = 3
• Qualitative study, n = 1
• Outcome measures not relevant, n = 1
• Reliability study, n = 1
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FIGURE 42 Systematic review and meta-analysis of the effectiveness of occupational therapy interventions in THR:
flow diagram
TABLE 82 Systematic review and meta-analysis of the effectiveness of occupational therapy interventions in THR:
study characteristics
Study; location;
dates
Indication; number
randomised
(intervention : control);
mean age (years)
(% female) Intervention; control
Outcomes; follow-up; losses to
follow-up (intervention : control)
Butler and
colleagues 1996;489
Canada; 1993–4
Not specified; n= 80
(32 : 48); 62.6 (51.3)
Pre-admission education booklet;
usual care – same information as in
pre-admission booklet given
following admission
State-Trait Anxiety Inventory,
patient satisfaction questionnaire,
exercise log and details of home
adaptations, length of hospital stay;
to discharge; one patient died and
no follow-up data from eight
patients
Ferrara and
colleagues 2008;493
Italy; 2006–7
End-stage osteoarthritis;
n= 23 (11 : 12); 63.4
(60.9)
5-day pre-admission intervention
package 1 month before admission
consisting of exercise, postural
advice, advice on movement
restrictions and prevention of
prosthesis dislocation, use of
devices (crutches, elevated toilet
sets, bed raises, dressing/undressing
adaptive devices), washing and
bathing; no pre-admission
intervention
WOMAC, SF-36, VAS (pain),
Barthel, hip strength and range of
movement; day before surgery,
15 days, 4 weeks, 3 months;
two (0 : 2) patients lost to 3-month
follow-up
continued
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
283
Participants
Studies included a total of 366 participants (range 23–89). The mean age of participants ranged from
51 to 75 years. The proportion of female patients in trials ranged from 36% to 85%.
Interventions
Five studies reported a pre-admission intervention with occupational therapy content compared with
controls receiving usual care. Pre-surgical interventions were education with a booklet489 or a booklet and
class501 or multidisciplinary with occupational therapy provided within an education and exercise
programme.493,496,504 One study evaluated a multidisciplinary intervention that provided occupational
therapy as part of pre- and post-surgery education and home-based rehabilitation.568 One study compared
early rehabilitation including an occupational therapy session starting on post-surgical day 3 with similar
post-surgery care commencing on post-surgical day 7.567
TABLE 82 Systematic review and meta-analysis of the effectiveness of occupational therapy interventions in THR:
study characteristics (continued )
Study; location;
dates
Indication; number
randomised
(intervention : control);
mean age (years)
(% female) Intervention; control
Outcomes; follow-up; losses to
follow-up (intervention : control)
Gocen and
colleagues 2004;496
Turkey; not
specified
Primary or secondary
osteoarthritis; n= 59
(29 : 30) also one patient
in intervention group
who did not receive
replacement; 51.3 (35.6)
Pre-operative exercises plus
occupational therapy-based
education class (movement
restriction, use of adaptive devices,
lifting and carrying, washing and
dressing; no pre-operative
intervention
HHS, VAS (pain), days to achieve
functional milestones (walking,
stairs, bed transfer, toilet transfer,
chair transfer); day of discharge,
3 months, 2 years; no losses to
follow-up
McGregor and
colleagues 2004;501
UK; 1998–9
Osteoarthritis; n= 39
(19 : 20); 71.9 (42.9)
Pre-admission hip class plus
education booklet with information
on surgery, rehabilitation, walking
aids and home adaptations; usual
care – no pre-operative advice
WOMAC, HHS, Barthel ADL,
Positive-affect Negative-affect scale,
Helplessness subscale of
Rheumatology attitudes index,
Cantril life satisfaction ladder,
VAS (pain, fatigue and function),
EQ-5D; day of admission,
discharge, 3 months; four (4 : 0)
patients lost to follow-up
Munin and
colleagues 1998;567
USA; 1994–6
High risk for requiring
inpatient rehabilitation;
n= 35 (19 : 16); 75 (85)
Phased postoperative rehabilitation
starting day 3 post surgery; usual
care – rehabilitation starting day 7
post surgery
Functional Status Index,
SF-36, length of hospital stay,
complications; 4 months; ITT
analysis; nine (5 : 4) patients lost to
follow-up
Sandell 2008;504
UK; 2003
Waiting time of
≥ 6 months; n= 89
(43 : 46); 68.2 (65.1)
Preadmission multidisciplinary
intervention by physiotherapist
(exercises and gait improvement),
nurse (additional advice).
Pre-operative occupational therapy
home assessment of functional
constraints and provision of
adaptive devices; no additional
pre-operative treatment by OT or
physiotherapist and standard advice
from nurse
AIMS2, NHP; day of admission;
26 (10 : 16) lost to follow-up
Siggeirsdottir and
colleagues 2005;568
Iceland; 1997–2000
90% osteoarthritis;
n= 50 (27 : 23); 68 (52)
Pre-admission training and
education programme.
Post-discharge home
physiotherapist, OT or nurse input
as required; usual care – not
specified
OHS, NHP, HHS Merle d’Aubigné
and Postel score; 2, 4, 6 months;
2 (0 : 2) lost to pre-operative
follow-up; three lost to 6-month
follow-up (0 : 3)
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Risk of bias
Potential sources of bias are summarised in Appendix 32. The main sources of possible bias were high
losses to follow-up in three studies.501,504,567 In one study, possible bias was identified as 123 patients with
any hip replacement were randomised but only data from 80 patients with a primary hip replacement
were analysed.489
Outcomes
Results are summarised in Table 83. In analyses we only considered patient-reported physical function
and pain.
Physical function
Five studies assessed patient-reported physical function using functional domains of the OHS,568 SF-36,567
NHP,504 or WOMAC.493,501 The results of meta-analyses are shown in Table 83 and Figure 43. Two studies
included in the meta-analyses reported change scores.504,567
TABLE 83 Systematic review and meta-analysis of the effectiveness of occupational therapy interventions in THR:
meta-analysis
Outcome Studies Patients Pooled effect size (95% CI) p-value I2 (%)
Patient-reported physical function
Pre-surgery 4 173 –0.40 (–0.70 to –0.09) 0.01 0
Discharge 1 39 –0.24 (–0.87 to 0.39) 0.45
Long term 4 135 –0.52 (–1.17 to 0.13) 0.12 69
Patient-reported physical function: low risk of bias
Pre-surgery 2 71 –0.63 (–1.12 to –0.15) 0.01 0
Discharge
Long term 2 70 –1.09 (–1.60 to –0.58) < 0.0001 0
Patient-reported pain
Pre-surgery 3 125 –0.29 (–0.64 to 0.07) 0.11 0
Discharge 2 98 –0.20 (–0.59 to 0.20) 0.33 0
Long term 3 90 0.06 (–0.67 to 0.80) 0.87 66
Patient-reported pain: low risk of bias
Pre-surgery 2 86 –0.41 (–0.84 to 0.02) 0.06 0
Discharge 1 59 –0.04 (–0.55 to 0.47) 0.89
Long term 1 23 –0.23 (–1.06 to 0.59) 0.58
Length of hospital stay
MD 3 146 –2.25 (–4.15 to –0.34) 0.02 64
Length of hospital stay: low risk of bias
MD 1 50 –3.60 (–5.29 to –1.91) < 0.0001
HRQoL
Pre-surgery 3 125 –0.52 (–0.91 to –0.12) 0.01 14
Discharge 1 39 –0.06 (–0.68 to 0.57) 0.86
Long term 3 90 –0.20 (–0.62 to 0.22) 0.35 1
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In the four studies with follow-up before surgery, physical function was better in patients who received an
intervention with occupational therapy content (SMD –0.40, 95% CI –0.70 to –0.09; p= 0.01).493,501,504,568
Benefit was apparent in the two studies with low or no reason to assume risk of bias.493,568 In one study
with follow-up at hospital discharge there was no suggestion of benefit501 but in four studies with
longer-term follow-up there was a trend favouring occupational therapy interventions.493,501,567,568 In two
studies with low risk of bias or in which there was no reason to assume risk of bias, there was benefit for
occupational therapy at long-term follow-up (SMD –1.09, 95% CI –1.60 to –0.58; p< 0.0001).493,568
Pain
Pain outcomes were reported in five studies using a VAS pain scale,493,496,501 SF-36 bodily pain,567 NHP
pain,504 or WOMAC pain score.493,501 In the meta-analyses summarised in Table 83 and Figure 44, we used
WOMAC pain scores in preference to VAS scores when available. One study reported a change score.567
There was a trend in three studies for reduced pain in patients who received occupational therapy
followed up before surgery,493,501,504 but only one study had a low risk of bias.493 Studies were small and
the limited evidence available from three studies did not support a long-term benefit.493,501,567
Length of hospital stay
The length of stay or time to hospital discharge was reported in three studies.489,567,568 The overall mean
hospital stay was 10.1 days. As shown in Table 83 and Figure 45, patients receiving occupational therapy
interventions spent a mean of 2.25 days fewer in hospital (95% CI –4.1 to –0.34 days; p= 0.02). Only one
study was at low risk of bias and in this study the hospital stay was reduced further.568
Health-related quality of life
Four studies reported a measure of HRQoL. These were SF-36 physical domains,493,504,567 and EQ-5D.501
As shown in Table 83 and Figure 46, interventions with occupational therapy content before surgery
showed benefit for improved HR-QoL but this was not sustained in the long term.
Other outcomes
Other key outcomes in studies of occupational therapy relate to prevention of dislocation (hip precautions)
anxiety and social participation. These were infrequently reported. Dislocation was reported in one study
with a total of only three events in 50 patients randomised.568
One study reported a measure of anxiety.489 After adjustment for sex, anxiety before surgery and at time
of hospital discharge was lower in patients who received an intervention with pre-surgical education
including occupational therapy content.
Social activity domains of the AIMS2 and NHP measured after the intervention but before surgery were
reported in one study.504 There was a statistically significant difference between groups in the NHP social
isolation domain favouring the intervention. For the AIMS2 social activity domain, the effect was in the
opposite direction, favouring the control group, but this was marginally not statistically significant.
Discussion
Few studies have evaluated the effectiveness of occupational therapy in patients receiving THR. In the
seven studies that we identified, occupational therapy was mainly evaluated in combination with
physiotherapy. Only in two studies was the occupational therapy component the principal focus of the
intervention. In the study of Ferrara and colleagues,493 patients received a 5-day pre-admission occupational
therapy-based intervention but only 23 patients were randomised. McGregor and colleagues501 evaluated
a pre-admission educational hip class and booklet with a major focus on occupational therapy in
39 patients.
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Overall, studies suggested a possible benefit for improved function and reduced pain before surgery, but
this was not sustained after surgery. However, in three studies with data, there was a reduction in length
of hospital stay of over 2 days when the overall average length of stay was 10 days.
Studies were generally small with little possibility of exploring key outcomes. A primary focus of
occupational therapy in THR is the prevention of dislocation. This occurs in about 1% of patients treated
by a posterior approach and about 4% of people treated with a lateral approach.570 Only one study with
three events in 50 patients randomised reported this outcome. OTs teach a range of hip precautions
and provide equipment designed to help avoid extreme hip flexion, adduction and rotation with the aim
of reducing the risk of dislocation,571,572 but recently their value in preventing dislocation has been
questioned.150,573,574 Recovery after hip replacement without traditional restrictions to movement may allow
earlier rehabilitation.
Conclusion
The evidence base on the clinical effectiveness of occupational therapy in patients receiving THR is limited.
The need for high-quality, appropriately powered randomised trials to evaluate aspects of occupational
therapy in this population is indicated.
Occupational therapy: PROOF-THR
Background
We conducted a RCT to evaluate the feasibility of a randomised evaluation of a pre-surgical occupational
therapy intervention in patients waiting for THR. The content of the intervention was based on evidence
from literature review and discussions with the RESTORE steering group, experts in occupational therapy
research and the PEP-R group. Control patients received usual care including occupational therapy after
surgery as provided by the hospital.
The primary objectives were to assess rates of patient identification, recruitment and retention; acceptability
of the intervention and control allocation; health resource use; and outcome measures. Secondary
outcomes related to pain, functional activity and societal participation.
Methods
Study design and setting
We conducted a single-blind parallel-arm pilot RCT with randomisation at the level of the individual.
Randomisation was stratified by hospital and age (< 65 years; ≥ 65 years). The feasibility study took place
at the Royal Orthopaedic Hospital NHS Trust in Birmingham, which is a specialist orthopaedic hospital,
and at Russells Hall Hospital, which is a general hospital and part of the Dudley Group NHS Foundation
Trust. Participants were followed up for a period of 6 months after surgery and completed a series of
quality-of-life questionnaires measuring function, societal participation and resource use.
Participants
Selection criteria
Inclusion criteria were:
l patients listed for primary unilateral THR following review in orthopaedic clinic
l osteoarthritis as the primary indication for surgery
l no previous lower limb joint replacement surgery
l no planned additional lower limb joint replacement surgery within 12 months
l sufficient understanding of English to complete questionnaires (or proxy completion by representative
who understood English).
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Exclusion criteria were:
l patients with inflammatory arthritis
l primary indication for surgery was for pain relief only and no functional improvement is anticipated
l patients who were unable to provide informed consent.
Recruitment
Research nurses screened the records of patients listed for a primary THR following assessment in
participating orthopaedic assessment clinics. When eligibility was confirmed against the inclusion and
exclusion criteria, the research nurse sent the potential participants an information study pack. The study
pack contained the patient information leaflet, copy of the consent form and a letter of invitation to join
the study. One week after posting of this information, potential participants were contacted by a member
of the research team to ask if they would consider taking part in the study. Patients who expressed an
interest in joining the study were approached by a member of the research team when they attended their
pre-assessment clinic. The research nurses gave the potential participants time to discuss any issues
or concerns they may have had prior to obtaining informed consent. Participants who did not use English
as their first language were given a covering letter in their own language to invite them to take part.
However, the assessments needed to be carried out using the English versions with the help of a relative or
friend. Participants who were unable to do this were excluded as many of the outcome questionnaires
were not validated in other languages. The patient’s GP was informed of the patient’s participation in the
trial in writing, with the patient’s consent.
Randomisation
Participants were randomised between the two groups (1 : 1) using a random assignment computer algorithm.
A block allocation sequence was used with stratification by hospital site and age (< 65 years; ≥ 65 years).
The randomisation and sequence generation was performed by a statistician within the Primary Care – Clinical
Research Trials Unit, based at the University of Birmingham.
Allocation concealment and blinding
Following randomisation and group allocation, a study OT was contacted by the randomisation team
when a participant was allocated to receive the intervention and given the study ID of the participant.
The OT then obtained participant contact details from the password-protected database and arranged a
convenient time to deliver the intervention. Within the research team, group allocation was revealed to the
treating therapist only. As is usual in non-pharmacological trials, the participants could not be blinded to
their group assignment. All other investigators, and the trial statistician, were blind to the randomisation
outcome and to all information indicating assignment.
Treatment as usual
Patients randomised to the control ‘treatment as usual’ arm of the study received the usual NHS care
provided to all patients undergoing elective THR in the NHS trust where they received surgery. At both
NHS trusts in this feasibility study, OTs provided compensatory equipment in hospital post surgery, which is
usual UK practice. Both NHS trusts also provided a pre-surgery multidisciplinary education package.
Intervention
Patients randomised to the intervention arm of the study were visited prior to surgery by an OT, who
assessed the individual needs of each participant and their home circumstances. The OT delivered an
intervention package that included providing the compensatory devices required by the participant and
educating them in how they should be used. In addition, the OT discussed with the participants any
expectations and anxieties they (or their carer) may have had, gave explanations about the surgery,
hospital stay and postoperative inpatient rehabilitation, and discussed in depth with the participant how
they planned to manage when they returned home. This included liaising with other professionals as
appropriate. In addition, the OT explained how the layout of the participant’s home may need temporary
adaptation to reduce the risk of accidental dislocation. A structured home safety assessment was also
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performed by the OT, based on the Westmead Home Safety Assessment form.575 In order to standardise
the intervention effect, the OT delivered the intervention to all participants at 4 weeks prior to their
individual planned admittance date for surgery.
Once the home-based intervention had been delivered, the participant received the usual care pathway of the
trust providing their THR surgery. This included access to the pre-surgery multidisciplinary education session.
Outcomes
The primary outcomes address the feasibility issues with respect to a full-scale RCT:
l Recruitment procedures and rates: recruitment procedures, identification of eligible patients, willingness
of participants to be randomised, rates of recruitment and retention of participants in the trial.
l Suitability of outcome measures: to refine the choice of outcome measures to be taken forward to the
main trial.
l Fidelity of the intervention: to investigate practicalities of OT compliance to the intervention delivery as
designed in the protocol, the quality of the delivery and patient adherence with the intervention.
An intervention study log will be completed which has been used successfully in previous studies.
l Effect size and sample size: to provide data on the effect size to allow for an accurate estimate of the
sample size required for the main trial.
l Economic evaluation: to refine data collection required in order that an economic evaluation can be
performed in the main trial.
Secondary outcomes
l Pain.
l Functional activity.
l Societal participation.
Outcome measurement timing
Baseline assessments were completed before randomisation immediately after patients consented to
participate. For follow-up assessments, a questionnaire pack with pre-paid return envelope was posted to
all participants for completion at 4, 12 and 26 weeks post surgery. This questionnaire pack contained the
following validated self-completed questionnaires:
l OHS274,576
l WOMAC114
l Ab-IAP285
l HADS – anxiety subscale (HADS-A) and depression subscale (HADS-D)281
l Nottingham Extended Activities of Daily Living scale (NEADL)298
l EQ-5D-3L278
l ICEpop CAPability measure for Older people (ICECAP-O).299
At the final 26-week time point, the Client Service Receipt Inventory (CSRI)577 was used to record the
frequency and duration with which participants used education, health and social care services and
support over the duration of the assessment period. Records included accommodation and personal care/
staff arrangements, and relevant informal care inputs. The CSRI allows systematic recording of service use
in a manner commensurate with estimating the costs of support packages. Once the data were collected,
all services and supports were listed, and a unit cost (per day, per hour, per contact, etc.) estimated for
each one. When available, service costs were taken from publicly available sources for health such as the
Department of Health NHS Reference Costs435 and social care costs from the PSS Research Unit health and
social care unit costs.441 In other cases, when services were unusual or likely to absorb a significant
proportion of the total costs of support packages, service-specific unit costs were estimated using an
equivalent methodology.578 Each unit cost was multiplied by the frequency with which each participant
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uses each service to arrive a total care package cost for each person. This total can be disaggregated in
various ways, for example, by perspective or by different groups of participants. This information was then
be used in conjunction with the EQ-5D and the ICECAP-O results to establish the feasibility of conducting
a cost per QALY analysis from the data collected.
Statistical analysis
The primary aims of this feasibility study were to identify effective recruitment procedures, suitability of
outcome measures and the fidelity of the intervention. This was evaluated by assessment of recruitment
rates and response rates to all the outcome measures at 4, 12 and 26 weeks following surgery in the
intervention and control arms of the study.
Secondary outcome analyses of the data collected were by ITT with no interim analysis.
Results
The recruitment of participants for this study (n= 44) fell short of the initial target of 60. The CONSORT
flow diagram in Figure 47 details the participant pathway through the study from the number of
participants screened for inclusion in the study through to the number analysed.
Assessed for eligibility
(n = 491)
Excluded
(n = 446)
• Did not meet inclusion criteria, n = 114
• Declined to participate, n = 151
• Other reasons, n = 181
Allocated to control
(n = 23)
• Received allocated intervention, n = 23
• Did not receive allocated 
   intervention, n = 0
Allocated to intervention
(n = 21)
• Received allocated intervention, n = 21
• Did not receive allocated intervention
   (give reasons), n = 0
One participant was 
withdrawn after consent but 
before randomisation because
surgery was postponed
Randomised
(n = 44)
Allocation
Lost to follow-up at 26 weeks
(give reasons)
• Questionnaire not returned, n = 2
• Discontinued intervention, n = 0
Lost to follow-up at 26 weeks
(give reasons)
• Questionnaire not returned, n = 6
• Discontinued intervention, n = 0
Follow-up
Analysed: 26-week data
(n = 21)
• Excluded from analysis, n = 0
Analysed: 26-week data
(n = 15)
• Excluded from analysis, n = 0
Analysis
Enrolment
FIGURE 47 PROOF-THR CONSORT flow diagram.
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PROOF-THR descriptive statistics
Retention and missing data
Baseline demographic and clinical characteristics of the participants are shown in Table 84. The mean
age at the time of surgery was 66 years (SD 10.8 years), with similar means observed in the intervention
group, 67 years (SD 11.2 years), and standard care group, 65 years (SD 10.7 years). Overall, there were
more male patients (54%), although the distribution of sex differed between the intervention (67% male,
33% female) and standard care (44% male, 56% female) groups. In total, 14% of the study participants
lived alone, with 5% of these randomised to the intervention group and 22% allocated to standard care.
Forty-four participants completed the baseline questionnaire. The retention rates for each of the follow-up
periods are presented in Table 85. The retention rate remained consistent throughout the study period,
with 82% of the participants retained after 26 weeks for the follow-up questionnaire, although the CSRI
return rate was slightly lower (70%) despite being sent alongside the 26-week questionnaire.
Questionnaire completion rates are presented in Table 86. Although the number of fully complete returned
questionnaires was reasonable at baseline and at 26 weeks, completion rates were low in weeks 4 and 12,
and for the CSRI questionnaire (< 50% complete).
TABLE 84 Baseline demographic and clinical characteristics of participants
Characteristic
Overall
(n= 44)
Allocated to
intervention (n= 21)
Allocated to standard
care (n= 23)
Mean age at surgery (years) (SD) 66 (10.8) 67 (11.2) 65 (10.7)
% female :male 46:54 33:67 56:44
% lives alone 14 5 22
TABLE 85 PROOF-THR retention and follow-up data
Time point
Participants
recruited, n
Data collected,
n (%) Lost to follow-up, %
Baseline 44 44 (100) 0
4 week 44 37 (84) 16
12 week 44 37 (84) 16
26 week 44 36 (82) 18
CSRI 44 31 (70) 30
TABLE 86 PROOF-THR questionnaire completion rates
Time point/questionnaire
Number of
completers
% of returners
(n/N) % all (n/N)
Baseline 33 75 (33/44) 75 (33/44)
4 weeks 13 35 (13/37) 30 (13/44)
12 weeks 18 49 (18/37) 41 (18/44)
26 weeks 23 64 (23/36) 52 (23/44)
CSRI (26 weeks) 15 48 (15/31) 34 (15/44)
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Table 87 presents the distribution of missing (non-answered) questions for each scale used in the study
and each time point. Missing data are most prevalent in the WOMAC (122 total missing) and NEADL
(105 total missing), while a number of scales exhibit little in the way of missing data (e.g. HADS-A,
HADS-D, Ab-P). Of the total missing data, the 4-week returned questionnaires are the greatest contributor,
accounting for more than half of the missing WOMAC and NEADL data. Questionnaires with the least
missing data were observed in the baseline (54 total missing) and 26-week (35 total missing) follow-ups.
Descriptive statistics of scales
Tables 87–89 show the descriptive statistics for each of the outcome measures. Data for participants that
had two or fewer missing questions per scale were filled using the mean of the data from the rest of the
questions in that scale. Participants missing three or more questions per scale did not have a score
calculated for that scale and were classed as missing (n= 6).
Table 88 presents the descriptive statistics for the functional section of the questionnaire comprising the
WOMAC, OHS, Ab-IAP, NEADL, and HADS (-A and -D). The means for each scale grouped by allocation
are also presented in Table 89. Data for each scale showed improvement at 4 weeks, apart from the
NEADL scale, which showed improvement at 12 weeks. Improvement then continued to 26 weeks.
TABLE 87 PROOF-THR summary of missing data
Questionnaire
(number of questions) Baseline missing 4-week missing 12-week missing 26-week missing Total missing
WOMAC (24) 14 66 30 12 122
OHS (12) 3 8 2 1 14
Ab-I (9) 4 5 1 1 11
Ab-A (17) 9 26 21 3 59
Ab-P (9) 0 3 0 1 4
NEADL (20) 21 59 13 12 105
HADS-A (7) 2 2 0 0 4
HADS-D (7) 1 2 0 0 3
EQ-5D (6) 0 8 0 4 12
ICECAP (5) 0 6 0 1 7
Total 54 185 67 35 341
ICECAP, ICEpop CAPability measure.
TABLE 88 PROOF-THR descriptive statistics (functional scales)
Scale Scale range Baseline mean (SD) 4-week mean (SD) 12-week mean (SD) 26-week mean (SD)
WOMAC 0a–100 59.13 (17.47) 31.38 (18.79) 23.93 (19.09) 13.31 (14.32)
OHS 0–48a 17.85 (7.32) 27.80 (9.99) 35.57 (9.69) 40.43 (7.43)
Ab-I 9a–45 31.62 (7.42) 18.79 (7.60) 16.21 (6.44) 14.71 (5.51)
Ab-A 17a–85 50.78 (14.15) 33.61 (14.15) 28.92 (12.57) 25.24 (8.43)
Ab-P 9a–45 21.57 (7.31) 17.21 (6.65) 13.43 (6.78) 11.47 (3.63)
NEADL 0–66a 48.32 (12.46) 44.20 (13.51) 52.09 (17.34) 59.63 (13.04)
HADS-A 0a–21 6.63 (4.89) 4.57 (4.32) 3.27 (4.07) 3.25 (3.61)
HADS-D 0a–21 6.04 (3.59) 4.46 (3.82) 2.81 (3.44) 2.28 (2.77)
a Best outcome.
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Tables 90 and 91 present the categorised HADS scores for anxiety and depression, respectively.
The categories are as follows: low (0–7), borderline (8–10) and clinically significant (11–21). Percentages
at both baseline and at 26 weeks are relatively consistent with those observed in the intervention
and standard care groups, especially in the ‘low’ category. This is most apparent in the HADS-A data
(see Table 90) where, at 26 weeks, the overall mean, mean intervention or mean standard care
percentages are identical. Both the HADS-A and HADS-D mean data exhibit an increase in ‘low’
categorised responses from baseline to 26 weeks, in conjunction with a decrease in ‘borderline’ and
‘clinically significant’ responses.
Tables 92 and 93 present summaries of the EQ-5D and ICECAP-O scales from the health economics
section of the questionnaire. All three of the scales used exhibit a mean increase in HRQoL, with high
values observed at 26 weeks. A detailed breakdown of the answers to the EQ-5D and ICE-CAP-O
questions is given in Appendices 33 and 34.
TABLE 89 PROOF-THR descriptive statistics by allocation (functional scales)
Scale
(scale range)
Baseline mean 26-week mean
Overall (SD) Control (SD) Intervention (SD) Overall (SD) Control (SD) Intervention (SD)
WOMAC (0a–100) 59.13 (17.47) 61.41 (18.32) 56.50 (16.51) 13.31 (14.32) 15.67 (16.60) 9.95 (9.86)
OHS (0–48a) 17.85 (7.32) 17.00 (6.28) 18.79 (8.38) 40.43 (7.43) 39.03 (8.33) 42.40 (5.63)
Ab-I (9a–45) 31.62 (7.42) 32.04 (6.15) 31.13 (8.79) 14.71 (5.51) 15.46 (6.41) 13.67 (3.89)
Ab-A (17a–85) 50.78 (14.15) 52.98 (13.82) 48.48 (14.46) 25.24 (8.43) 27.00 (9.53) 22.79 (6.09)
Ab-P (9a–45) 21.57 (7.31) 22.83 (6.36) 20.19 (8.17) 11.47 (3.63) 11.57 (3.08) 11.33 (4.41)
NEADL (0–66a) 48.32 (12.46) 49.26 (10.32) 47.28 (14.67) 59.63 (13.04) 57.34 (16.18) 62.53 (6.95)
HADS-A (0a–21) 6.63 (4.89) 6.56 (4.58) 6.71 (5.33) 3.25 (3.61) 3.52 (3.66) 2.87 (3.62)
HADS-D (0a–21) 6.04 (3.59) 5.64 (2.50) 6.48 (4.51) 2.28 (2.77) 2.00 (2.00) 2.67 (3.64)
a Best outcome.
TABLE 90 PROOF-THR HADS-A scores
HADS-A score
Baseline mean (n= 44) 26-week mean (n= 37)
Overall
(%)
Control
(%)
Intervention
(%)
Overall
(%)
Control
(%)
Intervention
(%)
Low (0–7) 61 61 62 86 86 86
Borderline (8–10) 18 22 14 8 9 7
Clinically significant (11–21) 21 17 24 6 5 7
TABLE 91 PROOF-THR HADS-D scores
HADS-D score
Baseline mean (n= 44) 26-week mean (n= 37)
Overall
(%)
Control
(%)
Intervention
(%)
Overall
(%)
Control
(%)
Intervention
(%)
Low (0–7) 75 82 67 97 100 93
Borderline (8–10) 14 9 19 0 0 0
Clinically significant (11–21) 11 9 14 3 0 7
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
297
Resource-use data
Table 94 presents a summary of the number of items missing from the returned CSRI questionnaires.
Missing data are most prevalent in the ‘medication’ and ‘friends/relatives help at home’ sections, while
both the ‘friends/relatives time off work’ and ‘current work situation’ sections were mostly returned
complete. Comparing the randomisation arms of the study, the greatest number of missing data was
observed in the control group, in particular in the ‘medication’ and ‘friends/relatives help at home’
sections, which have a considerably higher number of missing values than the same sections in the
intervention group.
TABLE 92 PROOF-THR summary of EQ-5D and ICECAP-O data
Scale Scale range Baseline mean 4-week mean 12-week mean 26-week mean
EQ-5D-3L –0.594–1a 0.36 0.62 0.76 0.86
EQ-5D health state 0–100a 66.27 72.97 79.24 83.63
ICECAP-O 0–1a 0.80 0.83 0.87 0.91
a Best outcome.
TABLE 93 PROOF-THR summary of EQ-5D and ICECAP-O data
Scale (scale range)
Baseline mean (n= 44) 26-week mean (n= 37)
Overall Control Intervention Overall Control Intervention
EQ-5D-3L (–0.594–1a) 0.36 0.40 0.33 0.86 0.86 0.86
EQ-5D health state (0–100a) 66.27 65.17 67.48 83.63 81.50 86.47
ICE-CAP-O (0–1a) 0.80 0.82 0.79 0.91 0.90 0.92
a Best outcome.
TABLE 94 Summary of resource-use questionnaire missing responses
Total missing responses
Question (number of possible responses per resource use) Control Intervention
Hospital resource use (A&E, outpatient appointments, overnight stays) (3) 12 13
Service use (e.g. GP, physiotherapy) (16) 16 11
Medication (type and payment) (7) 51 26
Personal costs incurred for NHS/social services (e.g. transport, cleaning, child care) (5) 23 16
Time off work (5) 4 1
Friends/relatives help at home (how many hours of help needed for household tasks) (11) 106 29
Friends/relatives time off work (how many hours taken off work to provide help) (1) 1 1
Current work situation (7) 3 0
Total 216 97
A&E, accident and emergency.
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Discussion
This study looked at the feasibility of a pre-surgical occupational therapy intervention in patients waiting
for THR. The primary objectives were to assess rates of patient identification, recruitment and retention;
acceptability of the intervention and control allocation; health resource use; and outcome measures.
Secondary outcomes related to pain, functional activity and societal participation.
Rates of patient identification
Participants were identified by research nurses screening patient notes in participating orthopaedic
assessment clinics. Of the 491 patients screened, 332 patients (68%) were identified as eligible for
inclusion in the trial. This represents a good rate of participant identification, with only 114 ineligible,
mainly owing to previous or planned lower limb replacement (75%), which was an exclusion criterion.
Recruitment and retention
The recruitment rate for this trial was 22% of eligible patients, which is lower than the 48–85% recruitment
rates reported in similar trials of rehabilitation regimes prior to or following THR surgery.503,579,580 However,
the recruitment rate may have been disproportionately influenced by the exclusion of patients enrolled in
another conflicting trial (24% of the total excluded, n= 109). This is quite substantial as it is almost as many
as the number of patients excluded because they did not meet the inclusion criteria (n= 114, 26%).
In addition, of the 151 patients classified as ‘declined to participate’, there were 43 patients who expressed
interest in the trial but were not randomised either because clinic appointments were brought forward,
making it impractical to deliver the intervention, or because there was insufficient OT capacity to deliver the
intervention. Therefore, the research nurses scheduled only 154 recruitment appointments, of which
20 were missed. In effect, this resulted in only 88 out of the 134 patients actually contacted refusing to
participate. This makes the recruitment rate of patients contacted by the research nurses 34%.
Retention of participants in the study was high, with a follow-up questionnaire return rate of 82% at
26 weeks. This compares favourably with the 44–99% retention rates in clinical trials conducted between
1990 and 1999 reported by Davis and colleagues.581
Of the returned follow-up questionnaires, 64% were fully complete with no missing answers. This is a
slightly lower rate of completion than the 75% noted in other trials;582 however, it is not unusual for this
type of trial to have some missing outcome data.583 Through researcher contact with the participants
involved with PROOF, it became apparent that some participants felt that the questionnaire pack was too
long and repetitive. This was mainly due to this study comparing a number of outcome measures to
determine which were most appropriate and useful for inclusion in a future definitive trial. Therefore,
in a future trial, the questionnaire pack would probably be shorter, which may result in higher rates of
response584 and fewer missing data.
Acceptability of the Intervention
There were no participant withdrawals after allocation and there was no crossover from the intervention
to control arm. In addition, all participants allocated to the intervention arm received the occupational
therapy intervention. This suggests that the content of the occupational therapy intervention was
acceptable to the participants and easily deliverable by the therapists involved. Therefore, the content of
the intervention in this feasibility study is suitable to be carried through to a definitive trial.
Health resource use
The health resource-use questionnaire (CSRI) had quite a poor rate of both return and completion, with
only 34% of the 44 participants returning correctly completed forms. This would suggest that for a future
definitive trial the CSRI form would need to be adapted perhaps to make it simpler to complete. Other
methods that could be considered would be for participants to keep a diary of NHS appointments and
other resource information or the sending of more frequent questionnaires to capture data rather than
asking people to think back over 6 months.
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Outcome measures
The outcome measures used in this trial varied in their level of completeness and number of missing data,
which ranged from 7 to 122 over the trial period. The scales with the most missing questions across the
four time points were WOMAC (122 missing items) and NEADL (105 missing items). The scales with the
fewest missing data were HADS (7 missing items), ICEpop CAPability measure (ICECAP) (seven missing
items), EQ-5D (12 missing items) and OHS (14 missing items).
Some of the questions in the outcome measures also conflict with the hip precautions clinicians generally
offer patients after hip replacements, for example not to bend more than 90 degrees for 6 weeks after
surgery. Therefore, this may suggest that the 4-week follow-up period is not suitable and can explain
higher rates of missing data.
Power calculation
We used data from PROOF to conduct a power calculation for a more definitive RCT of pre-operative
delivery of occupational therapy. Based on the OHS and assuming a power of 80%, α= 0.05 (two tailed),
SD of 0.46 between arms at 26 weeks and attrition rate of 20%, we would require a total of
219 participants.
Conclusion
The PROOF-THR feasibility study has generated valuable insight into the feasibility and acceptability of an
occupational therapy intervention for people having THR because of osteoarthritis. The recruitment of
patients was negatively influenced by another conflicting trial taking place at the same site and, to a lesser
extent, the practicalities of delivering the intervention when surgery times are very close to the pre-assessment
clinic appointment. Therefore, to attain a better rate of recruitment in a future trial, ways to overcome these
recruitment issues will need to be considered. The rates of follow-up were good, but there were high levels of
missing data at some time points (4 weeks) and for some outcome measures (WOMAC, NEADL), which
would suggest that these may need to be revised for future work. The CSRI form was not completed well by
participants, so it may be necessary to use other methods of collecting health economic data in a definitive
trial to accurately measure the cost-effectiveness of the intervention. However, with further strategies in place
to facilitate recruitment and intervention delivery, it would be feasible to evaluate this intervention in a
phase III definitive trial.
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Chapter 11 Physiotherapy exercise after total
knee replacement: systematic review, survey of
provision and feasibility randomised controlled trial
Parts of this chapter have been reproduced with permission from Artz N, Dixon S, Wylde V, Beswick A,Blom A, Gooberman-Hill R. Physiotherapy provision following discharge after total hip and total knee
replacement: a survey of current practice at high-volume NHS hospitals in England and Wales. Musculoskeletal
Care 2012;11:31–8.78 © 2012 John Wiley & Sons, Ltd. Some parts have also been reproduced from Artz and
colleagues585 © 2015 Artz et al.; licensee BioMed Central. This is an Open Access article distributed under
the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Some
parts of this chapter have also been reproduced from Artz and colleagues.586 This article is distributed under
the terms of the Creative Commons Attribution-NonCommercial 3.0 License (www.creativecommons.org/
licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without
further permission provided the original work is attributed as specified on the SAGE and Open Access page
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
Abstract
Background
Evidence on the clinical effectiveness of different aspects of post-discharge physiotherapy after hip and
knee replacement is limited. We aimed to review existing research, survey current provision and assess the
feasibility of a physiotherapy intervention.
Methods
In the light of other ongoing studies in THR we focused on TKR except in the survey of physiotherapy provision.
We conducted a systematic review of the clinical effectiveness of physiotherapy exercise in patients
receiving TKR.
Physiotherapy services were surveyed at 24 high-volume orthopaedic centres in England and Wales.
In the ARENA study, the feasibility of a RCT evaluating a 6-week activity-orientated rehabilitation
programme for patients with TKR was assessed.
Results
Systematic review and meta-analysis identified a few small studies suggesting that physiotherapy exercise
can have short-term benefits for patients with TKR.
In the UK, physiotherapy is usually provided for patients with THR depending on clinical need. After TKR,
group exercises focus on knee-specific strengthening, stretching and functional exercises.
In the ARENA study, we evaluated a 6-week group-based activity-orientated rehabilitation programme for
patients with TKR. Of 124 eligible patients, 46 were randomised (37%). The main reasons for non-participation
were travel related and the inability to commit to the intervention. The intervention was generally well
received, and attendance was good (73%), with 84% of participants reporting that they were satisfied.
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Conclusions
Our systematic review and survey suggest that research is required into effective provision of physiotherapy
after TKR. The ARENA study suggests that a fully powered RCT of individualised and task-orientated
exercise would be feasible.
Background
After TKR, current guidance recommends that in the immediate postoperative period patients have access
to routine inpatient physiotherapy to improve mobility and functional independence prior to discharge.587
However, following discharge from hospital after total joint replacement, physiotherapy service provision is
perceived to vary widely between centres and there is little guidance on best practice.
In the light of other ongoing studies on THR, we focused on TKR except in the survey of physiotherapy
provision, for which we also considered patients with THR.
We aimed to:
l review evidence on the effectiveness of physiotherapy exercise interventions provided for patients with
TKR after hospital discharge
l survey current UK physiotherapy practice after total hip and knee replacement
l carry out a small RCT to explore the feasibility of conducting a definitive trial of a group-based
physiotherapy programme with individualised exercises targeted to individual patient aims.
Systematic review and meta-analysis of the effectiveness of
physiotherapy exercise after total knee replacement
Background
As with all health technologies, evidence is required on the effectiveness of physiotherapy exercise after
TKR. Our aim was to update a previous review84 and further explore the possible benefit of specific
physiotherapy exercise modalities after TKR.
Methods
General methods As described in Chapter 2, Systematic review methods
Databases and dates MEDLINE, EMBASE, CINAHL, PsycINFO and The Cochrane Library databases from inception to
4 October 2013. Previous systematic reviews. Citations in Web of Science and reference lists
Search strategy Knee replacement/RCT/exercise, rehabilitation or physiotherapy. MEDLINE search strategy based
on terms in Appendix 3
Study design RCTs with individual or cluster randomisation. Quasi-randomised designs
Patients Adults with recent primary TKR
Intervention Exercise-based or physiotherapy intervention after hospital discharge. Outpatient, community or
home setting. Not electrical stimulation or acupuncture
Controls Usual care or minimal intervention. Alternative formats of care
Follow-up At least 3 months after surgery
Data extraction Country, baseline dates, participants (indication, age, sex), inclusion and exclusion criteria,
intervention and control group content, setting, timing, duration and intensity, follow-up time,
losses to follow-up and reasons
Outcomes Patient-reported disease-specific pain and function (e.g. WOMAC, KOOS, OKS, ILAS, VAS pain),
the physiological outcome ROM and functional performance tests relating to walking
Quality assessment Cochrane risk-of-bias table
ILAS, Iowa Level of Assistance Scale.
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Results
Included studies
Review progress is summarised as a flow diagram in Figure 48. Searches for studies in knees and hips
identified 1127 articles. After screening and detailed evaluation, 17 randomised trials met the inclusion
criteria and the characteristics of the studies are presented in Table 95.
Studies ranged in size from 43 to 160 patients (median 102 patients) and included a total of 1682 patients.
When reported, the main diagnosis was osteoarthritis and the mean age in studies ranged from 66 to
73.5 years. The duration of follow-up ranged from 3 weeks to 24 months, but we describe data in our
meta-analysis from 3 months onwards.
Intervention focus
The focus of the intervention was movement and exercise,591,596,601 exercises aimed at managing
kinesiophobia,598 functional588,597 or strengthening exercise514 compared with minimal physiotherapy
exercise as discussed in seven studies; home compared with outpatient provision as discussed in six
studies;520,592,594,595,602 physiotherapy with additional balance589,600 or cycling components593 compared with
standard physiotherapy as discussed in three studies; and pool-based compared with gym-based provision
as discussed in one study.590
Records identified through 
database searching
(n = 1127)
Studies included
(n = 17)
Records assessed for 
eligibility on basis of full article
(n = 92)
Not relevant
(n = 1035)
Excluded
(n = 75)
• Acupuncture, n = 1
• Continuous passive motion, n = 17
• Electrical/magnetic, n = 6
• Inpatient, n = 17
• Minority TKR, n = 5
• Not TKR, n = 7
• Not RCT, n = 5
• Pre-surgery, n = 13
• Protocol only, n = 1
• Retrospective identification, n = 3
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FIGURE 48 Systematic review and meta-analysis of the clinical effectiveness of physiotherapy exercise after TKR:
flow diagram.
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TABLE 95 Systematic review and meta-analysis of the effectiveness of physiotherapy exercise after TKR:
study characteristics
Publication;
location; date of
study
Indication; number
randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of intervention;
study setting; intervention,
health professional; timing,
duration and intensity;
control group care
Follow-up interval; outcomes;
losses to follow-up
(intervention : control)
Evgeniadis and
colleagues
2008;514 Greece;
2006
Osteoarthritis; n= 48
(24 : 24); 69 (56.3)
Strengthening; home; supervised
exercise programme with
emphasis on strengthening
lower extremities; 8 weeks;
controls received standard
pre-operative and postoperative
care
6, 10 and 14 weeks after
surgery; SF-36, ILAS, active ROM;
13 (9 : 4) not followed up
Frost and
colleagues
2002;588 UK;
1995–6
Osteoarthritis; n= 47
(23 : 24); 71.3 (48.9)
Functional exercise; home;
warm-up exercise, chair rise,
walking and leg lifts; number of
visits and duration not specified;
controls given instructions to
continue exercises taught in
hospital
3, 6 and 12 months; VAS pain,
ROM, leg extensor power,
walking speed, gait speed;
20 (7 : 13) not followed up
Fung and
colleagues
2012;589 Canada;
2009–10
Not specified; n= 50
(27 : 23); 68.1 (66);
Balance and posture control
additional to outpatient
physiotherapy; outpatient
department in rehabilitation
hospital; Wii Fit™ (Nintendo
Wii™; Nintendo of America,
Redmond, WA, USA) gaming
activities focused on
multidirectional balance, and
static and dynamic postural
control; twice weekly for mean
of about 8 weeks; all patients
received twice-weekly outpatient
physiotherapy; control patients
also received 15 minutes of
lower extremity strengthening
and balance training exercises
Discharge from physiotherapy,
estimate about 3 months; ROM,
2-minute walk test, NRS pain,
LEFS, Activity-specific Balance
Confidence Scale, length of
rehabilitation, satisfaction; 0 lost
to follow-up
Harmer and
colleagues
2009;590 Australia;
2005–6
Not specified; n= 102
(53 : 49); 68.3 (57)
Hydrotherapy compared with
gym-based therapy; community
pool; supervised classes in pool
with walking forward and
backward, stepping sideways,
step-ups, jogging, jumping,
kicking, knee ROM exercises,
lunges and combined squats and
upper extremity exercises; twice
a week, 60-minute duration for
6 weeks; control patients
received gym-based
rehabilitation with ergometer
cycling; walking on a treadmill;
stair climbing; standing
isometric, balance and knee
ROM exercises at a bar; and
sit-to-stand exercises
8 and 26 weeks; WOMAC, VAS,
6-minute walk test, stair ascent,
ROM, knee flexor and extensor,
knee oedema; three (2 : 1) lost to
26-week follow-up
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TABLE 95 Systematic review and meta-analysis of the effectiveness of physiotherapy exercise after TKR:
study characteristics (continued )
Publication;
location; date of
study
Indication; number
randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of intervention;
study setting; intervention,
health professional; timing,
duration and intensity;
control group care
Follow-up interval; outcomes;
losses to follow-up
(intervention : control)
Kauppila and
colleagues
2010;591 Finland;
2002–5
Osteoarthritis; n= 86
(44 : 42); 70.6 (75.6);
included 60–80 years
Multidisciplinary rehabilitation
programme; university hospital
outpatient department; week 1:
physiotherapist assessment;
three group sessions
(45 minutes) with lower limb
strengthening exercises, two
pool gymnastic sessions
(30 minutes) with lower limb
stretching and mobility, and
functional exercises focused on
walking; lectures by social
worker (60 minutes) and
nutritionist (90 minutes); week 2:
two lower limb strengthening
exercise group sessions
(45 minutes), three pool
gymnastic sessions (45 minutes);
orthopaedic surgeon lecture
(45 minutes) and clinical
assessment (15 minutes); daily
supervised group stretching
exercises (30 minutes); twice
weekly supervised group Nordic
walking (30 minutes); four group
rehearsals of relaxation strategies
(30 minutes); individualised
exercise recommendations
(40 minutes); two group
sessions on coping strategies
(90 minutes) and individual visit
with psychologist – total 10 days
at 2–4 months after surgery;
control received an exercise
programme to complete at
home from 2 months after
surgery
2 months, 6 months, 12 months;
WOMAC, 15-minute walk test,
stair ascent/descent test,
isometric strength, ROM; 11
(8 : 3) lost to 6- and 12-month
follow-ups
Kramer and
colleagues
2003;592 Canada;
date not specified
Osteoarthritis; n= 160
(80 : 80); 68.4 (56.9)
Basic and advanced ROM and
strengthening exercises;
home- and clinic-based groups;
attended outpatient physical
therapy; therapists able to
modify or add exercises, use
therapeutic modalities, joint
mobilisations or other measures
as appropriate; between 2 and
12 weeks after surgery, two
sessions per week for 1 hour
per session; home-based
rehabilitation only, received a
telephone call once in weeks
2–6 and once in weeks 7–12
reminding them of the
importance of exercise and to
give advice
12, 26 and 52 weeks; WOMAC,
SF-36, AKSS, stair ascent and
descent, 6-minute walk test; 26
(11 : 15) medical issues,
withdrawn consent
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TABLE 95 Systematic review and meta-analysis of the effectiveness of physiotherapy exercise after TKR:
study characteristics (continued )
Publication;
location; date of
study
Indication; number
randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of intervention;
study setting; intervention,
health professional; timing,
duration and intensity;
control group care
Follow-up interval; outcomes;
losses to follow-up
(intervention : control)
Liebs and
colleagues
2010;593 Germany;
2005–6
Osteoarthritis or
osteonecrosis; n= 159
(85 : 74); 69.8 (71.7)
Ergometer cycling (additional to
standard programme); multiple
hospitals; cycling with minimal
resistance under guidance of a
physical therapist, aim was to
improve muscle coordination,
proprioception and ROM; three
times a week for at least 3 weeks,
starting after the second
postoperative week; controls
received standard physiotherapy
programme only
3, 6, 12 and 24 months;
WOMAC, SF-36 PCS, patient
satisfaction; 24 (10 : 14) lost to
follow-up at 3 months
Madsen and
colleagues
2013;594 Denmark;
2010–11
Osteoarthritis; n= 80
(40 : 40); 66.6 (41)
Group-based programme
compared with home-based
programme; physiotherapist-led
strength endurance training,
education, patient discussion,
home exercises twice weekly
with strength training,
endurance training on exercise
bike, walking, balance, training
and muscle strength training;
two sessions per week for
6 weeks starting 4–8 weeks after
surgery, average of 10.5 sessions
(range 4–12); home exercises
with one or two planned visits
with a local physiotherapist
3 and 6 months; OKS, SF-36
physical function, EQ-5D, ROM,
peak leg extensor power,
balance test, 10-metre walk test,
sit-to-stand tests, VAS pain
during leg extensor power test;
10 (4 : 8) lost to follow-up
Minns Lowe and
colleagues
2012;595 UK;
2006–9
Osteoarthritis; n= 107;
94 (47 : 47) received
surgery; 69.2 (58)
Home-based functional
rehabilitation; home; two
physiotherapist home visits
within 2 weeks and at
6–8 weeks after discharge,
assessment of function and
rehabilitation progress on gait
re-education, and use of walking
aids; twice-daily exercise for
3 months: weight, partial knee
bends/quarter squats, standing
knee flexion and extension
wall sits, heel and knee raises,
step-overs and stretches; task
training: getting in and out of a
car, getting up from a chair at
a table, walking outside and
stairs; controls received usual
physiotherapy treatment
provided at the hospital without
additional home visits
3, 6 and 12 months; KOOS,
OKS, leg extensor press power,
30 seconds timed sit-to-stand
test, 10-metre timed walk test,
ROM (provided by author)
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TABLE 95 Systematic review and meta-analysis of the effectiveness of physiotherapy exercise after TKR:
study characteristics (continued )
Publication;
location; date of
study
Indication; number
randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of intervention;
study setting; intervention,
health professional; timing,
duration and intensity;
control group care
Follow-up interval; outcomes;
losses to follow-up
(intervention : control)
Mitchell and
colleagues
2005;520 UK;
1999–2000
Osteoarthritis; n= 115
(57 : 58); 70.3 (57.9)
Home physiotherapy compared
with outpatient group provision;
up to six post-discharge home
visits by community
physiotherapist, patient
assessment and individualised
therapy relating to pain relief,
knee flexion and extension, gait
re-education, home and
functional adaptations, reduction
of swelling and mobilisation of
soft tissues; before-surgery
patients received 3 visits; controls
received exercises and individual
treatment 1–2 times a week
12 weeks; WOMAC, SF-36,
resource use and cost; one (0 : 1)
lost to ITT analysis (45 patients
withdrawn mainly pre-surgery)
Mockford and
colleagues
2008;596 UK;
date not specified
Osteoarthritis,
rheumatoid arthritis;
n= 143 (71 : 72); 70.2
(61.5)
Outpatient physiotherapy;
outpatient department; 6 weeks
starting within 3 weeks of
hospital discharge; control
received no outpatient
physiotherapy following
discharge, all patients were
given a home exercise regime to
follow on discharge
3 months and 1 year; OKS,
SF-12, Bartlett Patella Score,
ROM, walking test; seven (4 : 3)
not followed up
Moffet and
colleagues
2004;597 Canada;
1997–9
Osteoarthritis; n= 77
(38 : 39); 67.7 (59.7)
Intensive functional rehabilitation;
rehabilitation institute;
12 physiotherapist-supervised
sessions from 2 months after
discharge with individualised
home exercises, 60–90 minutes
per week for 6–8 weeks; each
session included warm-up,
specific strengthening exercises,
functional task-oriented
exercises, endurance exercises
and cool-down; ROM, pain and
effusion monitored to optimise
intervention; control group
received usual care including
possibility of supervised
rehabilitation at home; all patients
were taught a home exercise
programme before hospital
discharge
4, 6, 12 months; WOMAC,
SF-36, 6MWT; six (0 : 6) at
12 months
Monticone and
colleagues
2013;598 Italy;
2010
Osteoarthritis; n= 110
(55 : 55); 67 (64)
Home-based functional exercise
programme; home; continuation
of functional exercises provided
in hospital, cognitive–behavioural
intervention with home exercise
book about the fear-avoidance
model and management of
kinesiophobia, monthly phone
calls to strengthen adherence;
twice-weekly 60-minute sessions
for 6 months; no physiotherapy;
advice to stay active
6 and 12 months; KOOS ADL
and pain, Tampa Scale for
Kinesiophobia, NRS pain, SF-36;
0 losses to follow-up
continued
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TABLE 95 Systematic review and meta-analysis of the effectiveness of physiotherapy exercise after TKR:
study characteristics (continued )
Publication;
location; date of
study
Indication; number
randomised
(intervention : control);
mean age (years)
(% female)
Primary focus of intervention;
study setting; intervention,
health professional; timing,
duration and intensity;
control group care
Follow-up interval; outcomes;
losses to follow-up
(intervention : control)
Piqueras and
colleagues
2013;599 Spain;
2008–10
Osteoarthritis; n= 142
(72 : 70), 181
randomised but 142
completed baseline
measures; 73.5 (72.4)
Outpatient and home-based
telerehabilitation; five sessions
under therapist supervision at
rehabilitation department and
five sessions at home; interactive
virtual telerehabilitation, patients
received information needed to
perform exercises and remote
therapist monitoring, therapy
modified as rehabilitation
evolved; system used wireless
movement sensors, interactive
software, a touch-screen
computer and a web portal;
daily 1-hour sessions for 10 days;
conventional out-patient physical
therapy, all randomised patients
received a 2-week rehabilitation
programme immediately after
hospital discharge
2 weeks after intervention and
3 months; ROM, muscle strength,
walk speed, pain, WOMAC,
timed up and go test; nine (4 : 5)
lost to follow-up
Piva and
colleagues
2010;600 USA;
2007–8
Not specified; n= 43
(21 : 22); 68.5 (71.4)
Balance exercises (additional to
supervised functional training
programme); outpatient physical
therapy department; additional
balance exercises (agility and
perturbation); control group
received a supervised functional
training programme without
additional balance exercises; all
patients received 12 sessions of
functional training over 6 weeks;
home exercises given to both
groups at the end of the
supervised programme
2 months and 6 months;
WOMAC, LEFS, timed chair rise
test, gait speed; eight (3 : 5) lost
to follow-up
Rajan and
colleagues
2004;601 UK;
1998–9
Monoarticular arthrosis;
n= 120 (59 : 61); 68.5
(62.9)
Outpatient physiotherapy;
outpatient; average 4–6
physiotherapy sessions; control
group did not receive outpatient
physiotherapy; all patients given
a home exercise regime on
discharge
3 months, 6 months and 1 year;
ROM; four (3 : 1) not followed up
Tousignant and
colleagues
2011;602 Canada;
date not specified
Not specified; n= 48
(24 : 24); 66 (not
reported)
Functional rehabilitation; home;
intervention group received
telerehabilitation through high-
speed internet. Progressive
exercises to reduce disability and
improve function in ADL. Family
member or friend present to
ensure safety; two sessions per
week for 8 weeks; approximately
1 hour in duration; control
group received usual home care
services and outpatient
rehabilitation over a 2-month
period
4 months; knee ROM, Berg
balance scale, 30-second
chair–stand test, WOMAC, timed
get-up-and-go test, Tinetti test,
functional autonomy measure
(SMAF), SF-36; seven (3 : 4) not
followed up
ILAS, Iowa Level of Assistance Scale; NRS, numerical response scale; SMAF, Système de Mesure de I’Autonomie Fonctionelle
(Functional Autonomy Measurement System).
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Outcome measures
Outcomes reported in studies were classified as patient-reported physical function or pain, physiological
tests and physical performance tests. The most frequently used physiological outcome was knee ROM
measured with a universal goniometer. Measures of walking were the most widely reported
performance outcomes.
Study quality
We completed a risk-of-bias assessment for each study and summarise these in Appendix 35. The main
potential source of bias was from large and unequal losses to follow-up in six studies.514,588,591–594 Two
further studies were judged to be of reasonable quality with overall losses to follow-up of between 10%
and 20%.600,602 There was no suggestion of risk of bias in nine studies.520,589,590,595–599,601
There was no clear evidence of publication bias from inspection of funnel plots. However, numbers of
studies were small for several outcomes and in subgroup analyses.
Comparison of different physiotherapy interventions
Results for all comparisons are summarised in Table 96. Meta-analyses used random-effects models, an a
priori decision based on the known variation in physiotherapy exercise content. Pooled effect sizes are
SMDs except for ROM, for which MDs are reported.
Physiotherapy exercise compared with no intervention
In seven studies, patients randomised to physiotherapy exercise intervention were compared with a control
group receiving no intervention or minimal intervention.514,588,591,596–598,601
Patient-reported physical function
Data were available at one or more time points for five studies that compared a physiotherapy intervention
with a control that received minimal physiotherapy.514,591,596–598 Studies reported WOMAC physical function,
OKS, KOOS ADL scale or Iowa Level of Assistance Scale (ILAS) total score.
TABLE 96 Systematic review and meta-analysis of the clinical effectiveness of physiotherapy exercise after TKR:
meta-analysis
Follow-up Studies Patients Pooled effect size (95% CI) p-value I2 (%)
Physiotherapy exercise compared with no intervention
Physical function
3- to 4-month follow-up 3 254 –0.37 (–0.62 to –0.12) 0.004 0
6-month follow-up 3 260 –0.43 (–0.95 to 0.08) 0.10 76
12-month follow-up 4 397 –0.21 (–0.70 to 0.29) 0.42 83
Physical function in studies with low risk of bias
3- to 4-month follow-up 2 119 –0.35 (–0.62, –0.08) 0.01 0
6-month follow-up 2 185 –0.64 (–1.15 to –0.13) 0.01 65
12-month follow-up 2 253 –0.37 (–1.36 to 0.61) 0.46 93
Pain
3- to 4-month follow-up 2 103 –0.45 (–0.85 to –0.06) 0.02 0
6-month follow-up 4 287 –0.29 (–0.68 to 0.10) 0.15 60
12-month follow-up 4 281 –0.15 (–0.64 to 0.35) 0.57 75
continued
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
309
TABLE 96 Systematic review and meta-analysis of the clinical effectiveness of physiotherapy exercise after TKR:
meta-analysis (continued )
Follow-up Studies Patients Pooled effect size (95% CI) p-value I2 (%)
Pain in studies with low risk of bias
3- to 4-month follow-up 1 27 –0.27 (–1.05 to 0.50) 0.49
6-month follow-up 2 137 –0.36 (–1.07 to 0.35) 0.32 65
12-month follow-up 1 110 –0.73 (–1.12 to –0.35) 0.0002
ROM extension
3- to 4-month follow-up 2 178 –4.14 (–7.10 to 1.18) 0.006 82
6-month follow-up 1 74 0.00 (–1.37 to 1.37) 1.00
12-month follow-up 2 217 0.42 (–0.54 to 1.38) 0.39 0
ROM extension in studies with low risk of bias
3- to 4-month follow-up 1 143 –2.60 (–4.48 to –0.72) 0.007
6-month follow-up 0
12-month follow-up 1 143 0.20 (–0.92 to 1.32) 0.73
ROM flexion
3- to 4-month follow-up 4 321 –5.23 (–11.16 to 0.70) 0.08 83
6-month follow-up 3 217 –4.06 (–6.67 to –1.46) 0.02 0
12-month follow-up 4 360 –2.21 (–4.31 to –0.10) 0.04 0
ROM flexion in studies with low risk of bias
3- to 4-month follow-up 1 116 –2.00 (–4.78 to 0.78) 0.16
6-month follow-up 1 116 –5.00 (–8.14 to –1.86) 0.002
12-month follow-up 2 259 –2.38 (–4.80 to 0.05) 0.05 0
Walking
Longest follow-up (all 12 months) 3 169 –0.17 (–0.48 to 0.13) 0.27 0
Home-based compared with outpatient delivery of physiotherapy exercise
Physical function
3- to 4-month follow-up 4 310 –0.03 (–0.25 to 0.19) 0.80 0
6-month follow-up 2 150 0.05 (–0.27 to 0.38) 0.74 0
12-month follow-up 2 214 0.11 (–0.16 to 0.38) 0.42 0
Physical function in studies with low risk of bias
3- to 4-month follow-up 2 199 –0.15 (–0.43 to 0.13) 0.29 0
6-month follow-up 1 82 0.18 (–0.25 to 0.62) 0.41
12-month follow-up 1 87 0.01 (–0.41 to 0.44) 0.95
Pain
3- to 4-month follow-up 3 248 –0.00 (–0.25 to 0.25) 0.98 0
6-month follow-up 1 85 –0.05 (–0.48 to 0.38) 0.82
12-month follow-up 1 92 –0.13 (–0.53 to 0.28) 0.55
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TABLE 96 Systematic review and meta-analysis of the clinical effectiveness of physiotherapy exercise after TKR:
meta-analysis (continued )
Follow-up Studies Patients Pooled effect size (95% CI) p-value I2 (%)
Pain in studies with low risk of bias
3- to 4-month follow-up 2 207 –0.07 (–0.35 to 0.20) 0.59 0
6-month follow-up 1 85 –0.05 (–0.48 to 0.38) 0.82
12-month follow-up 1 92 –0.13 (–0.53 to 0.28) 0.55
ROM extension
3- to 4-month follow-up 3 261 –0.21 (–0.46 to 0.05) 0.11 6
6-month follow-up 0
12-month follow-up 1 83 –0.18 (–0.61 to 0.25) 0.41
ROM extension in studies with low risk of bias
3- to 4-month follow-up 3 261 –0.21 (–0.46 to 0.05) 0.11 6
6-month follow-up 0
12-month follow-up 1 83 –0.18 (–0.61 to 0.25) 0.41
ROM flexion
3- to 4-month follow-up 3 329 –0.22 (–0.44 to –0.01) 0.04 0
6-month follow-up 1 68 –0.18 (–0.65 to 0.30) 0.47
12-month follow-up 2 202 0.07 (–0.21 to 0.35) 0.61 0
ROM flexion in studies with low risk of bias
3- to 4-month follow-up 3 329 –0.22 (–0.44 to –0.01) 0.04 0
6-month follow-up 1 68 –0.18 (–0.65 to 0.30) 0.47
12-month follow-up 1 83 –0.05 (–0.48 to 0.38) 0.81
Walking
Longest follow-up (2 studies 12 months,
1 study 6 months)
3 267 –0.02 (–0.26 to 0.22) 0.87 37
Enhanced physiotherapy compared with control
Physical function
3–4 months 2 185 0.00 (–0.29 to 0.29) 0.98 0
6 months 2 171 –0.16 (–0.46 to 0.15) 0.31 0
12 months 2 144 0.12 (–0.13 to 0.37) 0.35 0
Pain
3–4 months 2 185 –0.12 (–0.41 to 0.17) 0.43 0
6 months 2 171 –0.17 (–0.47 to 0.13) 0.27 0
12 months 1 126 0.16 (–0.20 to 0.51) 0.39
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As shown in the meta-analysis in Table 96 and Figure 49, in three studies with 254 patients, physiotherapy
exercise was associated with an improvement in physical function at 3–4 months (average SMD –0.37,
95% CI –0.62 to –0.12; p= 0.004). At 6 months there was a non-significant trend for benefit (SMD –0.43,
95%CI –0.95 to 0.08; p= 0.10), and little difference between groups at 12 months. Heterogeneity was
high in studies reporting outcomes at six and 12 months and this was not explained by inclusion of studies
with risk of bias. After exclusion of these studies with risk of bias, benefit was apparent at 3 and
particularly at 6 months (SMD –0.64, –1.15 to –0.13; p= 0.01), but this was based on only two studies at
each follow-up.
Patient-reported pain
Four studies reported a pain outcome at one or more follow-up times.588,591,597,598 Studies reported WOMAC
pain, KOOS pain or OKS pain. As shown in Table 96 and Figure 50, in two studies with 103 patients a pain
outcome was reported at 3–4 months with an average SMD of –0.45 (95% CI –0.85 to –0.06; p= 0.02)
favouring physiotherapy exercise. There was a trend for benefit at 6 months in four studies with 287
patients (average SMD –0.29, 95% CI –0.68 to 0.10; p= 0.15). At the 12-month follow-up there was little
to suggest benefit for patients receiving physiotherapy exercise compared with untreated controls in four
studies with 281 patients. Heterogeneity was high at 6- and 12-month follow-ups. Only one study had low
risk of bias at each of 3–4 and 12 months, precluding meta-analysis. At 6 months, two studies with low risk
of bias maintained a trend for benefit but this did not approach conventional levels of statistical significance
(average SMD –0.36, 95% CI –1.07 to 0.35; p= 0.32).
Range of motion
Range of motion extension data suitable for meta-analysis was available from three studies with 252
patients514,591,596 and ROM flexion from five studies with 396 patients.514,588,591,596,601 As shown in Table 96
and Figure 51, there was little to suggest improved long-term ROM in patients receiving outpatient
physiotherapy. Benefit was evident in only two studies with follow-up at 3 months after TKR (average MD
–4.14, 95% CI –7.10 to –1.18; p= 0.006).514,596
For ROM flexion there was no suggestion of short-term benefit from physiotherapy exercise. There was
evidence of long-term benefit with average MD at 6 months of –4.06 (95% CI –6.67 to –1.46; p= 0.02)
and at 12 months of –2.21 (95% CI –4.31 to –0.10; p= 0.04) in three588,591,597 and four studies,588,591,596,597
respectively. In studies with low risk of bias, the effect was still apparent although marginal at 12 months
but this was based on only one study at 6 months601 and two studies at 12 months.596,601
Physical performance
Measures of walking performance (metres walked in a set time, time to walk a specified distance and
walking speed) were combined with attention paid to direction of effect. An improvement in walking
performance in three studies was not significant588,591,597 (average SMD –0.17, 95% CI –0.48 to 0.13;
p= 0.27). There was no heterogeneity across studies.
Home-based compared with outpatient delivery of physiotherapy exercise
Home-based provision was compared with outpatient physiotherapy in six studies.520,592,594,595,599,602
Patient-reported physical function
Physical function was measured using WOMAC, KOOS and OKS measures. Data were available at one or
more time points for five studies with 437 patients.520,592,594,595,602 As shown in Table 96 and Figure 52,
there was no suggestion of a difference in functional outcome between home and outpatient provision at
3–4, 6 or 12 months. For example, at 3–4 months, the average SMD was –0.03 (95% CI –0.25 to 0.19;
p= 0.80). No heterogeneity was apparent and consideration of higher-quality studies only marginally
affected the outcome at 3–4 months in two studies (average SMD –0.15, 95%CI –0.43 to 0.13; p= 0.29),
in favour of home-based rehabilitation.
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Study or subgroup
Extension 3–4 months
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Mockford 2008596
Subtotal (95% CI)
Heterogeneity: τ2 = 3.72; χ2 = 5.44, df = 1 (p = 0.02); I2 = 82%
Test for overall effect: z = 2.74 (p = 0.006)
Extension 6 months
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Subtotal (95% CI)
Heterogeneity: not applicable
Test for overall effect: z = 0.00 (p = 1.00)
Extension 12 months
Kauppila 2010591
Mockford 2008596
Subtotal (95% CI)
Heterogeneity: τ2 = 0.00; χ2 = 0.54, df = 1 (p = 0.46); I2 = 0%
Test for overall effect: z = 0.86 (p = 0.39)
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Evgeniadis 2008513
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Rajan 2004597
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Test for overall effect: z = 1.73 (p = 0.08)
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–2.21 (–4.31 to –0.10)
Intervention Control MD
IV, random, 95% CI
MD
IV, random, 95% CI
–20 –10 0 10 20
Favours physiotherapy Favours control
FIGURE 51 Physiotherapy exercise compared with no intervention: ROM. df, degrees of freedom;
IV, inverse variance.
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Patient-reported pain
Studies reported WOMAC pain, KOOS pain or VAS pain. Data were available at 3–4 months for three
studies with 248 patients.520,595,602 As shown in Table 96 and Figure 53, there was no difference in pain
outcome between patients randomised to home-based or outpatient physiotherapy exercise (average SMD
–0.00, 95% CI –0.25 to 0.25; p= 0.98). One study595 followed up 85 and 92 patients at 6 and 12 months
and showed no benefit for reduced pain at either follow-up.
Range of motion
Range of motion extension was reported in three studies with 261 patients595,599,602 and ROM flexion in five
studies with 448 patients.594,595,599,602 Outcomes are summarised in Table 96 and Figure 54. There was no
suggestion of a difference in ROM extension between randomised groups at any time point. For ROM
flexion there was an improved ROM flexion at 3–4 months in patients who received home-based
physiotherapy exercise compared with outpatient provision. This was maintained in studies with low risk of
bias. There was no evidence for longer-term benefit in a small number of studies.
Physical performance
In three studies with 267 patients randomised there was no suggestion that walking performance differed
between groups.592,594,595
Pool-based physiotherapy
One study compared pool-based physiotherapy with gym-based physiotherapy exercise.590 There was no
difference in WOMAC physical function between randomised groups. Similarly, there was no difference for
WOMAC pain between groups. For ROM extension and flexion, the authors reported that there were no
group differences between pool-based and gym-based provision.
Additional physiotherapy components
One study with 159 patients evaluated addition of ergometer cycling to a general physiotherapy
intervention.593 There were no differences in pain outcome between randomised groups at any of the
follow-up intervals from 3–4 months to 24 months.
Two studies evaluated addition of a balancing component to a general physiotherapy intervention with a
total of 93 patients randomised.589,600 Studies reported different follow-up times but individually there was
no evidence for improvement in LEFS or WOMAC physical function. Similarly, numerical response scale
pain and WOMAC pain were similar at all follow-up periods. Only one study that included additional
balance training reported ROM extension and flexion at short-term follow-up.589 There were no differences
in either measure between intervention and control groups.
Discussion
Randomised controlled trials of physiotherapy and exercise interventions after TKR provide some evidence
for short-term effectiveness. In the key analysis comparing patients who received a programme of
physiotherapy exercise with those receiving no intervention, there were short-term benefits for physical
function (SMD –0.37, 95% CI –0.62 to –0.12; p= 0.004), and pain (SMD –0.45, 95% CI –0.8 to –0.06;
p= 0.02). However, these small-to-medium-sized effects,535 were based on only three studies with
254 patients514,596,597 and two studies with 103 patients randomised, respectively.588,597
Facilitation of early recovery is an important objective of physiotherapy exercise-based rehabilitation.604
However, physiotherapy should address patient expectations603 and the key expectations of patients
undergoing knee replacement relate to long-term functional and pain outcomes.145,146,605,606 No benefit,
in terms of longer-term improvements in function or reduction in pain, were found in the RCTs of
physiotherapy exercise that we identified.
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Across the trials reporting the outcome, we observed benefit for physiotherapy exercise in studies with low
risk of bias compared with controls for flexion only. ROM is a component of clinician-based outcome
measures such as the Knee Society Clinical Rating System,113 which is a useful objective measure in clinical
trials; however, it is a poor marker of implant success607,608 and does not influence patient satisfaction with
their implant.338
A measure of walking performance was included in over half of the studies we identified, but we were
unable to confirm any possible benefit from physiotherapy exercise. In three studies, there was a trend for
benefit, but this was not statistically significant.588,591,597 Parent and Moffett609 evaluated a number of
locomotor tests before and after TKR. They concluded that the 6-minute gait test is a simple and
responsive measure of locomotor performance which, in conjunction with the WOMAC function difficulty
subscale, provides accurate monitoring of early recovery. The need for measures of both gait and a
patient-reported functional outcome was highlighted in the study of Lindemann and colleagues,610
in which the correlation between measures was low.
The PROMs included in our meta-analyses were chosen pragmatically based on published trial outcomes
and reflect the move away from surgeon-assessed scores.95 While WOMAC and other disease- and
joint-specific PROMs can be used to describe the pattern of recovery after joint replacement,48 their
sensitivity to change is affected by floor and ceiling effects. At 12 months after knee replacement, Roos
and Toksvig-Larsen306 reported ceiling effects in 11% of patients for WOMAC function and 30% for
WOMAC pain.
According to the ICF, the key measures of health relate to functional limitation, activity limitations and
participation restriction.80 In a review of outcome measures commonly used in joint arthroplasty
rehabilitation research, Alviar and colleagues611 concluded that these issues are inadequately addressed.
The Ab-IAP has been developed with the aim of assessing disability according to the ICF components.285
The MyMOP2 focuses on management of symptoms but also includes assessment of a patient-specified
activity restriction.287 Use of such methods should allow assessment of an outcome pertaining to the
patient’s pre-operative expectations.
There were insufficient studies with adequate patient numbers to provide conclusive evidence on different
methods of provision. Physiotherapy exercise provided at home is an appealing approach with the possibility
of wider acceptability and uptake. However, as previously estimated, equivalence or non-inferiority
trials need large numbers of patients and have yet to be undertaken. Our meta-analysis included only
310 patients for the short-term physical function outcome and fewer for the key longer-term outcomes.
Similar issues of study size affect interpretation of physiotherapy exercise provided in a hydrotherapy pool or
enhanced with additional cycling and balancing components. This highlights the difficulty of developing a
complex physiotherapy exercise intervention.
An important problem that home-based physiotherapy exercise may address is that uptake of rehabilitation
is frequently low and that patients who do not attend are more likely to be those with poorer functional
health. Optimising uptake and adherence to interventions is an important issue in rehabilitation.612,613
In their systematic review of interventions for enhancing adherence with physiotherapy, McLean and
colleagues612 found evidence of only short-term clinical effectiveness and cost-effectiveness of exercise
adherence strategies. They concluded that a strategy to improve adherence to physiotherapy treatment
should probably be multidimensional.
Some physiotherapy exercise will generally be provided to patients with TKR even if this comprises only
advice following on from inpatient rehabilitation. Health-care professionals and policy-makers need to
know what content and duration of physiotherapy exercise is necessary to improve short- and long-term
outcomes and which patients are likely to benefit. Appropriate care can then be provided to each
individual patient.
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Despite the inclusion of 17 RCTs compared with six trials in the review of Minns Lowe and colleagues,84
our conclusion is similar, with a possible short-term benefit for physiotherapy exercise after TKR. Future
studies should include credible evaluation of methods with well-designed and appropriately powered
randomised trials with a focus on completeness of follow-up.
Physiotherapy: current provision
Background
To provide information about physiotherapy provision after THR and TKR, we conducted a survey of
current post-discharge physiotherapy services provided to patients at high-volume orthopaedic centres in
England and Wales.
Methods
The National Joint Registry for England and Wales 2010614 online database was screened for high-volume
orthopaedic centres, defined as orthopaedic centres with > 500 hip or knee procedures,615 for inclusion
in this survey. Twenty-four centres were identified and contacted. Fourteen centres were included in the
survey of physiotherapy following THR and 23 centres in the survey of physiotherapy following TKR.
The physiotherapy department at each orthopaedic centre was contacted by telephone by a member of the
research team and an appropriate physiotherapy clinician was identified and requested to complete a short
survey either over the telephone or via e-mail. The survey was conducted as a service evaluation with
agreement from North Bristol NHS Trust.
Survey questionnaire
A short questionnaire, shown in Appendix 36, was developed to ascertain current physiotherapy delivered to
patients after discharge from hospital following either primary THR or TKR. The questionnaire covered topics
including routine physiotherapy pathways and referral processes following discharge, type of physiotherapy
treatment provided, relevant precautions and information provided to patients. Survey information was
collected on a Microsoft Word document then stored on a Microsoft Excel database for analysis. Data on hip
and knee replacements were analysed separately. Orthopaedic centres participating were assigned a unique
study number for anonymity and the respondent role was also recorded. Respondents were asked to confirm
responses to the survey questionnaire via e-mail or post and make adjustments as necessary.
Analysis
Routine physiotherapy services provided at each centre were categorised into no routine physiotherapy
(including provision of leaflets only), outpatient physiotherapy, home-based physiotherapy, or other
(physiotherapy including telephone consultation and/or drop-in services). Outpatient physiotherapy was
further categorised into one to one or group based. Treatment and exercises types were also categorised.
Results
Respondents from all of the 24 orthopaedic centres selected from the National Joint Registry completed
the survey. The distribution of orthopaedic centres surveyed covered a large area of England and Wales
with six in northern regions, four in southern regions, four in western regions, two in eastern regions,
seven in the Midlands and one in South Wales. The job title of each respondent is shown in Appendix 37.
Physiotherapy following discharge after total hip replacement
None of the 14 centres surveyed referred patients to outpatient physiotherapy as a routine pathway of
care following THR (Table 97). Three centres offered additional physiotherapy support either by telephone
follow-up, drop-in service or a review appointment. One centre reported that the majority of patients were
referred to outpatient physiotherapy at the patient’s local community hospital on the day of discharge.
All centres reported that patients were referred to outpatient physiotherapy depending on clinical need.
In one centre, patients were referred to outpatient physiotherapy only if they were on restricted weight
bearing, progressing slowly with gait or exercise, of higher functional level and keen to return to physical
exercise such as running or sport, had a leg length discrepancy, or had a foot drop following surgery.
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Physiotherapy following discharge after total knee replacement
Sixteen out of the 23 centres surveyed referred patients to outpatient physiotherapy (see Table 97). Eleven
of these centres referred direct to an exercise group after discharge and five referred patients directly to
one-to-one outpatient physiotherapy. No physiotherapy treatment was recorded in six centres and one
centre offered a short assessment within 2 weeks of discharge. Centres not providing routine outpatient
physiotherapy stated that patients could be referred to one-to-one physiotherapy if a clinical need was
identified. For example, in one centre, patients were referred to physiotherapy from the orthopaedic ward
if they were not achieving full knee extension or 90° knee flexion, had evidence of poor quadriceps
strength, required assistance to progress exercises and mobility, or if the patient was returning to hobbies
or work that required a higher level of function. Difficulty achieving 90° knee flexion and evidence of poor
quadriceps function were common criteria for provision of one-to-one outpatient physiotherapy.
Group physiotherapy following total knee replacement
All 11 orthopaedic centres providing group outpatient physiotherapy referred patients within 2 weeks of
discharge from hospital. Group physiotherapy sessions varied in number and duration (20–60 minutes).
Staffing of group sessions ranged between two and five physiotherapist practitioners working with at least
one assistant or technician. One centre reported a mixed physiotherapy and occupational therapy group
with eight members of staff in attendance. Types of treatment and exercise provided within group sessions
are shown in Table 98.
TABLE 97 Routine physiotherapy services following discharge after THR and TKR in high-volume orthopaedic centres
THR TKR
Total number of units 14 23
No additional routine physiotherapy input 11 6
Outpatient (1 : 1) physiotherapy 0 5
Group physiotherapy 0 11
Telephone consultation 2a 0
Drop-in service 1a 0
Review appointment/clinic 1 1
a One hospital offered both telephone consultation and a drop-in service.
Reproduced from Artz N, Dixon S, Wylde V, Beswick A, Blom A, Gooberman-Hill R. Physiotherapy provision following
discharge after total hip and total knee replacement: a survey of current practice at high-volume NHS hospitals in England
and Wales. Musculoskeletal Care 2012;11:31–8.78 Copyright © 2012 John Wiley & Sons, Ltd.
TABLE 98 Types of treatment and exercises described by the 11 high-volume centres that provided routine group
physiotherapy following TKR
Strengthening 11
Stretching 11
Functional exercises 9
Task-related exercises 3
Cardiovascular exercise 5
Individualised exercise 6
One-to-one treatment 6
Reproduced from Artz N, Dixon S, Wylde V, Beswick A, Blom A, Gooberman-Hill R. Physiotherapy provision following
discharge after total hip and total knee replacement: a survey of current practice at high-volume NHS hospitals in England
and Wales. Musculoskeletal Care 2012;11:31–8.78 Copyright © 2012 John Wiley & Sons, Ltd.
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One-to-one physiotherapy after discharge following total knee replacement
Most (four out of five) centres providing one-to-one physiotherapy saw patients within 2 weeks of
discharge. The other centre referred patients at 6 weeks post operation to a single clinic for assessment
and progression of gait re-education. At this centre, further physiotherapy was provided depending on
patient needs. The treatments routinely delivered during one-to-one outpatient physiotherapy included
specific knee joint exercises, functional exercises and advice. Manual therapy was used as required, often
for restricted range of knee motion. No centres reported use of electrotherapy or acupuncture as a routine
treatment. One centre indicated that patients with chronic pain had access to a pain management team.
Discussion
This survey of high-volume orthopaedic centres describes the routine physiotherapy services provided to
patients following discharge after either THR or TKR. After THR, no high-volume orthopaedic centres
offered routine physiotherapy unless patients were considered in clinical need of additional physiotherapy
support. It has been suggested that physiotherapy provided after discharge is not necessary to achieve
excellent short-term recovery.616 The clinical reasoning around the decision not to provide additional
physiotherapy following THR was not explored but may reflect the uncertain evidence supporting
long-term benefits of physiotherapy after hip replacement,253 despite many patients continuing to have
persistent muscle weakness and functional deficits compared with their age-matched peers592 up to 2 years
after surgery.
In contrast to THR, most high-volume orthopaedic centres provide physiotherapy following TKR. Greater
deficits in pain and function exist after TKR than THR,18,617 with patients reporting a greater need for
physiotherapy after TKR.618 In this survey, we found that 70% of centres routinely referred patients to
outpatient services that included either one-to-one physiotherapy or an exercise group. Our findings are
similar to that of previous research.619 In addition, we found that 26% of centres did not offer routine
physiotherapy after TKR – a proportion greater than that previously reported.620 However, after TKR,
centres in our survey not offering routine physiotherapy did refer on a needs basis.
Routine referral to supervised exercise groups was the most commonly reported physiotherapy treatment
for patients after TKR. In patients with knee osteoarthritis, group physiotherapy can be a cost-effective way
to deliver treatment without compromising effectiveness.621,622 This approach allows patients with similar
impairments to exercise within a supported environment621 and appears to be a favoured method of
delivering physiotherapy after TKR.
Knee strengthening, stretching and functional exercises were the most common exercises reported in the
physiotherapy groups, similar to that seen by Naylor and colleagues.620 This inclusion of functional exercises
is important as greater functional deficits are experience by dissatisfied patients254 and function-based
exercises are of more benefit to patients after TKR.84 Functional difficulties after TKR are observed in many
patients, particularly with activities such as kneeling, squatting and gardening.623,624 Including functional
exercises in an exercise group may be a beneficial and cost-effective way to assist patients in returning to
higher demanding activities and future research in this area is required.
This survey targeted high-volume orthopaedic centres and we report an excellent response rate. Although
not a comprehensive survey of all orthopaedic centres in England and Wales, collecting information from
these centres means the results are likely to represent the current trend in post-discharge physiotherapy
provision and has allowed us to compare post-discharge physiotherapy between THR and TKR. Information
was not gathered from smaller volume orthopaedic units, private or independent treatment centres
limiting generalisability to all centres in England and Wales. However, future research should include such
centres and gather information from other countries. Exploring the rationale behind provision of
physiotherapy pathways was not investigated here; however, research is required to identify the factors
that influence the physiotherapy service provision after THR and TKR.
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Conclusion
The provision of physiotherapy following discharge after TKR is a more common practice than after THR
for which ongoing physiotherapy is provided depending on clinical need. Group exercises are the favoured
destination for patients following TKR in high-volume centres with focus on knee specific strengthening,
stretching and functional exercises.
Physiotherapy: ARENA
Background
According to the WHO ICF model, rehabilitation should be patient centred and aim to maximise functional
ability, facilitate activities and increase social participation.80
Provision of rehabilitation following TKR should address patients’ individual preferences and needs,604 with
exercises orientated towards activities that they consider important. This individualised approach is the
basis of an exercise class developed for this study. Group physiotherapy gives a cost-effective way of
delivering treatment without compromising its effectiveness625 and allows patients to participate in exercise
within a supported environment in the company of peers with similar experiences and impairments. The
inclusion of individualised exercise specific to each patient aims to increase self-efficacy and empower
patients to take an active role as recommended by patient focus groups.626 Higher levels of self-efficacy
at 3 months have been associated with a greater level of functional activity at 9 months after joint
replacement,627 and may enhance adherence to continued home exercise. Involving patients in the design
of their rehabilitation may result in better long-term outcome and forms the basis of this function-based
group intervention.
Our systematic review identified no particular format of post-discharge physiotherapy associated with
improved long-term patient outcomes. Addressing individualisation and patient preferences as described in
the MRC framework,94 we conducted a RCT to evaluate the feasibility of providing a 6-week postoperative
activity-orientated rehabilitation programme for patients undergoing TKR. The objectives of the study
were to determine uptake rates, reasons for non-attendance at classes, patient satisfaction with classes,
patient-reported outcomes, and timing and suitability of the exercises and outcomes measures. The study
also piloted a methodology to collect costs and outcomes to perform an economic evaluation.
Patients and methods
Ethics approval
Ethics approval for this study was provided by the South West – Cornwall and Plymouth Research Ethical
Committee (NHS reference number 11/SW/0341), with study sponsorship and research and development
approval provided from North Bristol NHS Trust (reference 2713). As a feasibility study of a RCT, the study
was registered, UKCRN ID 12100.
Patient recruitment
Patients listed for primary TKR at the AOC were identified by a member of the clinical care team and
invited to participate in this study. These patients were sent a study pack containing a patient information
leaflet describing the nature and purpose of the study. When the patients attended their pre-assessment
clinic, they were approached by a research nurse to discuss the study further and check eligibility. Patients
wishing to participate in the study were asked to provide informed consent by signing the consent form.
Patients not wishing to participate in the study were asked if they were willing to explain their reasons for
not participating.
Inclusion criteria
Patients listed for primary TKR due to osteoarthritis.
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Exclusion criteria
Patients listed for TKR for reasons other than osteoarthritis, patients listed for revision knee surgery
including previous unicompartmental, tibial osteotomy or patellofemoral knee replacement surgery; patients
unable to participate in exercise for any medical reason such as unstable cardiovascular or cardiorespiratory
disease; patients with severe neurological disorders; patients unable to provide informed consent; and
patients unable to understand written English, because not all the questionnaires have been validated in
other languages.
Randomisation
Participants were allocated into either the intervention or usual care group, using Minim, by a member of
administrative staff at the MRU not directly involved in the research study. Minimisation was used to ensure
that each group had equal sex and age proportions. Patients were informed of the results of minimisation
by telephone 2 weeks after their knee replacement by a member of the research team. Participants in
the usual care group were instructed to continue with their current care and participants in the intervention
group were invited to the AOC to participate in the exercise class. Prior to the exercise class, participants
were asked to identify two functional goals that they would like to achieve following their knee
replacement. Participants allocated to the exercise class were invited to bring a partner with them to the
classes. Blinding of the research team or patients was not possible in this study because the intervention
involved attending exercise classes run by the research physiotherapists.
Intervention: usual care
Usual physiotherapy care following TKR at the study centre consisted of a knee replacement booklet given
out at a pre-operative education class. The booklet contained information about discharge planning, the
pre-operative period, the operation day, early and later stage postoperative exercises, performing everyday
functional activities, returning to work and hobbies, discharge goals, precautions, expectations and
potential problems. Patients are advised on discharge to continue with the exercises in the booklet five
times a day at home. Some patients could be referred to their local physiotherapy department for follow-up
appointments and others may receive physiotherapy at home. This was at the discretion of the inpatient
physiotherapy team or orthopaedic team. The patients may also be referred for physiotherapy by their GP
or consultant.
Intervention: physiotherapy exercise class
The physiotherapy exercise class started 6 weeks after surgery and lasted for 6 weeks. Each class was
1 hour long and contained 14 separate 4-minute tasks-related exercise stations (Table 99) designed to
address functional needs including muscle strength, balance, function and confidence. Participants were
instructed to exercise at their own pace with a focus on performing quality movement rather than high
quantity. In the first session, all the exercises were demonstrated to the participant by the physiotherapist
and the two activity goals were discussed. These activity goals then formed the basis of individualised
exercises incorporated into remaining exercise sessions. Two experienced physiotherapists supervised the
class and participants were encouraged to discuss progression of exercise with the physiotherapists during
the class. On completion of the class, participants were given a list of exercises, including their individual
exercises, to continue with at home on a regular basis at their leisure. All travel and parking cost incurred
by participants were refunded. Taxis were provided for patients unable to get to and from the class by
public or personal transport.
Assessment times and outcome measures
All participants were asked to complete study questionnaires before surgery and at 2 weeks, 3 months and
6 months after surgery. In addition, participants were contacted at 6 weeks and 3 months after surgery to
complete a MYMOP2 questionnaire. A study evaluation was completed by all participants at 3 months
after surgery. Participants in the physiotherapy exercise class were also asked to provide feedback about
exercise classes by completing an exercise class evaluation following the final exercise session.
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Primary outcome measure
The main outcome measures for this study were the KOOS273 and the LEFS.294 The KOOS is an extended
version of the WOMAC and contains information about knee pain and stiffness, knee function, sports and
recreation, and the LEFS is a 20-item scoring system to measure lower limb function.
Additional outcome measures
The study questionnaire also contained additional outcome measures to determine completion rates
for the following: MYMOP2,287 University of California at Los Angeles (UCLA) Activity Score,295
Activities-specific Balance Confidence Scale,296 Self-efficacy for Rehabilitation,297 Ab-IAP,285 EQ-5D,278
satisfaction with knee replacement and rehabilitation, service and resource usage, and adherence to
home exercise.
Study and exercise class evaluation
Participants were asked to complete a study evaluation at 3 months following surgery. This included
questions about study documentation, appropriateness of study questionnaires and assessment times.
TABLE 99 Description of exercises in the physiotherapy exercise class
Exercise Description Task
Plinth exercises This station is available for continuation of lower grade
exercises such as ROM, quadriceps and hamstring
strengthening and stretches. This can also be used for
kicking practice and eccentric hamstrings
Maintain range and strength.
Simulated kicking/swimming
Getting in/out of bed Practise turning from back to side and to sitting.
Then stand from sitting. Return to sitting then lying.
Alternative exercise includes bridging then sit to stand.
Plinth height can varied to increase level of difficulty
Getting in and out of bed.
Sit-to-stand test
Balance tasks Series of exercises including single-leg stance, wobble
board, balance training, trampette, tandem walking.
Exercises are progressed to include upper limb actions
such as throwing and catching, reaching
Standing balance. Falls
prevention
Treadmill Practise straight line and inclined walking at various
speeds
Walking on flat and uphill.
Jogging
Squatting and crouching Mini squat and semisquats. Progressing to full squat and
crouching. Squats can be performed with the assistance
of chairs, gym ball. Tasks can include cleaning floor,
loading washing machine/dishwasher, DIY
Squatting down. Crouching
down
Cycling Static bike with variable levels of resistance Cardiovascular fitness
Rowing and stepper machines Optional cardiovascular station for those who may wish
to return to gymnasium-based aerobic exercise machines
Gymnasium-based
cardiovascular exercises
Individualised exercises (× 2) Exercise designed specifically for individual patients Individual task
Progressive kneeling Kneeling at progressively increasing ranges of knee
flexion on to cushioned or hard surfaces. Full kneeling
and high kneeling. Kneeling to practise digging
Kneeling down. Gardening
Walking exercises Walking over uneven surfaces. Walking carrying objects.
Stepping into hoops over sticks
Walking. Falls prevention
Lunges Mini lunges. Progressing depth of lunge. Lunge walking.
Lunge to bowling or picking up objects
Picking up from floor.
Bowling
Getting up from floor Practise getting down and back up from a floor mat
using chairs to assist
Getting off floor
Step up/down stairs Stepping up and down on stairs of varying height Stair ascent and descent
DIY, do it yourself.
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Participants allocated to the physiotherapy exercise group were also asked to complete a class evaluation
after completion of the exercise class. This included questions about the timing and duration of the
exercise class, satisfaction with the class and exercises available and the opportunity to provide general
comments on the class.
Reasons for non-attendance at classes
To assess adherence and any barriers to participation in the intervention, attendance and reasons for
non-attendance at the exercise class were recorded.
Assessing non-participation
Ethical approval was provided to approach non-participants by telephone to ask their reasons for not
taking part.
Statistical analysis
Descriptive statistics on study participants, recruitment and attrition rates, and physiotherapy outpatient
referral rates were calculated. Participant feedback on the physiotherapy intervention was also explored.
Analysis of return rates of study questionnaires and completion rates of outcome measures was calculated.
Sample size calculations for future trials were calculated from selected outcome measures.
Results
Recruitment
A CONSORT flow diagram showing patient recruitment and retention in the study is shown in Figure 55.
A total of 238 study packs were posted to potential participants, with 124 patients approached in the
orthopaedic pre-assessment clinic. Of the 124 patients approached, 46 consented to participate in
the study, giving a recruitment rate of 37.1%. Five patients were ineligible and one patient had surgery
arranged outside the study period. Of the patients who declined to participate, 72 agreed to disclose their
reasons for non-participation in this study. Baseline details of the 46 participants are summarised in
Table 100 and were similar between both groups.
Reasons for non-participation
Seventy-two patients (23 male and 49 female) agreed to disclose their reasons for non-participation in this
study. The average age of patients not participating was 70.1 years (range 50–91 years). Fifteen reasons
for no participation were reported; the most frequent issues for not participating in the study were related
to travelling distance, transportation and commitment to attend the exercise class if allocated. These
reasons accounted for 54% of the reported reasons why patients did not wish to participate in the study.
Other reasons included concerns around existing comorbidities, caring for partners or family members,
resistance to completion of questionnaires, planned vacations following surgery, uncomfortable about
exercising in groups and anxiety about the forthcoming surgery.
Post-discharge referral for additional physiotherapy
Overall, 53.7% of participants in this study were referred for outpatient physiotherapy after their TKR.
In the usual care group, 52.6% of participants were referred for outpatient physiotherapy, compared
with 57.1% in the physiotherapy intervention group.
Attendance at the exercise class
A total of 23 participants were randomised into the physiotherapy intervention. Of the 23 participants
randomised, two participants were excluded prior to starting the exercise class, three participants did
not attend, and one participant attended a single exercise before admission for a manipulation under
anaesthetic for joint pain and stiffness. Of the three participants who did not attend, reasons for
non-attendance were a complication of medical condition, readmission for manipulation under anaesthetic
and one participant decided to take a vacation overseas. Overall, the attendance rate was 73%, with
13 participants attending all six exercise classes and four participants missing only one exercise class.
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Assessed for eligibility
(n = 124)
Excluded
• Did not meet inclusion criteria, n = 5
• Declined to participate, n = 72
• Surgery scheduled beyond study 
   period, n = 1
Attended intervention
 (n = 17)
• Withdrawals, n = 2
• MUA, n = 2
• Medical complication, n = 1
• Vacation, n = 1
Completed 2-week follow-up
 (n = 20/21)
• Withdrawals, n = 2
• Non-responder, n = 1
Recruited and randomised
(n = 46)
Allocated to intervention
(n = 23)
Allocated to usual care
(n = 23)
Completed 3-month follow-up
 (n = 19/21)
• Withdrawals, n = 2
• Non-responder, n = 2
• Death, n = 0
Completed 6-month follow-up
 (n = 21/21)
• Withdrawals, n = 2
• Non-responder, n = 0
• Death, n = 0
Completed 2-week follow-up
 (n = 19/20)
• Withdrawals, n = 2
• Surgery arranged at different hospital, n = 1
• Non-responder, n = 1
Completed 3-month follow-up
 (n = 14/20)
• Withdrawals, n = 2
• Non-responders, n = 6
• Death, n = 0
Completed 6-month follow-up
 (n = 15/20)
• Withdrawals, n = 2
• Non-responders, n = 5
• Death, n = 0
Surgery 
(n = 23)
Surgery 
(n = 22)
• Surgery delayed beyond study period, n = 1
FIGURE 55 ARENA CONSORT flow diagram. MUA, manipulation under anaesthetic.
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The main non-medical reasons for non-attendance were that patients had arranged visits out of area on
the day of the exercise class.
Evaluation of the exercise class
A total of 17 participants provided feedback on the exercise class. All participants felt that the duration of
the session, at 1 hour, was the right amount of time to exercise. Three participants (18%) would have like
to receive more than six sessions and one participant (6%) reported that the exercise class should have
started sooner after surgery. Overall, all participants were satisfied with the range of exercises offered,
with 15 (88%) participants reporting that they were very satisfied. The average usefulness of functional
exercises and individual exercises within the class were scored as 9.6 out of 10 and 9.5 out of 10,
respectively, on a numerical rating scale. All patients felt that the exercise class met their functional needs.
For example:
coming to the class has been extremely useful. I felt the exercises were all relevant to everyday
activities and really boosted my confidence on a day to day basis.
Pt042
there is no doubt that the sessions have expedited and enhanced my recovery. An extremely
valuable experience.
Pt031
I think attending these sessions were very helpful emotionally and I felt better in that respect after the
first session. Meeting other people to discuss problems with them and the staff was definitely a bonus.
Pt030
TABLE 100 Baseline demographics for participants in the ARENA study
Characteristic All
Intervention group
(n= 23)
Usual care group
(n= 23)
Mean age, years (range) 68.6 (51–82) 70.0 (57–81) 67.2 (51–82)
Sex (male/female) 22/24 11/12 11/12
Laterality of implant (left/right) 19/27 9/14 10/13
Mean distance (miles) residing from hospital (range) 8.1 (1.3–18.6) 9.2 (1.7–17.7) 7.1 (1.3–18.6)
Living alone, % 27.7 17.3 38.1
Retired, % 71.3 82.6 60.0
Additional joint pains, % 85.7 100 71.4
Back pain, % 34.1 34.8 33.3
Diabetes, % 13.3 21.7 4.8
Angina, % 6.7 13.0 0.0
Mean KOOS pain score (95% CI) 42.4 (37.3 to 47.5) 40.5 (33.4 to 47.6) 44.5 (37.1 to 51.8)
Mean KOOS symptoms score (95% CI) 42.2 (37.1 to 47.3) 40.7 (33.6 to 47.8) 43.9 (36.4 to 51.3)
Mean KOOS ADL score (95% CI) 46.3 (40.7 to 51.8) 41.8 (34.2 to 49.3) 51.2 (43.3 to 59.1)
Mean KOOS sport/recreation score (SD) 14.9 (20.9) 12.2 (24.4) 18.1 (15.8)
Mean KOOS QoL score (SD) 15.6 (11.3) 12.5 (12.6) 18.4 (8.5)
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Return of study questionnaires and resource-use logs
Study questionnaire return rates were high at 2 weeks after surgery with a 95% return rate in both
groups. At 3 months after surgery, the rate of the questionnaire return was lower in the usual care group
with 70.0% (14/20) returning the study questionnaire, compared with 90.5% (19/21) for the intervention
group. Two participants in the usual care group were contacted by telephone to complete the KOOS.
At 6 months, the questionnaire return rate in the usual care and intervention group was 75% (15/20) and
100% (21/21), respectively. Resource-use log return rate at 3 months was 55% (11/20) in the usual care
group compared with 90.5% (19/21) in the intervention group. A slight increase in return rate was
observed at 6 months after surgery with resource-use log return rates of 75% (14/20) and 100% (21/21)
in the usual care and intervention groups, respectively.
Completion of KOOS and LEFS outcome measures
Completion rates of the KOOS and LEFS are shown in Table 101. Completion of the KOOS subsections
and the LEFS at 2 weeks after surgery was high for both intervention groups. At the 3- and 6-month
stages, completion rates were lower in the usual care for all KOOS subsections and the LEFS compared
with the intervention group. Completion of the KOOS and LEFS was generally less likely at the 3-month
post-operation stage for both intervention groups.
TABLE 101 Completion rates of the LEFS and KOOS subsections at 2 weeks, 3 months and 6 months after surgery
in both the usual care and physiotherapy intervention groups
Outcome
2 weeks after surgery 3 months after surgery 6 months after surgery
Return,
n/N (%)
Completion,
x/n (%)
Return,
n/N (%)
Completion,
x/n (%)
Return,
n/N (%)
Completion,
x/n (%)
KOOS pain
Usual care 19/20 (95) 19/19 (100) 14/20 (70) 14/14 (100) 15/20 (75) 14/15 (93)
Physiotherapy 20/21 (95) 20/20 (100) 19/21 (90) 19/19 (100) 21/21 (100) 21/21 (100)
KOOS symptoms
Usual care 19/20 (95) 19/19 (100) 14/20 (70) 14/14 (100) 15/20 (75) 14/15 (93)
Physiotherapy 20/21 (95) 20/2 (100) 19/21 (90) 19/19 (100) 21/21 (100) 21/21 (100)
KOOS ADL
Usual care 19/20 (95) 19/19 (100) 14/20 (70) 14/14 (100) 15/20 (75) 15/15 (100)
Physiotherapy 20/21 (95) 20/20 (100) 19/21 (90) 19/19 (100) 21/21 (100) 21/21 (100)
KOOS sport recreation
Usual care 19/20 (95) 18/19 (95) 14/20 (70) 13/14 (93) 15/20 (75) 15/15 (100)
Physiotherapy 20/21 (95) 17/20 (85) 19/21 (90) 19/19 (100) 21/21 (100) 18/21 (86)
KOOS QoL
Usual care 19/20 (95) 19/19 (100) 14/20 (70) 13/14 (93) 15/20 (75) 14/15 (93)
Physiotherapy 20/21 (95) 20/20 (100) 19/21 (90) 19/19 (100) 21/21 (100) 21/21 (100)
LEFS
Usual care 18/20 (90) 17/18 (94) 12/20 (60) 11/12 (92) 15/20 (75) 14/15 (93)
Physiotherapy 20/21 (95) 19/20 (95) 19/21 (91) 19/19 (100) 21/21 (100) 19/21 (91)
n, number of outcome returned; N, total number of potential returnable outcomes; x, number completed.
Note
Completion rates (x/n) (%) of (N) returned questionnaires.
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Completion of additional outcome measures
Completion rates of the additional outcome measures are shown in Table 102. Similarly to the LEFS
and KOOS outcome measures, completion rates at 2 weeks were high in both groups. However, at
3 months after surgery, completion was poorer in the usual care group, with rates between 55% and
60%, than in the physiotherapy intervention group (76.2–90% completion). Similarly, at 6 months after
surgery, completion rates were higher for the physiotherapy group than for the usual care group.
Pain measured using a VAS demonstrated the poorest completion in both groups, with rates of 55%
at 3 months and 50% at 6 months for the usual care group at 76.2% and 85.7%, respectively in the
intervention group.
Completion of MYMOP2 questionnaires
Initial (6 weeks post operation) MYMOP2 scores were recorded for all participants that had surgery (41/41)
and were not excluded from the study. At 3 months after surgery, the completion rate for the first
follow-up MYMOP2 scores was 95% in the usual care group and 100% in the intervention group.
At 6 months, the completion rates for the usual care and intervention groups were 85.7% and
95.2%, respectively.
Outcome data
Outcome scores for the KOOS subsections are shown in Table 103 and those for the LEFS and additional
measures are shown in Table 104. Improvements in score are observed for all measures in both
intervention groups from 2 weeks to 6 months after surgery. There is a trend for higher scores in the
exercise group for all KOOS subsections and LEFS scores, but no statistical analysis has been carried due to
the feasibility nature of this study.
TABLE 102 Completion rate (%) of additional outcome measures at 2 weeks, 3 months and 6 months after surgery
in both the usual care and physiotherapy intervention groups
Completion rates (%) of
additional outcome measures 2 weeks after surgery 3 months after surgery 6 months after surgery
ABC scale
Usual care 17/20 (85%) 12/20 (60%) 15/20 (75%)
Physiotherapy 20/21 (95%) 19/21 (91%) 21/21 (100%)
Pain (VAS)
Usual care 17/20 (85%) 11/20 (55% 10/20 (50%)
Physiotherapy 20/21 (95%) 17/21 (76%) 18/21 (86%)
UCLA activity score
Usual care 18/20 (90%) 12/20 (60%) 15/20 (75%)
Physiotherapy 20/21 (95%) 19/21 (91%) 20/21 (95%)
SER
Usual care 18/20 (90%) 12/20 (60%) 14/20 (70%)
Physiotherapy 20/21 (95%) 19/21 (91%) 20/21 (95%)
Ab-IAP
Usual care 17/20 (85%) 12/20 (60%) 15/20 (75%)
Physiotherapy 20/21 (95%) 19/21 (91%) 21/21 (100%)
ABC, activities-specific balance confidence; SER, self-efficacy for rehabilitation.
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TABLE 103 Mean (95% CI) scores for KOOS outcome data before surgery and at 2 weeks, 3 and 6 months after surgery
Outcome Baseline surgery 2 weeks after surgery 3 months after surgery 6 months after surgery
KOOS pain
Usual care 44.5 (36.7 to 52.2) 52.8 (44.1 to 61.5) 69.2 (57.9 to 80.5) 70.9 (60.4 to 81.4)
Physiotherapy 40.4 (33.3 to 47.5) 46.7 (40.4 to 53.0) 74.1 (64.6 to 83.8) 78.6 (70.1 to 87.2)
KOOS symptoms
Usual care 43.9 (36.3 to 51.5) 42.9 (37.8 to 48.0) 54.8 (45.1 to 64.6) 56.7 (48.3 to 65.1)
Physiotherapy 40.6 (33.2 to 48.0) 52.2 (45.7 to 58.8) 59.6 (51.7 to 67.5) 58.5 (51.6 to 65.3)
KOOS ADL
Usual care 51.1 (42.0 to 60.2) 58.1 (48.3 to 68.0) 76.1 (65.4 to 86.8) 73.5 (63.4 to 83.7)
Physiotherapy 40.9 (34.0 to 47.7) 53.6 (43.5 to 63.8) 81.2 (73.5 to 88.8) 79.6 (71.1 to 88.3)
KOOS sport recreation
Usual care 18.0 (10.6 to 25.4) 12.9 (7.0 to 18.8) 27.9 (15.1 to 40.1) 37.1 (24.5 to 49.7)
Physiotherapy 12.2 (1.6 to 22.7) 16.8 (2.8 to 29.5) 39.2 (25.0 to 53.4) 46.3 (34.8 to 57.8)
KOOS QoL
Usual care 19.0 (15.0 to 23.0) 16.7 (13.1 to 18.8) 36.1 (25.6 to 46.6) 45.1 (34.2 to 56.0)
Physiotherapy 12.4 (7.0 to 17.9) 23.9 (15.6 to 32.1) 52.4 (39.4 to 65.5) 61.5 (52.6 to 70.5)
TABLE 104 Mean (95% CI) for the LEFS and additional outcome measures before surgery and at 2 week and
3 months after surgery in both the physiotherapy intervention and usual care groups
Outcome Before surgery 2 weeks after surgery 3 months after surgery 6 months after surgery
LEFS
Usual care 30.1 (24.01 to 36.23) 48.8 (38.78 to 58.85) 45.0 (35.32 to 54.68)
Physiotherapy 26.1 (20.32 to 31.89) 55.8 (48.21 to 63.48) 57.8 (49.54 to 66.15)
ABC scale
Usual care 62.9 (51.9 to 74.0) 60.5 (49.1 to 71.9) 79.0 (66.7 to 91.3) 80.6 (71.0 to 90.3)
Physiotherapy 48.2 (37.7 to 58.6) 43.7 (32.8 to 54.6) 84.3 (77.1 to 91.7) 84.1 (75.9 to 92.2)
Pain (VAS)
Usual care 6.0 (5.0 to 7.1) 5.7 (4.6 to 6.8) 3.6 (2.2 to 5.0) 3.9 (1.7 to 6.0)
Physiotherapy 7.3 (6.4 to 8.2) 5.3 (4.1 to 6.5) 3.5 (1.8 to 5.2) 2.9 (1.3 to 4.6)
UCLA activity score
Usual care 4.4 (3.6 to 5.3) 2.5 (2.2 to 2.9) 4.3 (3.7 to 5.0) 4.6 (3.7 to 5.6)
Physiotherapy 3.5 (3.1 to 4.0) 2.8 (2.4 to 3.1) 4.9 (4.1 to 5.7) 5.2 (4.4 to 5.9)
SER
Usual care 91.9 (78.7 to 105.0) 91.2 (82.9 to 99.6) 101.5 (86.8 to 116.2) 103.8 (95.9 to 111.6)
Physiotherapy 86.5 (71.0 to 101.9) 87.3 (76.1 to 98.4) 108.7 (102.4 to 115.0) 110.7 (104.0 to 117.5)
Ab-IAP
Usual care 17.2 (13.9 to 20.4) 20.8 (18.1 to 23.6) 13.9 (10.0 to 17.8) 15.4 (11.9 to 18.9)
Physiotherapy 18.7 (15.4 to 21.9) 19.5 (16.1 to 22.9) 11.5 (9.5 to 13.5) 10.9 (7.8 to 14.0)
ABC, activities-specific balance confidence; SER, self-efficacy for rehabilitation.
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Sample size calculation
The minimal clinically important difference for the LEFS is nine scale points.294 In our feasibility study, we
observed a mean LEFS score of 45.0 points (SD 18.4 points). We have also allowed for a 39% missing data
rate but we will implement measures in the definitive trial to improve LEFS completion rates. For the
purposes of the sample size calculation we have assumed a similar SD for the LEFS at 12 months post
operation, owing to the lack of published data on LEFS scores at this time point. We have also accounted
for a missing data rate of 39%, although we will implement measures in the definitive trial to improve
LEFS completion rates. Therefore, we have calculated that we will need to recruit a sample of 256 patients
to allow us to detect a minimal clinically important difference on the LEFS between trial arms at 12 months
post operation, assuming a power of 80%, a two-sided 5% significance level and accounting for up to
39% missing data or attrition.
Discussion
This study was designed to evaluate the feasibility of implementing a RCT comparing a physiotherapy
exercise class with usual care for patients after TKR. We recruited 46 participants from 124 patients
approached in an orthopaedic clinic, giving a recruitment rate of 37.1%. This rate is similar to that of a
recent feasibility trial by Minns Lowe and colleagues595 with a recruitment rate of 34%, but lower than
previous RCTs where recruitment rates range from 47% to 63%.520,597 Recruitment into trials can be
difficult and investigations to evaluate barriers in the recruitment process are important to optimise
participant uptake. The main reasons for non-participation in our study were travel-related issues and the
inability to commit to the intervention if allocated to this group. Issues with transportation have been
highlighted in a previous feasibility study in which 43% of non-participation was due to travel and parking
issues,595 indicating that provision of independent travel to study appointments could potentially increase
recruitment rates. However, in our study participants were offered transport if allocated to the intervention
group and reimbursement of travel costs. Greater emphasis on the provided travel arrangements in future
trials may also be beneficial for patients considering participation in studies involving travelling to
additional appointments.
Despite the burden of attending six additional physiotherapy appointments, the group physiotherapy
exercise class was generally well received and attendance was high. The attendance rate of 73% is similar
to that of other studies that involve repeated appointments for a physiotherapy intervention.590 Harmer
and colleagues compared land-based with water-based rehabilitation after TKR and reported an
81% attendance rate when participants attended more than eight treatment sessions.590 Feedback from
participants allocated to the intervention group in our study was generally positive and supportive of the
exercise class, with 84% of participants reporting that they were satisfied. Participants reported that the
class was of adequate duration and included exercises that met their needs. Although satisfaction
following knee replacement is high,628 levels of physical function are lower in TKR patients,629 who often
require more physiotherapy input than patients with other arthroplasties.618 Several ongoing difficulties are
reported after surgery.618,630 Wright and colleagues630 reported that the most common functional
complaints do not improve after knee replacement, the complaints include difficulty kneeling and
crouching, and impaired ability to walk up and down stairs. Rogers and colleagues629 also found bending/
stooping and walking 1 km a frequently reported difficulty after TKR. The aim of the exercise class was to
provide patients with a series of different exercises, including kneeling, stairs and treadmill walking, to
address these common difficulties and that can be transferable into normal daily life. Unfortunately, this
study was not powered to determine whether or not such improvements can occur with the provision of
our physiotherapy exercise class design and a larger-scale RCT is required.
It was also noted that the class was beneficial on an emotional level by increasing confidence and having
regular contact with other patients, and access to professionals with expertise in rehabilitation was valued.
Health professional support and engagement with peers is important for patients after joint replacement626
and can have a positive impact on functional attainment and QoL.631 Group-based physiotherapy can be
enjoyable for patients,628 allows patients to compare their progress with that of their peers and offers
interaction between patients who have experienced knee replacement surgery.628 Involving participants
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with designing their own rehabilitation was well received with the individualised exercise component
scoring 9.5 out of 10 for usefulness. Thus, offering a one-to-one component, albeit in the initial stages of
the class, and devising strategies to involve patients in their own rehabilitation is important to assist in
adherence, empowerment and self-efficacy.626,627 The concept of incorporating one-to-one physiotherapy
within the group setting has been highlighted by Naylor and colleagues628 as potentially beneficial in
allowing identification of persistent postoperative problems and by influencing adherence. Our study
indicates that patients were satisfied with the nature of the exercise class and individualised component
offered, suggesting that this is a feasible design for future large-scale RCTs.
In addition to developing an exercise intervention, we evaluated the use of a postal study questionnaire
and resource-use log. Questionnaire return rates were found to be higher in the intervention group than
the usual care group, particularly at 3 and 6 months after surgery. Additional telephone contact to collect
the primary outcome measure increased the number KOOS scores recorded. Reasons for this low return
rate in the usual care group were not explored in this study but this highlights the limitations of using
postal questionnaires. The higher return rates in the intervention group are not unexpected and may
reflect closer relationships developed between participants attending the group and the research team/
physiotherapists compared with those not invited to attend the class. One participant in the usual care
group quoted in the study evaluation document that ‘if I was in the group (referring to the exercise class)
I would have probably filled out the forms’.
Another key part of this feasibility study was to investigate the use of different outcome measures for
patients after TKR. It has been suggested that there is a need for newer measures to evaluate
rehabilitation outcome in patients with TKR595 and part of this study was to look at the return and
completion rates of study outcome measures. Of particular interest were the KOOS and LEFS. Although
the return rates were higher in the physiotherapy intervention group than in the usual care group, the
completion rates of those measures returned were similar between groups at both 3 and 6 months
after surgery. Completion rates were lowest for the KOOS sport and recreation subsection at 6 months
following surgery, particularly with questions related to running, jumping, kneeling and squatting, indicating
that participants may have found these specific questions irrelevant and this should be a consideration for
the use of this outcome measure in future trials.
Sample size
Using the LEFS as a functional outcome measure to generate a sample size calculation demonstrated that a
total of 256 participants would be required to run a full-scale RCT powered at 80%. Using the LEFS as an
outcome measure may provide a more feasible method of delivering a RCT comparing our physiotherapy
intervention with usual care in a timely manner at our centre. The LEFS is a validated 20-item questionnaire
that assesses lower limb functional impairment and difficulty in performing everyday tasks. The LEFS has
been recommended as the outcome measure of choice to measure physical functioning in patients with
knee osteoarthritis because of its good psychometric properties and minimal floor and ceiling effects,497
and has more recently been used in trials to compare physiotherapy interventions after TKR.589,600 In the
study by Fung and colleagues589 the LEFS was used as an outcome measure to compare the effects of
additional Wii-Fit (Nintendo Wii™; Nintendo of America, Redmond, WA, USA) exercises with outpatient
physiotherapy after TKR. The study included 50 participants and had a medium effect size. A sample size of
80 would be required for a fully powered trial. Other authors report varying sample sizes depending on
outcome measures used. Minns Lowe and colleagues595 used the OKS to demonstrate that 521 participants
would be required in each arm (90% power, level of significance 0.05) to run a RCT comparing usual care
with home physiotherapy after TKR. Furthermore, Frost and colleagues588 reported that, depending on the
outcome measure used, between 100 and 550 participants would be required to compare the effects of
traditional and functional exercises in patients after TKR. Thus, the use of the LEFS in the present study
would allow acceptable recruitment numbers and sufficient power to run a fully powered RCT comparing
the physiotherapy group exercise with usual care.
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Conclusion
The implementation of a RCT to compare a 6-week functional exercise group with usual care for patients
after TKR is a feasible and acceptable design in a large orthopaedic centre. In order to run fully powered
trial, a total of 256 participants would need to be recruited for the LEFS to be used as a primary
outcome measure.
Physiotherapy exercise general discussion
We conducted a survey in 2011 of physiotherapy provision after total hip and knee replacement at
high-volume orthopaedic centres in England and Wales. We found that physiotherapy following discharge
after TKR was a more common practice than after THR, for which ongoing physiotherapy was provided
depending on clinical need. Group exercises were the favoured destination for patients following TKR in
high-volume centres with focus on knee-specific strengthening, stretching and functional exercises.
After THR, no high-volume orthopaedic centres offered routine physiotherapy unless patients were
considered in clinical need of additional physiotherapy support.
In our studies of evaluations of physiotherapy exercise we focused on patients with TKR. We were aware of a
systematic review in progress that was updating the review of physiotherapy exercise by Minns Lowe and
colleagues,85 which is now published.632 Although the authors concluded that published studies support some
potential benefit for physiotherapy exercise in relation to patient function, walking and muscle strengthening,
there is a need for further high-quality studies with adequate statistical power and long-term follow-up.
In our systematic review and meta-analysis of studies including patients with TKR, there was a suggestion
that patients who received a programme of physiotherapy exercise achieved short-term improvements in
physical function and pain compared with controls. However, this was based on a small number of studies
with small numbers of patients randomised. Again based on limited evidence, there was no benefit
suggested in relation to longer-term recovery.
There were insufficient studies with adequate patient numbers to provide conclusive evidence on different
methods of provision. To evaluate the clinical effectiveness of home-based provision compared with
physiotherapy exercise in an outpatient setting would require large studies, as the objective would be to
show equivalence. On the basis of their pilot study, Minns Lowe and colleagues595 concluded that a more
definitive evaluation of home-based compared with outpatient provision would require randomisation of
1271 patients with TKR.
In developing a new physiotherapy exercise intervention for evaluation in patients with TKR, we recognised
the importance of individual patient concerns and the need to focus on activities that they consider
important. This formed the basis of an individualised and task-orientated exercise class developed for
evaluation in the ARENA study. Group physiotherapy is a cost-effective method of delivery and allows
patients to participate in exercise within a supported environment in the company of other patients with
similar problems. The inclusion of individualised exercises specific to each patient’s problems aimed to
increase self-efficacy and to empower patients to take an active role in their rehabilitation.
We conducted a RCT to evaluate the feasibility of providing a 6-week postoperative activity-orientated
rehabilitation programme for patients undergoing TKR. The group physiotherapy exercise class was generally
well received and attendance was high, with 84% of participants reporting that they were satisfied. Participants
reported that the class was of adequate duration and included exercises that met their needs. The main reasons
for non-participation in the study were travel related and the inability to commit to the intervention.
In order to run a fully powered trial, we estimate that 256 participants would need to be recruited with
the LEFS used as a primary outcome measure.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
335

Chapter 12 Discussion and conclusions
The RESTORE programme
Well-conducted studies in representative populations of patients with total hip and knee joint replacement
suggest that many people continue to have painful joints after surgery. The proportion of people with an
unfavourable long-term pain outcome ranges from about 7% to 23% after hip replacement and 10% to
34% after knee replacement. Similarly, about 10% of patients with hip replacement and 30% with knee
replacement do not have a long-term functional improvement that is clinically or statistically significant.
The amount of improvement in walking performance is rarely large.
Improving the experience and outcome of joint replacement has the potential to impact on patients
and services. The RESTORE programme was designed to deliver high-quality research focusing on
understanding the experience of joint replacement and to identify ways to improve the experience and
outcomes of people undergoing total hip or knee replacement for osteoarthritis.
We conducted research into care at key times in the patient pathway from being referred for total hip or
knee replacement to the time after surgery when an optimal outcome should be achieved. We have used
appropriate research methods to synthesise evidence from previous research, to explore the patient
experience of surgery, to evaluate the clinical effectiveness, cost-effectiveness and acceptability of a
perioperative pain management strategy, to compare the properties and responsiveness of outcome
measures, and to assess the feasibility of new interventions before and after joint replacement. Approaches
used were systematic reviews, cohort studies, fully powered RCTs and smaller feasibility randomised trials,
a survey of current practice and qualitative studies. To ensure PPI throughout the programme, all studies
were discussed and developed in collaboration with patient representatives and a patient forum.
Originally we had aimed to focus our ADAPT study on the development of new outcome measures
relating to the pain and functional problems experienced by people with osteoarthritis, specifically ICOAP
and Ab-IAP. Our patient group argued strongly that we should avoid using questionnaires that repeated
themselves and we are aware of the fatigue experienced by study participants completing multiple
questionnaires with associated poor-quality and incompleteness of data. Thus, in ADAPT, we studied key
patient-reported outcomes, performance tests and movement analysis.
Another change from our original objectives relates to the design of a complex package of care supporting
patients throughout the joint replacement pathway. We identified five possible elements: pre-surgical
education, optimisation of pre-surgical health, occupational therapy and home modifications provided
before surgery, physical therapy, and pain control. Preliminary systematic reviews by us as well as others
did not identify evidence-based interventions to fulfil the specific elements. This indicated the need for
feasibility studies as conducted in the RESTORE programme and ultimately fully powered RCTs. One of
these, the ARENA randomised trial of physiotherapy exercise after TKR commenced in March 2015.633
Ultimately, we aim to develop consensus statements and the conclusions of the RESTORE programme will
be a cornerstone of these along with new studies based on these research findings and information from
the National Joint Registry.
To draw together the conclusions from the separate research strands we now consider our findings in the
context of research practice and the patient pathway from waiting for total hip or knee replacement
through surgery and rehabilitation to long-term recovery.
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Research practice
Numerous methods are available to assess general health and functional outcomes after hip and knee
replacement. A limitation to several of our studies was the need for questionnaires to be completed in
English by participants or carers. Validated translations of several questionnaires are now available and this
should be a factor considered in future research.
In our ADAPT cohort study, we compared different measures used to assess function in people
undergoing hip and knee replacement. The strongest correlations were between the different
self-assessment measures and between the different performance tests. However, the correlations
between self-assessment measures and performance tests were much lower, highlighting the importance
of using both a self-assessment measure and a performance test to obtain a comprehensive assessment of
function. Furthermore, associations between functional measures and other patient factors suggest that
age, pain and psychological health should be considered as covariates in future analyses.
Ceiling effects were noted for self-assessment measures such as WOMAC and to a lesser extent for the
clinician-administered scores. Some objective measures and gait analyses were still improving after surgery
at a time when WOMAC function scores were reaching a plateau. However, other objective measures had
a similar pattern of improvement, suggesting that the WOMAC function score provides a reasonable
reflection of functional change.
Range of motion is commonly used to evaluate joint replacement outcome in clinical practice after hip and
knee replacement and forms part of widely used outcome scores. In the ADAPT study, ROM did not
correlate well with other measures of function and seemed to add little value to the assessment of
functional impairment.
In our systematic review looking at pain outcome assessment in published research in TKR, we found that
assessment has been inconsistent with extensive variation in measures used. The most commonly used
outcome measure relied on clinician assessment with a single question about pain. Despite the availability
of many validated pain-related instruments, few studies had attempted to capture the incidence, character
and impact of chronic pain after TKR. Our review showed a reduction over time in the use of the AKSS,
accompanied by an increase in the use of the WOMAC index, an established PROM. Future research is
needed to develop consensus and standardisation on which pain domains should be assessed after TKR.
In evaluating the clinical effectiveness of interventions, RCTs and ultimately their systematic review and
meta-analysis provide the most reliable evidence on the clinical effectiveness of interventions. In our APEX
randomised trials investigating the clinical effectiveness and cost-effectiveness of wound infiltration
anaesthesia in reducing chronic pain after hip and knee replacement, we achieved a recruitment rate of
> 50%. Within the trials, research nurses used peer-review methods to support training and optimise
recruitment practice. In qualitative interviews, patients and health-care professionals reported that they had
weighed up the benefit and cost of involvement. They were interested in involvement in the APEX trials
because they considered the trials to be important and relevant. Patients expressed their desire to help
others by contributing to the furthering of clinical knowledge and many patients thought that they might
benefit physically and psychologically from taking part.
Qualitative studies including APEX participants and health-care professionals also demonstrated the
importance of clinical trials placing minimal burden on patients and health-care professionals. Health-care
professionals wanted the trial to have minimal impact on daily clinical practice and patients wanted data
collection and participation to be as easy as possible.
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Waiting for total hip or knee replacement
In the APEX cohort we compared radiographic assessment of osteoarthritis severity with patient-reported
function and pain severity. For patients with hip osteoarthritis, there was no strong association but in
patients with knee osteoarthritis, those with less severe radiographic osteoarthritis had more severe pain
and functional problems. This suggests that some patients may have pain that is driven predominantly by
central pain sensitisation rather than peripheral changes within the joint.
Comparisons of recovery trajectories in hip and knee replacement show different inter-relationships
between pain and function. In the APEX cohort, chronic pain after THR was driven predominantly by pain
at rest while chronic pain after TKR was driven predominantly by pain on movement. These findings
suggest different pain mechanisms within hip and knee osteoarthritis and highlight the importance of
future work to identify the sources and potential treatment options for these different pain mechanisms.
Interviews with patients found that delays for surgery are a common occurrence in the NHS for patients
awaiting orthopaedic intervention. Patients can experience a range of emotional reactions if their surgery is
delayed or cancelled and the wait for surgery can have detrimental physical and emotional consequences.
It is important that health professionals identify those at increased risk and work towards minimising delay
and cancellation of operation dates where possible.
In our review of longitudinal studies, patients with better physical function and lower pain before total hip
and knee replacement generally achieved a better recovery in terms of joint specific pain and function.
Patients with poor physical function before surgery may have greater absolute improvement. This was also
noted in the ADAPT study, in which patients with very severe disease at the time of surgery were more
likely to have substantially improved long-term function. However, in patients receiving TKR, functional
levels achieved were related to the levels of function before surgery. This suggests that delays to surgery
with associated functional decline may lead to worse outcomes for patients with knee osteoarthritis.
In the longitudinal studies identified in the review, patients with depression before surgery had poorer
long-term pain and functional outcomes. For patients receiving TKR, there was evidence of a relationship
between anxiety and poor general psychological health before surgery and poorer long-term pain and
functional outcomes. In the APEX cohort study, we found that pre-operative widespread pain sensitisation
was not predictive of the amount of pain relief that patients gained from total hip or TKR.
Patients with a broad range of BMIs benefited from total hip and knee replacement but those with the
highest BMIs may not achieve good long-term levels of function and pain control.
Our qualitative research, cohort study, feasibility trials and systematic review of longitudinal studies suggest
that interventions before surgery to optimise a patient’s physical function, pain levels and psychological
health merit further study. In the context of advanced osteoarthritis in which conservative treatments have
not controlled symptoms, an exercise and education intervention may aim to maintain functional levels or
prevent further decline. Alternatively, reduction of surgery waiting times may mean that patients do not
experience further worsening of symptoms and thus poorer long-term functional outcomes.
In randomised evaluations of pre-surgical exercise and education identified in our systematic review, there
was a suggestion that physical function can be enhanced and pain reduced before surgery in patients
waiting for hip replacement. Studies in patients with knee replacement did not provide strong evidence for
benefit. Interventions were associated with reduced anxiety during the hospital admission and quicker
mobilisation. The value of specific exercise content was unclear, which may reflect the aims of pre-surgical
exercise to maintain functional ability and prevent decline whereas post-surgical rehabilitation is
substantially based on adjustment to physical changes associated with the prosthesis.
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Pain management before surgery is important, particularly in the context of prolonged waiting times.
In our feasibility randomised trial of a group-based pain self-management intervention for patients
undergoing THR, the recruitment rate was 23%. Barriers to participation related to patient views of the
course, satisfaction with current self-management and difficulty getting to the study centre. An issue in
evaluation of pre-surgical interventions may be the perception of patients that conservative strategies
have been exhausted and that only surgery can relieve pain. However, among those who attended,
the group-based pain self-management intervention was acceptable and well received.
Conventionally, aids and home modifications to support independence are provided after surgery. Other
aspects of occupational therapy, such as hip precautions, which aim to reduce the risk of dislocation, may
be provided at pre-operative classes, in written material and reinforced during the hospital stay. In our
systematic review (see Chapter 10), we found some evidence from a few small studies for benefit for
occupational therapy in improving physical function, usually when provided in combination with
physiotherapy exercise. Improvements to physical function and pain were only short-term. In the
PROOF-THR study, we conducted a feasibility randomised trial of a pre-operative occupational therapy
home visit with provision and instruction in use of compensatory devices, education and counselling. The
successful recruitment, randomisation of participants and delivery of the intervention, plus the reasonable
attrition rate, suggested that this trial design would be feasible to take forward into a large definitive trial.
Perioperative pain management
Our systematic review suggested that local anaesthetic infiltration before wound closure was effective in
reducing short-term pain after total hip and knee replacement. Pain was further reduced with the addition
of post-closure analgesia and, in TKR, with inclusion of ketorolac in the infiltrate. In TKR, there was little
evidence to suggest additional benefit to that provided by FNB. Few studies explored the potential
long-term impact of perioperative pain management with local anaesthetic infiltration.
Our APEX RCTs were fully powered evaluations including 322 patients receiving THR and 316 patients
receiving TKR. Patients were randomised to an intervention of local anaesthetic wound infiltration or to
a control group receiving usual care. In patients with THR, there was little benefit for local infiltration
anaesthesia in reducing pain during the first 3 days after surgery. In our meta-analysis of previous studies,
benefit for the specific regimen evaluated in the APEX trials was apparent only at rest at 24 hours with no
benefit during activity or at 48 hours. Only when additional post-closure anaesthesia was provided through
a catheter or injection was there benefit at 48 hours and during activity. Few previous studies reported
long-term outcomes. In our APEX hip trial, local anaesthetic infiltration was associated with reduced
incidence of long-term pain after THR.
In the APEX trial in patients with TKR, all patients had a FNB sited during surgery, a recognised method of
providing analgesia after TKR. In the first 48 hours after surgery there was little suggestion of improvement in
pain control in patients receiving local anaesthetic infiltration compared with controls. This was consistent with
short-term results from systematic review in trials in which FNB was provided. There was no strong evidence
for improved long-term pain control in patients receiving local anaesthetic infiltration in the APEX knee trial.
In the absence of FNB, our systematic review showed short-term benefit for local anaesthetic infiltration in
patients receiving TKR, particularly if additional analgesia was provided through a catheter or injection after
wound closure. In developing the protocol for the APEX trials, we decided against the use of extra delivery of
anaesthesia. The use of catheters generally in health care is associated with a risk of infection. In the studies
we reviewed, the rate of deep infection after hip or knee replacement was low and it is not possible to state
conclusively that use of a catheter was associated with increased risk of infection. However, there were six
infections in 505 patients who received an active catheter (1.19%), compared with a total of eight infections
in all 2348 patients randomised (0.34%). Further cohort or registry studies may provide more definitive
evidence on the safety of additional analgesia provided through catheters after wound closure.
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From the perspective of the NHS and PSS, the addition of local anaesthetic infiltration to the usual
analgesia regimen was a cost-effective treatment option in primary THR. Our findings also indicate positive
health benefits and cost savings in TKR, but with considerably more uncertainty around the
cost-effectiveness result.
Qualitative interviews with patients in the APEX study showed that the experience of joint replacement can
temporarily alter patients’ views of the acceptability, necessity and value of pain relief medication around
the time of surgery. Once recovery from surgery has started, then long-standing beliefs about appropriate
use of pain relief medications may take prominence. This alteration is related to views about pain due to
surgical intervention in contrast with interpretation of pain from living with long-term osteoarthritis.
Importantly, views about pain medication use are influenced by interactions with health-care professionals.
Rehabilitation
Interviews highlighted how patients value the offer of postoperative physiotherapy shortly after surgery as
well as longer-term follow-up in secondary care. The latter may be of particular value for those patients
who experience complications after surgery or who lack confidence in their prosthesis.
In our survey of physiotherapy provision at high-volume orthopaedic centres in England and Wales,
we found that physiotherapy following discharge after TKR was a more common practice than after THR.
For patients following TKR, the focus was on knee-specific strengthening, stretching and functional
exercises provided in a group setting.
In our systematic review and meta-analysis there was a suggestion that patients who received a
programme of post-discharge physiotherapy exercise after TKR achieved short-term improvements in
physical function and pain compared with controls (see Chapter 11).585 However, this was based on a small
number of studies with low numbers of patients randomised. There was no evidence, again from a few
small studies, for better longer-term recovery in patients receiving physiotherapy exercise. Regarding
provision at home, further research is needed to establish equivalence or additional benefit in comparison
with that provided in an outpatient setting.
In the ARENA study, we assessed the feasibility of a randomised trial to evaluate a 6-week individualised
and task-orientated exercise class. The inclusion of individualised exercises specific to each patient’s own
concerns aimed to increase self-efficacy and to empower patients to take an active role in their
rehabilitation. The group physiotherapy exercise class was generally well received and attendance and
satisfaction were high. The main reasons for non-participation in the study were travel related and the
inability to commit to the intervention. The ARENA study suggested that a fully powered RCT of
individualised and task-orientated exercises would be feasible in patients with TKR.
Potential value of a complex package of care
In the RESTORE programme we have identified key time points when specific interventions merit evaluation in
fully powered RCTs. Once there is evidence in place about the clinical effectiveness and cost-effectiveness of
specific interventions, their value may be greatest if implemented as a complex intervention.
In the care of older people, a complex intervention can be regarded as ‘a combination of interdisciplinary
teamwork for health and social problems’.634 According to the UK MRC framework, a complex intervention
has a number of interacting components, a number of behaviours and level of difficulty required by those
delivering or receiving the intervention, a number of groups or organisational levels targeted, and a number
and variability of outcomes.94 A degree of flexibility or tailoring of the intervention can be incorporated.
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Some published interventions have covered both the pre- and post-surgical rehabilitation periods.
For example, Gilbey and colleagues494 and Mitchell and colleagues520 demonstrated the feasibility of
physiotherapy exercise in total hip and knee replacement patients, respectively.
Our research suggests potential value for a number of components for incorporation in a complex intervention:
l pre-surgical education on the patient pathway, pain management, psychological counselling and advice
or interventions relating to maintenance or improvement of physical function
l pre-surgical health check to ensure appropriate management of health conditions
l occupational therapy provided before surgery at home visit
l evidence-based perioperative pain management
l post-discharge physiotherapy with a patient choice element.
For patients, interventions embedded within a care pathway might be more acceptable than those
provided exclusively before surgery when the perception is that little can be achieved, or after a care
pathway when, for the majority of patients, a degree of improved function and pain relief have been
achieved by the joint replacement itself.
Conclusions and recommendations
Future research is needed to develop consensus and standardisation on which pain domains should be
assessed after TKR. For assessment of functional outcomes, researchers should consider a patient-reported
outcome and a performance test.
Large-scale randomised evaluations in patients receiving total hip and knee replacements are feasible and
their value is recognised by patients and health-care professionals. Health-care professionals want
randomised trials to have minimal impact on daily clinical practice and patients want data collection and
participation to be as easy as possible.
Local anaesthetic infiltration as evaluated in the APEX RCT is effective in reducing the incidence of
long-term pain after THR and is also cost-effective. In TKR, there may be limited benefit for improved pain
control if a FNB has already been sited.
We have shown that a group-based activity-orientated physiotherapy intervention is both feasible and
acceptable to patients who have received a TKR. Further research is indicated to evaluate its clinical
effectiveness and cost-effectiveness in an appropriately powered randomised evaluation.
Future research should evaluate the clinical effectiveness and cost-effectiveness of providing aids, home
modifications and other aspects of occupational therapy to patients before their hospital admission for
THR. We have shown this to be both feasible and acceptable to patients. Background research is required
to support similar interventions in TKR.
Research should explore the possibility that optimising management of comorbid health conditions may
improve outcomes for patients with total hip and knee replacement. In the first instance, this will require
up-to-date systematic reviews of health management interventions and ultimately RCTs to evaluate the
clinical effectiveness and cost-effectiveness of optimising the treatment of comorbid conditions. Provision
of education, exercise and counselling before surgery may not be acceptable to a large proportion of
patients waiting for total hip or knee replacement.
Ultimately, the optimal care for patients receiving total hip and knee replacement may be a complex
intervention covering all stages of the patient pathway with the incorporation of patient choice and
individualisation of therapies.
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(see Item 16)]
Where appropriate
Discussion
Summary of
evidence
24 Summarise the main findings including the strength of
evidence for each main outcome; consider their
relevance to key groups (e.g. health-care providers,
users, and policy-makers)
All yes
Limitations 25 Discuss limitations at study and outcome level
(e.g. risk of bias), and at review-level (e.g. incomplete
retrieval of identified research, reporting bias)
All yes
Conclusions 26 Provide a general interpretation of the results in the
context of other evidence, and implications for future
research
All yes
Funding
Funding 27 Describe sources of funding for the systematic review
and other support (e.g. supply of data); role of
funders for the systematic review
As for the whole report
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Appendix 2 MOOSE checklist
Relating to Chapter 2
Recommendation Reported
Reporting of background should include
Problem definition All yes
Hypothesis statement Aim described for all
Description of study outcome(s) All yes
Type of exposure or intervention used All yes
Type of study designs used All yes
Study population All yes
Reporting of search strategy should include
Qualifications of searchers (e.g. librarians and investigators) In the context of the overall programme
Search strategy, including time period included in the synthesis
and keywords
Appendix 3
Effort to include all available studies, including contact with
authors
Where appropriate. We did not request new analyses
of longitudinal studies
Databases and registries searched All yes
Search software used, name and version, including special
features used (e.g. explosion)
All yes
Use of hand searching (e.g. reference lists of obtained articles) All yes
List of citations located and those excluded, including justification Reasons for exclusion summarised in Review flow
diagrams. Details of individual reasons for study
exclusion available from report authors
Method of addressing articles published in languages other than
English
Described in each review methods section
Method of handling abstracts and unpublished studies Generally excluded
Description of any contact with authors Authors of studies with appropriate data but with
specific missing information were contacted by e-mail
Reporting of methods should include
Description of relevance or appropriateness of studies assembled
for assessing the hypothesis to be tested
All yes
Rationale for the selection and coding of data (e.g. sound clinical
principles or convenience)
Where appropriate
Documentation of how data were classified and coded
(e.g. multiple raters, blinding, and interrater reliability)
Where appropriate
Assessment of confounding (e.g. comparability of cases and
controls in studies where appropriate)
Not relevant
Assessment of study quality, including blinding of quality
assessors; stratification or regression on possible predictors of
study results
Cohort generalisability
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Recommendation Reported
Assessment of heterogeneity In relation to methods of assessment
Description of statistical methods (eg, complete description of
fixed or random-effects models, justification of whether the
chosen models account for predictors of study results,
dose–response models, or cumulative meta-analysis) in sufficient
detail to be replicated
Where applicable described in methods sections
Provision of appropriate tables and graphics All yes
Reporting of results should include
Graphic summarising individual study estimates and overall
estimate
Where applicable included in results sections
Table giving descriptive information for each study included All yes
Results of sensitivity testing (eg, subgroup analysis) In narrative reviews considering different measures
Indication of statistical uncertainty of findings All yes
Reporting of discussion should include
Quantitative assessment of bias (e.g. publication bias) Risk of bias limited by strict inclusion criteria
Justification for exclusion (e.g. exclusion of non–English-language
citations)
As feasible in individual reviews
Assessment of quality of included studies If appropriate, good-quality studies identified
according to inclusion criteria
Reporting of conclusions should include
Consideration of alternative explanations for observed results All yes
Generalisation of the conclusions (i.e. appropriate for the data
presented and within the domain of the literature review)
All yes
Guidelines for future research All yes
Disclosure of funding source As for overall programme
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Appendix 3 Systematic review search strategies
as applied in MEDLINE via Ovid SP
Total hip or total knee replacement terms
1. Arthroplasty, Replacement, Knee/ or Arthroplasty, Replacement, Hip/
2. exp Arthroplasty, Replacement, Hip/ or exp Hip Prosthesis/ or hip replacement.mp.
3. exp Arthroplasty, Replacement, Knee/ or exp Knee Prosthesis/ or knee replacement.mp.
4. hip prosthesis.mp. or exp Hip Prosthesis/
5. knee prosthesis.mp. or exp Knee Prosthesis/
6. total hip.tw.
7. total knee.tw.
8. hip implant.mp.
9. knee implant.mp.
10. (knee$ adj5 (arthroplast$ or replacement$ or implant$ or prothes$)).mp.
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
Osteoarthritis
1. osteoarthriti$.mp. or Osteoarthritis, Hip/ or Osteoarthritis/ or Osteoarthritis, Knee/
Epidemiological study design
1. survey.mp. or exp Data Collection/
2. randomized controlled trial.mp. or exp Randomized Controlled Trials/
3. prospective study.mp. or exp Prospective Studies/
4. observational study.mp.
5. Comparative Study/
6. exp EPIDEMIOLOGY/ or epidemiology.mp.
7. longitudinal study.mp. or exp Longitudinal Studies/
8. case control study.mp. or exp Case-Control Studies/
9. evaluation study.mp. or exp Evaluation Studies/
10. follow up study.mp. or exp Follow-Up Studies/
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or10
Key patient-reported pain outcome measures
1. WOMAC.mp.
2. western ontario.mp.
3. american knee.mp.
4. aks.mp.
5. arthritis impact.mp.
6. oxford hip.mp.
7. oxford knee.mp.
8. hoos.mp.
9. koos.mp.
10. lequesne.mp.
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11. self appraisal.mp.
12. vas.mp.
13. visual analogue.mp.
14. osteoarthritis outcome score.mp.
15. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14
Chronic pain
1. exp Pain/ or exp Complex Regional Pain Syndromes/ or exp Pain Clinics/ or exp Pain, Postoperative/ or
exp Pain, Intractable/ or exp Pain Measurement/ or exp Patellofemoral Pain Syndrome/ or exp Pain,
Referred/ or pain.mp. or exp Pain Threshold/ or exp Pain Perception/
2. (pain adj5 (chronic or persistent or long-term)).mp.
3. analgesi$.mp.
4. ache$.mp.
5. discomfort$.mp.
6. outcome$.mp.
7. neuropath$.mp.
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
Patient-reported outcome measures (hip, knee,
osteoarthritis, generic)
1. Arthritis Impact Measurement Scale.tw.
2. “Quality of Life”/ or Sickness Impact Profile/ or Assessment of Quality of Life.mp.
3. Osteoarthritis Treatment Satisfaction Questionnaire.tw.
4. Euroqol.tw.
5. eq5d.mp.
6. eq-5d.mp.
7. (Hip and knee questionnaire).mp. [mp=title, abstract, subject headings, heading word, drug trade
name, original title, device manufacturer, drug manufacturer]
8. Health Status Questionnaire.mp.
9. (Knee Injury and Osteoarthritis Outcome Score).mp. [mp=title, abstract, subject headings, heading
word, drug trade name, original title, device manufacturer, drug manufacturer]
10. McMaster Toronto Arthritis Patient Preference Disability Questionnaire.mp.
11. McGill Pain.mp.
12. Patient-based Measure of the Severity of Osteoarthritis of the Knee.mp.
13. Nottingham health profile.mp.
14. Oxford knee score.mp.
15. Osteoarthritis Pain Assessment.mp.
16. Rand 36-Item.mp.
17. sf12.tw.
18. sf-12.tw.
19. MOS short.tw.
20. sf36.tw.
21. sf-36.tw.
22. Arthoplasty Outcome Evaluation Questionnaire.tw.
23. Visual analog.tw.
24. World Health Organization Quality of Life assessment instrument.tw.
25. (Western Ontario and McMaster Universities Arthritis Index).mp. [mp=title, abstract, subject headings,
heading word, drug trade name, original title, device manufacturer, drug manufacturer]
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26. Hip disability.mp. and Osteoarthritis Outcome Score.tw. [mp=title, abstract, subject headings, heading
word, drug trade name, original title, device manufacturer, drug manufacturer]
27. International Knee Documentation Committee Subjective Knee Form.tw.
28. bristol knee score.mp.
29. Short Musculoskeletal Function Assessment.tw.
30. Lequesne.mp.
31. New zealand score.mp.
32. modems.tw.
33. mood adjective.tw.
34. MACL.tw.
35. arthritis impact.tw.
36. KOOS.tw.
37. HOOS.tw.
38. osteoarthitis outcome score.tw.
39. mactar.tw.
40. NHP.tw.
41. Nottingham health.tw.
42. OHS.tw.
43. OKS.tw.
44. Oxford hip score.tw.
45. short form.tw.
46. vas.tw.
47. womac.mp.
48. western ontario.tw.
49. IKD.tw.
50. International knee.tw.
51. smfa.tw.
52. short musculoskeletal.tw.
53. satisfaction.tw.
54. function score.tw.
55. (activit$ adj8 daily living).tw.
56. ADL.tw.
57. QOL.tw.
58. likert.tw.
59. depression.tw.
60. anxiety.tw.
61. PROM.tw.
62. patient reported.tw.
63. visual analog$.tw.
64. expectation.mp. or EXPECTATION/
65. satisfaction.mp. or SATISFACTION/ or PATIENT SATISFACTION/
66. depressive symptoms.tw.
67. POSTOPERATIVE PAIN/
68. POSTOPERATIVE COMPLICATION/
69. psychological distress.tw.
70. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or
20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or
37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or
54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 69
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Pre-surgical exercise and education
1. exp preoperative care/
2. preoperative period.mp. or Preoperative Period/
3. pre-surg$.tw.
4. presurg$.tw.
5. before surg$.tw.
6. pre-operat$.tw.
7. preoperat$.tw.
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
Anaesthsia and analgesia in joint replacement
1. Anesthetics, Local/ or local anaesthetic.mp.
2. Anesthetics, Local/ or Anesthesia, Local/ or Local anaesthesia.mp.
3. Anesthetics/ or Anesthesia/ or anaesthesia.mp. or Anesthetics, Local/ or Anesthesia, Local/
4. anesthesia.mp.
5. anaesthetic.mp.
6. amides.mp. or Amides/
7. (“Huneke neural therapy” or “ Neural therapy of Huneke” or benzocaine or bensokain or “
Aminobenzoic Acid” or “ Aminobenzoate” or bupivacain* or buvacaina or sensorcaine or marcain* or
svedocain* or levobupivacaine or carticain* or articain* or dibucaine or cinchocaine or Cincain or
Nupercain* or Sovcaine or etidocaine or duranest or “ W19053” or “ W 19053” or “ W-19053” or
Lidocaine or Lignocaine or Octocaine or Xylesthesin or Xylocaine or Dalcaine or Xylocitin or Xyloneural
or Mepivacain* or Carbocaine or Polocaine or isocaine or isogaine or Scandicain* or prilocaine or
Propitocaine or Tetracaine or Tetrakain or Amethocaine or Dicaine or Pantocaine or Pontocaine or
Trimecaine or Mesocaine or ropivacaine).mp. [mp=title, abstract, original title, name of substance word,
subject heading word, protocol supplementary concept, rare disease supplementary concept,
unique identifier]
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
Perioperative wound infiltration
1. (incision or port* or (surg* and wound)).mp. [mp=title, abstract, original title, name of substance
word, subject heading word, protocol supplementary concept, rare disease supplementary concept,
unique identifier]
2. acetabular.mp.
3. infiltration.mp.
4. wound infiltration.mp.
5. wound catheter.mp.
6. peri-articular.mp.
7. periarticular.mp.
8. intraarticular.mp.
9. intra-articular.mp.
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
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Randomised controlled trial
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. randomly.ab.
6. trial.ab.
7. groups.ab.
8. (animals not (humans and animals)).sh.
9. 1 or 2 or 3 or 4 or 5 or 6 or 7
10. 9 not 8
Randomised controlled trial terms for physiotherapy
systematic review
1. Randomized Controlled Trials as Topic/
2. randomized controlled trial/
3. random allocation/
4. double blind method/
5. single blind method/
6. clinical trial/
7. clinical trial, phase i.pt.
8. clinical trial, phase ii.pt.
9. clinical trial, phase iii.pt.
10. clinical trial, phase iv.pt.
11. randomized controlled trial.pt.
12. multicenter study.pt.
13. clinical trial.pt.
14. exp clinical trials as topic/
15. (clinical adj trial$).tw.
16. ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw.
17. Placebos/
18. placebo$.tw.
19. randomly allocated.tw.
20. (allocated adj2 random$).tw.
21. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
or 20
Occupational therapy
1. occupational therapy.sh.
2. self help devices.sh.
3. splints.sh.
4. (occupational adj1 therap$).ti,ab.
5. splint$.ti,ab.
6. ((assist$ or help$) adj5 (device$ or technolog$)).ti,ab.
7. ((sel$ or home$) adj5 (care$ or manage$)).ti,ab.
8. ((environment$ or home$ or domestic$ or house$) adj5 adapt$).ti,ab.
9. ((daily or domestic$ or house$ or home$) adj5 (activit$ or task$ or skill$ or chore$)).ti,ab.
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
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Physiotherapy
1. physical therapy techniques/ or cryotherapy/ or electric stimulation therapy/ or transcutaneous electric
nerve stimulation/ or hydrotherapy/
2. exercise movement techniques/ or exercise/ or exercise therapy/ or walking/
3. rehabilitation/ or “activities of daily living”/ or early ambulation/
4. Postoperative Care/
5. Ambulatory Care/
6. Rehabilitation Centers/
7. Home Care Services/
8. (physiotherap$ or physio therap$ or pt).mp. [mp=title, original title, abstract, name of substance word,
subject heading word, unique identifier]
9. therap$.mp. [mp=title, original title, abstract, name of substance word, subject heading word,
unique identifier]
10. rehab$.mp. [mp=title, original title, abstract, name of substance word, subject heading word,
unique identifier]
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
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Appendix 4 Systematic review of long-term pain
after hip or knee replacement: study characteristics
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Appendix 5 Systematic review of pre-operative
predictors of patient-centred outcomes after total hip
replacement: study characteristics
Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis Predictor
Outcome
measures
Registry
Rolfson and
colleagues 2009;125
Sweden; 2002–5
n=6, 158 (approximately
92% of eligible); 12 months,
estimated 8% not
followed up
ANCOVA with EQ-5D anxiety
and depression, age, sex,
comorbidities, VAS pain, EQ-5D
Mental health VAS pain,
satisfaction,
EQ-5D
domains
Multiple centres
Hajat and
colleagues 2002;126
UK; 1996–7
n= 3600 (4657 eligible);
12 months, 22.7% not
followed up
Multiple regression analysis with
OHS, waiting time, comorbidities,
age, sex, housing, surgical factors
Physical function OHS
Jones and
colleagues 2012;127
Canada; 1995–7
n= approximately 167
(231 eligible); 3 years,
28% not followed up
Linear mixed model with BMI
(< 25, 25–29.9, 30–34.9,
≥ 35 kg/m2), age, sex, diabetes
and cardiac disease
BMI WOMAC
Judge and
colleagues 2011;31
Europe; dates not
specified
n= 845 (1327 eligible);
12-month follow-up,
36.3% with no baseline or
follow-up data
Ordered logistic regression
modelling with WOMAC score,
EQ-5D, age, sex, BMI, education,
living arrangements, ambulatory
status, comorbidities and
radiographic status
Physical function WOMAC
Judge and
colleagues 2013;128
UK; 1999–2002
n= 1375 patients with 1431
THR at baseline; 60 months,
20% lost to 1-year follow-
up, 30% lost to 5-year
follow-up
Repeated measures linear
regression with BMI as a
continuous variable, age, sex,
primary diagnosis, occupation,
specific comorbidities, SF-36,
OHS, ROM, surgical variables
BMI, mental
health physical
function
OHS
Stevens and
colleagues 2012;129
Netherlands;
2005–7
n= 653 (848 eligible);
12 months, 23% lost to
follow-up
Linear regression (structural
equation model) with BMI (< 25,
25–30, > 30 kg/m2), age, sex,
comorbidities and complications
BMI WOMAC,
SF-36
Single centre
Anakwe and
colleagues 2011;130
UK; 2003–8
Osteoarthritis estimated
98%; n= 850 (907 eligible);
12 months, 6.3% not
followed up
Multivariate binary logistic
regression with SF-12 mental
health component, diabetes,
hypertension, history of
depression, age, sex, SF-12
physical components, OHS,
musculoskeletal comorbidities
Mental health,
physical function
Satisfaction
Clement and
colleagues 2011;131
UK; 2006–8
Osteoarthritis; n= 1312
patients with 1359 THR
followed up; 12 months,
no loss to follow-up
information
Ordinal logistic regression with
SF-12 mental health, age,
deprivation, Charlson
comorbidities including
depression, OHS, length of stay
and SF-12 physical health
Mental health,
physical function
OHS
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Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis Predictor
Outcome
measures
Davis and
colleagues 2011;132
UK; 1998–2005
n= 1095 (1617 at baseline);
60 months, 32% not
followed up
Multiple regression linear
analysis with BMI (< 25,
25–29.9, 30–34.9, ≥ 35 kg/m2),
age, sex, pre-operative HHS,
SF-36, comorbidities, consultant
BMI SF-36
Gandhi and
colleagues 2010;133
Canada;
1998–2005
n= 636 with pre- and
postoperative data;
12 months and up to 72
months (mean 39 months),
loss to follow-up not
described
Multivariable longitudinal
regression with BMI as a
continuous variable, age, sex,
comorbidities, WOMAC, SF-36
BMI, mental
health
WOMAC,
SF-36
physical
function
Garbuz and
colleagues 2006;134
also Xu and
colleagues 2005;136
Canada; 2001–3
n= 147 (total 201 eligible);
12 months, 27% lost to
follow-up
Log-linear regression with
WOMAC pain, age, sex and
comorbidities
Pain, physical
function
WOMAC
pain
Moran and
colleagues 2005;135
UK; 1998–2000
n= 687 (800 eligible);
minimum 18 months,
14% lost to follow-up
Multiple linear regression
analysis with BMI as a
continuous variable, sex,
comorbidities, OHS, SF-36
BMI SF-36
Nilsdotter and
colleagues 2003;103
Sweden; 1995–8
n= 198 (total 219
recruited); 12 month and at
mean 43-month follow-up,
6% lost to follow-up
Stepwise multivariate logistic
regression with BMI as a
continuous variable, age, sex,
comorbidity, WOMAC, SF-36
(including mental health),
employment, marital status,
contralateral osteoarthritis, need
of walking assistance, walking
distance, analgesic use, regional
or widespread pain
BMI, mental
health, pain
WOMAC
function
Singh and
Lewallen 2010;104
USA; 1993–2005
n= 5707 (9154 at baseline);
24 months (and longer),
38% of patients not
followed up at 2 years
Multivariable-adjusted logistic
regression analyses with BMI
(< 25, 25–29.9, 30–34.9,
35–39.9, ≥ 40 kg/m2), age, sex,
Deyo-Charlson, ASA, depression,
anxiety, operative diagnosis,
distance from centre and implant
design
BMI, mental
health
Pain (5-item
response
scale)
ANCOVA, analysis of covariance; ASA, American Society of Anesthesiologists.
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Appendix 6 Systematic review of pre-operative
predictors of patient-centred outcomes after total
knee replacement: study characteristics
Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis
Outcome
measures
Registry
Baker and
colleagues 2012;148
UK; 2008–11
n= 22,691 (40,925
eligible); minimum
6-month follow-up,
44.6% not followed up
Stepwise multiple regression
analysis with EQ-5D depression
and anxiety, age, OKS, EQ-5D,
comorbidities, disability, general
health, ASA grade, and surgical
and hospital variables
Mental health OKS, EQ-5D
Franklin and
colleagues 2008;147
USA; 2000–5
n= 8050 (17,270 eligible);
follow-up at 12 months,
53.4% not followed up
Multivariate mixture models
with BMI analysed as < 30,
30–40, > 40 kg/m2, sex, age,
SF-12 MCS and PCS,
osteoarthritis diagnosis and poor
quadriceps strength
BMI, mental
health
SF-12 PCS
Multiple centres
Alzahrani and
colleagues 2011;149
Canada;
1998–2007
n= 3,177; follow-up at
12 months, losses to
follow-up not described
Multivariable logistic regression
modelling with BMI analysed as
a continuous variable, age, sex
and comorbidities
BMI OKS (2720
patients), total
WOMAC
(457 patients)
Cushnaghan and
colleagues 2009;151
UK; 1995–7
n= 259 (657 eligible but
not all had TKR); mean
follow-up of 6 years,
approximately 60.6% not
followed up
Linear regression with BMI
analysed as < 25, 25 to < 30,
≥ 30 kg/m2, age, sex, SF-36 PCS,
smoking habits, comorbidities,
Kellgren and Lawrence grade,
previous knee injury, other
painful joints and Heberden’s
nodes
BMI SF-36 PCS
Heck and
colleagues 1998;157
USA; 1992–3
n= 268 (291 eligible);
24-month follow-up,
7.9% not followed up
Stepwise logistic regression
model with SF-36 mental
health, age, ethnicity, sex,
poverty, patient health status,
WOMAC scales, SF-36, knee
ROM, comorbidities, surgical
factors and joint problems in the
other knee
Mental
health, pain,
physical
function
SF-36 physical
component
Jones and
colleagues 2012;127
Canada; 1995–7
n= approximately 209
(289 eligible); follow-up at
3 years, approximately
27.7% not followed up
Linear mixed modelling with
BMI analysed as binary variable
(30–34.9 and ≥ 35 kg/m2), age,
sex and comorbidities
BMI WOMAC
Lingard and
colleagues 2004;46
UK, USA, Australia;
1997–8
n= 741 at 1 year, 678 at
2 years (860 eligible);
follow-up at 12 and
24 months, 13.8% and
21.2% lost to follow-up at
12 and 24 months
Hierarchical model with BMI
analysed as a continuous
variable, age, sex, PROMs score,
mental health, knee flexion,
working status, education,
income, comorbidities and
country
BMI, pain,
physical
function
WOMAC pain
and function,
SF-36 PCS
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Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis
Outcome
measures
Lingard and
colleagues 2007;150
also Lingard and
colleagues 2004;46
UK, USA, Australia;
1997–8
n= 682 (974 eligible);
follow-up at 12 and
24 months, 30.0% not
followed up at 2 years
General linear model with SF-36
mental distress, age, sex, and
comorbidities
Mental health WOMAC pain
and function
scores
Merle-Vincent and
colleagues 2011;158
France; dates not
specified
n= 264 (299 eligible);
24-month follow-up,
13.3% not followed up
Multivariate logistic regression
with feelings of depression, age,
sex, BMI, Lequesne index and
joint space narrowing
Mental health Satisfaction
Naylor and
colleagues 2012;154
Australia; 2008–9
n= 146 (191 eligible);
follow-up at 12 months,
23.6% not followed up
Mixed model with BMI analysed
as continuous variable, age and
sex as covariates. Performed
separately for pre-operative
flexion and extension variables
BMI OKS
Papakostidou and
colleagues 2012;155
Greece; dates not
specified
n= 204 (224 eligible);
follow-up at 12 months,
9.8% not followed up
General linear model
multivariable analysis with BMI
analysed as binary variable
(under and over 30 kg/m2), sex,
education, social support, age,
place of residence, baseline
status of knee
BMI, mental
health, pain
WOMAC
Perruccio and
colleagues 2012;152
Canada; 2006–8
n= 435 (494 eligible);
mean follow-up at
12.5 months, 11.9% not
followed up
Linear regression with BMI
analysed as 25–29 kg/m2
(overweight) and > 30 kg/m2
(obese), age, sex, education,
comorbidity count, other painful
joints and pain/function
BMI WOMAC
Singh and
Lewallen 2013;156
USA; 1993–2005
n= 7139 (approximately
10,980 eligible); follow-up
at 2 and 5 years, 35% and
43% lost to follow-up,
respectively
Multivariable adjusted model
with age, sex, BMI, ASA class,
distance from medical centre,
operative diagnosis, implant
fixation (cement status), six
Deyo-Charlson comorbidity
categories, anxiety and
depression
Mental health Pain severity
questionnaire
Sullivan and
colleagues 2011;153
Canada; dates not
specified
n= 120 (number eligible
not specified); follow-up
at 12 months, loss to
follow-up not described
Multiple regression with BMI
analysed as continuous variable,
pain, function, age, sex,
comorbidities, surgery duration,
surgeon, pain catastrophising,
pain-related fear of movement
and depression
BMI, pain WOMAC
function and
pain
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Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis
Outcome
measures
Single centre
Ayers and
colleagues 2005;163
USA; dates not
specified
n= 165 (number eligible
not specified); 12 months,
loss to follow-up not
described
Blocked multiple regression
analysis with SF-36 mental
health, age, sex, comorbidities,
SF-36 physical component and
WOMAC physical function
Mental health,
physical
function
WOMAC
physical
function, SF-36
physical
component
Brander and
colleagues 2003;50
USA; 1998–2000
n= 116 consecutive
patients with 149 TKRs (no
information on eligibility);
follow-up at 12 months, no
information on losses to
follow-up
Multiple regression analysis with
anxiety (STAI) and depression
(Beck Depression Inventory),
age, sex, BMI, physiologic,
psychometric and heightened
pain
Mental health Pain VAS and
McGill
questionnaire-SF
scores
Clement and
colleagues 2013;164
UK; 2007–9
n= 966 (number eligible
not specified); 12-month
follow-up, losses to
follow-up not described
Multivariate linear and bivariate
regression analyses with SF-36
mental health component,
age, sex, comorbidities,
socioeconomic deprivation, OKS
and SF-12 physical component
Mental health,
physical
function
OKS,
satisfaction
Deshmukh and
colleagues 2002;161
UK; 1992–5
n= 139 (180 eligible);
follow-up at 12 months,
22.8% not followed up
Hierarchical multiple regression
analysis with BMI analysed as
continuous variable, age, sex,
side of arthritis, comorbidities,
NHP and AKSS scores
BMI NHP
Gandhi and
colleagues 2010;160
Gandhi and
colleagues 2010;166
Canada;
1998–2005
n= 551 (number eligible
not specified); mean
follow-up 3 years, loss to
follow-up not described
Multivariable longitudinal
regression model with BMI
analysed as continuous variable,
age, sex, ethnicity, education,
comorbidities and SF-36 mental
health
BMI, mental
health
Total WOMAC
score, SF-36
Role Physical,
SF-36 Physical
Function
Núñez; and
colleagues 2009;159
Spain; 2000
n= 112 (146 eligible);
follow-up at 7 years,
23.3% not followed up
Explanatory multiple linear
regression models with BMI
analysed as a binary variable
(< 35 and ≥ 35 kg/m2), age,
sex, comorbidities,
sociodemographic and clinical
characteristics, intraoperative
variables, inpatient variables,
postoperative clinical variables
and pre-operative WOMAC
scores
BMI WOMAC
function and
pain
Rajgopal and
colleagues 2008;162
Canada;
1987–2004
n= 550 (number eligible
not specified); follow-up at
1 year, loss to follow-up
not described
Linear regression model with
BMI analysed as binary variable
(< 40 or ≥ 40 kg/m2), age, sex,
mental health, prior
contralateral TKR, WOMAC
score and presence of
comorbidity affecting gait
BMI WOMAC
Scott and
colleagues 2010;165
UK; 2006–8
n= 1141 (1290 eligible);
12 months, 13.1% not
followed up
Multiple ordinal logistic
regression with depression,
SF-12 MCS, age, sex, SF-12
PCS, OKS and comorbidities
Mental
health, pain,
physical
function
Satisfaction
ASA, American Society of Anesthesiologists; MCS, mental component score.
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Appendix 7 Systematic review of comorbid
conditions and long-term patient-centred outcomes
after total hip replacement: study characteristics
Study; country; dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis Comorbidity
Outcome
measures
Multiple centres
Cushnaghan and
colleagues 2007;184
Judge and colleagues
2012;185 UK; 1993–5;
two health districts
Osteoarthritis; n= 249
(643 eligible); mean
follow-up approximately
96 months, 49.9% not
followed up
Logistic regression modelling;
diabetes, hypertension, thyroid
disease, age, sex, BMI, smoking
habit, previous knee injury,
Heberden’s nodes, number of
painful joints and radiographic
grade
Hypertension SF-36 PCS
Jones and colleagues
2012;127 Canada;
1995–7
n= approximately 167
(231 eligible); 3 years,
28% not followed up
Linear mixed modelling;
comorbidity including diabetes
and cardiac disease, age, sex,
BMI, education, principal
diagnosis, living arrangements,
type of living accommodation,
previous joint surgery,
ambulatory status and number
of comorbid conditions
Diabetes,
cardiovascular
disease
WOMAC
function
and pain
Judge and colleagues
2012;185 Cushnaghan
and colleagues 2007;184
UK; 1993–5
Osteoarthritis; n= 249
(643 eligible); mean
follow-up approximately
96 months, 49.9% not
followed up
Logistic regression modelling;
diabetes, hypertension, thyroid
disease, age, sex, BMI, smoking
habit, previous knee injury,
Heberden’s nodes, number of
painful joints and radiographic
grade
Diabetes,
thyroid disease
SF-36
Single centre
Anakwe and colleagues
2011;130 UK; 2003–8
Osteoarthritis estimated
98%; n= 850 (907
eligible); 12 months,
6.3% not followed up
Multivariate binary logistic
regression; diabetes,
hypertension, history of
depression, age, sex, SF-12
physical and mental
components, OHS and
musculoskeletal comorbidities
Diabetes,
hypertension
Satisfaction
Gandhi and colleagues
2010;166 Canada;
1998–2006
Osteoarthritis; n= 707
(approximately 850
eligible); 12 months,
16.7% not followed up
Linear regression; number of
metabolic syndrome factors
(BMI of > 30 kg/m2, diabetes,
hypertension and
hypercholesterolaemia), age,
sex, BMI, WOMAC and
Cumulative Illness Rating Scale
Diabetes,
hypertension
WOMAC
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Appendix 8 Systematic review of comorbid
conditions and long-term patient-centred outcomes
after total knee replacement: study characteristics
Study; country;
dates
Number of patients;
follow-up
Statistical analysis and
variables in analysis Comorbidity
Outcome
measures
Multiple centres
Cushnaghan and
colleagues 2009;151
UK; 1995–7
n= 259 (657 eligible but
not all had TKR); mean
follow-up of 6 years,
approximately 60.6% not
followed up
Linear regression; diabetes,
hypertension, thyroid disease,
age, sex, BMI, smoking habit,
previous knee injury, Heberden’s
nodes, number of painful joints,
and radiographic grade
Diabetes,
hypertension,
thyroid disease
SF-36 physical
function
Jones and
colleagues 2012;127
Canada; 1995–7
n= approximately 209
(289 eligible); follow-up
at 3 years, approximately
27.7% not followed up
Linear mixed modelling;
comorbidity including cardiac
disease and diabetes, age, sex,
BMI, education, principal
diagnosis, living arrangements,
type of living accommodation,
previous joint surgery,
ambulatory status and number
of comorbid conditions
Diabetes,
cardiovascular
disease
WOMAC
Single centre
Ayers and
colleagues 2005;163
USA; not specified
n= 165 (number eligible
not specified); 12 months,
loss to follow-up not
described
Blocked multiple regression
analyses with cardiovascular
disease, pulmonary disease,
lower extremity (non-arthritis),
rheumatoid, endocrine disease,
age, sex, SF-36 physical and
mental health, components and
WOMAC physical component
Diabetes,
cardiovascular
disease
WOMAC
function, SF-36
physical
component
Clement and
colleagues 2013;164
UK; 2007–9
n= 966 (number eligible
not specified); 12-month
follow-up, losses to
follow-up not described
Multivariate linear and bivariate
regression analyses with
SF-36 mental health component,
age, sex, comorbidities,
socioeconomic deprivation, OKS
and SF-12 physical component
Diabetes,
cardiovascular
disease,
hypertension,
anaemia
OKS Satisfaction
Gandhi and
colleagues 2010;166
Canada;
1998–2006
n= 889 (approximately
1067 eligible);
12 months, 16.7% not
followed up
Linear regression; number of
metabolic syndrome risk
factors (BMI of > 30 kg/m2;
diabetes, hypertension and
hypercholesterolaemia), age, sex,
BMI, WOMAC and Cumulative
Illness Rating Scale
Diabetes,
hypertension
WOMAC
Scott and
colleagues 2010;165
UK; 2006–8
n= 1141 (1,290 eligible);
12 months, 13.1% not
followed up
Multiple ordinal logistic
regression; heart disease,
hypertension, lung disease,
vascular disease, neurological
problems, diabetes, stomach
ulcer kidney disease, liver
disease, anaemia and depression
Diabetes,
cardiovascular
disease,
hypertension
Satisfaction
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Appendix 9 Local anaesthetic infiltration in total
knee and hip replacement: Cochrane risk-of-bias table
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Appendix 10 CONSORT 2010 checklist of
information for APEX randomised controlled trial
Section/topic Item Checklist item Reported
Title and abstract
1a Identification as a randomised trial in the title Yes
1b Structured summary of trial design, methods, results, and
conclusions (for specific guidance see CONSORT for abstracts)
Yes
Introduction
Background and objectives 2a Scientific background and explanation of rationale Yes
2b Specific objectives or hypotheses Yes
Methods
Trial design 3a Description of trial design (such as parallel, factorial) including
allocation ratio
Yes
3b Important changes to methods after trial commencement (such as
eligibility criteria), with reasons
N/A
Participants 4a Eligibility criteria for participants Yes
4b Settings and locations where the data were collected Yes
Interventions 5 The interventions for each group with sufficient details to allow
replication, including how and when they were actually
administered
Yes
Outcomes 6a Completely defined pre-specified primary and secondary outcome
measures, including how and when they were assessed
Yes
6b Any changes to trial outcomes after the trial commenced, with
reasons
Statistical
analysis as
described
Sample size 7a How sample size was determined Yes
7b When applicable, explanation of any interim analyses and
stopping guidelines
N/A
Randomisation: Yes
Sequence generation 8a Method used to generate the random allocation sequence Yes
8b Type of randomisation; details of any restriction (such as blocking
and block size)
Yes
Allocation concealment
mechanism
9 Mechanism used to implement the random allocation sequence
(such as sequentially numbered containers), describing any steps
taken to conceal the sequence until interventions were assigned
Yes
Implementation 10 Who generated the random allocation sequence, who enrolled
participants, and who assigned participants to interventions
Yes
Blinding 11a If done, who was blinded after assignment to interventions (for
example, participants, care providers, those assessing outcomes)
and how
Yes
11b If relevant, description of the similarity of interventions N/A
Statistical methods 12a Statistical methods used to compare groups for primary and
secondary outcomes
Yes
12b Methods for additional analyses, such as subgroup analyses and
adjusted analyses
Yes
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
425
Section/topic Item Checklist item Reported
Results
Participant flow
(a diagram is strongly
recommended)
13a For each group, the numbers of participants who were randomly
assigned, received intended treatment, and were analysed for the
primary outcome
Yes
13b For each group, losses and exclusions after randomisation,
together with reasons
Yes
Recruitment 14a Dates defining the periods of recruitment and follow-up Yes
14b Why the trial ended or was stopped N/A
Baseline data 15 A table showing baseline demographic and clinical characteristics
for each group
Yes
Numbers analysed 16 For each group, number of participants (denominator) included in
each analysis and whether the analysis was by original assigned
groups
Yes
Outcomes and estimation 17a For each primary and secondary outcome, results for each group,
and the estimated effect size and its precision (such as 95% CI)
Yes
17b For binary outcomes, presentation of both absolute and relative
effect sizes is recommended
N/A
Ancillary analyses 18 Results of any other analyses performed, including subgroup
analyses and adjusted analyses, distinguishing pre-specified from
exploratory
Yes
Harms 19 All important harms or unintended effects in each group (for
specific guidance see CONSORT for harms)
Yes
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision,
and, if relevant, multiplicity of analyses
Yes
Generalisability 21 Generalisability (external validity, applicability) of the trial findings Yes
Interpretation 22 Interpretation consistent with results, balancing benefits and
harms, and considering other relevant evidence
Yes
Other information
Registration 23 Registration number and name of trial registry Yes
Protocol 24 Where the full trial protocol can be accessed, if available Yes
Funding 25 Sources of funding and other support (such as supply of drugs),
role of funders
Yes
N/A, not applicable.
APPENDIX 10
NIHR Journals Library www.journalslibrary.nihr.ac.uk
426
Appendix 11 Pain on admission to the recovery
ward, on discharge from the recovery ward and
during the day of surgery for the APEX THR and
TKR trial
Pain outcome
Hips Knees
Intervention,
(N= 163),
n (%)
Standard care,
(N= 159),
n (%) p-valuesa,b
Intervention,
(N= 157),
n (%)
Standard care,
(N= 159),
n (%) p-valuesa,b
Pain on admission to the recovery ward 0.169 0.062
No pain 115 (70.6) 111 (69.8) 108 (68.8) 86 (54.1)
Mild pain 9 (5.5) 3 (1.9) 7 (4.5) 11 (6.9)
Moderate pain 4 (2.5) 10 (6.3) 8 (5.1) 16 (10.1)
Severe pain 4 (2.5) 2 (1.3) 12 (7.6) 18 (11.3)
Missing 31 (19) 33 (20.8) 22 (14) 28 (17.6)
Pain on discharge from the recovery ward 0.759 0.097
No pain 92 (56.4) 87 (54.7) 93 (59.2) 78 (49.1)
Mild pain 29 (17.8) 25 (15.7) 34 (21.7) 31 (19.5)
Moderate pain 4 (2.5) 6 (3.8) 6 (3.8) 13 (8.2)
Severe pain 0 (0) 0 (0) 1 (0.6) 5 (3.1)
Missing 38 (23.3) 41 (25.8) 23 (14.6) 32 (20.1)
Pain during day of surgery 0.515 0.325
No pain 26 (16) 28 (17.6) 37 (23.6) 30 (18.9)
Mild pain 65 (39.9) 51 (32.1) 41 (26.1) 36 (22.6)
Moderate pain 44 (27) 43 (27) 44 (28) 61 (38.4)
Severe pain 8 (4.9) 11 (6.9) 14 (8.9) 16 (10.1)
Missing 20 (12.3) 26 (16.4) 21 (13.4) 16 (10.1)
a Between-arms comparisons were only conducted in the complete cases.
b Chi-squared test or Fisher-exact test.
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Appendix 12 Length of stay for the APEX THR
and TKR trial
Length of
hospital stay
Hips Knees
Intervention,
(n= 163)
Standard care,
(n= 159) p-value1,2a,b
Intervention,
(n= 157)
Standard care,
(n= 159) p-value1,2a,b
Median days
(25th, 75th)
4 (4, 5) 5 (4, 6) 0.2476 4 (4, 6) 5 (4, 6) 0.5864
Missing, n (%) 10 (6.1) 8 (5.0) 14 (8.9) 12 (7.6)
a Between-arms comparisons were only conducted in the complete cases.
b Wilcoxon–Mann–Whitney test.
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Appendix 13 Postoperative inpatient pain scores
for the APEX THR and TKR trial
Postoperative
day Pain outcome
Hips Knees
Intervention,
(n= 163)
Standard care,
(n= 159)
Intervention,
(n= 157)
Standard care,
(n= 159)
Pain at night
Day 1 Median (IQRa) 35 (50) 36 (45) 48 (55) 42 (55)
Missing number (%) 17 (10.4) 12 (7.5) 28 (17.8) 18 (11.3)
Day 2 Median (IQRa) 12 (22) 23 (33) 45 (55) 39 (49)
Missing number (%) 18 (11.0) 13 (8.2) 23 (14.7) 15 (9.4)
Day 3 Median (IQRa) 8 (20) 11 (28) 24 (37) 32 (47)
Missing number (%)b 22 (14.2) 17 (11.1) 29 (18.8) 25 (16.0)
Pain at rest
Day 1 Median (IQRa) 23 (28) 26 (30) 37 (34) 44 (32)
Missing number (%) 16 (9.8) 10 (6.3) 26 (16.7) 17 (10.7)
Day 2 Median (IQRa) 12 (26) 16 (24) 35 (53) 35 (37)
Missing number (%) 17 (10.4) 13 (8.2) 22 (14.0) 15 (9.4)
Day 3 Median (IQRa) 7 (18) 13 (18) 21 (28) 21 (36)
Missing number (%)b 23 (14.8) 17 (11.1) 29 (18.8) 25 (16.0)
Pain on movement
Day 1 Median (IQRa) 52 (34) 56 (37) 58 (37) 62 (26)
Missing number (%) 16 (9.8) 10 (6.3) 26 (16.6) 17 (10.7)
Day 2 Median (IQRa) 39 (41) 42 (40) 56 (37) 57 (36)
Missing number (%) 18 (11.0) 13 (8.2) 22 (14.0) 15 (9.4)
Day 3 Median (IQRa) 28 (44) 32 (37) 42 (39) 46 (40)
Missing number (%)b 23 (14.8) 17 (11.1) 29 (18.8) 25 (16.0)
a The IQR is the difference between the 25th and 75th quintiles.
b Percentage derived from the patients still hospitalised. In the THR trial, eight patients (4.9%) had been discharged in the
intervention group and six (3.8%) in the standard care group. In the TKR trial, three patients (1.9%) had been
discharged in the intervention group and three (1.9%) in the standard care group.
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Appendix 14 Drugs and side effects during
recovery for the APEX THR and TKR trial
Drugs and side effects
Hips Knees
Intervention,
(n= 163)
Standard
care,
(n= 159) p-valuea,b
Intervention,
(n= 157)
Standard
care,
(n= 159) p-valuea,b
Drugs
Drugs
administered
Number (%) 109 (66.9) 100 (62.9) 0.176 98 (62.4) 118 (74.2) 0.010
Missing Number (%) 11 (6.8) 4 (2.5) 12 (7.6) 13 (8.2)
Strong opioids
(units)
Median (IQR) 3 (8) 4.5 (9) 0.4503 3 (6) 3 (15) 0.441c
Side effects
Nausea and
vomiting
Number (%) 80 (49.1) 88 (55.4) 0.429 79 (50.3) 87 (54.7) 0.417
Missing
number (%)
10 (6.1) 4 (2.5) 12 (7.6) 12 (7.6)
Antiemetics Number (%) 19 (11.7) 20 (12.6) 0.916 16 (10.2) 21 (13.2) 0.391
Missing
number (%)
10 (6.1) 4 (2.5) 12 (7.6) 13 (8.2)
Repeat femoral
block
Number (%) 0 (0.0) 0 (0.0) N/A 2 (1.3) 3 (1.9) 0.909
Missing
number (%)
10 (6.1) 4 (2.5) 12 (7.6) 12 (7.6)
Sign of toxicity Number (%) 1 (0.6) 0 (0.0) 0.497 1 (0.6) 0 (0.0) 0.313
Missing
number (%)
10 (6.1) 4 (2.5) 12 (7.6) 12 (7.6)
N/A, not applicable.
a Between-arms comparisons were only conducted in the complete cases.
b Chi-squared test or Fisher-exact test.
c Wilcoxon–Mann–Whitney test.
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Appendix 15 Prevalence of vomiting, nausea and
analgesia intake during the first 48 hours after
recovery for the APEX THR and TKR trial
Opioid intake, vomiting and
nausea
Hips Knees
Intervention
(n= 163)
Standard
care
(n= 159) p-valuea,b
Intervention
(n= 157)
Standard
care
(n= 159) p-valuea,b
Opioid intake
Strongc Median (IQR) 97 (88) 101 (105) 0.381d 120 (99) 130 (115) 0.324d
Missing number (%) 10 (6.1) 12 (7.6) 13 (8.3) 13 (8.2)
Weakc Median (IQR) 0 (0) 0 (0) 0.625d 0 (0) 0 (0) 0.433d
Missing number (%) 10 (6.1) 12 (7.6) 13 (8.3) 13 (8.2)
Vomiting
Day 1 Number (%) 47 (33.3) 51 (35.4) 0.711 32 (26.0) 51 (39.2) 0.025
Missing number (%) 22 (13.5) 15 (9.4) 34 (21.7) 29 (18.2)
Day 2 Number (%) 28 (17.2) 33 (20.8) 0.392 19 (15.1) 29 (20.4) 0.255
Missing number (%) 24 (14.7) 24 (15.1) 31 (19.8) 17 (10.7)
Day 3 Number (%) 10 (8.9) 10 (8.3) 0.888 9 (8.0) 14 (12.6) 0.261
Missing number (%) 42 (27.1) 33 (21.6) 45 (28.7) 48 (30.2)
Nausea
Day 1 Number (%) 71 (50.4) 100 (69.4) 0.001 58 (47.5) 85 (64.9) 0.005
Missing number (%) 15 (9.4) 22 (13.5) 35 (22.3) 28 (17.6)
Day 2 Number (%) 67 (48.6) 77 (56.6) 0.181 52 (41.6) 72 (51.1) 0.123
Missing number (%) 25 (15.3) 23 (14.5) 32 (20.4) 18 (11.3)
Day 3 Number (%) 38 (33.6) 46 (38.3) 0.455 36 (32.1) 44 (39.6) 0.243
Missing number (%) 42 (27.1) 33 (21.6) 45 (28.7) 48 (30.2)
a Between-arms comparisons were only conducted in the complete-cases.
b Chi-squared test or Fisher-exact test.
c In oral morphine equivalent (mg).
d Wilcoxon–Mann–Whitney test.
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Appendix 16 Intention-to-treat and per-protocol
analysesa of the effect of the intervention on pain
(WOMAC) at 3 and 6 months after surgery for the
APEX THR and TKR trial
Analysis model
ITT-CC ITT-imputed PP
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Hips
3 months
Unadjusted 2.92
(–1.12 to 6.97)
0.156 3.38
(–0.76 to 7.53)
0.110 2.78
(–1.40 to 6.97)
0.192
Adjusted 1.71
(–2.32 to 5.74)
0.405 2.05
(–2.00 to 6.10)
0.321 1.49
(–2.57 to 5.56)
0.472
6 months
Unadjusted 1.87
(–2.15 to 5.88)
0.362 2.84
(–1.00 to 6.67)
0.147 1.25
(–2.91 to 5.40)
0.556
Adjusted 0.61
(–3.31 to 4.53)
0.761 1.51
(–2.24 to 5.26)
0.431 –0.08
(–4.13 to 3.97)
0.968
Knees
3 months
Unadjusted –0.52
(–4.85 to 3.79)
0.813 –0.80
(–5.12 to 3.52)
0.716 –0.26
(–4.72 to 4.20)
0.91
Adjusted –0.32
(–4.52 to 3.88)
0.881 –0.42
(–4.62 to 3.79)
0.846 –0.26
(–4.61 to 4.09)
0.907
6 months
Unadjusted 4.10
(–0.22 to 8.43)
0.063 4.37
(0.11 to 8.63)
0.044 4.34
(–0.15 to 8.83)
0.058
Adjusted 4.26
(0.04 to 8.48)
0.048 4.75
(0.61 to 8.90)
0.025 4.30
(–0.08 to 8.68)
0.055
a Baseline model.
Linear mixed regression adjusted for baseline pain score, surgical approach and measurement times. Interaction terms used
between time and intervention effect to assess 3- and 6-months effects.
Adjusted model
Hip: baseline model+ adjustments for sex, living arrangement and number of comorbidities.
Knee: baseline model+ adjustments for working status, number of comorbidities, depression and anxiety.
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Appendix 17 Intention-to-treat and per-protocol
analysesa of the effect of the intervention on pain
(WOMAC) at 3 and 6 months after surgery for the
APEX THR trial
Analysis model
ITT-CC ITT-imputed PP
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
3 months post operation
(Moderate, mild or none) vs. reference= (severe)
Baseline 2.36 (0.54 to 10.37) 0.255 2.67 (0.60 to 11.92) 0.198 2.47 (0.52 to 11.78) 0.257
Adjusted 1.86 (0.43 to 8.00) 0.406 2.01 (0.46 to 8.81) 0.357 1.88 (0.41 to 8.74) 0.418
(Mild or none) vs. reference= (severe or moderate)
Baseline 2.63 (0.95 to 7.29) 0.064 2.85 (1.02 to 7.94) 0.045 2.72 (0.90 to 8.24) 0.076
Adjusted 2.14 (0.79 to 5.79) 0.134 2.24 (0.83 to 6.08) 0.112 2.19 (0.75 to 6.42) 0.153
(None) vs. reference= (severe, moderate or mild)
Baseline 2.61 (1.03 to 6.65) 0.044 2.61 (1.04 to 6.52) 0.040 2.84 (1.02 to 7.93) 0.046
Adjusted 2.05 (0.83 to 5.10) 0.122 2.04 (0.84 to 4.94) 0.113 2.15 (0.80 to 5.81) 0.130
6 months post operation
(Moderate, mild or none) vs. reference= (severe)
Baseline 6.52 (1.21 to 35.29) 0.030 7.19 (1.40 to 36.97) 0.018 5.66 (0.94 to 33.87) 0.058
Adjusted 5.04 (0.93 to 27.22) 0.06 5.32 (1.05 to 26.85) 0.043 4.26 (0.72 to 25.27) 0.111
(Mild or none) vs. reference= (severe or moderate)
Baseline 2.28 (0.79 to 6.57) 0.128 2.50 (0.90 to 6.94) 0.079 2.26 (0.72 to 7.13) 0.165
Adjusted 1.74 (0.61 to 4.94) 0.297 1.92 (0.70 to 5.28) 0.206 1.69 (0.55 to 5.22) 0.361
(None) vs. reference= (severe, moderate or mild)
Baseline 1.16 (0.47 to 2.86) 0.740 1.22 (0.50 to 2.99) 0.658 1.18 (0.44 to 3.16) 0.737
Adjusted 0.93 (0.38 to 2.23) 0.863 0.98 (0.41 to 2.33) 0.958 0.92 (0.35 to 2.39) 0.858
a Modelled with multilevel ordinal regression allowing for partial proportional odds. Baseline model adjusted for baseline
pain score and surgical approach. Adjusted model: baseline model + adjustments for sex, living arrangement and
number of comorbidities.
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Appendix 18 Intention-to-treat and per-protocol
analysesa of the effect of the intervention on pain
(WOMAC) at 3 and 6 months after surgery for the
APEX TKR trial
Analysis model
ITT-CC ITT-imputed PP
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
3 months post operation
(Moderate, mild or none) vs. reference= (severe)
Baseline 1.12 (0.35 to 3.60) 0.850 1.09 (0.37 to 3.26) 0.873 1.19 (0.36 to 4.01) 0.774
Adjusted 1.01 (0.32 to 3.19) 0.989 1.22 (0.41 to 3.63) 0.723 1.03 (0.31 to 3.42) 0.957
(Mild or none) vs. reference= (severe or moderate)
Baseline 0.86 (0.32 to 2.32) 0.770 0.79 (0.31 to 2.02) 0.621 0.86 (0.31 to 2.40) 0.772
Adjusted 0.86 (0.32 to 2.27) 0.760 0.89 (0.35 to 2.26) 0.798 0.82 (0.30 to 2.26) 0.700
(None) vs. reference= (severe, moderate or mild)
Baseline 1.45 (0.33 to 6.39) 0.623 1.77 (0.44 to 7.13) 0.425 1.47 (0.31 to 6.94) 0.628
Adjusted 1.58 (0.36 to 6.87) 0.540 1.98 (0.49 to 7.93) 0.335 1.57 (0.33 to 7.33) 0.570
6 months post operation
(Moderate, mild or none) vs. reference= (severe)
Baseline 2.95 (0.81 to 10.71) 0.100 2.80 (0.85 to 9.29) 0.091 3.08 (0.81 to 11.68) 0.097
Adjusted 2.48 (0.70 to 8.82) 0.161 2.73 (0.82 to 9.09) 0.101 2.55 (0.69 to 9.44) 0.162
(Mild or none) vs. reference= (severe or moderate)
Baseline 1.83 (0.68 to 4.95) 0.235 1.84 (0.72 to 4.72) 0.205 1.92 (0.68 to 5.40) 0.217
Adjusted 1.70 (0.64 to 4.52) 0.289 1.98 (0.78 to 5.05) 0.151 1.71 (0.62 to 4.73) 0.303
(None) vs. reference= (severe, moderate or mild)
Baseline 1.92 (0.58 to 6.29) 0.283 1.98 (0.63 to 6.23) 0.242 1.68 (0.49 to 5.75) 0.408
Adjusted 2.03 (0.63 to 6.55) 0.235 2.42 (0.76 to 7.66) 0.134 1.72 (0.51 to 5.81) 0.380
a Modelled with multilevel ordinal regression allowing for partial proportional odds. Baseline model adjusted for baseline
pain score and surgical approach. Adjusted model: baseline model adjusted for working status, comorbidities, depression
and anxiety.
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Appendix 19 Intention-to-treat and per-protocol
analyses of the effect of the intervention on pain
(ICOAP)a at 3, 6 and 12 months after surgery in the
APEX THR trial
Analysis model
ITT-CC ITT-imputed PP
RR (95% CI) p-value RR (95% CI) p-value RR (95% CI) p-value
3 monthsb (n = 259) (n = 322) (n = 246)
Baseline 0.58 (0.30 to 1.15) 0.120 0.56 (0.29 to 1.08) 0.086 0.59 (0.30 to 1.15) 0.122
Adjusted 0.66 (0.34 to 1.29) 0.222 0.65 (0.34 to 1.25) 0.195 0.66 (0.34 to 1.30) 0.233
6 monthsb (n = 251) (n = 322) (n = 239)
Baseline 0.77 (0.37 to 1.62) 0.495 0.69 (0.35 to 1.38) 0.295 0.77 (0.35 to 1.68) 0.515
Adjusted 0.88 (0.41 to 1.86) 0.731 0.80 (0.40 to 1.60) 0.525 0.88 (0.40 to 1.92) 0.742
12 monthsc (n = 265) (n = 322) (n = 251)
Baseline 0.40 (0.18 to 0.86) 0.020 0.49 (0.25 to 0.96) 0.038 0.42 (0.19 to 0.92) 0.031
Adjusted 0.44 (0.21 to 0.96) 0.038 0.58 (0.30 to 1.14) 0.115 0.47 (0.22 to 1.03) 0.059
RR, relative risk.
a Modelled as ICOAP pain (≥ 30, < 30).
b Modelled with an extension of the Poisson modified regression with robust variance estimation to account for
repeated measurements.
c Modelled with a Poisson modified regression with robust variance estimation.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for sex, living arrangement and number of comorbidities.
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Appendix 20 Intention-to-treat and per-protocol
analyses of the effect of the intervention on pain
(ICOAP)a at 3, 6 and 12 months after surgery in the
APEX TKR trial
Analysis model
ITT-CC ITT-imputed PP
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
3 monthsb (n = 242) (n = 316) (n = 231)
Baseline 0.11
(–0.50 to 0.72)
0.725 0.13
(–0.44 to 0.71)
0.649 0.08
(–0.54 to 0.70)
0.801
Adjusted 0.12
(–0.48 to 0.72)
0.697 0.10
(–0.49 to 0.68)
0.746 0.11
(–0.49 to 0.72)
0.711
6 monthsb (n = 231) (n = 316) (n = 218)
Baseline –0.46
(–1.08 to 0.15)
0.140 –0.38
(–0.98 to 0.21)
0.205 –0.47
(–1.10 to 0.16)
0.144
Adjusted –0.45
(–1.06 to 0.16)
0.146 –0.42
(–1.01 to 0.16)
0.158 –0.45
(–1.07 to 0.17)
0.159
12 monthsc (n = 257) (n = 316) (n = 243)
Baseline –0.15
(–0.76 to 0.48)
0.646 –0.06
(–0.68 to 0.57)
0.855 –0.16
(–0.81 to 0.50)
0.632
Adjusted –0.29
(–0.90 to 0.34)
0.380 –0.20
(–0.81 to 0.42)
0.529 –0.30
(–0.95 to 0.35)
0.364
a Modelled as square root of ICOAP.
b Modelled with a linear mixed regression.
c Modelled with a linear regression.
Note
Baseline model adjusted for baseline pain score and surgical approach, Adjusted model: baseline model plus adjustments
for working status, number of comorbidities, depression and anxiety.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
445

Appendix 21 Intention-to-treat and per-protocol
analyses of the effect of the intervention on function
(WOMAC)a at 3, 6 and 12 months after surgery in the
APEX THR trial
Analysis
model
ITT-CC ITT-imputed PP
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
3 monthsb (n = 257) (n = 322) (n = 244)
Baseline 636.04
(71.40 to 1200.68)
0.027 632.0
(40.01 to 1223.99)
0.036 614.4
(42.3 to 1186.5)
0.035
Adjusted 487.9
(–59.29 to 1035.1)
0.081 472.8
(–102.7 to 1048.3)
0.107 443.9
(–108.0 to 995.9)
0.115
6 monthsb (n = 254) (n = 322) (n = 241)
Baseline 326.6
(–239.28 to 892.40)
0.258 425.9
(–141.8 to 993.5)
0.141 265.1
(–308.0 to 838.2)
0.365
Adjusted 188.2
(–361.7 to 738.1)
0.502 266.7
(–286.5 to 819.9)
0.344 106.6
(–447.5 to 660.7)
0.706
12 monthsc (n = 266) (n = 322) (n = 252)
Baseline 500.6
(–80.6 to 1081.9)
0.091 623.4
(46.1 to 1200.7)
0.034 400.7
(–192.2 to 993.6)
0.184
Adjusted 459.4
(–97.3 to 1016.13)
0.105 499.4
(–58.61 to 1057.5)
0.079 363.2
(–201.3 to 930.7)
0.209
a Modelled as WOMAC function.
b Modelled with a linear mixed model.
c Modelled with a linear model.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for sex, living arrangement and number of comorbidities.
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Appendix 22 Intention-to-treat and per-protocol
analyses of the effect of the intervention on function
(WOMAC) at 3, 6 and 12 months after surgery in the
APEX TKR trial
Analysis model
ITT-CC ITT-imputed PP
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
3 monthsa (n = 233) (n = 316) (n = 223)
Baseline 0.19
(–4.12 to 4.50)
0.931 –0.68
(–4.99 to 3.64)
0.759 0.60
(–3.86 to 5.07)
0.790
Adjusted 0.71
(–3.44 to 4.86)
0.738 0.04
(–4.13 to 4.21)
0.985 0.97
(–3.32 to 5.26)
0.658
6 monthsa (n = 227) (n = 316) (n = 215)
Baseline 2.54
(–1.79 to 6.88)
0.250 1.76
(–2.56 to 6.09)
0.425 2.82
(–1.67 to 7.32)
0.218
Adjusted 2.97
(–1.21 to 7.15)
0.164 2.48
(–1.72 to 6.67)
0.247 3.11
(–1.21 to 7.44)
0.159
12 monthsb (n = 258) (n = 316) (n = 246)
Baseline 1.20
(–3.24 to 5.65)
0.594 1.81
(–3.38 to 7.00)
0.491 1.22
(–3.41 to 5.86)
0.604
Adjusted 1.88
(–2.49 to 6.24)
0.398 3.03
(–2.22 to 8.28)
0.256 1.85
(–2.69 to 6.40)
0.422
a Modelled with a linear mixed regression.
b Modelled with a linear regression.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for working status, number of comorbidities, depression and anxiety.
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Appendix 23 Intention-to-treat and per-protocol
analyses of the effect of the intervention on stiffness
(WOMAC)a at 3, 6 and 12 months after surgery for
the APEX THR trial
Analysis model
ITT-CC ITT-imputed PP
RR (95% CI) p-value RR (95% CI) p-value RR (95% CI) p-value
3 monthsb (n = 258) (n = 322) (n = 245)
Baseline 0.87 (0.50 to 1.53) 0.634 0.80 (0.46 to 1.37) 0.414 0.97 (0.55 to 1.72) 0.920
Adjusted 0.96 (0.55 to 1.67) 0.881 0.86 (0.51 to 1.45) 0.566 1.08 (0.62 to 1.90) 0.784
6 monthsb (n = 246) (n = 322) (n = 233)
Baseline 0.99 (0.45 to 2.19) 0.990 0.96 (0.46 to 2.00) 0.921 1.01 (0.44 to 2.30) 0.983
Adjusted 1.03 (0.48 to 2.21) 0.942 1.03 (0.50 to 2.13) 0.927 1.05 (0.47 to 2.34) 0.907
12 monthsc (n = 266) (n = 322) (n = 252)
Baseline 0.60 (0.29 to 1.24) 0.167 0.55 (0.29 to 1.04) 0.068 0.68 (0.33 to 1.44) 0.318
Adjusted 0.64 (0.31 to 1.35) 0.246 0.64 (0.34 to 1.21) 0.173 0.73 (0.34 to 1.56) 0.414
RR, relative risk.
a Modelled as stiffness (WOMAC) (≤ 50, > 50).
b Modelled with an extension of the Poisson modified regression with robust variance estimation to account for
repeated measurements.
c Modelled with a Poisson modified regression with robust variance estimation.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for sex, living arrangement and number of comorbidities.
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Appendix 24 Intention-to-treat and per-protocol
analyses of the effect of the intervention on stiffness
(WOMAC) at 3, 6 and 12 months after surgery in the
APEX TKR trial
Analysis model
ITT-CC ITT-imputed PP
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
Coefficient
(95% CI) p-value
3 monthsa (n = 237) (n = 316) (n = 227)
Baseline 2.94 (–2.05 to 7.94) 0.248 1.23 (–3.85 to 6.30) 0.635 2.89 (–2.24 to 8.02) 0.270
Adjusted 3.53 (–1.44 to 8.49) 0.164 2.10 (–3.04 to 7.24) 0.423 3.20 (–1.91 to 8.30) 0.219
6 monthsa (n = 228) (n = 316) (n = 216)
Baseline 4.03 (–1.02 to 9.08) 0.117 3.22 (–2.06 to 8.52) 0.234 3.68 (–1.52 to 8.89) 0.166
Adjusted 4.54 (–0.47 to 9.55) 0.076 4.09 (–1.18 to 9.36) 0.128 3.93 (–1.24 to 9.09) 0.136
12 monthsb (n = 256) (n = 316) (n = 242)
Baseline 1.78 (–3.21 to 6.78) 0.483 1.81 (–3.38 to 7.00) 0.491 1.77 (–3.40 to 6.94) 0.500
Adjusted 2.70 (–2.37 to 7.77) 0.296 3.03 (–2.22 to 8.28) 0.256 2.63 (–2.63 to 7.89) 0.325
a Modelled with a linear mixed regression.
b Modelled with a linear regression.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for working status, number of comorbidities, depression and anxiety.
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
453

Appendix 25 Intention-to-treat and per-protocol
analyses of the effect of the intervention on
neuropathic pain as measured by painDETECT
(< 13, ≥ 13) at 12 months after surgerya in the APEX
THR trial
Analysis model
ITT-CC (n= 267) ITT-imputed (n= 322) PP (n= 253)
RR (95% CI) p-value RR (95% CI) p-value RR (95% CI) p-value
Baseline 0.17 (0.04 to 0.76) 0.021 0.21 (0.05 to 0.83) 0.027 0.17 (0.04 to 0.77) 0.022
Adjusted 0.17 (0.03 to 0.82) 0.028 0.22 (0.05 to 0.90) 0.035 0.16 (0.03 to 0.83) 0.030
RR, relative risk.
a Modelled with a Poisson modified regression with robust variance estimation.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for sex, living arrangement and number of comorbidities.
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Appendix 26 Intention-to-treat and per-protocol
analyses of the effect of the intervention on
neuropathic pain as measured by painDETECT
(< 13, ≥ 13) at 12 months after surgerya in the APEX
TKR trial
Analysis model
ITT-CC (n= 254) ITT-imputed (n= 316) PP (n= 241)
RR (95% CI) p-value RR (95% CI) p-value RR (95% CI) p-value
Baseline 0.92 (0.60 to 1.42) 0.715 0.99 (0.67 to 1.47) 0.973 0.94 (0.60 to 1.47) 0.792
Adjusted 0.95 (0.61 to 1.49) 0.834 1.05 (0.69 to 1.61) 0.796 0.98 (0.62 to 1.53) 0.918
RR, relative risk.
a Modelled with a Poisson modified regression with robust variance estimation.
Note
Baseline model adjusted for baseline pain score and surgical approach. Adjusted model: baseline model plus adjustments
for working status, number of comorbidities depression and anxiety.
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Appendix 27 Patient complications and serious
adverse events in the APEX THR trial
Patient complications and SAE Intervention (N= 163) Standard care (N= 159) p-valuea
Deceased patient, n (%) 0 (0.0) 6 (3.8) N/A
Patient with an infection, n (%)b 3 (1.8) 3 (1.9) 1.000
Patients with SAE, n (%) 41 (25.2) 55 (34.6) 0.090
Patients by count of SAEs, n (%) 0.611
1 29 (17.8) 44 (27.7)
2 10 (6.1) 9 (5.7)
3 2 (1.2) 2 (1.3)
Total SAEs, n 55 68
Expedited SAEs, % 85.5 82.4 0.640
N/A, not applicable; SAE, serious adverse event.
a Chi-squared test or Fisher-exact test.
b Superficial or deep surgical site infection.
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Appendix 28 Patient complications and serious
adverse events for the APEX TKR trial
Patient complications and SAE Intervention (N= 157) Standard care (N= 159) p-valuea
Deceased patient, n (%) 3 (1.9) 1 (0.6) 0.369
Patient with an infection, n (%)b 5 (3.2) 3 (1.9) 0.500
Patients with SAE, n (%) 63 (40.1) 58 (36.5) 0.505
Patients by count of SAEs, n (%) 0.685
1 48 (30.6) 48 (30.2)
2 11 (7.0) 8 (5.0)
3 4 (2.6) 2 (1.3)
Total SAEs, n 82 69
Expedited SAEs, % 85.4 82.9 72
SAE, serious adverse event.
a Chi-squared test or Fisher-exact test.
b Superficial or deep surgical site infection.
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Appendix 29 Pre-operative hip X-ray form
Study ID       Initials     DOB       
    
A1a. Reader: Reader1  Other (Please Specify)…………………… 
A2. Date X-ray read:  ……/……/…… 
A3. Date X-ray taken:  ……/……/…… 
B1. Technical problem- film cannot be assessed accurately         No         Yes  
 
B2. Severe rotation (position of greater trochanters)          No           Yes 
 
B3. Severe tilt of film (Coccyx overlap >3mm with symphysis)   No                                          Yes
 
 (i) Right (ii) Left 
B4. Intra-articular implant (0/1)   
B5. Kellgren and Lawrence (0-4)   
B6. Superior acetabular ostephyte (0-3)   
B7. Superior femoral osteophyte (0-3)   
B8. Inferior acetabular osteophyte (0/1)   
B9. Inferior femoral osteophyte (0/1)   
B10. Acetabular sclerosis (0/1)   
B11. Acetabular cysts (0/1)   
B12. Acetabular flattening (0/1)   
B13. Femoral sclerosis (0/1)   
B14. Femoral cysts (0/1)   
B15. Femoral flattening (0/1)   
B16. Superior joint space narrowing (0-3)   
B17. Medial joint space narrowing (0-3)   
B18. Chondrocalcinosis (0/1)   
B19. Migration: None = 0; Superolateral = 1 Concentric = 2   
B20. No pattern = 0; hypertrophic = 1; atrophic = 2   
B21. Protrusio (0/1)   
B22. FAI Bump (0/1)   
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
463

Appendix 30 Pre-operative knee X-ray form
Study ID 
       Initials     DOB     19   
 
A1a. Reader :     Reader1    Other2      A1b. If other, please specify ………………….. 
 
A2. Date X-ray read:   ……/……/……… 
 
A3. Date X-ray taken:   ……/……/……… 
 
AP Knees 
 
B1. Technical problem – film cannot be assessed accurately                            No0              Yes1 
 
B2. Severe rotation of film                                                                                 No0              Yes1 
 
B3. Severe tilt of film (Medial tibial plateau superimposition  >1mm)             No0                Yes1 
 
    
 
 (i)  
Right 
(ii) 
Left 
B4. Intra-articular knee implant (0/1)   
B5. Kellgren & Lawrence (0-4)   
B6. Medial tibial osteophyte (0-3)   
B7. Medial femoral osteophyte (0-3)   
B8. Lateral tibial osteophyte (0-3)   
B9. Lateral femoral osteophyte (0-3)   
B10 Medial joint space narrowing (0-3)   
B11. Lateral joint space narrowing (0-3)   
B12. Medial subchondral sclerosis (0/1)*   
B13 Lateral subchondral sclerosis (0/1)*   
B14 Medial bony attrition (0/1)*   
B15 Lateral bony attrition (0/1)*   
B16 Chondrocalcinosis (0/1)   
 
 
Lateral Knees  
 
C1. Technical problem – film cannot be assessed accurately                               No0                    Yes1 
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C2. Severe rotation of film                                                                                   No0       Yes1 
 
(i)  
Right 
(ii) 
Left 
C3. Intra-articular knee implant (0/1)   
C4. Superior osteophyte (0-3)   
C5. Inferior osteophyte (0-3)   
C6. Joint space narrowing (0-3)   
 
(i)  
Right 
(ii) 
Left 
D1. Not done (=0), Available (=1)   
D2. Medial PFJ narrowing (0/1)   
D3. Lateral PFJ narrowing (0/1)   
D4. PFJ subluxation (absent=0, lateral=1, medial=2)   
 
 
  (i)  
Right 
(ii) 
Left 
E Pattern:  0=No OA, 1=Medial, 2=Lateral, 
3=Patellofemoral, 4=Bicompartmental/tricompartmental 
  
 
 
 
E . Notes 
 
 
 
 
 
 
 
 
 
 
*either femur, tibia or both 
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Appendix 31 Pre-surgical exercise and
educational interventions before total hip and knee
replacement: Cochrane risk-of-bias table
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Appendix 32 Occupational therapy in total hip
replacement: Cochrane risk-of-bias table
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Appendix 33 PROOF-THR detailed summary of
European Quality of Life-5 Dimensions scale
Topic
Baseline
(n= 44)
4 weeks
(n= 36)
12 weeks
(n= 37)
26 weeks
(n= 36)
Mobility
I have no problems in walking about 0% 44% 68% 72%
I have some problems in walking about 100% 56% 32% 28%
I am confined to bed 0% 0% 0% 0%
Self-care
I have no problems with self-care 36% 60% 76% 94%
I have some problems washing or dressing myself 64% 40% 21% 6%
I am unable to wash or dress myself 0% 0% 3% 0%
Usual activities
I have no problems with performing my usual activities 14% 31% 54% 74%
I have some problems with performing my usual activities 77% 47% 41% 26%
I am unable to perform my usual activities 9% 22% 5% 0%
Pain/discomfort
I have no pain or discomfort 0% 29% 43% 60%
I have moderate pain or discomfort 57% 66% 54% 40%
I have extreme pain or discomfort 43% 6% 3% 0%
Anxiety/depression
I am not anxious or depressed 66% 71% 84% 78%
I am moderately anxious or depressed 34% 29% 13% 22%
I am extremely anxious or depressed 0% 0% 3% 0%
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Appendix 34 PROOF-THR detailed summary of
ICECAP scale (baseline data)
Topic
Baseline
(n= 44)
4 weeks
(n= 36)
12 weeks
(n= 37)
26 weeks
(n= 36)
Love and friendship
I cannot have any of the love and friendship that I want 5% 3% 3% 3%
I can have a little of the love and friendship that I want 9% 8% 5% 3%
I can have a lot of the love and friendship that I want 23% 40% 22% 19%
I can have all the love and friendship that I want 64% 49% 70% 75%
Thinking about the future
I can only think about the future with a lot of concern 9% 6% 5% 3%
I can only think about the future with some concern 11% 11% 14% 11%
I can think about the future with only a little concern 55% 44% 38% 43%
I can think about the future without any concern 25% 39% 43% 43%
Doing things that make you feel valued
I am unable to do any of the things that make me feel valued 5% 3% 2% 0%
I am able to do a few of the things that make me feel valued 23% 17% 11% 6%
I am able to do many of the things that make me feel valued 48% 54% 38% 36%
I am able to do all of the things that make me feel valued 25% 26% 49% 58%
Enjoyment and pleasure
I cannot have any of the enjoyment and pleasure that I want 2% 3% 3% 0%
I can have a little of the enjoyment and pleasure that I want 43% 36% 16% 5%
I can have a lot of the enjoyment and pleasure that I want 39% 36% 46% 42%
I can have all of the enjoyment and pleasure that I want 16% 25% 35% 53%
Independence
I am unable to be at all independent 2% 3% 3% 0%
I am able to be independent in a few things 23% 13% 5% 3%
I am able to be independent in many things 45% 65% 43% 36%
I am able to be completely independent 30% 19% 49% 61%
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
477

Appendix 35 Physiotherapy interventions after
total knee replacement: Cochrane risk-of-bias table
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Appendix 36 Telephone survey questionnaire
for current provision of physiotherapy following
discharge after total hip replacement and total
knee replacement
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Appendix 37 Job title of the respondent at each
of the twenty-four orthopaedic centres surveyed
Orthopaedic unit Procedure surveyed (THR/TKR) Position of staff member surveyed
1 Both Clinical therapies manager
2 Both Orthopaedic therapy team lead
3 Both Clinical lead
4 Both Extended scope physiotherapy practitioner
5 Both Clinical lead
6 Both Team lead
7 Both Therapy lead
8 Both Senior physiotherapist
9 Both Clinical lead
10 TKR only Senior physiotherapist
11 Both Clinical lead
12 Both Senior physiotherapist
13 Both Clinical lead
14 Both Extended scope physiotherapy practitioner
15 TKR only Senior orthopaedic physiotherapist
16 TKR only Senior OT
17 TKR only Senior physiotherapist
18 TKR only Senior physiotherapist
19 TKR only Senior physiotherapist
20 TKR only Clinical lead
21 TKR only Clinical lead
22 TKR only Senior outpatient physiotherapist
23 TKR only Senior orthopaedic physiotherapist
24 THR only Outpatient manager
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Appendix 38 Study feedback reports for patients
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d 
to
 p
at
ie
nt
s 
w
ho
 d
id
 n
ot
 h
av
e 
th
e 
in
je
ct
io
n.
  
 
•
 
Th
er
e 
w
as
 n
o 
di
ffe
re
nc
e 
in
 p
ai
n 
le
ve
ls
 a
t 3
 m
on
th
s 
an
d 
6 
m
on
th
s 
af
te
r s
ur
ge
ry
 b
et
w
ee
n 
pa
tie
nt
s 
w
ho
 d
id
 
an
d 
di
d 
no
t h
av
e 
th
e 
in
je
ct
io
n 
of
 lo
ca
l a
na
es
th
et
ic
.  
 
•
 
W
e 
w
ill
 b
e 
re
co
m
m
en
di
ng
 th
at
 a
n 
in
je
ct
io
n 
of
 lo
ca
l 
an
ae
st
he
tic
 is
 g
iv
en
 to
 p
at
ie
nt
s 
ha
vi
ng
 a
 k
ne
e 
re
pl
ac
em
en
t. 
Th
is
 is
 b
ec
au
se
 o
ur
 s
tu
dy
 s
ug
ge
st
s 
it 
ca
n 
sl
ig
ht
ly
 re
du
ce
 th
e 
am
ou
nt
 o
f p
ai
n 
pe
op
le
 h
av
e 
in
 
th
ei
r r
ep
la
ce
d 
kn
ee
 a
t o
ne
 y
ea
r a
fte
r t
he
ir 
op
er
at
io
n.
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C
on
ta
ct
 d
et
ai
ls
 
If 
yo
u 
ha
ve
 a
ny
 q
ue
st
io
ns
 o
r y
ou
 w
ou
ld
 li
ke
 m
or
e 
in
fo
rm
at
io
n 
ab
ou
t t
hi
s 
st
ud
y,
 p
le
as
e 
te
le
ph
on
e 
V
ik
ki
 W
yl
de
 
(s
tu
dy
 c
o-
or
di
na
to
r)
 o
n 
   
   
   
   
   
   
   
   
 o
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m
ru
-r
es
to
re
@
br
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O
rth
op
ae
di
c 
C
en
tre
, 
S
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H
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l, 
B
S
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 5
N
B
 
      
 
S
om
e 
m
em
be
rs
 o
f t
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 A
D
A
P
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re
se
ar
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 te
am
 
 
Su
m
m
ar
y 
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 fi
nd
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gs
 
 
AD
AP
T  
A
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si
ng
 d
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r p
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Th
an
k 
yo
u 
fo
r b
ei
ng
 in
vo
lv
ed
 in
 th
e 
A
D
A
P
T 
st
ud
y.
 Y
ou
 
w
er
e 
on
e 
of
 2
54
 p
eo
pl
e 
w
ho
 k
in
dl
y 
to
ok
 p
ar
t i
n 
th
is
 s
tu
dy
 
w
hi
ch
 is
 o
ne
 o
f t
he
 la
rg
es
t s
tu
di
es
 o
f t
hi
s 
ty
pe
.  
  
B
A
C
K
G
R
O
U
N
D
 
   Th
e 
ai
m
 o
f t
he
 A
D
A
P
T 
st
ud
y 
w
as
 to
 c
om
pa
re
 d
iff
er
en
t 
w
ay
s 
th
at
 m
ob
ili
ty
 c
an
 b
e 
m
ea
su
re
d 
in
 p
eo
pl
e 
w
ho
 a
re
 
ha
vi
ng
 jo
in
t s
ur
ge
ry
. T
he
 s
tu
dy
 c
om
pa
re
d 
th
e 
in
fo
rm
at
io
n 
th
at
 c
an
 b
e 
co
lle
ct
ed
 th
ou
gh
 q
ue
st
io
nn
ai
re
s 
w
ith
 
in
fo
rm
at
io
n 
th
at
 c
an
 b
e 
co
lle
ct
ed
 th
ro
ug
h 
m
ob
ili
ty
 te
st
s 
an
d 
jo
in
t e
xa
m
in
at
io
ns
.  
 
 E
ve
ry
on
e 
ta
ki
ng
 p
ar
t i
n 
th
e 
st
ud
y 
w
as
 a
sk
ed
 to
 c
om
e 
fo
r a
 
re
se
ar
ch
 a
pp
oi
nt
m
en
t b
ef
or
e 
th
ei
r o
pe
ra
tio
n,
 a
nd
 th
en
 a
t 3
 
m
on
th
s 
an
d 
1 
ye
ar
 a
fte
r t
he
ir 
op
er
at
io
n.
  
 
ST
U
D
Y 
D
ES
IG
N
 
  P
eo
pl
e 
w
ho
 to
ok
 p
ar
t i
n 
th
e 
A
D
A
P
T 
st
ud
y 
fil
le
d 
in
 a
 
nu
m
be
r o
f q
ue
st
io
nn
ai
re
s 
ab
ou
t m
ob
ili
ty
 a
nd
 th
en
 
co
m
pl
et
ed
 th
e 
fo
llo
w
in
g 
m
ob
ili
ty
 te
st
s:
 
  
- 
W
al
ki
ng
 2
0 
m
et
re
s 
do
w
n 
a 
co
rr
id
or
 
- 
G
et
tin
g 
up
 fr
om
 a
 c
ha
ir 
 
- 
S
te
pp
in
g 
on
 a
nd
 o
ff 
a 
bo
x 
- 
B
al
an
ci
ng
 o
n 
on
e 
le
g 
  
A
 re
se
ar
ch
er
 a
ls
o 
lo
ok
ed
 a
t h
ow
 m
uc
h 
ev
er
yo
ne
’s
 jo
in
t 
m
ov
ed
.  
 
FI
N
D
IN
G
S 
  E
ar
ly
 fi
nd
in
gs
 s
ug
ge
st
 th
at
 q
ue
st
io
nn
ai
re
s,
 m
ob
ili
ty
 te
st
s 
an
d 
jo
in
t e
xa
m
in
at
io
ns
 a
ll 
pr
ov
id
e 
di
ffe
re
nt
 re
su
lts
. A
 
pe
rs
on
’s
 le
ve
l o
f j
oi
nt
 p
ai
n 
cl
ea
rly
 a
ffe
ct
ed
 th
e 
re
su
lts
 o
f a
ll 
th
e 
di
ffe
re
nt
 w
ay
s 
of
 m
ea
su
rin
g 
m
ob
ili
ty
. 
 Th
is
 m
ay
 s
ee
m
 o
bv
io
us
, b
ut
 in
 fa
ct
 th
is
 s
tu
dy
 is
 n
ew
 
be
ca
us
e 
un
til
 n
ow
 it
 w
as
 n
ot
 c
le
ar
 th
at
 d
oc
to
rs
 n
ee
de
d 
to
 
as
k 
ab
ou
t p
ai
n 
to
 u
nd
er
st
an
d 
in
fo
rm
at
io
n 
ab
ou
t m
ob
ili
ty
 
co
lle
ct
ed
 in
 q
ue
st
io
nn
ai
re
s 
an
d 
th
ro
ug
h 
te
st
s 
in
 c
lin
ic
s.
  
 Th
e 
st
ud
y 
te
am
 is
 w
or
ki
ng
 to
 a
na
ly
se
 th
e 
in
fo
rm
at
io
n 
fu
rth
er
. W
e 
ex
pe
ct
 fi
nd
in
gs
 to
 b
e 
av
ai
la
bl
e 
in
 th
e 
ne
xt
 tw
o 
ye
ar
s,
 a
nd
 th
es
e 
w
ill
 b
e 
pu
bl
ic
ly
 a
va
ila
bl
e 
th
ro
ug
h 
ou
r 
w
eb
si
te
 (p
le
as
e 
se
e 
ov
er
le
af
). 
  
W
H
A
T’
S 
N
EX
T?
 
  W
e 
w
ou
ld
 li
ke
 to
 th
an
k 
yo
u 
ag
ai
n 
fo
r t
ak
in
g 
pa
rt.
 T
he
 
re
se
ar
ch
 th
at
 is
 d
on
e 
at
 th
e 
M
us
cu
lo
sk
el
et
al
 R
es
ea
rc
h 
U
ni
t 
he
lp
s 
to
 in
fo
rm
 b
et
te
r h
ea
lth
ca
re
 in
 th
e 
U
K
, a
nd
 y
ou
r 
pa
rti
ci
pa
tio
n 
w
as
 v
ita
l i
n 
th
is
. T
he
 re
su
lts
 w
ill
 n
ow
 b
e 
pr
es
en
te
d 
in
 a
ca
de
m
ic
 jo
ur
na
ls
 a
nd
 a
t r
es
ea
rc
h 
co
nf
er
en
ce
s,
 w
hi
ch
 e
ns
ur
es
 th
at
 p
ol
ic
y 
m
ak
er
s 
an
d 
he
al
th
ca
re
 p
ro
fe
ss
io
na
ls
 h
ea
r a
bo
ut
 th
e 
re
se
ar
ch
. 
DOI: 10.3310/pgfar04120 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 12
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Blom et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
499
W
H
A
T’
S 
N
EX
T?
 
 Th
e 
st
ud
y 
te
am
 is
 n
ow
 lo
ok
in
g 
in
 m
or
e 
de
ta
il 
at
 th
e 
in
fo
rm
at
io
n.
 W
e 
ex
pe
ct
 fi
nd
in
gs
 to
 b
e 
av
ai
la
bl
e 
in
 2
01
4 
an
d 
th
es
e 
w
ill
 b
e 
pu
bl
ic
ly
 a
va
ila
bl
e 
th
ro
ug
h 
ou
r w
eb
si
te
. 
 W
e 
w
ou
ld
 li
ke
 to
 th
an
k 
yo
u 
ag
ai
n 
fo
r t
ak
in
g 
pa
rt.
 T
he
 
re
se
ar
ch
 th
at
 is
 d
on
e 
at
 th
e 
M
us
cu
lo
sk
el
et
al
 R
es
ea
rc
h 
U
ni
t 
he
lp
s 
to
 in
fo
rm
 b
et
te
r h
ea
lth
ca
re
 in
 th
e 
U
K
, a
nd
 y
ou
r 
pa
rti
ci
pa
tio
n 
w
as
 v
ita
l i
n 
th
is
.  
 Th
e 
re
su
lts
 w
ill
 n
ow
 b
e 
pr
es
en
te
d 
in
 a
n 
ac
ad
em
ic
 jo
ur
na
l, 
w
hi
ch
 e
ns
ur
es
 th
at
 p
ol
ic
y 
m
ak
er
s 
an
d 
he
al
th
ca
re
 
pr
of
es
si
on
al
s 
he
ar
 a
bo
ut
 th
e 
re
se
ar
ch
. 
 
C
on
ta
ct
 d
et
ai
ls
 
If 
yo
u 
ha
ve
 a
ny
 q
ue
st
io
ns
 o
r w
ou
ld
 li
ke
 m
or
e 
in
fo
rm
at
io
n 
ab
ou
t t
hi
s 
st
ud
y,
 p
le
as
e 
te
le
ph
on
e 
V
ik
ki
 W
yl
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 o
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 o
r e
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l m
ru
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@
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A
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Su
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 a
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Th
an
k 
yo
u 
fo
r b
ei
ng
 in
vo
lv
ed
 in
 th
e 
S
P
IR
A
L 
st
ud
y.
 Y
ou
 
w
er
e 
on
e 
of
 8
8 
pe
op
le
 w
ho
 k
in
dl
y 
to
ok
 p
ar
t i
n 
th
is
 s
tu
dy
.  
 
 
B
A
C
K
G
R
O
U
N
D
 
   Th
e 
S
P
IR
A
L 
st
ud
y 
ai
m
ed
 to
 fi
nd
 o
ut
 w
he
th
er
 w
e 
co
ul
d 
ru
n 
a 
st
ud
y 
of
 a
 p
ai
n 
se
lf-
m
an
ag
em
en
t c
ou
rs
e 
fo
r p
eo
pl
e 
ha
vi
ng
 a
 h
ip
 re
pl
ac
em
en
t. 
 
 
ST
U
D
Y 
D
ES
IG
N
  
  O
f t
he
 8
8 
pe
op
le
 in
 th
e 
st
ud
y,
 4
5 
pe
op
le
 w
er
e 
ch
os
en
 a
t 
ra
nd
om
 to
 h
av
e 
‘s
ta
nd
ar
d 
ca
re
’ t
ha
t p
at
ie
nt
s 
at
 S
ou
th
m
ea
d 
no
rm
al
ly
 re
ce
iv
e.
 4
3 
ot
he
r p
eo
pl
e 
w
er
e 
ch
os
en
 a
t r
an
do
m
 
to
 b
e 
in
vi
te
d 
to
 a
tte
nd
 a
 n
ew
 p
ai
n 
se
lf-
m
an
ag
em
en
t 
co
ur
se
. T
hi
s 
w
as
 im
po
rta
nt
 a
s 
re
se
ar
ch
 n
ee
ds
 to
 b
e 
ab
le
 
to
 c
om
pa
re
 th
e 
ex
pe
rie
nc
es
 o
f p
eo
pl
e 
ha
vi
ng
 th
e 
‘s
ta
nd
ar
d 
ca
re
’ w
ith
 e
xp
er
ie
nc
es
 o
f p
eo
pl
e 
ha
vi
ng
 s
om
et
hi
ng
 n
ew
.  
 W
e 
as
ke
d 
ev
er
yo
ne
 in
 th
e 
st
ud
y 
to
 fi
ll 
in
 q
ue
st
io
nn
ai
re
s 
be
fo
re
 th
ei
r o
pe
ra
tio
n,
 a
nd
 th
en
 a
t 1
-m
on
th
, 3
-m
on
th
s 
an
d 
6-
m
on
th
s 
af
te
r t
he
ir 
op
er
at
io
n.
 W
e 
ne
ed
ed
 to
 fi
nd
 o
ut
 
w
he
th
er
 p
eo
pl
e 
w
ou
ld
 b
e 
w
ill
in
g 
to
 fi
ll 
th
es
e 
in
.  
 W
e 
al
so
 ta
lk
ed
 to
 5
7 
ad
di
tio
na
l p
eo
pl
e 
w
ho
 d
id
 n
ot
 w
is
h 
to
 
ta
ke
 p
ar
t i
n 
th
e 
st
ud
y 
to
 fi
nd
 o
ut
 w
hy
.  
 
SO
M
E 
K
EY
 F
IN
D
IN
G
S 
  W
e 
w
ou
ld
 li
ke
 to
 s
ha
re
 th
re
e 
ke
y 
fin
di
ng
s 
w
ith
 y
ou
: 
 
•
 
B
et
w
ee
n 
81
%
 a
nd
 9
1%
 o
f p
eo
pl
e 
co
m
pl
et
ed
 th
e 
qu
es
tio
nn
ai
re
s 
at
 e
ac
h 
tim
e 
po
in
t. 
Th
is
 is
 a
 v
er
y 
hi
gh
 
co
m
pl
et
io
n 
ra
te
 c
om
pa
re
d 
w
ith
 o
th
er
 s
tu
di
es
. S
om
e 
pe
op
le
 th
ou
gh
t t
he
 q
ue
st
io
ns
 c
ou
ld
 b
e 
im
pr
ov
ed
, a
nd
 
fu
tu
re
 re
se
ar
ch
 c
ou
ld
 m
ak
e 
th
em
 b
et
te
r. 
 
•
 
P
eo
pl
e 
w
ho
 a
tte
nd
ed
 th
e 
co
ur
se
 g
av
e 
it 
an
 a
ve
ra
ge
 
sa
tis
fa
ct
io
n 
ra
tin
g 
of
 7
/1
0.
 In
 p
ar
tic
ul
ar
, p
eo
pl
e 
ga
ve
 
po
si
tiv
e 
fe
ed
ba
ck
 a
bo
ut
 th
e 
gr
ou
p-
ba
se
d 
fo
rm
at
 o
f 
th
e 
co
ur
se
 b
ec
au
se
 it
 p
ro
vi
de
d 
th
e 
op
po
rtu
ni
ty
 to
 
en
ga
ge
 w
ith
 o
th
er
 p
eo
pl
e 
ha
vi
ng
 a
 h
ip
 re
pl
ac
em
en
t. 
Th
is
 m
ea
ns
 th
at
 th
er
e 
is
 th
e 
po
te
nt
ia
l t
o 
ru
n 
fu
rth
er
 
re
se
ar
ch
 a
bo
ut
 th
e 
im
pa
ct
 o
f t
he
 c
ou
rs
e.
 
 
•
 
O
ne
 o
f t
he
 m
ai
n 
re
as
on
s 
th
at
 p
eo
pl
e 
ch
os
e 
no
t t
o 
ta
ke
 p
ar
t i
n 
th
is
 s
tu
dy
 w
as
 b
ec
au
se
 o
f d
iff
ic
ul
tie
s 
w
ith
 
ge
tti
ng
 to
 th
e 
ho
sp
ita
l. 
Th
is
 s
ho
w
s 
th
at
 fu
tu
re
 
re
se
ar
ch
 a
nd
 p
ai
n 
se
lf-
m
an
ag
em
en
t g
ro
up
s 
m
ay
 
ne
ed
 to
 b
e 
ru
n 
in
 p
la
ce
s 
th
at
 a
re
 e
as
ie
r t
o 
ge
t t
o.
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W
H
A
T’
S 
N
EX
T?
 
 Th
e 
fin
di
ng
s 
ha
ve
 in
fo
rm
ed
 a
n 
ap
pl
ic
at
io
n 
fo
r f
un
di
ng
 to
 
ru
n 
a 
la
rg
er
 s
tu
dy
 o
f p
hy
si
ot
he
ra
py
 a
fte
r k
ne
e 
re
pl
ac
em
en
t. 
Th
e 
re
su
lts
 w
ill
 a
ls
o 
be
 p
re
se
nt
ed
 in
 a
n 
ac
ad
em
ic
 jo
ur
na
l, 
w
hi
ch
 e
ns
ur
es
 th
at
 p
ol
ic
y 
m
ak
er
s 
an
d 
he
al
th
ca
re
 
pr
of
es
si
on
al
s 
he
ar
 a
bo
ut
 th
e 
re
se
ar
ch
. W
e 
ex
pe
ct
 fi
nd
in
gs
 
to
 b
e 
av
ai
la
bl
e 
in
 2
01
4 
an
d 
th
es
e 
w
ill
 b
e 
pu
bl
ic
ly
 a
va
ila
bl
e 
th
ro
ug
h 
ou
r w
eb
si
te
. 
 W
e 
w
ou
ld
 li
ke
 to
 th
an
k 
yo
u 
ag
ai
n 
fo
r t
ak
in
g 
pa
rt.
 T
he
 
re
se
ar
ch
 th
at
 is
 d
on
e 
at
 th
e 
M
us
cu
lo
sk
el
et
al
 R
es
ea
rc
h 
U
ni
t 
he
lp
s 
to
 in
fo
rm
 b
et
te
r h
ea
lth
ca
re
 in
 th
e 
U
K
, a
nd
 y
ou
r 
pa
rti
ci
pa
tio
n 
w
as
 v
ita
l i
n 
th
is
.  
C
on
ta
ct
 d
et
ai
ls
 
If 
yo
u 
ha
ve
 a
ny
 q
ue
st
io
ns
 o
r w
ou
ld
 li
ke
 m
or
e 
in
fo
rm
at
io
n 
ab
ou
t t
hi
s 
st
ud
y,
 p
le
as
e 
te
le
ph
on
e 
S
am
an
th
a 
D
ix
on
 o
n 
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 e
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l m
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S
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H
os
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ta
l, 
B
ris
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l, 
B
S
10
 5
N
B
 
   
 
 
   
Su
m
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ar
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 fi
nd
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gs
 
  
 
  
A
ct
iv
ity
 o
rie
nt
at
ed
 re
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Th
an
k 
yo
u 
fo
r b
ei
ng
 in
vo
lv
ed
 in
 th
e 
A
R
E
N
A
 s
tu
dy
. Y
ou
 
w
er
e 
on
e 
of
 4
6 
pe
op
le
 w
ho
 k
in
dl
y 
to
ok
 p
ar
t i
n 
th
is
 s
tu
dy
.  
 
B
A
C
K
G
R
O
U
N
D
 
   Th
e 
A
R
E
N
A
 s
tu
dy
 a
im
ed
 to
 fi
nd
 o
ut
 w
he
th
er
 w
e 
co
ul
d 
ru
n 
a 
st
ud
y 
of
 a
 p
hy
si
ot
he
ra
py
 c
la
ss
 fo
r p
eo
pl
e 
ha
vi
ng
 a
 k
ne
e 
re
pl
ac
em
en
t. 
 
 
ST
U
D
Y 
D
ES
IG
N
  
  O
f t
he
 4
6 
pe
op
le
 in
 th
e 
st
ud
y,
 2
3 
pe
op
le
 w
er
e 
ch
os
en
 a
t 
ra
nd
om
 to
 h
av
e 
‘s
ta
nd
ar
d 
ca
re
’ t
ha
t p
at
ie
nt
s 
at
 S
ou
th
m
ea
d 
no
rm
al
ly
 re
ce
iv
e.
 2
3 
ot
he
r p
eo
pl
e 
w
er
e 
ch
os
en
 a
t r
an
do
m
 
to
 b
e 
in
vi
te
d 
to
 a
tte
nd
 a
 n
ew
 6
 w
ee
k 
ph
ys
io
th
er
ap
y 
cl
as
s.
 
Th
is
 w
as
 im
po
rta
nt
 a
s 
re
se
ar
ch
 n
ee
ds
 to
 b
e 
ab
le
 to
 
co
m
pa
re
 th
e 
ex
pe
rie
nc
es
 o
f p
eo
pl
e 
ha
vi
ng
 th
e 
‘s
ta
nd
ar
d 
ca
re
’ w
ith
 e
xp
er
ie
nc
es
 o
f p
eo
pl
e 
ha
vi
ng
 s
om
et
hi
ng
 n
ew
.  
 W
e 
as
ke
d 
ev
er
yo
ne
 in
 th
e 
st
ud
y 
to
 fi
ll 
in
 q
ue
st
io
nn
ai
re
s 
be
fo
re
 th
ei
r o
pe
ra
tio
n,
 a
nd
 th
en
 a
t 2
 w
ee
ks
, 3
 m
on
th
s 
an
d 
6 
m
on
th
s 
af
te
r t
he
ir 
op
er
at
io
n.
 W
e 
ne
ed
ed
 to
 fi
nd
 o
ut
 
w
he
th
er
 p
eo
pl
e 
w
ou
ld
 b
e 
w
ill
in
g 
to
 fi
ll 
th
es
e 
in
. 
  
 
SO
M
E 
K
EY
 F
IN
D
IN
G
S 
  W
e 
w
ou
ld
 li
ke
 to
 s
ha
re
 th
re
e 
ke
y 
fin
di
ng
s 
w
ith
 y
ou
: 
 
•
 
37
%
 o
f p
eo
pl
e 
w
ho
 w
e 
ta
lk
ed
 to
 a
bo
ut
 th
e 
st
ud
y 
ag
re
ed
 to
 ta
ke
 p
ar
t. 
O
f t
he
 p
eo
pl
e 
w
ho
 a
gr
ee
d 
to
 
ta
ke
 p
ar
t i
n 
th
e 
st
ud
y,
 9
1%
 c
om
pl
et
ed
 th
e 
6 
m
on
th
 
fo
llo
w
-u
p 
of
 th
e 
st
ud
y.
 T
hi
s 
is
 a
 v
er
y 
go
od
 c
om
pl
et
io
n 
ra
te
 c
om
pa
re
d 
w
ith
 o
th
er
 s
tu
di
es
.  
 
•
 
O
ne
 o
f t
he
 m
ai
n 
re
as
on
s 
th
at
 p
eo
pl
e 
ch
os
e 
no
t t
o 
ta
ke
 p
ar
t i
n 
th
is
 s
tu
dy
 w
as
 b
ec
au
se
 o
f d
iff
ic
ul
tie
s 
w
ith
 
ge
tti
ng
 to
 th
e 
ho
sp
ita
l. 
Th
is
 s
ho
w
s 
th
at
 fu
tu
re
 
re
se
ar
ch
 a
nd
 p
hy
si
ot
he
ra
py
 c
la
ss
es
 m
ay
 n
ee
d 
to
 b
e 
ru
n 
in
 p
la
ce
s 
th
at
 a
re
 e
as
ie
r t
o 
ge
t t
o.
 
 
•
 
P
eo
pl
e 
w
ho
 a
tte
nd
ed
 th
e 
ph
ys
io
th
er
ap
y 
cl
as
se
s 
ga
ve
 
th
em
 a
n 
av
er
ag
e 
sa
tis
fa
ct
io
n 
ra
tin
g 
of
 9
/1
0.
 In
 
pa
rti
cu
la
r, 
pe
op
le
 g
av
e 
po
si
tiv
e 
fe
ed
ba
ck
 a
bo
ut
 th
e 
gr
ou
p-
ba
se
d 
fo
rm
at
 o
f t
he
 c
ou
rs
e 
be
ca
us
e 
it 
pr
ov
id
ed
 th
e 
op
po
rtu
ni
ty
 to
 e
ng
ag
e 
w
ith
 o
th
er
 p
eo
pl
e 
ha
vi
ng
 a
 k
ne
e 
re
pl
ac
em
en
t. 
Th
is
 m
ea
ns
 th
at
 th
er
e 
is
 
th
e 
po
te
nt
ia
l t
o 
ru
n 
fu
rth
er
 re
se
ar
ch
 a
bo
ut
 th
e 
im
pa
ct
 
of
 th
e 
co
ur
se
. 
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S
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m
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 re
se
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A
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an
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r b
ei
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 th
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w
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 p
ar
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P
E
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Y
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 p
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B
A
C
K
G
R
O
U
N
D
 
  Th
e 
in
te
rv
ie
w
 s
tu
dy
 a
im
ed
 to
 le
ar
n 
m
or
e 
ab
ou
t w
hy
 p
eo
pl
e 
ch
os
e 
to
 ta
ke
 p
ar
t i
n 
th
e 
A
P
E
X
 tr
ia
l a
nd
 w
ha
t t
he
y 
th
ou
gh
t 
of
 it
. W
e 
w
er
e 
al
so
 in
te
re
st
ed
 in
 le
ar
ni
ng
 a
bo
ut
 p
eo
pl
e’
s 
jo
ur
ne
ys
 to
 h
ip
 o
r k
ne
e 
re
pl
ac
em
en
t a
nd
 h
ow
 th
ey
 h
ad
 
m
an
ag
ed
 th
ei
r p
ai
n 
be
fo
re
 a
nd
 a
fte
r t
he
ir 
op
er
at
io
n.
   
 A
P
E
X
 is
 o
ne
 p
ar
t o
f t
he
 R
E
S
TO
R
E
 R
es
ea
rc
h 
P
ro
gr
am
m
e.
 
Th
e 
pr
og
ra
m
m
e 
is
 m
ad
e 
up
 o
f s
ev
er
al
 re
se
ar
ch
 p
ro
je
ct
s 
fo
cu
si
ng
 o
n 
im
pr
ov
in
g 
pa
tie
nt
 e
xp
er
ie
nc
es
 o
f j
oi
nt
 
re
pl
ac
em
en
t s
ur
ge
ry
. 
 
ST
U
D
Y 
D
ES
IG
N
  
  E
m
m
a 
Jo
hn
so
n 
vi
si
te
d 
yo
u 
af
te
r y
ou
r o
pe
ra
tio
n.
 E
m
m
a 
ta
lk
ed
 w
ith
 y
ou
 a
bo
ut
 y
ou
r e
xp
er
ie
nc
es
 o
f t
ak
in
g 
pa
rt 
in
 th
e 
tri
al
 a
nd
 o
f s
ur
ge
ry
. 
 A
ll 
in
te
rv
ie
w
s 
w
er
e 
au
di
o 
re
co
rd
ed
 a
nd
 th
es
e 
re
co
rd
in
gs
 
w
er
e 
ty
pe
d 
up
. W
e 
th
en
 lo
ok
ed
 a
t t
he
m
 to
 fi
nd
 a
ny
 
si
m
ila
rit
ie
s 
an
d 
di
ffe
re
nc
es
 in
 p
eo
pl
e’
s 
ex
pe
rie
nc
es
. 
  
FI
N
D
IN
G
S 
 
P
ar
tic
ip
an
ts
 to
ok
 p
ar
t i
n 
A
P
E
X
 fo
r m
an
y 
re
as
on
s 
in
cl
ud
in
g:
  
 
•
 
w
an
tin
g 
to
 h
el
p 
ot
he
rs
  
•
 
th
e 
va
lu
e 
of
 re
se
ar
ch
 to
 a
dv
an
ce
 k
no
w
le
dg
e 
 
 
Th
is
 in
fo
rm
at
io
n 
w
ill
 b
e 
us
ef
ul
 to
 im
pr
ov
e 
fu
tu
re
 tr
ia
ls
.  
W
e 
al
so
 lo
ok
ed
 a
t w
ha
t p
eo
pl
e 
th
ou
gh
t o
f p
ai
n 
re
lie
f 
m
ed
ic
at
io
n.
 P
eo
pl
e 
to
ld
 u
s 
th
at
: 
 
•
 a
lth
ou
gh
 in
 p
ai
n 
be
fo
re
 th
e 
op
er
at
io
n 
th
ey
 o
fte
n 
ch
os
e 
to
 li
m
it 
ho
w
 m
uc
h 
pa
in
 re
lie
f t
he
y 
to
ok
 
•
 h
av
in
g 
th
e 
op
er
at
io
n 
ch
an
ge
d 
th
ei
r t
ho
ug
ht
s 
ab
ou
t a
nd
 u
se
 o
f p
ai
n 
re
lie
f 
 
Th
is
 in
fo
rm
at
io
n 
is
 h
el
pf
ul
 to
 h
ea
lth
 p
ro
fe
ss
io
na
ls
.  
Th
e 
st
ud
y 
te
am
 is
 n
ow
 lo
ok
in
g 
in
 m
or
e 
de
ta
il 
at
 th
e 
in
fo
rm
at
io
n.
 F
in
di
ng
s 
w
ill
 b
e 
pu
bl
ic
al
ly
 a
va
ila
bl
e 
in
 th
e 
ne
xt
 
tw
o 
ye
ar
s 
th
ro
ug
h 
ou
r w
eb
si
te
 (p
le
as
e 
se
e 
ov
er
le
af
). 
 
W
H
A
T’
S 
N
EX
T?
 
 W
e 
w
ou
ld
 li
ke
 to
 th
an
k 
yo
u 
ag
ai
n 
fo
r t
ak
in
g 
pa
rt.
 T
he
 
re
se
ar
ch
 th
at
 is
 d
on
e 
at
 th
e 
M
us
cu
lo
sk
el
et
al
 R
es
ea
rc
h 
U
ni
t 
he
lp
s 
to
 in
fo
rm
 b
et
te
r h
ea
lth
ca
re
 in
 th
e 
U
K
, a
nd
 y
ou
r 
pa
rti
ci
pa
tio
n 
w
as
 v
ita
l i
n 
th
is
. T
he
 re
su
lts
 w
ill
 b
e 
pr
es
en
te
d 
in
 a
ca
de
m
ic
 jo
ur
na
ls
 a
nd
 a
t r
es
ea
rc
h 
co
nf
er
en
ce
s,
 w
hi
ch
 
en
su
re
s 
th
at
 p
ol
ic
y 
m
ak
er
s 
an
d 
he
al
th
ca
re
 p
ro
fe
ss
io
na
ls
 
he
ar
 a
bo
ut
 th
e 
re
se
ar
ch
. 
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Th
an
k 
yo
u 
fo
r b
ei
ng
 in
vo
lv
ed
 in
 th
e 
‘Y
ou
 a
nd
 y
ou
r j
oi
nt
 
re
pl
ac
em
en
t’ 
st
ud
y.
 Y
ou
 w
er
e 
on
e 
of
 3
4 
pe
op
le
 w
ho
 k
in
dl
y 
ga
ve
 u
p 
th
ei
r t
im
e 
to
 ta
ke
 p
ar
t. 
 
 
B
A
C
K
G
R
O
U
N
D
 
 
Th
e 
ai
m
 o
f t
he
 ‘Y
ou
 a
nd
 y
ou
r j
oi
nt
 re
pl
ac
em
en
t’ 
st
ud
y 
w
as
 
to
 le
ar
n 
m
or
e 
ab
ou
t p
eo
pl
e’
s 
ex
pe
rie
nc
es
 a
nd
 ‘j
ou
rn
ey
s’
 
th
ro
ug
h 
hi
p 
or
 k
ne
e 
re
pl
ac
em
en
t s
ur
ge
ry
. 
 Th
e 
st
ud
y 
is
 o
ne
 p
ar
t o
f t
he
 R
E
S
TO
R
E
 R
es
ea
rc
h 
P
ro
gr
am
m
e.
 T
he
 p
ro
gr
am
m
e 
is
 m
ad
e 
up
 o
f s
ev
er
al
 
re
se
ar
ch
 p
ro
je
ct
s 
fo
cu
si
ng
 o
n 
im
pr
ov
in
g 
pa
tie
nt
 
ex
pe
rie
nc
es
 o
f j
oi
nt
 re
pl
ac
em
en
t s
ur
ge
ry
. 
 
ST
U
D
Y 
D
ES
IG
N
  
 Ta
ki
ng
 p
ar
t i
n 
th
is
 s
tu
dy
 in
vo
lv
ed
 y
ou
 m
ee
tin
g 
w
ith
 E
m
m
a 
Jo
hn
so
n 
be
fo
re
 y
ou
 h
ad
 y
ou
r j
oi
nt
 re
pl
ac
em
en
t s
ur
ge
ry
. 
E
m
m
a 
as
ke
d 
yo
u 
qu
es
tio
ns
 a
bo
ut
 y
ou
r h
is
to
ry
 o
f j
oi
nt
 
pr
ob
le
m
s,
 e
xp
er
ie
nc
es
 o
f p
ai
n 
an
d 
yo
ur
 th
ou
gh
ts
 a
bo
ut
 th
e 
op
er
at
io
n.
 A
 m
em
be
r o
f t
he
 re
se
ar
ch
 te
am
 a
ls
o 
ai
m
ed
 to
 
ta
lk
 to
 y
ou
 a
ga
in
 2
-4
 w
ee
ks
, 6
 m
on
th
s 
an
d 
12
 m
on
th
s 
af
te
r 
th
e 
op
er
at
io
n 
to
 le
ar
n 
ab
ou
t y
ou
r r
ec
ov
er
y 
fro
m
 s
ur
ge
ry
.   
  A
ll 
in
te
rv
ie
w
s 
w
er
e 
au
di
o 
re
co
rd
ed
. T
he
se
 re
co
rd
in
gs
 w
er
e 
th
en
 ty
pe
d 
up
. W
e 
th
en
 lo
ok
ed
 a
t t
he
m
 to
 fi
nd
 a
ny
 
si
m
ila
rit
ie
s 
an
d 
di
ffe
re
nc
es
 in
 p
eo
pl
e’
s 
ex
pe
rie
nc
es
. 
FI
N
D
IN
G
S 
 M
an
y 
of
 y
ou
 to
ld
 u
s 
th
at
 y
ou
 h
ad
 to
 w
ai
t a
 lo
ng
 ti
m
e 
to
 
ha
ve
 y
ou
r o
pe
ra
tio
n.
 It
 w
as
 a
ls
o 
a 
co
m
m
on
 e
xp
er
ie
nc
e 
to
 
le
ar
n 
th
at
 y
ou
r o
pe
ra
tio
n 
ha
d 
be
en
 c
an
ce
lle
d 
or
 d
el
ay
ed
. 
W
e 
ha
ve
 b
ee
n 
in
te
re
st
ed
 in
 s
tu
dy
in
g 
th
e 
im
pa
ct
 th
at
 th
is
 
ha
d 
on
 y
ou
 a
nd
 th
e 
po
te
nt
ia
l w
ay
s 
to
 li
m
it 
th
is
 fo
r o
th
er
 
pa
tie
nt
s 
in
 th
e 
fu
tu
re
. 
 W
e 
w
er
e 
ab
le
 to
 le
ar
n 
a 
gr
ea
t d
ea
l a
bo
ut
 th
e 
su
pp
or
t t
ha
t 
yo
u 
re
ce
iv
ed
 fr
om
 h
ea
lth
 p
ro
fe
ss
io
na
ls
 b
ef
or
e,
 d
ur
in
g 
an
d 
af
te
r j
oi
nt
 re
pl
ac
em
en
t. 
Y
ou
 a
ls
o 
ga
ve
 u
s 
us
ef
ul
 
su
gg
es
tio
ns
 a
bo
ut
 in
pu
t t
ha
t y
ou
 fe
lt 
w
as
 m
is
si
ng
. T
hi
s 
in
fo
rm
at
io
n 
w
ill
 b
e 
us
ef
ul
 in
 h
el
pi
ng
 to
 im
pr
ov
e 
th
e 
su
pp
or
t 
pr
ov
id
ed
 to
 o
th
er
s 
ha
vi
ng
 jo
in
t r
ep
la
ce
m
en
t. 
   Th
e 
st
ud
y 
te
am
 is
 n
ow
 lo
ok
in
g 
in
 m
or
e 
de
ta
il 
at
 th
e 
in
fo
rm
at
io
n.
 F
in
di
ng
s 
w
ill
 b
e 
pu
bl
ic
al
ly
 a
va
ila
bl
e 
in
 th
e 
ne
xt
 
tw
o 
ye
ar
s 
th
ro
ug
h 
ou
r w
eb
si
te
 (p
le
as
e 
se
e 
ov
er
le
af
). 
 
W
H
A
T’
S 
N
EX
T?
 
 W
e 
w
ou
ld
 li
ke
 to
 th
an
k 
yo
u 
ag
ai
n 
fo
r t
ak
in
g 
pa
rt.
 T
he
 
re
se
ar
ch
 th
at
 is
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